Publications

Publications

This is a complete list of publications from all our faculty members. Publications by individual members can be found on their faculty pages. Aslo see, a full list of Epidemiology and Biostatistics Working Paper.

Abbi K, Zheng J, Devlin SM, Giralt S, Landau H. Second Autologous Stem Cell Transplant: An Effective Therapy for Relapsed Multiple Myeloma. Biol Blood Marrow Transplant. 2014 Dec 18. [Epub ahead of print]

Abou-Alfa GK, Capanu M, O’Reilly EM, Ma J, Chou JF, Gansukh B, Shia J, Kalin M, Katz S, Abad L, Reidy-Lagunes DL, Kelsen DP, Chen HX, Saltz LB. A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma. J Hepatol. 2014 Feb;60(2):319-24.

Agrawal N,Schultz, N, et al. The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Papillary Thyroid Carcinoma. Cell. 2014 Oct 23;159(3):676-90.

Ahles TA, Li Y, McDonald BC, Schwartz GN, Kaufman PA, Tsongalis GJ, Moore JH, Saykin AJ. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking. Psychooncology. 2014 Dec;23(12):1382-90.

Ahmed HU, Berge V, Bottomley D, Cross W, Heer R, Kaplan R, Leslie T, Parker C, Relton C, Stephens R, Sydes MR, Turnbull L, van der Meulen J, Vickers A, Wilt T, Emberton M; Prostate Cancer RCT Consensus Group. Can we deliver randomized trials of focal therapy in prostate cancer? Nat Rev Clin Oncol. 2014 Aug;11(8):482-91.

Aksoy BA, Demir E, Babur Ö, Wang W, Jing X, Schultz N, Sander C. Prediction of individualized therapeutic vulnerabilities in cancer from genomic profiles. Bioinformatics. 2014 Jul 15;30(14):2051-9.

Al-Ahmadie H, Iyer G and other authors including Taylor BS and Shultz N. Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy. Cancer Discov. 2014 Sep;4(9):1014-21.

Al-Ahmadie H, Iyer G, Hohl M, Asthana S, Inagaki A, Schultz N, Hanrahan AJ, Scott SN, Brannon AR, McDermott GC, Pirun M, Ostrovnaya I, Kim P, Socci ND, Viale A, Schwartz GK, Reuter V, Bochner BH, Rosenberg JE, Bajorin DF, Berger MF, Petrini JH, Solit DB, Taylor BS. Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy. Cancer Discov. 2014 Sep;4(9):1014-21.

Allen PJ, Gönen M, Brennan MF, Bucknor AA, Robinson LM, Pappas MM, Carlucci KE, D’Angelica MI, DeMatteo RP, Kingham TP, Fong Y, Jarnagin WR. Pasireotide for postoperative pancreatic fistula. N Engl J Med. 2014 May 22;370(21):2014-22.

Almendro V, Cheng YK, Randles A, Itzkovitz S, Marusyk A, Ametller E, Gonzalez-Farre X, Muñoz M, Russnes HG, Helland A, Rye IH, Borresen-Dale AL, Maruyama R, van Oudenaarden A, Dowsett M, Jones RL, Reis-Filho J, Gascon P, Gönen M, Michor F, Polyak K. Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity. Cell Rep. 2014 Feb 13;6(3):514-27. PMID: 24462293

Almendro V, Kim HJ, Cheng YK, Gönen M, Itzkovitz S, Argani P, van Oudenaarden A, Sukumar S, Michor F, Polyak K. Genetic and phenotypic diversity in breast tumor metastases. Cancer Res. 2014 Mar 1;74(5):1338-48.

Amankulor NM, Xu R, Iorgulescu JB, Chapman T, Reiner AS, Riedel E, Lis E, Yamada Y,

Bilsky M, Laufer I.The incidence and patterns of hardware failure after separation surgery in patients with spinal metastatic tumors. Spine J. 2014 Sep1;14(9):1850-9.

Amar D, Park B, Zhang H, Shi W, Fleisher M, Thaler, HT, Rusch, V. Beneficial Effects of Perioperative Statins for Major Pulmonary Resection. J Thorac Cardiovasc Surg. 2014 Dec 18.  [Epub ahead of print]

Amiri L, Cassidy-Bushrow AE, Dakki H, Li J, Wells K, Oliveria SA, Yood MU, Thomas A, Lanfear DE. Patient characteristics and participation in a genetic study: a type 2 diabetes cohort. J Investig Med. 2014 Jan;62(1):26-32.

Anderson, CB,  Elkin EB Baxi SS, Atoria CL, Eastham JA, Scardino PT, Touijer K.  The diffusion of minimally invasive radical prostatectomy in the United States: a case study of the introduction of new surgical devices. Prostate Cancer Prostatic Dis. 2014 Dec 16. [Epub ahead of print]

Andersson U, Wibom C, Cederquist K, Aradottir S, Borg A, Armstrong GN, Shete S, Lau CC, Bainbridge MN, Claus EB, Barnholtz-Sloan J, Lai R, Il’yasova D, Houlston RS, Schildkraut J, Bernstein JL, Olson SH, Jenkins RB, Lachance DH, Wrensch M, Davis FG, Merrell R, et al. Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer. Neuro Oncol. 2014 Oct;16(10):1333-40.

Andrade VP, Morrogh M, Qin LX, Olvera N, Giri D, Muhsen S, Sakr RA, Schizas M, Ng CK, Arroyo CD, Brogi E, Viale A, Morrow M, Reis-Filho JS, King TA. Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion. Mol Oncol. 2014 Dec 24.

Ankerst DP, Boeck A, Freedland SJ, Jones JS, Cronin AM, Roobol MJ, Hugosson J, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Moreira DM, Schröder FH, Lilja H, Vickers AJ, et al. Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. World J Urol. 2014 Feb;32(1):185-91.

Ankerst DP, Hoefler J, Bock S, Goodman PJ, Vickers A, Hernandez J, Sokoll LJ, Sanda MG, Wei JT, Leach RJ, Thompson IM. Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer. Urology. 2014 Jun;83(6):1362-7.

Antoniou AC, Casadei S and other authors including Bernstein J. Breast-cancer risk in families with mutations in PALB2. N Engl J Med. 2014 Aug 7;371(6):497-506.

Araujo RL, Karkar AM, Allen PJ, Gönen M, Chou JF, Brennan MF, Blumgart LH, D’Angelica MI, DeMatteo RP, Coit DG, Fong Y, Jarnagin WR. Timing of elective surgery as a perioperative outcome variable: analysis of pancreaticoduodenectomy. HPB (Oxford). 2014 Mar;16(3):250-62.

Asmussen J, Lasater EA, Tajon C, Oses-Prieto J, Jun YW, Taylor BS, Burlingame A, Craik CS, Shah NP. MEK-dependent negative feedback underlies BCR-ABL-mediated oncogene addiction. Cancer Discov. 2014 Feb;4(2):200-15.

Babur Ö, Dogrusoz U, Çakır M, Aksoy BA, Schultz N, Sander C, Demir E. Integrating

biological pathways and genomic profiles with ChiBE 2 .BMC Genomics. 2014 Aug

3;15:642.

Bach P, Knerr L, Fjellström O, Hansson K, Mattsson C, Gustafsson D. Design, synthesis, and SAR of a series of activated protein C (APC) inhibitors with selectivity against thrombin for the treatment of haemophilia. Bioorg Med Chem Lett. 2014 Feb 1;24(3):821-7.

Bach PB. Indication-specific pricing for cancer drugs. JAMA. 2014 Oct 22-29;312(16):1629-30.

Bach PB. Raising the bar for the U.S. Preventive Services Task Force. Ann Intern Med. 2014 Mar 4;160(5):365-6.

Bainbridge MN, Armstrong GN and other authors including Bernstein J and Olson SH. Germline mutations in shelterin complex genes are associated with familial glioma. J Natl Cancer Inst. 2014 Dec 7;107(1).

Baker SG, Schuit E, Steyerberg EW, Pencina MJ, Vickers A, Moons KG, Mol BW, Lindeman KS. How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes through. Statistics in medicine. 2014 Sep 28;33(22):3946-59

Bamboat ZM, Tang LH, Vinuela E, Kuk D, Gonen M, Shah MA, Brennan MF, Coit DG, Strong VE. Stage-stratified prognosis of signet ring cell histology in patients undergoing curative resection for gastric adenocarcinoma. Ann Surg Oncol. 2014 May;21(5):1678-85.

Bancroft EK, Page EC, Castro E, Lilja H, Vickers A, Sjoberg D, Assel M, Foster CS, Mitchell G, Drew K, Mæhle L, Axcrona K, Evans DG, Bulman B, Eccles D, McBride D, van Asperen C, Vasen H, Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, et al. Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study. Eur Urol. 2014 Sep;66(3):489-99.

Baranski M, Gopikrishna G, Robinson NA, Katneni VK, Shekhar MS, Shanmugakarthik J, Jothivel S, Gopal C, Ravichandran P, Kent M, Arnyasi M, Ponniah AG. The development of a high density linkage map for black tiger shrimp (Penaeus monodon) based on cSNPs. PLoS One. 2014;9(1):e85413.

Barlin JN, Zhou Q, Leitao MM, Bisogna M, Olvera N, Shih KK, Jacobsen A, Schultz N, Tap WD, Hensley ML, Schwartz GK, Boyd J, Qin LX, Levine DA. Molecular subtypes of uterine leiomyosarcoma and correlation with clinical outcome. Neoplasia. (In press.)

Basch E, Autio KA, Smith MR, Bennett AV, Weitzman AL, Scheffold C, Sweeney C, Rathkopf DE, Smith DC, George DJ, Higano CS, Harzstark AL, Sartor AO, Gordon MS, Vogelzang NJ, de Bono JS, Haas NB, Corn PG, Schimmoller F, Scher HI. Effects of Cabozantinib on Pain and Narcotic Use in Patients with Castration-resistant Prostate Cancer: Results from a Phase 2 Nonrandomized Expansion Cohort. Eur Urol. 2014 Feb 20. PMID: 24631409

Basch E, Bennett AV. Patient-reported outcomes in clinical trials of rare diseases. J Gen Intern Med. 2014 Aug;29 Suppl 3:S801-3. PMID: 25029974, PMCID: PMC4124120

Basch E, Loblaw DA, Oliver TK, Carducci M, Chen RC, Frame JN, Garrels K, Hotte S, Kattan MW, Raghavan D, Saad F, Taplin ME, Walker-Dilks C, Williams J, Winquist E, Bennett CL, Wootton T, Rumble RB, Dusetzina SB, Virgo KS. Systemic therapy in men with metastatic castration-resistant prostate cancer: American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline. J Clin Oncol. 2014 Oct 20;32(30):3436-48. PMID: 25199761

Basch E, Loblaw DA, Rumble RB. Systemic therapy in men with metastatic castration-resistant prostate cancer: American society of clinical oncology and cancer care Ontario clinical practice guideline summary. J Oncol Pract. 2014 Nov;10(6):e418-20. PMID: 25398964

Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP, Bruner DW, Cleeland CS, Sloan JA, Chilukuri R, Baumgartner P, Denicoff A, St Germain D, O’Mara AM, Chen A, Kelaghan J, Bennett AV, Sit L, et al. Development of the National Cancer Institute’s patient-reported  outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014 Sep 29;106(9).

Basch E, Snyder C, McNiff K, Brown R, Maddux S, Smith ML, Atkinson TM, Howell D, Chiang A, Wood W, Levitan N, Wu AW, Krzyzanowska M. Patient-reported outcome performance measures in oncology. J Oncol Pract. 2014 May;10(3):209-11. PMID: 24756142

Basch E, Trentacosti AM, Burke LB, Kwitkowski V, Kane RC, Autio KA, Papadopoulos E, Stansbury JP, Kluetz PG, Smith H, Justice R, Pazdur R. Pain palliation measurement in cancer clinical trials: the US Food and Drug Administration perspective. Cancer. 2014 Mar 1;120(5):761-7. PMID: 24375398

Basch E. New frontiers in patient-reported outcomes: adverse event reporting, comparative effectiveness, and quality assessment. Annu Rev Med. 2014;65:307-17. PMID: 24274179

Basch E. The rationale for collecting patient-reported symptoms during routine chemotherapy. Am Soc Clin Oncol Educ Book. 2014:161-5. PMID: 24857073

Bass AJ,Schultz, N, et al. The Cancer Genome Atlas Research Network. Comprehensive Molecular Characterization of Gastric Adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.

Bastos DA, Molina AM, Hatzoglou V, Jia X, Velasco S, Patil S, Voss MH, Feldman DR, Motzer RJ. Safety and Efficacy of Targeted Therapy for Renal Cell Carcinoma With Brain Metastasis. Clin Genitourin Cancer. 2014 Jun 8. PMID: 25023939

Baxi SS, O’Neill C, Sherman EJ, Atoria CL, Lee NY, Pfister DG, Elkin EB. Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximab. Head Neck. 2014 Dec 22. [Epub ahead of print]

Baxi SS, Pinheiro LC, Patil SM, Pfister DG, Oeffinger KC, Elkin EB. Causes of death in long-term survivors of head and neck cancer. Cancer. 2014 May 15;120(10):1507-13.

Bazzi WM, Sjoberg DD, Feuerstein MA, Maschino A, Verma S, Bernstein M, O’Brien MF, Jang T, Lowrance W, Motzer RJ, Russo P. Long-Term Survival Rates after Resection for Locally Advanced Kidney Cancer: Memorial Sloan Kettering Cancer Center 1989-2012 Experience. The Journal of urology. 2014 Dec 15.

Begg CB, Seshan VE, Zabor EC, Furberg H, Arora A, Shen R, Maranchie JK, Nielsen ME, Rathmell WK, Signoretti S, Tamboli P, Karam JA, Choueiri TK, Hakimi AA, Hsieh JJ. Genomic investigation of etiologic heterogeneity: methodologic challenges. BMC Med Res Methodol. 2014 Dec 22;14:138.

Begg CB, Kim K, Neaton JD.”Right to Try” laws. Clin Trials. 2014 Oct;11(5):519-20.

Begg CB. Editorial transition. Clin Trials. 2014 Feb;11(1):5-6.

Berwick M, MacArthur J, Orlow I, Kanetsky P, Begg CB, Luo L, Reiner A, Sharma A, Armstrong BK, Kricker A, Cust AE, Marrett LD, Gruber SB, Anton-Culver H, Zanetti R, Rosso S, Gallagher RP, Dwyer T, Venn A, Busam K, From L, White K, et al. MITF E318K’s effect on melanoma risk independent of, but modified by, other risk factors. Pigment Cell Melanoma Res. 2014 May;27(3):485-8.

Berwick M, Reiner AS, Paine S, Armstrong BK, Kricker A, Goumas C, Cust AE, Thomas NE, Groben PA, From L, Busam K, Orlow I, Marrett LD, Gallagher RP, Gruber SB, Anton-Culver H, Rosso S, Zanetti R, Kanetsky PA, Dwyer T, Venn A, Lee-Taylor J, Begg CB on behalf of the GEM Study Group. Sun exposure and melanoma survival: a GEM study. Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2145-52.

Bjurlin M, Elkin EB, Huang WC. Re: Maxine Sun, Andreas Becker, Zhe Tian, et al. Management of Localized Kidney Cancer: Calculating Cancer-specific Mortality and Competing Risks of Death for Surgery and Nonsurgical Management. Eur Urol 2014;65:235-41.Eur Urol. 2014 Aug 29.

Blinder, V, Helzer E, Zayas V, Breibart W. Cognitive bias modification for fear of breast cancer recurrence: The promise of aim-fbcr. Annals of behavioral medicine. 2014 Apr 1. (0883-6612), 47 (suppl.1), p. S99.

Block MS, Charbonneau B and other authors including Olson SH, Orlow I and Pike MC. Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1421-7.

Bochner BH, Dalbagni G, Sjoberg DD, Silberstein J, Keren Paz GE, Donat SM, Coleman JA, Mathew S, Vickers A, Schnorr GC, Feuerstein MA, Rapkin B, Parra RO, Herr HW, Laudone VP. Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial. Eur Urol. 2014 Dec 8. [Epub ahead of print]

Bochner BH, Sjoberg DD, Laudone VP; Memorial Sloan Kettering Cancer Center Bladder Cancer Surgical Trials Group (Vickers A, Member). A randomized trial of robot-assisted laparoscopic radical cystectomy. N Engl J Med. 2014 Jul 24;371(4):389-90.

Bogaerts J, Sydes MR, Keat N, McConnell A, Benson A, Ho A, Roth A, Fortpied C, Eng C, Peckitt C, Coens C, Pettaway C, Arnold D, Hall E, Marshall E, Sclafani F, Hatcher H, Earl H, Ray-Coquard I, Paul J, Blay JY, Whelan J, Panageas K, Wheatley K, Harrington K, Licitra L, Billingham L, Hensley M, McCabe M, Patel PM, Carvajal R, Wilson R, Glynne-Jones R, McWilliams R, Leyvraz S, Rao S, Nicholson S, Filiaci V, Negrouk A, Lacombe D, Dupont E, Pauporté I, Welch JJ, Law K, Trimble T, Seymour M. Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative. Eur J Cancer. 2014 Dec 23. [Epub ahead of print]

Bokacheva L, Kaplan JB, Giri DD, Patil S, Gnanasigamani M, Nyman CG, Deasy JO, Morris EA, Thakur SB. Intravoxel incoherent motion diffusion-weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchyma. J Magn Reson Imaging. 2014 Oct;40(4):813-23.

Bommeljé CC, Weeda VB, Huang G, Shah K, Bains S, Buss E, Shaha M, Gönen M, Ghossein R, Ramanathan SY, Singh B. Neddylation E3 activity and nuclear localization. Clin Cancer Res. 2014 Jan 15;20(2):372-81.

Borderud SP, Li Y, Burkhalter JE, Sheffer CE, Ostroff JS. Electronic cigarette use among patients with cancer: Characteristics of electronic cigarette users and their smoking cessation outcomes. Cancer. 2014 Nov 15;120(22):3527-35.

Boulad F, Wang X, Qu J, Taylor C, Ferro L, Karponi G, Bartido S, Giardina P, Heller G, Prockop SE, Maggio A, Sadelain M, Rivière I. Safe mobilization of CD34+ cells in adults with ?-thalassemia and validation of effective globin gene transfer for clinical investigation. Blood. 2014 Mar 6;123(10):1483-6.

Braun K, Ahallal Y, Sjoberg DD, Ghoneim T, Dominguez Esteban M, Mulhall J, Vickers A, Eastham J, Scardino PT, Touijer KA. Effect of repeated prostate biopsies on erectile function in men on active surveillance for prostate cancer. J Urol. 2014 Mar;191(3):744-9.

Brennan C, Yang TJ, Hilden P, Zhang Z, Chan K, Yamada Y, Chan TA, Lymberis SC, Narayana A, Tabar V, Gutin PH, Ballangrud Å, Lis E, Beal K. A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases. Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):130-6. PMID: 24331659

Brinton LA, Cook MB and other authors including Pike MC. Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results. J Natl Cancer Inst. 2014 Mar;106(3):djt465.

Brockman JA, Alanee S, Vickers AJ, Scardino PT, Wood DP, Kibel AS, Lin DW, Bianco Jr FJ, Rabah DM, Klein EA, Ciezki JP, Gao T, Kattan MW, Stephenson AJ. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy. Eur Urol. 2014 Oct 6.

Burger IA, Vargas HA, Apte A, Beattie BJ, Humm JL, Gonen M, Larson SM, Ross Schmidtlein C. PET quantification with a histogram derived total activity metric: superior quantitative consistency compared to total lesion glycolysis with absolute or relative SUV thresholds in phantoms and lung cancer patients. Nucl Med Biol. 2014 May-Jun;41(5):410-8.

Burger IA, Vargas HA, Beattie BJ, Goldman DA, Zheng J, Larson SM, Humm JL, Schmidtlein CR. How to assess background activity: introducing a histogram-based analysis as a first step for accurate one-step PET quantification. Nucl Med Commun. 2014 Mar;35(3):316-24.

Butte JM, Kingham TP, Gönen M, D’Angelica MI, Allen PJ, Fong Y, DeMatteo RP, Jarnagin WR. Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer. J Am Coll Surg. 2014 Sep;219(3):416-29.

Cancer Genome Atlas Research Network (Seshan VE and Shen R, Members). Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.

Cancer Genome Atlas Research Network (Shen R, Member). Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.

Cancer Genome Atlas Research Network (Shultz N and Taylor BS, Members). Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.

Cancer Genome Atlas Research Network (Shen R, Shultz N and Taylor BS, Members). Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.

Cancer Genome Atlas Research Network (Shultz N and Taylor BS, Members). Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.

Cancer Genome Atlas Research Network. Cancer Genome Atlas Research Network (Shen R, Shultz N and Taylor BS, Members). Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014 Oct 23;159(3):676-90.

Capanu M, Seshan VE. False Discovery Rates for Rare Variants From Sequenced Data. Genet Epidemiol. 2014 Dec 30. [Epub ahead of print]

Carlsson S, Assel M, Sjoberg D, Ulmert D, Hugosson J, Lilja H, Vickers A. Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study. BMJ. 2014 Mar 28;348:g2296.

Carlsson S, Berglund A, Sjoberg D, Khatami A, Stranne J, Bergdahl S, Lodding P, Aus G, Vickers A, Hugosson J. Effects of surgeon variability on oncologic and functional outcomes in a population-based setting. BMC Urol. 2014 Mar 6;14:25.

Carroll PR, Parsons JK and other authors including Vickers AJ. Prostate cancer early detection, version 1. 2014. Featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2014 Sep;12(9):1211-9; quiz 1219.

Carroll PR, Vickers AJ. Point/Counterpoint: early detection of prostate cancer: do the benefits outweigh the consequences? J Natl Compr Canc Netw. 2014 May;12(5 Suppl):768-71.

Carter J, Stabile C, Seidel B, Baser R, Gunn A, Chi S, Steed R, Goldfarb S, Goldfrank D. Baseline Characteristics and Concerns of Female Cancer Patients/ Survivors Seeking Treatment at a Female Sexual Medicine Program. Support Care Cancer. 2015 Jan 8. [Epub ahead of print]

Carter J, Goldfarb S, Sonoda Y, Nelson C, Dickler M and Mulhall J. Sexuality and Fertility. American Cancer Society Textbook of Cancer. Ted Gansler. John Wiley & Sons. Inc.: 2014

Carvajal RD, Sosman JA, Quevedo JF, Milhem MM, Joshua AM, Kudchadkar RR, Linette GP, Gajewski TF, Lutzky J, Lawson DH, Lao CD, Flynn PJ, Albertini MR, Sato T, Lewis K, Doyle A, Ancell K, Panageas KS, Bluth M, Hedvat C, Erinjeri J, Ambrosini G, et al. Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial. JAMA. 2014 Jun 18;311(23):2397-405.

Carver BS, Taylor BS, Wanjala J, Chapinski C, Hieronymus H, Wongvipat J, Chen Y, Schultz N, Xie Y, Liu S, Lu W, Yang Q, Sander C, Chen Z, Sawyers CL. MET amplification in advance stage murine and human prostate cancer. Mol Can. Ther. (In press).

Casey DL, Friedman DN, Moskowitz CS, Hilden PD, Sklar CA, Wexler LH, Wolden SL. Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy (IMRT). Pediatr Blood Cancer. 2014 Oct 18.

Catsburg CE, Gago-Dominguez M, Yuan JM, Castelao JE, Cortessis VK, Pike MC, Stern MC. Dietary sources of N-nitroso compounds and bladder cancer risk: findings from the Los Angeles bladder cancer study. Int J Cancer. 2014 Jan 1;134(1):125-35.

Catto JW, Cooperberg MR, Cornu JN, Gratzke C, Novara G, Shariat SF, Vickers A. European Urology: Serving Our Readership Through Systematic Peer Review, Use of Reporting Standards, and Encouragement of Postpublication Review. Eur Urol. 2014 Aug 27.

Ceberio I, Devlin SM, Sauter C, Barker JN, Castro-Malaspina H, Giralt S, Ponce DM, Lechner L, Maloy MA, Goldberg JD, Perales MA. Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant. Leuk Lymphoma. 2014 Aug 6:1-8.

Cercek A, D’Angelica M, Power D, Capanu M, Gewirtz A, Patel D, Allen P, Fong Y, DeMatteo RP, Jarnagin WR, Kemeny NE. Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab. Ann Surg Oncol. 2014 Feb;21(2):479-86.

Cercek A, Shia J, Gollub M, Chou JF, Capanu M, Raasch P, Reidy-Lagunes D, Proia DA, Vakiani E, Solit DB, Saltz LB. Ganetespib, a Novel Hsp90 Inhibitor in Patients With KRAS Mutated and Wild Type, Refractory Metastatic Colorectal Cancer. Clin Colorectal Cancer. 2014 Dec;13(4):207-12.

Chan AW, Song F, Vickers A, Jefferson T, Dickersin K, Gøtzsche PC, Krumholz HM, Ghersi D, van der Worp HB. Increasing value and reducing waste: addressing inaccessible research. Lancet. 2014 Jan 18;383(9913):257-66.

Charbonneau B, Block MS and other authors including Orlow I, Olson SH and Pike MC. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Res. 2014 Feb 1;74(3):852-61.

Charbonneau B, Moysich KB and other authors including Olson SH, Orlow, I and Pike MC. Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome. Cancer Immunol Res. 2014 Apr;2(4):332-40.

Chen C, Liu Y, Rappaport AR, Kitzing T, Schultz N, Zhao Z, Shroff AS, Dickins RA, Vakoc CR, Bradner JE, Stock W, LeBeau MM, Shannon KM, Kogan S, Zuber J, Lowe SW. MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia. Cancer Cell. 2014 May 12;25(5):652-65.

Chen MM, Crous-Bou M, Setiawan VW, Prescott J, Olson SH, Wentzensen N, Black A, Brinton L, Chen C, Chen C, Cook LS, Doherty J, Friedenreich CM, Hankinson SE, Hartge P, Henderson BE, Hunter DJ, Le Marchand L, Liang X, Lissowska J, Lu L, Orlow I, et al. Exome-wide association study of endometrial cancer in a multiethnic population. PLoS One. 2014;9(5):e97045.

Cheung IY, Farazi TA, Ostrovnaya I, Xu H, Tran H, Mihailovic A, Tuschl T, Cheung NK. Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis. Genes Chromosomes Cancer. 2014 Oct;53(10):803-14.

Cheung NK, Cheung IY, Kramer K, Modak S, Kuk D, Pandit-Taskar N, Chamberlain E, Ostrovnaya I, Kushner BH. Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma. Int J Cancer. 2014 Nov 1;135(9):2199-205.

Cheung NK, Modak S, Ostrovnaya I, Roberts SS, Basu EM, Kramer K, Kushner BH. When  Overall Survival Fails to Confirm Event-Free Survival, Should the Latter Be Used to Set the Standard of Care? J Clin Oncol. 2014 Nov 17.

Collisson EA,Schultz, N, et al. The Cancer Genome Atlas Research Network. Comprehensive Molecular Profiling of Lung Adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.

Conti RM, Bach PB. Improving outpatient oncology practice: several steps into a long journey. J Oncol Pract. 2014 Nov;10(6):355-6.

Conti RM, Bach PB. The 340B drug discount program: hospitals generate profits by expanding to reach more affluent communities. Health Aff (Millwood). 2014 Oct;33(10):1786-92.

Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK, Doubeni CA, Zauber AG, de Boer J, Fireman BH, Schottinger JE, Quinn VP, Ghai NR, Levin TR, Quesenberry CP. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014 Apr 3;370(14):1298-306.

Corral R, Lewinger JP, Van Den Berg D, Joshi AD, Yuan JM, Gago-Dominguez M, Cortessis VK, Pike MC, Conti DV, Thomas DC, Edlund CK, Gao YT, Xiang YB, Zhang W, Su YC, Stern MC. Comprehensive analyses of DNA repair pathways, smoking and bladder cancer risk in Los Angeles and Shanghai. Int J Cancer. 2014 Jul 15;135(2):335-47.

Correa DD, Satagopan J, Baser RE, Cheung K, Richards E, Lin M, Karimi S, Lyo J, DeAngelis LM, Orlow I. APOE polymorphisms and cognitive functions in patients with brain tumors. Neurology. 2014 Jul 22;83(4):320-7.

Correa-Gallego C, Fong Y, Gonen M, D’Angelica MI, Allen PJ, DeMatteo RP, Jarnagin WR, Kingham TP. A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases. Ann Surg Oncol. 2014 Dec;21(13):4278-83.

Costas Muniz, R.; Ramirez, J. M.; Aragones, A.; Leng, J. C.; Kung, A.; Blinder, V. S.; Gany, F. M. “Indicators of poverty after a cancer diagnosis in a multiethnic sample”(04/01/2014). “Indicators of poverty after a cancer diagnosis in a multiethnic sample”. Annals of behavioral medicine(0883-6612), 47 (suppl.1), p. S96.

Cryan JB, Haidar S, Ramkissoon LA, Bi WL, Knoff DS, Schultz N, Abedalthagafi M, Brown L, Wen PY, Reardon DA, Dunn IF, Folkerth RD, Santagata S, Lindeman NI, Ligon AH, Beroukhim R, Hornick JL, Alexander BM, Ligon KL, Ramkissoon SH. Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from  astrocytic and mixed lineage gliomas. Oncotarget. 2014 Sep 30;5(18):8083-92.

D’Agostino-McGowan L, Gennarelli RL, Lyons SA, Goodman MS. Using small-area analysis to estimate county-level racial disparities in obesity demonstrating the necessity of targeted interventions. Int J Environ Res Public Health. 2013 Dec 27;11(1):418-28.

D’Angelo SP, Shoushtari AN, Agaram NP, Kuk D, Qin LX, Carvajal RD, Dickson MA, Gounder M, Keohan ML, Schwartz GK, Tap WD. Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment. Hum Pathol. 2014 Nov 15. [Epub ahead of print]

Dahi PB, Barone J, Devlin SM, Byam C, Lubin M, Ponce DM, Giralt S, Kernan NA, Scaradavou A, Hsu SH, Barker JN. Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodies. Biol Blood Marrow Transplant. 2014 May;20(5):735-9.

Dahi PB, Perales MA, Devlin SM, Olson A, Lubin M, Gonzales AM, Scaradavou A, Kernan NA, O’Reilly RJ, Giralt S, Jakubowski A, Koehne G, Papadopoulos EB, Ponce  DM, Sauter C, Papanicolaou G, Barker JN. Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant. Leuk Lymphoma. 2014 Oct 21:1-7.

Dahi PB, Ponce DM, Devlin S, Evans KL, Lubin MN, Gonzales AM, Tonon J, Meagher R, Giralt S, Kernan NA, Scaradavou A, Barker JN. “No wash” albumin-dextran dilution for double-unit cord blood transplantation is safe with high rates of sustained donor engraftment. Biol Blood Marrow Transplant. 2014 Apr;20(4):490-4.

Dahi PB, Tamari R, Devlin SM, Maloy M, Bhatt V, Scordo M, Goldberg J, Zelenetz AD, Hamlin PA, Matasar MJ, Maragulia J, Giralt SA, Perales MA, Moskowitz CH, Sauter CS. Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-hodgkin lymphoma. Biol Blood Marrow Transplant. 2014 Dec;20(12):2004-9.

Dang C, Iyengar N, Datko F, D’Andrea G, Theodoulou M, Dickler M, Goldfarb S, Lake D, Fasano J, Fornier M, Gilewski T, Modi S, Gajria D, Moynahan ME, Hamilton N, Patil S, Jochelson M, Norton L, Baselga J, Hudis C. Phase II Study of Paclitaxel Given Once per Week Along With Trastuzumab and Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer. J Clin Oncol. 2014 Dec 29. [Epub ahead of print]

Dʼangelica MI, Correa-Gallego C, Paty PB, Cercek A, Gewirtz AN, Chou JF, Capanu M, Kingham TP, Fong Y, Dematteo RP, Allen PJ, Jarnagin WR, Kemeny N. Phase II Trial of Hepatic Artery Infusional and Systemic Chemotherapy for Patients With Unresectable Hepatic Metastases From Colorectal Cancer: Conversion to Resection and Long-term Outcomes. Ann Surg. 2014 Mar 21.

Damast S, Alektiar K, Eaton A, Gerber NK, Goldfarb S, Patil S, Jia R, Leitao M, Carter J, Basch E. Comparative patient-centered outcomes (health state and adverse sexual symptoms) between adjuvant brachytherapy versus no adjuvant brachytherapy in early stage endometrial cancer. Ann Surg Oncol. 2014 Aug;21(8):2740-54.

Danila DC, Anand A, Schultz N, Heller G, Wan M, Sung CC, Dai C, Khanin R, Fleisher M, Lilja H, Scher HI. Analytic and clinical validation of a prostate cancer-enhanced messenger RNA detection assay in whole blood as a prognostic biomarker for survival. Eur Urol. 2014 Jun;65(6):1191-7.

Davila ML, Riviere I, Wang X, Bartido S, Park J, Curran K, Chung SS, Stefanski J, Borquez-Ojeda O, Olszewska M, Qu J, Wasielewska T, He Q, Fink M, Shinglot H, Youssif M, Satter M, Wang Y, Hosey J, Quintanilla H, Halton E, Bernal Y, Bouhassira DC, Arcila ME, Gonen M, Roboz GJ, Maslak P, Douer D, Frattini MG, Giralt S, Sadelain M, Brentjens R. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci Transl Med. 2014 Feb 19;6(224):224ra25.

De Vivo I, Prescott J and other authors including Olson SH and Orlow I. Genome-wide association study of endometrial cancer in E2C2. Hum Genet. 2014 Feb;133(2):211-24.

Dengel LT, Van Zee KJ, King TA, Stempel M, Cody HS, El-Tamer M, Gemignani ML, Sclafani LM, Sacchini VS, Heerdt AS, Plitas G, Junqueira M, Capko D, Patil S, Morrow M. Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy. Ann Surg Oncol. 2014 Jan;21(1):22-7.

Di Paolo PL, Vargas HA, Karlo CA, Lakhman Y, Zheng J, Moskowitz CS, Al-Ahmadie HA, Sala E, Bochner BH, Hricak H. Intradiverticular bladder cancer: CT imaging features and their association with clinical outcomes. Clin Imaging. 2014 Oct 16.

Dikken JL, Coit DG, Baser RE, Gönen M, Goodman KA, Brennan MF, Jansen EP, Boot H, van de Velde CJ, Cats A, Verheij M. Performance of a nomogram predicting disease-specific survival after an R0 resection for gastric cancer in patients receiving postoperative chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):624-9.

Do RK, Katz SS, Gollub MJ, Li J, LaFemina J, Zabor EC, Moskowitz CS, Klimstra DS, Allen PJ. Interobserver Agreement for Detection of Malignant Features of Intraductal Papillary Mucinous Neoplasms of the Pancreas on MDCT. AJR Am J Roentgenol. 2014 Nov;203(5):973-9.

Donahue TF, Bochner BH, Sfakianos JP, Kent M, Bernstein M, Hilton WM, Cha EK, Yee AM, Dalbagni G, Vargas HA. Risk factors for the development of parastomal hernia after radical cystectomy. J Urol. 2014 Jun;191(6):1708-13.

Donaldson IA, Alonzi R, Barratt D, Barret E, Berge V, Bott S, Bottomley D, Eggener S, Ehdaie B, Emberton M, Hindley R, Leslie T, Miners A, McCartan N, Moore CM, Pinto P, Polascik TJ, Simmons L, van der Meulen J, Villers A, Willis S, Ahmed HU. Focal Therapy: Patients, Interventions, and Outcomes-A Report from a Consensus Meeting. Eur Urol. 2014 Sep 30.

Donati OF, Afaq A, Vargas HA, Mazaheri Y, Zheng J, Moskowitz CS, Hricak H, Akin O. Prostate MRI: evaluating tumor volume and apparent diffusion coefficient as surrogate biomarkers for predicting tumor Gleason score. Clin Cancer Res. 2014 Jul 15;20(14):3705-11.

Donati OF, Mazaheri Y, Afaq A, Vargas HA, Zheng J, Moskowitz CS, Hricak H, Akin O. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. Radiology. 2014 Apr;271(1):143-52.

Drilon A, Sugita H, Sima CS, Zauderer M, Rudin CM, Kris MG, Rusch VW, Azzoli CG. A prospective study of tumor suppressor gene methylation as a prognostic biomarker in surgically resected stage I to IIIA non-small-cell lung cancers. J Thorac Oncol. 2014 Sep;9(9):1272-7.

Dunkel IJ, Shi W, Salvaggio K, Marr BP, Brodie SE, Gobin YP, Abramson DH. Risk factors for severe neutropenia following intra-arterial chemotherapy for intra-ocular retinoblastoma. PLoS One. 2014;9(10):e108692.

Earp MA, Kelemen LE and other authors including Olson SH, Orlow I and Pike MC. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet. 2014 May;133(5):481-97.

Ehdaie B, Atoria CL, Lowrance WT, Herr HW, Bochner BH, Donat SM, Dalbagni G, Elkin EB. Adherence to surveillance guidelines after radical cystectomy: a population-based analysis. Urol Oncol. 2014 Aug;32(6):779-84.

Ehdaie B, Eastham JA. Standardization of Patient-centered Outcomes: Less Is More. Eur Urol. 2014 Oct 14.

Ehdaie B, Furberg H, Zabor EC, Hakimi AA, Russo P. Comprehensive assessment of the impact of cigarette smoking on survival of clear cell kidney cancer. J Urol. 2014 Mar;191(3):597-602.

Ehdaie B, Scardino PT. Decade in review-prostate cancer: A decade of progress in detection and treatment. Nat Rev Urol. 2014 Oct 14.

Ehdaie B, Shariat SF, Savage C, Coleman J, Dalbagni G. Postoperative nomogram for disease recurrence and cancer-specific death for upper tract urothelial carcinoma: comparison to American Joint Committee on Cancer staging classification. Urol J. 2014 May 6;11(2):1435-41.

Ehdaie B, Sjoberg DD, Dalecki PH, Scardino PT, Eastham JA, Amar D. Association of anesthesia technique for radical prostatectomy with biochemical recurrence: a retrospective cohort study. Can J Anaesth. 2014 Dec;61(12):1068-1074.

Ehdaie B, Sylvester R, Herr HW. Reply to Donald L. Lamm and Nilay M. Gandhi’s letter to the editor re: Behfar Ehdaie, Richard Sylvester, Harry W. Herr. Maintenance bacillus Calmette-Guérin treatment of non-muscle-invasive bladder cancer: a critical evaluation of the evidence. Eur Urol 2013;64:579-85. Eur Urol. 2014 Jan;65(1):e7.

Ehdaie B, Vertosick E, Spaliviero M, Giallo-Uvino A, Taur Y, O’Sullivan M, Livingston J, Sogani P, Eastham J, Scardino P, Touijer K. The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance. J Urol. 2014 Mar;191(3):660-4.

Ellis LM, Bernstein DS, Voest EE, Berlin JD, Sargent D, Cortazar P, Garrett-Mayer E, Herbst RS, Lilenbaum RC, Sima C, Venook AP, Gonen M, Schilsky RL, Meropol NJ, Schnipper LE. American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes. J Clin Oncol. 2014 Apr 20;32(12):1277-80.

Elterman DS, Chughtai BI, Vertosick E, Maschino A, Eastham JA, Sandhu JS. Changes in pelvic organ prolapse surgery in the last decade among United States urologists. J Urol. 2014 Apr;191(4):1022-7.

Engel LS, Buckley JP, Yang G, Liao LM, Satagopan J, Calafat AM, Matthews CE, Cai Q, Ji BT, Cai H, Engel SM, Wolff MS, Rothman N, Zheng W, Xiang YB, Shu XO, Gao YT, Chow WH. Predictors and variability of repeat measurements of urinary phenols and parabens in a cohort of shanghai women and men. Environ Health Perspect. 2014 Jul;122(7):733-40.

Engel LS, Satagopan J, Sima CS, Orlow I, Mujumdar U, Coble J, Roy P, Yoo S, Sandler DP, Alavanja MC. Sun exposure, vitamin D receptor genetic variants, and risk of breast cancer in the Agricultural Health Study. Environ Health Perspect. 2014 Feb;122(2):165-71.

Epstein AS, Crosbie C, Martin SC, Egan B, Goring TN, Koo DJ, Kumar CB, Salvit C, Capanu M, Chou J, Saltz LB. 30-day-or-sooner readmissions of gastrointestinal medical oncology patients following cancer center inpatient service discharge: characteristics and preventability. Hosp Pract (1995). 2014 Dec;42(5):34-44.

Eremenco S, Coons SJ, Paty J, Coyne K, Bennett AV, McEntegart D; ISPOR PRO Mixed  Modes Task Force (Basch E, Member). PRO data collection in clinical trials using mixed modes: report of the ISPOR PRO mixed modes good research practices task force.Value Health. 2014 Jul;17(5):501 16.

Feldman DR, Iyer G, Van Alstine L, Patil S, Al-Ahmadie H, Reuter VE, Bosl GJ, Chaganti RS, Solit DB. Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors. Clin Cancer Res. 2014 Jul 15;20(14):3712-20.

Felix AS, Gaudet MM and other authors including Liang X and Olson SH. Intrauterine devices and endometrial cancer risk: A pooled analysis of the Epidemiology of Endometrial Cancer Consortium. Int J Cancer. 2014 Sep 20.

Feuerstein MA, Atoria CL, Pinheiro LC, Huang WC, Russo P, Elkin EB. Patterns of Surveillance Imaging After Nephrectomy in the Medicare Population. BJU Int. 2014 Nov 10.

Feuerstein MA, Kent M, Bazzi WM, Bernstein M, Russo P. Analysis of lymph node dissection in patients with ≥7-cm renal tumors. World J Urol. 2014 Dec;32(6):1531-6.

Feuerstein MA, Kent M, Bernstein M, Russo P. Lymph node dissection during cytoreductive nephrectomy: a retrospective analysis. Int J Urol. 2014 Sep;21(9):874-9.

Figueroa JD, Han SS and other authors including Pike MC. Genome-wide interaction study of smoking and bladder cancer risk. Carcinogenesis. 2014 Aug;35(8):1737-44.

Figueroa JD, Ye Y and other authors including Pike MC. Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet. 2014 Mar 1;23(5):1387-98.

Fizazi K, Scher HI, Miller K, Basch E, Sternberg CN, Cella D, Forer D, Hirmand M, de Bono JS. Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial.Lancet Oncol. 2014 Sep;15(10):1147-56.

Folkert MR, Singer S, Brennan MF, Kuk D, Qin LX, Kobayashi WK, Crago AM, Alektiar KM. Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity. J Clin Oncol. 2014 Oct 10;32(29):3236-41.

Fossati N, Sjoberg DD, Capitanio U, Gandaglia G, Larcher A, Nini A, Mirone V, Vickers AJ, Montorsi F, Briganti A. Extended Pelvic Lymph Node Dissection in Prostate Cancer Patients Previously Treated With Surgery for Lower Urinary Tract  Symptoms. BJU Int. 2014 Aug 28.

Francescone MA, Jochelson MS, Dershaw DD, Sung JS, Hughes MC, Zheng J, Moskowitz C, Morris EA. Low energy mammogram obtained in contrast-enhanced digital mammography (CEDM) is comparable to routine full-field digital mammography (FFDM). Eur J Radiol. 2014 Aug;83(8):1350-5.

Frank L, Basch E, Selby JV; Patient-Centered Outcomes Research Institute. The PCORI perspective on patient-centered outcomes research. JAMA. 2014 Oct 15;312(15):1513-4.

Fu YP, Kohaar I and other authors including Pike MC. The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease. Cancer Res. 2014 Oct 15;74(20):5808-18.

Furberg H, Schoenberg M. The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancer. Urol Oncol. 2014 Nov 6.

Gajan J, Tajon C, Oses-Prieto J, Lasater EA, Taylor BS, Burlingame A, Craik C, Shah NP. MEK-dependent negative feedback underlies BCR-ABL-mediated oncogene addition. Cancer Discov. 2014; 4(2): 200-15

Gao J, Ciriello G, Sander C, Schultz N. Collection, integration and analysis of cancer genomic profiles: from data to insight. Curr Opin Genet Dev. 2014 Feb;24:92-8.

Gao J, Zhang C, van Iersel M, Zhang L, Xu D, Schultz N, R Pico A. BridgeDb app: unifying identifier mapping services for Cytoscape. F1000Res. 2014;3:148.

Garg T, Pinheiro LC, Atoria CL, Donat SM, Weissman JS, Herr HW, Elkin EB. Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis. J Urol. 2014 Oct;192(4):1072-7.

Gerber NK, Yamada Y, Rimner A, Shi W, Riely GJ, Beal K, Yu HA, Chan TA, Zhang Z, Wu AJ. Erlotinib versus radiation therapy for brain metastases in patients with EGFR-mutant lung adenocarcinoma .Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):322-9. PMID: 24679729

Gerber NK, Ilson DH, Wu AJ, Janjigian YY, Kelsen DP, Zheng J, Zhang Z, Bains MS, Rizk N, Rusch VW, Goodman KA. Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma. Dis Esophagus. 2014; 27:235-41.

Gholami S, Chen CH, Lou E, Belin LJ, Fujisawa S, Longo VA, Chen NG, Gönen M, Zanzonico PB, Szalay AA, Fong Y. Vaccinia virus GLV-1h153 in combination with 131I shows increased efficiency in treating triple-negative breast cancer. FASEB J. 2014 Feb;28(2):676-82.

Gin GE, Maschino AC, Spaliviero M, Vertosick EA, Bernstein ML, Coleman JA. Comparison of perioperative outcomes of retroperitoneal and transperitoneal minimally invasive partial nephrectomy after adjusting for tumor complexity. Urology. 2014 Dec;84(6):1355-60.

Giordanetto F, Bach P, Zetterberg F, Antonsson T, Bylund R, Johansson J, Sellén M, Brown D, Hideståhl L, Berntsson P, Hovdal D, Zachrisson H, Björkman JA, van Giezen JJ. Optimization of ketone-based P2Y(12) receptor antagonists as antithrombotic agents: pharmacodynamics and receptor kinetics considerations. Bioorg Med Chem Lett. 2014 Jul 1;24(13):2963-8.

Glare P, Shariff I, Thaler HT. External validation of the number of risk factors score in a palliative care outpatient clinic at a comprehensive cancer center. J Palliat Med. 2014 Jul;17(7):797-802.

Goldfarb S, Dickler M, Patil S, Jia X, Kaplan J, Fruscione M, Sit L, Damast S, Carter C, McCabe M, Norton L, Hudis C, Basch E. The Impact of Contemporary Breast Cancer Therapy on Sexual Function. Sexual Medicine. (in press).

Gondo T, Hricak H, Sala E, Zheng J, Moskowitz CS, Bernstein M, Eastham JA, Vargas HA. Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3+4 prostate cancer. Eur Radiol. 2014 Dec;24(12):3161-70.

Gondo T, Poon BY, Matsumoto K, Bernstein M, Sjoberg DD, Eastham JA. Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed Gleason score 3 + 4 prostate cancer. BJU Int. 2014 Apr 11. PMID: 24725760, PMCID: PMC4194186

Gönen M. [Bias, biostatistics, and prognostic factors]. Zhongguo Fei Ai Za Zhi. 2014 Feb;17(2):137-41.

Gooch J, King TA, Eaton A, Dengel L, Stempel M, Corben AD, Morrow M. The extent of extracapsular extension may influence the need for axillary lymph node dissection in patients with T1-T2 breast cancer. Ann Surg Oncol. 2014 Sep;21(9):2897-903.

Grisham RN, Iyer G, Sala E, Zhou Q, Iasonos A, DeLair D, Hyman DM, Aghajanian C. Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancer. Int J Gynecol Cancer. 2014 Jul;24(6):1010-4.

Gupta A, Atoria CL, Ehdaie B, Shariat SF, Rabbani F, Herr HW, Bochner BH, Elkin EB. Risk of fracture after radical cystectomy and urinary diversion for bladder cancer. J Clin Oncol. 2014 Oct 10;32(29):3291-8.

Gupta A, Young RJ, Shah AD, Schweitzer AD, Graber JJ, Shi W, Zhang Z, Huse J, Omuro AM. Pretreatment dynamic susceptibility contrast MRI perfusion in glioblastoma: Prediction of EGFR gene amplification. Clin Neuroradiol. 2014 Jan 29. [Epub ahead of print]

Hakimi AA, Mano R, Ciriello G, Gonen M, Mikkilineni N, Sfakianos JP, Kim PH, Motzer RJ, Russo P, Reuter VE, Hsieh JJ, Ostrovnaya I. Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma. J Urol. 2014 Jul;192(1):24-9.

Halpenny D, Ridge CA, Hayes S, Zheng J, Moskowitz CS, Rimner A, Ginsberg MS. Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapy. Clin Imaging. 2014 Dec 12.

Halpenny DF, Riely GJ, Hayes S, Yu H, Zheng J, Moskowitz CS, Ginsberg MS. Are there imaging characteristics associated with lung adenocarcinomas harboring ALK rearrangements? Lung Cancer. 2014 Nov;86(2):190-4.

Halpern MT, Viswanathan M, Evans TS, Birken SA, Basch E, Mayer DK. Models of Cancer Survivorship Care: Overview and Summary of Current Evidence. J Oncol Pract. 2014 Sep 9.

Hamilton RJ, Morilla D, Cabrera F, Leapman M, Chen LY, Bernstein M, Hakimi AA, Reuter VE, Russo P. The association between statin medication and progression after surgery for localized renal cell carcinoma. The Journal of urology. 2014 Apr;191(4):914-9.

Hatzoglou V, Patel GV, Morris MJ, Curtis K, Zhang Z, Shi W, Huse J, Rosenblum M, Holodny AI, Young RJ. Brain metastases from prostate cancer: An 11-year analysis in the MRI era with emphasis on imaging characteristics, incidence, and prognosis. J Neuroimaging 2014; 24:161-6.

Hay JL, Atkinson TM, Reeve BB, Mitchell SA, Mendoza TR, Willis G, Minasian LM, Clauser SB, Denicoff A, O’Mara A, Chen A, Bennett AV, Paul DB, Gagne J, Rogak LSit L, Viswanath V, Schrag D, Basch E; NCI PRO-CTCAE Study Group (Li Y, Member). Cognitive interviewing of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).Qual Life Res. 2014 Feb;23(1):257-69.

Hay JL, Baser R, Weinstein ND, Li Y, Primavera L, Kemeny MM. Examining intuitive risk perceptions for cancer in diverse populations. Health Risk Soc. 2014 Jan 1;16(3):227-242.

Hay JL, Geller AC, Schoenhammer M, Gordon M, Bishop M, Shuk E, Oliveria S, Halpern AC. Tanning and beauty: Mother and teenage daughters in discussion. J Health Psychol. 2014 Oct 15.

Hay JL, Gordon M, Li Y. Family Risk Discussions After Feedback on Genetic Risk of Melanoma. JAMA Dermatol. 2014 Oct 22. doi: 10.1001/jamadermatol.2014.3421.

Hayes SA, Huang J, Plodkowski AJ, Katzen J, Zheng J, Moskowitz CS, Ginsberg MS. Preoperative computed tomography findings predict surgical resectability of thymoma. J Thorac Oncol. 2014 Jul;9(7):1023-30.

Hayes SA, Soff GA, Zabor EC, Moskowitz CS, Liu CC, Ginsberg MS. Clinical consequences of an indeterminate CT pulmonary angiogram in cancer patients. Clin Imaging. 2014 Sep Oct;38(5):637-40.

Hieronymus H, Schultz N, Gopalan A, Carver BS, Chang MT, Xiao Y, Heguy A, Huberman K, Bernstein M, Assel M, Murali R, Vickers A, Scardino PT, Sander C, Reuter V, Taylor BS, Sawyers CL. Copy number alteration burden predicts prostate cancer relapse. Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):11139-44.

Ho AL, Lipson BL, Sherman EJ, Xiao H, Fury MG, Apollo A, Seetharamu N, Sima CS, Haque S, Lyo JK, Sales R, Cox L, Pfister DG. A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancer. Invest New Drugs. 2014 Jun;32(3):549-54.

Ho AY, Patel N, Ohri N, Morrow M, Mehrara BJ, Disa JJ, Cordeiro PG, Shi W, Zhang Z, Gelblum D, Nerbun CT, Woch KM, Ballangrud A, McCormick B, Powell SN. Med Dosim. Bilateral implant reconstruction does not affect the quality of postmastectomy radiation therapy. Med Dosim 2014; 39:18-22.

Hoadley KA, Yau C and other authors including Taylor BS and Shultz N. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell. 2014 Aug 14;158(4):929-44.

Hong SK, Poon BY, Sjoberg DD, Scardino PT, Eastham JA. Prostate size and adverse pathologic features in men undergoing radical prostatectomy. Urology. 2014 Jul;84(1):153-7.

Hong SK, Vertosick E, Sjoberg DD, Scardino PT, Eastham JA. Insignificant disease among men with intermediate-risk prostate cancer. World J Urol. 2014 Dec;32(6):1417-21.

Houldsworth J, Guttapalli A, Thodima V, Yan XJ, Mendiratta G, Zielonka T, Nanjangud G, Chen W, Patil S, Mato A, Brown JR, Rai K, Chiorazzi N, Chaganti RS. Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2014 Apr;55(4):920-8.

Howard DH, Bach PB, Berndt ER, Conti RM. Pricing in the Market for Anticancer Drugs. J Economic Perspectives.(In Press).

Howard JR, Ramirez J, Li Y, Gany F. Dental Care Access for Low-Income and Immigrant Cancer Patients in New York City. J Community Health. 2014 Jul 2.

Huang EP, Wang XF, Roy Choudhury K, McShane LM, Gönen M, Ye J, Buckler AJ, Kinahan PE, Reeves AP, Jackson EF, Guimaraes AR, Zahlmann G; Meta-Analysis Working Group. Meta-analysis of the technical performance of an imaging procedure: Guidelines and statistical methodology. Stat Methods Med Res. 2014 May 28. [Epub ahead of print]

Huang WC, Atoria CL, Bjurlin M, Pinheiro LC, Russo P, Lowrance WT, Elkin EB. Management of small kidney cancers in the new millennium: Contemporary trends and outcomes in a population-based cohort. JAMA Surg, 2014 (in press).

Huguet F, Yorke ED, Davidson M, Zhang Z, Jackson A, Mageras GS, Wu AJ, Goodman KA. Modeling pancreatic tumor motion using 4D-CT and surrogate markers. Int J Radiat Oncol Biol Phys; (In Press).

Hyman DM, Eaton AA, Gounder MM, Ivy SP, Iasonos A, Spriggs DR. Reply to M. Voskoboynik et al. J Clin Oncol. 2014 Oct 1;32(28):3199-200.

Hyman DM, Eaton AA, Gounder MM, Smith GL, Pamer EG, Hensley ML, Spriggs DR, Ivy P, Iasonos A. Nomogram to predict cycle-one serious drug-related toxicity in phase I oncology trials. J Clin Oncol. 2014 Feb 20;32(6):519-26.

Iacconi C, Thakur SB, Dershaw DD, Brooks J, Fry CW, Morris EA. Impact of fibroglandular tissue and background parenchymal enhancement on diffusion weighted imaging of breast lesions. Eur J Radiol. 2014 Sep 28;83(12):2137-2143.

Iasonos A, O’Quigley J. Adaptive dose-finding studies: a review of model-guided phase I clinical trials. J Clin Oncol. 2014 Aug 10;32(23):2505-11.

Ionita-Laza I, Capanu M, De Rubeis S, McCallum K, Buxbaum JD. Identification of Rare Causal Variants in Sequence-Based Studies: Methods and Applications to VPS13B, a Gene Involved in Cohen Syndrome and Autism. PLoS Genet. 2014 Dec 11;10(12):e1004729.

Janjigian YY, Ku GY, Campbell JC, Shah MA, Capanu M, Kelsen DP, Ilson DH. Phase II trial of cetuximab plus cisplatin and irinotecan in patients with cisplatin and irinotecan-refractory metastatic esophagogastric cancer. Am J Clin Oncol. 2014 Apr;37(2):126-30.

Jelinic P, Mueller JJ, Olvera N, Dao F, Scott SN, Shah R, Gao J, Schultz N, Gonen M, Soslow RA, Berger MF, Levine DA. Recurrent SMARCA4 mutations in small cell carcinoma of the ovary. Nat Genet. 2014 May;46(5):424-6.

Jensen CD, Doubeni CA, Quinn VP, Levin TR, Zauber AG, Schottinger JE, Marks AR, Zhao WK, Lee JK, Ghai NR, Schneider JL, Fireman BH, Quesenberry CP, Corley DA. Adjusting for Patient Demographics Has Minimal Effects on Rates of Adenoma Detection in a Large, Community-based Setting. Clin Gastroenterol Hepatol. 2014 Oct 25.

Jensen RE, Snyder CF, Abernethy AP, Basch E, Potosky AL, Roberts AC, Loeffler DR, Reeve BB. Review of electronic patient-reported outcomes systems used in cancer clinical care. J Oncol Pract. 2014 Jul;10(4):e215-22.

Jhaveri K, Chandarlapaty S, Lake D, Gilewski T, Robson M, Goldfarb S, Drullinsky P, Sugarman S, Wasserheit-Leiblich C, Fasano J, Moynahan ME, D’Andrea G, Lim K, Reddington L, Haque S, Patil S, Bauman L, Vukovic V, El-Hariry I, Hudis C, Modi S. A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer. Clin Breast Cancer. 2014 Jun;14(3):154-60.

Johnson BE, Mazor T, Hong C, Barnes M, Aihara K, McLean CY, Fouse SD, Yamamoto S, Ueda H, Tatsuno K, Asthana S, Jalbert LE, Nelson SJ, Bollen AW, Gustafson WC, Charron E, Weiss WA, Smirnov IV, Song JS, Olshen AB, Cha S, Zhao Y, and other authors including Taylor, BS. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science. 2014 Jan 10;343(6167):189-93.

Johnson DB, Lovly CM, Flavin M, Panageas KS, Ayers GD, Zhao Z, Iams WT, Colgan M, DeNoble S, Terry CR, Berry EG, Iafrate AJ, Sullivan RJ, Carvajal RD, Sosman JA. Impact of NRAS mutations for patients with advanced melanoma treated with immune-based therapies. Cancer Immun Res (in press).

Kaag M, Trost L, Thompson RH, Favaretto R, Elliott V, Shariat SF, Maschino A, Vertosick E, Raman JD, Dalbagni G. Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma. BJU Int. 2014 Nov;114(5):674-9.

Kachala SS, Bograd AJ, Villena-Vargas J, Suzuki K, Servais EL, Kadota K, Chou J, Sima CS, Vertes E, Rusch VW, Travis WD, Sadelain M, Adusumilli PS. Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma. Clin Cancer Res. 2014 Feb 15;20(4):1020-8.

Kadota K, Nitadori J, Woo KM, Sima CS, Finley DJ, Rusch VW, Adusumilli PS, Travis WD. Comprehensive pathological analyses in lung squamous cell carcinoma: single cell invasion, nuclear diameter, and tumor budding are independent prognostic factors for worse outcomes. J Thorac Oncol. 2014 Aug;9(8):1126-39.

Kadota K, Villena-Vargas J, Yoshizawa A, Motoi N, Sima CS, Riely GJ, Rusch VW, Adusumilli PS, Travis WD. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease. Am J Surg Pathol. 2014 Apr;38(4):448-60.

Kadota K, Yeh YC, D’Angelo SP, Moreira AL, Kuk D, Sima CS, Riely GJ, Arcila ME, Kris MG, Rusch VW, Adusumilli PS, Travis WD. Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation. Am J Surg Pathol. 2014 Aug;38(8):1118-27.

Kadota K, Yeh YC, Sima CS, Rusch VW, Moreira AL, Adusumilli PS, Travis WD. The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype. Mod Pathol. 2014 May;27(5):690-700.

Kaley T, Barani I, Chamberlain M, McDermott M, Panageas K, Raizer J, Rogers L, Schiff D, Vogelbaum M, Weber D, Wen P. Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review. Neuro Oncol. 2014 Jun;16(6):829-40.

Karlo CA, Di Paolo PL, Chaim J, Hakimi AA, Ostrovnaya I, Russo P, Hricak H, Motzer R, Hsieh JJ, Akin O. Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations. Radiology. 2014 Feb;270(2):464-71.

Keam J, Bilsky MH, Laufer I, Shi W, Zhang Z, Tam M, Zatcky J, Lovelock DM, Yamada Y. No association between excessive wound complications and preoperative high-dose, hypofractionated, image-guided radiation therapy for spine metastasis. J Neurosurg Spine. 2014 Apr;20(4):411-20.

Kedmi M, Hedvat CV, Maragulia J, Zhang Z, Zelenetz AD. Association of quantitative assessment of intrafolliuclar proliferation index with outcome in follicular lymphoma. Br J Haematol 2014; 164:646-52.

Kelemen LE, Terry KL and other authors including Olson SH, Orlow I and Pike MC. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Mol Nutr Food Res. 2014 Oct;58(10):2023-35.

Kelly KJ, Yoon SS, Kuk D, Qin LX, Dukleska K, Chang KK, Chen YL, Delaney TF, Brennan MF, Singer S. Comparison of perioperative radiation therapy and surgery versus surgery alone in 204 patients with primary retroperitoneal sarcoma: a retrospective 2-institution study. Ann Surg 2015. (In press.)

Kemeny NE, Chou JF, Capanu M, Gewirtz AN, Cercek A, Kingham TP, Jarnagin WR, Fong YC, DeMatteo RP, Allen PJ, Shia J, Ang C, Vakiani E, D’Angelica MI. KRAS mutation  influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases. Cancer. 2014 Dec 15;120(24):3965-71.

Kent M, Vickers AJ. A systematic literature review of life expectancy prediction tools for localized prostate cancer patients. J Urol. 2014 Nov 15.

Kim PH, Cha EK, Sfakianos JP, Iyer G, Zabor EC, Scott SN, Ostrovnaya I, Ramirez R, Sun A, Shah R, Yee AM, Reuter VE, Bajorin DF, Rosenberg JE, Schultz N, Berger MF, Al-Ahmadie HA, Solit DB, Bochner BH. Genomic Predictors of Survival in Patients with High-grade Urothelial Carcinoma of the Bladder. Eur Urol. 2014 Aug 1.

Kim PH, Kent M, Zhao P, Sfakianos JP, Bajorin DF, Bochner BH, Dalbagni G. The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer. World J Urol. 2014 Apr;32(2):453-9.

Kim PH, Sukhu R, Cordon BH, Sfakianos JP, Sjoberg DD, Hakimi AA, Dalbagni G, Lin O, Herr HW. Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy. BJU Int. 2014 Sep;114(3):354-9.

Kirsch M, Mitchell SA, Dobbels F, Stussi G, Basch E, Halter JP, De Geest S. Linguistic and content validation of a German-language PRO-CTCAE-based patient-reported outcomes instrument to evaluate the late effect symptom experience after allogeneic hematopoietic stem cell transplantation. Eur J Oncol Nurs. 2014 Sep 1.

Kitano S, Postow MA, Ziegler CG, Kuk D, Panageas KS, Cortez C, Rasalan T, Adamow M, Yuan J, Wong P, Altan-Bonnet G, Wolchok JD, Lesokhin AM. Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes. Cancer Immunol Res. 2014 Aug;2(8):812-21.

Kluth LA, Abdollah F, Xylinas E, Rieken M, Fajkovic H, Sun M, Karakiewicz PI, Seitz C, Schramek P, Herman MP, Becker A, Loidl W, Pummer K, Nonis A, Lee RK, Lotan Y, Scherr DS, Seiler D, Chun FK, Graefen M, Tewari A, Gönen M, Montorsi F, Shariat SF, Briganti A. Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool. Eur Urol. 2014 Sep;66(3):439-46.

Kluth LA, Xylinas E, Kent M, Hagiwara M, Kikuchi E, Ikeda M, Matsumoto K, Dalpiaz O, Zigeuner R, Aziz A, Fritsche HM, Deliere A, Raman JD, Bensalah K, Al-Matar B,  Gakis G, Novara G, Klatte T, Remzi M, Comploj E, Pycha A, Rouprêt M,Vickers AJ, et al. Predictors of survival in patients with disease recurrence after radical nephroureterectomy.BJU Int. 2014 Jun;113(6):911-7.

Koerkamp BG, Wiggers JK, Allen PJ, Busch OR, D’Angelica MI, DeMatteo RP, Fong Y, Gonen M, Gouma DJ, Kingham TP, van Gulik TM, Jarnagin WR. American Joint Committee on Cancer staging for resected perihilar cholangiocarcinoma: a comparison of the 6th and 7th editions. HPB (Oxford). 2014 Dec;16(12):1074-82.

Kohsaka S, Shukla N, Ameur N, Ito T, Ng CK, Wang L, Lim D, Marchetti A, Viale A, Pirun M, Socci ND, Qin LX, Sciot R, Bridge J, Singer S, Meyers P, Wexler LH, Barr FG, Dogan S, Fletcher JA, Reis-Filho JS, Ladanyi M. A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations. Nat Genet. 2014 Jun;46(6):595-600.

Konstantinidis IT, Do RK, Gultekin DH, Gönen M, Schwartz LH, Fong Y, Allen PJ, D’Angelica MI, DeMatteo RP, Klimstra DS, Kemeny NE, Jarnagin WR. Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials. Ann Surg Oncol. 2014 Aug;21(8):2675-83.

Korc-Grodzicki B, Sun SW, Zhou Q, Iasonos A, Lu B, Root JC, Downey RJ, Tew WP. Geriatric Assessment as a Predictor of Delirium and Other Outcomes in Elderly Patients With Cancer. Ann Surg. 2014 May 30.

Kuchenbaecker KB, Ramus SJ and other authors including Orlow I. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics 2014;(in press).

Kudenchuk PJ, Brown SP, Daya M, Morrison LJ, Grunau BE, Rea T, Aufderheide T, Powell J, Leroux B, Vaillancourt C, Larsen J, Wittwer L, Colella MR, Stephens SW, Gamber M, Egan D, Dorian P; Resuscitation Outcomes Consortium Investigators (Devlin SM, Member). Resuscitation Outcomes Consortium-Amiodarone, Lidocaine or Placebo Study (ROC-ALPS): Rationale and methodology behind an out-of-hospital cardiac arrest antiarrhythmic drug trial. Am Heart J. 2014 May;167(5):653-9.e4.

Kumar A, Blinder V,Shah PD, In Drilon AE, Postow MA, Krug LM (2014).  General Oncology (1-4511-8762-9,978-1-4511-8762-5)

Lakhman Y, Yakar D, Goldman DA, Katz SS, Vargas HA, Miccò M, Zheng J, Moskowitz CS, Soslow RA, Hricak H, Abu-Rustum NR, Sala E. Preoperative CT-based nomogram for predicting overall survival in women with non-endometrioid carcinomas of the uterine corpus. Abdom Imaging. 2014 Dec 31. [Epub ahead of print]

Lanning RM, Morrow M, Riaz N, McArthur HL, Dang C, Moo T-A, El-Tamer M, Krause K, Siu C, Hsu M, Zhang Z, Pei X, McCormick B, Powell SN, Ho A. The effect of adjuvant trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-positive breast cancer treated with mastectomy. Ann Surg Oncol. 2015 Jan 7. [Epub ahead of print]

Lansdorp-Vogelaar I, Gulati R, Mariotto AB, Schechter CB, de Carvalho TM, Knudsen AB, van Ravesteyn NT, Heijnsdijk EA, Pabiniak C, van Ballegooijen M, Rutter CM, Kuntz KM, Feuer EJ, Etzioni R, de Koning HJ, Zauber AG, Mandelblatt JS. Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits. Ann Intern Med. 2014 Jul 15;161(2):104-12.

Lawrence EM, Tang SY, Barrett T, Koo B, Goldman DA, Warren AY, Axell RG, Doble A, Gallagher FA, Gnanapragasam VJ, Kastner C, Sala E. Prostate cancer: performance characteristics of combined T₂W and DW-MRI scoring in the setting of template transperineal re-biopsy using MR-TRUS fusion. Eur Radiol. 2014 Jul;24(7):1497-505.

Lee AW, Tyrer JP and other authors including Olson SH,Orlow I and Pike, MC. Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study. Gynecol Oncol. 2014 Dec 17. [Epub ahead of print]

Lee DJ, Ahmed HU, Moore CM, Emberton M, Ehdaie B. Multiparametric magnetic resonance imaging in the management and diagnosis of prostate cancer: current applications and strategies. Curr Urol Rep. 2014 Mar;15(3):390.

Lee SY, Konstantinidis IT, Eaton AA, Gönen M, Kingham TP, D’Angelica MI, Allen PJ, Fong Y, DeMatteo RP, Jarnagin WR. Predicting recurrence patterns after resection of hepatocellular cancer. HPB (Oxford). 2014 Oct;16(10):943-53.

Lee W, Teckie S, Wiesner T, Ran L, Prieto Granada CN, Lin M, Zhu S, Cao Z, Liang Y, Sboner A, Tap WD, Fletcher JA, Huberman KH, Qin LX, Viale A, Singer S, Zheng D, Berger MF, Chen Y, Antonescu CR, Chi P. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nat Genet. 2014 Nov;46(11):1227-32.

Lee YJ, Zheng J, Kolitsopoulos Y, Chung D, Amigues I, Son T, Choo K, Hester J, Giralt SA, Glezerman IG, Jakubowski AA, Papanicolaou GA. Relationship of BK polyoma virus (BKV) in the urine with hemorrhagic cystitis and renal function in recipients of T Cell-depleted peripheral blood and cord blood stem cell transplantations. Biol Blood Marrow Transplant. 2014 Aug;20(8):1204-10.

Leitao MM Jr, Bartashnik A, Wagner I, Lee SJ, Caroline A, Hoskins WJ, Thaler HT, Abu-Rustum NR, Sonoda Y, Brown CL, Jewell EL, Barakat RR, Gardner GJ. Cost-effectiveness analysis of robotically assisted laparoscopy for newly diagnosed uterine cancers. Obstet Gynecol. 2014 May;123(5):1031-7.

Lendvai N, Hilden P, Devlin S, Landau H, Hassoun H, Lesokhin AM, Tsakos I, Redling K, Koehne G, Chung DJ, Schaffer WL, Giralt SA. A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma. Blood. 2014 Aug 7;124(6):899-906.

Leung U, Simpson AL, Araujo RL, Gönen M, McAuliffe C, Miga MI, Parada EP, Allen PJ, D’Angelica MI, Kingham TP, DeMatteo RP, Fong Y, Jarnagin WR. Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure. J Am Coll Surg. 2014 Oct;219(4):620-30.

Lin L, Asthana S, Chan E, Bandyopadhyay S, Martins MM, Olivas V, Yan JJ, Pham L, Wang MM, Bollag G, Solit DB, Collisson EA, Rudin CM, Taylor BS, Bivona TG. Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer. Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):E748-57.

Lin X, Cai B, Wang L, Zhang Z. A Bayesian proportional hazards model for general interval-censored data. Lifetime Data Analysis. Lifetime Data Anal. 2014 Aug 7. [Epub ahead of print]

Lipitz-Snyderman A, Atoria CL, Kumar C, Gendron M, Killen A. Does Laboratory Testing Decrease During Scheduled Downtime of an Electronic Order Entry System? Am J Med Qual. 2014 Aug 18.

Lipitz-Snyderman A, Sepkowitz KA, Elkin EB, Pinheiro LC, Sima CS, Son CH, Atoria CL, Bach PB. Long-term central venous catheter use and risk of infection in older adults with cancer. J Clin Oncol. 2014 Aug 1;32(22):2351-6.

Lipitz-Snyderman A, Klotz A, Atoria C, Martin S, Groeger J. Impact of observation status on hospital use for patients with cancer. J Oncol Pract. 2015 Jan 27. [Epub ahead of print]

Litvak AM, Paik PK, Woo KM, Sima CS, Hellmann MD, Arcila ME, Ladanyi M, Rudin CM, Kris MG, Riely GJ.Clinical Characteristics and Course of 63 Patients with BRAF Mutant Lung Cancers. J Thorac Oncol. 2014 Nov;9(11):1669-74.

Litvak AM, Woo K, Hayes S, Huang J, Rimner A, Sima CS, Moreira AL, Tsukazan M, Riely GJ. Clinical characteristics and outcomes for patients with thymic carcinoma: evaluation of masaoka staging. J Thorac Oncol. 2014 Dec;9(12):1810-5.

Liu W, Shia J, Gönen M, Lowery MA, O’Reilly EM, Klimstra DS. DNA mismatch repair abnormalities in acinar cell carcinoma of the pancreas: frequency and clinical significance. Pancreas. 2014 Nov;43(8):1264-70.

Lok BH, Chin C, Riaz N, Ho F, Hu M, Hong JC, Shi W, Zhang Z, Sherman E, Wong RJ, Morris LG, Ganly I, Wolden SL, Rao SS, Lee NY. Irradiation for locoregionally recurrent, never irradiated oral cavity cancers. Head Neck. 2014 Jun 21.

Lou E, Johnson M, Sima C, Gonzalez-Espinoza R, Fleisher M, Kris MG, Azzoli CG. Serum biomarkers for assessing histology and outcomes in patients with metastatic lung cancer. Cancer Biomark. 2014;14(4):207-14.

Lou F, Sima CS, Rusch VW, Jones DR, Huang J. Differences in patterns of recurrence in early-stage versus locally advanced non-small cell lung cancer. Ann Thorac Surg. 2014 Nov;98(5):1755-61.

Lovly CM, McDonald NT, Chen H, Ortiz-Cuaran S, Heukamp LC, Yan Y, Florin A, Ozreti L, Lim D, Wang L, Chen Z, Chen X, Lu P, Paik PK, Shen R, Jin H, Buettner R, Ansén S, Perner S, Brockmann M, Bos M, Wolf J, et al. Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer. Nat Med. 2014 Sep;20(9):1027-34.

Lubetkin EI, Zabor EC, Brennessel D, Kemeny MM, Hay JL. Beyond demographics: differences in patient activation across new immigrant, diverse language subgroups. J Community Health. 2014 Feb;39(1):40-9.

MacPherson H, Vertosick E, Lewith G, Linde K, Sherman KJ, Witt CM, Vickers AJ; Acupuncture Trialists’ Collaboration. Influence of control group on effect size in trials of acupuncture for chronic pain: a secondary analysis of an individual patient data meta-analysis. PLoS One. 2014;9(4):e93739.

Mango VL, Morris EA, David Dershaw D, Abramson A, Fry C, Moskowitz CS, Hughes M, Kaplan J, Jochelson MS. Abbreviated protocol for breast MRI: Are multiple sequences needed for cancer detection? Eur J Radiol. 2014 Oct 16.

Manning AT, Eaton A, Azu M, Sampson M, Patil S, Godfrey D, Beesen AA, Liberman L, Gemignani ML. Breast Cancer Screening at the Breast Examination Center of Harlem. Ann Surg Oncol. 2014 Dec 2.

Mano R, Hakimi AA, Zabor EC, Bury MA, Donati OF, Karlo CA, Bazzi WM, Furberg H, Russo P. Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma. Can Urol Assoc J. 2014 Sep;8(9-10):E675-E680.

Mano R, Vertosick E, Sankin AI, Chevinsky MS, Larish Y, Jakubowski CD, Hötker AM, Hakimi AA, Sjoberg DD, Akin O, Russo P. Subcentimeter Pulmonary Nodules Are Not Associated with Disease Progression in Patients with Renal Cell Carcinoma. J Urol. 2014 Sep 18.

Marchetti MA, Fonseca M, Dusza SW, Geller AC, Bishop M, Marghoob AA, Scope A, Oliveria SA, Halpern AC. Dermoscopic Imaging of Skin Lesions by High School Students: A Cross-Sectional Pilot Study. Dermatology Practical and Conceptual. Accepted for publication on October 15, 2014. (In Press).

Maker AV, Ito H, Mo Q, Weisenberg E, Qin LX, Turcotte S, Maithel S, Shia J, Blumgart L, Fong Y, Jarnagin WR, DeMatteo RP, D’Angelica1 MI. Genetic evidence that intratumoral T-cell proliferation and activation is associated with recurrence and survival in patients with resected colorectal liver metastases. Cancer Immunol Res. 2015 Jan 19. [Epub ahead of print]

Martelotto LG, Ng C, De Filippo MR, Zhang Y, Piscuoglio S, Lim R, Shen R, Norton L, Reis-Filho JS, Weigelt B. Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations. Genome Biol. 2014 Oct 28;15(10):484.

Martin NE, Massey L and other authors including Vickers A. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol. 2014 Sep 15.

Matasar, M, Ford J, Riedel E. Salz T, Oeffinger KC, Straus D.  Late morbidity and mortality in patients with Hodgkin lymphoma treated during adulthood. (In press)

Matignon M, Ding R, Dadhania DM, Mueller FB, Hartono C, Snopkowski C, Li C, Lee JR, Sjoberg D, Seshan SV, Sharma VK, Yang H, Nour B, Vickers AJ, Suthanthiran M,  Muthukumar T. Urinary cell mRNA profiles and differential diagnosis of acute kidney graft dysfunction. J Am Soc Nephrol. 2014 Jul;25(7):1586-97.

Matsen CB, Hirsch A, Eaton A, Stempel M, Heerdt A, Van Zee KJ, Cody HS 3rd, Morrow M, Plitas G. Extent of microinvasion in ductal carcinoma in situ is not associated with sentinel lymph node metastases. Ann Surg Oncol. 2014 Oct;21(10):3330-5.

Mazzone P, Powell CA, Arenberg D, Bach P, Detterbeck F, Gould M, Jaklitsch MT, Jett J, Naidich D, Vachani A, Wiener RS, Silvestri G. Components Necessary for High Quality Lung Cancer Screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest. 2014 Oct 30.

McCarthy CM, Mehrara BJ, Long T, Garcia P, Kropf N, Klassen AF, Cano SJ, Li Y, Hurley K, Scott A, Disa JJ, Cordeiro PG, Pusic AL. Chest and upper body morbidity following immediate postmastectomy breast reconstruction. Ann Surg Oncol. 2014 Jan;21(1):107-12.

McMillan RR, Berger A, Sima CS, Lou F, Dycoco J, Rusch V, Rizk NP, Jones DR, Huang J. Thirty-day mortality underestimates the risk of early death after major resections for thoracic malignancies. Ann Thorac Surg. 2014 Nov;98(5):1769-75.

Meisel JL, Hyman DM, Jotwani A, Zhou Q, Abu-Rustum NR, Iasonos A, Pike MC, Aghajanian C. The role of systemic chemotherapy in the management of granulosa cell tumors. Gynecol Oncol. 2014 Dec 26.

Meisel M, Hyman DM, Garg K, Zhou Q, Dao F, Gao J, Schultz N, Phillips M, Iasonos A, Kauff N, Levine DA, Soslow RA, Spriggs D. The Performance of BRCA1 Immunohistochemistry for Detecting Germline, Somatic, and Epigenetic BRCA Loss in High-Grade Serous Ovarian Cancer. Ann Oncol. 2014 Dec;25(12):2372-8.Mol Cancer Ther. 2014 Nov 7.

Melstrom LG, Taylor E, Kuk D, Frankel TL, Panageas K, Haydu L, Sabel MS, Thompson JF, Ariyan C, Coit DG, Brady MS. International Multi-institutional Management and Outcome of Melanoma Patients with Positive Sentinel Lymph Nodes in More than One Nodal Basin. Ann Surg Oncol. 2014 Dec;21(13):4324-9.

Meyer AM, Olshan AF, Green L, Meyer A, Wheeler SB, Basch E, Carpenter WR. Big data for population-based cancer research: the integrated cancer information and surveillance system. N C Med J. 2014 Jul-Aug;75(4):265-9.

Miccò M, Vargas HA, Burger IA, Kollmeier MA, Goldman DA, Park KJ, Abu-Rustum NR,  Hricak H, Sala E. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer. Eur J Radiol. 2014 Jul;83(7):1169-76.

Modh A, Rimner A, Williams E, Foster A, Shah M, Shi W, Zhang Z, Gelblum DY, Rosenzweig KE, Yorke ED, Jackson A, Wu AJ. Local Control and Toxicity in a Large Cohort of Central Lung Tumors Treated With Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2014 Oct 8.

Moo TA, Choi L, Culpepper C, Olcese C, Heerdt A, Sclafani L, King TA, Reiner AS, Patil S, Brogi E, Morrow M, Van Zee KJ. Impact of margin assessment method on positive margin rate and total volume excised. Ann Surg Oncol. 2014 Jan;21(1):86-92.

Moo TA, McMillan R, Lee M, Stempel M, Ho A, Patil S, El-Tamer M. Impact of molecular subtype on locoregional recurrence in mastectomy patients with T1-T2 breast cancer and 1-3 positive lymph nodes. Ann Surg Oncol. 2014 May;21(5):1569-74.

Moses KA, Winer A, Sfakianos JP, Poon SA, Kent M, Bernstein M, Russo P, Dalbagni G. Contemporary management of penile cancer: greater than 15 year MSKCC experience. Can J Urol. 2014 Apr;21(2):7201-6.

Moskowitz CS, Chou JF, Wolden SL, Bernstein JL, Malhotra J, Novetsky Friedman D, Mubdi NZ, Leisenring WM, Stovall M, Hammond S, Smith SA, Henderson TO, Boice JD, Hudson MM, Diller LR, Bhatia S, Kenney LB, Neglia JP, Begg CB, Robison LL, Oeffinger KC. Breast cancer after chest radiation therapy for childhood cancer. J Clin Oncol. 2014 Jul 20;32(21):2217-23.

Moskowitz CS, Oeffinger KC. Predicting Adverse Health Outcomes in Long-Term Surivors of a Childhood Cancer. Children. 2014;1:63-73.

Musser JE, Assel M, Guglielmetti GB, Pathak P, Silberstein JL, Sjoberg DD, Bernstein M, Laudone VP. Impact of routine use of surgical drains on incidence of complications with robot-assisted radical prostatectomy. J Endourol. 2014 Nov;28(11):1333-7.

Musser JE, Assel M, Mashni JW, Sjoberg DD, Russo P. Adult prostate sarcoma: the Memorial Sloan Kettering experience. Urology. 2014 Sep;84(3):624-8.

Mutter RW, Lok BH, Dutta PR, Riaz N, Setton J, Berry SL, Goenka A, Zhang Z, Rao SS, Wolden SL, Lee NY. Constraining the brachial plexus does not compromise regional control in oropharyngeal carcinoma. Radiat Oncol 2014; 8:173.

Nathan H, Atoria CL, Bach PB, Elkin EB. Hospital Volume, Complications, and Cost of Cancer Surgery in the Elderly. J Clin Oncol. 2014 Nov 24.

Navi BB, Reiner AS, Kamel H, Iadecola C, Elkind MS, Panageas KS, DeAngelis LM. Association between Incident Cancer and Subsequent Stroke. Ann Neurol. 2014 Dec 4.

Nazarian A, Lawlor K, Yi SS, Philip J, Ghosh M, Yaneva M, Villanueva J, Saghatelian A, Assel M, Vickers AJ, Eastham JA, Scher HI, Carver BS, Lilja H, Tempst P. Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer. Mol Cell Proteomics. 2014 Nov;13(11):3082-96.

Ng CK, Weigelt B, A’Hern R, Bidard FC, Lemetre C, Swanton C, Shen R, Reis-Filho JS. Predictive performance of microarray gene signatures: impact of tumor heterogeneity and multiple mechanisms of drug resistance. Cancer Res. 2014 Jun 1;74(11):2946-61.

Nissan MH, Pratilas CA, Jones AM, Ramirez R, Won H, Liu C, Tiwari S, Kong L, Hanrahan AJ, Yao Z, Merghoub T, Ribas A, Chapman PB, Yaeger R, Taylor BS, Schultz N, Berger MF, Rosen N, Solit DB. Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence. Cancer Res. 2014 Apr 15;74(8):2340-50.

Nordström T, Vickers A, Assel M, Lilja H, Grönberg H, Eklund M. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol. 2014 Aug 20.

Oliveria SA, Scope A, Satagopan JM, Geller AC, Dusza SW, Weinstock MA, Berwick M, Bishop M, Marghoob AA, Halpern AC. Factors associated with nevus volatility in early adolescence. J Invest Dermatol. 2014 Sep;134(9):2469-71.

Oliveria SA, Selvam N, Mehregan D, Marchetti MA, Divan HA, Dasgeb B, Halpern AC. Biopsies of Nevi in Children and Adolescents in the United States, 2009 Through 2013. JAMA Dermatol. 2014 Dec 10. [Epub ahead of print]

Olshen A, Tang M, Cortes J, Gonen M, Hughes T, Branford S, Quintás-Cardama A, Michor F. Dynamics of chronic myeloid leukemia response to dasatinib, nilotinib, and high-dose imatinib. Haematologica. 2014 Nov;99(11):1701-9.

Olson AL, Dahi PB, Zheng J, Devlin SM, Lubin M, Gonzales AM, Giralt SA, Perales MA, Papadopoulos EB, Ponce DM, Young JW, Kernan NA, Scaradavou A, O’Reilly RJ, Small TN, Papanicolaou G, Barker JN. Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin. Biol Blood Marrow Transplant. 2014 Jun;20(6):787-93.

Olson SH, Hsu M, Wiemels JL, Bracci PM, Zhou M, Patoka J, Reisacher WR, Wang J, Kurtz RC, Silverman DT, Stolzenberg-Solomon RZ. Serum immunoglobulin e and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1414-20.

Omuro A, Beal K, Gutin P, Karimi S, Correa DD, Kaley TJ, DeAngelis LM, Chan TA, Gavrilovic IT, Nolan C, Hormigo A, Lassman AB, Mellinghoff I, Grommes C, Reiner AS, Panageas KS, Baser RE, Tabar V, Pentsova E, Sanchez J, Barradas-Panchal R, Zhang J, et al. Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma. Clin Cancer Res. 2014 Oct 1;20(19):5023-31.

Omuro A, Correa DD, DeAngelis LM, Moskowitz CH, Matasar MJ, Kaley TJ, Gavrilovic IT, Nolan C, Pentsova E, Grommes CC, Panageas KS, Baser RE, Faivre G, Abrey LE, Sauter CS. R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma. Blood. 2015 Jan 7. [Epub ahead of print]

O’Neill CB, O’Neill JP, Atoria CL, Baxi SS, Henman MC, Ganly I, Elkin EB. Treatment complications and survival in advanced laryngeal cancer: A population-based analysis. Laryngoscope. 2014 Dec;124(12):2707-13.

O’Neill CB, Baxi SS, Atoria CL, O’Neill JP, Henman MC, Sherman EJ, Lee NY, Pfister DG, Elkin EB. Treatment-related toxicities in older adults with head and neck cancer:  A population-based analysis. Cancer (in press).

Oppong BA, Pharmer LA, Oskar S, Eaton A, Stempel M, Patil S, King TA. The effect of metformin on breast cancer outcomes in patients with type 2 diabetes. Cancer Med. 2014 Aug;3(4):1025-34.

O’Quigley J, Iasonos A. Bridging Solutions in Dose Finding Problems. Stat Biopharm  Res. 2014 May 1;6(2):185-197.

O’Reilly EM, Perelshteyn A, Jarnagin WR, Schattner M, Gerdes H, Capanu M, Tang LH, LaValle J, Winston C, DeMatteo RP, D’Angelica M, Kurtz RC, Abou-Alfa GK, Klimstra DS, Lowery MA, Brennan MF, Coit DG, Reidy DL, Kingham TP, Allen PJ.A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma. Ann Surg. 2014 Jul;260(1):142-8.

Oricchio E, Ciriello G, Jiang M, Boice MH, Schatz JH, Heguy A, Viale A, de Stanchina E, Teruya-Feldstein J, Bouska A, McKeithan T, Sander C, Tam W, Seshan VE, Chan WC, Chaganti RS, Wendel HG. Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy. J Exp Med. 2014 Jun 30;211(7):1379-91.

Orlow I, Satagopan JM, Berwick M, Enriquez HL, White KAM, Cheung K, Dusza SW, Oliveria SA, Marchetti MA, Scope A, Marghoob AA, Halpern AC. Genetic factors associated with naevus count and dermoscopic patterns: preliminary results from the Study of Nevi in Children (SONIC). Br J Dermatol. 2014 Oct 11. [Epub ahead of print]

Ortiz B, Fabius AW, Wu WH, Pedraza A, Brennan CW, Schultz N, Pitter KL, Bromberg JF, Huse JT, Holland EC, Chan TA. Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis. Proc Natl Acad Sci USA. 2014 Jun 3;111(22):8149-54.

Ostroff JS, Burkhalter JE, Cinciripini PM, Li Y, Shiyko MP, Lam CY, Hay JL, Dhingra LK, Lord-Bessen J, Holland SM, Manna R. Randomized trial of a presurgical scheduled reduced smoking intervention for patients newly diagnosed with cancer. Health Psychol. 2014 Jul;33(7):737-47.

Ostroff JS, Li Y, Shelley DR. Dentists United to Extinguish Tobacco (DUET): a study protocol for a cluster randomized, controlled trial for enhancing implementation of clinical practice guidelines for treating tobacco dependence in dental care settings. Implement Sci. 2014 Feb 21;9:25.

Panageas KS, Reiner AS, Iwamoto FM, Cloughesy TF, Aldape KD, Rivera AL, Eichler AF, Louis DN, Paleologos NA, Fisher BJ, Ashby LS, Cairncross JG, Urgoiti GB, Wen PY, Ligon KL, Schiff D, Robins HI, Rocque BG, Chamberlain MC, Mason WP, Weaver SA, Green RM, et al. Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors. Neuro Oncol. 2014 Nov;16(11):1541-6.

Pandit-Taskar N, O’Donoghue JA, Beylergil V, Lyashchenko S, Ruan S, Solomon SB, Durack JC, Carrasquillo JA, Lefkowitz RA, Gonen M, Lewis JS, Holland JP, Cheal SM, Reuter VE, Osborne JR, Loda MF, Smith-Jones PM, Weber WA, Bander NH, Scher HI, Morris MJ, Larson SM. ⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer. Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2093-105.

Parekh DJ, Punnen S, Sjoberg DD, Asroff SW, Bailen JL, Cochran JS, Concepcion R, David RD, Deck KB, Dumbadze I, Gambla M, Grable MS, Henderson RJ, Karsh L, Krisch EB, Langford TD, Lin DW, McGee SM, Munoz JJ, Pieczonka CM, Rieger-Christ K, Saltzstein DR, et al. A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer. Eur Urol. 2014 Oct 27.

Parfenov M, Pedamallu CS and other authors including Taylor BS and Shultz N. Characterization of HPV and host genome interactions in primary head and neck cancers. Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15544-9.

Parfenov M, Pedamallu CS et al.; Cancer Genome Atlas Research Network (Shen R, Member). Characterization of HPV and host genome interactions in primary head and neck cancers. Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15544-9.

Patel JD, Krilov L, Adams S, Aghajanian C, Basch E, Brose MS, Carroll WL, de Lima M, Gilbert MR, Kris MG, Marshall JL, Masters GA, O’Day SJ, Polite B, Schwartz GK, Sharma S, Thompson I, Vogelzang NJ, Roth BJ. Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology. J Clin Oncol. 2014 Jan 10;32(2):129-60.

Phillips E, Penate-Medina O, Zanzonico PB, Carvajal RD, Mohan P, Ye Y, Humm J, Gönen M, Kalaigian H, Schöder H, Strauss HW, Larson SM, Wiesner U, Bradbury MS. Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe. Sci Transl Med. 2014 Oct 29;6(260):260ra149.

Pilewskie M, Ho A, Orell E, Stempel M, Chen Y, Eaton A, Patil S, Morrow M. Effect of margin width on local recurrence in triple-negative breast cancer patients treated with breast-conserving therapy. Ann Surg Oncol. 2014 Apr;21(4):1209-14.

Pilewskie M, Olcese C, Eaton A, Patil S, Morris E, Morrow M, Van Zee KJ. Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation. Ann Surg Oncol. 2014 May;21(5):1552-60.

Podlaha O, De S, Gonen M, Michor F. Histone modifications are associated with transcript isoform diversity in normal and cancer cells. PLoS Comput Biol. 2014 Jun 5;10(6):e1003611.

Ponce DM, Hilden P, Mumaw C, Devlin SM, Lubin M, Giralt S, Goldberg JD, Hanash A, Hsu K, Jenq R, Perales MA, Sauter C, van den Brink MR, Young JW, Brentjens R, Kernan NA, Prockop S, O’Reilly RJ, Scaradavou A, Paczesny S, Barker JN. High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation. Blood. 2014 Nov 6.

Prager A, Beal K, Martinez N, Omuro A, Zhang Z, Young RJ. (2014). Diffusion and perfusion MRI to differentiate treatment related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic evidence. Am J Neuroradiol. (In Press).

Primrose JN, Perera R, Gray A, Rose P, Fuller A, Corkhill A, George S, Mant D; FACS Trial Investigators (Taylor, BS, Member). Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA. 2014 Jan 15;311(3):263-70.

Purtill D, Smith K, Devlin S, Meagher R, Tonon J, Lubin M, Ponce DM, Giralt S, Kernan NA, Scaradavou A, Stevens CE, Barker JN. Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice. Blood. 2014 Nov 6;124(19):2905-12.

Qin LX, Breeden L, Self SG. Finding gene clusters for a replicated time course study.BMC Res Notes. 2014 Jan 24;7:60.

Qin LX, Ma S, Huang YT, Zhang H, Cao H. Introductory Editorial: Array Platform Modeling and Analysis (A). Cancer Informatics. (In press.)

Qin LX, Zhou Q, Bogomolniy F, Villafania L, Olvera N, Cavatore M, Satagopan JM, Begg CB, Levine DA. Blocking and randomization to improve molecular biomarker discovery. Clin Cancer Res. 2014 Jul 1;20(13):3371-8.

Qin LX, Zhou Q. MicroRNA array normalization: an evaluation using a randomized dataset as the benchmark. PLoS One. 2014;9(6):e98879.

Raunig DL, McShane LM, Pennello G, Gatsonis C, Carson PL, Voyvodic JT, Wahl RL, Kurland BF, Schwarz AJ, Gönen M, Zahlmann G, Kondratovich M, O’Donnell K, Petrick N, Cole PE, Garra B, Sullivan DC; QIBA Technical Performance Working Group. Quantitative imaging biomarkers: A review of statistical methods for technical performance assessment. Stat Methods Med Res. 2014 Jun 11.[Epub ahead of print]

Reeve BB, Mitchell SA, Dueck AC, Basch E, Cella D, Reilly CM, Minasian LM, Denicoff AM, O’Mara AM, Fisch MJ, Chauhan C, Aaronson NK, Coens C, Bruner DW. Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. 2014 Jul 8;106(7).

Riaz N, Sherman E, Koutcher L, Shapiro L, Katabi N, Zhang Z, Shi W, Fury M, Wong R, Wolden S, Rao S, Lee N. Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck. Am J Clin Oncol. 2014 Jan 7.

Rich BS, Honeyman JN, Darcy DG, Smith PT, Williams AR, Lim II, Johnson LK, Gönen M, Simon JS, LaQuaglia MP, Simon SM. Endogenous antibodies for tumor detection. Sci Rep. 2014 May 30;4:5088.

Riedl CC, Slobod E, Jochelson M, Morrow M, Goldman DA, Gonen M, Weber WA, Ulaner GA. Retrospective analysis of 18F-FDG PET/CT for staging asymptomatic breast cancer patients younger than 40 years. J Nucl Med. 2014 Oct;55(10):1578-83.

Rieken M, Djajadiningrat RS, Kluth LA, Favaretto RL, Xylinas E, Guimaraes GC, Soares FA, Kent M, Sjoberg DD, Horenblas S, Shariat SF. Predictors of Cancer-specific Mortality After Disease Recurrence in Patients with Squamous Cell Carcinoma of the Penis. Eur Urol. 2014 Jun 9.

Rimner A, Gomez DR, Wu AJ, Shi W, Yorke ED, Moreira AL, Rice D, Komaki R, Rosenzweig KE, Riely GJ, Huang J. Failure patterns relative to radiation treatment fields for stage II-IV thymoma. J Thorac Oncol. 2014 Mar;9(3):403-9.

Ripley RT, McMillan RR, Sima CS, Hasan SM, Ahmad U, Lou F, Jones DR, Rusch VW, Rizk NP, Huang J. Second primary lung cancers: smokers versus nonsmokers after resection of stage I lung adenocarcinoma. Ann Thorac Surg. 2014 Sep;98(3):968-74.

Rizk NP, Ghanie A, Hsu M, Bains MS, Downey RJ, Sarkaria IS, Finley DJ, Adusumilli PS, Huang J, Sima CS, Burkhalter JE, Park BJ, Rusch VW. A prospective trial comparing pain and quality of life measures after anatomic lung resection using thoracoscopy or thoracotomy. Ann Thorac Surg. 2014 Oct;98(4):1160-6.

Robertson DJ, Lieberman DA, Winawer SJ, Ahnen DJ, Baron JA, Schatzkin A, Cross AJ, Zauber AG, Church TR, Lance P, Greenberg ER, Martínez ME. Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut. 2014 Jun;63(6):949-56.

Robinson N, Baranski M, Mahapatra KD, Saha JN, Das S, Mishra J, Das P, Kent M, Arnyasi M, Sahoo PK. A linkage map of transcribed single nucleotide polymorphisms  in rohu (Labeo rohita) and QTL associated with resistance to Aeromonas hydrophila. BMC Genomics. 2014 Jun 30;15:541.

Robinson WR, Furberg H, Banack HR. Selection bias: a missing factor in the obesity paradox debate. Obesity (Silver Spring). 2014 Mar;22(3):625.

Ruterbusch JJ, Ali-Fehmi R, Olson SH, Sealy-Jefferson S, Rybicki BA, Hensley-Alford S, Elshaikh MA, Gaba AR, Schultz D, Munkarah AR, Cote ML. The influence of comorbid conditions on racial disparities in endometrial cancer survival. Am J Obstet Gynecol. 2014 Dec;211(6):627.e1-9.

Sadot E, Brennan MF, Lee SY, Allen PJ, Gönen M, Groeger JS, Peter Kingham T, D’Angelica MI, DeMatteo RP, Jarnagin WR, Fong Y. Readmission after pancreatic resection: causes and causality pattern. Ann Surg Oncol. 2014 Dec;21(13):4342-50.

Sadot E, Yahalom J, Do RK, Teruya-Feldstein J, Allen PJ, Gönen M, D’Angelica MI, Peter Kingham T, Jarnagin WR, DeMatteo RP. Clinical Features and Outcome of Primary Pancreatic Lymphoma. Ann Surg Oncol. 2014 Oct 24. [Epub ahead of print]

Saltz LB, Bach PB. Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer. N Engl J Med. 2014 Jan 30;370(5):478.

Saluja S, Alatise OI, Adewale A, Misholy J, Chou J, Gonen M, Weiser M, Kingham TP. A comparison of colorectal cancer in Nigerian and North American patients: is the cancer biology different? Surgery. 2014 Aug;156(2):305-10.

Salz T, Baxi SS, Blinder VS, Elkin EB, Kemeny MM, McCabe MS, Moskowitz CS, Onstad EE, Saltz LB, Temple LK, Oeffinger KC. Colorectal cancer survivors’ needs and preferences for survivorship information. J Oncol Pract. 2014 Jul;10(4):e277-82.

Salz T, McCabe MS, Onstad EE, Baxi SS, Deming RL, Franco RA, Glenn LA, Harper GR, Jumonville AJ 4th, Payne RM, Peters EA, Salner AL, Schallenkamp JM, Williams SR, Yiee K, Oeffinger KC. Survivorship care plans: is there buy-in from community oncology providers? Cancer. 2014 Mar 1;120(5):722-30.

Sankin A, Hakimi AA, Mikkilineni N, Ostrovnaya I, Silk MT, Liang Y, Mano R, Chevinsky M, Motzer RJ, Solomon SB, Cheng EH, Durack JC, Coleman JA, Russo P, Hsieh JJ. The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling. Cancer Med. 2014 Aug 14. [Epub ahead of print]

Sauter CS, Barker JN, Lechner L, Zheng J, Devlin SM, Papadopoulos EB, Perales MA, Jakubowski AA, Goldberg JD, Koehne G, Ceberio I, Giralt S, Zelenetz AD, Moskowitz CH, Castro-Malaspina H. A phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with B cell lymphoid malignancies: favorably durable event-free survival in chemosensitive patients. Biol Blood Marrow Transplant. 2014 Mar;20(3):354-60.

Sauter CS, Chou JF, Papadopoulos EB, Perales MA, Jakubowski AA, Young JW, Scordo M, Giralt S, Castro-Malaspina H. A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies. Leuk Lymphoma. 2014 Mar 20. [Epub ahead of print]

Sauter CS, Lechner L, Scordo M, Zheng J, Devlin SM, Fleming SE, Castro-Malaspina H, Moskowitz CH. Pretransplantation fluorine-18-deoxyglucose—positron emission tomography scan lacks prognostic value in chemosensitive B cell non-hodgkin lymphoma patients undergoing nonmyeloablative allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2014 Jun;20(6):881-4.

Sävblom C, Halldén C, Cronin AM, Säll T, Savage C, Vertosick EA, Klein RJ, Giwercman A, Lilja H. Genetic variation in KLK2 and KLK3 is associated with concentrations of hK2 and PSA in serum and seminal plasma in young men. Clin Chem. 2014 Mar;60(3):490-9.

Schrag D, Weiser MR, Goodman KA, Gonen M, Hollywood E, Cercek A, Reidy-Lagunes DL, Gollub MJ, Shia J, Guillem JG, Temple LK, Paty PB, Saltz LB. Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. J Clin Oncol. 2014 Feb 20;32(6):513-8.

Schuler TA, Zaider TI, Li Y, Hichenberg S, Masterson M, Kissane DW. Typology of perceived family functioning in an American sample of patients with advanced cancer. J Pain Symptom Manage. 2014 Aug;48(2):281-8.

Scope A, Marghoob AA, Dusza SW, Oliveria SA, Halpern AC. Change in dermoscopic pattern of naevi in children: a commentary. Acta Derm Venereol. 2014 Jan;94(1):120-2.

Setton J, Lee NY, Riaz N, Huang SH, Waldron J, O’Sullivan B, Zhang Z, Shi W, Rosenthal DI, Hutcheson KA, Garden AS. A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy. Cancer. 2014 Oct 6. [Epub ahead of print]

Shapiro LQ, Sherman EJ, Riaz N, Setton J, Koutcher L, Zhang Z, Shi W, Fury MG, Wolden SL, Pfister DG, Morris L, Lee N. Efficacy of concurrent cetuximab vs.5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC). Oral Oncol. 2014 Oct;50(10):947-55.

Shen MJ, Coups EJ, Li Y, Holland JC, Hamann HA, Ostroff JS. The role of posttraumatic growth and timing of quitting smoking as moderators of the relationship between stigma and psychological distress among lung cancer survivors who are former smokers. Psychooncology. 2014 Oct 27. [Epub ahead of print]

Shi J, Qin LX. CORM: An R Package Implementing the Clustering of Regression Models Method for Gene Clustering. Cancer Inform. 2014;13(Suppl 4):11-13.

Shim JH, Song KY, Jeon HM, Park CH, Jacks LM, Gonen M, Shah MA, Brennan MF, Coit DG, Strong VE. Is gastric cancer different in Korea and the United States? Impact of tumor location on prognosis. Ann Surg Oncol. 2014 Jul;21(7):2332-9.

Shinbrot E, Henninger EE, Weinhold N, Covington KR, Göksenin AY, Schultz N, Chao

H, Doddapaneni H, Muzny DM, Gibbs RA, Sander C, Pursell ZF, Wheeler DA. Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication. Genome Res. 2014 Nov;24(11):1740-50.

Silberhumer GR, Paty PB, Temple LK, Araujo RL, Denton B, Gonen M, Nash GM, Allen PJ, DeMatteo RP, Guillem J, Weiser MR, D’Angelica MI, Jarnagin WR, W Wong D, Fong Y. Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. Am J Surg. 2014 Dec 13. [Epub ahead of print]

Silberstein JL, Bazzi WM, Vertosick E, Carver BS, Bosl GJ, Feldman DR, Bajorin DF, Motzer RJ, Al-Ahmadie H, Reuter VE, Sheinfeld J. Clinical outcomes of local and metastatic testicular sex cord-stromal tumors. J Urol. 2014 Aug;192(2):415-9.

Silberstein JL, Poon SA, Sjoberg DD, Maschino AC, Vickers AJ, Bernie A, Konety BR, Kelly WK, Eastham JA. Long term oncologic outcomes of a Phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients  with clinically localized, high-risk prostate cancer. BJU Int. 2014 Feb 19. [Epub ahead of print]

Sim HW, Morris PG, Patil S, Khasraw M. Brain metastases in breast cancer. Expert Rev Anticancer Ther. 2014 Feb;14(2):173-83.

Simpson AL, Geller DA, Hemming AW, Jarnagin WR, Clements LW, D’Angelica MI, Dumpuri P, Gönen M, Zendejas I, Miga MI, Stefansic JD. Liver planning software accurately predicts postoperative liver volume and measures early regeneration. J Am Coll Surg. 2014 Aug;219(2):199-207.

Sjoberg DD. Toward a Smarter Prostate Cancer Screening Program. Eur Urol. 2014 May 15. [Epub ahead of print]

Smith MR, Sweeney CJ, Corn PG, Rathkopf DE, Smith DC, Hussain M, George DJ, Higano CS, Harzstark AL, Sartor AO, Vogelzang NJ, Gordon MS, de Bono JS, Haas NB, Logothetis CJ, Elfiky A, Scheffold C, Laird AD, Schimmoller F, Basch EM, Scher HI. Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study. J Clin Oncol. 2014 Oct 20;32(30):3391-9.

Sofocleous CT, Garcia AR, Pandit-Taskar N, Do KG, Brody LA, Petre EN, Capanu M, Longing AP, Chou JF, Carrasquillo JA, Kemeny NE. Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy. Clin Colorectal Cancer. 2014 Mar;13(1):27-36.

Sofocleous CT, Petre EN, Gonen M, Reidy-Lagunes D, Ip IK, Alago W, Covey AM, Erinjeri JP, Brody LA, Maybody M, Thornton RH, Solomon SB, Getrajdman GI, Brown KT. Factors affecting periprocedural morbidity and mortality and long-term patient survival after arterial embolization of hepatic neuroendocrine metastases. J Vasc Interv Radiol. 2014 Jan;25(1):22-30; quiz 31.

Spaliviero M, Dalbagni G, Bochner BH, Poon BY, Huang H, Al-Ahmadie HA, Donahue TF, Taylor JM, Meeks JJ, Sjoberg DD, Donat SM, Reuter VE, Herr HW. Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder. J Urol. 2014 Sep;192(3):702-7.

Spaliviero M, Poon BY, Aras O, Di Paolo PL, Guglielmetti GB, Coleman CZ, Karlo CA, Bernstein ML, Sjoberg DD, Russo P, Touijer KA, Akin O, Coleman JA. Interobserver variability of R.E.N.A.L., PADUA, and centrality index nephrometry score systems. World J Urol. 2014 Aug 24. [Epub ahead of print]

Spratt DE, Zumsteg ZS, Pei X, Romesser PB, Yamada J, Kollmeier MA, Woo K, Zhang Z, Zelefsky MJ. Predictors of castration-resistant prostate cancer after dose-escalated external beam radiotherapy.Prostate. 2015 Feb;75(2):175-82.

Stattin P, Carlsson S, Holmström B, Vickers A, Hugosson J, Lilja H, Jonsson H. Prostate cancer mortality in areas with high and low prostate cancer incidence. J Natl Cancer Inst. 2014 Mar;106(3):dju007.

Suidan RS, Ramirez PT, Sarasohn DM, Teitcher JB, Mironov S, Iyer RB, Zhou Q, Iasonos A, Paul H, Hosaka M, Aghajanian CA, Leitao MM Jr, Gardner GJ, Abu-Rustum NR, Sonoda Y, Levine DA, Hricak H, Chi DS. A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer. Gynecol Oncol. 2014 Sep;134(3):455-61.

Sung JS, Li J, Da Costa G, Patil S, Van Zee KJ, Dershaw DD, Morris EA. Preoperative breast MRI for early-stage breast cancer: effect on surgical and long-term outcomes. AJR Am J Roentgenol. 2014 Jun;202(6):1376-82.

Sweldens C, Peeters S, van Limbergen E, Janssen H, Laenen A, Patil S, Van Zee KJ, Weltens C. Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram. Cancer J. 2014 Jan-Feb;20(1):1-7.

Swisher-McClure S, Mitra N, Woo K, Smaldone M, Uzzo R, Bekelman JE. Increasing use of dose-escalated external beam radiation therapy for men with nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):103-12.

Tang H, Wei P, Duell EJ, Risch HA, Olson SH, Bueno-de-Mesquita HB, Gallinger S, Holly EA, Petersen G, Bracci PM, McWilliams RR, Jenab M, Riboli E, Tjønneland A, Boutron-Ruault MC, Kaaks R, Trichopoulos D, Panico S, Sund M, Peeters PH, Khaw KT, Amos CI, et al. Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS data. Carcinogenesis. 2014 May;35(5):1039-45.

Tang H, Wei P, Duell EJ, Risch HA, Olson SH, Bueno-de-Mesquita HB, Gallinger S, Holly EA, Petersen GM, Bracci PM, McWilliams RR, Jenab M, Riboli E, Tjønneland A, Boutron-Ruault MC, Kaaks R, Trichopoulos D, Panico S, Sund M, Peeters PH, Khaw KT, Amos CI, et al. Genes-environment interactions in obesity- and diabetes-associated pancreatic cancer: a GWAS data analysis. Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):98-106.

Tan MCB, Brennan M, Kuk D, Agaram N, Antonescu C, Qin L, Moraco N, Crago AM, Singer S. Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma. Ann Surg 2015:in press. PMID: 25307738

Tarin T, Feifer A, Kimm S, Chen L, Sjoberg D, Coleman J, Russo P. Impact of a common clinical pathway on length of hospital stay in patients undergoing open and minimally invasive kidney surgery. J Urol. 2014 May;191(5):1225-30.

Taylor JM, Yaneva M, Velasco K, Philip J, Erdjument-Bromage H, Ostrovnaya I, Lilja HG, Bochner BH, Tempst P. Aminopeptidase activities as prospective urinary biomarkers for bladder cancer. Proteomics Clin Appl. 2014 Jun;8(5-6):317-26.

Taylor NJ, Reiner AS, Begg CB, Cust AE, Busam KJ, Anton-Culver H, Dwyer T, From L, Gallagher RP, Gruber SB, Rosso S, White KA, Zanetti R, Orlow I, Thomas NE, Rebbeck TR, Berwick M, Kanetsky PA; on behalf of the GEM Study Group. Inherited variation at MC1R and ASIP and association with melanoma-specific survival. Int J  Cancer. 2014 Nov 10.

Terezakis S, Morikawa L, Wu AJ, Zhang Z, Shi W, Weiser MR, Paty PB, Guillem J, Temple L, Nash GM, Zelefsky MJ, Goodman KA. Long-term survival after high-dose rate intraoperative radiotherapy (HDR-IORT) for locally advanced or recurrent colorectal adenocarcinoma. Ann Surg Oncol. (In Press).

Terezakis SA, Schöder H, Kowalski A, McCann P, Lim R, Turlakov A, Gonen M, Barker C, Goenka A, Lovie S, Yahalom J. A prospective study of ¹⁸FDG-PET with CT coregistration for radiation treatment planning of lymphomas and other hematologic malignancies. Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):376-83.

Thomas NE, Kricker A and other authors including Orlow I, Reiner AS and Begg CB. Comparison of Clinicopathologic Features and Survival of Histopathologically Amelanotic and Pigmented Melanomas: A Population-Based Study. JAMA Dermatol. 2014 Dec 1;150(12):1306-1314.

Trakarnsanga A, Gönen M, Shia J, Nash GM, Temple LK, Guillem JG, Paty PB, Goodman KA, Wu A, Gollub M, Segal N, Saltz L, Garcia-Aguilar J, Weiser MR. Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment. J Natl Cancer Inst. 2014 Sep 22;106(10).

Touijer KA, Mazzola CR, Sjoberg DD, Scardino PT, Eastham JA. Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. Eur Urol. 2014 Jan;65(1):20-5.

Touijer KA, Mazzola CR, Sjoberg DD, Scardino PT, Eastham JA. Reply to Michael Froehner, Rainer Koch, and Manfred P. Wirth’s letter to the editor re: Karim A. Touijer, Clarisse R. Mazzola, Daniel D. Sjoberg, Peter T. Scardino, James A. Eastham. Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. Eur Urol 2014;65:20-5.

Trabert B, Ness RB and other authors including Olson SH and Pike MC. Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst. 2014 Feb;106(2):djt431.

Tuman MM, Lichthenthal WG, Corner G, Beard C, Duhamel K, Sweeney C, Farberov, Roberts K, Blinder V, Breitbard W. (04/01/2014. “Fear of breast cancer recurrent:The importance of personalized interventions”.  Annals of behavioral medicine (0883-6612),47(supp.1),p. S104

Ugras S, Stempel M, Patil S, Morrow M. Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvement. Ann Surg Oncol. 2014 Nov;21(12):3780-6.

Ulaner GA, Lilienstein J, Gönen M, Maragulia J, Moskowitz CH, Zelenetz AD. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma. J Clin Oncol. 2014 Jan 1;32(1):51-6.

Ulbricht C, Basch E, Cheung L, Goldberg H, Hammerness P, Isaac R, Khalsa KP, Romm A, Rychlik I, Varghese M, Weissner W, Windsor RC, Wortley J. An evidence-based systematic review of elderberry and elderflower (Sambucus nigra) by the Natural Standard Research Collaboration. J Diet Suppl. 2014 Mar;11(1):80-120.

Väänänen RM, Lilja H, Kauko L, Helo P, Kekki H, Cronin AM, Vickers AJ, Nurmi M, Alanen K, Bjartell A, Pettersson K. Cancer-associated changes in the expression of TMPRSS2-ERG, PCA3, and SPINK1 in histologically benign tissue from cancerous vs noncancerous prostatectomy specimens. Urology. 2014 Feb;83(2):511.e1-7.

Valerio M, Donaldson I, Emberton M, Ehdaie B, Hadaschik BA, Marks LS, Mozer P, Rastinehad AR, Ahmed HU. Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review. Eur Urol. 2014 Nov 1.

Valerio M, Emberton M, Barret E, Eberli D, Eggener SE, Ehdaie B, Jichlinski P, Ward JF, Ahmed HU. Health technology assessment in evolution - focal therapy in localised prostate cancer. Expert Rev Anticancer Ther. 2014 Nov;14(11):1359-67.

Van Allen EM, Mouw KW, Kim P, Iyer G, Wagle N, Al-Ahmadie H, Zhu C, Ostrovnaya I, Kryukov GV, O’Connor KW, Sfakianos J, Garcia-Grossman I, Kim J, Guancial EA, Bambury R, Bahl S, Gupta N, Farlow D, Qu A, Signoretti S, Barletta JA, Reuter V,  et al. Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma. Cancer Discov. 2014 Oct;4(10):1140-53.

Van Calster B, Vickers AJ. Calibration of Risk Prediction Models: Impact on Decision-Analytic Performance. Med Decis Making. 2014 Aug 25.

van den Bos W, Muller BG, Ehdaie B, Scardino P, de la Rosette JJ. What is still needed to make focal therapy an accepted segment of standard therapy? Curr Opin Urol. 2014 May;24(3):247-55.

van der Steen A, Knudsen AB, van Hees F, Walter GP, Berger FG, Daguise VG, Kuntz KM, Zauber AG, van Ballegooijen M, Lansdorp-Vogelaar I. Optimal Colorectal Cancer Screening in States’ Low-Income, Uninsured Populations-The Case of South Carolina. Health Serv Res. 2014 Oct 16.

van Hees F, Habbema JD, Meester RG, Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG. Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med. 2014 Jun 3;160(11):750-9.

van Hees F, Zauber AG, Klabunde CN, Goede SL, Lansdorp-Vogelaar I, van Ballegooijen M. The appropriateness of more intensive colonoscopy screening than recommended in medicare beneficiaries: a modeling study. JAMA Intern Med. 2014 Oct;174(10):1568-76.

Vargas HA, Donati OF, Wibmer A, Goldman DA, Mulhall JP, Sala E, Hricak H. Association between penile dynamic contrast-enhanced MRI-derived quantitative parameters and self-reported sexual function in patients with newly diagnosed prostate cancer. J Sex Med. 2014 Oct;11(10):2581-8.

Vargas HA, Miccò M, Hong SI, Goldman DA, Dao F, Weigelt B, Soslow RA, Hricak H, Levine DA, Sala E. Association between Morphologic CT Imaging Traits and Prognostically Relevant Gene Signatures in Women with High-Grade Serous Ovarian Cancer: A Hypothesis-generating Study. Radiology. 2014 Nov 10:141477.

Vargas HA, Wassberg C, Fox JJ, Wibmer A, Goldman DA, Kuk D, Gonen M, Larson SM, Morris MJ, Scher HI, Hricak H. Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival. Radiology. 2014 Apr;271(1):220-9.

Vedder MM, de Bekker-Grob EW, Lilja HG, Vickers AJ, van Leenders GJ, Steyerberg EW, Roobol MJ. The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men. Eur Urol. 2014 Dec;66(6):1109-15.

Vertosick EA, Poon BY, Vickers AJ. Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screening. J Urol. 2014 Sep;192(3):724-8.

Vickers A, Carlsson S, Laudone V, Lilja H. It ain’t what you do, it’s the way you do it: five golden rules for transforming prostate-specific antigen screening. Eur Urol. 2014 Aug;66(2):188-90.

Vickers AJ, Edwards K, Cooperberg MR, Mushlin AI. A simple schema for informed decision making about prostate cancer screening. Ann Intern Med. 2014 Sep 16;161(6):441-2.

Vickers AJ, Kent M, Mulhall J, Sandhu J. Counseling the post-radical prostatectomy patients about functional recovery: high predictiveness of current status. Urology. 2014 Jul;84(1):158-63.

Vickers AJ, Kent M. Reply on: Counseling the post-radical prostatectomy patients about functional recovery: high predictiveness of current status. Urology. 2014 Jul;84(1):163.

Vickers AJ, Linde K. Acupuncture for chronic pain. JAMA. 2014 Mar 5;311(9):955-6.

Vickers AJ, Pepe M. Does the net reclassification improvement help us evaluate models and markers? Ann Intern Med. 2014 Jan 21;160(2):136-7.

Vickers AJ, Sjoberg DD, Ulmert D, Vertosick E, Roobol MJ, Thompson I, Heijnsdijk EA, De Koning H, Atoria-Swartz C, Scardino PT, Lilja H. Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen.BMC Med. 2014 Feb 11;12:26.

Vickers AJ, Sjoberg DD. Guidelines for Reporting of Statistics in European Urology. Eur Urol. 2014 Jul 15.

Vickers AJ, Thompson IM, Klein E, Carroll PR, Scardino PT.A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer. Urology. 2014 Mar;83(3):592-6.

Vickers AJ. Clinical trials in crisis: Four simple methodologic fixes. Clin Trials. 2014 Dec;11(6):615-21.

Vickers AJ. Markers for the Early Detection of Prostate Cancer: Some Principles for Statistical Reporting and Interpretation. J Clin Oncol. 2014 Nov 3.

Vickers AJ. Response from the author. Clin Trials. 2014 Dec;11(6):628.

Vickers AJ. What are the implications of the surgical learning curve? Eur Urol. 2014 Mar;65(3):532-3.

Viswanathan M, Halpern M, Swinson Evans T, Birken SA, Mayer DK, Basch E. Models of Cancer Survivorship Care [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Mar.

Voss MH, Hakimi AA, Pham CG, Brannon AR, Chen YB, Cunha LF, Akin O, Liu H, Takeda

S, Scott SN, Socci ND, Viale A, Schultz N, Sander C, Reuter VE, Russo P, Cheng EH, Motzer RJ, Berger MF, Hsieh JJ. Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy. Clin Cancer Res. 2014 Apr 1;20(7):1955-64.

Vuong K, McGeechan K, Armstrong BK; AMFS Investigators; GEM Investigators (Begg CB and Orlow I, Members), Cust AE. Occupational sun exposure and risk of melanoma according to anatomical site. Int J Cancer. 2014 Jun 1;134(11):2735-41.

Wang H, Sima CS, Beasley MB, Illei P, Saqi A, Nonaka D, Geisinger KR, Huang J, Moreira AL. Classification of thymic epithelial neoplasms is still a challenge to thoracic pathologists: a reproducibility study using digital microscopy. Arch Pathol Lab Med. 2014 May;138(5):658-63.

Wang LC, Xylinas E, Kent MT, Kluth LA, Rink M, Jamzadeh A, Rieken M, Al Awamlh BA, Trinh QD, Sun M, Karakiewicz PI, Novara G, Chrystal J, Zerbib M, Scherr DS, Lotan Y, Vickers A, Shariat SF. Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder. Urol Oncol. 2014 May;32(4):433-40.

Wang M, Subramanian M, Abramowicz S, Murphy AJ, Gonen A, Witztum J, Welch C, Tabas I, Westerterp M, Tall AR. Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency. Arterioscler Thromb Vasc Biol. 2014 May;34(5):976-84.

Wang Z, Zhu B and other authors including Olson SH and Pike MC. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.Hum Mol Genet. 2014 Dec 15;23(24):6616-33.

Wanjala J, Taylor BS, Chapinski C, Hieronymus H, Wongvipat J, Chen Y, Nanjangud GJ, Schultz N, Xie Y, Liu S, Lu W, Yang Q, Sander C, Chen Z, Sawyers CL, Carver BS. Identifying actionable targets through integrative analyses of GEM model and human prostate cancer genomic profiling. Mol Cancer Ther. 2014 Nov 7.

Weigelt B, Ng CK, Shen R, Popova T, Schizas M, Natrajan R, Mariani O, Stern MH, Norton L, Vincent-Salomon A, Reis-Filho JS. Metastatic breast carcinomas display genomic and transcriptomic heterogeneity. Mod Pathol. 2014 Nov 21.

Weinhold N, Jacobsen A, Schultz N, Sander C, Lee W. Genome-wide analysis of noncoding regulatory mutations in cancer. Nat Genet. 2014 Nov;46(11):1160-5.

Weinstein JN, Schultz N,et al. The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.

Weiss CO, Varadhan R, Puhan MA, Vickers A, Bandeen-Roche K, Boyd CM, Kent DM. Multimorbidity and evidence generation. J Gen Intern Med. 2014 Apr;29(4):653-60.

Wesa KM, Cunningham-Rundles S, Klimek VM, Vertosick E, Coleton MI, Yeung KS, Lin H, Nimer S, Cassileth BR. Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study. Cancer Immunol Immunother. 2014 Oct 29.

Westhoff CL, Pike MC, Tang R, DiNapoli MN, Sull M, Cremers S. Estimating systemic exposure to ethinyl estradiol from an oral contraceptive. Am J Obstet Gynecol. 2014 Dec 12. [Epub ahead of print]

Wheeler SB, Basch E. Cancer care research in North Carolina: the state of the state. N C Med J. 2014 Jul-Aug;75(4):248-52.

Wibmer A, Vargas HA, Sosa R, Zheng J, Moskowitz C, Hricak H. Value of a standardized lexicon for reporting levels of diagnostic certainty in prostate MRI. AJR Am J Roentgenol. 2014 Dec;203(6):W651-7.

Willis JA, Mukherjee S, Orlow I, Viale A, Offit K, Kurtz RC, Olson SH, Klein RJ. Genome-wide analysis of the role of copy-number variation in pancreatic cancer risk. Front Genet. 2014;5:29.

Wilt TJ, Scardino PT, Carlsson SV, Basch E. Prostate-specific antigen screening in prostate cancer: perspectives on the evidence. J Natl Cancer Inst. 2014 Mar;106(3):dju010.

Winters-Stone KM, Laudermilk M, Woo K, Brown JC, Schmitz KH. Influence of weight training on skeletal health of breast cancer survivors with or at risk for breast cancer-related lymphedema. J Cancer Surviv. 2014 Jun;8(2):260-8.

Wolpin BM, Rizzato C and other authors including Olson SH. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nat Genet. 2014 Sep;46(9):994-1000.

Wong AC, Stock S, Schrag D, Kahn KL, Salz T, Charlton ME, Rogers SO Jr, Goodman KA, Keating NL. Physicians’ Beliefs About the Benefits and Risks of Adjuvant Therapies for Stage II and Stage III Colorectal Cancer. J Oncol Pract. 2014 Sep;10(5):e360-7.

Wood WA, Bennett AV, Basch E. Emerging uses of patient generated health data in clinical research. Mol Oncol. 2014 Aug 27.

Wood WA, Deal AM, Bennett AV, Mitchell SA, Abernethy AP, Basch E, Bailey C, Reeve BB. Comparison of Seven-Day and Repeated 24-Hour Recall of Symptoms in the First 100 Days After Hematopoietic Cell Transplantation.J Pain Symptom Manage. 2014 Aug 13.

Wu X, Oliveria SA, Yagerman S, Chen L, DeFazio J, Braun R, Marghoob AA. Feasibility and efficacy of patient-initiated mobile teledermoscopy for short term monitoring of clinically atypical nevi. JAMA Dermatol. Accepted for publication on  September 14, 2014. (In Press).

Yaeger R, Cercek A, Chou JF, Sylvester BE, Kemeny NE, Hechtman JF, Ladanyi M, Rosen N, Weiser MR, Capanu M, Solit DB, D’Angelica MI, Vakiani E, Saltz LB. BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer. Cancer. 2014 Aug 1;120(15):2316-24.

Yaeger R, Cowell E, Chou JF, Gewirtz AN, Borsu L, Vakiani E, Solit DB, Rosen N, Capanu M, Ladanyi M, Kemeny N. RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer. Cancer. 2014 Dec 9.

Yang TJ, Oh JH, Folkert MR, Gupta G, Shi W, Zhang Z, Morikawa A, Seidman A, Brennan C, Yamada Y, Chan TA, Beal K. Outcomes and prognostic factors in women with 1 to 3 breast cancer brain metastases treated with definitive stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):518-25.

Ye J, Zhou Y, Weiser MR, Gönen M, Zhang L, Samdani T, Bacares R, DeLair D, Ivelja S, Vakiani E, Klimstra DS, Soslow RA, Shia J. Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors with medullary histology and high TNM stage. Hum Pathol. 2014 Dec;45(12):2430-6.

Yeh YC, Nitadori JI, Kadota K, Yoshizawa A, Rekhtman N, Moreira AL, Sima CS, Rusch VW, Adusumilli PS, Travis WD. Using Frozen Section to Identify Histologic Patterns in Stage I Lung Adenocarcinoma ≤ 3 cm: Accuracy and Interobserver Agreement. Histopathology. 2014 May 29.

Young RJ, Lee V, Peck KK, Sierra T, Zhang Z, Jacks LM, Holodny AI. Diffusion tensor imaging and tractography of the corticospinal tract in the presence of enlarged Virchow-Robin spaces. J Neuroimaging 2014;24:79-82.

Yu HA, Sima CS, Shen R, Kass S, Gainor J, Shaw A, Hames M, Iams W, Aston J, Lovly CM, Horn L, Lydon C, Oxnard GR, Kris MG, Ladanyi M, Riely GJ. Prognostic impact of KRAS mutation subtypes in 677 patients with metastatic lung adenocarcinomas. J Thorac Oncol. 2014 Nov 20.

Yuan J, Zhou J, Dong Z, Tandon S, Kuk D, Panageas KS, Wong P, Wu X, Naidoo J, Page DB, Wolchok JD, Hodi FS. Pretreatment serum VEGF is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab. Cancer Immunol Res. 2014 Feb;2(2):127-32.

Zauderer MG, Drilon A, Kadota K, Huberman K, Sima CS, Bergagnini I, Sumner DK, Travis WD, Heguy A, Ginsberg MS, Holodny AI, Riely GJ, Kris MG, Krug LM, Pietanza MC. Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase. Lung Cancer. 2014 Nov;86(2):237-40.

Zauderer MG, Kass SL, Woo K, Sima CS, Ginsberg MS, Krug LM. Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesothelioma. Lung Cancer. 2014 Jun;84(3):271-4.

Zelnick LR, Morrison LJ, Devlin SM, Bulger EM, Brasel KJ, Sheehan K, Minei JP, Kerby JD, Tisherman SA, Rizoli S, Karmy-Jones R, van Heest R, Newgard CD; Resuscitation Outcomes Consortium Investigators. Addressing the challenges of obtaining functional outcomes in traumatic brain injury research: missing data patterns, timing of follow-up, and three prognostic models. J Neurotrauma. 2014 Jun 1;31(11):1029-38.

Zhang H, Huang R, Cheung NK, Guo H, Zanzonico PB, Thaler HT, Lewis JS, Blasberg RG. Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.Clin Cancer Res. 2014 Apr 15;20(8):2182-91.

Zhang LR, Morgenstern H, Greenland S, Chang SC, Lazarus P, Teare MD, Woll PJ, Orlow I, Cox B; on behalf of the Cannabis and Respiratory Disease Research Group of New Zealand, Brhane Y, Liu G, Hung RJ. Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium. Int J Cancer. 2014 Jun 20.

Zhou Q, Huang HC, Qin LX. Preprocessing steps for Agilent microRNA arrays: does the order matter. Cancer Informatics. (In press.)

Zumsteg ZS, Spratt DE, Romesser PB, Pei X, Zhang Z, Polkinghorn W, McBride S, Kollmeier M, Yamada Y, Zelefsky MJ. The Natural History and Predictors of Outcome Following Biochemical Relapse in the Dose Escalation Era for Prostate Cancer Patients Undergoing Definitive External Beam Radiotherapy. Eur Urol. 2014 Oct 9.

Abou-Alfa GK, Capanu M, O’Reilly EM, Ma J, Chou JF, Gansukh B, Shia J, Kalin M, Katz S, Abad L, Reidy-Lagunes DL, Kelsen DP, Chen HX, Saltz LB. A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma. Journal of Hepatology 2014;60(2):319-324.

Albornoz CR, Bach PB, Mehrara BJ, Disa JJ, Pusic AL, McCarthy CM, Cordeiro PG, Matros E. A paradigm shift in U.S. Breast reconstruction: increasing implant rates. Plastic and Reconstructive Surgery 2013;131(1):15-23.

Amankulor NM, Xu R, Iorgulescu JB, Chapman T, Reiner AS, Riedel E, Lis E, Yamada Y, Bilsky M, Laufer I. The incidence and patters of hardware failure after separation surgery in patients with spinal metastatic tumors. Spine Journal 2013;S1529-9430(13):1623-1629.

Ang CS, Kelley RK, Choti MA, Cosgrove DP, Chou JF, Klimstra D, Torbenson MS, Ferrell L, Pawlik TM, Fong Y, O’Reilly EM, Ma J, McGuire J, Vallarapu GP, Griffin A, Stipa F, Capanu M, Dematteo RP, Venook AP, Abou-Alfa GK. Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium. Gastrointestal Cancer Research 2013;6(1):3-9.

Ang CS, Sun MY, Huitzil-Melendez DF, Chou JF, Capanu M, Jarnagin W, Fong Y, Dematteo RP, D’Angelica M, Allen P, Chen CT, O’Reilly EM, Weiser MR, Abou-Alfa GK. c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival. Anticancer Research 2013;33(8):3241-3245.

Apolo AB, Ostrovnaya I, Halabi S, Iasonos A, Philips GK, Rosenberg JE, Riches J, Small EJ, Milowsky MI, Bajorin DF. Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy. Journal of the National Cancer Institute 2013;105(7):499-503.

Araujo RL, Karkar Am, Allen PJ, Gönen M, Chou JF, Brennan MF, Blumgart LH, D’Angelica MI, Dematteo RP, Coit DG, Fong Y, Jarnagin WR. Timing of elective surgery as a preioperative outcome variable: analysis of pancreaticoduodenectomy. International Hepato-Pancreato-Biliary Association 2013;[epub ahead of print].

Arsov C, Becker N, Hadaschik BA, Hohenfellner M, Herkommer K, Gschwend JE, Imkamp F, Kuczyk MA, Antoch G, Kristiansen G, Siener R, Semjonow A, Hamdy FC, Lilja H, Vickers AJ, Schroder FH, Albers P. Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men: the PROBASE trial. European Urology 2013;64(6):873-875.

Autio KA, Bennett AV, Jia X, Fruscione M, Beer TM, George DJ, Carducci MA, Logothetis CJ, Kane RC, Sit L, Rogak L, Morris MJ, Scher HI, Basch EM. Prevalence of pain and analgesic use in men with metastatic prostate cancer using a patient-reported outcome measure. Journal of Oncology Practice 2013;9(5):223-229.

Autio KA, Pandit-Taskar N, Carrasquillo JA, Stephenson RD, Slovin SF, Rathkopf DE, Hong C, Heller G, Scher HI, Larson SM, Morris MJ. Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer. Cancer 2013;119(17):3186-3194.

Bach PB. Raising the Bar for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2013;[epub ahead of print].

Bach PB. Perilous potential: The chance to save lives, or lose them, through low dose computed tomography screening for lung cancer. Journal of Surgical Oncology 2013;108(5):287-288.

Bach PB. Reforming the payment system for medical oncology. Journal of the American Medical Association 2013;310(3):261-262.

Bach PB. Visions of hope in cancer: focus on infrastructure: comment on “characteristics of oncology clinical trials” and “toward accountable cancer care”. JAMA Internal Medicine 2013; 173(11):979-980.

Balar AV, Apolo A, Ostrovnaya I, Mironov S, Iasonos A, Trout A, Regazzi AM, Garcia-Grossman IR, Gallagher DJ, Milowsky MI, Bajorin DF. Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer. Journal of Clinical Oncology 2013;31(6):724-730.

Baldwin MR, Narain WR, Wunsch H, Schluger NW, Cooke JT, Maurer MS, Rowe JW, Lederer DJ, Bach PB. A prognostic model for 6-month mortality in elderly survivors of critical illness. Chest 2013;143(4):910-919.

Barlin JN, Soslow RA, Lutz M, Zhou QC, St Clair CM, Leitao MM Jr, Iasonos A, Hensley ML, Barakat RR, Matias-Guiu X, Abu-Rustum NR. Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment. International Journal of Gynecological Cancer 2013;23(9):1620-1628.

Barlin JN, Zhou Q, St Clair CM, Iasonos A, Soslow RA, Alektiar KM, Hensley ML, Leitao MM Jr, Barakat RR, Abu-Rustum NR. Classification and regression tree (CART) analysis of endometrial carcinoma: Seeing the forest for the trees. Gynecological Oncology 2013; 130(3):452-456.

Baxi SS, Pinheiro LC, Patil SM, Pfister DG, Oeffinger KC, Elkin EB. Causes of death in long-term survivors of head and neck cancer. Cancer 2013;(in press).

Begg CB, Gönen M, Seshan VE. Testing the incremental predictive accuracy of new markers. Clinical Trials 2013;10(5):690-692.

Begg CB, Zabor EC, Bernstein JL, Bernstein L, Press MF, Seshan VE. A conceptual and methodological framework for investigating etiologic heterogeneity. Statistics in Medicine 2013;32(29):5039-5052.

Begg CB. Justifying the choice of endpoints for clinical trials. Journal of the National Cancer Institute 2013;105(21):1594-1595.

Bello DM, Chou JF, Panageas KS, Brady MS, Coit DG, Carvajal RD, Ariyan CE. Prognosis of acral melanoma: a series of 281 patients. Annals of Surgical Oncology 2013;20(11):3618-3625.

Berman E, Girotra M, Cheng C, Chanel S, Maki R, Shelat M, Strauss HW, Fleisher M, Heller G, Farooki A. Effect of long term imatinib on bone in adults with chronic myelogenous leukemia and gastrointestinal stromal tumors. Leukemia Research 2013;37(7):790-794.

Bernstein JL, Thomas DC, Shore RE, Robson M, Boice JD Jr, Stovall M, Andersson M, Bernstein L, Malone KE, Reiner AS, Lynch CF, Capanu M, Smith SA, Tellhed L, Teraoka SN, Begg CB, Olsen JH, Mellemkjaer L, Liang X, Diep AT, Borg A, Concannon P, Haile RW; WECARE Study Collaborative Group. Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report. European Journal of Cancer 2013;49(14):2979-2985.

Berwick M, MacArthur J, Orlow I, Kanetsky P, Begg CB, Luo L, Reiner A, Sharma A, Armstrong BK, Kricker Anne, Cust AE, Marrett LD, Gruber SB, Anton-Culver H, Zanetti R, Rosso S, Gallagher RP, Dwyer T, Venn A, Busam K, From L, White K, Thomas NE for the GEM Study Group. MITF E318K’s effect on melanoma risk independent of, but modified by, other risk factors. Pigment Cell & Melanoma Research 2014;[epub ahead of print].

Blinder V, Patil S, Eberle C, Griggs J, Maly RC. Early predictors of not returning to work in low-income breast cancer survivors: a 5-year longitudinal study. Breast Cancer Research and Treatment 2013;140(2):407-416.

Blinder VS. Editorial comment. Breast Diseases: A Year Book Quarterly 2013;24(13):265-267.

Blinder VS, Griggs JJ. Health disparities and the cancer survivor. Seminars in Oncology 2013;40(6):796-803.

Blinder VS, Norris VW, Peacock NW, Griggs JJ, Harrington DP, Moore A, Theriault RL, Partridge AH; American Society of Clinical Oncology Breast Cancer Registry Pilot Steering Group. Patient perspectives on breast cancer treatment plan and summary documents in community oncology care: a pilot program. Cancer 2013;119(1):164-172.

Blinder VS. Lack of patient-reported outcomes assessment in phase III breast cancer studies: a missed opportunity for informed decision making. Annals of Palliative Medicine 2013;(in press).

Bojesen SE, Pooley KA and other authors including Olson SH, Orlow I and Pike MC. Multiple independent TERT variants associated with telomere length and risks of breast and ovarian cancer. Nature Genetics 2013;45(4):371-384, 384e1-2.

Bokacheva L, Kaplan JB, Giri DD, Patil S, Gnanasigamani M, Nyman CG, Deasy JO, Morris EA, Thakur SB. Intravoxel incoherent motion diffusion-weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchyma. Journal of Magnetic Resonance Imaging 2013;[epub ahead of print].

Bombard Y, Bach PB, Offit K. Translating genomics in cancer care. Journal of the National Comprehensive Cancer Network 2013;11(11):1343-1353.

Bosetti C, Lucenteforte E, Bracci PM, Ji BT, Negri E, Neale RE, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Holly EA, Gao YT, Yu H, Kurtz RC, Cotterchio M, Maisonneuve P, Zeegers MP, Duell EJ, Boffetta P, LaVecchia C. Ulcer, gastric surgery and pancreatic cancer risk: an analysis from the international Pancreatic Cancer Case-Control Consortium. Annals of Oncology 2013;24(11):2903-2910.

Braun K, Ahallal Y, Sjoberg DD, Ghoneim T, Dominguez Esteban M, Mulhall J, Vickers A, Eastham J, Scardino PT, Touijer KA. Effect of repeated prostate biopsies on erectile function in men on active surveillance for prostate cancer. Journal of Urology 2013;[epub ahead of print].

Brennan C, Yang TJ, Hilden P, Zhang Z, Chan K, Yamada Y, Chan TA, Lymberis SC, Narayana A, Tabar V, Gutin PH, Ballangrud A, Lis E, Beal K. A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases. International Journal of Radiation Oncology, Biology, Physics 2014;88(1):130-136.

Brooks JD, Teraoka S, Malone K, Haile R, Bernstein L, Lynch CF, Mellemkjaer L, Duggan D, Reiner AS, Lewinger J, Figueiredo J, Bernstein JL. Variants in tamoxifen metabolizing genes: A case-control study of contralateral breast cancer risk in the WECARE Study. International Journal of Molecular Epidemiology and Genetics 2013;4(1):35-48.

Brooks JD, Teraoka SN, Bernstein L, Mellemkjær L, Malone KE, Lynch CF, Haile RW, Concannon P, Reiner AS, Duggan DJ, Schiermeyer K; WECARE Study Collaborative Group, Bernstein JL, Figueiredo JC. Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study. Cancer Causes and Control 2013;24(8):1605-1614.

Burger IA, Vargas HA, Goldman DA, Gönen M, Kumar A, Zelenetz AD, Schöder H, Hricak H. The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin’s lymphoma. Eur opean Journal of Nuclear Medicine and Molecular Imaging 2013;40(5):701-707.

Burger IA, Vargas HA, Donati OF, Andikyan V, Sala E, Gönen M, Goldman DA, Chi DS, Schöder H, Hricak H. The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration. Gynecologic Oncology 2013;129(3):586-592.

Butte JM, Torres J, Veras EF, Matsuo K, Gönen M, D’Angelica MI, Waugh E, Meneses M, Inayama Y, Fong Y, Dematteo RP, De La Fuente H, Endo I, Klimstra DS, Jarnagin WR. Regional differences in gallbladder cancer pathogenesis: insights from a comparison of cell cycle-regulatory, PI3K, and pro-angiogenic protein expression. Annals of Surgical Oncology 2013;20(5):1470-1481.

Cancer Genome Atlas Research Network (Shen R, Member). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013;499(7456):43-49.

Cancer Genome Atlas Research Network (Shen R, Member). Integrated genomic characterization of endometrial carcinoma. Nature 2013;497(7447):67-73.

Cancer Genome Atlas Research Network (Shen R, Member). The Cancer Genome Atlas Pan-Cancer analysis project. Nature Genetics 2013;45(10):1113-1120.

Cancer Genome Atlas Research Network (Shen R, Member). The somatic genomic landscape of glioblastoma. Cell 2013;155(2):462-477.

Cancer Genome Atlas Research Network (Ostrovnaya I, Member). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013;499(7456):43-49.

Capanu M, Gönen M, Begg CB. An assessment of estimation methods for generalized linear mixed models with binary outcomes. Statistics in Medicine 2013;32(26):4550-4566.

Cardona K, Zhou Q, Gönen M, Shah MA Strong VE, Brennan MF, Coit DG. Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy. Annals of Surgical Oncology 2013;20(2):548-554.

Carlsson SV, Ehdaie B, Atoria CL, Elkin EB, Eastham JA. Risk of incisional hernia after minimally invasive and open radical prostatectomy. Journal of Urology 2013;190(5):1757-1762.

Carlsson S, Maschino A, Schroder F, Bangma C, Steyerberg EW, van der Kwast T, van Leenders G, Vickers A, Lilja H, Roobol MJ. Predictive value of four kallikrein markers for pathologically insignificant compared with aggressive prostate cancer in radical prostatectomy specimens: results from the European Randomized Study of Screening for Prostate Cancer section Rotterdam. European Urology 2013;64(5):693-699.

Carlsson S, Sandin F, Fall K, Lambe M, Adolfsson J, Stattin P, Bill-Axelson A. Risk of suicide in men with low-risk prostate cancer. European Journal of Cancer 2013;49(7):1588-1599.

Carlsson S, Vickers A, Hugosson J. Four-hundredfold overestimation of biopsy mortality. BJU International 2013;111(3):E16-E17.

Carlsson SV, Ehdaie B, Atoria CL, Elkin EB, Eastham JA. Risk of incisional hernia after minimally invasive and open radical prostatectomy. Journal of Urology 2013;190(5):1757-1762.

Carlsson SV, Peltola MT, Sjoberg D, Schroder FH, Hugosson J, Pettersson K, Scardino PT, Vickers AJ, Lilja H, Roobol MJ. Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk? BJU International 2013;112(5):602-609.

Carlsson SV, Tafe LJ, Chade DC, Sjoberg DD, Passoni N, Shariat SF, Eastham J, Scardino PT, Fine SW, Touijer KA. Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer. Journal of Urology 2013;189(4):1314-1318.

Carvajal-Carmona LG, Zauber AG, Jones AM, Howarth K, Wang J, Cheng T; APC Trial Collaborators; APPROVe Trial Collaborators; CORGI Study Collaborators; Colon Cancer Family Registry Collaborators; CGEMS Collaborators, Riddell R, Lanas A, Morton D, Bertagnolli MM, Tomlinson I. Much of the population genetic risk of colorectal cancer is likely to be mediated through susceptibility to adenomas. Gastroenterology 2013;144(1):53-55.

Cassileth BR, Van Zee KJ, Yeung KS, Coleton MI, Cohen S, Chan YH, Vickers AJ, Sjoberg DD, Hudis CA. Acupuncture in the treatment of upper-limb lymphedema: results of a pilot study. Cancer 2013;119(13):2455-2461.

Catalanotti F, Solit DB, Pulitzer MB, Berger MF, Scott SN, Iyriboz T, Lacouture ME, Panageas KS, Wolchok JD, Carvajal RD, Schwartz GK, Rosen N, Chapman PB. Phase II trial of MEK inhibitor selumetinib (AZD6244) in patients with BRAFV600E/K-mutated melanoma. Clinical Cancer Research 2013;19(8):2257-2264.

Catsburg CE, Gago-Dominguez M, Yuan JM, Castelao JE, Cortessis VK, Pike MC, Stern MC. Dietary sources of N-nitroso compounds and bladder cancer risk: findings from the Los Angeles bladder cancer study. International Journal of Cancer 2014; 134(1):125-135.

Cavell Lk, Allen PJ, Vinova C, Eaton AA, Gönen M, Gerdes H, Mendelsohn RB, D’Angelica MI, Kingham TP, Fong Y, Dematteo R, Jarniagin We, Kurtz RC, Schattner MA. Biliary self-expandable metal stents do not adversely affect pancreaticoduodenectomy. American Journal of Gastroenterology 2013;108(7):1166-1173.

Cercek A, D’Angelica M, Power D, Capanu M, Gewirtz A, Patel D, Allen P, Fong Y, Dematteo RP, Jarnagin WR, Kemeny NE. Floxuridine Hepatic Arterial Infusion Associated Biliary Toxicity Is Increased by Concurrent Administration of Systemic Bevacizumab. Annals of Surgical Oncology 2013;[epub ahead of print].

Cercek A, Siegel CL, Capanu M, Reidy-Lagunes D, Saltz LB. Incidence of chemotherapy-induced amenorrhea in premenopausal women treated with adjuvant FOLFOX for colorectal cancer. Clinical Colorectal Cancer 2013;12(3):163-167.

Chaft JE, Rusch V, Ginsberg MS, Paik PK, Finley DJ, Kris MG, Price KA, Azzoli CG, Fury MG, Riely GJ, Krug LM, Downey RJ, Bains MS, Sima CS, Rizk N, Travis WD, Rizvi NA. Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancers. Journal of Thoracic Oncology 2013;8(8):1084-1090.

Charbonneau B, Block MS and other authors including Orlow I, Olson SH and Pike MC.Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Research 2013;[epub ahead of print].

Charbonneau B, Moysich KB and other authors including Pike MC, Orlow I and Olson SH. Large-scale evaluation of common variation in regulatory T cell genes and ovarian cancer outcome. Cancer Immunology Research 2013;(in press).

Chen D, Jiang B, Xing J, Liu M, Cui M, Liu Y, Wang Z, Chen L, Yang H, Zhang C, Yao Z, Zhang N, Ji J, Qu H, Su X. Validation of the Memorial Sloan-Kettering Cancer Center nomogram to predict disease-specific survival after r0 resection in a Chinese gastric cancer population. PLoS One 2013;8(10):e76041.

Cheung NK, Cheung IY, Ostrovnaya I, Kushner BH. Reply to L. Moreno et al. Journal of Clinical Oncology 2013;31(5):650-651.

Choi DX, Eaton AA, Olcese C, Patil S, Morrow M, Van Zee KJ. Blurry boundaries: do epithelial borderline lesions of the breast and ductal carcinoma in situ have similar rates of subsequent invasive cancer. Annals of Surgical Oncology 2013;20(4)1302-1310.

Choudhary A, Chou J, Heller G, Sklar C. Prevalence of vitamin D insufficiency in survivors of childhood cancer. Pediatric Blood Cancer 2013;60(7):1237-1239.

Choudhury S, Almendro V, Merino VF, Wu Z, Maruyama R, Su Y, Martins FC, Fackler MJ, Bessarabova M, Kowalczyk A, Conway T, Beresford-Smith B, Macintyre G, Cheng YK, Lopez-Bujanda Z, Kaspi A, Hu R, Robens J, Nikolskaya T, Haakensen VD, Schnitt SJ, Argani P, Ethington G, Panos L, Grant M, Clark J, Herlihy W, Lin SJ, Chew G, Thompson EW, Greene-Colozzi A, Richardson AL, Rosson GD, Pike M, Garber JE, Nikolsky Y, Blum JL, Au A, Hwang ES, Tamimi RM, Michor F, Haviv I, Liu XS, Sukumar S, Polyak K. Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. Cell Stem Cell 2013;13(1):117-130.

Christensson A, Savage C, Sjoberg DD, Cronin AM, O’Brien MF, Lowrance W, Nilsson PM, Vickers AJ, Russo P, Lilja H. Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 years. International Journal of Cancer 2013;133(6):1452-1458.

Chromecki T, Cha E, Fajkovic H, Rink M, Ehdaie B, Svatek R, Karakiewicz P, Lotan Y, Tilki D, Bastian P, Daneshmand S, Kassouf W, Durand M, Novara G, Fritsche H, Burger M, Izawa J, Brisuda A, Babjuk M, Pummer K, Shariat S. Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy. BJU International 2013;111(2):249-255.

Clendenen TV, Kim S, Moy L, Wan L, Rusinek H, Stanczyk FZ, Pike MC, Zeleniuch-Jacquotte A. Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women. Magnetic Resonance Imaging 2013;31(1):1-9.

Clendenen TV, Zeleniuch-Jacquotte A, Moy L, Pike MC, Rusinek H, Kim S. Comparison of 3-point dixon imaging and fuzzy C-means clustering methods for breast density measurement. Journal of Magnetic Resonance Imaging 2013;38(2):474-481.

Cobrinik D, Ostrovnaya I, Hassimi M, Tickoo SK, Cheung IY, Cheung NKV. Recurrent pre-existing and acquired DNA copy number alterations, including focal TERT gains, in neuroblastoma central nervous system metastases. Genes Chromosomes Cancer 2013;[epub ahead of print].

Conti RM, Bach PB. Cost consequences of the 340B drug discount program. Journal of the American Medical Association 2013;309(19):1995-1996.

Conti RM, Bernstein AC, Villaflor VM, Schilsky RL, Rosenthal MB, Bach PB. Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologists. Journal of Clinical Oncology 2013;31(9):1134-1139.

Cook LS, Nelson HE, Cockburn M, Olson SH, Muller CY, Wiggins CL. Comorbidities and endometrial cancer survival in Hispanics and non-Hispanic whites. Cancer Causes Control 2013;24(1):61-69.

Correa DD, Root JC, Baser R, Moore D, Peck KK, Lis E, Shore TB, Thaler HT, Jakubowski A, Relkin N. A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients. Brain Imaging Behavior 2013;7(4):478-490.

Crago AM, Denton B, Salas S, Dufresne A, Mezhir JJ, Hameed M, Gönen M, Singer S, Brennan MF. A prognostic nomogram for prediction of recurrence in desmoid fibromatosis. Annals of Surgery 2013;258(2):347-353.

Cuaron JJ, Yorke ED, Foster A, Hsu M, Zhang Z, Liu F, Jackson A, Mychalczak B, Rosenzweig KE, Wu AJ, Rimner A. Stereotactic body radiation therapy for primary lung cancers >3 centimeters. Journal of Thoracic Oncology 2013;8(11):1396-1401.

Dahi PB, Ponce DM, Devlin S, Evans KL, Lubin MN, Gonzales AM, Tonon J, Meagher R, Giralt S, Kernan NA, Scaradavou A, Barker JN. “No Wash” albumin-dextran dilution for double-unit cord blood transplantation is safe with high rates of sustained donor engraftment. Biology of Blood and Marrow Transplantation 2013;[epub ahead of print].

Dallat MA, Hunter FE, Tully MA, Cairns KJ, Kee F. A lesion in business: cost-effectiveness analysis of a novel financial incentive intervention for increasing physical activity in the workplace. BMC Public Health 2013;13:953.

Danila DC, Anand A, Schultz N, Heller G, Wan M, Sung CC, Dai C, Khanin R, Fleisher M, Lilja H, Scher HI. Analytic and clinical validation of a prostate cancer-enhanced messenger RNA detection assay in whole blood as a prognostic biomarker for survival. European Urology 2013;[epub ahead of print].

Dasgupta T, Rothenstein D, Chou JF, Zhang Z, Wright JL, Saltz LB, Temple LK, Paty PB, Weiser MR, Guillem JG, Nash GM, Goodman KA. Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: a propensity score analysis. Radiotherapy and Oncology 2013;107(2):189-194.

De Vivo I, Prescott J, Setiawan VW, Olson SH, Wentzensen N, The Australian National Endometrial Cancer Study Group, Black A, Brinton L, Chen C, Chen C, Cook LS, Crous-Bou M, Doherty J, Easton D, Friedenreich CM, Garcia-Closas M, Gaudet MM, Haiman C, Hankinson SE, Hartge P, Henderson BE, Horn-Ross PL, Hunter D, LeMarchand L, Liang X, Lissowska J, Orlow I, Rastogi R, Rebbeck TR, Sacerdote C, Shu X, Spurdle AB, Thompson D, Yang HP, Yu H, Chanock S, Kraft P. Genome-wide association study of endometrial cancer in E2C2. Human Genetics 2014;133(2):211-224.

D’Angelo SP, Antonescu CR, Kuk D, Qin L, Moraco N, Carvajal RC, Chi P, Dickson MA, Gounder M, Keohan ML, Singer S, Schwartz GK, Tap WD. High-risk features in radiation-associated breast angiosarcomas. British Journal of Cancer 2013;109(9): 2340-2346.

D’Amico Fe, Allen PJ, Eaton A, DeMatteo RP, Fong Y, Kingham TP, Blumgart LH, Jarnagian WR, D’Angelica MI. Vascular inflow control during hemi-hepatectomy: a comparison between intrahepatic pedicle ligation and extrahepatic vascular ligation. International Hepato-Pancreato-Biliary Association 2013;15(6):449-456.

DeFrank JT, Salz T, Reeder-Hayes K, Brewer NT. Who gets genomic testing for breast cancer recurrence risk? Public Health Genomics 2013;16(5):215-222.

Deng G, Chan Y, Sjoberg D, Vickers A, Yeung KS, Kris M, Straus D, Cassileth B. Acupuncture for the treatment of post-chemotherapy chronic fatigue: a randomized, blinded, sham-controlled trial. Support Care Cancer 2013;21(6):1735-1741.

Deng G, Wong WD, Guillem J, Chan Y, Affuso T, Yeung KS, Coleton M, Sjoberg D, Vickers A, Cassileth B. A phase II, randomized, controlled trial of acupuncture for reduction of postcolectomy ileus. Annals of Surgical Oncology 2013;20(4):1164-1169.

Dengel LT, Van Zee KJ, King TA, Stempel M, Cody HS, El-Tamer M, Gemignani ML, Sclafani LM, Sacchini VS, Heerdt AS, Plitas G, Junqueira M, Capko D, Patil S, Morrow M. Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy. Annals of Surgical Oncology 2014;21(1):22-27.

Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143(5 Suppl):e78S-e92S.

Deutsch MB, Panageas KS, Lassman AB, DeAngelis LM. Steroid management in newly diagnosed glioblastoma. Journal of Neurooncology 2013;113(1):111-116.

Diab A, Zickl L, Abdel-Wahab O, Jhanwar S, Gulam MA, Panageas KS, Patel JP, Jurcic J, Maslak P, Paietta E, Mangan JK, Carroll M, Fernandez HF, Teruya-Feldstein J, Luger SM, Douer D, Litzow MR, Lazarus HM, Rowe JM, Levine RL, Tallman MS. Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosis. Leukemia Research 2013;37(1):32-36.

Dickson MA, Tap WD, Keohan ML, D’Angelo SP, Gounder MM, Antonescu CR, Landa J, Qin LX, Rathbone DD, Condy MM, Ustoyev Y, Crago AM, Singer S, Schwartz GK. Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma. Journal of Clinical Oncology 2013;31(16):2024-2028.

Dikken Jl, Baser RE, Gönen M, Kattan MW, Shah Ma, Verheij M, van de Velde CJ, Brennan MF, Coit DG. Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer. Annals of Surgical Oncology 2013;20(5):1623-1630.

Donahue TF, Bochner BH, Sfakianos JP, Kent M, Bernstein M, Hilton WM, Cha EK, Yee AM, Dalbagni G, Vargas HA. Risk factors for the development ofparastomal hernia after radical cystectomy. Journal of Urology 2013;[epub ahead of print].

Donati OF, Jung SI, Vargas HA, Gultekin DH, Zheng J, Moskowitz CS, Hricak H, Zelefsky MJ, Akin O. Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy? Radiology 2013;268(2):440-450.

Donati OF, Lakhman Y, Sala E, Burger IA, Vargas HA, Goldman DA, Andikyan V, Park KJ, Chi DS, Hricak H. Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration. European Radiology 2013;23(10):2906-2915.

Donati OF, Mazaheri Y, Afag A, Vargas HA, Zheng J, Moskowitz CS, Hricak H, Akin O. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. Radiology 2013;[epub ahead of print].

Duan L, Thomas DC, The WECARE Study Collaborative Group (Bernstein J, Member). A Bayesian hierarchical model for relating multiple SNPs within multiple genes to disease risk. International Journal of Genomics 2013;(in press).

Earp MA, Kelemen LE and other authors including Orlow I, Olson SH and Pike MC. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Human Genetics 2013;[epub ahead of print].

Ehdaie B, Furberg H, Zabor E, Shariat S, Ostroff J, Bochner B, Coleman J, Dalbagni G. The impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma. BJU International 2013;111(4):589-595.

Ehdaie B, Furberg H, Zabor EC, Hakimi AA, Russo P. Comprehensive assessment of the impact of cigarette smoking on survival in clear cell kidney cancer. Journal of Urology 2013;[epub ahead of print].

Ehdaie B, Furberg H, Zabor EC, Ostroff JS, Shariat SF, Bochner BH, Coleman JA, Dalbagni G. Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma. BJU International 2013;111(4):589-595.

Ehdaie B, Shariat S. Magnetic resonance imaging-targeted prostate biopsy: back to the future. European Urology 2013;63(1):141-142.

Ehdaie B, Sylvester R, Herr H. Maintenance Bacillus Calmette-Guerin treatment of non-muscle-invasive bladder cancer: a critical evaluation of the evidence. European Urology 2013;64(4):579-585.

Ehdaie B, Touijer K. 5-alpha reductase inhibitors in prostate cancer: from clinical trials to clinical practice. European Urology 2013;63(5):788-789.

Ehdaie B, Vertosick E, Spaliviero M, Giallo-Uvino A, Taur Y, O’Sullivan M, Livingston J, Sogani P, Eastham J, Scardino P, Touijer K. The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance. Journal of Urology 2013;191(3):660-664.

Eldridge RC, Doubeni CA, Fletcher RH, Zauber AG, Corley DA, Doria-Rose VP, Goodman M. Uncontrolled confounding in studies of screening effectiveness: an example of colonoscopy. Journal of Medical Screening 2013;20(4):198-207.

Elkin EB, Atoria CL, Leoce N, Bach PB, Schrag D. Changes in the availability of screening mammography, 2000-2010. Cancer 2013;119(21):3847-3853.

Elkin EB, Nobles PJ, Pinheiro LC, Atoria CL, Schrag D. Changes in access to screening mammography 2008-2011. Cancer Causes and Control 2013;24(5):1057-1059.

Elnekave E, Erinjeri JP, Brown KT, Thornton RH, Petre En, Maybody M, Maluccio MA, Hsu M, Sofocieous CT, Getrajdman GI, Brody LA, Solomon SB, Alago W, Fong Y, Jarnagin WR, Covey AM. Long-term outcomes comparing surgery to embolization-ablation for treatment of solitary HCC<7 cm. Annals of Surgical Oncology 2013;20(9):2881-2886.

Engel LS, Satagopan J, Sima CS, Orlow I, Mujumdar U, Coble J, Roy P, Yoo S, Sandler DP, Alavanja MC. Sun exposure, vitamin D receptor genetic variants, and risk of breast cancer in the Agricultural Health Study. Environmental Health Perspectives 2013;[epub ahead of print].

Epstein AS, Volandes AE, Chen LY, Gary KA, Li Y, Agre P, Levin TT, Reidy DL, Meng RD, Segal NH, Yu KH, Abou-Alfa GK, Janjigian YY, Kelsen DP, O’Reilly EM. A randomized controlled trial of a cardiopulmonary resuscitation video in advance care planning for progressive pancreas and hepatobiliary cancer patients. Journal of Palliative Medicine 2013;16(6):623-631.

Erinjeri JP, Thomas CT, Samoilia A, Fleisher M, Gönen M, Sofocleous CT, Thornton RH, Siegelbaum RH, Covey AM, Brody LA, Alago W Jr, Maybody M, Brown KT, Getrajdman GI, Solomon SB. Image-guided thermal ablation of tumors increases the plasma level of interleukin-6 and interleukin-10. Journal of Vascular and Interventional Radiology 2013;24(8):1105-1112.

Evans DM, Brion MJ, Paternoster L, Kemp JP, McMahon G, Munafò M, Whitfield JB, Medland SE, Montgomery GW; GIANT Consortium; CRP Consortium; TAG Consortium, Timpson NJ, St Pourcain B, Lawlor DA, Martin NG, Dehghan A, Hirschhorn J, Davey Smith G, Furberg H (collaborator). Mining the human phenome using allelic scores that index biological intermediates. PLoS Genetics 2013;9(10):e1003919.

Faber MT, Kjaer SK, Dehlendorff C, Chang-Claude J, Andersen KK, Hogdall E, Webb PM, Jordan SM, the Australian Cancer Study (Ovarian Cancer), Australian Ovarian Cancer Study Group, Rossing MA, Doherty JA, Goodman MT, Ness R, Goode EL, Schildkraut J, Cramer DW, Terry KL, Bandera EV, Olson SH, Kiemeny LA, Massuger L, Moysich K, Odunsi K, Song H, Pharaoh P, Whittemore A, McGuire V, Sieh W, Sutphen R, Narod SA, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Pearce CL, Risch HA, Jensen A on behalf of the Ovarian Cancer Association Consortium. Cigarette smoking and risk of ovarian cancer – a pooled analysis of 21 case-control studies. Cancer Causes Control 2013;24(5):989-1004.

Farjah F, Lou F, Sima C, Rusch VW, Rizk NP. A prediction model for pathologic N2 disease in lung cancer patients with a negative mediastinum by positron emission tomography. Journal of Thoracic Oncology 2013;8(9):1170-1180.

Feldman DR, Voss MH, Jacobsen EP, Jia X, Suarez JA, Turkula S, Sheinfeld J, Bosl GJ, Motzer RJ, Patil S. Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older. Cancer 2013;119(14):2574-2581.

Felix AS, Cook LS, Gaudet MM, Rohan TE, Schouten LJ, Setiawan VW, Wise LW, Anderson KE, Bernstein LE, De Vivo I, Friedenreich CM, Gapstur SM, Goldbohm RA, Henderson B, Horn-Ross PL, Kolonel L, Lacey JV, Liang X, Lissowska J, Magliocco A, McCullough ML, Miller AB, Olson SH, Palmer JR, Park Y, Patel AV, Prescott J, Rastogi R, Robien K, Rosenberg L, Schairer C, Shu XO, van den Brandt PA, Virkus RA, Wentzensen N, Xiang Y-B, Xu W-H, Yang HP, Brinton LA. The etiology of uterine sarcomas: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium. British Journal of Cancer 2013;108(3):727-734.

Ford JS, Chou JF, Sklar CA. Attendance at a survivorship clinic: impact on knowledge and psychosocial adjustment. Journal of Cancer Survivorship 2013;7(4):535-543.

Forsberg JA, Sjoberg D, Chen QR, Vickers A, Healey JH. Treating metastatic disease: which survival model is best suited for the clinic? Clinical Orthopaedics and Related Research 2013;471(3):843-850.

Frankel TL, Fischer M, Grant F, Krone J, D’Angelica MI, DeMatteo RP, Jarnagin WR, Gönen M. Selecting patients for acute normovolemic hemodilution during hepatic resection: a prospective randomized evaluation of nomogram-based allocation. Journal of American College of Surgeons 2013;217(2):210-220.

Furberg H, Bochner BH. Bladder cancer: towards risk stratification in bladder cancer. Nature Reviews Urology 2013;10(7):374-375.

Fury MG, Lee NY, Sherman E, Ho AL, Rao S, Heguy A, Shen R, Korte S, Lisa D, Ganly I, Patel S, Wong RJ, Shaha A, Shah J, Haque S, Katabi N, Pfister DG. A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics 2013, 87(3):479-486.

Fury MG, Sherman E, Ho AL, Xiao H, Tsai F, Nwankwo O, Sima C, Heguy A, Katabi N, Haque S, Pfister DG. A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer. Cancer 2013;119(10):1823-1831.

Gallagher DJ, Vijai J, Hamilton RJ, Ostrovnaya I, Iyer G, Garcia-Grossman IR, Kim PH, Przybylo JA, Alanee S, Riches JC, Regazzi AM, Milowsky MI, Offit K, Bajorin DF. Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host. Annals of Oncology 2013;24(9):2414-2421.

Garg T, Chen LY, Kim PH, Zhao PT, Herr HW, Donat SM. Preoperative serum albumin is associated with mortality and complications after radical cystectomy. BJU International 2013;[epub ahead of print].

Gemignani ML, Patil S, Seshan VE, Sampson M, Humm JL, Lewis JS, Brogi E, Larson SM, Morrow M, Pandit-Taskar N. Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancer. Journal of Nuclear Medicine 2013;54(10):1697-1702.

Gerber N, Ilson DH, Wu AJ, Janjigian YY, Kelsen DP, Zheng J, Zhang Z, Bains MS, Rizk N, Rusch VW, Goodman KA. Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma. Diseases of the Esophagus 2013;[epub ahead of print].

Gerber N, Wexler LH, Singer S, Alektiar KM, Keohan ML, Shi W, Zhang Z, Wolden SL. Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols. International Journal of Radiation Oncology, Biology, Physics 2013;86(1):58-63.

Gladdy RA, Qin LX, Moraco N, Agaram NP, Brennan MF, Singer S. Predictors of survival and recurrence in primary leiomyosarcoma. Annals of Surgical Oncology 2013;20(6):1851-1857.

Goldberg JD, Linker A, Kuk D, Ratan R, Jurcic J, Barker JN, Castro-Malaspina H, Giralt S, Hsu K, Jakubowski AA, Jenq R, Koehne G, Papadopoulos EB, van den Brink MR, Young JW, Boulad F, Kernan NA, O’Reilly RJ, Prockop SE, Yahalom J, Heller G, Perales MA. T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease. Biology of Blood and Marrow Transplantation 2013;19(2):208-213.

Goldberg JD, Zheng J, Castro-Malaspina H, Jakubowski AA, Heller G, van den Brink MR, Perales MA. Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants. Bone Marrow Transplantation 2013;48(1):99-104.

Goldfarb S, Abramsohn E, Andersen B, Baron S, Carter J, Dickler M, Florendo J, Freeman L, Githens K, Kushner D, Makelarski J, Yamada D, Lindau S. A national network to advance the field of cancer and female sexuality. Journal of Sexual Medicine 2013;10(2):319-325.

Goldfarb S, Baron S, Lindau S. Female sexuality and sexual function. In: Women and Health, 2nd ed. Goldman M, ed. San Diego, CA: Academic Press; 2013:347-357.

Goldfarb S, Didwania A, Oeffinger K. Sexual dysfunction. In: Oncology in Primary Care. Rose M, ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2013:257-259.

Goldfarb S, Mulhall J, Nelson C, Kelvin J, Dickler M, Carter J. Sexual and reproductive health in cancer survivors. Seminars in Oncology 2013;40(6):726-744.

Goldfarb SB, Abramsohn E, Andersen BL, Baron SR, Carter J, Dickler M, Florendo J, Freeman L, Githens K, Kushner D, Makelarski JA, Yamada SD, Lindau ST. A national network to advance the field of cancer and female sexuality. Journal of Sexual Medicine 2013;10(2):319-325.

Goldman DA, Gönen M, Hricak H, Kang SK, Touijer KA. Correction of data reporting errors. Radiology 2013;269(3):949-950.

Gollub MJ, Cao K, Gultekin DH, Kuk D, Gönen M, Sohn M, Schwartz LH, Weiser MR, Temple LK, Nash GM, Guillem JG, Wang M, Garcia-Aguilar J, Goodman K, Paty PB. Prognostic aspects of DCE-MRI in recurrent rectal cancer. European Radiology 2013; 23(12):3336-3344.

Gönen M. Mixtures of receiver operating characteristic curves. Academic Radiology 2013;20(7):831-837.

Gopalan A, Leversha MA, Dudas ME, Maschino AC, Chang J, Al-Ahmadie HA, Chen YB, Tickoo SK, Reuter VE, Fine SW. TMPRSS2-ERG rearrangement in dominant anterior prostatic tumours: incidence and correlation with ERG immunohistochemistry. Histopathology 2013;63(2):279-286.

Grant FM, Protic M, Gönen M, Allen P, Brennan MF. Intraoperative fluid management and complications following pancreatectomy. Journal of Surgical Oncology 2013;107(5):529-535.

Grisham RN, Iyer G, Garg K, DeLair D, Hyman DM, Zhou Q, Iasonos A, Berger MF, Dao F, Spriggs DR, Levine DA, Aghajanian C, Solit DB. BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer. Cancer 2013;119(3):548-554.

Gucalp A, Tolaney S, Isakoff SJ, Ingle JN, Liu MC, Carey LA, Blackwell KL, Rugo H, Nabell L, Forero-Torres A, Stearns V, Doane AS, Danso M, Moynahan ME, Momen LF, Gonzalez JM, Akhtar A, Giri D, Patil S, Feigin KN, Hudis CA, Traina TA. Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancer. Clinical Cancer Research 2013;19(19):5505-5512.

Guillem JG, Rudy JA, Leibold T, Akhurst TJ, Yeung HW, Gollub MJ, Ginsberg MS, Shia J, Suriawinata AA, Riedel ER, Mazumdar M, Saltz LB, Minsky BD, Nash GM, Paty PB, Temple LK, Weiser MR, Larson SM. Neither FDG-PET nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective study. Annals of Surgery 2013;258(2):289-295.

Gupta A, Shah AD, Zhang Z, Phillips CD, Young RJ. Variability in the position of the retropharyngeal internal carotid artery. The Laryngoscope 2013;123(2):401-403.

Haiman CA, Stram DO, Vickers AJ, Wilkens LR, Braun K, Valtonen-Andre C, Peltola M, Pettersson K, Waters KM, Marchand LL, Kolonel LN, Henderson BE, Lilja H. Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations. Journal of the National Cancer Institute 2013;105(3):237-243.

Hakimi AA, Chen L, Kim PH, Sjoberg D, Glickman L, Walker MR, Russo P. The impact of metformin use on recurrence and cancer-specific survival in clinically localized high-risk renal cell carcinoma. Canadian Urological Association Journal 2013;7(11-12):E687-E691.

Hakimi AA, Furberg H, Zabor EC, Jacobsen A, Schultz N, Ciriello G, Mikkineni N, Fiegoil B, Kim PH, Voss MH, Shen H, Laird PW, Sander C, Reuter VE, Motzer RJ, Hsieh JJ, Russo P. An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. Journal of the National Cancer Institute 2013;105(24):1862-1870.

Hakimi AA, Ghavamian R, Williams SK, Kim PH, Chen L, Sfakianos JP, Keren-Paz GE, Sankin A, Ginzburg N, Coleman JA. Factors that affect proportional glomerular filtration rate after minimally invasive partial nephrectomy. Journal of Endourology 2013;27(11):1371-1375.

Hakimi AA, Ostrovnaya I, Reva B, Schultz N, Chen YB, Gönen M, Liu H, Takeda S, Voss MH, Tickoo SK, Reuter VE, Russo P, Cheng EH, Sander C, Motzer RJ, Hsieh JJ; ccRCC Cancer Genome Atlas (KIRC TCGA) Research Network investigators. Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network. Clinical Cancer Research 2013;19(12):3259-3267.

Hamilton RJ, Morilla D, Cabrera F, Leapman M, Chen LY, Bernstein M, Hakimi AA, Reuter VE, Russo P. The association between statin medication and progression after surgery for localized renal cell carcinoma. The Journal of Urology 2013;[epub ahead of print].

Harvey E, Rogak L, Ford R, Holland J. Rapid access to mental health professionals with experience in treating cancer-related distress: the American Psychosocial Oncology Referral Helpline. Journal of the National Comprehensive Cancer Network 2013;11(11):1358-1361.

Hassett MJ, Elkin EB. What does breast cancer treatment cost and what is it worth? Hematology/Oncology Clinics of North America 2013;27(4):829-841.

Hatzoglou V, Patel GV, Morris MJ, Curtis K, Zhang Z, Shi W, Huse J, Rosenblum M, Holodny AI, Young RJ. Brain metastases from prostate cancer: an 11-year analysis in the MRI era with emphasis on imaging characteristics, incidence, and prognosis. Journal of Neuroimaging 2013;[epub ahead of print].

Hatzoglou V, Ulaner GA, Zhang Z, Beal K, Holodny AI, Young RJ. Comparison of the effectiveness of MRI perfusion and Fluorine-18 FDG PET-CT for differentiating radiation injury from viable brain tumor. Clinical Imaging 2013; 37(3):451-457.

Hay JL, Atkinson TM, Reeve BB, Mitchell SA, Mendoza TR, Willis G, Minasian LM, Clauser SB, Denicoff A, O’Mara A, Chen A, Bennett AV, Paul DB, Gagne J, Rogak L, Sit L, Viswanath V, Schrag D, Basch E, NCI PRO-CTCAE Study Group. Cognitive interviewing of the US National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Quality of Life Research 2013;[epub ahead a print].

Haynes S, Ryan E, Wood H, Fallon J, Cook E, Bolutayo K, Li Y, Hudis C, Traina T, Ahles T. Rehabilitation of cognitive changes in breast cancer survivors. Psycho-Oncology 2013;22(suppl 2):115-116.

Hellmann MD, Chaft JE, Rusch V, Ginsberg MS, Finley DJ, Kris MG, Price KA, Azzoli CG, Fury MG, Riely GJ, Krug LM, Downey RJ, Bains MS, Sima CS, Rizk N, Travis WD, Rizvi NA, Paik PK. Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab. Cancer Chemotherapy Pharmacology 2013;72(2):453-461.

Ho AL, Grewal RK, Leboeuf R, Sherman EJ, Pfister DG, Deandreis D, Pentlow KS, Zanzonico PB, Haque S, Gavane S, Ghossein RA, Ricarte-Filho JC, Domínguez JM, Shen R, Tuttle RM, Larson SM, Fagin JA. Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. New England Journal of Medicine 2013;368(7):623-632.

Ho AY, Patel N, Ohri N, Morrow M, Mehrara BJ, Disa JJ, Cordeiro PG, Shi W, Zhang Z, Gelblum D, Nerbun CT, Woch KM, Ballangrud A, McCormick B, Powell SN. Bilateral implant reconstruction does not affect the quality of postmastectomy radiation therapy. Medical Dosimetry 2013;[epub ahead of print].

Holmberg L, Vickers A. Evaluation of prediction models for decision-making: beyond calibration and discrimination. PLoS Medicine 2013;10(7):e1001491.

Houldsworth J, Guttapalli A, Thodima V, Yan XJ, Mendiratta G, Zielonka T, Nanjangud G, Chen W, Patil S, Mato A, Brown JR, Rai K, Chiorazzi N, Chaganti RS. Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia. Leukemia & Lymphoma 2013;[epub ahead of print].

Hugosson J, Carlsson SV. The dilemmas of prostate cancer screening. Medical Journal of Australia 2013;198(10):528-529.

Hyman D, Eaton A, Gounder M, Smith GL, Pamer EG Hensley M, Spriggs DR, Ivy P, Iasonos A. A nomogram to predict cycle 1 serious drug-related toxicity on phase I oncology trials. Journal of Clinical Oncology 2013;(in press).

Iasonos A, Keung EZ, Zivanovic O, Mancari R, Peiretti M, Nucci M, George S, Colombo N, Carinelli S, Hensley ML, Raut CP. External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma. Cancer 2013;119(10):1816-1822.

Iasonos A, O’Quigley J. Design considerations for dose-expansion cohorts in phase I trials. Journal of Clinical Oncology 2013;31(31):4014-4021.

Ito H, Mo Q, Qin LX, Viale A, Maithel SK, Maker AV, Shia J, Kingham P, Allen P, Dematteo RP, Fong Y, Jarnagin WR, D’Angelica M. Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer. PLoS One 2013, 8(12):e81680.

Ito K, Elkin E, Blinder V, Keating N, Choudhry N. Cost-effectiveness of full coverage of aromatase inhibitors for Medicare beneficiaries with early breast cancer. Cancer 2013;119(13):2494-2502.

Iyer G, Al-Ahmadie H, Schultz N, Hanrahan AJ, Ostrovnaya I, Balar AV, Kim PH, Lin O, Weinhold N, Sander C, Zabor EC, Janakiraman M, Garcia-Grossman IR, Heguy A, Viale A, Bochner BH, Reuter VE, Bajorin DF, Milowsky MI, Taylor BS, Solit DB. Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer. Journal Clinical Oncology 2013;31(25):3133-3140.

Jaimes N, Oliveria S, Halpern A. A cautionary note on melanoma screening in the Hispanic/Latino population. JAMA Dermatology 2013;149(4):396-397.

Jhaveri K, Chandarlapaty S, Lake D, Gilewski T, Robson M, Goldfarb S, Drullinsky P, Sugarman S, Wasserheit-Leiblich C, Fasano J, Moynahan ME, D’Andrea G, Lim K, Reddington L, Haque S, Patil S, Bauman L, Vukovic V, El-Hariry I, Hudis C, Modi S. A phase 2 open-label study of ganetespib, a novel heat shock protein 90 (HSP90) inhibitor for patients with metastatic breast cancer (MBC). Clinical Breast Cancer 2013;(in press).

Jia X, Sima CS, Brennan MB, Panageas KS. Cure models for the analysis of time-to-event data in cancer studies. Journal of Surgical Oncology 2013;108(6):342-347.

Jochelson MS, Dershaw DD, Sung JS, Heerdt AS, Thornton C, Moskowitz CS, Ferrara J, Morris EA. Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. Radiology 2013;266(3):743-751.

Jordan NE, Li Y, Magrini D, Simpson S, Reilly NR, Defelice AR, Sockolow R, Green PH. Development and validation of a celiac disease quality of life instrument for North American children. Journal of Pediatric Gastroenterology and Nutrition 2013;57(4):477-486.

Judson TJ, Bennett AV, Rogak LJ, Sit L, Barz A, Kris MG, Hudis CA, Scher HI, Sabattini P, Schrag D, Basch E. Feasibility of long-term patient self-reporting of toxicities from home via the internet during reouting chemotherapy. Journal of Clinical Oncology 2013;31(20):2580-2585.

Jung SI, Donati OF, Vargas HA, Goldman D, Hricak H, Akin O. Transition zone prostate cancer: incremental value of diffusion-weighted endorectal MR imaging in tumor detection and assessment of aggressiveness. Radiology 2013;269(2):493-503.

Kaag M, Trost L, Thompson RH, Favaretto R, Elliott V, Shariat SF, Maschino A, Vertosick E, Raman JD, Dalbagni G. Pre-operative predictors of renal function decline following radical nephroureterectomy for upper tract urothelial carcinoma. BJU International 2013;[epub ahead of print].

Kadota K, Nitadori J, Sarkaria IS, Sima CS, Jix X, Yoshizawa A, Rusch VW, Travis WD, Adusumilli PS. Thyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologica classification in patients with stage I lung adenocarcinoma. Cancer 2013;119(5):931-938.

Kapoor NS, Eaton A, King TA, Patil S, Stempel M, Morris E, Brogi E, Morrow M. Should breast density influence patient selection for breast-conserving surgery. Annals of Surgical Oncology 2013;20(2):600-606.

Karakousis GC, Pandid-Taskar N, Hsu M, Panageas K, Atherton S, Ariyan C, Brady MS. Prognostic significance of drainage to pelvic nodes at sentinel lymph node mapping in patients with extremity melanoma. Melanoma Research 2013;23(1):40-46.

Karlo CA, Di Paolo PL, Chaim J, Hakimi AA, Ostrovnaya I, Russo P, Hricak H, Motzer R, Hsieh JJ, Akin O. Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations. Radiology 2014;270(2):464-471.

Karlo CA, Donati OF, Burger IA, Zheng J, Moskowitz CS, Hricak H, Akin O. MR imaging of renal cortical tumours: qualitative and quantitative chemical shift imaging parameters. European Radiology 2013;(6):1738-1744.

Kedmi M, Hedvat CV, Maragulia J, Zhang Z, Zelenetz AD. Association of quantitative assessment of intrafolliuclar proliferation index with outcome in follicular lymphoma. British Journal of Haematology 2013;[epub ahead of print].

Kelemen LE, Bandera EV, Terry KL, Rossing MA, Brinton LA, Doherty JA, Ness RB, Kjaer SK, Chang-Claude J, Kobel M, Lurie G, Thompson PJ, Carney ME, Moysich K, Edwards R, Bunker C, Jensen A, Hogdall E, Cramer DW, Vitonis AF, Olson SH, King M, Chandran U, Lissowska J, Garcia-Closas M, Yang H, Webb PM, Schildkraut JM, Goodman MT, Risch HA on behalf of the Ovarian Cancer Association Consortium. Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls form the Ovarian Cancer Association Consortium. BMC Cancer 2013;13:28.

Kelly KJ, Dukleska K, Kuk D, Kingham TP, D’Angelica MI, Dematteo RP, Allen PJ, Jarnagin WR, Fong Y. Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma. Annals of Surgical Oncology 2013;[epub ahead of print].

Khoury MJ, Lam TK, Ioannidis JP, Hartge P, Spitz MR, Buring JE, Chanock SJ, Croyle RT, Goddard KA, Ginsburg GS, Herceg Z, Hiatt RA, Hoover RN, Hunter DJ, Kramer BS, Lauer MS, Meyerhardt JA, Olopade OI, Palmer JR, Sellers TA, Seminara D, Ransohoff DF, Rebbeck TR, Tourassi G, Winn DM, Zauber A, Schully SD. Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiology, Biomarkers & Prevention 2013;22(4):508-516.

Khrizman P, Miland JC, ter Veer A, Milne D, Bullard Dunn K, Carson WE 3rd, Engstrom PF, Shibata S, Skibber JM, Weiser MR, Schrag D, Benson AB 3rd. Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a noational comprehensive cancer network analysis. Journal of Clinical Oncology 2013;31(1):30-38.

Kidden JL, Coit DG, Baser RE, Gönen M, Goodman KA, Brennan MF, Jansen EP, Boot H, van de Velde DJ, Cats A, Verheij M. Performance of a nomogram predicting disease-specific survival after an R0 resection for gastric cancer in patients receiving postoperative chemoradiation therapy. International Journal of Radiation Oncology Biology Physics 2013;[epub ahead of print].

Kim PH, Kent M, Zhao P, Sfakianos JP, Bajorin DF, Bochner BH, Dalbagni G. The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer. World Journal of Urology 2013;[epub ahead of print].

Kim PH, Pinheiro LC, Atoria CL, Eastham JA, Sandhu JS, Elkin EB. Trends in the use of incontinence procedures after radical prostatectomy: a population based analysis. Journal of Urology 2013;189(2):602-608.

Kim PH, Sukhu R, Cordon BH, Sfakianos JP, Sjoberg DD, Hakimi AA, Dalbagni G, Lin O, Herr HW. Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in bladder cancer patients with negative surveillance cystoscopy. BJU international 2013;[epub ahead of print].

King MG, Olson SH, Demissie K, Lu S-E, Chandran U, Parekh N, Bandera EV. Consumption of sugary foods and drinks and risk of endometrial cancer. Cancer Causes Control 2013;24(7):1427-1436.

King MG, Olson SH, Paddock L, Chandran U, Demissie K, Lu S-E, Parekh N, Rodriguez-Rodriguez L, Bandera EV. Sugary food and beverage consumption and epithelial ovarian cancer risk: a population-based case-control study. BMC Cancer 2013;13:94.

King TA, Muhsen S, Patil S, Koslow S, Oskar S, Park A, Morrogh M, Sakr RA, Morrow M. Is there a role for routine screening MRI in women with LCIS? Breast Cancer Research Treatment 2013;142(2):445-453.

Kissane DW, Patel SG, Baser RE, Bell R, Farberov M, Ostroff JS, Li Y, Singh B, Kraus DH, Shah JP. Preliminary evaluation of the reliability and validity of the shame and stigma scale in head and neck cancer. Head Neck Cancer 2013;35(2):172-183.

Klein AP, Lindstrom S, Mendelsohn JB, Steplowski E, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, LaCroix A, Li D, Mandelson MT, Olson SH, Petersen GM, Risch HA, Stolzenberg-Solomon RZ, Zheng W, Amundadottir L, Albanes D, Allen NE, Bamlet WR, Boutron-Ruault M-C, Buring JE, Bracci PM, Canzian F, Clipp S, Cotterchio M, Duell EJ, Elena J, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hassan M, Hutchinson A, Hunter DJ, Kooperberg C, Kurtz RC, Liu S, Overvad K, Palli D, Patel AV, Rabe KG, Shu X-O, Slimani N, Tobias GS, Trichopoulos D, Van Den Eeden SK, Vineis P, Virtamo J, Wactawski-Wende J, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Chanock SJ, Hoover RN, Hartge P, Kraft P. An absolute risk model to identify individuals at high risk for pancreatic cancer in the general population. PLoS One 2013;8(9):e72311.

Kluth LA, Rieken M, Xylinas E, Kent M, Rink M, Roupret M, Sharifi N, Jamzadeh A, Kassouf W, Kaushik D, Boorjian SA, Roghmann F, Noldus J, Masson-Lecomte A, Vordos D, Ikeda M, Matsumoto K, Hagiwara M, Kikuchi E, Fradet Y, Izawa J, Rendon R, Fairey A, Lotan Y, Bachmann A, Zerbib M, Fisch M, Scherr DS, Vickers A, Shariat SF. Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. European Urology 2013;[epub ahead of print].

Kluth LA, Xylinas E, Kent M, Hagiwara M, Kikuchi E, Matsumoto K, Ikeda M, Dalpiaz O, Zigeuner R, Aziz A, Fritsche HM, Deliere A, Raman JD, Bensalah K, Al-Matar B, Gakis G, Novara G, Klatte T, Remzi M, Comploj E, Pycha A, Roupret M, Tagawa ST, Chun FK, Scherr DS, Vickers A, Shariat SF. Predictors of survival in patients with disease recurrence following radical nephroureterectomy. BJU International 2013;[epub ahead of print].

Kobos R, Nagai M, Tsuda M, Merl MY, Saito T, La M, Mo Q, Olshen A, Lianoglou S, Leslie C, Ostrovnaya I, Antczak C, Djaballah H, Ladanyi M. Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein. Journal of Pathology 2013;229(5):743-754.

Kuk D, Varadhan R. Model selection in competing risks regression. Statistics in Medicine 2013; 32(18):3077-3088.

Kumar JK, Winawer SJ, Zauber AG. Colorectal cancer. In: Epidemiology of Women’s Health. Senie RT, ed. Burlington, VT: James & Barlett Learning 2014;397-409.

Lafemina J, Qin LX, Moraco NH, Antonescu CR, Fields RC, Crago AM, Brennan MF, Singer S. Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors. Annals of Surgical Oncology 2013;20(1):66-72.

Lakhman Y, Akin O, Park KJ, Sarasohn DM, Zheng J, Goldman DA, Sohn MJ, Moskowitz CS, Sonoda Y, Hricak H, Abu-Rustum NR. Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy. Radiology 2013;269(1):149-158.

Lamanna N, Heffner LT, Kalaycio M, Schiller G, Coutre S, Moore J, Seiter K, Maslak P, Panageas K, Golde D, Weiss MA. Treatment of adults with ALL: do the specifics of regimen matter? Results of a prospective randomized trial. Cancer 2013;119(6):1186-1194.

Larsen SB, Brasso K, Iversen P, Christensen J, Christiansen M, Carlsson S, Lija H, Friis S, Tjonneland A, Dalton SO. Baseline prostate-specific anti-gen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort. European Journal of Cancer 2013;49(14):3041-3048.

Laufer I, Iorgulescu JB, Chapman T, Lis E, Shi W, Zhang Z, Cox BW, Yamada Y, Bilsky MH. Local disease control for spinal metastases following “separation surgery” and adjuvant hypofractionated or high-dose single-fraction stereotactic radiation therapy: outcomes analysis in 186 patients. Journal of Neurosurgery Spine 2013;18(3):207-214.

Lee JK, Capanu M, O’Reilly EM, Ma J, Chou JF, Shia J, Katz SS, Gansukh B, Reidy-Lagunes D, Segal NH, Yu KH, Chung KY, Saltz LB, Abou-Alfa GK. A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas. British Journal of Cancer 2013;109(4):915-919.

Lee YJ, Chung D, Xiao K, Papadopoulos EB, Barker JN, Small TN, Siralt SA, Zheng J, Jakubowski AA, Papanicolaou GA. Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institution. Biology of Blood and Marrow Transplantation 2013;19(3):387-392.

Leenders M, Bhattacharjee S and other authors including Olson SH. Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Cancer Causes Control 2013;24(3):595-602.

Lefkowitz RA, Landa J, Hwang S, Zabor EC, Moskowitz CS, Agaram NP, Panicek DM. Myxofibrosarcoma: prevalence and diagnostic value of the “tail sign” on magnetic resonance imaging. Skeletal Radiology 2013;42(6):809-818.

Li Z, Holodny A, Brennan N, Hsu M, Zhang Z, Peck K, Jenabi M, Young RJ. Diffusion tensor tractography of the arcuate fasciculus in patients with brain tumors: comparison between deterministic and probabilistic models. Journal of Biomedical Science and Engineering 2013;6(2):192-200.

Lipitz-Snyderman A, Bach PB. Overuse of health care services: when less is more … more or less. JAMA Internal Medicine 2013;173(14):1277-1278.

Loeb S, Drevin L, Robinson D, Holmberg E, Carlsson S, Lambe M, Stattin P. Risk of localized and advanced prostate cancer amng immigrants versus native-born Swedish men: a nation-wide population-based study. Cancer Causes and Control 2013;24(2):383-390.

Lou F, Huang J, Sima CS, Dycoco J, Rusch V, Bach PB. Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computer tomography surveillance. Journal of Thoracic Cardiovascular Surgery 2013;145(1):75-82.

Lowery AE, Starr T, Dhingra LK, Rogak L, Hamrick-Price JR, Farberov M, Kirsh KL, Saltz LB, Breitbart WS, Passik SD. Frequency, characteristics, and correlates of pain in a pilot study of colorectal cancer survivors 1-10 years post-treatment. Pain Medication 2013;14(11):1673-1680.

Lowrance WT, Southwick A, Maschino AC, Sandhu JS. Contemporary practice patterns of endoscopic surgical management for benign prostatic hyperplasia among urologists in the United States. Journal of Urology 2013;189(5):1811-1816.

MacPherson H, Maschino AC, Lewith G, Foster NE, Witt C, Vickers AJ. Characteristics of acupuncture treatment associated with outcome: an individual patient meta-analysis of 17,922 patients with chronic pain in randomised controlled trials. PloS One 2013;8(10):e77438.

Makker V, Hensley ML, Zhou Q, Iasonos A, Aghajanian CA. Treatment of advanced or recurrent endometrial carcinoma with doxorubicin in patients progressing after paclitaxel/carboplatin: Memorial Sloan-Kettering Cancer Center experience from 1995 to 2009. International Journal of Gynecological Cancer 2013;23(5):929-934.

Makker V, Kravetz SJ, Gallagher J, Orodel OP, Zhou Q, Iasonos A, Delair D, Aghajanian C, Hensley ML. Treatment outcomes in completely resected stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiation. International Journal of Gynecological Cancer 2013;23(9):1635-1641.

Marigliano C, Donati OF, Vargas HA, Akin O, Goldman DA, Eastham JA, Zelefsky MJ, Hricak H. MRI findings of radiation-induced changes in the urethra and periurethral tissues after treatment for prostate cancer. European Journal of Radiology 2013;82(12):e775-e781.

Marionneaux S, Francisco N, Chan V, Hanenberg J, Rafeal J, Chua C, Jia R, Yao J, Lynch J, Chan V, Masiak P. Comparison of automated platelet counts and potential effect on transfusion decisions in cancer patients. American Journal of Clinical Pathology 2013;140(5):747-754.

Margulis V, Shariat SF, Rapoport Y, Rink M, Sjoberg DD, Tannir NM, Abel EJ, Culp SH, Tamboli P, Wood CG. Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. European Urology 2013;63(5):947-952.

McErlean A, Huang J, Zabor EC, Moskowitz CS, Ginsberg MS. Distinguishing benign thymic lesions from early-stage thymic malignancies on computed tomography. Journal of Thoracic Oncology 2013;8(7):967-973.

McErlean A, Panicek DM, Zabor EC, Moskowitz CS, Bitar R, Motzer RJ, Hricak H, Ginsberg MS. Intra- and interobserver variability in CT measurements in oncology. Radiology 2013;269(2):451-459.

McMillan RR, Sima CS, Moraco NH, Rusch VW, Huang J. Recurrence patterns after resection of soft tissue sarcomas of the chest wall. Annals of Thoracic Surgery 2013;96(4):1223-1228.

Meeks JJ, Maschino AC, McVary KT, Sandhu JS. Clinically significant prostate cancer is rarely missed by ablative procedures of the prostate in men with prostate specific antigen less than 4 ng/ml. Journal of Urology 2013;189(1):111-115.

Meeks JJ, Walker M, Bernstein M, Kent M, Eastham JA. Accuracy of post-radiotherapy biopsy before salvage radical prostatectomy. BJU International 2013;112(3):308-312.

Milowsky M, Iyer G, Regazzi AM, Al-Ahmadie H, Gerst SR, Ostrovnaya I, Gellert LL, Kaplan R, Garcia-Grossman IR, Pendse D, Balar AV, Flaherty AM, Trout A, Solit DB, Bajorin DF Phase II study of everolimus in metastatic urothelial cancer. BJU International 2013;112(4):462-470.

Mo Q, Wang S, Seshan VE, Olshen AB, Schultz N, Sander C, Powers RS, Ladanyi M, Shen R. Pattern discovery and cancer gene identification in integrated cancer genomic data. Proceedings of the National Academy of Sciences 2013;110(11):4245-4250.

Modak S, Kushner BH, Kramer K, Vickers A, Cheung IY, Cheung NK. Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan: a Phase I study in patients with chemoresistant neuroblastoma. Oncoimmunology 2013;2(3):e23402.

Molina AM, Jia X, Feldman DR, Hsieh JJ, Ginsberg MS, Velasco S, Patil S, Motzer RJ. Long-term response to sunitinib therapy for metastatic renal cell carcinoma. Clinical Genitourinary Cancer 2013;11(3):297-302.

Monroe KR, Stanczyk FZ, Besinque KH, Pike MC. The effect of grapefruit intake on endogenous serum estrogen levels in postmenopausal women. Nutrition and Cancer 2013; 65(5):644-652.

Moo TA, Choi L, Culpepper C, Olcese C, Heerdt A, Sclafani L, King TA, Reiner AS, Patil S, Brogi E, Morrow M, Van Zee KJ. Impact of margin assessment method on positive margin rate and total volume excised. Annals of Surgical Oncology 2014;21(1):86-92.

Moo TA, McMillan R, Lee M, Stempel M, Patil S, Ho A, El-Tamer M. Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes. Annals of Surgical Oncology 2013;20(10):3169-3174.

Morris MJ, Autio KA, Basch EM, Danila DC, Larson S, Scher HI. Monitoring the clinical outcomes in advanced prostate cancer: what imaging modalities and other markers are reliable? Seminars in Oncology 2013;40(3):375-392.

Morris PG, Correa DD, Yahalom J, Raizer JJ, Schiff D, Grant B, Grimm S, Lai RK, Reiner AS, Panageas K, Karimi S, Curry R, Shah G, Abrey LE, DeAngelis LM and Omuro A. Rituximab, methotrexate, procarbazine and vincristine followed by consolidation reduced-dose whole brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. Journal of Clinical Oncology 2013;31(31):3971-3979.

Morris PG, Iyengar NM, Patil S, Chen C, Abbruzzi A, Lehman R, Steingart R, Oeffinger KC, Lin N, Moy B, Come SE, Winer EP, Norton L, Hudis CA, Dang CT. Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer. Cancer 2013;[epub ahead of print].

Moskowitz CS, Zabor EC, Jochelson M. Response to the “letter to the editor” by Dr. Thomas Filleron. Breast Journal 2013;19(2):227.

Murphy JO, Moo TA, King TA, Van Zee KJ, Villegas KA, Stempel M, Eaton A, St Germain JM, Morris E, Morrow M. Annals of Surgical Oncology 2013;20(13):4121-4127.

Mutter RW, Lok BH, Dutta PR, Riaz N, Setton J, Berry SL, Goenka A, Zhang Z, Rao SS, Wolden SL, Lee NY. Constraining the brachial plexus does not compromise regional control in oropharyngeal carcinoma. Radiation Oncology 2013;[epub ahead of print].

Nayak L, Fleisher M, Gonzalez-Espinoza R, Lin O, Panageas K, Reiner A, Liu C-M, DeAngelis LM, Omuro A. Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors. Neurology 2013;80(17):1598-1605.

Nitadori J, Bograd AJ, Kadota K, Sima CS, Rizk NP, Morales EA, Rusch VW, Travis WD, Adusumilli PS. Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller. Journal of the National Cancer Institute 2013;105(16):1212-1220.

Nitadori J, Bograd AJ, Morales EA, Rizk NP, Dunphy MP, Sima CS, Rusch VW, Adusumilli PS. Preoperative consolidation-to-tumor ratio and SUVmax stratify the risk of recurrence in patients undergoing limited resection for lung adenocarcinoma ≤2 cm. Annals of Surgical Oncology 2013;20(13):4282-4288.

Nitadori J, Colovos C, Kadota K, Sima CS, Sarkaria IS, Rizk NP, Rusch VW, Travis WD, Adusumilli PS. Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: a proposal to reclassify T1 lung adenocarcinoma. Chest 2013;144(5):1622-1631.

O’Brien KM, Orlow I, Antonescu CR, Ballman K, McCall L, DeMatteo R, Engel LS. Gastrointestinal stromal tumors: a case-only analysis of single nucleotide polymorphisms and somatic mutations. Clinical Sarcoma Research 2013;3(1):12.

O’Brien KM, Orlow I, Antonescu CR, Ballman K, McCall L, DeMatteo R, Engel LS. Gastrointestinal stromal tumors, somatic mutations and candidate genetic risk variants. PLoS One 2013;8(4):e62119.

Oeffinger KC, Baxi SS, Novetsky Friedman D, Moskowitz CS. Solid tumor second primary neoplasms: who is at risk, what can we do? Seminars in Oncology 2013;40(6):676-689.

Oliveria SA, Shuk E, Hay JL, Heneghan M, Goulart JM, Panageas K, Geller AC, Halpern AC. Melanoma survivors: health behaviors, surveillance, psychosocial factors, and family concerns. Psycho-Oncology 2013;22(1):106-116.

Oliveria SA, Yagerman SE, Jaimes N, Goodwin AI, Dusza SW, Halpern AC, Marghoob AA. Clinical and dermoscopic characteristics of new naevi in adults: results from a cohort study. British Journal of Dermatology 2013;169(4):848-853.

Olsen CM, Nagle CM and other authors including Pike MC and Olson SH. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocrine-Related Cancer 2013;20(2):251-262.

Olson SH, Hsu M, Satagopan JM, Maisonneuve P, Silverman DT, Lucenteforte E, Anderson KE, Borgida A, Bracci PM, Bueno-de-Mesquita HB, Cotterchio M, Dai Q, Duell EJ, Fontham EH, Gallinger S, Holly EA, Ji BT, Kurtz RC, La Vecchia C, Lowenfels AB, Luckett B, Ludwig E, Petersen GM, Polesel J, Seminara D, Strayer L, Talamini R; Pancreatic Cancer Case-Control Consortium. Allergies and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. American Journal of Epidemiology 2013;178(5):691-700.

Olson SH, Kurtz RC. Epidemiology of pancreatic cancer and the role of family history. Journal of Surgical Oncology 2013;107(1):1-7.

Omuro A, Chan TA, Abrey LE, Khasraw M, Reiner AS, Kaley TJ, Deangelis LM, Lassman AB, Nolan CP, Gavrilovic IT, Hormigo A, Salvant C, Heguy A, Kaufman A, Huse JT, Panageas KS, Hottinger AF, Mellinghoff I. Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma. Neuro-Oncology 2013;15(2):242-250.

Ostroff JS, Burkhalter JE, Cinciripini PM, Li Y, Shiyko MP, Lam CY, Hay JL, Dhingra LK, Lord-Bessen J, Holland SM, Manna R. Randomized trial of a presurgical scheduled reduced smoking intervention for patients newly diagnosed with cancer. Health Psychology 2013;[epub ahead of print].

Pannu HK, Ma W, Zabor EC, Moskowitz CS, Barakat RR, Hricak H. Enhancement of ovarian malignancy on clinical contrast enhanced MRI studies. ISRN Obstetrics and Gynecology 2013;2013:979345.

Partridge AH, Norris VW, Blinder VS, Cutter BA, Halpern MT, Malin J, Neuss MN, Wolff AC. Implementing a breast cancer registry and treatment plan/summary program in clinical practice: a pilot program. Cancer 2013;119(1):158-163.

Pearce CL, Rossing MA and other authors including Pike MC. Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention 2013;22(5):880-890.

Perez CA, Zumsteg ZS, Gupta G, Morrow M, Arnold B, Patil SM, Traina TA, Robson ME, Wen YH, McCormick B, Powell SN, Ho AY. Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysis. Breast Cancer Research and Treatment 2013;139(2):497-506.

Perez DR, Baser RE, Carnar MJ, Balachandran VP, Antonescu CR, Tap WD, Strong VE, Brennan MF, Coit DG, Singer S, Dematteo RP. Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor. Annals of Surgical Oncology 2013;20(2)593-596.

Permuth-Wey J, Lawrenson K and other authors including Olson SH, Orlow I and Pike MC. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nature Communications 2013;4:1627.

Petre EN, Jia X, Thornton RH, Sofocleous CT, Alago W, Kemeny NE, Solomon SB. Treatment of pulmonary colorectal metastases by radiofrequency ablation. Clinical Colorectal Cancer 2013;12(1):37-44

Pharoah PD, Tsai YY and other authors including Olson S, Orlow I and Pike MC. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nature Genetics 2013;45(4):362-370.

Pietanza MC, Basch EM, Lash A, Schwartz LH, Ginsberg MS, Zhao B, Shouery M, Shaw M, Rogak LJ, Wilson M, Gabow A, Latif M, Lin KH, Wu Q, Kass SL, Miller CP, Tyson L, Sumner DK, Berkowitz-Hergianto A, Sima CS, Kris MG. Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes in a phase II clinical trial. Journal of Clinical Oncology 2013;31(16):2004-2009.

Pike MC, Pearce CL. Mammographic density, MRI background parenchymal enhancement and breast cancer risk. Annals of Oncology 2013;24(suppl 8):viii37-viii41.

Pilewskie M, Ho A, Orell E, Stempel M, Chen Y, Eaton A, Patil S, Morrow M. Effect of margin width on local recurrence in triple-negative breast cancer patients treated with breast-conserving therapy. Annals of Surgical Oncology 2013;[epub ahead of print].

Pilewskie M, Olcese C, Eaton A, Patil S, Morris E, Morrow M, Van Zee KJ. Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation. Annals of Surgical Oncology 2013;[epub ahead of print].

Ponce DM, Sauter C, Lubin M, Gonzales AM, Devlin SM, Kernan NA, Scaradavou A, Giralt S, Goldberg JD, Koehne G, Perales MA, Young JW, Castro-Malaspina H, Jakubowski A, Papadopoulos EB, Barker JB. A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platement engraftment after double-unit cord blood transplantation. Biology of Blood and Marrow Transplantation 2013;19(5):799-803.

Poon SA, Silberstein JL, Chen LY, Ehdaie B, Kim PH, Russo P. Trends in partial and radical nephrectomy: an analysis of case logs from certifying urologists. Journal of Urology 2013;190(2):464-469.

Postow MA, Luke JJ, Bluth MJ, Ramaiya N, Panageas KS, Lawrence DP, Ibrahim N, Flaherty KT, Sullivan RJ, Ott PA, Callahan MK, Harding JJ, D’Angelo SP, Dickson MA, Schwartz GK, Chapman PB, Gnjatic S, Wolchok JD, Hodi FS, Carvajal RD. Ipilimumab for patients with advanced mucosal melanoma. Oncologist 2013;18(6):726-732.

Price ER, Brooks JD, Watson EJ, Brennan SB, Comen EA, Morris EA. The impact of bilateral salpingo-oophorectomy on breast MRI background parenchymal enhancement and fibroglandular tissue. European Radiology 2013;24(1):162-168.

Qin LX, Tuschl T, Singer S. An empirical evaluation of normalization methods for microRNA arrays in a liposarcoma study. Cancer Informatics 2013;12:83-101.

Rabeneck L, Horton S, Zauber AG, Eagle C. Colorectal cancer. In: Disease Control Priorities in Developing Countries, 3rd ed. Jamison D, ed. Washington, DC: World Bank; 2014(in press).

Reiner AS, John EM, Brooks JD, Lynch CF, Bernstein L, Mellemkjær L, Malone KE, Knight JA, Capanu M, Teraoka SN, Concannon P, Liang X, Figueiredo JC, Smith SA, Stovall M, Pike MC, Haile RW, Thomas DC, Begg CB, Bernstein JL. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women’s Environmental Cancer and Radiation Epidemiology Study. Journal of Clinical Oncology 2013;31(4):433-439.

Rekhtman N, Tafe LJ, Chaft JE, Wang L, Arcila ME, Colanta A, Moreira AL, Zakowski MF, Travis WD, Sima CS, Kris MG, Ladanyi M. Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma. Modern Pathology 2014;27(1):163.

Reyngold M, Wu AJ, McLane A, Zhang Z, Hsu M, Stein NF, Zhou Y, Ho AY, Rosenzweig KE, Yorke ED, Rimner A. Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT). Radiation Oncology 2013;8:99-105.

Ridge CA, Huang J, Cardoza S, Zabor EC, Moskowitz CS, Zakowski MF, Ginsberg MS. Comparison of multiplanar reformatted CT lung tumor measurements to axial tumor measurement alone: impact on maximal tumor dimension and T stage. American Journal of Roentgenology 2013;201(5):959-963.

Rink M, Furberg H, Zabor EC, Xylinas E, Babjuk M, Pycha A, Lotan Y, Karakiewicz PI, Novara G, Robinson BD, Montorsi F, Chun FK, Scherr DS, Shariat SF. Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer. European Urology 2013;63(4):724-732.

Rink M, Lee DJ, Kent M, Xylinas E, Fritsche HM, Babjuk M, Brisuda A, Hansen J, Green DA, Aziz A, Cha EK, Novara G, Chun FK, Lotan Y, Bastian PJ, Tilki D, Gontero P, Pycha A, Baniel J, Mano R, Ficarra V, Trinh QD, Tagawa ST, Karakiewicz PI, Scherr DS, Sjoberg DD, Shariat SF. Predictors of cancer-specific mortality after disease recurrence following radical cystectomy. BJU International 2013;111(3 pt B):E30-36.

Rink M, Xylinas E, Margulis V, Cha E, Ehdaie B, Raman J, Chun F, Matsumoto K, Lotan Y, Furberg H, Babjuk M, Pycha A, Wood C, Scherr D, Shariat S. Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. European Urology 2013;63(6):1082-1090.

Rink M, Zabor EC, Furberg H, Xylinas E, Ehdaie B, Novara G, Babjuk M, Pycha A, Lotan Y, Trinh QD, Chun FK, Lee RK, Karakiewicz PI, Fisch M, Robinson BD, Scherr DS, Shariat SF. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy. European Urology 2013;64(3):456-464.

Robertson DJ, Lieberman DA, Winawer SJ, Ahnen DJ, Baron JA, Schatzkin A, Cross AJ, Zauber AG, Church TR, Lance P, Greenberg ER, Martínez ME. Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut 2013;[epub ahead of print].

Roobol MJ, Carlsson SV. Risk stratification in prostate cancer screening. Nature Reviews Urology 2013;10(1):38-48.

Roth BJ, Krilov L, Adams S, Aghajanian CA, Bach P, Braiteh F, Brose MS, Ellis LM, Erba H, George DJ, Gilbert MR, Jacobson JO, Larsen EC, Lichtman SM, Partridge AH, Patel JD, Quinn DI, Robison LL,Von Roenn JH, Samlowski W, Schwartz GK, Vogelzang NJ. Clinical cancer advances 2012: annual report on progress against cancer from the American Society of Clinical Oncology. Journal of Clinical Oncology 2013;31(1):131-161.

Ruddy KJ, Giobbie-Hurder A, Giordano SH, Goldfarb S, Kereakoglow S, Winer EP, Partridge AH. Quality of life and symptoms in male breast cancer survivors. Breast 2013;22(2):197-199.

Ryan CJ, Smith MR, de Borio JS, Molin A, Logothetis CJ, de Souza P, Fizazi K, Mainwaring P, Piulats JM, Ng S, Carles J, Mulders FP, Basch E, Small EJ, Saad F, Schrivers D, Van Poppel H, Mukherjee SD, Suttmann H, Gerritsen WR, Flaig TW, George DJ, Yu EY, Efstathiou E, Pantuck A, Winguist E, Higano CS, Taplin ME, Park Y, Kheoh T, Griffin T, Scher HI, Rathkopf DE, COU-AA-302 Investigators. Abiraterone in metastatic prostate cancer without previous chemotherapy. New England Journal of Medicine 2013;368(2):138-148.

Ryan ER, Thornton R, Sofocleous CT, Erinjeri JP, Hsu M, Quinn B, Dauer LT, Solomon SB. PET/CT-guided interventions: personnel radiation dose. Cardiovascular and Interventional Radiology 2013;36(4):1063-1070.

Sadetzki S, Bruchim R, Oberman B, Armstrong GN, Lau CC, Claus EB, Barnholtz-Sloan JS, Ilyasova D, Schildkraut J, Johansen C, Houlston RS, Shete S, Amos CI, Bernstein JL, Olson SH, Jenkins RB, Lachance D, Vick NA, Merrell R, Wrensch M, Davis FG, McCarthy BJ, Lai R, The Gliogene Consortium, Melin BS, Bondy ML. Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium. European Journal of Cancer 2013;49(6):1335-1345.

Salz T, McCabe MS, Onstad EE, Baxi SS, Deming RL, Franco RA, Glenn LA, Harper GR, Jumonville AJ, Payne RM, Peters EA, Salner AL, Schallenkamp JM, Williams SR, Yiee K, Oeffinger KC. Survivorship care plans: is there buy-in from community oncology providers? Cancer 2013;[epub ahead of print].

Satagopan JM, Elston RC. Evaluation of removable statistical interaction for binary traits. Statistics in Medicine 2013;32(7):1164-1190.

Sauter CS, Barker JN, Lechner L, Zheng J, Devlin SM, Papadopoulos EB, Perales MA, Jakubowski AA, Goldberg JD, Koehne G, Ceberio I, Giralt S, Zelenetz AD, Moskowitz CH, Castro-Malaspina H. A phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with b cell lymphoid malignancies: favorably durable event-free survival in chemosensitive patients. Biology of Blood and Marrow Transplantation 2013;[epub ahead of print].

Savblom C, Hallden C, Cronin AM, Sall T, Savage C, Vertosick EA, Klein RJ, Giwercman A, Lilja H. Genetic variation in KLK2 and KLK3 is associated with concentrations of hK2 and PSA in serum and seminal plasma in young men. Clinical Chemistry 2013;[epub ahead of print].

Scher HI, Morris MJ, Larson S, Heller G. Validation and clinical utility of prostate cancer biomarkers. Nature Reviews in Clinical Oncology 2013;10(4):225-234.

Schork AJ, Thompson WK, Pham P, Torkamani A, Roddey JC, Sullivan PF, Kelsoe JR, O’Donovan MC, Furberg H; Tobacco and Genetics Consortium; Bipolar Disorder Psychiatric Genomics Consortium; Schizophrenia Psychiatric Genomics Consortium, Schork NJ, Andreassen OA, Dale AM. All SNPs are not created equal: genome-wide association studies reveal a consistent pattern of enrichment among functionally annotated SNPs. PLoS Genetics 2013;9(4):e1003449.

Schumacher FR, Wang Z, Skotheim RI, Koster R, Chung CC, Hildebrandt MA, Kratz CP, Bakken AC, Bishop DT, Cook MB, Erickson RL, Fosså SD, Greene MH, Jacobs KB, Kanetsky PA, Kolonel LN, Loud JT, Korde LA, Le Marchand L, Lewinger JP, Lothe RA, Pike MC, Rahman N, Rubertone MV, Schwartz SM, Siegmund KD, Skinner EC, Turnbull C, Van Den Berg DJ, Wu X, Yeager M, Nathanson KL, Chanock SJ, Cortessis VK, McGlynn KA. Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. Human Molecular Genetics 2013;22(13):2748-2753.

Schwartz GK, Tap WD, Qin LX, Livingston MB, Undevia SD, Chmielowski B, Agulnik M, Schuetze SM, Reed DR, Okuno SH, Ludwig JA, Keedy V, Rietschel P, Kraft AS, Adkins D, Van Tine BA, Brockstein B, Yim V, Bitas C, Abdullah A, Antonescu CR, Condy M, Dickson MA, Vasudeva SD, Ho AL, Doyle LA, Chen HX, Maki RG. Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial. Lancet Oncology 2013;14(4):371-382.

Scope A, Marghoob AA, Dusza SW, Oliveria SA, Halpern AC. Change in dermoscopic pattern of naevi in children: a commentary. Acta Dermato-Venereologica 2013;94(1):120-122.

Seshan VE, Gönen M, Begg CB. Comparing ROC curves derived from regression models. Statistics in Medicine 2013;32(9):1483-1493.

Setiawan VW, Yang HP and other authors including Pike MC, Olson SH and Liang X. Type I and II endometrial cancers: have they different risk factors? Journal of Clinical Oncology 2013;31(20):2607-2618.

Shah S, Kim Y, Ostrovnaya I, Murali R, Schrader KA, Lach FP, Sarrel K, Rau-Murthy R, Hansen N, Zhang L, Kirchhoff T, Stadler Z, Robson M, Vijai J, Offit K, Smogorzewska A. Assessment of SLX4 mutations in hereditary breast cancers. PLoS One 2013;8(6):e66961.

Shaikh WR, Weinstock MA, Halpern AC, Oliveria SA, Geller AC, Dusza SW. The characterization and potential impact of melanoma cases with unknown thickness in the United States’ Surveillance, Epidemiology, and End Results Program, 1989-2008. Cancer Epidemiology 2013;37(1):64-70.

Shapiro LQ, Beal K, Goenka A, Karimi S, Iwamoto FM, Yamada Y, Zhang Z, Lassman AB, Abrey LE, Gutin PH. Patterns of failure following concurrent bevacizumab and hypofractionated stereotactic radiotherapy for recurrent high-grade glioma. International Journal of Radiation Oncology Biology Physics 2013;85:636-642.

Shariat S, Rink M, Ehdaie B, Xylinas E, Babjuk M, Merseburger A, Svatek R, Cha E, Tagawa S, Fajkovic H, Novara G, Karakiewicz P, Trinh Q, Daneshmand S, Lotan Y, Kassouf W, Fritsche H, Chun F, Sonpavde G, Joual A, Scherr D, Gönen M. Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy. European Urology 2013;63(2):371-378.

Shaykhiev R, Wang R, Zwick RK, Hackett NR, Leung R, Moore MA, Sima CS, Chao IW, Downey RJ, Strulovici-Barel Y, Salit J, Crystal RG. Airway basal cells of healthy smokers express an embryonic stem cell signature relevant to lung cancer. Stem Cells 2013;31(9):1992-2002.

Shen H, Fridley BL and other authors including Pike MC, Orlow I and Olson SH. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications 2013;4:1628.

Shen R, Wang S, Mo Q. Sparse integrative clustering of multiple omics data sets. Annals of Applied Statistics 2013;7(1):269-294.

Sieh W, Salvador S and other authors including Olson SH and Pike MC. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies. International Journal of Epidemiology 2013;42(2):579-589.

Silberhumer GR, Rahmel A, Karam V, Gönen M., Gyoeri G, Kern B, Adam R, Muehlbacher F, Rogiers X, Burroughs AK, Berlakovich GA. The difficulty in defining extended donor criteria for liver grafts: the Eurotransplant experience. Transplant International 2013;26(10):990-998.

Silberstein JL, Poon SA, Maschino AC, Lowrance WT, Garg T, Herr HW, Donat SM, Dalbagni G, Bochner BH, Sandhu JS. Urinary diversion practice patterns among certifying American urologists. Journal of Urology 2013;189(3):1042-10427.

Silberstein JL, Sprenkle PC, Su D, Power NE, Tarin TV, Ezell P, Sjoberg DD, Feifer A, Fleisher M, Russo P, Touijer KA. Neutrophil gelatinase-associated lipocalin (NGAL) levels in response to unilateral renal ischaemia in a novel pilot two-kidney porcine model. BJU International 2013;112(4):517-525.

Silberstein JL, Su D, Glickman L, Kent M, Keren-Paz G, Vickers AJ, Coleman JA, Eastham JA, Scardino PT, Laudone VP. A case-mix-adjusted comparison of early oncological outcomes of open and robotic prostatectomy performed by experienced high volume surgeons. BJU International 2013;111(2):206-212.

Sim HW, Morris PG, Patil S, Khasraw M. Brain metastases in breast cancer. Expert Review of Anticancer Therapy 2014;14(2):173-183.

Sima CS, Gönen M. Optimal cutpoint estimation with censored data. Journal of Statistical Theory and Practice 2013;7(2):345-359.

Sofocleous CT, Garcia AR, Pandit-Taskar N, Do KG, Brody LA, Petre EN, Capanu M, Longing AP, Chou JF, Carrasquillo JA, Kemeny NE. Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy. Clinical Colorectal Cancer 2013;[epub ahead of print].

Sofocleous CT, Garg SK, Cohen P, Petre EN, Gönen M., Erinjeri JP, Downey RJ, Travis WD, Solomon SB. Ki 67 is an independent predictive biomarker of cancer specific and local recurrence-free survival after lung tumor ablation. Annals of Surgical Oncology 2013;20(3):S676-S683.

Spindler M, Jacks LM, Chen X, Panageas K, DeAngelis LM, Avila EK. The spectrum of non-convulsive status epilepticus in patients with cancer. Journal of Clinical Neurophysiology 2013;30(4):339-343.

Spratt DE, Zhang C, Zumsteg ZS, Pei X, Zhang Z, Zelefsky MJ. Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality. European Urology 2013;63(4):709-716.

Sprenkle PC, Wren J, Maschino AC, Feifer A, Power N, Ghoneim T, Sternberg I, Fleisher M, Russo P. Urine neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after kidney surgery. Journal of Urology 2013;190(1):159-164.

Stanczyk FZ, Azen CG, Pike MC. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer. Journal of Steroid Biochemistry and Molecular Biology 2013;138:10-16.

Steinhagen E, Moore HG, Lee-Kong SA, Shia J, Eaton A, Markowitz AJ, Russo P, Guillem JG. Patients with colorectal and renal cell carcinoma diagnoses appear to be at risk for additional malignancies. Clinical Colorectal Cancer 2013;12(1):23-27.

Steinhagen E, Shia J, Riedel E, Nash GM, Weiser MR, Temple LK, Paty PB, Guillem JG. Response to neoadjuvant therapy in patients with early age-of-onset rectal cancer. Disease of the Colon, Rectum 2013;56(1):56-63.

Stephens SH, Hartz SM and other authors including Furberg H. Distinct loci in the CHRNA5/CHRNA3/CHRNB4 gene cluster are associated with onset of regular smoking. Genetic Epidemiology 2013;37(8):846-859.

Sternberg IA, Dalbagni G, Chen LY, Donat SM, Bochner BH, Herr HW. Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guerin treatment failure. The Journal of Urology 2013;190(5):1686-1691.

Sternberg IA, Keren Paz GE, Chen LY, Herr HW, Dalbagni G. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection. BJU International 2013;112(1):54-59.

Sternberg IA, Keren Paz GE, Chen LY, Herr HW, Donat SM, Bochner BH, Dalbagni G. Upper tract imaging surveillance is not effective in diagnosing upper tract recurrence in patients followed for nonmuscle invasive bladder cancer. Journal of Urology 2013;190(4):1187-1191.

Strope SA, Chang SH, Chen L, Sandhu G, Piccirillo JF, Schootman M. Survival impact of followup care after radical cystectomy for bladder cancer. The Journal of Urology 2013;190(5):1698-1703.

Sugaya L, de Alcantara Filho PR, Mota BS, Patil SM, Van Zee KJ, Bevilacqua JLB. A comparison of breast surgeon and nomogram-generated risk predictions of sentinel and non-sentinel node metastases. Journal of Cancer Therapy 2013;4(7A):1-6.

Sung JS, Jochelson MS, Brennan S, Joo S, Wen YH, Moskowitz C, Zheng J, Dershaw DD, Morris EA. MR imaging features of triple-negative breast cancers. Breast 2013;19(6):643-649.

Sung JS, King V, Thornton CM, Brooks JD, Fry CW, El-Tamer M, Dauer LT, Brogi E, St Germain JM, Morris EA. Safety and efficacy of radioactive seed localization with I-125 prior to lumpectomy and/or excisional biopsy. European Journal of Radiology 2013;82(9):1453-1457.

Sweldens C, Peeters S, van Limbergen E, Janssen H, Laenen A, Patil SM, Van Zee KJ, Weltens C. Local relapse after breast conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram. Cancer Journal 2014;20(1):1-7.

Tan MC, Butte JM, Gönen M., Kemeny N, Fong Y, Allen PJ, Kingham TP, Dematteo RP, Jarnagin WR, D’Angelica MI. Prognostic significance of early recurrence: a conditional survival analysis in patients with resected colorectal liver metastasis. Journal of the International Hepato-Pancreato-Biliary Association 2013;15(10):803-813.

Tang H, Wei P, Duell EJ, Risch HA, Olson SH, Bueno-de-Mesquita HB, Gallinger S, Holly EA, Petersen G, Bracci PM, McWilliams RR, Amos CI, Li D. Gene-environment interactions in obesity- and diabetes-associated pancreatic cancer: a GWAS data analysis. Cancer Epidemiology, Biomarkers & Prevention 2014;23(1):98-106.

Tang H, Wei P, Duell EJ, Risch HA, Olson SH, Bueno-de-Mesquita HB, Gallinger S, Holly EA, Petersen G, Bracci PM, McWilliams RR, Jenab M, Riboli E, Tjonneland A, Boutron-Ruault MC, Kaaks R, Trichopoulos D, Panico S, Sund M, Peeters PHM, Khaw K-T, Amos CI, Li D. Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene and pathway-based interaction analysis of GWAS data. Carcinogenesis 2013;[epub ahead of print].

Tao L, Day BW, Hu B, Xiang YB, Wang R, Stern MC, Gago-Dominguez M, Cortessis VK, Conti DV, Van Den Berg D, Pike MC, Gao YT, Yu MC, Yuan JM. Elevated 4-aminobiphenyl and 2,6-dimethylaniline hemoglobin adducts and increased risk of bladder cancer among lifelong nonsmokers - The Shanghai Bladder Cancer Study. Cancer Epidemiology, Biomarkers & Prevention 2013;22(5):937-945.

Tarin T, Feifer A, Kimm S, Chen L, Sjoberg D, Coleman J, Russo P. Impact of a common clinical pathway on length of hospital stay for patients undergoing open and minimally invasive kidney surgery. The Journal of Urology 2013;[epub ahead of print].

Terry KL, Karageorgi S, Shvetsov YB, Merritt MA, Lurie G, Thompson PJ, Carney ME, Weber RP, Akushevich L, Lo-Ciganic WH, Cushing-Haugen K, Sieh W, Moysich K, Doherty JA, Nagle CM, Berchuck A, Pearce CL, Pike M, Ness RB, Webb PM; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Rossing MA, Schildkraut J, Risch H, Goodman MT; Ovarian Cancer Association Consortium. Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls. Cancer Prevention Research 2013;6(8):811-821.

Themeli M, Kloss CC, Ciriello G, Fedorov VD, Perna F, Gönen M., Sadelain M. Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy. Nature Biotechnology 2013;31(10):928-933.

Thomas NE, Busam KJ, From L, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Venn A, Kanetsky PA, Groben PA, Hao H, Orlow I, Reiner AS, Luo L, Paine S, Ollila DW, Wilcox H, Begg CB, Berwick M. Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study. Journal of Clinical Oncology 2013;31(33):4252-4259.

Thorek DL, Evans MJ, Carlsson SV, Ulmert D, Lilja H. Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Established relevance and emerging roles. Thrombosis Haemostasis 2013;110(3):484-492.

Thorgeirsson TE, Gudbjartsson DF, Sulem P, Besenbacher S, Styrkarsdottir U, Thorleifsson G, Walters GB; TAG Consortium; Oxford-GSK Consortium; ENGAGE consortium, Furberg H, Sullivan PF, Marchini J, McCarthy MI, Steinthorsdottir V, Thorsteinsdottir U, Stefansson K. A common biological basis of obesity and nicotine addiction. Translational Psychiatry 2013;3(10):e308.

Tonorezos E, Baxi SS, Blinder V, Feldman DR, Novetsky Friedman D, Matasar M, Salz T, Shahrokni A, Oeffinger KC. Survivorship Care. In: ACS Textbook of Cancer. Wiley-Blackwell 2013;(in press).

Tonorezos ES, Robien K, Eshelman-Kent D, Moskowitz CS, Church TS, Ross R, Oeffinger KC. Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia. Cancer Causes Control 2013;24(2):313-321.

Tonorezos ES, Snell PG, Moskowitz CS, Eshelman-Kent DA, Liu JE, Chou JF, Smith SM, Dunn AL, Church TS, Oeffinger KC. Reduced cardiorespiratory fitness in adult survivors of childhood acute lymphoblastic leukemia. Pediatric Blood Cancer 2013;60(8):1358-1364.

Touijer KA, Mazzola CR, Sjoberg DD, Scardino PT, Eastham JA. Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. European Urology 2014;65(1):20-25.

Touijer KA, Mazzola CR, Sjoberg DD, Scardino PT, Eastham JA. Reply to Michael Froehner, Rainer Koch, Manfred P. Wirth’s Letter to the Editor re: Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. European Urology 2014;65(2):e25-e26.

Trakarnsanga A, Gönen M, Shia J, Goodman KA, Nash GM, Temple LK, Guillem JG, Paty PB, Garcia-Aguilar J, Weiser MR. What is the significance of the circumferential margin in locally advanced rectal cancer after neoadjuvant chemoradiotherapy? Annals of Surgical Oncology 2013;20(4):1179-1184.

Trinh QD, Bjartell A, Freedland SJ, Hollenbeck BK, Hu JC, Shariat SF, Sun M, Vickers AJ. A systematic review of the volume-outcome relationship for radical prostatectomy. European Urology 2013;64(5):786-798.

Udo K, Cronin AM, Carlino LJ, Savage CJ, Maschino AC, Al-Ahmadie HA, Gopalan A, Tickoo SK, Scardino PT, Eastham JA, Reuter VE, Fine SW. Prognostic impact of subclassification of radical prostatectomy positive margins by linear extent and Gleason grade. The Journal of Urology 2013;189(4):1302-1307.

Ulaner GA, Eaton A, Morris PG, Lilienstein J, Jhaveri K, Patil S, Fazio M, Larson S, Hudis CA, Jochelson MS. Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer. Cancer Medicine 2013;2(5):725-733.

Van Calster B, Vickers AJ, Pencina MJ, Baker SG, Timmerman D, Steyerberg EW. Evaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measures. Medical Decision Making 2013;33(4):490-501.

Van den Bergh RC, Albertsen PC, Bangma CH, Freedland SJ, Graefen M, Vickers A, van der Poel HG. Timing of curative treatment for prostate cancer: a systematic review. European Urology 2013;64(2):204-215.

Vargas HA, Burger IA, Donati OF, Andikyan V, Lakhman Y, Goldman DA, Schöder H, Chi DS, Sala E, Hricak H. Magnetic resonance imaging/positron emission tomography provides a roadmap for surgical planning and serves as a predictive biomarker in patients with recurrent gynecological cancers undergoing pelvic exenteration. International Journal of Gynecological Cancer 2013;23(8):1512-1519.

Vargas HA, Delaney HG, Delappe EM, Wang Y, Zheng J, Moskowitz CS, Tan Y, Zhao B, Schwartz LH, Hricak H, Russo P, Akin O. Multiphasic contrast-enhanced MRI: Single-slice versus volumetric quantification of tumor enhancement for the assessment of renal clear-cell carcinoma fuhrman grade. Journal of Magnetic Resonance Imaging 2013;37(5):1160-1167.

Vargas HA, Wassberg C, Fox JJ, Wibmer A, Goldman DA, Kuk D, Gönen M, Larson SM, Morris MJ, Scher HI, Hricak H. Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival. Radiology 2013;[epub ahead of print].

Veldhuis WB, Akin O, Goldman D, Mironov S, Mironov O, Soslow RA, Barakat RR, Hricak H. Peritoneal inclusion cysts: clinical characteristics and imaging features. European Radiology 2013;23(4):1167-1174.

Vertosick E, Vickers A. Re: Alberto Briganti, Thomas Wiegel, Steven Joniau, et al. early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis. Eur Urol 2012;62:472-87: statistical concerns with Briganti radiotherapy analysis. European Urology 2013;63(4):e50.

Vickers A. Words of wisdom: Re: Comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies: model estimates of potential benefits and harms. European Urology 2013;64(4):682-683.

Vickers AJ, Altman DG. Statistics notes: missing outcomes in randomised trials. BMJ 2013;346:f3438.

Vickers AJ, Bennette C, Kibel AS, Black A, Izmirlian G, Stephenson AJ, Bochner B. Who should be included in a clinical trial of screening for bladder cancer?: a decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Cancer 2013;119(1):143-149.

Vickers A, Carlsson S, Laudone V, Lija H. It ain’t what you do, it’s the way you do it: five golden rules for transforming prostate-specific antigen screening. European Urology 2013;[epub ahead of print].

Vickers AJ, Cronin AM, Gönen M. A simple decision analytic solution to the comparison of two binary diagnostic tests. Statistics in Medicine 2013;32(11):1865-1876.

Vickers AJ, Maschino AC, Lewith G, MacPherson H, Sherman KJ, Witt CM. Responses to the Acupuncture Trialists’ Collaboration individual patient data meta-analysis. Acupuncture in Medicine 2013;31(1):98-100.

Vickers AJ, Pencina MJ. Prostate-specific antigen velocity: new methods, same results, still no evidence of clinical utility. European Urology 2013;64(3):394-296.

Vickers AJ, Sjoberg DD, Ankerst DP, Tangen CM, Goodman PJ, Thompson IM Jr. The prostate cancer prevention trial risk calculator and the relationship between prostate-specific antigen and biopsy outcome. Cancer 2013;119(16):3007-3011.

Vickers AJ, Ulmert D, Sjoberg DD, Bennette CJ, Bjork T, Gerdtsson A, Manjer J, Nilsson PM, Dahlin A, Bjartell A, Scardino PT, Lilja H. Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study. BMJ 2013;346:f2023.

Vickers AJ. Counterpoint: Prostate-specific antigen velocity is not of value for early detection of cancer. Journal of the National Comprehensive Cancer Network 2013;11(3):286-290.

Vickers AJ. If something looks too good to be true, it probably is. BJU International 2013;112(4):430-431.

Vickers AJ. Placing acupuncture in perspective — reply. JAMA Internal Medicine 2013;173(8):714.

Vickers AJ. Prostate cancer: Why is PSA velocity such a sticky concept? Nature Reviews Urology 2013;10(4):189-190.

Vickers AJ. What are the implications of the surgical learning curve? European Urology 2014;65(3):532-533.Vickers AJ. Writing up clinical research: a statistician’s view. Journal of General Internal Medicine 2013;28(9):1127-1129.

Voss MH, Bastos DA, Karlo CA, Ajeti A, Hakimi AA, Feldman DR, Hsieh J, Molina AM, Patil SM, Motzer RJ. Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with non-clear and sarcomatoid histologies. Annals of Oncology 2014;[epub ahead of print].

Wang J, Carvajal-Carmona LG, Chu JH, Zauber AG; APC Trial Collaborators, Kubo M, Matsuda K, Dunlop M, Houlston RS, Sieber O, Lipton L, Gibbs P, Martin NG, Montgomery GW, Young J, Baird PN, Ratain MJ, Nakamura Y, Weiss ST, Tomlinson I, Bertagnolli MM. Germline variants and advanced colorectal adenomas: adenoma preveention with celecoxib trial genome-wide association study. Clinical Cancer Research 2013;19(23):6430-6437.

Wang LC, Xylinas E, Kent MT, Kluth LA, Rink M, Jamzadeh A, Rieken M, Al Awamih BA, Trinn QD, Sun M, Karakiewicz PI, Novara G, Chrystal J, Zerbib M, Scherr DS, Lotan Y, Vickers A, Shariat SF. Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder. Urologic Oncology 2013;[epub ahead of print].

Wang YC, Graubard BI, Rosenberg MA, Kuntz KM, Zauber AG, Kahle L, Schechter CB, Feuer EJ. Derivation of background mortality by smoking and obesity in cancer simulation models. Medical Decision Making 2013;33(2):176-197.

Wang X, Erinjeri JP, Jia X, Gönen M, Brown KT, Sofocleous CT, Getrajdman GI, Brody LA, Thornton RH, Maybody M, Covey AM, Siegelbaum RH, Alago W, Solomon SB. Pattern of retained contrast on immediate postprocedure computed tomography (CT) after article embolization of liver tumors predicts subsequent treatment response. Cardiovascular and Internventional Radiology 2013;36(4):1030-1038.

Watters AL, Hansen HJ, Williams T, Chou JF, Riedel E, Halpern J, Tunick S, Bohle G, Huryn JM, Estilo CL. Intravenous bisphosphonate-related osteonecrosis of the jaw: long-term follow-up of 109 patients. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology. 2013;115(2):192-200.

Weiss MJ, Ito H, Arauio RL, Zabor EC, Gönen M, D’Angelica MI, Allen PJ, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Hepatic pedicle clamping during hepatic resection for colorectal liver metastases: no impact on survival or hepatic recurrence. Annals of Surgical Oncology 2013;20(1):285-294.

White KL, Vierkant RA and other authors including Olson SH, Orlow I and Pike MC. Analysis of over 10,000 cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer Epidemiology, Biomarkers & Prevention 2013;22(5):987-992.

Wolf PS, Park JO, Bao F, Allen PJ, Dematteo RP, Fong Y, Jarnagin WR, Kingham TP, Gönen M, Kemeny N, Shia J, D’Angelica MI. Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: A single institution experience. Journal of the American College of Surgeons 2013;216(1):41-49.

Wiren SM, Drevin LI, Carlsson SV, Akre O, Holmberg EC, Robinson DE, Garmo HG, Stattin PE. Fatherhood status and risk of prostate cancer: nationwide, population-based case-control study. International Journal of Cancer 2013;133(4):937-943.

Wu X, Ragupathi G, Panageas K, Hong F, Livingston PO. Accelerated tumor growth mediated by sub-lytic levels of antibody-induced complement activation is associated with activation of the PI3K/AKT survival pathway. Clinical Cancer Research 2013;19(17):4728-4739.

Yancovitz M, Rizzo C, Julian P, Oliveria SA, Becker D. Patient perceptions of nonmelanoma skin cancer before diagnosis. Dermatologic Surgery 2013;39(10):1496-1501.

Yoshioka T, Otero J, Chen Y, Kim YM, Koutcher JA, Satagopan J, Reuter V, Carver B, de Stanchina E, Enomoto K, Greenberg NM, Scardino PT, Scher HI, Sawyers CL, Giancotti FG. β4 Integrin signaling induces expansion of prostate tumor progenitors. Journal of Clinical Investigation 2013;123(2):682-699.

Young RJ, Gupta A, Shah AD, Graber JJ, Chan TA, Zhang Z, Shi W, Beal K, Omuro AM. MRI perfusion in determining pseudoprogression in patients with glioblastoma. Clinical Imaging 2013;37(1):41-49.

Young RJ, Gupta A, Shah AD, Graber JJ, Schweitzer AD, Prager A, Shi W, Zhang Z, Huse J, Omuro AM. Potential role of preoperative conventional MRI including diffusion measurements in assessing epidermal growth factor receptor gene amplification status in patients with glioblastoma. American Journal of Neuroradiology 2013; 34(12):2271-2277.

Young RJ, Lee V, Peck KK, Sierra T, Zhang Z, Jacks LM, Holodny AI. Diffusion tensor imaging and tractography of the corticospinal tract in the presence of enlarged Virchow-Robin spaces. Journal of Neuroimaging 2014;24(1):79-82.

Yu HA, Arcila ME, Rekhtman N, Sima CS, Zakowski MF, Pao W, Kris MG, Miller VA, Ladanyi M, Riely GJ. Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers. Clinical Cancer Research 2013;19(8):2240-2247.

Yu HA, Sima CS, Huang J, Solomon SB, Rimner A, Paik P, Pietanza MC, Azzoli CG, Rizvi NA, Krug LM, Miller VA, Kris MG, Riely GJ. Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors. Journal of Thoracic Oncology 2013;8(3):346-351.

Yu SS, Spicer DV,Hawes D, Tseng CC, Yang CS, Pike MC, Wu AH. Biological effects of green tea capsule supplementation in pre-surgery postmenopausal breast cancer patients. Frontiers in Oncology 2013;3:298.

Yuan J, Ku GY, Adamow M, Mu Z, Tandon S, Hannaman D, Chapman P, Schwartz G, Carvajal R, Panageas KS, Houghton AN, Wolchok JD. Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma. Immunotherapy of Cancer 2013;(in press).

Yuan J, Zhou J, Dong Z, Tandon S, Kuk D, Panageas KS, Wong P, Wu X, Naidoo J, Page DB, Wolchok JD, Hodi FS. Pre-treatment serum vascular endothelial growth factor is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab. Cancer Immunology Research 2013;(in press).

Zabor EC, Gönen M, Chapman PB, Panageas KS. Dynamic prognostication using conditional survival estimates. Cancer 2013;119(20):3589-3592.

Zabor EC, Li Y, Thornton LM, Shuman MR, Bulik CM, Lichtenstein P, Pedersen NL, Sullivan PF, Furberg H. Initial reactions to tobacco use and risk of future regular use. Nicotine & Tobacco Research 2013;15(2):509-517.

Zamarin D, Devlin SM, Arcila ME, Landau H, Lesokhin A, Lendvai N, Chung DJ, Chimento D, Weltz J, Babu D, Giralt S, Hassoun H. Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: incidence and prognostic significance. Leukemia 2013;27(12):2422–2424.

Zamarin D, Giralt S, Landau H, Lendvai N, Lesokhin A, Chung D, Koehne G, Chimento D, Devlin SM, Riedel E, Bhutani M, Babu D, Hassoun H. Patterns of relapse and progression in multiple myeloma patients after auto-SCT: implications for patients’ monitoring after transplantation. Bone Marrow Transplant 2013;48(3):419-424.

Zappa M, Puliti D, Hugosson J, Schroder FH, van Leeuwen PJ, Kranse R, Auvinen A, Carlsson S, Kwiatkowski M, Nelen V, Borda Ap, Roobol MJ, Villers A. A different method of evaluation of the ERSPC trail confirms that prostate-specific antigen testing has a significant impact on prostate cancer mortality. European Urology 2013;[epub ahead of print].

Zauderer MG, Sima CS, Korc-Grodzicki B, Kris MG, Krug LM. Toxicity of initial chemotherapy in older patients with lung cancers. Journal of Geriatric Oncology 2013;4(1):64-70.

Zhang Z, Zhao Y. Empirical likelihood for linear transformation models with interval-censored failure time data. Journal of Multivariate Analysis 2013;116:398-409.

Zumsteg ZS, Morrow M, Arnold B, Zheng J, Zhang Z, Robson M, Traina T, McCormick B, Powell S, Ho AY. Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer. Annals of Surgical Oncology 2013;20(11):3469-3476.

Zumsteg ZS, Spratt DE, Pei I, Zhang Z, Yamada Y, Kollmeier M, Zelefsky MJ. A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy. European Urology 2013; 64(6):895-902.

Zumsteg ZS, Spratt DE, Pei X, Yamada Y, Kalikstein A, Kuk D, Zhang Z, Zelefsky MJ. Short-term androgen-deprivation therapy improves prostate cancer-specific mortality in intermediate-risk prostate cancer patients undergoing dose-escalated external beam radiation therapy. International Journal of Radiation Oncology Biology Physics 2013;85(4):1012-1017.

Abramson DH, Marr BP, Dunkel IJ, Brodie S, Zabor EC, Driscoll SJ, Gobin YP. Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results.

Br J Ophthalmology 2012;96:499-502.

Acharyya S, Oskarsson T, Vanharanta S, Malladi S, Kim J, Morris PG, Manova-Todorova K,

Leversha M, Hogg N, Seshan VE, Norton L, Brogi E, Massagué J. A CXCL1 paracrine network

links cancer chemoresistance and metastasis. Cell 2012;150:165-178.

Albornoz CR, Bach PB, Pusic AL, McCarthy CM, Mehrara BJ, Disa JJ, Cordeiro PG, Matros E.

The influence of sociodemographic factors and hospital characteristics on the method of breast reconstruction, including microsurgery: a U.S. population-based study. Plastic and Reconstructive Surgery 2012;129:1071-1079.

Amar D, Zhang H, Shi W, Downey RJ, Bains MS, Park BJ, Flores R, Rizk N, Thaler HT, 
Rusch VW. Brain natriuretic peptide and risk of atrial fibrillation after thoracic surgery. Journal 
of Thorac and Cardiovascular Surgery 2012;144:1249-1253. 

Ambrosini G, Pratilas CA, Qin LX, Tadi M, Surriga O, Carvajal RD, Schwartz GK. Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK-resistance. Clinical Cancer Research 2012;18:3552-3561.

Andrade VP, Ostrovnaya I, Seshan VE, Morrogh M, Giri D, Olvera N, De Brot M, Morrow M,

Begg CB, King T. Clonal relatedness between lobular carcinoma in situ and synchronous

malignant lesions. Breast Cancer Research 2012;14:R103.

Ang C, O’Reilly EM, Carvajal RD, Capanu M, Gonen M, Doyle L, Ghossein R, Schwartz L, Jacobs G, Ma J, Schwartz GK, Abou-Alfa GK. A nonrandomized, phase II study of sequential irinotecan and flavopiridol in patients with advanced hepatocellular carcinoma. Gastrointestinal Cancer Research 2012;5:185-189.

Ankerst DP, Boeck A, Freedland SJ, Stephen Jones J, Cronin AM, Roobol MJ, Hugosson J, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Moreira DM, Schroder FH, Lilja H, Vickers AJ, Thompson IM. Evaluating the Prostate Cancer Prevention Trial High Grade prostate cancer risk calculator in 10 international biopsy cohorts: results from the prostate biopsy collaborative group. World Journal of Urology 2012;[epub ahead of print].

Ankerst DP, Boeck A, Freedland SJ, Thompson IM, Cronin AM, Roobol MJ, Hugosson J, Stephen Jones J, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Moreira DM, Schroder FH, Lilja H, Vickers AJ. Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. World Journal of Urology 2012;30:181-187.

Araten DJ, Notaro R, Thaler HT, Kernan N, Boulad F, Castro-Malaspina H, Small  T, Scaradavou A, Magnan H, Prockop S, Chaffee S, Gonsky J, Thertulien R, Tarquini R, Luzzatto L. Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literature. Haematologica 2012;97:344-352.

Arber N, Lieberman D, Wang TC, Zhang R, Sands GH, Bertagnolli MM, Hawk ET, Eagle C, Coindreau J, Zauber A, Lanas A, Levin B. The APC and PreSAP Trials: A post hoc noninferiority analysis using a comprehensive new measure for gastrointestinal tract injury in 2 randomized, double-blind studies comparing celecoxib and placebo. Clinical Therapeutics 2012; 34:569-579.

Atkinson, TM, Halabi S, Bennett AV, Rogak L, Sit L, Li Y, Kaplan E, Basch E, Cancer and Leukemia Group B. Measurement of affective and activity pain interference using the Brief Pain Inventory (BPI): Cancer and Leukemia Group B 70903. Pain Medicine 2012;13:1417-1424.

Atkinson TM, Li Y, Coffey CW, Sit L, Shaw M, Lavene D, Bennett AV, Fruscione M, Rogak L, Hay J, Gönen M, Schrag D, Basch E. Reliability of adverse symptom event reporting by clinicians. Quality of Life Research 2012;21:1159-1164.

Bach PB, Gould MK. When the average applies to no one: personalized decision making about potential benefits of lung cancer screening. Annals of Internal Medicine 2012;157:571-573.

Bach PB, Lewis RJ. Multiplicities in the assessment of multiple vitamins: is it too soon to tell men that vitamins prevent cancer? Journal of the American Medical Association 2012;308:1916-1917.

Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, Sabichi AL, Smith-Bindman R, Wood DE, Qaseem A, Detterbeck FC.

 Benefits and harms of CT screening for lung cancer: a systematic review. Journal of the American Medical Association 2012;307:2418-2429.

Barker CA, Chang M, Chou JF, Zhang Z, Beal K, Gutin PH, Iwamoto FM. Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma. Journal of Neuro-Oncology 2012;109:391-397.

Bartlett RM, Beattie BJ, Naryanan M, Georgi JC, Chen Q, Carlin SD, Roble G, Zanzonico PB, Gönen M, O’Donoghue J, Fischer A, Humm JL. Image-guided PO 2 probe measurements correlated with parametric images derived from 18F-fluoromisonidazole small-animal PET data in rats. Journal of Nuclear Medicine 2012;53:1608-1615.

Basch E, Oliver TK, Vickers A, Thompson I, Kantoff P, Parnes H, Loblaw DA, Roth B, Williams J, Nam RK. Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion. Journal of Clinical Oncology 2012;30:3020-3025.

Baser RE, Li Y, Carter J. Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors. Cancer 2012;118:4606-4618.

Baxi SS, Shuman AG, Corner GW, Shuk E, Sherman EJ, Elkin EB, Hay JL, Pfister DG. Sharing a diagnosis of HPV-related head and neck cancer: The emotions, the confusion, and what patients want to know. Head Neck 2012;[epub ahead of print].

Begg CB, Gonen M, Seshan VE. Testing the incremental predictive accuracy of new markers. Clinical Trials 2013;(in press).

Begg CB, Pike MCComment on “the predictive capacity of personal genome sequencing”.  Science Translational Medicine 2012;4:135le3.

Begg CB, Zabor E. Detecting and exploiting etiologic heterogeneity in epidemiologic studies. American Journal of Epidemiology 2012;176:512-518.

Bennette C, Vickers A. Against quantiles: categorization of continuous variables in epidemiologic research, and its discontents. BMC Medical Research Methodology 2012;12:21.

Bickenbach KA, Denton B, Gönen M, Brennan MF, Coit DG, Strong VE. Impact of obesity on perioperative complications and long-term survival of patients with gastric cancer. Annals of Surgical Oncology 2012;[epub ahead of print].

Bickenbach KA, Gönen M, Tang LH, O’Reilly E, Goodman K, Brennan MF, D’Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR, Allen PJ. Downstaging in pancreatic cancer: A matched analysis of patients resected following systemic treatment of initially locally unresectable disease. Annals of Surgical Oncology 2012;19:1663-1669.

Blajchman MA, Carson JL, Eikelboom JW, Heddle NM, Lacroix J, Lauer MS, Platt R, Tilley B, Triulzi D, Vickers AJ, Yusuf S, Glynn S, Mondoro TH, Wagner E. The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshop. Transfusion 2012;52:1363-1378.

Blinder VS. Disparities in breast cancer outcomes: receipt of chemotherapy is only part of the story. Journal of Clinical Oncology 2012, 30:3041-3043.

Blinder VS, Murphy MM, Vahdat LT, Gold HT, de Melo-Martin I, Hayes MK, Scheff RJ, Chuang E, Moore A, Mazumdar M. Employment after a breast cancer diagnosis: A qualitative study of ethnically diverse urban women. Journal of Community Health 2012; 37:763-772.

Blinder VS, Norris VW, Peacock NW, Griggs JJ, Harrington DP, Moore A, Theriault RL, Partridge AH on behalf of the ASCO Breast Cancer Registry Pilot Steering Group. Patient perspectives on breast cancer treatment plan and summary documents in community oncology care: A pilot program. Cancer 2013, 119: 164-172.

Blinder VS, Patil S, Thind A, Diamant A, Hudis CA, Basch E, Maly RC. Return to work in low-income Latina and non-Latina white breast cancer survivors: A 3-year longitudinal study. Cancer 2012; 118:1664-1674.

Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji B-T, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Bamlet WR, Holly EA, Bertuccio P, Gao Y-T, Hassan M, Yu H, Kurtz RC, Cotterchio M, Su J, Maisonneuve P, Duell EJ, Boffetta P, La Vecchia C. Cigarette smoking and pancreatic cancer: an analysis from the international Pancreatic Cancer Case-Control Consortium (PanC4).  Annals of Oncology 2012;23:1880-1888.

Bowers M, Eng L, Lao Z, Turnbull RK, Bao X, Riedel E, Mackem S, Joyner AL. Limb anterior-posterior polarity integrates activator and repressor functions of GLI2 as well as GLI3. Developmental Biology 2012;370:110-124.

Breitbart W, Poppito S, Rosenfeld B, Vickers AJ, Li Y, Abbey J, Olden M, Pessin H, Lichtenthal W, Sjoberg D, Cassileth BR. Pilot randomized controlled trial of individual meaning-centered psychotherapy for patients with advanced cancer. Journal of Clinical Oncology 2012; 30:1304-1309.

Brenner DR, Boffetta P, Duell EJ, Bickeböller H, Rosenberger A, McCormack V, Muscat JE, Yang P, Wichmann HE, Brueske-Hohlfeld I, Schwartz AG , Cote ML, Tjønneland A, Friis S, LeMarchand L, Zhang ZF, Morgenstern H, Szeszenia-Dabrowska N, Lissowska J, Zaridze D, Rudnai P, Fabianova E, Foretova L, Janout V, Bencko V, Schejbalova M, Brennan P, Mates IN, Lazarus P, Field JK, Raji O, McLaughlin JR, Liu G, Wiencke J, Neri M , Ugolini D, Andrew AS, Lan Q , Orlow I, Park BJ, Hung RJ. Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium. American Journal of Epidemiology 2012;;176:573-585.

Brooks JD, Bernstein L, Teraoka SN, Knight JA, Mellemkjaer L, John EM, Malone KE, Reiner AS, Lynch CF, Concannon P, Haile RW, Bernstein JL. Variation in genes related to obesity, weight and weight change and risk of contralateral breast cancer in the WECARE Study population. Cancer Epidemiology, Biomarkers & Prevention 2012;21:2261-2267.

Brooks JD, Boice JD, Jr, Stovall M, Reiner AS, Bernstein L, John EM, Lynch CF, Mellemkjær L, Knight JA, Thomas DC, Haile RW, Smith SA, Capanu C, The WECARE Collaborative Group, Bernstein JL, Shore RE. Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in The WECARE Study. International Journal of Radiation Oncology, Biology, Physics 2012;84:917-924.

Brooks JD, John EM, Mellemkjær L, Reiner AS, Malone KE, Lynch CF, Figueiredo JC, Haile RW, Shore RE, The WECARE Study Collaborative Group, Bernstein JL, Bernstein L. Body mass index and risk of second primary breast cancer: the WECARE Study. Breast Cancer Research and Treatment 2012; 131:571-580.

Brooks JD, Teraoka SN, Malone KE, Haile, RW, Bernstein L, Lynch CF, Mellemkjær L, Duggan DJ, Reiner AS, Concannon P, Schiermeyer K, Lewinger JP, The WECARE Study Collaborative Group, Bernstein JL, Figueiredo JC.  Variants in tamoxifen metabolizing genes: A case-control study of contralateral breast cancer risk in the WECARE Study. International Journal of Molecular Epidemiology and Genetics 2013;(in press).

Brooks JD, Teraoka SN, Reiner AS, Satagopan JM, Bernstein L, Thomas DC, Capanu M, Stovall M, Smith SA, Wei S, Shore RE, Boice Jr JD, Lynch CF, Mellemkjaer L, Malone KE, Liang X; WECARE Study Collaboratiev Group, Haile RW, Concannon P, Bernstein JL. Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study. Human Mutations 2012;33: 158-164.

Brown RF, Bylund CL, Li Y, Edgerson S, Butow P. Testing the utility of a cancer clinical trial specific Question Prompt List (QPL-CT) during oncology consultations. Patient Education and Counseling 2012;88:311-317.

Busque L, Patel JP, Figueroa ME, Vasanthakumar A, Provost S, Hamilou Z, Mollica L, Li J, Viale A, Heguy A, Hassimi M, Socci N, Bhatt PK, Gönen M, Mason CE, Melnick A, Godley LA, Brennan CW, Abdel-Wahab O, Levine RL. Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis. Nature Genetics 2012;44:1179-1181.

Butte JM, Gönen M, Ding P, Goodman KA, Allen PJ, Nash GM, Guillem J, Paty PB, Saltz LB, Kemeny NE, Dematteo RP, Fong Y, Jarnagin WR, Weiser MR, D’Angelica MI. Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer. Cancer 2012;118:5414-5423.

Butte JM, Tang P, Gönen M, Shia J, Schattner M, Nash GM, Temple LKF, Weiser MR. Rate of residual disease after complete endoscopic resection of malignant colonic polyp. Diseases of the Colon and Rectum 2012;55:122-127.

Butte JM, Torres J, Veras EF, Matsuo K, Gönen M, D’Angelica MI, Waugh E, Meneses M, Inayama Y, Fong Y, DeMatteo RP, De La Fuente H, Endo I, Klimstra DS, Jarnagin WR. Regional differences in gallbladder cancer pathogenesis: insights from a comparison of cell cycle-regulatory, PI3K, and pro-angiogenic protein expression. Annals of Surgical Oncology 2012;[epub ahead of print].

Bylund CL, D’Agostino TA, Ostroff J, Heerdt A, Li Y, Dickler M. Exposure to and intention to discuss cancer-related internet information among patients with breast cancer. Journal of Oncology Practice 2012;8:40-45.

Cahlon O, Brennan MF, Jia X, Qin LX, Singer S, Alektiar KM. A postoperative nomogram for local recurrence risk in extremity soft tissue sarcomas after limb-sparing surgery without adjuvant radiation. Annals of Surgery 2012;255:343-347.

Cancer Genome Atlas Research Network, Hammerman PS, Hayes DN, Wilkerson MD,

Schultz N, Bose R, Chu A, Collisson EA, Cope L, Creighton CJ, Getz G, Herman JG,

Johnson BE, Kucherlapati R, Ladanyi M, Maher CA, Robertson G, Sander C, Shen R,

Sinha R, Sivachenko A, Thomas RK, Travis WD, Tsao MS, Weinstein JN, Wigle DA,

Baylin SB, Govindan R, Meyerson M. Comprehensive genomic characterization of

squamous cell lung cancers. Nature 2012;489:519-525.

Cancer Genome Atlas Network (Shen R, Member). Comprehensive molecular portraits of human breast tumours. Nature 2012;490:61-70.

Cancer Genome Atlas Network (Shen, R, Member). Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012;487:330-337.

Cardona K, Mastrodomenico P, D’Amico F, Shia J, Gönen M, Weiser MR, Paty PB, Kingham TP, Allen PJ, De Matteo RP, Fong Y, Jarnagin WR, D’Angelica MI. Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases. Annals of Surgical Oncology 2013;20:148-154.

Cardona K, Zhou Q, Gönen M, Shah MA, Strong VE, Brennan MF, Coit DG. Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy. Annals of Surgical Oncology 2013;20:548-554.

Carlsson S, Vickers A, Lilja H, Hugosson J. Screening for prostate cancer. Annals of Internal Medicine. 2012;156:539; author reply 40.

Carlsson S, Vickers AJ, Roobol M, Eastham J, Scardino P, Lilja H, Hugosson J. Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review. Journal of Clinical Oncology 2012;30:2581-2584.

Carvajal-Carmona LG, Zauber AG, Jones AM, Howarth K, Wang J, Cheng T; APC Trial Collaborators; APPROVe Trial Collaborators; CORGI Study Collaborators; Colon Cancer Family Registry Collaborators; CGEMS Collaborators, Riddell R, Lanas A, Morton D, Bertagnolli MM, Tomlinson I. Much of the population genetic risk of colorectal cancer is likely to be mediated through susceptibility to adenomas.  Gastroenterology 2013;144:53-55.

Chaft JE, Arcila ME, Paik PK, Lau C, Riely GJ, Pietanza MC, Zakowski MF, Rusch V, Sima CS, Ladanyi M, Kris MG. Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling. Molecular Cancer Therapeutics 2012;11:485-491.

Chaft JE, Sima CS, Ginsberg MS, Huang J, Kris MG, Travis WD, Azzoli CG. Clinical outcomes with perioperative chemotherapy in sarcomatoid carcinomas of the lung. Journal of Thoracic Oncology 2012;7:1400-1405.

Chandarlapaty S, Sakr RA, Giri D, Patil S, Heguy A, Morrow M, Modi S, Norton L, Rosen N, Hudis C, King TA. Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer. Clinical Cancer Research 2012;18:6784-6791. 

Chawla S, D’Agostino RL, Pastores SM, Thirumala R, Kostelecky N, Chou JF, Thaler HT, Halpern NA. Homeward bound: an analysis of patients discharged home from an oncologic intensive care unit. Journal of Critical Care 2012;27:681-687.

Chen J, Guo T, Zhang L, Qin LX, Singer S, Maki RG, Taguchi T, Dematteo R, Besmer P, Antonescu CR. CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers. Genes Chromosomes & Cancer 2012;51:186-195.

Chen L-S, Saccone NL, Culverhouse RC, Bracci PM, Chen C-H, Dueker N,  Han Y, Huang H, Jin G, Kohno T, Ma JZ, Przybeck TR, Sanders AR, Smith JA, Sung YJ, Wenzlaff AS, Wu C, Yoon D, Bergen AW, Chen Y-T, Cheng Y-C, Cho YS, David SP, Duan J, Eaton C, Furberg H, Goate AM, Gu D, Hansen HM, Hartz S, Hu Z, Kim YJ , Kittner SJ, Levinson DF, Mosley TH, Payne TJ, Rao DC, Rice JP, TK, Schwantes-An T-H, Shete SS, Shi J, Spitz MR, Sun YV, Tsai F-J, Wang JC, Wrensch MR, Xian H, Gejman PV, He J, Hunt SC, Kardia SL, Li MD, Lin D, Mitchell BD, Park T, Schwartz AG, Shen H, Wiencke JK, Wu J-Y, Yokota J, Amos CI, Bierut LJ. Smoking and genetic risk variation across populations of European, Asian, and African-American Ancestry - a meta-analysis of chromosome 15q25. Genetic Epidemiology 2012;36:340-351.

Cheung NKV, Cheung IY, Kushner BH, Ostrovnaya I, Kramer K, Modak S. Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte- macrophage colony stimulating factor and

13-cis-retinoic acid is effective against chemoresistant marrow MRD among high-risk patients with stage 4 neuroblastoma in first remission. Journal of Clinical Oncology 2012;30:3264-3270.

Chmielecki J, Pietanza MC, Aftab D, Shen R, Zhao Z, Chen X, Hutchinson K, Viale A, Kris MG, Stout T, Miller V, Rizvi N, Pao W. EGFR-mutant lung adenocarcinomas treated first-line with the novel EGFR inhibitor, XL647, can subsequently retain moderate sensitivity to erlotinib. Journal of Thoracic Oncology 2012;7:434-442.

Choi DX, Eaton AA, Olcese C, Patil S, Morrow M, Van Zee KJ. Blurry boundaries: do epithelial borderline lesions of the breast and ductal carcinoma in situ have similar rates of subsequent invasive cancer? Annals of Surgical Oncology 2012;[epub ahead of print]. 

Choudhary A, Chou J, Heller G, Sklar C. Prevalence of vitamin D insufficiency in survivors of childhood cancer. Pediatric Blood & Cancer 2012;[epub ahead of print].

Chung K, Hovanessian-Larsen LJ, Hawes D, Taylor D, Downey S, Spicer DV, Stanczyk FZ, Patel S, Anderson AR, Pike MC, Wu AH, Pearce CL. Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation.  Breast Cancer Research and Treatment 2012;132:653-660.

Clendenen TV, Kim S, Moy L, Wan L, Rusinek H, Stanczyk FZ, Pike MC, Zeleniuch-Jacquotte A.  Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women.  Journal of Magnetic Resonance Imaging 2013; 31:1-9.

Clendenen TV, Zeleniuch-Jacquotte A, Moy L, Pike MC, Rusinek H, Kim S. Comparison of 3-point dixon imaging and fuzzy C-means clustering methods for breast density measurement.  Journal of Magnetic Resonance Imaging 2013;[epub ahead of print].

Collaborative Group on Epidemiological Studies of Ovarian Cancer (Pike MC, Member), Beral V, Gaitskell K, Hermon C, Moser K, Reeves G, Peto R. Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies.  Lancet Oncology 2012; 13:946-956.

Conti RM, Rosenthal MB, Polite BN, Bach PB, Shih YC. Infused chemotherapy use in the elderly after patent expiration. The American Journal of Managed Care 2012;18:e173-e178.

Cook LS, Nelson HE, Cockburn M, Olson SH, Muller CY, Wiggins CL.  Comorbidities and endometrial cancer survival in Hispanics and non-Hispanic whites.  Cancer Causes Control 2013; 24:61-69.

Correa DD, Root JC, Baser R, Moore D, Peck KK, Lis E, Shore TB, Thaler HT, Jakubowski A, Relkin N. A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients. Brain Imaging and Behavior 2013;[epub ahead of print].

Correa DD, Shi W, Abrey LE, Deangelis LM, Omuro AM, Deutsch MB, Thaler HT. Cognitive functions in primary CNS lymphoma after single or combined modality regimens. Neuro-Oncology 2012;14:101-108.

Cote ML, Atikukke G, Ruterbusch JJ, Olson SH, Sealy-Jefferson S, Rybicki BA, Hensley Alford S, Elshaikh MA, Gaba AR, Schultz D, Haddad R, Munkarah AR, Ali-Fehmi R.  Racial differences in oncogene mutations detected in early stage, low grade endometrial cancers.  International Journal of Gynecological Cancer 2012; 22:1367-1372.

Coté ML, Liu M, Bonassi S, Neri M, Schwartz AG, Christiani DC, Spitz MR, Muscat JE, Rennert G, Aben KK, Andrew AS, Bencko V, Bickeböller H, Boffetta P, Brennan P, Brenner H, Duell EJ, Fabianova E, Field JK, Foretova L, Friis S, Harris CC, Holcatova I, Hong YC, Isla D, Janout V, Kiemeney LA, Kiyohara C, Lan Q, Lazarus P, Lissowska J, Le Marchand L, Mates D, Matsuo K, Mayordomo JI, McLaughlin JR, Morgenstern H, Müeller H, Orlow I, Park BJ, Pinchev M, Raji OY, Rennert HS, Rudnai P, Seow A, Stucker I, Szeszenia-Dabrowska N, Dawn Teare M, Tjønnelan A, Ugolini D, van der Heijden HF, Wichmann E, Wiencke JK, Woll PJ, Yang P, Zaridze D, Zhang ZF, Etzel CJ, Hung RJ. Increased risk of lung cancer in individuals with a family history of the disease: A pooled analysis from the International Lung Cancer Consortium. European Journal of Cancer 2012;48:1957-1968.

Cotignola J, Chou JF, Roy P, Mitra N, Busam K, Halpern AC, Orlow I. Investigation of the effect of MDM2 SNP309 and TP53 Arg72Pro polymorphisms on the age of onset of cutaneous melanoma. Journal of Investigative Dermatology 2012;132:1471-1478.

Crago AM, Socci ND, Decarolis P, O’Connor R, Taylor BS, Qin LX, Antonescu CR, Singer S. Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability. Clinical Cancer Research 2012;18:1334-1340.

D’Agostino TA, Ostroff JS, Heerdt A, Dickler M, Li Y, Bylund CL. Toward a greater understanding of breast cancer patients’ decisions to discuss cancer-related internet information with their doctors: an exploratory study. Patient Education and Counseling 2012;89:109-115.

Damast S, Alektiar KM, Goldfarb S, Eaton A, Patil S, Mosenkis J, Bennett A, Atkinson T, Jewell E, Leitao M, Barakat R, Carter J, Basch E. Sexual functioning among endometrial cancer patients treated with adjuvant high-dose-rate intra-vaginal radiation therapy. International Journal of Radiation Oncology, Biology, Physics 2012;84:e187-e193. 

D’Amico FE, Allen PJ, Eaton AA, DeMatteo RP, Fong Y, Kingham TP, Blumgart LH, Jarnagin WR, D’Angelica MI.  Vascular inflow control during hemi-hepatectomy: a comparison between intrahepatic pedicle ligation and extrahepatic vascular ligation. HPB: The Official Journal of the International Hepato-Pancreato-Biliary Association 2012;[epub ahead of print].

D’Angelo SP, Janjigian YY, Ahye N, Riely GJ, Chaft JE, Sima CS, Shen R, Zheng J, Dycoco J, Kris MG, Zakowski MF, Ladanyi M, Rusch V, Azzoli CG. Distinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib. Journal of Thoracic Oncology 2012;7:1815-1822.

Dansie EJ, Furberg H, Afari N, Buchwald D, Edwards K, Goldberg J, Schur E, Sullivan PF Conditions comorbid with chronic fatigue in a population-based sample. Psychosomatics 2012;53:44-50.

Dansie EJ, Heppner P, Furberg H, Goldberg J, Buchwald D, Afari N. The comorbidity of self-reported chronic fatigue syndrome, post-traumatic stress disorder, and traumatic symptoms. Psychosomatics 2012;53:250-257.

David SP, Hamidovic A, Chen GK, Bergen AW, Wessel J, Kasberger JL, Brown WM, Petruzella S, Thacker EL, Kim Y, Nalls MA, Tranah GJ, Sung YJ, Ambrosone CB, Arnett D, Bandera EV, Becker DM, Becker L, Berndt SI, Bernstein L, Blot WJ, Broeckel U, Buxbaum SG, Caporaso N, Casey G, Chanock SJ, Deming SL, Diver WR, Eaton CB, Evans DS, Evans MK, Fornage M, Franceschini N, Harris TB, Henderson BE, Hernandez DG, Hitsman B, Hu JJ, Hunt SC, Ingles SA, John EM, Kittles R, Kolb S, Kolonel LN, Le Marchand L, Liu Y, Lohman KK, McKnight B, Millikan RC, Murphy A, Neslund-Dudas C,  Nyante S, Press M, Psaty BM, Rao DC, Redline S, Rodriguez-Gil JL, Rybicki BA, Signorello LB, Singleton AB, Smoller J, Snively B, Spring B, Stanford JL, Strom SS, Swan GE, Taylor KD, Thun MJ, Wilson AF,  Witte JS, Yamamura Y, Yanek LR, Yu K, Zheng W, Ziegler RG, Zonderman AB, Jorgenson E, Haiman CA, Furberg H. Genome-wide meta-analyses of smoking behaviors in African Americans. Translational Psychiatry 2012;[epub ahead of print].

Davis-Dao C, Koh CJ, Hardy BE, Chang A, Kim SS, De Filippo R, Hwang A, Pike MC, Carroll JD, Coetzee GA, Vandenberg D, Siegmund K, Cortessis VK. Shorter androgen receptor CAG repeat lengths associated with cryptorchidism risk among Hispanic white boys.  Journal of Clinical Endocrinology and Metabolism 2012;97:E393-E399.

Deng G, Wong WD, Guillem J, Chan Y, Affuso T, Yeung KS, Coleton M, Sjoberg D, Vickers A, Cassileth B. A phase II, randomized, controlled trial of acupuncture for reduction of postcolectomy ileus. Annals of Surgical Oncology 2012;[epub ahead of print].

Dennis ER, Jia X, Mezheritskiy IS, Stephenson RD, Schoder H, Fox JJ, Heller G, Scher HI, Larson SM, Morris MJ. Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer. Journal of Clinical Oncology 2012;30:519-524.

Devlin SM, Thomas E, Emerson SS. Robustness of approaches to ROC curve modeling under misspecification of the underlying probability model. Communications in Statistics – Theory and Methods 2013;(in press).

Diab A, Zickl L, Abdel-Wahab O, Jhanwar S, Gulam MA, Panageas KS, Patel JP, Jurcic J, Maslak P, Paietta E, Mangan JK, Carroll M, Fernandez HF, Teruya-Feldstein J, Luger SM, Douer D, Litzow MR, Lazarus HM, Rowe JM, Levine RL, Tallman MS. Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosis. Leukemia Research 2013;37:32-36.

Dikken JL, Baser RE, Gonen M, Kattan MW, Shah, MA, Verheij M, van de Velde CJ, Brennan MF, Coit DG. Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer. Annals of Surgical Oncology 2012;[epub ahead of print].

Dikken JL, Van De Velde CJH, Gönen M, Verheij M, Brennan MF, Coit DG. The new american joint committee on cancer/international union against cancer staging system for adenocarcinoma of the stomach: Increased complexity without clear improvement in predictive accuracy. Annals of Surgical Oncology 2012;19:2443-2451.

Dikken JL, Van Grieken NCT, Krijnen P, Gönen M, Tang LH, Cats A, Verheij M, Brennan MF, Van De Velde CJH, Coit DG. Preoperative chemotherapy does not influence the number of evaluable lymph nodes in resected gastric cancer. European Journal of Surgical Oncology 2012;38:319-325.

Dogan S, Shen R, Ang DC, Johnson ML, D’Angelo SP, Paik PK, Brzostowski EB, Riely GJ, Kris MG, Zakowski MF, Ladanyi M. Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers. Clinical Cancer Research 2012;18:6169-6177.

Domchek SM, Jhaveri K, Patil S, Stopfer JE, Hudis C, Powers J, Stadler Z, Goldstein L, Kauff N, Khasraw M, Offit K, Nathanson KL, Robson M. Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer. Cancer 2012;[epub ahead of print]. 

Doubeni CA, Major JM, Laiyemo AO, Schootman M, Zauber AG, Hollenbeck AR, Sinha R, Allison J. Contribution of behavioral risk factors and obesity to socioeconomic differences in colorectal cancer incidence. Journal of the National Cancer Institute 2012;104:1353-1362.

Doubrovina E, Oflaz-Sozmen B, Prockop SE, Kernan NA, Abramson S, Teruya-Feldstein J, Hedvat C, Chou JF, Heller G, Barker JN, Boulad F, Castro-Malaspina H, George D, Jakubowski A, Koehne G, Papadopoulos EB, Scaradavou A, Small TN, Khalaf R, Young JW, O’Reilly RJ. Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation. Blood 2012;119:2644-2656.

Duell EJ, Lucenteforte E, Olson SH, Bracci PM, Li D, Risch HA, Silverman DT, Ji BT, Gallinger S, Holly EA, Fontham EH, Maisonneuve P, Bueno-de-Mesquita HB, Ghadirian P, Kurtz RC, Ludwig E, Yu H, Lowenfels AB, Seminara D, Petersen GM, La Vecchia C, Boffetta P. Pancreatitis and pancreas cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Annals of Oncology 2012;23:2964-2970.

Dusza SW, Halpern AC, Satagopan JM, Oliveria SA, Weinstock MA, Scope A, Berwick M, Geller AC. Prospective study of sunburn and sun behavior patterns during adolescence. Pediatrics 2012;129:309-317.

Ehdaie B, Atoria CL, Gupta A, Feifer A, Lowrance WT, Morris MJ, Scardino PT, Eastham JA, Elkin EB. Androgen deprivation and thromboembolic events in men with prostate cancer. Cancer 2012;118:3397-3406.

Ehdaie B, Furberg H, Zabor EC, Ostroff J, Shariat S, Bochner B, Coleman J, Dalbagni G. Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma. BJU International 2012;[epub ahead of print].

Ehdaie B, Maschino A, Shariat SF, Rioja J, Hamilton RJ, Lowrance WT, Poon SA, Al-Ahmadie HA, Herr HW. Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy. Journal of Urology 2012;187:74-79.

Elkin EB, Shapiro E, Snow JG, Zauber AG, Krauskopf MS. The economic impact of a patient navigator program to increase screening colonoscopy. Cancer 2012;118:5982-5988.

Elkin EB, Snow JG, Leoce NM, Atoria CL, Schrag D. Mammography capacity and appointment wait times: Barriers to breast cancer screening. Cancer Causes Control 2012;23:45-50.

Elston RC, Satagopan JM, Sun S. Genetic terminology. In Statistical Human Genetics – Methods and Protocols. Methods in Molecular Biology Series. Humana Press 2012; Springer. 850: 1-9.

Elston RC, Satagopan JM, Sun S. Statistical Human Genetics – Methods and Protocols. Human Press 2012, Springer. ISBN: 978-1-61779-554-1.

Engel LS, Orlow I, Sima CS, Satagopan J, Mujumdar U, Roy P, Yoo S, Sandler DP, Alavanja MC. Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: a nested case-control study. Cancer Epidemiology Biomarkers and Prevention 2012;21:1856-1867.

Epstein AS, Soff GA, Capanu M, Crosbie C, Shah MA, Kelsen DP, Denton B, Gardos S, O’Reilly EM. Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer. Cancer 2012;118:3053-3061.

Feldman DR, Patil S, Trinos MJ, Carousso M, Ginsberg MS, Sheinfeld J, Bajorin DF, Bosl GJ, Motzer RJ. Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial design. Cancer 2012;118:981-986.

Feldman DR, Voss MH, Jacobsen EP, Jia X, Suarez JA, Turkula S, Sheinfeld J, Bosl GJ, Motzer RJ, Patil S. Clinical features, presentation and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older. Cancer 2013;(in press).

Fields RC, Busam KJ, Chou JF, Panageas KS, Pulitzer MP, Allen PJ, Kraus DH, Brady MS, Coit DG. Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma. Cancer 2012;118:3311-3320.

Forsberg JA, Sjoberg D, Chen QR, Vickers A, Healey JH. Treating metastatic disease: which survival model is best suited for the clinic? Clinical Orthopaedics and Related Research 2012;[epub ahead of print].

Furberg H, Zabor E, Burkhalter JE, Holland S, Li Y, Ostroff J. Nicotine dependence and smoking abstinence among recently diagnosed cancer patients. The American Journal on Addictions 2012;(in press).

Fury MG, Lee NY, Sherman E, Lisa D, Kelly K, Lipson B, Carlson D, Stambuk H, Haque S, Shen R, Kraus D, Shah J, Pfister DG. A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer. Cancer 2012;118:5008-5014.

Fury MG, Sherman E, Ho A, Katabi N, Sima C, Kelly KW, Nwankwo O, Haque S, Pfister DG. A phase I study of temsirolimus plus carboplatin plus paclitaxel for patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC). Cancer Chemotherapy and Pharmacology 2012;70:121-128.

Gajria D, Gonzalez J, Feigin K, Patil S, Chen C, Theodoulou M, Drullinsky P,  D’Andrea G, Lake D, Norton L, Hudis CA, Traina TA. Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer. Breast Cancer Research and Treatment 2012;131:111-116.

Gao H, Chakraborty G, Lee-Lim AP, Mo Q, Decker M, Vonica A, Shen R, Brogi E, Brivanlou AH, Giancotti FG. The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell 2012;150:764-779.

Gardner GJ, Baser RE, Brady MF, Bristow RE, Markman M, Spriggs D, Thaler HT. CA125 regression in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy: A gynecologic oncology group study.  Gynecologic Oncology 2012;124:216-220.

Gaudet MM, Brooks JD, Robson ME, Bernstein JL. Genetic epidemiology of breast cancer. In: Women and Health. Goldman, ed. Elsevier, Amsterdam. Chapter 73, p. 1-13, 2012.

Gaujoux S, Al-Ahmadie H, Allen PJ, Gönen M, Shia J, D’Angelica M, Dematteo R, Fong Y, Blumgart L, Jarnagin WR. Resection of adrenocortical carcinoma liver metastasis: Is it justified? Annals of Surgical Oncology 2012;19:2643-2651.

Gaujoux S, Gönen M, Tang L, Klimstra D, Brennan MF, D’Angelica M, DeMatteo R, Allen PJ, Jarnagin W, Fong Y. Synchronous resection of primary and liver metastases for neuroendocrine tumors. Annals of Surgical Oncology 2012;19:4270-4277.

Gaujoux S, Tang L, Klimstra D, Gönen M, Brennan MF, D’Angelica M, Dematteo R, Fong Y, Jarnagin W, Allen PJ. The outcome of resected cystic pancreatic endocrine neoplasms: A case-matched analysis. Surgery 2012;151:518-525.

Gaujoux S, Torres J, Olson S, Winston C, Gönen M, Brennan MF, Klimstra DS, D’Angelica M, Dematteo R, Fong Y, House M, Jarnagin W, Kurtz RC, Allen PJ. Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Annals of Surgical Oncology 2012;19:2908-2916.

Geller AC, Swetter SM, Oliveria S, Dusza S, Halpern AC. Reducing mortality in individuals at high risk for advanced melanoma through education and screening. Journal of the American Academy of Dermatology 2011;65:S87-S94.

Gerber N, Wexler LH, Singer S, Alektiar KM, Keohan ML, Shi W, Zhang Z, Wolden SL. Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols. International Journal of Radiation Oncology Biology Physics 2012;[epub ahead of print].

Gerecitano J, Gounder S, Teruya-Feldstein J, Arcila M, Ogilvie S, Gonzalez C, Lin D, Zheng J, Zhang Z, McDonald A, Mulligan G, O’Connor OA. Tissue microarray analysis reveals protein expression patterns and potential biomarkers of clinical benefit to bortezomib in relapsed/refractory non-Hodgkin lymphoma. British Journal of Haematology 2012;158:290-292.

Gifkins D, Olson SH, Demissie K, Lu S-E, Bandera EV.  Total and individual antioxidant intake and endometrial cancer risk: results from a population-based case-control study in New Jersey.  Cancer Causes & Control 2012;23:887-895.

Gifkins D, Olson SH, Paddock L, King M, Demissie K, Lu S, Kong AT, Rodriguez-Rodriguez L, Bandera EV.  Total and individual antioxidant intake and risk of epithelial ovarian cancer. BMC Cancer 2012;12:211.

Goldberg JD, Chou JF, Horwitz S, Teruya-Feldstein J, Barker JN, Boulad F, Castro-Malaspina H, Giralt S, Jakubowski AA, Koehne G, van den Brink MR, Young JW, Zhang Z, Papadopoulos EB, Perales MA. Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplantation. Leukemia and Lymphoma 2012; 53:1124-1129.

Goldberg JD, Linker A, Kuk D, Ratan R, Jurcic J, Barker JN, Castro-Malaspina H, Giralt S, Hsu K, Jakubowski AA, Jenq R, Koehne G, Papadopoulos EB, van den Brink MR, Young JW, Boulad F, Kernan NA, O’Reilly RJ, Prockop SE, Yahalom J, Heller G, Perales MA. T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease. Biology of Blood and Marrow Transplantation 2013;19:208-213.

Goldberg JD, Zheng J, Castro-Malaspina H, Jakubowski AA, Heller G, van den Brink MR, Perales MA. Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants. Bone Marrow Transplantation 2013;48:99-104.

Goldfarb S, Abramsohn E, Andersen B, Baron S, Carter J, Dickler M, Florendo J, Freeman L, Githens K, Kushner D, Makelarski J, Yamada D, Lindau S. Convening a national network to advance the field of cancer and female sexuality. Journal of Sexual Medicine 2013;(in press).

Goldfarb S, Baron S, Lindau S. Female Sexuality. Women and Health, Second Edition. Ed.  Goldman M, Troisi R, and Rexrode K. NIH: Fall 2012.

Goldfarb S, Didwania A, Oeffinger K. Sexual dysfunction. Oncology for the Primary Care Clinician. Ed. Rose M, DeVita, Jr. V, Lawrence T, and Rosenberg S.  Lippincott Williams & Wilkins: Winter 2013;(in press).

Goldlust SA, Hsu M, Lassman AB, Panageas KS, Avila EK. Seizure prophylaxis and melanoma brain metastases. Journal of Neuro-Oncology 2012;108:109-114.

Gollub MJ, Gultekin DH, Akin O, Do RK, Fuqua Iii JL, Gönen M, Kuk D, Weiser M, Saltz L, Schrag D, Goodman K, Paty P, Guillem J, Nash GM, Temple L, Shia J, Schwartz LH. Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer. European Radiology 2012;22:821-831.

Gollub MJ, Panu N, Delaney H, Sohn M, Zheng J, Moskowitz CS, Rademaker J, Liu J. Shall we report cardiomegaly at routine computed tomography of the chest? Journal of Computer Assisted Tomography 2012;36:67-71.

Gönen M. Optimal bayesian enrichment: A view from the closet. Biometrics 2012;68:215-216.

Gönen M, Sun Z, Figueroa ME, Patel JP, Abdel-Wahab O, Racevskis J, Ketterling RP, Fernandez H, Rowe JM, Tallman MS, Melnick A, Levine RL, Paietta E. CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900. Blood 2012;120:2297-2306.

Gorovets D, Kannan K, Shen R, Kastenhuber ER, Islamdoust N, Campos C, Pentsova E, Heguy A, Jhanwar SC, Mellinghoff IK, Chan TA, Huse JT. IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic glioma. Clinical Cancer Research 2012;18:2490-2501.

Grant FM, Protic M, Gönen M, Allen P, Brennan MF. Intraoperative fluid management and complications following pancreatectomy. Journal of Surgical Oncology 2012[epub ahead of print].

Green PHR, Jordan, N, Li Y. Development and validation of a celiac disease quality of life instrument for American children. Journal of Pediatric Gastroenterology and Nutrition 2013;(in press).

Grisham RN, Adaniel C, Hyman DM, Ma W, Iasonos A, Aghajanian C, Konner J. Gemcitabine for advanced endometrial cancer: a retrospective study of the Memorial Sloan-Kettering Cancer Center experience. International Journal of Gynecological Cancer 2012;22:807-811.

Grisham RN, Iyer G, Garg K, Delair D, Hyman DM, Zhou Q, Iasonos A, Berger MF, Dao F, Spriggs DR, Levine DA, Aghajanian C, Solit DB. BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer. Cancer 2013;119:548-554.

Guillem, JG, Ruby JA,  Leibold T, Akhurst TJ, Yeung HW, Gollub MJ, Ginsberg MS, Shia J, Suriawinata AA, Riedel ER, Mazumdar M, Saltz LB, Minsky BD, Nash GM, Paty PB, Temple LK, Weiser MR, Larson SM. Neither FDG-PET nor CT is able to distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: A prospective study. Annals of Surgery 2012;2012[epub ahead of print].

Gupta A, Omuro AM, Shah AD, Graber JJ, Shi W, Zhang Z, Young RJ. Continuing the search for MR imaging biomarkers for MGMT promoter methylation status: conventional and perfusion MRI revisited. Neuroradiology 2012;54:641-643.

Gupta A, Shah AD, Zhang Z, Phillips CD, Young RJ. Variability in the position of the retropharyngeal internal carotid artery: A potential surgical hazard. The Laryngoscope 2012; [epub ahead of print].

Haddad D, Chen CH, Carlin S, Silberhumer G, Chen NG, Zhang Q, Longo V, Carpenter SG, Mittra A, Carson J, Au J, Gönen M, Zanzonico PB, Szalay AA, Fong Y. Imaging characteristics, tissue distribution, and spread of a novel oncolytic vaccinia virus carrying the human sodium iodide symporter. PLoS One 2012;7:e41647.

Haeno H, Gönen M, Davis MB, Herman JM, Iacobuzio-Donahue CA, Michor F. Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell 2012;148:362-375.

Haile RW, John EM, Levine AJ, Cortessis VK, Unger JB, Gonzales M, Ziv E, Thompson P, Spruijt-Metz D, Tucker KL, Bernstein JL, Rohan TE, Ho GY, Bondy ML, Martinez ME, Cook L, Stern MC, Correa MC, Wright J, Schwartz SJ, Baezconde-Garbanati L, Blinder V, Miranda P, Hayes R, Friedman-Jiménez G, Monroe KR, Haiman CA, Henderson BE, Thomas DC, Boffetta P. A review of cancer in US Hispanic populations. Cancer Prevention Research 2012;5:150-163.

Haile RW, John E, Unger J, Cortessi, Gonzales M, Thompson P, Tucker KI, Ho G, Bondy M, Martinez E, Cook L, Cruz M, Wright J, Schwartz S, Blinder V, Hayes RB, Friedman Jimenez G, Monroe K, Thomas D, Boffetta P. A review of cancer in US Hispanic populations. Cancer Prevention Research 2012; 5:150-163.

Haiman CA, Stram DO, Vickers AJ, Wilkens LR, Braun K, Valtonen-Andre C, Peltola M, Pettersson K, Waters KM, Marchand LL, Kolonel LN, Henderson BE, Lilja H. Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations. Journal of the National Cancer Institute 2012;[epub ahead of print].

Hakimi AA, Chen YB, Wren J, Gönen M, Abdel-Wahab O, Heguy A, Liu H, Takeda S, Tickoo SK, Reuter VE, Voss MH, Motzer RJ, Coleman JA, Cheng EH, Russo P, Hsieh JJ. Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma. European Urology 2012;[epub ahead of print].

Hartz SM, Short SE, Saccone NL, Culverhouse R, Chen L, Schwantes-An TH, Coon H, Han Y, Stephens SH, Sun J, Chen X, Ducci F, Dueker N, Franceschini N, Frank J, Geller F, Gubjartsson D, Hansel NN, Jiang C, Keskitalo-Vuokko K, Liu Z, Lyytikäinen LP, Michel M, Rawal R, Rosenberger A, Scheet P, Shaffer JR, Teumer A, Thompson JR, Vink JM, Vogelzangs N, Wenzlaff AS, Wheeler W, Xiao X, Yang BZ, Aggen SH, Balmforth AJ, Baumeister SE, Beaty T, Bennett S, Bergen AW, Boyd HA, Broms U, Campbell H, Chatterjee N, Chen J, Cheng YC, Cichon S, Couper D, Cucca F, Dick DM, Foroud T, Furberg H, Giegling I, Gu F, Hall AS, Hällfors J, Han S, Hartmann AM, Hayward C, Heikkilä K, Hewitt JK, Hottenga JJ, Jensen MK, Jousilahti P, Kaakinen M, Kittner SJ, Konte B, Korhonen T, Landi MT, Laatikainen T, Leppert  M, Levy SM, Mathias RA, McNeil DW, Medland SE, Montgomery GW, Muley T, Murray T, Nauck M, North K, Pergadia M, Polasek O, Ramos EM, Ripatti S, Risch A, Ruczinski  I, Rudan I, Salomaa V, Schlessinger D, Styrkársdóttir U, Terracciano A, Uda M, Willemsen G, Wu X, Abecasis G, Barnes K, Bickeböller H, Boerwinkle E, Boomsma DI, Caporaso N, Duan J, Edenberg HJ, Francks C, Gejman PV, Gelernter J, Grabe HJ, Hops H, Jarvelin MR, Viikari J, Kähönen M, Kendler KS, Lehtimäki T, Levinson DF,  Marazita ML, Marchini J, Melbye M, Mitchell BD, Murray JC, Nöthen MM, Penninx BW, Raitakari O, Rietschel M, Rujescu D, Samani NJ, Sanders AR, Schwartz AG, Shete S, Shi J, Spitz M, Stefansson K, Swan GE, Thorgeirsson T, Völzke H, Wei Q, Wichmann  HE, Amos CI, Breslau N, Cannon DS, Ehringer M, Grucza R, Hatsukami D, Heath A, Johnson EO, Kaprio J, Madden P, Martin NG, Stevens VL, Stitzel JA, Weiss RB, Kraft P, Bierut LJ. Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers. Archives of General Psychiatry 2012;69:854-860.

Hatzoglou V, Ulaner GA, Zhang Z, Beal K, Holodny AI, Young RJ. Comparison of the effectiveness of MRI perfusion and Fluorine-18 FDG PET-CT for differentiating radiation injury from viable brain tumor. Clinical Imaging 2012;[epub ahead of print].

Hay JL, Baguer C, Li Y, Orlow I, Berwick M. Interpretation of melanoma risk feedback in first-degree relatives of melanoma patients. Journal of Cancer Epidemiology 2012;2012:374842.

Hay J, Kaphingst KA, Baser R, Li Y, Hensley-Alford S, McBride CM. Skin cancer concerns and genetic risk information-seeking in primary care. Public Health Genomics 2012;15:57–72.

Heller G. A measure of explained risk in the proportional hazards model. Biostatistics 2012;13:315-325.

Ho AY, Cordeiro P, Disa J, Mehrara B, Wright J, Van Zee KJ, Hudis C, McLane A, Chou JF, Zhang Z, Norton L, Powell S, McCormick B. Long-term outcomes in breast cancer patients undergoing immediate two-stage expander/implant reconstruction and postmastectomy radiation. Cancer 2012;118:2552-2559.

Ho AY, Gupta G, King TA, Perez CA, Patil SM, Rogers KH, Wen YH, Brogi E, Morrow M, Hudis CA, Traina T, McCormick B, Powell SN, Robson ME. Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy. Cancer 2012;118:4944-4952.

Honeyman JN, Rich BS, McEvoy MP, Knowles MA, Heller G, Riachy E, Kobos R, Shukla N, Wolden SL, Steinherz PG, La Quaglia MP. Factors associated with relapse and survival in Wilms tumor: a multivariate analysis. Journal of Pediatric Surgery 2012; 47:1228-1233.

Hovanessian-Larsen L, Taylor D, Hawes D, Spicer DV, Press MF, Wu AH, Pike MC, Pearce CL. Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial.  Contraception 2012;86:238-243.

Hyman D, Zhou Q, Iasonos A, Grisham R, Arnold AG, Phillips MF, Bhatia J, Levine D, Aghajanian C, Offit K, Barakat RR, Spriggs DR, Kauff ND. Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer. Cancer 2012;118:3703-3709.

Iasonos A, Gounder M, Spriggs DR, Gerecitano JF, Hyman DM,  Zohar S, O’Quigley J. The impact of non–drug-related toxicities on the estimation of the maximum tolerated dose in phase I trials. Clinical Cancer Research 2012;18:5179-5187.

Iasonos A, Keung E, Zivanovic O, Mancari R, Peiretti M, Nucci M, George S, Colombo N, Carinelli S, Hensley ML, Raut CP. External validation of a nomogram predicting overall survival of women with uterine leiomyosarcoma. Cancer 2013; (in press).

Iasonos A, O’Quigley J. Interplay of priors and skeletons in two-stage continual reassessment method. Statistics in Medicine 2012;31:4321-4336.

Iasonos A, Sabbatini P, Spriggs DR, Aghajanian CA, O’Cearbhaill RE, Hensley ML, Thaler HT. Identifying clinical improvement in consolidation single-arm phase II trials in patients with  ovarian cancer in second or greater clinical remission. International Journal of Gynecological Cancer 2012;22:63-69.

Ilson DH, Minsky BD, Ku GY, Rusch V, Rizk N, Shah M, Kelsen DP, Capanu M, Tang L, Campbell J, Bains M. Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer. Cancer 2012;118:2820-2807.

Ito K, Blinder V, Elkin EB. Cost-effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer. Journal of Clinical Oncology 2012; 30:1468-1475.

Ito K, Ito H, Kemeny NE, Gönen M, Allen PJ, Paty PB, Fong Y, DeMatteo RP, Blumgart LH, Jarnagin WR, D’Angelica MI. Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: Incidence, clinical features, and risk factors. Annals of Surgical Oncology 2012;19:1609-1617.

Iyer G, Hanrahan AJ, Milowsky MI, Al-Ahmadie H, Scott SN, Janakiraman M, Pirun M, Sander C, Socci ND, Ostrovnaya I, Viale A, Heguy A, Peng L, Chan TA, Bochner B, Bajorin DF, Berger MF, Taylor BS, Solit DB. Genome sequencing identifies a basis for everolimus sensitivity. Science 2012;338:221.

Iyer G, Morris MJ, Rathkopf D, Slovin SF, Steers M, Larson SM, Schwartz LH, Curley T, DeLaCruz A, Ye Q, Heller G, Egorin MJ, Ivy SP, Rosen N, Scher HI, Solit DB. A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumors. Cancer Chemotherapy and Pharmacology 2012; 69:1089-1097.

Janjigian YY, Ku GY, Campbell JC, Shah MA, Capanu M, Kelsen DP, Ilson DH. Phase II trial of cetuximab plus cisplatin and irinotecan in patients with cisplatin and irinotecan-refractory metastatic esophagogastric cancer. American Journal of Clinical Oncology 2012;[epub ahead of print].

Jiang X, Castelao JE, Yuan JM, Stern MC, Conti DV, Cortessis VK, Pike MC, Gago-Dominguez M. Cigarette smoking and subtypes of bladder cancer.  International Journal of Cancer 2012;130:896-901.

Jochelson MS, Dershaw DD, Sung JS, Heerdt AS, Thornton C, Moskowitz CS, Ferrara J, Morris EA. Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. Radiology 2012;[epub ahead of print].

Johnson ML, Sima CS, Chaft J, Paik PK, Pao W, Kris MG, Ladanyi M, Riely GJ. Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas. Cancer 2013;119:356-362.

Kadota K, Colovos C, Suzuki K, Rizk NP, Dunphy MP, Zabor EC, Sima CS, Yoshizawa A, Travis WD, Rusch VW, Adusumilli PS. FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma. Annals of Surgical Oncology 2012;19:3598-3605.

Kadota K, Kachala SS, Nitadori J, Suzuki K, Dunphy MP, Sima CS, Travis WD, Rusch VW, Adusumilli PS. High SUVmax on FDG-PET indicates pleomorphic subtype in epithelioid malignant pleural mesothelioma: supportive evidence to reclassify pleomorphic as nonepithelioid histology. Journal of Thorac Oncology 2012;7:1192-1197.

Kadota K, Nitadori JI, Sarkaria IS, Sima CS, Jia X, Yoshizawa A, Rusch VW, Travis WD, Adusumilli PS. Thyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinoma. Cancer 2012;[epub ahead of print].

Kadota K, Suzuki K, Colovos C, Sima CS, Rusch VW, Travis WD, Adusumilli PS. A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma. Modern Pathology 2012;25:260-271.

Kadota K, Suzuki K, Kachala SS, Zabor EC, Sima CS, Moreira AL, Yoshizawa A, Riely GJ, Rusch VW, Adusumilli PS, Travis WD. A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma. Modern Pathology 2012;25:1117-1127.

Kaminski MF, Bretthauer M, Zauber AG, Kuipers EJ, Adami H-O, van Ballegooijen M, Regula J, van Leerdam M, Stefansson T, Påhlman L, Dekker E, Hernán MA, Garborg K, Hoff G. The NordICC Study: Rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy 2012;44:1-8.

Kaminski MF, Bretthauer M, Zauber AG, Kuipers EJ, Adami HO, van Ballegooijen M, Regula J, van Leerdam M, Stefansson T, Påhlman L, Dekker E, Hernán MA, Garborg K, Hoff G. The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy 2012;44:695-702.

Kapidzic A, Korfage IJ, van Dam L, van Roon AH, Reijerink JC, Zauber AG, van Ballegooijen M, Kuipers EJ, van Leerdam ME. Quality of life in participants of a CRC screening program. British Journal of Cancer 2012;107:1295-1301.

Kapoor NS, Eaton A, King TA, Patil S, Stempel M, Morris E, Brogi E, Morrow M.  Should breast density influence patient selection for breast-conserving surgery?  Annals of Surgical Oncology 2013;20:600-606.

Karakousis GC, Pandid-Taskar N, Hsu M, Panageas K, Atherton S, Ariyan C, Brady MS. Prognostic significance of drainage to pelvic nodes at sentinel lymph node mapping in patients with extremity melanoma.  Melanoma Research 2013;23:40-46.

Karkar AM, Tang LH, Kashikar ND, Gönen M, Solomon SB, Dematteo RP, D’ Angelica MI, Correa-Gallego C, Jarnagin WR, Fong Y, Getrajdman GI, Allen P, Kingham TP. Management of hepatocellular adenoma: Comparison of resection, embolization and observation. HPB: The Official Journal of the International Hepato-Pancreato-Billary Association 2013;15:235-43.

Katz SC, Bamboat ZM, Maker AV, Shia J, Pillarisetty VG, Yopp AC, Hedvat CV, Gönen M, Jarnagin WR, Fong Y, D’Angelica MI, DeMatteo RP. Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases. Annals of Surgical Oncology 2012;[epub ahead of print].

Kiess AP, McArthur HL, Mahoney K, Patil S, Morris PG, Ho A, Hudis CA, McCormick B. Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer. Cancer 2012;118:1982-1988.

Kim HJ, Boland PJ, Meredith DS, Lis E, Zhang Z, Shi W, Yamada YJ, Goodman KA. Fractures of the sacrum after chemoradiation for rectal carcinoma: Incidence, risk factors, and radiographic evaluation. International Journal of Radiation Oncology Biology Physics 2012;84:694-699.

Kim PH, Pinheiro LC, Atoria CL, Eastham JA, Sandhu JS, Elkin EB. Trends in the use of incontinence procedures after radical prostatectomy: A population-based analysis. Journal of Urology 2013;189:602-608.

King V, Goldfarb SB, Brooks JD, Sung JS, Nulsen BF, Jozefara JE, Pike MC, Dickler MN, Morris EA.  Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging. Radiology 2012;264:670-678.

King V, Gu Y, Kaplan JB, Brooks JD, Pike MC, Morris EA.  Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI. European Radiology 2012;22:2641-2647.

King V, Kaplan J, Pike MC, Liberman L, David Dershaw D, Lee CH, Brooks JD, Morris EA. Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging. Breast Journal 2012;18:527-534.

Kingham TP, Tanoue M, Eaton A, Rocha FG, Do R, Allen P, De Matteo RP, D’Angelica M, Fong Y, Jarnagin WR. Patterns of recurrence after ablation of colorectal cancer liver metastases. Annals of Surgical Oncology 2012;19:834-841.

Kissane DW, Patel SG, Baser RE, Bell R, Farberov M, Ostroff JS, Li Y, Singh B, Draus, DH, Shah JP. Preliminary evaluation of the reliability and validity of the Shame and Stigma Scale in head and neck cancer. Head & Neck 2013;35:172-183.

Kissane DW, Zaider TI, Li Y, Del Gaudio F. Family therapy for complicated grief. In Complicated Grief: Scientific Foundations for Health Care Professionals. Stroebe M, Schut H, Van Den Bout J, (Eds). Routledge; (in press).

Klein RJ, Hallden C, Gupta A, Savage CJ, Dahlin A, Bjartell A, Manjer J, Scardino PT, Ulmert D, Wallstrom P, Vickers AJ, Lilja H. Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men. European Urology 2012;61:471-477.

Klimek VM, Dolezal EK, Tees MT, Devlin SM, Stein K, Romero A, Nimer SD. Efficacy of hypomethylating agents in therapy-related myelodysplastic syndromes. Leukemia Research 2012; 36:1093-1097.

Koppikar P, Bhagwat N, Kilpivaara O, Manshouri T, Adli M, Hricik T, Liu F, Saunders LM, Mullally A, Abdel-Wahab O, Leung L, Weinstein A, Marubayashi S, Goel A, Gönen M, Estrov Z, Ebert BL, Chiosis G, Nimer SD, Bernstein BE, Verstovsek S, Levine RL. Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy. Nature 2012;489:155-159.

Lafemina J, Qin LX, Moraco NH, Antonescu CR, Fields RC, Crago AM, Brennan MF, Singer S. Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors. Annals of Surgical Oncology 2013;20:66-72.

Lakhman Y, Akin O, Sohn MJ, Zheng J, Moskowitz CS, Iyer RB, Barakat RR, Sabbatini PJ, Chi DS, Hricak H. Early postoperative CT as a prognostic biomarker in patients with advanced ovarian, tubal, and primary peritoneal cancer deemed optimally debulked at primary cytoreductive surgery. AJR American Journal Roentgenology 2012;198:1453-1459.

Lamanna N, Heffner LT, Kalaycio M, Schiller G, Coutre S, Moore J, Seiter K, Maslak P, Panageas K, Golde D, Weiss MA.  Treatment of adults with ALL:  Do the specifics of regimen matter? Results of a prospective randomized trial. Cancer 2012;[epub ahead of print].

Lampen-Sachar K, Zhao B, Zheng J, Moskowitz CS, Schwartz LH, Zakowski MF, Rizvi NA, Kris MG, Ginsberg MS. Correlation between tumor measurement on Computed Tomography and resected specimen size in lung adenocarcinomas. Lung Cancer 2012;75:332-5.

Landau H. Hassoun H, Rosenzweig MA, Maurer M, Liu J, Flombaum C, Bello C, Hoover E, Riedel E, Giralt S, Comenzo RL. Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis. Leukemia 2012;[epub ahead of print].

Landau H, Pandit-Taskar N, Hassoun H, Cohen A, Lesokhin A, Lendvai N, Drullinsky P, Schulman P, Jhanwar S, Hoover E, Bello C, Riedel E, Nimer SD, Comenzo RL. Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with International Staging System stage II or III, or extramedullary disease. Leukemia Lymphoma 2012;53:275-281.

Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, van Ballegooijen M, Zauber AG, Jemal A. Contribution of screening and survival differences to racial disparities in colorectal cancer rates.  Cancer Epidemiology Biomarkers Prevention 2012;21:728-736.

Laufer I, Iorgulescu JB, Chapman T, Lis E, Shi W, Zhang Z, Cox BW, Yamada Y, Bilsky MH. Local disease control for spinal metastases following “separation surgery” and adjuvant hypofractionated or high-dose single-fraction stereotactic radiation therapy: Outcomes analysis in 186 patients. Journal of Neurosurgery Spine 2012;[epub ahead of print].

Laurie CC, Laurie CA, Rice K, Doheny KF, Zelnick LR, McHugh CP, Ling H, Hetrick KN, Pugh EW, Amos C, Wei Q, Wang LE, Lee JE, Barnes KC, Hansel NN, Mathias R, Daley D, Beaty TH, Scott AF, Ruczinski I, Scharpf RB, Bierut LJ, Hartz SM, Landi MT, Freedman ND, Goldin LR, Ginsburg D, Li J, Desch KC, Strom SS, Blot WJ, Signorello LB, Ingles SA, Chanock SJ, Berndt SI, Le Marchand L, Henderson BE, Monroe KR, Heit JA, de Andrade M, Armasu

SM, Regnier C, Lowe WL, Hayes MG, Marazita ML, Feingold E, Murray JC, Melbye M, Feenstra B, Kang JH, Wiggs JL, Jarvik GP, McDavid AN, Seshan VE, Mirel DB, Crenshaw A, Sharopova N, Wise A, Shen J, Crosslin DR, Levine DM, Zheng X, Udren JI, Bennett S, Nelson SC, Gogarten SM, Conomos MP, Heagerty P, Manolio T, Pasquale LR, Haiman CA, Caporaso N, Weir BS. Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nature Genetics 2012;44:642-650.

Lee-Kong, SA, Ruby JA, Chessin DB, Pucciarelli S, Shia J, Riedel ER, Nitti D, Guillem JG. Hypoxia-related proteins in patients with rectal cancer undergoing neoadjuvant combined modality therapy. Disease of the Colon and Rectum 2012; 55:990-995.

Li D, Duell EJ, Yu K, Risch HA, Olson SH, Kooperberg C, Wolpin BM, Jiao L, Dong X, Wheeler B, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross M, Hartge P, Hoover RN, Holly EA, Jacobs EJ, Klein AP, LaCroix A, Mandelson MT, Petersen G, Zheng W, Agalliu I, Albanes D, Boutron-Ruault M, Bracci PM, Buring JE, Canzian F, Chang K, Chanock SJ, Cotterchio M, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hankinson SE, Hoffman Bolton JA, Hunter DJ, Hutchinson A, Jacobs KB, Jenab M, Khaw K, Kraft P, Krogh V, Kurtz RC, McWilliams RR, Mendelsohn JB, Patel AV, Rabe KG, Riboli E, Shu X, Tjønneland A, Tobias GS, Trichopoulos D, Virtamo J, Visvanathan K, Watters J, Yu H, Zeleniuch-Jacquotte A, Amundadottir L, Stolzenberg-Solomon RZ. Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Carcinogenesis 2012;33:1384-1390.

Li Y, Baser R. Using R and WinBUGS to fit a generalized partial credit model for developing and evaluating patient‐reported outcomes assessments. Statistics in Medicine 2012;31:2010-2026.

Lim R, Eaton A, Lee NY, Setton J, Ohri N, Rao S, Wong R, Fury M, Schöder H. 18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma. Journal of Nuclear Medicine 2012;[epub ahead of print].

Lin X , Cai B, Wang L, Zhang Z. Bayesian semiparametric models for interval-censored failure time data. Statistics in Medicine 2012;[epub ahead of print].

Liu Y, Melin BS, Rajaraman P, Wang Z, Linet M, Shete S, Amos CI, Lau C, Scheurer ME, Armstrong GN, Houlston RS,  Hosking FJ, Claus EB, Barnholtz-Sloan J, Lai R, Il’yasova D, Schildkraut J, Sadetzki S, Johansen C, Bernstein JL, Olson SH, Jenkins RB, LaChance D, Vick NA, Wrensch M, Davis F, McCarthy BJ, Andersson U, Chanock S, The Gliogene Consortium, Bondy ML. Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma. Human Genetics 2012;131:1507-1517.

Lok BH, Khan S, Mutter R, Liu J, Fields R, Pulitzer M, Shi W, Zhang Z, Kraus D, Pfister D, Busam KJ, Brownell I, Lee N. Selective radiotherapy for the treatment of head and neck Merkel cell carcinoma. Cancer 2012;118:3937-3944.

Lok BH, Setton J, Caria N, Romanyshyn J, Wolden SL, Zelefsky MJ, Park J, Rowan N, Sherman EJ, Fury MG, Ho A, Pfister DG, Wong RJ, Shah JP, Kraus DH, Zhang Z, Schupak KD, Gelblum DY, Rao SD, Lee NY. Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes. International Journal of Radiation Oncology Biology Physics 2012;82:1851-1857.

Long KC, Zhou Q, Hensley ML, Alektiar KM, Gomez J, Gardner GJ, Chi DS, Barakat RR, Abu-Rustum NR. Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer. Gynecologic Oncology 2012;125:99-102.

Lou F, Huang J, Sima CS, Dycoco J, Rusch V, Bach PB. Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. Journal of Thoracic and Cardiovascular Surgery 2013;145:75-82.

Lowrance WT, Eastham JA, Yee DS, Laudone VP, Denton B, Scardino PT, Elkin EB. Costs of medical care after open or minimally invasive prostate cancer surgery: A population-based analysis. Cancer 2012;118:3079-3086.

Lowrance WT, Elkin EB, Yee DS, Feifer A, Ehdaie B, Jacks LM, Atoria CL, Zelefsky MJ, Scher HI, Scardino PT, Eastham JA. Locally advanced prostate cancer: a population-based study of treatment patterns. BJU International 2012; 109:1309-1314.

Lu Y, Chen X, Beesley J, Johnatty SE, Defazio A; Australian Ovarian Cancer Study (AOCS) Study Group, Lambrechts S, Lambrechts D, Despierre E, Vergotes I,Chang-Claude J, Hein R, Nickels S, Wang-Gohrke S, Dörk T, Dürst M, Antonenkova N,Bogdanova N, Goodman MT, Lurie G, Wilkens LR, Carney ME, Butzow R, Nevanlinna H, Heikkinen T, Leminen A, Kiemeney LA, Massuger LF, van Altena AM, Aben KK, Kjaer SK, Høgdall E, Jensen A, Brooks-Wilson A, Le N, Cook L, Earp M, Kelemen L, Easton D, Pharoah P, Song H, Tyrer J, Ramus S, Menon U, Gentry-Maharaj A, Gayther SA,Bandera EV, Olson SH, Orlow I, Rodriguez-Rodriguez L, Macgregor S,Chenevix-Trench G. Genome-wide association study for ovarian cancer susceptibility using pooled DNA. Twin Research and Human Genetics 2012;15:615-623.

Lughezzani G, Zorn KC, Budaus L, Sun M, Lee DI, Shalhav AL, Zagaya GP, Shikanov SA, Gofrit ON, Thong AE, Albala DM, Sun L, Cronin A, Vickers AJ, Karakiewicz PI. Comparison of three different tools for prediction of seminal vesicle invasion at radical prostatectomy. European Urology 2012;62:590-596.

Lyall A, Capobianco J, Strauss HW, Gönen M, Schöder H. Treadmill exercise inducing mild to moderate ischemia has no significant effect on skeletal muscle or cardiac 18F-FDG uptake and image quality on subsequent whole-body PET scan. Journal of Nuclear Medicine 2012;53:917-921.

Maithel SK, Gönen M, Ito H, Dematteo RP, Allen PJ, Fong Y, Blumgart LH, Jarnagin WR, D’Angelica MI. Improving the clinical risk score: An analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases. Surgery 2012;151:162-170.

Maker AV, Butte JM, Oxenberg J, Kuk D, Gönen M, Fong Y, Dematteo RP, D’Angelica MI, Allen PJ, Jarnagin WR. Is port site resection necessary in the surgical management of gallbladder cancer? Annals of Surgical Oncology 2012;19:409-417.

Malhotra J, Tonorezos ES, Rozenberg M, Vega GL, Sklar CA, Chou J, Moskowitz CS, Eshelman-Kent DA, Janiszewski P, Ross R, Oeffinger KC. Atherogenic low density lipoprotein phenotype in long-term survivors of childhood acute lymphoblastic leukemia. Journal of Lipid Research 2012;53:2747-2754.

Marberger M, Barentsz J, Emberton M, Hugosson J, Loeb S, Klotz L, Koch M, Shariat SF, Vickers A. Novel approaches to improve prostate cancer diagnosis and management in early-stage disease. BJU International 2012;109 Suppl 2:1-7.

Martins FC, De S, Almendro V, Gönen M, Park SY, Blum JL, Herlihy W, Ethington G, Schnitt SJ, Tung N, Gar JE, Fetten K, Michor F, Polyak K. Evolutionary pathways in BRCA1-associated breast tumors. Cancer Discovery 2012;2:503-511.

Matasar MJ, Shi W, Silberstien J, Lin O, Busam KJ, Teruya-Feldstein J, Filippa DA, Zelenetz AD, Noy A. Expert second-opinion pathology review of lymphoma in the era of the World Health Organization classification. Annals of Oncology 2012;23:159-166.

Matsuo K, Rocha FG, Ito K, D’Angelica MI, Allen PJ, Fong Y, Dematteo RP, Gönen M, Endo I, Jarnagin WR. The blumgart preoperative staging system for hilar cholangiocarcinoma: Analysis of resectability and outcomes in 380 patients. Journal of the American College of Surgeons 2012; 215:343-355.

McCarthy CM, Lee CN, Halvorson EG, Riedel E, Pusic AL, Mehrara BJ, Disa JJ. The use of acellular dermal matrices in two-stage expander/implant reconstruction: a multicenter, blinded, randomized controlled trial. Plastic and Reconstructive Surgery 2012;130(5 Suppl 2):57S-66S.

Meehan CP, Fuqua Iii JL 3rd, Reiner AS, Moskowitz CS, Schwartz LH, Panicek DM. Prognostic significance of adrenal gland morphology at CT in patients with three common malignancies. British Journal of Radiology 2012;85:807-812.

Mezhir JJ, Shia J, Riedel E, Temple LK, Nash GM, Weiser MR, Paty PB, Wong WD, Guillem JG. Whole-mount pathologic analysis of rectal cancer following neoadjuvant therapy: implications of margin status on long-term oncologic outcome. Annals of Surgery 2012;256: 274-279.

Milgrom S, Cody H, Tan L, Morrow M, Pesce C, Setton J, Rogers K, Arnold B, Eaton A, Catalano J, McCormick B, Powell S, Ho A. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment. Annals of Surgical Oncology 2012;[epub ahead of print].

Minn AY, Riedel E, Halpern J, Johnston LJ, Horning SJ, Hoppe RT, Goodman KA. Long-term outcomes after high dose therapy and autologous haematopoietic cell rescue for refractory/relapsed Hodgkin lymphoma. British Journal of Haematology 2012;159:329-339.

Mirkin JN, Lowrance WT, Feifer AH, Mulhall JP, Eastham JE, Elkin EB. Direct-to-consumer internet promotion of robotic prostatectomy exhibits varying quality of information. Health Affairs 2012;31:760-769.

Mo Q. A fully Bayesian hidden Ising model for ChIP-seq data analysis. Biostatistics 2012;13:113-128.

Mo Q, Wang S, Seshan VE, Olshen AB, Schultz N, Sander C, Powers RS, Ladanyi M, Shen R. Pattern discovery and cancer gene identification in integrated cancer genomic data. Proceedings of the National Academy of Sciences 2013;(in press)

Molina AM, Feldman DR, Voss MH, Ginsberg MS, Baum MS, Brocks DR, Fischer PM, Trinos MJ, Patil S, Motzer RJ. Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma. Cancer 2012;118:1868-1876.  

Molina AM, Jia X, Feldman DR, Hsieh JJ, Ginsberg MS, Velasco S, Patil S, Motzer RJ.  Long-term response to sunitinib therapy for metastatic renal cell carcinoma. Clinical Genitourinary Cancer 2013;(in press).

Morris PG, Fazio M, Farooki A, Estilo C, Mallam D, Conlin A, Patil S, Fleisher M, Cremers S, Huryn J, Hudis CA, Fornier MN. Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastases. Journal of Oral and Maxillofacial Surgery 2012;70:2768-2775.

Morris PG, Murphy CG, Mallam D, Accordino M, Patil S, Howard J, Omuro A, Beal K, Seidman AD, Hudis CA, Fornier MN. Limited overall survival in patients with brain metastases from triple negative breast cancer. Breast Journal 2012;18:345-350.

Morris PG, Reiner AS, Szenberg OR, Clarke JL, Panageas KS, Perez HR, Kris MG, Chan TA, Deangelis LM, Omuro AM. Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy. Journal of Thoracic Oncology 2012;7:382-385.

Morris PG, Ulaner GA, Eaton A, Fazio M, Jhaveri K, Patil S, Evangelista L, Park JY, Serna-Tamayo C, Howard J, Larson S, Hudis CA, McArthur HL, Jochelson MS. Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer. Cancer 2012;118:5454-5462.

Morrogh M, Andrade VP, Giri D, Sakr RA, Paik W, Qin LX, Arroyo CD, Brogi E, Morrow M, King TA. Cadherin-catenin complex dissociation in lobular neoplasia of the breast. Breast Cancer Research and Treatment 2012;132:641-652.

Morrogh M, Andrade VP, Patil AJ, Qin LX, Mo Q, Sakr R, Arroyo CD, Brogi E, Morrow M, King TA. Differentially expressed genes in window trials are influenced by the wound-healing process: lessons learned from a pilot study with Anastrozole. Journal of Surgical Research 2012; 176:121-132.

Moskowitz CS, Zabor EC, Jochelson M. Breast Imaging: Understanding how accuracy is measured when lesions are the unit of analysis. The Breast Journal 2012;18:557-563.

Mukherjee B, Delancey JO, Raskin L, Everett J, Jeter J, Begg CB, Orlow I, Berwick M, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Culver HA, Rosso S, Zanetti R, Kanetsky PA, From L, Gruber SB; GEM Study Investigators. Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers. Journal of the National Cancer Institute 2012;104:953-956. 

Murali R, Goumas C, Fromm L, Busam KJ, Begg CB, Dwyer T, Gruber SB, Kanetsky PA,  Kricker A, Orlow I, Rosso S, Thomas NE, Berwick M, Scolyer RA, Armstrong BK for the GEM Study Group. Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomas. Annals of Surgical Oncology 2012;19:1024-1033.

Murphy CG, Mallam D, Stein S, Patil S, Howard J, Sklarin N, Hudis CA, Gemignani ML, Seidman AD. Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer. Cancer 2012;118:3254-3259.

Mutter RW, Singer S, Zhang Z, Brennan MF, Alektiar KM. The enigma of local recurrence in myxofibrosarcoma of the extremity. Cancer 2012;118:518-527.

Nayak L, Fleisher M, Gonzalez-Espinoza R, Lin O, Panageas K, Reiner A, Liu C-M, DeAngelis LM, Omuro A. Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors.  Neurology 2013;(in press).

O’Cearbhaill R, Lia D, Shi W, Thaler HT, Sabbatini PJ, Konner J, Hensley ML, Aghajaniana CA, Lichtman SM, Tew WP. Intraperitoneal chemotherapy in older women with epithelial ovarian cancer. Journal of Geriatric Oncology 2013;(in press).

Ohri N, Cordeiro PG, Keam J, Ballangrud A, Shi W, Zhang Z, Nerbun CT, Woch KM, Stein NF, Zhou Y, McCormick B, Powell SN, Ho AY. Quantifying the impact of immediate reconstruction in post-mastectomy radiation: A large, dose-volume histogram-based analysis. International Journal of Radiation Oncology Biology Physics 2012;84:153-159.

Oliveria SA, Heneghan MK, Halpern AC, Hay JL, Geller AC. Communication about family members’ risk of melanoma: self-reported practices of dermatologists in the United States. Archives of Dermatology 2012;148:621-627.

Oliveria SA, Shuk E, Hay JL, Heneghan M, Goulart JM, Panageas K, Geller AC,

Halpern AC. Melanoma survivors: health behaviors, surveillance, psychosocial factors, and family concerns. Psychooncology 2013;22:106-116.

Olson SH. Selected medical conditions and risk of pancreatic cancer. Molecular Carcinogenesis 2012; 51:75-97.

Olson SH, Atoria CL, Cote ML, Cook LS, Rastogi R, Soslow RA, Brown CL, Elkin EB.  The impact of race and comorbidity on survival in endometrial cancer.  Cancer Epidemiology, Biomarkers & Prevention 2012;21:753-760.

O’Mahony JF, van Rosmalen J, Zauber AG, van Ballegooijen M. Multicohort models in cost-effectiveness analysis: why aggregating estimates over multiple cohorts can hide useful information. Medical Decision Making 2012;[epub ahead of print].

Omuro A, Chan TA, Abrey LE, Khasraw M, Reiner AS, Kaley TJ, Deangelis LM, Lassman AB, Nolan CP, Gavrilovic IT, Hormigo A, Salvant C, Heguy A, Kaufman A, Huse JT, Panageas KS, Hottinger AF, Mellinghoff I. Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma. Neuro-Oncology 2013;15:242-250.

O’Neill CB, Atoria CL, O’Reilly EM, Lafemina J, Henman MC, Elkin EB. Costs and trends in pancreatic cancer treatment. Cancer 2012;118:5132-5139.

Orlow I, Roy P, Reiner AS, Yoo, S, Patel H, Paine S, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Thomas NE, Gruber SB, Anton-Culver H, Rosso S, Gallagher RP, Dwyer T, Kanetsky PA, Busam K, From L, Begg CB, Berwick M; GEM Study Group. Vitamin D receptor polymorphisms in patients with cutaneous melanoma. International  Journal of Cancer 2012;130:405-418.

Ostrovnaya I. Testing clonality of three and more tumors using their loss of heterozygosity

profiles. Statistical Applications in Genetics and Molecular Biology 2012;11(4).

Ostrovnaya I, Nicolae DL. Estimating the proportion of true null hypotheses under dependence.

Statistica Sinica 2012;22:1689-1716.

Paik PK, Johnson ML, D’Angelo SP, Sima CS, Ang D, Dogan S, Miller VA, Ladanyi M, Kris MG, Riely GJ. Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas. Cancer 2012;118:5840-5847.

Paik PK, Varghese AM, Sima CS, Moreira AL, Ladanyi M, Kris MG, Rekhtman N. Response to Erlotinib in patients with EGFR mutant advanced non-small cell lung cancers with a squamous or squamous-like component. Molecular Cancer Therapeutics 2012;11:2535-2540.

Panageas KS, Iwamoto FM, Cloughesy TF, Aldape KD, Rivera AL, Eichler AF, Louis DN, Paleologos NA, Fisher BJ, Ashby LS, Cairncross JG, Roldán Urgoiti GB, Wen PY, Ligon KL, Schiff D, Robins HI, Rocque BG, Chamberlain MC, Mason WP, Weaver SA, Green RM, Kamar FG, Abrey LE, Deangelis LM, Jhanwar SC, Rosenblum MK, Lassman AB. Initial treatment patterns over time for anaplastic oligodendroglial tumors. Neuro-Oncology 2012;14:761-767.

Panages KS, Sima CS, Liberman L, Schrag D. Use of high technology imaging for surveillance of early stage breast cancer. Breast Cancer Research and Treatment 2012;131:663-670.

Partridge AH, Norris VW, Blinder VS, Cutter BA, Halpern MT, Malin J, Neuss MN, Wolff AC. Implementing a breast cancer registry and treatment plan/summary program in clinical practice: A pilot program. Cancer 2013, 119: 158-163.

Patel JP, Gönen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J, Van Vlierberghe P, Dolgalev I, Thomas S, Aminova O, Huberman K, Cheng J, Viale A, Socci ND, Heguy A, Cherry A, Vance G, Higgins RR, Ketterling RP, Gallagher RE, Litzow M, Van Den Brink MRM, Lazarus HM, Rowe JM, Luger S, Ferrando A, Paietta E, Tallman MS, Melnick A, Abdel-Wahab O, Levine RL. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. New England Journal of Medicine 2012;366:1079-1089.

Patel JP, Gönen M, Levine RL. The authors reply. New England Journal of Medicine 2012; 366:2321-2322.

Patil S, Figlin RA, Hutson TE, Michaelson MD, Negrier S, Kim ST, Huang X, Motzer RJ.  Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib versus interferon-alfa. British Journal of Cancer. 2012;106:1587-1590.

Patil S, Manola J, Elson P, Negrier S, Escudier B, Eisen T, Atkins M, Bukowski R, Motzer RJ. Improvement in overall survival of patients with advanced renal cell carcinoma: prognostic factor trend analysis from an international data set of clinical trials. Journal of Urology 2012;188:2095-2100. 

Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG, Chang-Claude J, Hein R, Lurie G, Wilkens LR, Carney ME, Goodman MT, Moysich K, Kjaer SK, Hogdall E, Jensen A, Goode EL, Fridley BL, Larson MC, Schildkraut JM, Palmieri RT, Cramer DW, Terry KL, Vitonis AF, Titus LJ, Ziogas A, Brewster W, Anton-Culver H, Gentry-Maharaj A, Ramus SJ, Anderson AR, Brueggmann D, Fasching PA, Gayther SA, Huntsman DG, Menon U, Ness RB, Pike MC, Risch H, Wu AH, Berchuck A; Ovarian Cancer Association Consortium. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.  Lancet Oncology 2012;13:385-394.

Perales MA, Goldberg JD, Yuan J, Koehne G, Lechner L, Papadopoulos EB, Young JW, Jakubowski AA, Zaidi B, Gallardo H, Liu C, Rasalan T, Wolchok JD, Croughs T, Morre M, Devlin SM, van den Brink MR. Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation. Blood 2012; 120:4882-4891.

Perez DR, Baser RE, Cavnar MJ, Balachandran VP, Antonescu CR, Tap WD, Strong VE, Brennan MF, Coit DG, Singer S, Dematteo RP. Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor. Annals of Surgical Oncology 2012;[epub ahead of print].

Petre EN, Jia X, Thornton RH, Sofocleous CT, Alago W, Kemeny NE, Solomon SB. Treatment of pulmonary colorectal metastases by radiofrequency ablation. Clinical Colorectal Cancer 2012;[epub ahead of print].

Pietanza MC, Kadota K, Huberman K, Sima CS, Fiore JJ, Sumner DK, Travis WD, Heguy A, Ginsberg MS, Holodny AI, Chan TA, Rizvi NA, Azzoli CG, Riely GJ, Kris MG, Krug LM. Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker. Clinical Cancer Research 2012;18:1138-1145.

Plummer M, Peto J, Franceschi S; International Collaboration of Epidemiological Studies of Cervical Cancer (Pike MC, Member). Time since first sexual intercourse and the risk of cervical cancer.  International Journal of Cancer 2012;130:2638-2644.

Polterauer S, Zhou Q, Grimm C, Seebacher V, Reinthaller A, Hofstetter G, Concin N, Leitao MM, Barakat RR, Abu-Rustum NR, Iasonos A. External validation of a nomogram predicting overall survival of patients diagnosed with endometrial cancer. Gynecologic Oncology 2012; 125:526-530.

Ponce DM, Lubin M, Gonzales AM, Byam C, Wells D, Ferrante R, Heller G, Giralt S, Papadopoulos EB, Kernan NA, Scaradavou A, Barker JN. The use of back-up units to enhance the safety of unrelated donor cord blood transplantation. Biology of Blood and Marrow Transplantation 2012;18:648-651.

Ponce DM, Sauter C, Lubin M, Gonzales AM, Devlin SM, Kernan NA, Scaradavou A, Giralt S, Goldberg JD, Koehne G, Perales MA, Young JW, Castro-Malaspina H, Jakubowski A, Papadopoulos EB, Barker JB.  A novel reduced intensity conditioning regimen induces a high incidence of sustained donor engraftment after double-unit cord blood transplantation. Biology of Blood and Marrow Transplantation 2013;(in press).

Qi J, Fong Y, Saltz L, D’Angelica MI, Kemeny NE, Gönen M, Shia J, Shukla-Dave A, Jarnagin WM, Do RKG, Schwartz LH, Koutcher JA, Zakian KL. Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: A 1H MRS study. NMR in Biomedicine 2013;26:204-212.

Quintana MA, Schumacher F,Casey G, Bernstein JL, Li L, Conti DV. Incorporating prior biologic information for high dimensional rare variant association studies. Human Heredity 2013; (in press).

Raimondi S, Gandini S, Fargnoli MC, Bagnardi V, Maisonneuve P, Specchia C, Kumar R, Nagore E, Han J, Hansson J, Kanetsky PA, Ghiorzo P, Gruis NA, Dwyer T, Blizzard L, Fernandez-de-Misa R, Branicki W, Debniak D, Morling N, Landi MT, Palmieri G, Ribas G, Stratigos A, Cornelius L, Motokawa T, Anno S, Helsing P, Wong TH, Autier P, García-Borrón JC,Little J,Newton-Bishop J, Sera F, Liu F, Kayser M, Nijsten T, and the GEM Study Group. Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studies. BMC Medical Research Methodology 2012,[epub ahead of print].

Raman T, Roistacher N, Liu J, Zhang H, Shi W, Thaler HT, Amar D. Preoperative left atrial dysfunction and risk of postoperative atrial fibrillation complicating thoracic surgery. Journal of Thoracic and Cardiovascular Surgery 2012;143:482-487.

Rasmussen A, Crager M, Baser RE, Chu T, Gany, F. Onset of posttraumatic stress disorder and major depression among refugees and voluntary migrants to the United States.  Journal of Traumatic Stress 2012;25:705-712.

Reichman J, Singer S, Navi B, Reiner A, Panageas K, Gutin PH, DeAngelis LM.  Subdural hematoma in patients with cancer.  Neurosurgery  2012;71:74-79.

Reidy-Lagunes DL, Vakiani E, Segal MF, Hollywood EM, Tang LH, Solit DB, Pietanza MC, Capanu M, Saltz LB. A phase 2 study of the insulin-like growth factor-1 receptor inhibitor MK-0646 in patients with metastatic, well-differentiated neuroendocrine tumors. Cancer 2012;118:4795-4800.

Reiner AS, John E, Brooks JD, Lynch CF, Bernstein L, Mellemkjær L, Malone KE, Knight JA, Capanu M, Teraoka SN, Concannon P, Liang X, Figueiredo JC, Smith SA, Stovall M, Pike MC, Haile RW, Thomas DC, Begg CB, The WECARE Collaborative, Bernstein JL.  Risk of asynchronous contralateral breast cancer in non-carriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: A Report from the WECARE Study. Journal of Clinical Oncology 2013;31:433-439.

Rekhtman N, Tafe LJ, Chaft JE, Wang L, Arcila ME, Colanta A, Moreira AL, Zakowski MF, Travis WD, Sima CS, Kris MG, Ladanyi M. Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma. Modern Pathology 2012;[epub ahead of print].

Rink M, Sjoberg D, Comploj E, Margulis V, Xylinas E, Lee RK, Hansen J, Cha EK, Raman JD, Remzi M, Bensalah K, Novara G, Matin SF, Chun FK, Kikuchi E, Kassouf W, Martinez-Salamanca JI, Lotan Y, Seitz C, Pycha A, Zigeuner R, Karakiewicz PI, Scherr DS, Vickers AJ, Shariat SF. Risk of cancer-specific mortality following recurrence after radical nephroureterectomy. Annals of Surgical oOncology 2012;19:4337-4344.

Rink M, Xylinas E, Margulis V, Cha EK, Ehdaie B, Raman JD, Chun FK, Matsumoto K, Lotan Y, Furberg H, Babjuk M, Pycha A, Wood CG, Karakiewicz PI, Fisch M, Scherr DS, Shariat SF; for the Upper Tract Urothelial Carcinoma Collaboration. Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. European Urology 2012[epub ahead of print].

Rink M, Zabor EC, Furberg H, Xylinas E, Ehdaie B, Novara G, Babjuk M, Pycha A, Lotan Y, Trinh QD, Chun FK, Lee RK, Karakiewicz PI, Fisch M, Robinson BD, Scherr DS, Shariat SF. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy. European Urology 2012;[epub ahead of print].

Rizk NP, Servais EL, Tang LH, Sima CS, Gerdes H, Fleisher M, Rusch VW, Adusumilli PS. Tissue and serum mesothelin are potential markers of neoplastic progression in Barrett’s associated esophageal adenocarcinoma. Cancer Epidemiology, Biomarkers & Prevention 2012;21:482-486.

Roble GS, Boteler W, Riedel E, Lipman NS. Total IgE as a serodiagnostic marker to aid murine fur mite detection. Journal of the American Association for Laboratory Animal Science 2012; 51:199-208.

Romano E, Cotari JW, Barreira da Silva R, Betts BC, Chung DJ, Avogadri F, Fink MJ, St Angelo ET, Mehrara B, Heller G, Münz C, Altan-Bonnet G, Young JW. Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1. Blood 2012;119:5182-5190.

Roobol MJ, Schroder FH, Hugosson J, Jones JS, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Ankerst D, Bartsch G, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Freedland SJ, Moreira DM, Vickers AJ, Lilja H, Steyerberg EW. Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group. World Journal of Urology 2012;30:149-155.

Rosen A, Balagula Y, Goldfarb S, Lacouture M. Dermatologic adverse events during treatment. Principles and Practice of Palliative Care and Supportive Oncology, Fourth Edition. Wolters Kluwer Health/Lippincott Williams & Wilkins: 2012;(in press).

Rosenberger A, Bickeböller H, McCormack V, Brenner DR, Duell EJ, Tjønneland A, Friis S, Muscat JE, Yang P, Wichmann H-E, Heinrich J, Szeszenia-Dabrowska N, Lissowska J, Zaridze D, Rudnai P, Fabianova E, Janout V, Bencko V, Brennan P, Mates D, Schwartz AG, Cote ML, Zhang Z-F, Morgenstern H, Oh S, Field J-K, Raji O, McLaughlin JR, Wiencke J, LeMarchand L, Neri M, Bonassi S, Andrew A, Lan Q, Hu W, Orlow I, Park BJ, Boffetta P, Hung RJ. Asthma and lung cancer risk: an analysis from the International Lung Cancer Consortium (ILCCO). Carcinogenesis 2012; 33:587-597.

Rosenzweig KE, Zauderer MG, Laser B, Krug LM, Yorke E, Sima CS, Rimner A, Flores R, Rusch V. Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. International Journal of Radiation Oncology, Biology, Physics 2012;83:1278-1283.

Ruby JA, Leibold T, Akhurst TJ, Shia J, Saltz LB., Mazumdar M, Riedel ER, Larson SM, Guillem JG. FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluation. Disease of the Colon and Rectum 2012;55:378-386.

Ruddy K, Giobbie-Hurder A, Giordano S, Goldfarb S, Kereakoglow S, Winer EP, Partridge A. Quality of life and symptoms in male breast cancer survivors. Breast 2013;[epub ahead of print].

Sadetzki S, Bruchim R, Oberman B, Armstrong GN, Lau CC, Claus EB, Barnholtz-Sloan JS, Ilyasova D, Schildkraut J, Johansen C, Houlston RS, Shete S, Amos CI, Bernstein JL, Olson SH, Jenkins RB, Lachance D, Vick NA, Merrell R, Wrensch M, Davis FG, McCarthy BJ, Lai R, Melin BS, Bondy ML; Gliogene Consortium. Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium. European Journal of Cancer 2013;[epub ahead of print].

Saltz L, Badarinath S, Dakhil S, Bienvenu B, Harker WG, Birchfield G, Tokaz LK, Barrera D, Conkling PR, O’Rourke MA, Richards DA, Reidy D, Solit D, Vakiani E, Capanu M, Scales A, Zhan F, Boehm KA, Asmar L, Cohn A. Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancer. Clinical Colorectal Cancer 2012;11:101-111.

Salz T. Review of health services for cancer survivors. Psycho-Oncology 2012:21:e12–e13.

Salz T, Oeffinger KC, Lewis PR, Williams RL, Rhyne RL, Yeazel MW. Primary care providers’ needs and preferences for information about colorectal cancer survivorship care. Journal of the American Board of Family Medicine 2012;25:635-651.

Salz T, Oeffinger KC, McCabe MS, Layne TM, Bach PB.  Survivorship care plans in research and practice.  CA: A Cancer Journal for Clinicians 2012;[epub ahead of print].

Salz T, Woo H, Starr TD, Jandorf LH, DuHamel KN. Ethnic disparities in colonoscopy use among colorectal cancer survivors: A systematic review. Journal of Cancer Survivorship: Research and Practice 2012;[epub ahead of print].

Satagopan JM, Elston RC. Evaluation of removable statistical interaction for binary traits. Statistics in Medicine 2012;[epub ahead of print].

Schoellnast H, Deodhar A, Hsu M, Moskowitz CS, Nehmeh SA, Thornton RH, Sofocleous CT, Alago W Jr, Downey RJ, Azzoli CG, Rosenzweig KE, Solomon SB. Recurrent non-small cell lung cancer: evaluation of CT-guided radiofrequency ablation as salvage therapy. Acta Radiologica 2012;53:893-899.

Servais EL, Colovos C, Rodriguez L, Bograd AJ, Nitadori J, Sima C, Rusch VW, Sadelain M, Adusumilli PS. Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients. Clinical Cancer Research 2012;18:2478-2489.

Servais EL, Suzuki K, Colovos C, Rodriguez L, Sima C, Fleisher M, Rusch VW, Sadelain M, Adusumilli PS. An in vivo platform for tumor biomarker assessment. PLoS One 2011;6:e26722.

Seshan VE, Gönen M, Begg CB. Comparing ROC curves derived from regression models. Statistics in Medicine 2012;[epub ahead of print].

Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, Brinton LA, Cai H, Cerhan JR, Cozen W, Chen C, Doherty J, Freudenheim JL, Goodman MT, Hankinson SE, Lacey JV Jr, Liang X, Lissowska J, Lu L, Lurie G, Mack T, Matsuno RK, McCann S, Moysich KB, Olson SH, Rastogi R, Rebbeck TR, Risch H, Robien K, Schairer C, Shu XO, Spurdle AB, Strom BL, Thompson PJ, Ursin G, Webb PM, Weiss NS, Wentzensen N, Xiang YB, Yang HP, Yu H, Horn-Ross PL, De Vivo I; Australian National Endometrial Cancer Study Group. Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium.  American Journal of Epidemiology 2012;176:269-278.

Setton J, Caria N, Romanyshyn J, Koutcher L, Wolden SL, Zelefsky MJ, Rowan N, Sherman EJ, Fury MG, Pfister DG, Wong RJ, Shah JP, Kraus DH, Shi W, Zhang Z, Schupak KD, Gelblum DY, Rao SD, Lee NY. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: An update of the Memorial Sloan-Kettering Cancer Center experience. International Journal of Radiation Oncology Biology Physics 2012;82:291-298.

Shaikh WR, Weinstock MA, Halpern AC, Oliveria SA, Geller AC, Dusza SW. The characterization and potential impact of melanoma cases with unknown thickness in the United States’ Surveillance, Epidemiology, and End Results Program, 1989-2008. Cancer Epidemiology 2013;37:64-70.

Shapiro LQ, Beal K, Goenka A, Karimi S, Iwamoto FM, Yamada Y, Zhang Z, Lassman AB, Abrey LE, Gutin PH. Patterns of failure following concurrent bevacizumab and hypofractionated stereotactic radiotherapy for recurrent high-grade glioma. International Journal of Radiation Oncology Biology Physics 2012; [epub ahead of print].

Shariat SF, Ehdaie B, Rink M, Cha EK, Svatek RS, Chromecki TF, Fajkovic H, Novara G, David SG, Daneshmand S, Fradet Y, Lotan Y, Sagalowsky AI, Clozel T, Bastian PJ, Kassouf W, Fritsche HM, Burger M, Izawa JI, Tilki D, Abdollah F, Chun FK, Sonpavde G, Karakiewicz PI, Scherr DS, Gönen M. Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. European Urology 2012;61:237-242.

Shariat SF, Rink M, Ehdaie B, Xylinas E, Babjuk M, Merseburger AS, Svatek RS, Cha EK, Tagawa ST, Fajkovic H, Novara G, Karakiewicz PI, Trinh QD, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Chun FK, Sonpavde G, Joual A, Scherr DS, Gönen M. Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy. European Urology 2013;63:371-378.

Shen R, Mo Q, Schultz N, Seshan VE, Olshen AB, Huse J, Ladanyi M, Sander C. Integrative subtype discovery in glioblastoma using iCluster. PLoS One 2012;7:e35236.

Shen R, Wang S, Mo Q. Sparse integrative clustering of multiple omics data sets. Annals of Applied Statistics 2013; (in press)

Sherman EJ, Fisher SG, Kraus DH, Zelefsky MJ, Seshan VE, Singh B, Shaha AR, Shah JP,

Wolf GT, Pfister DG. TALK score: Development and validation of a prognostic model for

predicting larynx preservation outcome. Laryngoscope 2012;122:1043-1050.

Sigel CS, Rudomina DE, Sima CS, Rekhtman N, Travis WD, Geisinger KR, Moreira AL. Predicting pulmonary adenocarcinoma outcome based on a cytology grading system. Cancer Cytopathology 2012;120:35-43.

Silberstein JL, Adamy A, Maschino AC, Ehdaie B, Garg T, Favaretto RL, Ghoneim TP, Motzer RJ, Russo P. Systematic classification and prediction of complications after nephrectomy in patients with metastatic renal cell carcinoma (RCC). BJU International 2012;110:1276-1282.

Silberstein JL, Vickers AJ, Power NE, Parra RO, Coleman JA, Pinochet R, Touijer KA, Scardino PT, Eastham JA, Laudone VP. Pelvic lymph node dissection for patients with elevated risk of lymph node invasion during radical prostatectomy: comparison of open, laparoscopic and robot-assisted procedures. Journal of Endourology / Endourological Society 2012;26:748-753.

Smyth EC, Capanu M, Janjigian YY, Kelsen DK, Coit D, Strong VE, Shah MA. Tobacco use is associated with increased recurrence and death from gastric cancer. Annals of Surgical Oncology 2012;19:2088-2094.

Smyth E, Schöder H, Strong VE, Capanu M, Kelsen DP, Coit DG, Shah MA. A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced  gastric cancer. Cancer 2012;118:5481-5488.

Sofocleous CT, Garg S, Petrovic LM, Gönen M, Petre EN, Klimstra DS, Solomon SB, Brown KT, Brody LA, Covey AM, DeMatteo RP, Schwartz L, Kemeny NE. Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies. Annals of Surgical Oncology 2012;19:4262-4269.

Song TJ, Fong Y, Cho SJ, Gönen M, Hezel M, Tuorto S, Choi SY, Kim YC, Suh SO, Koo BH, Chae YS, Jarnagin WR, Klimstra DS. Comparison of hepatocellular carcinoma in American and Asian patients by tissue array analysis. Journal of Surgical Oncology 2012;106:84-88.

Song TJ, Haddad D, Adusumilli P, Kim T, Stiles B, Hezel M, Socci ND, Gönen M, Fong Y. Molecular network pathways and functional analysis of tumor signatures associated with development of resistance to viral gene therapy. Cancer Gene Therapy 2012;19:38-48.

Spindler M, Jacks LM, Chen X, Panageas K, DeAngelis LM, Avila EK.  The spectrum of non-convulsive status epilepticus in patients with cancer.  Journal of Clinical Neurophysiology 2013(in press).

Spratt DE, Sakae M, Lok B, Essandoh S, Hsu M, Zhang Z, Schupak K, Setton J, Lee NY. Time course and predictors for cancer-related fatigue in a series of oropharyngeal cancer patients treated with chemoradiation therapy. The Oncologist 2012;17:569-576.

Spratt DE, Zhang C, Zumsteg ZS, Pei X, Zhang Z, Zelefsky MJ. Metformin and prostate cancer: Benefit on development of castration resistant disease and prostate cancer mortality. European Urology 2012;[epub ahead of print].

Steinhagen E, Moore HG, Lee-Kong SA, Shia J, Eaton A, Markowitz AJ, Russo, P Guillem JG. Patients with colorectal and renal cell carcinoma diagnoses appear to be at risk for additional malignancies. Clinical Colorectal Cancer 2012;[epub ahead of print].

Steyerberg EW, Pencina MJ, Lingsma HF, Kattan MW, Vickers AJ, Van Calster B. Assessing the incremental value of diagnostic and prognostic markers: a review and illustration. European Journal of Clinical Investigation 2012;42:216-228.

Stram DO, Seshan VE. Multi-SNP haplotype analysis methods for association analysis. Methods

in Molecular Biology 2012;850:423-452.

Strong VE, Song KY, Park CH, Jacks LM, Gönen M, Shah MA, Coit DG, Brennan MF. Comparison of disease-specific survival in the United States and Korea after resection for early-stage node-negative gastric carcinoma. Journal of Surgical Oncology 2012;[epub ahead of print].

Sun L, Song X, Zhang Z. Mean residual life models with time dependent coefficients under right censoring. Biometrika 2012;99:185-197.

Sun X, Vengochea  J, Elston R, Chen Y, Amos C, Armstrong G, Bernstein JL, Claus E, Davis F, Houlston RS, , Il’yasova D, Jenkins RB, Johansen C, Lai R, Lau CC, Liu Y, McCarthy BJ, Olson S, Sadetzki S, Schildkraut J, Shete S, Vick NA, Wrensch M, Yang P, The Gliogene Consortium, Melin B, Bondy ML,  Barnholtz-Sloan J. A variable age of onset segregation model for linkage analysis, with correction for ascertainment, applied to glioma. Cancer Epidemiology, Biomarkers & Prevention 2012;21:2242-2251.

Suzuki K, Kadota K, Sima CS, Nitadori JI, Rusch VW, Travis WD, Sadelain M, Adusumilli PS. Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence. Journal of Clinical Oncology 2013;31:490-498.

Tang LH, Gönen M, Hedvat C, Modlin IM, and Klimstra DS. Objective quantification of the ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: A comparison of digital image analysis with manual methods. American Journal of Surgical Pathology 2012. 36:1761-1770.

Tang M, Foo J, Gönen M, Guilhot J, Mahon F, Michor F. Selection pressure exerted by imatinib therapy leads to disparate outcomes of imatinib discontinuation trials. Haematologica 2012;97:1553-1561.

Tanner EJ, Long KC, Zhou Q, Brightwell RM, Gardner GJ, Abu-Rustum NR, Leitao MM Jr, Sonoda Y, Barakat RR, Iasonos A, Chi DS. Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian cancer. Gynecologic Oncology 2012;126:58-63.

Taylor JM, Feifer A, Savage CJ, Maschino AC, Bernstein M, Herr HW, Donat SM. Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer. BJU International 2012;109:855-859.

Tarek N, Le Luduec JB, Gallagher MM, Zheng J, Venstrom JM, Chamberlain E, Modak S, Heller G, Dupont B, Cheung NK, Hsu KC. Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment. Journal of Clinical Investigation 2012;122:3260-3270.

Thornton RH, Ulrich R, Hsu M, Moskowitz CS, Reidy-Lagunes D, Covey AM, Brody LA, Robson PM, Sofocleous CT, Solomon SB, Getrajdman GI, Brown KT. Outcomes of patients undergoing percutaneous biliary drainage to reduce bilirubin for administration of chemotherapy. Journal of Vascular and Interventional Radiology 2012;23:89-95.

Tischkowitz M, Capanu M, Sabbaghian N, Li L, Liang X, Vallee M, Tavtigian S, Concannon P, Foulkes WD, Bernstein L, Bernstein JL, Begg CB. Rare germline mutations in PALB2 and breast cancer risk: a population-based study.  Human Mutation 2012;33:674-680.

Tonorezos ES, Robien K, Eshelman-Kent D, Moskowitz CS, Church TS, Ross R, Oeffinger KC. Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia. Cancer Causes Control 2013;24:313-321.

Ulmert D, Vickers AJ, Scher HI, Becker C, Iversen P, Frankel D, Jensen JK, Kold Olesen T, Lilja H. Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses. Clinical Chemistry and Laboratory Medicine: CCLM / FESCC 2012;50:1993-1998.

Vakiani E, Janakiraman M, Shen R, Sinha R, Zeng Z, Shia J, Cercek A, Kemeny N, D’Angelica M, Viale A, Heguy A, Paty P, Chan TA, Saltz LB, Weiser M, Solit DB. Comparative genomic analysis of primary versus metastatic colorectal carcinomas. Journal of Clinical Oncology 2012;30:2956-2962.

Van Zee KJ, Patil S. Validation of a nomogram for predicting risk of local recurrence for ductal carcinoma in situ. Journal of Clinical Oncology 2012;30:3143-3144; author reply 3144-3145. 

Vargas HA, Akin O, Afaq A, Goldman D, Zheng J, Moskowitz CS, Shukla-Dave A, Eastham J, Scardino P, Hricak H. Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer. Journal of Urology 2012;188:1732-1738.

Vargas HA, Akin O, Shukla-Dave A, Zhang J, Zakian KL, Zheng J, Kanao K, Goldman DA, Moskowitz CS, Reuter VE, Eastham JA, Scardino PT, Hricak H. Performance characteristics of MR Imaging in the evaluation of clinically low-risk prostate cancer: a prospective study. Radiology 2012;265:478-487.

Vargas HA, Chaim J, Lefkowitz RA, Lakhman Y, Zheng J, Moskowitz CS, Sohn MJ, Schwartz LH, Russo P, Akin O. Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes. Radiology 2012;264:779-788.

Vargas HA, Delaney HG, Delappe EM, Wang Y, Zheng J, Moskowitz CS, Tan Y, Zhao B, Schwartz LH, Hricak H, Russo P, Akin O. Multiphasic contrast-enhanced MRI: Single-slice versus volumetric quantification of tumor enhancement for the assessment of renal clear-cell carcinoma fuhrman grade. Journal of Magnetic Resonance Imaging 2012;[epub ahead of print].

Varghese AM, Sima CS, Chaft JE, Johnson ML, Riely GJ, Ladanyi M, Kris MG. Lungs don’t forget: comparison of the KRAS and EGFR mutation profile and survival of collegiate smokers and never smokers with advanced lung cancers. Journal of Thoracic Oncology 2013;8:123-125.

Vickers AJ. Editorial comment. The Journal of Urology. 2012;187:1638; discussion.

Vickers AJ. The trifecta: great concept, lousy statistic. BJU International 2012;110:771-772.

Vickers AJ. Words of wisdom. Re: Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up. European Urology. 2012;62:353.

Vickers AJ, Bennette C, Kibel AS, Black A, Izmirlian G, Stephenson AJ, Bochner B. Who should be included in a clinical trial of screening for bladder cancer?: A decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Cancer 2012;[epub ahead of print].

Vickers AJ, Bennette C, Steineck G, Adami HO, Johansson JE, Bill-Axelson A, Palmgren J, Garmo H, Holmberg L. Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial. European Urology 2012;62:204-209.

Vickers AJ, Bennette C, Touijer K, Coleman J, Laudone V, Carver B, Eastham JA, Scardino PT. Feasibility study of a clinically-integrated randomized trial of modifications to radical prostatectomy. Trials 2012;13:23.

Vickers AJ, Brewster SF. PSA velocity and doubling time in diagnosis and prognosis of prostate cancer. British Journal of Medical & Surgical Urology 2012;5:162-168.

Vickers AJ, Cronin AM, Gonen M. A simple decision analytic solution to the comparison of two binary diagnostic tests. Statistics in Medicine 2012;[epub ahead of print].

Vickers AJ, Cronin AM, Maschino AC, Lewith G, Macpherson H, Foster NE, Sherman KJ, Witt CM, Linde K. Acupuncture for chronic pain: Individual patient data meta-analysis. Archives of Internal Medicine 2012;10:1-10.

Vickers AJ, Eastham JA, Scardino PT. Radical prostatectomy versus observation for prostate cancer. The New England Journal of Medicine 2012;367:1467-1468; author reply 8-9.

Vickers AJ, Lilja H. Predicting prostate cancer many years before diagnosis: how and why? World Journal of Urology 2012;30:131-135.

Vickers AJ, Lilja H. Urological Cancer: Time for another rethink on prostate cancer screening. Nature Reviews Clinical Oncology 2012;9:7-8.

Vickers AJ, Lilja H. PSA is dead, long live PSA. European Urology 2012;61:467-468; discussion 9-70.

Vickers AJ, Lilja H. We need a better marker for prostate cancer. How about renaming PSA? Urology 2012;79:254-255.

Vickers AJ, Roobol MJ, Lilja H. Screening for prostate cancer: early detection or overdetection? Annual Review of Medicine 2012;63:161-170.

Vickers AJ, Sjoberg D, Basch E, Sculli F, Shouery M, Laudone V, Touijer K, Eastham J, Scardino PT. How do you know if you are any good? A surgeon performance feedback system for the outcomes of radical prostatectomy. European Urology 2012;61:284-289.

Viñuela EF, Gönen M, Brennan MF, Coit DG, Strong VE. Laparoscopic versus open distal gastrectomy for gastric cancer: A meta-analysis of randomized controlled trials and high-quality nonrandomized studies. Annals of Surgery 2012;255:446-456.

Wang HE, Devlin SM, Sears GK, Vaillancourt C, Morrison LJ, Weisfeldt M, Callaway CW; ROC Investigators. Regional variations in early and late survival after out-of-hospital cardiac arrest. Resuscitation 2012;83:1343-1348.

Wang X, Erinjeri JP, Jia X, Gönen M, Brown KT, Sofocleous CT, Getrajdman GI, Brody LA, Thornton RH, Maybody M, Covey AM, Siegelbaum RH, Alago W, Solomon SB. Pattern of retained contrast on immediate postprocedure computed tomography (CT) after particle embolization of liver tumors predicts subsequent treatment response. CardioVascular and Interventional Radiology 2012;[epub ahead of print].

Wang X, Sofocleous CT, Erinjeri JP, Petre EN, Gönen M, Do KG, Brown KT, Covey AM, Brody LA, Alago W, Thornton RH, Kemeny NE, Solomon SB. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. CardioVascular and Interventional Radiology 2013;36:166-175.

Wang YC, Graubard BI, Rosenberg MA, Kuntz KM, Zauber AG, Kahle L, Schechter CB, Feuer EJ. Derivation of background mortality by smoking and obesity in cancer simulation models. Medical Decision Making 2012; [epub ahead of print].

Weiss MJ, Ito H, Araujo RLC, Zabor EC, Gönen M, D’Angelica MI, Allen PJ, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Hepatic pedicle clamping during hepatic resection for colorectal liver metastases: no impact on survival or hepatic recurrence. Annals of Surgical Oncology 2013;20:285-294.

Wen YH, Ho A, Patil S, Akram M, Catalano J, Eaton A, Norton L, Benezra R, Brogi E. Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulation. Breast Cancer Research and Treatment 2012;135:93-102.

Westhoff CL, Torgal AT, Mayeda ER, Shimoni N, Stanczyk FZ, Pike MC.  Predictors of

noncompliance in an oral contraceptive clinical trial.  Contraception 2012;85:465-469.

Willis JA, Olson SH, Orlow I, Mukherjee S, McWilliams RR, Kurtz RC, Klein RJ. A replication study and genome-wide scan of single nucleotide polymorphisms associated with pancreatic cancer risk and overall survival. Clinical Cancer Research 2012;18:3942-3951.

Winter JM, Tang LH, Klimstra DS, Brennan MF, Brody JR, Rocha FG, Jia X, Qin LX, D’Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR, O’Reilly EM, Allen PJ. A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers. PLoS One 2012;7:e40157.

Wolf PS, Park JO, Bao F, Allen PJ, Dematteo RP, Fong Y, Jarnagin WR, Kingham TP, Gönen M, Kemeny N, Shia J, D’Angelica MI. Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: A single institution experience. Journal of the American College of Surgeons 2013;216:41-49.

Wong J, Kelly KJ, Mittra A, Gönen M, Allen P, Fong Y, Coit D. RT-PCR increases detection of submicroscopic peritoneal metastases in gastric cancer and has prognostic significance. Journal of Gastrointestinal Surgery 2012;16:889-896.

Wu AH, Spicer DV, Pike MCSoy isoflavones for breast cancer risk reduction.  Cancer

Prevention Research 2012; 5:984-985; author reply 986-987.

Wu AH, Spicer D, Stanczyk FZ, Tseng CC, Yang CS, Pike MC.  Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy

postmenopausal women.  Cancer Prevention Research 2012; 5:393-402.

Xylinas E, Rink M, Margulis V, Faison T, Comploj E, Novara G, Raman JD, Lotan Y, Guillonneau B, Weizer A, Pycha A, Scherr DS, Seitz C, Sun M, Trinh QD, Karakiewicz PI, Montorsi F, Zerbib M, Gönen M, Shariat SF. Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy. Journal of Urology 2013;189:468-473.

Yaligar J, Thakur SB, Bokacheva L, Carlin S, Thaler HT, Rizwan A, Lupu ME, Wang Y, Matei

CC, Zakian KL, Koutcher JA. Lactate MRSI and DCE MRI as surrogate markers of prostate

tumor aggressiveness. NMR in Biomedicine 2012;25:113-122.

Yen HY, Gabet Y, Liu Y, Martin A, Wu NL, Pike MC, Frenkel B, Maxson R, Dubeau L.

Alterations in Brca1 expression in mouse ovarian granulosa cells have short-term and long-term

consequences on estrogen-responsive organs. Laboratory Investigation 2012; 92:802-811.

Young RJ, Gupta A, Shah AD, Graber JJ, Chan TA, Zhang Z, Shi W, Beal K, Omuro AM. MRI perfusion in determining pseudoprogression in patients with glioblastoma. Clinical Imaging 2013;37:41-49.

Young RJ, Lee V, Peck KK, Sierra T, Zhang Z, Jacks LM, Holodny AI. Diffusion tensor imaging and tractography of the corticospinal tract in the presence of enlarged Virchow-Robin spaces. Journal of Neuroimaging 2012;[epub ahead of print].

Zabor EC, Li Y, Thornton LM, Shuman MR, Bulik CM, Lichtenstein P, Pedersen NL, Sullivan PF, Furberg H. Initial reactions to tobacco use and risk of future regular use. Nicotine & Tobacco Research 2013;15:509-517.

Zamarin, D, Giralt S, Landau H, Lendvai N, Lesokhin A, Chung D, Koehne G, Chimento D, Devlin SM, Riedel E, Bhutani M, Babu D, Hassoun H. Patterns of relapse and progression in multiple myeloma patients after auto-SCT: implications for patients’ monitoring after transplantation. Bone Marrow Transplantation 2012;[epub ahead of print].

Zauber AG, Winawer SJ, O’Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, Shi W, Bond JH, Schapiro M, Panish JF, Stewart ET, Waye JD. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. New England Journal of Medicine 2012;366:687-696.

Zelefsky MJ, Chou JF, Pei X, Yamada Y, Kollmeier M, Cox B, Zhang Z, Schechter M, Cohen GN, Zaider M. Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: The Memorial Sloan-Kettering Cancer Center experience. Brachytherapy 2012; 11:245-249.

Zelefsky MJ, Housman DM, Pei X, Alicikus Z, Magsanoc JM, Dauer LT, St Germain J, Yamada Y, Kollmeier M, Cox B, Zhang Z. Incidence of secondary cancer development after high-dose IMRT and image-guided brachytherapy for the treatment of localized prostate cancer. International Journal of Radiation Oncology Biology Physics 2012;83:953-959.

Zelefsky MJ, Pei X, Teslova T, Kuk D, Magsanoc JM, Kollmeier M, Cox B, Zhang Z. Secondary cancers after intensity-modulated radiotherapy, brachytherapy, and surgery for the treatment of prostate cancer: Incidence and cause-specific survival outcomes according to the initial treatment intervention. British Journal of Urology 2012;110:1696-1701.

Zhang SJ, Rampal R, Manshouri T, Patel J, Mensah N, Kayserian A, Hricik T, Heguy A, Hedvat C, Gönen M, Kantarjian H, Levine RL, Abdel-Wahab O, Verstovsek S. Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome. Blood 2012;119:4480-4485.

Zhang Z, Zhao Y. Empirical likelihood for linear transformation models with interval-censored failure time data. Journal of Multivariate Analysis 2012;[epub ahead of print].

Zhu X, Albertsen PC, Andriole GL, Roobol MJ, Schroder FH, Vickers AJ. Risk-based prostate cancer screening. European Urology. 2012;61:652-661.

Zumsteg ZS, Spratt DE, Pei X, Yamada Y, Kalikstein A, Kuk D, Zhang Z, Zelefsky MJ. Short-term androgen-deprivation therapy improves prostate cancer-specific mortality in intermediate-risk prostate cancer patients undergoing dose-escalated external beam radiation therapy. International Journal of Radiation Oncology Biology Physics 2012;[epub ahead of print].

Abernethy AP, Basch E. Clinical cancer informatics: creating pathways for personalized medicine and rapid learning cancer care. Cancer Journal 2011;17:195-196.

Abou-Alfa GK, Chapman PB, Feilchenfeldt J, Brennan MF, Capanu M, Gansukh B, Jacobs G, Levin A, Neville D, Kelsen DP, O’Reilly EM. Targeting mutated k-ras in pancreatic adenocarcinoma using an adjuvant vaccine. American Journal of Clinical Oncology 2011;34:321-325.

Abu-Rustum NR, Zhou Q, Iasonos A, Alektiar KM, Leitao MM Jr, Chi DS, Sonoda Y, Soslow R, Hensley M, Barakat RR. The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered? International Journal of Gynecological Cancer 2011;21:511-516.

Adamy A, Yee DS, Matsushita K, Maschino A, Cronin A, Vickers AJ, Guillonneau B, Scardino PT, Eastham JA. Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer. Journal of Urology 2011;185:477-482.

Akin O, Gultekin DH, Vargas HA, Zheng J, Moskowitz C, Pei X, Sperling D, Schwartz LH, Hricak H, Zelefsky MJ. Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results. European Radiology 2011;21:1970-1978.

Alicikus ZA, Yamada Y, Zhang Z, Pei X, Hunt M, Kollmeier M, Cox B, Zelefsky MJ. Ten-year outcomes of high-dose intensity-modulated radiotherapy for localized prostate cancer. Cancer 2011;117:1429-1437.

Allen PJ, Chou J, Janakos M, Strong VE, Coit DG, Brennan MF. Prospective evaluation of laparoscopic celiac plexus block in patients with unresectable pancreatic adenocarcinoma. Annals of Surgical Oncology 2011;18:636-641.

Amankwah EK, Kelemen LE, Wang Q, Song H, Chenevix-Trench G, Australian Ovarian Cancer Study Group, Beesley J, Webb PM, Australian Cancer Study (Ovarian Cancer), Pearce CL, Wu AH, Pike MC, Stram DO, Chang-Claude J, Wang-Gohrke S, Ness RB, Goode EL, Cunningham JM, Fridley BL, Vierkant RA, Tworoger SS, Whittemore AS, McGuire V, Sieh W, Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Rossing MA, Doherty JA, Goodman MT, Carney ME, Lurie G, Wilkens LR, Kjær SK, Høgdall E, Cramer DW, Terry KL, Garcia-Closas M, Yang H, Lissowska J, Anton-Culver H, Ziogas A, Schildkraut JM, Berchuck A, Pharoah PD, Ovarian Cancer Association Consortium. Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer. Cancer Epidemiology Biomarkers and Prevention 2011;20:1028-1031.

Araten DJ, Notaro R, Thaler HT, Kernan N, Boulad F, Castro-Malaspina H, Small T, Scaradavou A, Magnan H, Prockop S, Chaffee S, Gonsky J, Thertulien R, Tarquini R, Luzzatto L. Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of 9 patients and a review of the literature. Haematologica 2011;[epub ahead of print].

Artzrouni M, Begg CB, Chabiniok R, Clairambault J, Foss A, Hargrove J, Lee EK, Siggers JH, Tindall M. The first international workshop on the role and impact of mathematics in medicine: a collective account. American Journal of Translational Research 2011;3:492-497.

Atkinson TM, Li Y, Coffey CW, Sit L, Shaw M, Lavene D, Bennett AV, Fruscione M, Rogak L, Hay J, Gönen M, Schrag D, Basch E. Reliability of adverse symptom event reporting by clinicians. Quality of Life Research 2011;[epub ahead of print].

Atkinson TM, Rosenfeld BD, Sit L, Mendoza TR, Fruscione M, Lavene D, Shaw M, Li Y, Hay J, Cleeland CS, Scher HI, Breitbart WS, Basch E. Using confirmatory factor analysis to evaluate construct validity of the brief pain inventory (BPI). Journal of Pain Symptom Management 2011;41:558-565.

Avery S, Shi W, Lubin M, Gonzales AM, Heller G, Castro-Malaspina H, Giralt S, Kernan NA, Scaradavou A, Barker JN. Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts. Blood 2011;117:3277-3285; quiz 3478.

Bach PB, Doring T, Gesenberg A, Mohring C, Goepel M. Quality of life of patients after retropubic prostatectomy-pre-and postoperative scores of the EORTC QLQ-C30 and QLQ-PR25. Health Quality of Life Outcomes 2011;9:93.

Bach PB, Mirkin JN, Luke JJ. Episode-based payment for cancer care: a proposed pilot for Medicare. Health Aff (Millwood) 2011;30:500-509.

Bach PB, Vickers AJ. Do the data support the co-morbidity hypothesis for the prostate, lung, colorectal and ovarian cancer screening trial results? Journal of Clinical Oncology 2011;29:e387; author reply e388-389.

Bach PB. Inconsistencies in findings from the early lung cancer action project studies of lung cancer screening. Journal of the National Cancer Institute 2011;103:1002-1006.

Bach PB. Reduced lung-cancer mortality with CT screening. New England Journal of Medicine 2011;365:2036;author reply 2037-2038.

Bandera EV, King M, Chandran U, Paddock LE, Rodriguez-Rodriguez L, Olson SH. Phytoestrogen consumption from food and supplements and epithelial ovarian cancer risk: a population-based case-control study.  BMC Women’s Health 2011;11:40.

Barnett SA, Rusch VW, Zheng J, Park BJ, Rizk NP, Plourde G, Bains MS, Downey RJ, Shen R, Kris MG. Contemporary results of surgical resection of non-small cell lung cancer after induction therapy: a review of 549 consecutive cases. Journal of Thoracic Oncology 2011;6:1530-1536.

Basch E, Abernethy A. Encouraging clinicians to incorporate longitudinal patient-reported symptoms in routine clinical practice. Journal of Oncology Practice 2011;7:23-25.

Basch E, Abernethy AP, Reeve BB. Assuring the patient centeredness of patient-reported outcomes: content validity in medical product development and comparative effectiveness research. Value Health 2011;14:965-966.

Basch E, Abernethy AP. Supporting clinical practice decisions with real-time patient-reported outcomes. Journal of Clinical Oncology 2011;29:954-956.

Basch E, Bennett A, Pietanza MC. Use of patient-reported outcomes to improve the predictive accuracy of clinician-reported adverse events. Journal of the National Cancer Institute 2011;103:1808-1810.

Basch E, Loblaw A, Prestrud A, Oliver TK, Bacher A, Casscells S, Carducci M, Garrels K, Nordquist L, Raghavan D, Singer E, Taplin ME, Virgo K, Winquist E, Somerfield M, Nam RK. Second-line hormonal therapy for castration-resistant prostate cancer: American Society of Clinical Oncology consensus-based clinical practice guideline. Journal of Clinical Oncology 2011 (in press).

Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B, Morrow G, Rao KV, Schwartz RN, Lyman GH. American Society of Clinical Oncology clinical practice guideline update on antiemetics. Journal of Clinical Oncology 2011;29:4189-4198.

Basch E, Somerfield M, Partridge A, Schnipper L, Lyman GH. Should cost and comparative value of treatments be considered in clinical practice guidelines? Journal of Oncology Practice 2011;(in press).

Basch EM, Reeve BB, Mitchell SA, Clauser SB, Minasian L, Sit L, Chilukuri R, Baumgartner P, Rogak L, Blauel E, Abernethy AP, Bruner D. Electronic toxicity monitoring and patient-reported outcomes. Cancer Journal 2011;17:231-234.

Beesley J, Pickett HA, Johnatty SE, Dunning AM, Chen X, Li J, Michailidou K, Lu J, Rider DN, Palmieri RT, Stutz MD, Lambrechts D, Despierre E, Lambrechts S, Vergote I, Chang-Claude J, Nickels S, Vrieling A, Flesch-Janys D, Wang-Gohrke S, Eilber U, Bogdanova N, Antonenkova N, Runnebaum IB, Dörk T, Goodman MT, Lurie G, Wilkens LR, Matsuno RK, Kiemeney LA, Aben KKH, Marees T, Massuger LFAG, Fridley BL, Vierkant RA, Bandera EV, Olson SH, Orlow I, Rodriguez-Rodriguez L, Cook LS, Le ND, Brooks-Wilson A, Kelemen LE, Campbell I, Gayther SA, Ramus SJ, Gentry-Maharaj A, Menon U, Ahmed S, Baynes C, Pharoah PD, Muir K, Lophatananon A, Chaiwerawattana A, Wiangnon S, Macgregor S, Easton DF, Reddel RR, Goode EL, Chenevix-Trench G. Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. PLoS One 2011;6:e24987.

Begg CB. A strategy for distinguishing optimal cancer subtypes. International Journal of Cancer 2011;129:931-937.

Bell D, Berchuck A, Birrer M, Chien J, Cramer DW, Dao F, Dhir R, DiSaia P, Gabra H, Glenn P, Godwin AK, Gross J, Hartmann L, Huang M, Huntsman DG, Iacocca M, Imielinski M, Kalloger S, Karlan BY, Levine DA, Mills GB, Morrison C, Mutch D, Olvera N, Orsulic S, Park K, Petrelli N, Rabeno B, Rader JS, Sikic BI, Smith-McCune K, Sood AK, Bowtell D, Penny R, Testa JR, Chang K, Dinh HH, Drummond JA, Fowler G, Gunaratne P, Hawes AC, Kovar CL, Lewis LR, Morgan MB, Newsham IF, Santibanez J, Reid JG, Trevino LR, Wu YQ, Wang M, Muzny DM, Wheeler DA, Gibbs RA, Getz G, Lawrence MS, Cibulskis K, Sivachenko AY, Sougnez C, Voet D, Wilkinson J, Bloom T, Ardlie K, Fennell T, Baldwin J, Gabriel S, Lander ES, Ding LL, Fulton RS, Koboldt DC, McLellan MD, Wylie T, Walker J, O’Laughlin M, Dooling DJ, Fulton L, Abbott R, Dees ND, Zhang Q, Kandoth C, Wendl M, Schierding W, Shen D, Harris CC, Schmidt H, Kalicki J, Delehaunty KD, Fronick CC, Demeter R, Cook L, Wallis JW, Lin L, Magrini VJ, Hodges JS, Eldred JM, Smith SM, Pohl CS, Vandin F, Raphael BJ, Weinstock GM, Mardis ER, Wilson RK, Meyerson M, Winckler W, Getz G, Verhaak RG, Carter SL, Mermel CH, Saksena G, Nguyen H, Onofrio RC, Lawrence MS, Hubbard D, Gupta S, Crenshaw A, Ramos AH, Ardlie K, Chin L, Protopopov A, Zhang J, Kim TM, Perna I, Xiao Y, Zhang H, Ren G, Sathiamoorthy N, Park RW, Lee E, Park PJ, Kucherlapati R, Absher M, Waite L, Sherlock G, Brooks JD, Li JZ, Xu J, Myers RM, Laird PW, Cope L, Herman JG, Shen H, Weisenberger DJ, Noushmehr H, Pan F, Triche T Jr, Berman BP, Van Den Berg DJ, Buckley J, Baylin SB, Spellman PT, Purdom E, Neuvial P, Bengtsson H, Jakkula LR, Durinck S, Han J, Dorton S, Marr H, Choi YG, Wang V, Wang NJ, Ngai J, Conboy JG, Parvin B, Feiler HS, Speed TP, Gray JW, Levine A, Socci ND, Liang Y, Taylor BS, Schultz N, Borsu L, Lash AE, Brennan C, Viale A, Sander C, Ladanyi M, Hoadley KA, Meng S, Du Y, Shi Y, Li L, Turman YJ, Zang D, Helms EB, Balu S, Zhou X, Wu J, Topal MD, Hayes DN, Perou CM, Getz G, Voet D, Saksena G, Zhang J, Zhang H, Wu CJ, Shukla S, Cibulskis K, Lawrence MS, Sivachenko A, Jing R, Park RW, Liu Y, Park PJ, Noble M, Chin L, Carter H, Kim D, Karchin R, Spellman PT, Purdom E, Neuvial P, Bengtsson H, Durinck S, Han J, Korkola JE, Heiser LM, Cho RJ, Hu Z, Parvin B, Speed TP, Gray JW, Schultz N, Cerami E, Taylor BS, Olshen A, Reva B, Antipin Y, Shen R, Mankoo P, Sheridan R, Ciriello G, Chang WK, Bernanke JA, Borsu L, Levine DA, Ladanyi M, Sander C, Haussler D, Benz CC, Stuart JM, Benz SC, Sanborn JZ, Vaske CJ, Zhu J, Szeto C, Scott GK, Yau C, Hoadley KA, Du Y, Balu S, Hayes DN, Perou CM, Wilkerson MD, Zhang N, Akbani R, Baggerly KA, Yung WK, Mills GB, Weinstein JN, Penny R, Shelton T, Grimm D, Hatfield M, Morris S, Yena P, Rhodes P, Sherman M, Paulauskis J, Millis S, Kahn A, Greene JM, Sfeir R, Jensen MA, Chen J, Whitmore J, Alonso S, Jordan J, Chu A, Zhang J, Barker A, Compton C, Eley G, Ferguson M, Fielding P, Gerhard DS, Myles R, Schaefer C, Mills Shaw KR, Vaught J, Vockley JB, Good PJ, Guyer MS, Ozenberger B, Peterson J, Thomson E. The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474:609-615.

Bennett AV, Patrick DL, Bushnell DM, Chiou CF, Diehr P. Comparison of 7-day and repeated 24-h recall of type 2 diabetes. Quality of Life Research 2011;20:769-777.

Bertuccio P, La Vecchia C, Silverman D, Petersen G, Bracci PM, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Bamlet WR, Holly EA, Lucenteforte E, Hassan M, Yu H, Kurtz RC, Cotterchio M, Su J, Maisonneuve P, Duell EJ, Bosetti C, Boffetta P. Cigar and pipe  smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4), Annals of Oncology 2011;22:1420-1426.

Berwick M, Begg CB, Armstrong BK, Reiner AS, Thomas NE, Cook LS, Orlow I, Kricker A, Marrett LD, Gruber SB, Anton-Culver H, Millikan RC, Gallagher RP, Dwyer T, Rosso S, Kanetsky P, Lee-Taylor J, for the GEM Study Group. Interaction of CDKN2A and sun exposure in the etiology of melanoma in the general population. Journal of Investigational Dermatology 2011;131:2500-2503.

Bickenbach KA, Gönen M, Tang LH, O’Reilly E, Goodman K, Brennan MF, D’Angelica MI, Dematteo RP, Fong Y, Jarnagin WR, Allen PJ. Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease. Annals of Surgical Oncology 2011;[epub ahead of print].

Blinder VS, Patil S, Thind A, Diamant A, Hudis CA, Basch E, Maly RC. Return to work in low-income Latina and non-Latina white breast cancer survivors: A 3-year longitudinal study. Cancer 2011;[epub ahead of print].

Blinder VS, Murphy MM, Vahdat LT, Gold HT, de Melo-Martin I, Hayes MK, Scheff RJ, Chuang E, Moore A, Mazumdar M. Employment after a breast cancer diagnosis: a qualitiative study of ethnically diverse urban women. Journal of Community Health 2011;[epub ahead of print].

Boscoe FP, Johnson CJ, Henry KA, Goldberg DW, Shahabi K, Elkin EB, Ballas LK, Cockburn M. Geographic proximity to treatment for early stage breast cancer and likelihood of mastectomy. Breast 2011;20:324-328.

Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji B-T, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Bamlet WR, Holly EA, Bertuccio P, Gao Y-T, Hassan M, Yu H, Kurtz RC, Cotterchio M, Su J, Maisonneuve P, Duell EJ, Boffetta P, La Vecchia C. Cigarette smoking and pancreatic cancer: an analysis from the international Pancreatic Cancer Case-Control Consortium (PanC4). Annals of Oncology 2011;[epub ahead of print].

Bosl GJ, Patil S. Reply to S. Stenning et al and J. Lipshitz. Journal of Clinical Oncology 2011:4211-4212.

Bosl GJB, Patil SM. Carboplatin in clinical stage I seminoma: too much and too little at the same time. Journal of Clinical Oncology 2011;29:949-952.

Bott M, Brevet M, Taylor BS, Shimizu S, Ito T, Wang L, Creaney J, Lake RA, Zakowski MF, Reva B, Sander C, Delsite R, Powell S, Zhou Q, Shen R, Olshen A, Rusch V, Ladanyi M. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nature Genetics 2011;43:668-672.

Brader P, Abramson SJ, Price AP, Ishill NM, Zabor EC, Moskowitz CS, La Quaglia MP, Ginsberg MS. Do characteristics of pulmonary nodules on computed tomography in children with known osteosarcoma help distinguish whether the nodules are malignant or benign? Journal of Pediatric Surgery 2011;46:729-735.

Brogi E, Murphy CG, Johnson ML, Conlin A, Hsu M, Patil S, Akram M, NehhozinaT, Jhaveri KL, Hudis CA, Seidman AD.  Breast carcinoma with brain metastases: clinical analysis and immunoprofile on tissue microarrays. Annals of Oncology 2011;22:2597-2603.

Brooks JD, Boice JD, Jr, Stovall M, Reiner AS, Bernstein L, John EM, Lynch CF, Mellemkjær L, Knight JA, Thomas DC, Haile RW, Smith SA, Capanu M, The WECARE Collaborative Group, Bernstein JL, Shore RE. Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in The WECARE Study. International Journal of Radiation Oncology, Biology, Physic 2011;(in press).

Brooks JD, John EM, Mellemkjaer L, Reiner AS, Malone KE, Lynch CF, Figueiredo JC, Haile RW, Shore RE; The WECARE Study Collaborative Group, Bernstein JL, Bernstein L. Body mass index and risk of second primary breast cancer: The WECARE Study. Breast Cancer Research and Treatment 2012;131:571-580.

Brooks JD, Teraoka SN, Reiner AS, Satagopan JM, Bernstein L, Thomas DC, Capanu M, Stovall M, Smith SA, Wei S, Shore RE, Boice, Jr. JD, Lynch CF, Mellemkjær L, Malone KE, Liang X, the WECARE Study Collaborative Group, Haile RW, Concannon P, Bernstein JL. Variants in activators and downstream targets of ATM, radiation exposure and contralateral breast cancer risk in the WECARE study. Human Mutation 2012;33:158-164.

Bruner DW, Hanisch LJ, Trotti A, Reeve BB, Schrag D, Sit L, Minasian L, O’Mara A, Denicoff A, Rowland J, Montello M, Geoghegan C, Abernethy A, Clauser S, Castro K, Mitchell S, Burke L, Trentacosti AM, Basch E. Stakeholder perspectives on implementing the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Translational Behavioral Medicine 2011;1:110-122.

Butte JM, Do RK, Shia J, Gönen M, D’Angelica MI, Getrajdman GI, Allen PJ, Fong Y, Dematteo RP, Klimstra DS, Jarnagin WR. Liver angiomyolipomas: A clinical, radiologic, and pathologic analysis of 22 patients from a single center. Surgery 2011;150:557-567.

Butte JM, Gönen M, Allen PJ, D’Angelica MI, Kingham TP, Fong Y, Dematteo RP, Blumgart L, Jarnagin WR. The role of laparoscopic staging in patients with incidental gallbladder cancer. HPB: the office journal of the International Hepato Pancreato Biliary Association 2011;13:463-472.

Butte JM, Matsuo K, Gönen M, D’Angelica MI, Waugh E, Allen PJ, Fong Y, DeMatteo RP, Blumgart L, Endo I, De La Fuente H, Jarnagin WR. Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. Journal of the American College of Surgeons 2011;212:50-61.

Bylund CL, Goytia EJ, D’Agostino TA, Bulone L, Horner J, Li Y, Kemeny M, Ostroff JS. Evaluation of a pilot communication skills training intervention for minority cancer patients. Journal of Psychosocial Oncology 2011;29:347-358.

Cahlon O, Brennan MF, Jia X, Qin LX, Singer S, Alektiar KM. A postoperative nomogram for local recurrence risk in extremity soft tissue sarcomas after limb-sparing surgery without adjuvant radiation. Annals of Surgery 2012;255:343-347.

Capanu M, Begg CB. Hierarchical modeling for estimating relative risks of rare genetic variants: properties of the pseudo-likelihood method. Biometrics 2011;67:371-380.

Capanu M, Concannon P, Haile RW, Bernstein L, Malone KE, Lynch CF, Liang X, Teraoka SN, Diep AT, Thomas DC, Bernstein JL, The WECARE Study Collaborative Group, Begg CB. Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling. Genetic Epidemiology 2011;35:389-397.

Carrasquillo JA, Pandit-Taskar N, O’Donoghue JA, Humm JL, Zanzonico P, Smith-Jones P, Divgi CR, Pryma D, Ruan S, Kemeny NE, Fong Y, Wong D, Jaggi JS, Scheinberg D, Gonen M, Panageas KS, Ritter G, Jungbluth A, Old LJ, Larson SM. I-124 huA33 antibody PET imaging of colorectal cancer. Journal of Nuclear Medicine 2011;52:1173-1180.

Carrier ER, Schneider E, Pham HH, Bach PB. Association between quality of care and the socio-demographic composition of physicians’ patient panels: a repeat cross-sectional analysis. Journal of General Internal Medicine 2011;26:987-994.

Carvajal RD, Antonescu CR, Wolchok JD, Chapman PB, Roman RA, Teitcher J, Panageas KS, Busam KJ, Chmielowski B, Lutzky J, Pavlick AC, Fusco A, Cane L, Takebe N, Vemula S, Bouvier N, Bastian BC, Schwartz GK. KIT as a therapeutic target in metastatic melanoma. Journal of the American Medical Association 2011;305:2327-2334.

Cassileth BR, Van Zee KJ, Chan Y, Coleton MI, Hudis CA, Cohen S, Lozada J, Vickers AJ. A safety and efficacy pilot study of acupuncture for the treatment of chronic lymphoedema. Acupuncture in Medicine 2011;29:170-172.

Chaft JE, Arcila ME, Paik PK, Lau C, Riely GJ, Pietanza MC, Zakowski MF, Rusch VW, Sima CS, Ladanyi M, Kris MG. Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma - rationale for comprehensive mutation profiling. Molecular Cancer Theraputics 2012;[epub ahead of print].

Chaft JE, Oxnard GR, Sima CS, Kris MG, Miller VA, Riely GJ. Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to erlotinib or gefitinib: implications for clinical trial design. Clinical Cancer Research 2011;17:6298-6303.

Chan AT, Hsu M, Zauber AG, Hawk ET, Bertagnolli MM. The influence of UGT1A6 variants and aspirin use in a randomized trial of celeboxib for prevention of colorectal adenoma. Cancer Prevention Research 2012;5:61-72.

Chan AT, Sima CS, Zauber AG, Ridker PM, Hawk ET, Bertagnolli MM. C-reactive protein and risk of colorectal adenoma according to celecoxib treatment. Cancer Prevention Research 2011;4:1172-1180.

Chandran U, Bandera EV, Williams-King MG, Paddock L, Rodriguez-Rodriguez L, Lu S-E, Faulkner S, Pulick K, Olson SH. Adherence to the dietary guidelines for Americans and ovarian cancer risk. Cancer Causes Control 2011;22:563-571.

Chen J, Guo T, Zhang L, Qin LX, Singer S, Maki RG, Taguchi T, Dematteo R, Besmer P, Antonescu CR. CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers. Genes Chromosomes & Cancer 2012;51:186-195.

Chen L-S, Saccone NL, Culverhouse RC, Bracci PM, Chen C-H, Dueker N, Han Y, Huang H, Jin G, Kohno T, Ma JZ, Przybeck TR, Sanders AR, Smith JA, Sung YJ, Wenzlaff AS, Wu C, Yoon D, Bergen AW, Chen Y-T, Cheng Y-C, Cho YS, David SP, Duan J, Eaton C, Furberg H, Goate AM, Gu D, Hansen HM, Hartz S, Hu Z, Kim YJ, Kittner SJ, Levinson DF, Mosley TH, Payne TJ, Rao DC, Rice JP, TK, Schwantes-An T-H, Shete SS, Shi J, Spitz MR, Sun YV, Tsai F-J, Wang JC, Wrensch MR, Xian H, Gejman PV, He J, Hunt SC, Kardia SL, Li MD, Lin D, Mitchell BD, Park T, Schwartz AG, Shen H, Wiencke JK, Wu J-Y, Yokota J, Amos CI, Bierut LJ. Smoking and genetic risk variation across populations of European, Asian and African-American Ancestry - A meta-analysis of chromosome 15q25. Genetic Epidemiology 2011;(in press).

Chmielecki J, Pietanza MC, Aftab D, Shen R, Zhao Z, Chen X, Hutchinson K, Viale A, Kris MG, Stout T, Miller V, Rizvi N, Pao W. EGFR-mutant lung adenocarcinomas treated first-line with the novel EGFR inhibitor, XL647, can subsequently retain moderate sensitivity to erlotinib. Journal of Thoracic Oncology 2012;7:434-442.

Chou JF, Kernan NA, Prockop S, Heller G, Scaradavou A, Kobos R, Knowles MA, Papadopoulos EB, Casson A, Copeland C, Torok-Castanza J, Zakak N, Ruggiero J, Small TN. Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T Cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT). Biology of Blood and Marrow Transplantation 2011;17:1708-1713.

Chung K, Hovanessian-Larsen LJ, Hawes D, Taylor D, Downey S, Spicer DV, Stanczyk FZ, Patel S, Anderson AR, Pike MC, Wu AH, Pearce CL. Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation. Breast Cancer Research and Treatment 2011;[epub ahead of print].

Correa D, Shi W, Abrey L, DeAngelis L, Omuro A, Deutsch M, Thaler HT. Cognitive functions in primary CNS lymphoma after single or combined modality regimens. Neuro-Oncology 2011;14:101-108.

Crago AM, Socci ND, DeCarolis P, O’Connor R, Taylor BS, Qin LX, Antonescu CR, Singer S. Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability. Clinical Cancer Research 2012; [epub ahead of print].

Damast S, Wright J, Bilsky M, Hsu M, Zhang Z, Lovelock M, Cox B, Zatcky J, Yamada Y. Impact of dose on local failure rates after image-guided reirradiation of recurrent paraspinal metastases. International Journal of Radiation Oncology, Biology, Physics 2011;81:819-826.

D’Angelica M, Ammori J, Gönen M, Klimstra DS, Low PS, Murphy L, Weiser MR, Paty PB, Fong Y, Dematteo RP, Allen P, Jarnagin WR, Shia J. Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance. Modern Pathology 2011;24:1221-1228.

D’Angelica M, Kornprat P, Gonen M, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases. Annals of Surgical Oncology 2011;18:1096-1103.

D’Angelo SP, Pietanza MC, Johnson ML, Riely GJ, Miller VA, Sima CS, Zakowski MF, Rusch VW, Ladanyi M, Kris MG. Incidence of EGFR exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas. Journal of Clinical Oncology 2011;29:2066-2070.

Danila DC, Anand A, Sung CC, Heller G, Leversha MA, Cao L, Lilja H, Molina A, Sawyers CL, Fleisher M, Scher HI. TMPRSS2-ERG status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate. European Urology 2011;60:897-904.

Danise EJ, Furberg H, Afari N, Buchwald D, Edwards K, Goldberg J, Schur E, Sullivan PF. Conditions comorbid with chronic fatigue in a population-based sample. Psychosomatics 2012;53:44-50.

Davis-Dao C, Koh CJ, Hardy BE, Chang A, Kim SS, De Filippo R, Hwang A, Pike MC, Carroll JD, Coetzee GA, Vandenberg D, Siegmund K, Cortessis VK. Shorter androgen receptor CAG repeat lengths associated with cryptorchidism risk among Hispanic white boys. Journal of Clinical Endocrinology & Metabolism 2011;[epub ahead of print].

Davis-Dao CA, Henderson KD, Sullivan-Halley J, Ma H, West D, Xiang YB, Gago-Dominguez M, Stern MC, Castelao JE, Conti DV, Pike MC, Bernstein L, Cortessis VK. Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiology. Cancer Epidemiology Biomarkers and Prevention 2011;20:1156-1170.

Davis-Dao CA, Siegmund KD, Vandenberg DJ, Skinner EC, Coetzee GA, Thomas DC, Pike MC, Cortessis VK. Heterogeneous effect of androgen receptor CAG tract length on testicular germ cell tumor risk: shorter repeats associated with seminoma but not other histologic types. Carcinogenesis 2011;32:1238-1243.

de Gonzalez AB, Kim KP, Landsdorp-Vogelaar I, Rutter CM, Smith-Bindman R, Yee J, Kuntz KM, van Ballegooijen M, Zauber AG, Berg CD. Radiation-related cancer risks from CT colonography screening: a risk-benefit analysis. American Journal of Roentgenology 2011;196:816-823.

Deng G, Kurtz RC, Vickers A, Lau N, Yeung KS, Shia J, Cassileth B. A single arm phase II study of a Far-Eastern traditional herbal formulation (sho-sai-ko-to or xiao-chai-hu-tang) in chronic hepatitis C patients. Journal of Ethnopharmacology 2011;136:83-87.

Deodhar A, Dickfeld T, Single GW, Hamilton WC Jr, Thornton RH, Sofocleous CT, Maybody, Gönen M, Rubinsky B, Solomon SB. Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization. AJR American Journal of Roentgenology 2011;196:W330-335.

Devlin SM, Thomas E, Emerson SS. Robustness of approaches to ROC curve modeling under misspecification of the underlying probability model. Communications in Statistics - Theory and Methods 2011; (in press).

Dickson MA, Carvajal RD, Merrill AH, Gönen M, Cane LM, Schwartz GK. A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors. Clinical Cancer Research 2011;17:2484-2492.

DuHamel K, Li Y, Rakowski W, Samimi P, Jandorf L. Validity of the process of change for colorectal cancer screening among African Americans. Psychological Assessment. Annals of Behavioral Medicine 2011;41:271-283.

Dusza SW, Halpern AC, Satagopan JM, Oliveria SA, Weinstock MA, Scope A, Berwick M, Geller AC. Prospective study of sunburn and sun behavior patterns during adolescence. Pediatrics 2012;129:309-317.

Dworkin RH, Turk DC, Basch E, Berger A, Cleeland C, Farrar JT, Haythornthwaite JA, Jensen MP, Kerns RD, Markman J, Porter L, Raja SN, Ross E, Todd K, Wallace M, Woolf CJ. Considerations for extrapolating evidence of acute and chronic pain analgesic efficacy. Pain 2011;152:1705-1708.

Edwards-Bennett SM, Jacks LM, McCormick B, Zhang Z, Azu M, Ho A, Powell S, Brown C. Patterns of utilization of adjuvant radiation therapy and outcomes in black women after breast conservation at a large multidisciplinary cancer center. International Journal of Radiation Oncology, Biology, Physics 2011;80:1102-1108.

Ehdaie B, Atoria CL, Gupta A, Feifer A, Lowrance WT, Morris MJ, Scardino PT, Eastham JA, Elkin EB. Androgen deprivation and thromboembolic events in men with prostate cancer. Cancer 2011;[epub ahead of print].

Elkin EB, Klem ML, Gonzales AM, Ishill NM, Hodgson D, Ng AK, Marks LB, Weidhaas J, Freedman GM, Miller RC, Constine LS, Myrehaug S, Yahalom J. Characteristics and outcomes of breast cancer in women with and without a history of radiation for hodgkin’s lymphoma: a multi-institutional, matched cohort study. Journal of Clinical Oncology 2011;29:2466-2473.

Elkin EB, Marshall DA, Kulin NA, Ferrusi IL, Hassett MJ, Ladabaum U, Phillips KA. Economic evaluation of targeted cancer interventions: critical review and recommendations. Genetic Medicine 2011;13:853-860.

Elkin EB, Snow JG, Leoce NM, Atoria CL, Schrag D. Mammography capacity and appointment wait times: Barriers to breast cancer screening. Cancer Causes Control 2012;23:45-50.

Elston RC, Satagopan JM, Sun S. Statistical Human Genetics: Methods and Protocols (Methods in Molecular Biology). Springer, New York 2012 edition (February 29, 2012).

Epstein AS, Soff GA, Capanu M, Crosbie C, Shah MA, Kelsen DP, Denton B, Gardos S, O’Reilly EM. Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer. Cancer 2011;[epub ahead of print].

Etzel CJ, Bach PB. Estimating individual risk for lung cancer. Seminars in Respiratory and Critical Care Medicine 2011;32:3-9.

Fang F, Turcan S, Rimner A, Kaufman A, Giri D, Morris LG, Shen R, Seshan V, Mo Q, Heguy A, Baylin SB, Ahuja N, Viale A, Massague J, Norton L, Vahdat LT, Moynahan ME, Chan TA. Breast cancer methylomes establish an epigenomic foundation for metastasis. Science Translational Medicine 2011;3:75ra25.

Feifer AH, Elkin EB, Lowrance WT, Denton B, Jacks L, Yee DS, Coleman JA, Laudone VP, Scardino PT, Eastham JA. Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy. Cancer 2011;117:3933-3942.

Feldman DR, Patil S, Trinos MJ, Carousso M, Ginsberg MS, Sheinfeld J, Bajorin DF, Bosl GJ, Motzer RJ. Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial design. Cancer 2012;118:981-986.

Fields RC, Busam KJ, Chou JF, Panageas KS, Pulitzer MP, Allen PJ, Kraus DH, Brady MS, Coit DG. 500 Patients with merkel cell carcinoma evaluated at a single institution. Annals of Surgery 2011;254:465-473; discussion 473-475.

Fields RC, Busam KJ, Chou JF, Panageas KS, Pulitzer MP, Allen PJ, Kraus DH, Brady MS, Coit DG. Recurrence after complete resection and selective use of adjuvant therapy for stage 1-3 Merkel cell carcinoma. Cancer 2011;[epub ahead of print].

Fields RC, Hameed M, Qin LX, Moraco N, Jia X, Maki RG, Singer S, Brennan MF. Dermatofibrosarcoma protuberans (DFSP): predictors of recurrence and the use of systemic therapy. Annals of Surgical Oncology 2011;18:328-336.

Fields RC, Strong VE, Gönen M, Goodman KA, Rizk NP, Kelsen DP, Ilson DH, Tang LH, Brennan MF, Coit DG, Shah MA. Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma. British Journal of Cancer 2011;104:1840-1847.

Figueiredo JC, Brooks JD, Conti DV, Poynter JN, Teraoka SN, Malone KE, Bernstein L, Lee WD, Duggan DJ, Siniard A, Concannon P, Capanu  M, Lynch CF, Olsen JH, Haile RW, Bernstein JL. Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: Potential modifying effect of BRCA1/BRCA2 mutation carrier status. Breast Cancer Research and Treatment 2011;127:819-829.

Fox JJ, Autran-Blanc E, Morris MJ, Gavane S, Nehmeh S, Van Nuffel A, Gönen M, Schöder H, Humm JL, Scher HI, Larson SM. Practical approach for comparative analysis of multilesion molecular imaging using a semiautomated program for PET/CT. Journal of Nuclear Medicine 2011;52:1727-1732.

Fury MG, Baxi S, Shen R, Kelly KW, Lipson BL, Carlson D, Stambuk H, Haque S, Pfister DG. Phase II study of saracatinib (AZD0530) for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). Anticancer Research 2011;31:249-253.

Fury MG, Drobnjak M, Sima CS, Asher M, Shah J, Lee N, Carlson D, Wendel HG, Pfister DG. Tissue microarray evidence of association between p16 and phosphorylated eIF4E in tonsillar squamous cell carcinoma. Head Neck 2011;33:1340-1345.

Fury MG, Haque S, Stambuk H, Shen R, Carlson D, Pfister D. A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer. Cancer 2011;117:795-801.

Fury MG, Sherman E, Haque S, Korte S, Lisa D, Shen R, Wu N, Pfister D. A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumors. Cancer Chemotherapy Pharmacology 2011;[epub ahead of print].

Gajria D, Feigin K, Tan LK, Patil S, Geneus S, Theodoulou M, Norton L, Hudis CA, Traina TA. Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer. Cancer 2011;117:4125-4131.

Gajria D, Gonzalez J, Feigin K, Patil S, Chen C, Theodoulou M, Drullinsky P, D’Andrea G, Lake D, Norton L, Hudis CA, Traina TA. Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer. Breast Cancer Research and Treatment 2012;131:111-116.

Gallagher DJ, Al-Ahmadie H, Ostrovnaya I, Gerst SR, Regazzi A, Garcia-Grossman I, Riches J, Gounder SK, Flaherty AM, Trout A, Milowsky MI, Bajorin DF. Sunitinib in urothelial cancer: clinical, pharmacokinetic, and immunohistochemical study of predictors of response. European Urology 2011;60:344-349.

Gardner GJ, Baser R, Brady MF, Bristow RE, Markman M, Spriggs D, Thaler HT. CA125 regression in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy: a Gynecologic Oncology Group study. Gynecologic Oncology 2012;124:216-220.

Gaudet MM, Press MF, Haile RW, Lynch CF, Glaser SL, Schildkraut J, Gammon MD, Thompson WD, Bernstein JL. Risk factors by molecular subtypes of breast cancer among a population-based study of women 56 years or younger. Breast Cancer Research and Treatment 2011;130:587-597.

Gaujoux S, Brennan MF, Gönen M, D’Angelica MI, DeMatteo R, Fong Y, Schattner M, DiMaio C, Janakos M, Jarnagin WR, Allen PJ. Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period. Journal of American College of Surgeons 2011;212:590-600; discussion 600-603.

Gaujoux S, Tang L, Klimstra D, Gönen M, Brennan MF, D’Angelica M, Dematteo R, Fong Y, Jarnagin W, Allen PJ. The outcome of resected cystic pancreatic endocrine neoplasms: a case-matched analysis. Surgery 2011;[epub ahead of print].

Gerecitano J, Portlock C, Hamlin P, Moskowitz CH, Noy A, Straus D, Schulman P, Dumitrescu O, Sarasohn D, Pappanicholaou J, Iasonos A, Zhang Z, Mo Q, Horanlli E, Rojas CN, Zelenetz AD, O’Connor OA. Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphoma. Clinical Cancer Research 2011;17:2493-2501.

Gerst S, Hann LE, Li D, Gonen M, Tickoo S, Sohn MJ, Russo P. Evaluation of renal masses with contrast-enhanced ultrasound: initial experience. AJR American Journal of Roentgenology 2011;197:897-906.

Ghosh P, Nathoo F, Gönen M, Tiwari RC. Assessing noninferiority in a three-arm trial using the Bayesian approach. Statistics in Medicine 2011;30:1795-808.

Girard N, Sima CS, Jackman DM, Sequist LV, Chen H, Yang JC, Ji H, Waltman B, Rosell R, Taron M, Zakowski MF, Ladanyi M, Riely G, Pao W. Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma. European Respirator Journal 2012;39:366-372.

Gobble RM, Qin LX, Brill ER, Angeles CV, Ugras S, O’Connor RB, Moraco NH, Decarolis PL, Antonescu CR, Singer S. Expression profiling of liposarcoma yields a multigene predictor of patient outcome and identifies genes that contribute to liposarcomagenesis. Cancer Research 2011;71:2697-2705.

Goldberg JD, Chou JF, Horwitz S, Teruya-Feldstein J, Barker JN, Boulad F, Castro-Malaspina H, Giralt S, Jakubowski AA, Koehne G, van den Brink MR, Young JW, Zhang Z, Papadopoulos EB, Perales MA. Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplantation. Leukemia and Lymphoma 2012;[epub ahead of print].

Goldfarb S, Baron S, Lindau S. Female Sexuality Women and Health, Second Edition. Ed. Goldman M, Troisi R, and Rexrode K. NIH: 2011;(in press).

Goldfarb S, Carter J, Dickler M. Addressing sexual function after breast cancer therapy. Coping: September/October 2011.

Goldfarb S, Hudis C, Dickler M. Bevacizumab in metastatic breast cancer: when may it be used? Therapeutic Advances in Medical Oncology 2011;3:85-93.

Goldfarb S. The impact of breast cancer and its treatment on sexuality. Journal of Sexual Medicine 2011;(in press).

Goldfarb S.Venlafaxine and clonidine for treatment of hot flashes in women with breast cancer. Journal of Clinical Oncology podcast: September 12th, 2011.

Gollub MJ, Gultekin DH, Akin O, Do RK, Fuqua JL 3rd, Gönen M, Kuk D, Weiser M, Saltz L, Schrag D, Goodman K, Paty P, Guillem J, Nash GM, Temple L, Shia J, Schwartz LH. Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer. European Radiology 2011;[epub ahead of print].

Gönen M. Bayesian enrichment strategies for randomized discontinuation trials. Biometrics 2011;[epub ahead of print].

Gönen M. Bias, biostatistics, and prognostic factors. Journal of Thoracic Oncology 2011;6:Suppl 3:S1705-1709.

González SJ, Wong J, González L, Brader P, Zakowski M, Gönen M, Fong Y, Strong VE. Novel handheld PET probes provide intraoperative localization of PET-avid lymph nodes. Surgical Endoscopy 2011;25:3214-3221.

Goulart JM, Oliveria SA, Levitt J. Safety during dermatologic procedures and surgeries: a survey of resident injuries and prevention strategies. Journal of the American Academy of Dermatology 2011; 65:648-650.

Govindarajan A, Gönen M, Weiser MR, Shia J, Temple LK, Guillem JG, Paty PB, Nash GM. Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy. Journal of Clinical Oncology 2011;29:4568-4573.

Gucalp A, Sparano J, Caravelli J, Santamauro, Patil S, Abbruzzi A, Pelligrino C, Bromberg J, Dang C, Theodoulou M, Massague J, Norton L, Hudis CA, Traina TA. Phase II trial of saracatinib (AZD0530), an oral src-inhibitor for the treatment of patients with hormone receptor negative metastatic breast cancer. Clinical Breast Cancer 2011;11:306-311.

Guest RS, Baser R, Li Y, Scardino PT, Brown AE, Kissane DW. Cancer surgeons’ distress and well-being, I: the tension between a culture of productivity and the need for self-care. Annals of Surgical Oncology 2011;18:1229-1235.

Guest RS, Baser R, Li Y, Scardino PT, Brown AE, Kissane DW. Cancer surgeons’ distress and well-being, II: modifiable factors and the potential for organizational interventions. Annals of Surgical Oncology 2011;18:1236-1242.

Gupta A, Omuro AM, Shah AD, Graber JJ, Shi W, Zhang Z, Young RJ. Continuing the search for MR imaging biomarkers for MGMT promoter methylation status: conventional and perfusion MRI revisited. Neuro-radiology2011;[epub ahead of print].

Gupta A, Young RJ, Sood S, Karimi S, Zhang Z, Mo Q, Gutin PH, Holodny AI, Lassman AB. Isolated diffusion restriction precedes the development of enhancing tumor in a subset of patients with glioblastoma. American Journal of Neuroradiology 2011;32:1301-1306.

Haddad D, Chen NG, Zhang Q, Chen CH, Yu YA, Gonzalez L, Carpenter SG, Carson J, Au J, Mittra A, Gönen M, Zanzonico PB, Fong Y, Szalay AA. Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus. Journal of Translational Medicine 2011;9:36.

Haeno H, Gönen M, Davis MB, Herman JM, Iacobuzio-Donahue JA, Michor FM. Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell 2012;148:362-375.

Halpern NA, Pastores SM, Chou JF, Chawla S, Thaler HT. Advance directives in an oncologic intensive care unit: a contemporary analysis of their frequency, type, and impact. Journal of Palliative Medicine 2011;14:483-489.

Hambly NM, Gönen M, Gerst SR, Li D, Jia X, Mironov S, Sarasohn D, Fleming SE, Hann LE. Implementation of evidence-based guidelines for thyroid nodule biopsy: a model for establishment of practice standards. AJR American Journal of Roentgenology 2011;196:655-660.

Hanash AM, Kappel LW, Yim NL, Nejat RA, Goldberg GL, Smith OM, Rao UK, Dykstra L, Na IK, Holland AM, Dudakov JA, Liu C, Murphy GF, Leonard WJ, Heller G, van den Brink MR. Abrogation of donor T cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL. Blood 2011;118:446-455.

Hartz SM, Short S, Saccone NL, Culverhouse R, Chen LS, Schwantes-An T, Coon H, Han Y, Stephens SH, Sun J, Chen X,  Ducci F, Dueker N, Franceschini N, Frank J, Geller F, Guðbjartsson D, Hansel N, Jiang C, Keskitalo-Vuokko K, Liu J, Lyytikäinen L, Michel M, Rawal R, Rosenberger A, Scheet P, Shaffer JR, Teumer A, Thompson JR, Vink JM, Vogelzangs N, Wenzlaff A, Wheeler W, Xiangjun X, Yang BZ, Aggen SH, Balmforth A, Baumeister S, Beaty T, Bennett S, Bergen A, Boyd H, Broms U, Campbell H, Chatterjee N, Chen J, Cheng YC, Cichon S, Couper D, Cucca F, Dick D, Foroud T, Furberg H, Giegling I, Gu F, Hall AS, Hällfors J, Han S, Hartmann AM, Hayward C, Heikkilä K, Hewitt JK, Hottenga JJ, Jensen M, Jousilahti P, Kaakinen M, Kittner S, Konte B, Korhonen B, Landi MT, Laatikainen T, Leppert M, Levy SM, Mathias R, McNeil DW, Medland S, Montgomery G, Muley T, Murray T, Nauck M, North K, Pergadia M, Polasek O, Ramos E, Ripatti S, Risch A, Ruczinski I, Rudan I, Salomaa V, Schlessinger D, Styrkársdóttir U, Terracciano A, Uda M, Willemsen G, Wu X, Abecasis G, Barnes K, Bickeböller H, Boerwinkle E, Boomsma DI, Caporaso N, Duan J, Edenberg HJ, Francks C, Gejman PV, Gelernter J, Grabe HJ, Hops H, Jarvelin MR, Jorma V, Kähönen M, KendlerKS, Lehtimäki T, Levinson DF, Marazita ML, Marchini J, Melbye M, Mitchell B, Murray JC, Nöthen MM, Penninx BW, Raitakari O, Rietschel M, Rujescu D, Samani NJ, Sanders AR, Schwartz A Shete S, Shi J, Spitz M, Stefansson K, Swan G, Thorgeirsson T, Völzke H, Wei Q, Wichmann HE, Amos C, Breslau N, Cannon D, Ehringer M, Grucza R, Hatsukami D, Heath A, Johnson E, Kaprio J, Madden P, Martin NG, Stevens V, StitzelJA,  Weiss RB, Kraft P, Bierut LJ. Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers. Archives of General Psychiatry 2011;(in press).

Haas JS, Liang SY, Hassett MJ, Shiboski S, Elkin EB, Phillips KA. Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care. Breast Cancer Research and Treatment 2011;130:619-626.

Haas JS, Phillips KA, Liang SY, Hassett MJ, Keohane C, Elkin EB, Armstrong J, Toscano M. Genomic testing and therapies for breast cancer in clinical practice. American Journal of Managed Care 2011;17(5 Spec No):e174-181.

Haas JS, Phillips KA, Liang SY, Hassett MJ, Keohane C, Elkin EB, Armstrong J, Toscano M. Genomic testing and therapies for breast cancer in clinical practice. Journal of Oncology Practice 2011;7(3 Suppl):e1s-7s.

Hay J, Kaphingst KA, Baser R, Li Y, Hesley-Alford S, McBride CM. Skin cancer concerns and genetic risk information-seeking in primary care. Public Health Genomics 2012;15:57-72.

Heller G. A measure of explained risk in the proportional hazards model. Biostatistics 2011;[epub ahead of print].

Heller G. Proportional hazards regression with interval censored data using an inverse probability weight. Lifetime Data Analysis 2011;17:373-385.

Hensley ML, Kravetz S, Jia X, Iasonos A, Tew W, Pereira L, Sabbatini P, Whalen C, Aghajanian CA, Zarwan C, Berlin S. Eribulin mesylate (halichondrin B analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer: A 2-cohort, phase 2 study. Cancer 2011;[epub ahead of print].

Ho AY, Cordeiro P, Disa J, Mehrara B, Wright J, Van Zee KJ, Hudis C, McLane A, Chou JC, Zhang Z, Norton L, Powell S, McCormick B. Long-term outcomes in breast cancer patients undergoing immediate two-stage expander/implant reconstruction and postmastectomy radiation. Cancer 2011;[epub ahead of print].

Hottinger AF, Iwamoto FM, Karimi S, Riedel E, Dantis J, Park J, Panageas KS, Lassman, Abrey LE, Fleisher M, Holland EC, DeAngelis LM, Hormigo A. YKL-40 and MMP-9 as serum markers for patients with primary CNS lymphoma. Annals of Neurology 2011;70:163-169.

House MG, Kemeny NE, Gönen M, Fong Y, Allen PJ, Paty PB, Dematteo RP, Blumgart LH, Jarnagin WR, D’Angelica MI. Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer. Annals of Surgery 2011;254:851-856.

Hovanessian-Larsen L, Taylor D, Hawes D, Spicer DV, Press MF, Wu AH, Pike MC, Pearce CL. Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial. Contraception 2011;(in press).

Huguet F, Wu AJ, Zhang Z, Shi W, O’Reilly EM, Winston CB, Reidy DL, Ho AY, Allen P, Goodman KA. Chemotherapy and intensity-modulated radiation therapy for locally advanced pancreatic cancer achieves high rate of R0 resection and prolonged survival. Journal of Clinical Oncology 2011;[epub ahead of print].

Hwang S, Lefkowitz R, Landa J, Zheng J, Moskowitz CS, Maybody M, Hameed M, Panicek DM. Percutaneous CT-guided bone biopsy: diagnosis of malignancy in lesions with initially indeterminate biopsy results and CT features associated with diagnostic or indeterminate results. American Journal of Roentgenology 2011;197:1417-1425.

Hyman D, Zhou Q, Iasonos A, Grisham R, Arnold AG, Phillips MF, Bhatia J, Levine D, Aghajanian C, Barakta RR, Spriggs DR, Kauff ND. Improved survival for BRCA2, but not BRCA1, carriers with epithelial ovarian cancer. Cancer;(in press).

Hyman DM, Zhou Q, Arnold AG, Grisham RN, Iasonos A, Kauff ND, Spriggs D. Topotecan in patients with BRCA-associated and sporadic platinum-resistant ovarian, fallopian tube, and primary peritoneal cancers. Gynecologic Oncology 2011;123:196-199.

Iasonos A, O’Quigley J. Continual reassessment and related designs in dose finding studies. Statistics in Medicine 2011;30:2057-2061. Editorial.

Iasonos A, Ostrovnaya I. Estimating the dose-toxicity curve in completed phase I studies. Statistics in Medicine 2011;30:2117-2129.

Iasonos A, Sabbatini P, Spriggs DR, Aghajanian CA, O’Cearbhaill RE, Hensley ML, Thaler HT. Identifying clinical improvement in consolidation single-arm phase II trials in patients with ovarian cancer in second or greater clinical remission. International Journal of Gynecological Cancer 2012;22:63-69.

Iasonos A, Zohar S, O’Quigley J. Incorporating lower grade toxicity information into dose finding designs. Clinical Trials 2011;8:370-379.

Ilson DH, Kelsen D, Shah M, Schwartz G, Levine DA, Boyd J, Capanu M, Miron B, Klimstra D. A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagus. Cancer 2011;117:1409-1414.

Ilson DH, Minsky BD, Ku GY, Rusch V, Rizk N, Shah M, Kelsen DP, Capanu M, Tang L, Campbell J, Bains M. Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer. Cancer 2011;[epub ahead of print].

Ito H, Ito K, D’Angelica M, Gönen M, Klimstra D, Allen P, Dematteo RP, Fong Y, Blumgart LH, Jarnagin WR. Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment. Annals of Surgery 2011;254:320-325.

Ito K, Blinder V, Elkin E. Cost-effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer. Journal of Clinical Oncology. 2011;(in press).

Ito K, Ito H, Kemeny NE, Gönen M, Allen PJ, Paty PB, Fong Y, Dematteo RP, Blumgart LH, Jarnagin WR, D’Angelica MI. Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors. Annals of Surgical Oncology 2011;[epub ahead of print].

Iwamoto FM, Hottinger AF, Karimi S, Riedel E, Dantis J, Jahdi M, Panageas KS, Lassman AB, Abrey LE, Fleisher M, DeAngelis LM, Holland EC, Hormigo A. Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas. Neuro-Oncology 2011;13:1244-1251.

Iwamoto FM, Hottinger AF, Karimi S, Riedel E, Dantis J, Jahdi M, Panageas KS, Lassman AB, Abrey LE, Fleisher M, DeAngelis LM, Holland EC, Hormigo A. Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas. Journal of Neuro-Oncology 2011;105:607-612.

Jardines L, Goyal S, Fisher P, Weitzel J, Royce M, Goldfarb S. Breast Cancer Overview. Cancer Management: A Multidisciplinary Approach 14th Edition. UBM Medica 2011.

Jiang X, Castelao JE, Yuan JM, Stern MC, Conti DV, Cortessis VK, Pike MC, Gago-Dominguez M. Cigarette smoking and subtypes of bladder cancer. International Journal of Cancer 2012;130:896-901.

Johnson ML, Riely GJ, Rizvi NA, Azzoli CG, Kris MG, Sima CS, Ginsberg MS, Pao W, Miller VA. Phase II trial of dasatinib for patients with acquired resistance to treatment with the epidermal growth factor receptor tyrosine kinase inhibitors erlotinib or gefitinib. Journal of Thoracic Oncology 2011;6:1128-1131.

Jones AM, Beggs AD, Carvajal-Carmona L, Farrington S, Tenesa A, Walker M, Howarth K, Ballereau S, Hodgson SV, Zauber AG, Bertagnolli M, Midgley R, Campbell H, Kerr D, Dunlop MG, Tomlinson IP. TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres. Gut 2012;61:248-254.

Kadota K, Suzuki K, Colovos C, Sima CS, Rusch VW, Travis WD, Adusumilli PS. A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma. Modern Pathology 2012;25:260-271.

Kadota K, Suzuki K, Sima CS, Rusch VW, Adusumilli PS, Travis WD. Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma. Journal of Thoracic Oncology 2011;6:896-904.

Kalinsky K, Heguy A, Bhanot U, Patil S, Moynahan ME. PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression. Breast Cancer Research and Treatment 2011;129:635-643.

Karakousis GC, Singer S, Zheng J, Gönen M, Coit D, Dematteo RP, Strong VE. Laparoscopic versus open gastric resections for primary gastrointestinal stromal tumors (GISTs): a size-matched comparison. Annals of Surgical Oncology 2011;18:1599-1605.

Karanicolas PJ, Elkin EB, Jacks LM, Atoria CL, Strong VE, Brennan MF, Coit DG. Staging laparoscopy in the management of gastric cancer: a population-based analysis. Journal of the American College of Surgeons 2011;213:644-651.

Kemeny NE, Jarnagin WR, Capanu M, Fong Y, Gewirtz AN, Dematteo RP, D’Angelica MI. Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer. Journal of Clinical Oncology 2011;29:884-889.

Kemeny NE, Schwartz L, Gönen M, Yopp A, Gultekin D, D’Angelica MI, Fong Y, Haviland D, Gewirtz AN, Allen P, Jarnagin WR. Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results? Oncology 2011;80:153-159.

Kiess AP, McArthur HL, Mahoney K, Patil S, Morris PG, Ho A, Hudis CA, McCormick B. Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer. Cancer 2011;[epub ahead of print].

Kim SK, Wu X, Ragupathi G, Gathuru J, Koide F, Cheung NK, Panageas K, Livingston PO. Impact of minimal tumor burden on antibody response to vaccination. Cancer Immunology Immunotherapy 2011;60:621-627.

King TA, Gurevich I, Sakr R, Patil S, Stempel M, Morrow M. Occult malignancy in patients undergoing contralateral prophylactic mastectomy. Annals of Surgery 2011;254:2-7.

King TA, Sakr R, Patil S, Gurevich I, Stempel M, Sampson M, Morrow M. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. Journal of Clinical Oncology 2011;29:2158-2164.

King V, Brooks JD, Bernstein JL, Reiner AS, Pike MC, Morris EA. Background parenchymal enhancement on breast MRI and breast cancer risk. Radiology 2011;260:50-60.

Klein RJ, Hallden C, Gupta A, Savage CJ, Dahlin A, Bjartell A, Manjer J, Scardino PT, Ulmert D, Wallström P, Vickers AJ, Lilja H. Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men. European Urology 2012;61:471-477.

Kollmeier MA, Katz MS, Mak K, Yamada Y, Feder DJ, Zhang Z, Jia X, Shi W, Zelefsky MJ. Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiation therapy. International Journal of Radiation Oncology, Biology, Physics 2011;79:713-718.

Konner JA, Grabon DM, Gerst SR, Iasonos A, Thaler H, Pezzulli SD, Sabbatini PJ, Bell-McGuinn KM, Tew WP, Hensley ML, Spriggs DR, Aghajanian CA. A Phase II study of intraperitoneal paclitaxel plus cisplatin and intravenous paclitaxel plus bevacizumab as adjuvant treatment of optimal stage II/III epithelial ovarian cancer. Journal of Clinical Oncology 2011;29:4662-4668.

Koutcher L, Sherman E, Fury M, Wolden S, Zhang Z, Mo Q, Stewart L, Schupak K, Gelblum D, Wong R, Kraus D, Shah J, Zelefsky M, Pfister D, Lee N. Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics 2011;81:915-922.

Krug LM, Ragupathi G, Hood C, George C, Hong F, Shen R, Abrey L, Jennings HJ, Kris MG, Livingston PO. Immunization with N-propionyl polysialic acid-KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci. Cancer Immunology and Immunotherapy 2011;61:9-18.

Kuntz KM, Lansdorp-Vogelaar I, Rutter CM, Knudsen AB, van Ballegooijen M, Savarino JE, Feuer EJ, Zauber AG. A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression. Medical Decision Making 2011;31:530-539.

Ladabaum U, Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, Ford J, Elkin E, Phillips KA. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Annals of Internal Medicine 2011;155:69-79.

Lampen-Sachar K, Zhao B, Zheng J, Moskowitz CS, Schwartz LH, Zakowski MF, Rizvi NA, Kris MG, Ginsberg MS. Correlation between tumor measurement on computed tomography and resected specimen size in lung adenocarcinomas. Lung Cancer 2012;75:332-335.

Lassman AB, Iwamoto FM, Cloughesy TF, Aldape KD, Rivera AL, Eichler AF, Louis DN, Paleologos NA, Fisher BJ, Ashby LS, Cairncross JG, Roldán GB, Wen PY, Ligon KL, Schiff D, Robins HI, Rocque BG, Chamberlain MC, Mason WP, Weaver SA, Green RM, Kamar FG, Abrey LE, DeAngelis LM, Jhanwar SC, Rosenblum MK, Panageas KS. International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. Neuro-Oncology 2011;13:649-659.

Lee JC, Hayman E, Pegram HJ, Santos E, Heller G, Sadelain M, Brentjens R. In vivo inhibition of human CD19-targeted effector T cells by natural T regulatory cells in a xenotransplant murine model of B cell malignancy. Cancer Research 2011;71:2871-2881.

Li Y, Baser R. Using R and WinBUGS to fit a generalized partial credit model for developing and evaluating patient-reported outcomes assessments. Statistics in Medicine 2011;(in press).

Li Y, Schwartz C. Data mining for response shift patterns in multiple sclerosis patients using recursive partitioning tree analysis. Quality of Life Research 2011;20:1543-1553.

Lilja H, Cronin AM, Dahlin A, Manjer J, Nilsson PM, Eastham JA, Bjartell AS, Scardino PT, Ulmert D, Vickers AJ. Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50. Cancer 2011;117:1210-1219.

Lindau S, Sandbo S, Goldfarb S, Dickler M. Sexuality, Breast Cancer and Aging: A Multidisciplinary and Life Course Perspective. Cancer and Sexuality. Ed. Mulhall JP, Goldstein I, Incrocci L, Rosen R. Springer 2011.

Lipitz-Snyderman A, Needham DM, Colantuoni E, Goeschel CA, Marsteller JA, Thompson DA, Berenholtz SM, Lubomski LH, Watson S, Pronovost PJ.  How long can intensive care units maintain zero central line-associated bloodstream infections?  Archives of Internal Medicine 2011;171:856-858.

Lipitz-Snyderman A, Steinwachs D, Needham DM, Colantuoni E, Morlock LL, Pronovost PJ.  Impact of a statewide intensive care unit quality improvement initiative on hospital mortality and length of stay. BMJ 2011; 2-11; 342:d219.

Liu L, Zhang J, Wu AH, Pike MC, Deapen D. Invasive breast cancer incidence trends by detailed race/ethnicity and age. International Journal of Cancer 2012;130:395-404.

Lok BH, Khan S, Mutter R, Liu J, Fields R, Pulitzer M, Shi W, Zhang Z, Kraus D, Pfister D, Busam KJ, Brownell I, Lee N. Selective radiotherapy for the treatment of head and neck Merkel cell carcinoma. Cancer 2011;[epub ahead of print].

Lok BH, Setton J, Caria N, Romanyshyn J, Wolden SL, Zelefsky MJ, Park J, Rowan N, Sherman EJ, Fury MG, Ho A, Pfister DG, Wong RJ, Shah JP, Kraus DH, Zhang Z, Schupak KD, Gelblum DY, Rao SD, Lee NY. Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes. International Journal of Radiation Oncology, Biology, Physics 2011;[epub ahead of print].

Lowrance WT, Eastham JA, Yee DS, Laudone VP, Denton B, Scardino PT, Elkin EB. Costs of medical care after open or minimally invasive prostate cancer surgery: a population-based analysis. Cancer 2011;[epub ahead of print].

Lowrance WT, Elkin EB, Yee DS, Feifer A, Ehdaie B, Jacks LM, Atoria CL, Zelefsky MJ, Scher HI, Scardino PT, Eastham JA. Locally advanced prostate cancer: a population-based study of treatment patterns. BJU Internation 2011;[epub ahead of print].

Ludwig E, Olson SH, Bayuga S, Simon J, Schattner MA, Gerdes H, Allen PJ, Jarnagin WR, Kurtz RC. Feasibility and yield of screening in relatives from familial pancreatic cancer families. American Journal of Gastroenterology 2011;106:946-954.

Lurie G, Gaudet MM, Spurdle AB, Carney ME, Wilkens LR, Yang HP, Weiss NS, Webb PM, Thompson PJ, Terada K, Setiawan VW, Rebbeck TR, Prescott J, Orlow I, O’Mara T, Olson SH, Narod SA, Matsuno RK, Lissowska J, Liang X, Levine DA, LeMarchand L, Kolonel LN, Henderson BR, Garcia-Closas M, Doherty JA, De Vivo I, Chen C, Brinton LA, Akbari MR, Australian National Endometrial Cancer Study Group, Australian National Endometrial Cancer Study Group, Goodman MT. The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women. PLoS One 2011;8:6:e16756.

Lurie G, Wilkens LR, Thompson PJ, Shvetsov YB, Matsuno RK, Carney ME, Palmieri RT, Wu AH, Pike MC, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, Ramus SJ, Whittemore AS, McGuire V, Sieh W, Pharoah PD, Song H, Gronwald J, Jakubowska A, Cybulski C, Lubinski J, Schildkraut JM, Berchuck A, Krüger Kjær S, Høgdall E, Fasching PA, Beckmann MW, Ekici AB, Hein A, Chenevix-Trench G, Webb PM, Beesley J, Australian Ovarian Cancer Study Group, Australian Cancer Study Group, Goodman MT, Ovarian Cancer Association Consortium. Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium. PLoS One 2011;6:e20703.

Maithel SK, Gönen M, Ito H, Dematteo RP, Allen PJ, Fong Y, Blumgart LH, Jarnagin WR, D’Angelica MI. Improving the clinical risk score: An analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases. Surgery 2012;151:162-170.

Maker AV, Butte JM, Oxenberg J, Kuk D, Gönen M, Fong Y, Dematteo RP, D’Angelica MI, Allen PJ, Jarnagin WR. Is port site resection necessary in the surgical management of gallbladder cancer? Annals of Surgical Oncology 2012;19:409-417.

Maker AV, Katabi N, Qin LX, Klimstra DS, Schattner M, Brennan MF, Jarnagin WR, Allen PJ. Cyst fluid interleukin-1b levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas. Clinical Cancer Research 2011;17:1502-1508.

Mandelcorn-Monson R, Marrett L, Kricker L, Armstrong B, Orlow I, Goumas C,  Paine S , Stefano Rossof, Thomas N,  Millikan RC, Pole JD, Cotignola J, Rosen C, Kanetsky P, Lee-Taylor J, Begg CB, Berwick M. Sun exposure, vitamin D receptor polymorphisms FokI and BsmI and risk of multiple primary melanoma. Cancer Epidemiology 2011;35:e105-110.

Mankoo PK, Shen R, Schultz N, Levine DA, Sander C. Time to recurrence and survival in serous ovarian tumors predicted from integrated genomic profiles. PLoS One 2011;6:e24709.

Marotta LL, Almendro V, Marusyk A, Shipitsin M, Schemme J, Walker SR, Bloushtain-Qimron N, Kim JJ, Choudhury SA, Maruyama R, Wu Z, Gönen M, Mulvey LA, Bessarabova MO, Huh SJ, Silver SJ, Kim SY, Park SY, Lee HE, Anderson KS, Richardson AL, Nikolskaya T, Nikolsky Y, Liu XS, Root DE, Hahn WC, Frank DA, Polyak K. The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24- stem cell-like breast cancer cells in human tumors. Journal of Clinical Investigation 2011;121:2723-2735.

Marti JL, Dauer LT, Stempel M, Patil S, Kaplan JB, Montgomery LL. Cumulative imaging radiation exposure following breast-conservation therapy. Annals of Surgical Oncology 2011;18:104-108.

McArthur HL, Mahoney KM, Morris PG, Patil S, Jacks LM, Howard J, Norton L, Hudis CA. Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer. Cancer 2011;117:5461-5468.

McArthur HL, Rugo H, Nulsen B, Hawks L, Grothusen J, Melisko M, Moasser M, Paulson M, Traina T, Patil S, Zhou Q, Steingart R, Dang C, Morrow M, Cordeiro P, Fornier M, Park J, Seidman A, Lake D, Gilewski T, Theodoulou M, Modi S, D’Andrea G, Sklarin N, Robson M, Moynahan ME, Sugarman S, Sealey JE, Laragh JH, Merali C, Norton L, Hudis CA, Dickler MN. A feasibility study of bevacizumab plus dose-dense doxorubicin-cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancer. Clinical Cancer Research 2011;17:3398-3407.

McCormack V, Hung RJ, Brenner DR, Bickeböller H, Rosenberger A, Muscat JE, Lazarus P, Tjønneland A, Friis S, Christiani DC, Chun E-M, LeMarchand L, Rennert G, Rennert HS, Andrew AS, Orlow I, Park B, Boffetta P, Eric J Duell EJ. Aspirin and NSAID use in lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO). Cancer Causes Control 2011;22:1709-1720.

Medina OP, Pillarsetty N, Glekas A, Punzalan B, Longo V, Gönen M, Zanzonico P, Smith-Jones P, Larson SM. Optimizing tumor targeting of the lipophilic EGFR-binding radiotracer SKI 243 using a liposomal nanoparticle delivery system. Journal of Controlled Release 2011;149:292-298.

Meehan CP, Fuqua Iii JL 3rd, Reiner AS, Moskowitz CS, Schwartz LH, Panicek DM. Prognostic significance of adrenal gland morphology at CT in patients with three common malignancies. British Journal of Radiology 2011;[epub ahead of print].

Mirkin JN, Bach PB. Outcome-blinded peer review. Archive of Internal Medicine 2011;171:1213-1214;author reply 1214.

Mironov O, Ishill NM, Mironov S, Vargas HA, Zheng J, Moskowitz CS, Sonoda Y, Papas RS, Chi DS, Hricak H. Pleural effusion detected at CT prior to primary cytoreduction for Stage III or IV ovarian carcinoma: effect on survival. Radiology 2011;258:776-784.

Mo Q. A fully Bayesian hidden ising model for ChIP-seq data analysis. Biostatistics 2012;13:113-128.

Modi S, Stopeck A, Linden H, Solit D, Chandarlapaty S, Rosen N, D’Andrea G, Dickler M, Moynahan ME, Sugarman S, Ma W, Patil S, Norton L, Hannah AL, Hudis C. HSP90 inhibition is effective in breast cancer: a phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab. Clinical Cancer Research 2011;17:5132-5139.

Molina AM, Feldman DR, Voss MH, Ginsberg MS, Baum MS, Brocks DR, Fischer PM, Trinos MJ, Patil S, Motzer RJ. Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma. Cancer 2011;[epub ahead of print].

Molina AM, Tickoo SK, Ishill N, Trinos MJ, Schwartz LH, Patil S, Feldman DR, Reuter VE, Russo P, Motzer RJ. Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease. American Journal of Clinical Oncology 2011;34:454-459.

Moroz MA, Huang R, Kochetkov T, Shi W, Thaler H, de Stanchina E, Gamez I, Ryan RP, Blasberg RG. Comparison of corticotropin-releasing factor, dexamethasone, and temozolomide: treatment efficacy and toxicity in U87 and C6 intracranial gliomas. Clinical Cancer Research 2011;17:3282-3292.

Morris P, Murphy C, Mallam D, Accordino M, Patil S, Howard J, Omur A, Beal K, Seidman AD, Hudis CA, Fornier M. Limited overall survival in patients with brain metastases from triple negative breast cancer. The Breast Journal 2011;(in press).

Morris PG, Abrey LE, Reiner AS, Wu N, Panageas KS, Seko BS, DeAngelis LM, Omuro A. Methotrexate area under the curve as a prognostic factor in primary CNS lymphoma treated with immunochemoradiotherapy. Leukemia Lymphoma 2011;52:1891-1897.

Morris PG, Chen C, Steingart RM, Fleisher M, Lin NU, Moy B, Come S, Sugarman S, Abbruzzi A, Lehman R, Patil S, Dickler M, McArthur HL, Winer E, Norton L, Hudis CA, Dang CT. Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib. Clinical Cancer Research 2011;17:3490-3499.

Morris PG, Reiner AS, Szenberg OR, Clarke JL, Panageas KS, Perez HR, Kris MG, Chan TA, DeAngelis LM, Omuro AM. Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy. Journal of Thoracic Oncology 2011[epub ahead of print].

Morrogh M, Andrade VP, Giri D, Sakr RA, Paik W, Qin LX, Arroyo CD, Brogi E, Morrow M, King TA. Cadherin-catenin complex dissociation in lobular neoplasia of the breast. Breast Cancer Research and Treatment 2011;[epub ahead of print].

Morrogh M, Andrade VP, Patil AJ, Qin LX, Mo Q, Sakr R, Arroyo CD, Brogi E, Morrow M, King TA. Differentially expressed genes in window trials are influenced by the wound-healing process: lessons learned from a pilot study with anastrozole. Journal of Surgical Research 2011;[epub ahead of print].

Mosher CE, DuHamel KN, Lam J, Dickler M, Li Y, Massie MJ, Norton L. Randomized trial of expressive writing for distressed metastatic breast cancer patients. Psychology and Health 2011:1-13.

Moskowitz CS, Zabor EC, Jochelson M. Breast imaging: understanding how accuracy is measured when lesions are the unit of analysis. The Breast Journal 2011;(in press).

Movsas B, Vikram B, Hauer-Jensen M, Moulder J, Basch E, Brown SL, Kachnic LA, Dicker A, Coleman CN, Okunieff P. Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigators. Clinical Cancer Research 2011;17:222-228.

Mukherjee S, Simon J, Bayuga S, Ludwig E, Orlow I, Viale A, Offit K, Kurtz RC,Olson SH, Klein RJ. Shared controls to improve the power of genome wide association studies. Human Heredity 2011;72:21-34.

Murali R, Goumas C, Fromm L, Busam KJ, Begg CB, Dwyer T, Gruber SB, Kanetsky PA, Kricker A, Orlow I, Rosso S, Thomas NE, Berwick M, Scolyer RA, Armstrong BK for the GEM Study Group. Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomas. Annals of Surgical Oncology 2011;[epub ahead of print].

Murphy CG, Mallam D, Stein S, Patil S, Howard J, Sklarin N, Hudis CA, Gemignani ML, Seidman AD. Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer. Cancer 2011;[epub ahead of print].

Mutter RW, Singer S, Zhang Z, Brennan MF, Alektiar KM. The enigma of myxofibrosarcoma of the extremity. Cancer 2012;118:518-527.

Nash GM, Row D, Weiss A, Shia J, Guillem JG, Paty PB, Gonen M, Weiser MR, Temple LK, Fitzmaurice G, Wong WD. A predictive model for lymph node yield in colon cancer resection specimens. Annals of Surgery 2011;253:318-322.

Near AM, Wu AH, Templeman C, Van Den Berg DJ, Doherty JA, Rossing MA, Goode EL, Cunningham JM, Vierkant RA, Fridley BL, Chenevix-Trench G, Webb PM, Kjær SK, Hogdall E, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Schildkraut JM, Moorman PG, Palmieri RT, Ness RB, Moysich K, Cramer DW, Terry KL, Vitonis AF, Pike MC, Berchuck A, Pearce CL, Ovarian Cancer Association Consortium, Australian Cancer Study (Ovarian Cancer) (ACS), Australian Ovarian Cancer Study Group (AOCS). Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort. Fertility and Sterility 2011; 95:40-45.

Neuman HB, Patil S, Fuzesi S, Wong WD, Weiser MR, Guillem JG, Paty PB, Nash GM, Temple LK. Impact of a temporary stoma on the quality of life of rectal cancer patients undergoing treatment. Annals of Surgical Oncology 2011;18:1397-1403.

Notaridou M, Quaye L, Dafou D, Jones C, Song H, Høgdall E, Kjaer SK, Christensen L, Høgdall C, Blaakaer J, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Gentry-Maharaj A, Wozniak E, Sher T, Jacobs IJ, Tyrer J, Schildkraut JM, Moorman PG, Iversen ES, Jakubowska A, Mędrek K, Lubiński J, Ness RB, Moysich KB, Lurie G, Wilkens LR, Carney ME, Wang-Gohrke S, Doherty JA, Rossing MA, Beckmann MW, Thiel FC, Ekici AB, Chen X, Beesley J, Australian Ovarian Cancer Study Group/Australian Cancer Study (Ovarian Cancer), Gronwald J, Fasching PA, Chang-Claude J, Goodman MT, Chenevix-Trench G, Berchuck A, Pearce CL, Whittemore AS, Menon U, Pharoah PD, Gayther SA, Ramus SJ, Ovarian Cancer Association Consortium. Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. International Journal of Cancer 2011;128:2063-2074.

O’Brien MF, Cronin AM, Fearn PA, Savage CJ, Smith B, Stasi J, Scardino PT, Fisher G, Cuzick J, Møller H, Oliver RT, Berney DM, Foster CS, Eastham JA, Vickers AJ, Lilja H; on behalf of the Trans-Atlantic Prostate Group. Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively. International Journal of Cancer 2011;128:2373-2381.

Oliveria SA, Heneghan MK, Cushman LF, Ughetta EA, Halpern AC. Skin cancer screening by dermatologists, family practitioners, and internists: barriers and facilitating factors. Archives of Dermatology 2011;147:39-44.

Oliveria SA, Shuk E, Hay JL, Heneghan M, Goulart JM, Panageas K, Geller AC, Halpern AC. Melanoma survivors: health behaviors, surveillance, psychosocial factors, and family concerns. Psycho-oncology 2011;(in press).

Olson SH, Atoria CL, Cote ML, Cook LS, Rastogi R, Soslow RA, Brown CL, Elkin EB. The impact of race and comorbidity on survival in endometrial cancer. Cancer Epidemiology Biomarkers and Prevention 2011;(in press).

Olson SH, Layne TM, Simon JA, Ludwig E, O’Reilly E, Allen PJ, Kurtz RC. Studying cancer in minorities: a look at the numbers. Cancer 2011;117:2762-2769.

Olson SH. Medical conditions and risk of pancreatic cancer. Molecular Carcinogenesis 2011;(in press).

O’Quigley J, Iasonos A. Dose finding designs based on the continual reassessment method.  Handbook of Statistics in Clinical Oncology ed. by John Crowley, Маrcеl Dеkkеr 2011.

Orlow I, Roy P, Reiner AS, Yoo S, Patel H, Paine S, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Thomas NE, Gruber SB, Anton-Culver H, Rosso S, Gallagher RP, Dwyer T, Kanetsky PA, Busam K, From L, Begg CB, Berwick M; for the GEM Study Group. Vitamin D receptor polymorphisms in patients with cutaneous melanoma. International Journal of Cancer 2012;130:405-418.

Ostrovnaya I, Nicolae D. Estimating the proportion of true null hypotheses under dependence. Statistica Sinica 2011;(in press).

Ostrovnaya I, Seshan VE, Olshen AB, Begg CB. Clonality: an R package for testing clonal relatedness of two tumors from the same patient based on their genomic profiles. Bioinformatics 2011;27:1698-1699.

Oxnard GR, Arcila ME, Sima CS, Riely GJ, Chmielecki J, Kris MG, Pao W, Ladanyi M, Miller VA. Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutation. Clinical Cancer Research 2011;17:1616-1622.

Oxnard GR, Janjigian YY, Arcila ME, Sima CS, Kass SL, Riely GJ, Pao W, Kris MG, Ladanyi M, Azzoli CG, Miller VA. Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib. Clinical Cancer Research 2011;17:6322-6328.

Oxnard GR, Zhao B, Sima CS, Ginsberg MS, James LP, Lefkowitz RA, Guo P, Kris MG, Schwartz LH, Riely GJ. Variability of lung tumor measurements on repeat computed tomography scans taken within 15 minutes. Journal of Clinical Oncology 2011;29:3114-3119.

Paik PK, Arcila ME, Fara M, Sima CS, Miller VA, Kris MG, Ladanyi M, Riely GJ. Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations. Journal of Clinical Oncology 2011;29:2046-2051.

Paik PK, James LP, Riely GJ, Azzoli CG, Miller VA, Ng KK, Sima CS, Heelan RT, Kris MG, Moore E, Rizvi NA. A phase 2 study of weekly albumin-bound paclitaxel (Abraxane(®)) given as a two-hour infusion. Cancer Chemotherapy Pharmacology 2011;68:1331-1337.

Panageas KS, Iwamoto FM, Cloughesy TF, Aldape KD, Rivera AL, Eichler AF, Louis DN, Paleologos NA, Fisher BJ, Ashby LS, Cairncross JG, Roldán GB, Wen PY, Ligon KL, Schiff D, Robins HI, Rocque BG, Chamberlain MC, Mason WP, Weaver SA, Green RM, Kamar FG, Abrey LE, DeAngelis LM, Jhanwar SC, Rosenblum MK, Lassman AB. Oligodendroglioma: Initial treatment patterns over time. Neuro-Oncology 2011;(in press).

Panageas KS, Sima CS, Liberman L, Schrag D. Use of high technology imaging for surveillance of early stage breast cancer. Breast Cancer Research and Treatment 2011;131:663-670.

Park JH, Qiao B, Panageas KS, Schymura MJ, Jurcic JG, Rosenblat TL, Altman JK, Douer D, Rowe JM, Tallman MS. Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood 2011;118:1248-1254.

Patil S, Figlin RA, Hutson TE, Michaelson MD, Négrier S, Kim ST, Huang X, Motzer RJ. Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma. Annals of Oncology 2011;22:295-300.

Pearce CL, Doherty JA, Van Den Berg DJ, Moysich K, Hsu C, Cushing-Haugen KL, Conti DV, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Pharoah PD, Song H, Kjaer SK, Hogdall E, Hogdall C, Whittemore AS, McGuire V, Sieh W, Gronwald J, Medrek K, Jakubowska A, Lubinski J, Chenevix-Trench G, AOCS/ACS Study Group, Beesley J, Webb PM, Berchuck A, Schildkraut JM, Iversen ES, Moorman PG, Edlund CK, Stram DO, Pike MC, Ness RB, Rossing MA, Wu AH. Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk. Human Molecular Genetics 2011;20:2263-2272.

Pharoah PD, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, BCFR Investigators, Beattie MS, Beckmann MW, Birrer MJ, Bogdanova N, Bolton KL, Brewster W, Brooks-Wilson A, Brown R, Butzow R, Caldes T, Caligo MA, Campbell I, Chang-Claude J, Chen YA, Cook LS, Couch FJ, Cramer DW, Cunningham JM, Despierre E, Doherty JA, Dörk T, Dürst M, Eccles DM, Ekici AB, Easton D; EMBRACE Investigators, Fasching PA, de Fazio A, Fenstermacher DA, Flanagan JM, Fridley BL, Friedman E, Gao B, Sinilnikova O, GEMO Study Collaborators, Gentry-Maharaj A, Godwin AK, Goode EL, Goodman MT, Gross J, Hansen TV, Harnett P, Rookus M, HEBON Investigators, Heikkinen T, Hein R, Høgdall C, Høgdall E, Iversen ES, Jakubowska A, Johnatty SE, Karlan BY, Kauff ND, Kaye SB, Chenevix-Trench G, kConFab Investigators and the Consortium of Investigators of Modifiers of BRCA1/2, Kelemen LE, Kiemeney LA, Kjaer SK, Lambrechts D, Lapolla JP, Lázaro C, Le ND, Leminen A, Leunen K, Levine DA, Lu Y, Lundvall L, Macgregor S, Marees T, Massuger LF, McLaughlin JR, Menon U, Montagna M, Moysich KB, Narod SA, Nathanson KL, Nedergaard L, Ness RB, Nevanlinna H, Nickels S, Osorio A, Paul J, Pearce CL, Phelan CM, Pike MC, Radice P, Rossing MA, Schildkraut JM, Sellers TA, Singer CF, Song H, Stram DO, Sutphen R, Lindblom A, SWE-BRCA Investigators, Terry KL, Tsai YY, van Altena AM, Vergote I, Vierkant RA, Vitonis AF, Walsh C, Wang-Gohrke S, Wappenschmidt B, Wu AH, Ziogas A, Berchuck A, Risch HA, Ovarian Cancer Association Consortium. The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clinical Cancer Research 2011;17:3742-3750.

Ponce DM, Zheng J, Gonzales AM, Lubin M, Heller G, Castro-Malaspina H, Giralt S, Hsu K, Jakubowski AA, Jenq RR, Koehne G, Papadopoulos EB, Perales MA, van den Brink MR, Young JW, Boulad F, Kernan NA, Kobos R, Prockop S, Scaradavou A, Small T, O’Reilly RJ, Barker JN. Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation. Biology and Blood Marrow Transplantation 2011;17:1316-1326.

Qi J, Shukla-Dave A, Fong Y, Gönen M, Schwartz LH, Jarnagin WM, Koutcher JA, Zakian KL. (31) P MR spectroscopic imaging detects regenerative changes in human liver stimulated by portal vein embolization. Journal of Magnetic Resonance Imaging 2011;34:336-344.

Quintana MA, Bernstein JL, Thomas DC, Conti DV. Incorporating model uncertainty in detecting rare variants: the Bayesian Risk Index. Genetic Epidemiology 2011;35:638-649.

Raman T, Roistacher N, Liu J, Zhang H, Shi W, Thaler HT, Amar D. Preoperative left atrial dysfunction and risk of postoperative atrial fibrillation complicating thoracic surgery. Journal of Thoracic and Cardiovascular Surgery 2012;143:482-487.

Reiner AS, Jacks LM, Van Zee KJ, Panageas KS. A SEER-Medicare population-based study of lymphedema-related claims incidence following breast cancer in men. Breast Cancer Research and Treatment 2011;130:301-306.

Reinersman JM, Johnson ML, Riely GJ, Chitale DA, Nicastri AD, Soff GA, Schwartz AG, Sima CS, Ayalew G, Lau C, Zakowski MF, Rusch VW, Ladanyi M, Kris MG. Frequency of EGFR and KRAS mutations in lung adenocarcinomas in African Americans. Journal of Thoracic Oncology 2011;6:28-31.

Rekhtman N, Ang DC, Sima CS, Travis WD, Moreira AL. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens. Modern Pathology 2011;24:1348-1359.

Rizvi NA, Rusch V, Pao W, Chaft JE, Ladanyi M, Miller VA, Krug LM, Azzoli CG, Bains M, Downey R, Flores R, Park B, Singh B, Zakowski M, Heelan RT, Shen R, Kris MG. Molecular characteristics predict clinical outcomes: prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR gene. Clinical Cancer Research 2011;17:3500-3506.

Romano E, Rossi M, Ratzinger G, de Cos MA, Chung DJ, Panageas KS, Wolchock JD, Houghton AN, Chapman PB, Heller G, Yuan J, Young JW. Peptide-loaded Langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo. Clinical Cancer Research 2011;17:1984-1997.

Romanus D, Kindler HL, Archer L, Basch E, Niedzwiecki D, Weeks J, Schrag D; Cancer and Leukemia Group B. Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303). Journal of Pain and Symptom Management 2012;43:205-217.

Rosen A, Balagula Y, Goldfarb S, Lacouture M. Dermatologic adverse events during treatment. In Principles and Practice of Palliative Care and Supportive Oncology. 2011;(in press).

Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, Real FX, Van Den Berg D, Matullo G, Baris D, Thun M, Kiemeney LA, Vineis P, De Vivo I, Albanes D, Purdue MP, Rafnar T, Hildebrandt MA, Kiltie AE, Cussenot O, Golka K, Kumar R, Taylor JA, Mayordomo JI, Jacobs KB, Kogevinas M, Hutchinson A, Wang Z, Fu YP, Prokunina-Olsson L, Burdett L, Yeager M, Wheeler W, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole G Jr, Grubb R 3rd, Black A, Jacobs EJ, Diver WR, Gapstur SM, Weinstein SJ, Virtamo J, Cortessis VK, Gago-Dominguez M, Pike MC, Stern MC, Yuan JM, Hunter DJ, McGrath M, Dinney CP, Czerniak B, Chen M, Yang H, Vermeulen SH, Aben KK, Witjes JA, Makkinje RR, Sulem P, Besenbacher S, Stefansson K, Riboli E, Brennan P, Panico S, Navarro C, Allen NE, Bueno-de-Mesquita HB, Trichopoulos D, Caporaso N, Landi MT, Canzian F, Ljungberg B, Tjonneland A, Clavel-Chapelon F, Bishop DT, Teo MT, Knowles MA, Guarrera S, Polidoro S, Ricceri F, Sacerdote C, Allione A, Cancel-Tassin G, Selinski S, Hengstler JG, Dietrich H, Fletcher T, Rudnai P, Gurzau E, Koppova K, Bolick SC, Godfrey A, Xu Z, Sanz-Velez JI, D García-Prats M, Sanchez M, Valdivia G, Porru S, Benhamou S, Hoover RN, Fraumeni JF Jr, Silverman DT, Chanock SJ. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nature Genetics 2011;42:978-984.

Saltz L, Badarinath S, Dakhil S, Bienvenu B, Harker WG, Birchfield G, Tokaz LK, Barrera D, Conkling PR, O’Rourke MA, Richards DA, Reidy D, Solit D, Vakiani E, Capanu M, Scales A, Zhan F, Boehm KA, Asmar L, Cohn A. Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancer. Clinical Colorectal Cancer 2011;[epub ahead of print].

Salz T, Brewer NT. Direct-to-consumer genomewide profiling. [Letter] New England Journal of Medicine. 2011;364:2074.

Salz T, DeFrank JT, Brewer NT. False positive mammograms in Europe: do they affect reattendance? Breast Cancer Research and Treatment 2011;127:229-231.

Salz T, Oeffinger KC, McCabe MS, Layne TM, Bach PB. Survivorship care plans in research and practice. CA: A Cancer Journal for Clinicians 2012; [epub ahead of print].

Sandhu JS, Maschino AC, Vickers AJ. The surgical learning curve for artificial urinary sphincter procedures compared to typical surgeon experience. European Urology 2011;60:1285-1290.

Sarkaria IS, Bains MS, Sood S, Sima CS, Reuter VE, Flores RM, Motzer RJ, Bosl GJ, Rusch VW. Resection of primary mediastinal non-seminomatous germ cell tumors: a 28-year experience at Memorial Sloan Kettering Cancer Center. Journal of Thoracic Oncology 2011;6:1236-1241.

Sarkaria IS, Iyoda A, Roh MS, Sica G, Kuk D, Sima CS, Pietanza MC, Park BJ, Travis WD, Rusch VW. Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience. Annals of Thoracic Surgery 2011;92:1180-1186; discussion 1186-1187.

Satagopan JM, Zhou Q, Oliveria SA, Dusza SW, Weinstock MA, Berwick M, Halpern AC. Properties of preliminary test estimators and shrinkage estimators for evaluating multiple exposure – Application questionnaire data from the SONIC study. Journal of the Royal Statistical Society Series C, Applied Statistics 2011;60:619-632.

Sauter C, Abboud M, Jia X, Heller G, Gonzales AM, Lubin M, Hawke R, Perales MA, van den Brink MR, Giralt S, Papanicolaou G, Scaradavou A, Small TN, Barker JN. Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin. Biology of Blood and Marrow Transplantation 2011;17:1460-1471.

Schatz JH, Oricchio E, Wolfe AL, Jiang M, Linkov I, Maragulia J, Shi W, Zhang Z, Rajasekhar VK, Pagano NC, Porco JA Jr, Teruya-Feldstein J, Rosen N, Zelenetz AD, Pelletier J, Wendel HG. Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma. Journal of Experimental Medicine 2011;208:1799-1807.

Scher HI, Jia X, Chi K, de Wit R, Berry WR, Albers P, Henick B, Waterhouse D, Ruether DJ, Rosen PJ, Meluch AA, Nordquist LT, Venner PM, Heidenreich A, Chu L, Heller G. Randomized open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer. Journal of Clinical Oncology 2011;29:2191-2198.

Scher HI, Morris MJ, Basch E, Heller G. End points and outcomes in castration-resistant prostate cancer: from clinical trials to clinical practice. Journal of Clinical Oncology 2011;29:3695-3704.

Schwartz J, Humm JL, Gönen M, Kalaigian H, Schoder H, Larson SM, Nehmeh SA. Repeatability of SUV measurements in serial PET. Medical Physics 2011;38:2629-2638.

Schwartz LH, Panicek DM, Berk AR, Li Y, Hricak H. Improving communication of diagnostic radiology findings through structured reporting. Radiology 2011;260:174-181.

Scope A, Dusza SW, Marghoob AA, Satagopan JM, Braga C, Tavoloni J, Psaty EL, Weinstock MA, Oliveria SA, Bishop M, Geller AC, Halpern AC. Clinical and dermoscopic stability and volatility of melanocytic nevi in a population-based cohort of children in Framingham school system. Journal of Investigative Dermatology 2011;131:1615-1621.

Servais EL, Suzuki K, Colovos C, Rodriguez L, Sima C, Fleisher M, Rusch VW, Sadelain M, Adusumilli PS. An in vivo platform for tumor biomarker assessment. PLoS One 2011;6:e26722.

Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, Brinton LA, Cai H, Cerhan JR, Cozen W, Chen C, Doherty J, Freudenheim JL, Goodman MT, Hankinson SE, Lacey Jr. JV, Liang X, Lissowska J, Lu L, Lurie G, Mack T, Matsuno RK, McCann S, Moysich KB, Olson SH, Rastogi R, Rebbeck TR, Risch H, Robien K, Schairer C, Shu X, Spurdle AB, Strom BL, The Australian National Endometrial Cancer Study Group, Thompson PJ, Ursin G, Webb PM, Weiss N, Wentzensen N, Xiang Y, Yang HP, Yu H, Horn-Ross PL, De Vivo I. Age at last birth in relation to risk of endometrial cancer: Pooled analysis in the Epidemiology of Endometrial Cancer Consortium. American Journal of Epidemiology 2011;(in press).

Setton J, Caria N, Romanyshyn J, Koutcher L, Wolden SL, Zelefsky MJ, Rowan N, Sherman EJ, Fury MG, Pfister DG, Wong RJ, Shah JP, Kraus DH, Shi W, Zhang Z, Schupak KD, Gelblum DY, Rao SD, Lee NY. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan Kettering Cancer Center experience. International Journal of Radiation Oncology Biology Physics 2012; 82:291-298.

Shah MA, Jhawer M, Ilson DH, Lefkowitz RA, Robinson E, Capanu M, Kelsen DP. Phase II study of modified docetaxel, cisplatin, and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma. Journal of Clinical Oncology 2011;29:868-874.

Shah MA, Power DG, Kindler HL, Holen KD, Kemeny MM, Ilson DH, Tang L, Capanu M, Wright JJ, Kelsen DP. A multicenter, phase II study of Bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma. Investigational New Drugs 2011;29:1475-1481.

Shariat SF, Ehdaie B, Rink M, Cha EK, Svatek RS, Chromecki TF, Fajkovic H, Novara G, David SG, Daneshmand S, Fradet Y, Lotan Y, Sagalowsky AI, Clozel T, Bastian PJ, Kassouf W, Fritsche HM, Burger M, Izawa JI, Tilki D, Abdollah F, Chun FK, Sonpavde G, Karakiewicz PI, Scherr DS, Gönen M. Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. European Urology 2012;61:237-42.

Shariat SF, Savage C, Chromecki TF, Sun M, Scherr DS, Lee RK, Lughezzani G, Remzi M, Marberger MJ, Karakiewicz PI, Vickers AJ. Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive  bladder cancer and negative cytology: A decision-curve analysis. Cancer 2011;117:2892-2897.

Shariat SF, Semjonow A, Lilja H, Savage C, Vickers AJ, Bjartell A. Tumor markers in prostate cancer I: blood-based markers. Acta Oncologica 2011;50 Suppl 1:61-75.

Shete S, Lau CC, Houlston RS, Claus EB, Barnholtz-Sloan J, Lai R, Il’yasova D, Schildkraut J, Sadetzki S, Johansen C, Bernstein JL, Olson SH, Jenkins RB, Yang P, Vick NA, Wrensch M, Davis FG, McCarthy BJ, Leung EH, Davis C, Cheng R, Hosking FJ, Armstrong GN, Liu Y, Yu RK, Henriksson R, The Gliogene Consortium, Melin BS, Bondy ML. Genome-wide high-density SNP linkage search for glioma susceptibility loci-results from the Gliogene Consortium. Cancer Research 2011;71:7568-7575.

Shia J, Stadler Z, Weiser MR, Rentz M, Gonen M, Tang LH, Vakiani E, Katabi N, Xiong X, Markowitz AJ, Shike M, Guillem J, Klimstra DS. Immunohistochemical staining for DNA mismatch repair proteins in intestinal tract carcinoma: how reliable are biopsy samples? American Journal of Surgical Pathology 2011;35:447-454.

Shia J, Stadler Z, Weiser MR, Rentz M, Gönen M, Tang LH, Vakiani E, Katabi N, Xiong X, Markowitz AJ, Shike M, Guillem J, Klimstra DS. Immunohistochemical staining for DNA mismatch repair proteins in intestinal tract carcinoma: How reliable are biopsy samples? American Journal of Surgical Pathology 2011;35:447-454.

Shih KK, Qin LX, Tanner EJ, Zhou Q, Bisogna M, Dao F, Olvera N, Viale A, Barakat RR, Levine DA. A microRNA survival signature (MiSS) for advanced ovarian cancer. Gynecological Oncology 2011;121:444-450.

Shih KK, Zhou Q, Huh J, Morgan JC, Iasonos A, Aghajanian C, Chi DS, Barakat RR, Abu-Rustum NR. Risk factors for recurrence of ovarian borderline tumors. Gynecologic Oncology 2011;120:480-484.

Shike M, Schattner M, Genao A, Grant W, Burke M, Zauber A, Russo L, Cuyjet V. Expanding colorectal cancer screening among minority women. Cancer 2011;117:70-76.

Shukla-Dave A, Lee NY, Jansen JF, Thaler HT, Stambuk HE, Fury MG, Patel SG, Moreira AL, Sherman E, Karimi S, Wang Y, Kraus D, Shah JP, Pfister DG, Koutcher JA. Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head and neck squamous cell carcinoma patients with nodal metastases. International Journal of Radiation Oncology Biology Physics 2011;[epub ahead of print].

Sigel CS, Rudomina DE, Sima CS, Rekhtman N, Travis WD, Geisinger KR, Moreira AL. Predicting pulmonary adenocarcinoma outcome based on a cytology grading system. Cancer Cytopathology 2011;[epub ahead of print].

Silberstein JL, Vickers AJ, Power NE, Fine SW, Scardino PT, Eastham JA, Laudone VP. Reverse stage shift at a tertiary care center: escalating risk in men undergoing radical prostatectomy. Cancer 2011;117:4855-4860.

Silberstein JL, Vickers AJ, Power NE, Parra RO, Coleman JA, Pinochet R, Touijer KA, Scardino PT, Eastham JA, Laudone VP. Pelvic lymph node dissection for patients with elevated risk of lymph node invasion during radical prostatectomy: comparison of open, laparoscopic and robot-assisted procedures. Journal of Endourology 2011;[epub ahead of print].

Smyth EC, Hsu M, Panageas KS, Chapman PB. Histology and outcomes of newly detected lung lesions in melanoma patients. Annals of Oncology 2011;[epub ahead of print].

Sofocleous CT, May B, Petre EN, Gonen M, Thornton RH, Alago W, Rizk NP, Dupuy DE, Solomon SB. Pulmonary thermal ablation in patients with prior pneumonectomy. AJR American Journal of Roentgenology 2011;196:W606-612.

Sofocleous CT, Petre EN, Gonen M, Brown KT, Solomon SB, Covey AM, Alago W, Brody LA, Thornton RH, D’Angelica M, Fong Y, Kemeny NE. CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. Journal of Vascular and Interventional Radiology 2011;22:755-761.

Song TJ, Haddad D, Adusumilli P, Kim T, Stiles B, Hezel M, Socci ND, Gönen M, Fong Y. Molecular network pathways and functional analysis of tumor signatures associated with development of resistance to viral gene therapy. Cancer Gene Therapy 2012;19:38-48.

Stadler ZK, Salo-Mullen E, Patil SM, Pietanza MC, Vijai J, Saloustros E, Hansen NA, Kauff ND, Kurtz RC, Kelsen DP, Offit K, Robson ME. Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer. Cancer 2012;118:493-499.

Stadler ZK, Salo-Mullen E, Sabbaghian N, Simon JA, Zhang L, Olson SH, Kurtz R, Offit K, Foulkes WD, Robson ME, Tischkowitz M. Germline PALB2 mutation analysis in breast-pancreas cancer families. Journal of Medical Genetics 2011;48:523-525.

Steyerberg EW, Pencina MJ, Lingsma HF, Kattan MW, Vickers AJ, Van Calster B. Assessing the incremental value of diagnostic and prognostic markers: a review and illustration. European Journal of Clinical Investigation 2012;42:216-228.

Sun L, Song X, Zhang Z. Mean residual life models with time-dependent coefficients under right censoring. Biometrika 2011;[epub ahead of print].

Suzuki K, Kachala SS, Kadota K, Shen R, Mo Q, Beer DG, Rusch VW, Travis WD, Adusumilli PS. Prognostic immune markers in non-small cell lung cancer. Clinical Cancer Research 2011;17:5247-5256.

Suzuki K, Kadota K, Sima CS, Sadelain M, Rusch VW, Travis WD, Adusumilli PS. Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients. Cancer Immunology Immunotherapy 2011;60:1721-1728.

Suzuki K, Servais EL, Rizk NP, Solomon SB, Sima CS, Park BJ, Kachala SS, Zlobinsky M, Rusch VW, Adusumilli PS. Palliation and pleurodesis in malignant pleural effusion: the role for tunneled pleural catheters. Journal of Thoracic Oncology 2011;6:762-767.

Swartz RJ, Schwartz C, Basch E, Cai L, Fairclough DL, McLeod L, Mendoza TR, Rapkin B; SAMSI psychometric program longitudinal assessment of patient-reported outcomes working group. The king’s foot of patient-reported outcomes: current practices and new developments for the measurement of change. Quality of Life Research 2011;20:1159-1167.

Tal R, Jacks LM, Elkin E, Mulhall JP. Penile implant utilization following treatment for prostate cancer: Analysis of the SEER-Medicare database. The Journal of Sexual Medicine 2011;8:1797-1804.

Tang M, Gönen M, Quintas-Cardama A, Cortes J, Kantarjian H, Field C, Hughes TP, Branford S, Michor F. Dynamics of chronic myeloid leukemia response to long-term targeted therapy reveal treatment effects on leukemic stem cells. Blood 2011;118:1622-1631.

Teraoka SN, Bernstein JL, Reiner AS, Haile RW, Bernstein L, Lynch CF, Malone KE, Stovall M, Capanu M, Liang X, Smith SA, Mychaleckyj J, Hou X, Mellemkjaer L, Boice JD Jr. Siniard A, Duggan D, Thomas DC, The WECARE Study Collaborative Group, Concannon P. Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women’s Environment, Cancer and Radiation Epidemiology (WECARE) study. Breast Cancer Research 2011;13:R114.

The Cancer Genome Atlas Research Network. Bell D et al. (Shen R is 230th author) Integrated genomic analyses of ovarian carcinoma. Nature 2011;474:609-615.

Thornton RH, Ulrich R, Hsu M, Moskowitz CS, Reidy-Lagunes D, Covey AM, Brody LA, Robson PM, Sofocleous CT, Solomon SB, Getrajdman GI, Brown KT. Outcomes of patients undergoing  percutaneous biliary drainage to reduce bilirubin for administration of chemotherapy. Journal of Vascular and Interventional Radiology 2012;23:89-95.

Tischkowitz M, Capanu M, Sabbaghian N, Li L, Liang X, Vallee M, Tavtigian S, Concannon P, Foulkes WD, Bernstein L, Bernstein JL, Begg CB. Rare germline mutations in PALB2 and breast cancer risk: A population-based study. Human Mutation 2012;[epub ahead of print].

Tonorezos ES, Vega GL, Sklar CA, Chou JF, Moskowitz CS, Mo Q, Church TS, Ross R, Janiszewski PM, Oeffinger KC. Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia. Pediatric Blood & Cancer 2011;258:776-784.

van Ballegooijen M, Rutter CM, Knudsen AB, Zauber AG, Savarino JE, Lansdorp-Vogelaar I, Boer R, Feuer EJ, Habbema JD, Kuntz KM. Clarifying differences in natural history between models of screening: the case of colorectal cancer. Medical Decision Making 2011;31:540-549.

Van Zee KJ, Rudloff U, Brogi E, Patil S. Reply to C. Manzouni et al. Journal of Clinical Oncology 2011;e45-e46.

Vanness DJ, Knudsen AB, Lansdorp-Vogelaar I, Rutter CM, Gareen IF, Herman BA, Kuntz KM, Zauber AG, van Ballegooijen M, Feuer EJ, Chen MH, Johnson CD. Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations. Radiology 2011;261:487-498.

Vargas HA, Akin O, Franiel T, Mazaheri Y, Zheng J, Moskowitz CS, Udo K, Eastham J, Hricak H. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. Radiology 2011;259:775-784.

Vargas HA, Akin O, Zheng J, Moskowitz C, Soslow R, Abu-Rustum N, Barakat RR, Hricak H. The value of MR imaging when the site of uterine cancer origin is uncertain. Radiology 2011;258:785-792.

Vickers A, Eastham J. What has to happen before we report radical prostatectomy outcomes of individual surgeons to the public? Urologic Oncology 2011;29:118-123.

Vickers A, Savage C, Bianco F, Mulhall J, Sandhu J, Guillonneau B, Cronin A, Scardino P. Cancer control and functional outcomes after radical prostatectomy as markers of surgical quality: analysis of heterogeneity between surgeons at a single cancer center. European Urology 2011;59:317-322.

Vickers A. Words of wisdom: Re: Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States. European Urology 2011;60:392.

Vickers AJ, Cronin AM, Begg CB. One statistical test is sufficient for assessing new predictive markers. BMC Medical Research Methodology 2011;11:13.

Vickers AJ, Gupta A, Savage C, Pettersson K, Dahlin A, Bjartell AS, Manjer J, Scardino PT, Ulmert D, Lilja H. A panel of kallikrein markers predicts prostate cancer in a large, population-based cohort followed for 15 years without screening. Cancer Epidemiology Biomarkers and Prevention 2011;20:255-261.

Vickers AJ, Lilja H. Predicting prostate cancer many years before diagnosis: how and why? World Journal of Urology 2011;[epub ahead of print].

Vickers AJ, Lilja H. Urological cancer: Time for another rethink on prostate cancer screening. Nature Reviews Clinical Oncology 2011;9:7-8.

Vickers AJ, Roobol MJ, Lilja H. Screening for prostate cancer: early detection or overdetection? Annual Review of Medicine 2012;63:161-170.

Vickers AJ, Savage CJ, Bianco FJ, Klein EA, Kattan MW, Secin FP, Guilloneau BD, Scardino PT. Surgery confounds biology: the predictive value of stage, grade and prostate-specific antigen for recurrence after radical prostatectomy as a function of surgeon experience. International Journal of Cancer 2011;128:1697-1702.

Vickers AJ, Sjoberg D, Basch E, Sculli F, Shouery M, Laudone V, Touijer K, Eastham J, Scardino PT. How do you know if you are any good? A surgeon performance feedback system for the outcomes of radical prostatectomy. European Urology 2012;61:284-289.

Vickers AJ, Till C, Tangen CM, Lilja H, Thompson IM. An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection. Journal of the National Cancer Institute 2011;103:462-469.

Vickers AJ. Great meaningless questions in urology: which is better, open, laparoscopic, or robotic radical prostatectomy? Urology 2011;77:1025-1026.

Vickers AJ. Making raw data more widely available. BMJ 2011;342:d2323.

Vickers AJ. On behalf of the study team Memorial Sloan Kettering Cancer Center. Re: An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection. Journal of National Cancer Institute 2011;103:1635-1636.

Vickers AJ. Prediction models in cancer care. CA Cancer Journal of Clinicians 2011;[epub ahead of print].

Vickers AJ. Prediction models: revolutionary in principle, but do they do more good than harm? Journal of Clinical Oncology 2011;29:2951-2952.

Vickers AJ. Re: comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data. Journal of the National Cancer Institute 2011;103:1134.

Vickers AJ. Surgical volumes and patient outcomes in urological oncology. AUA Update Series 2011;36:30.

Waters HR, Korn R, Colantuoni E, Berenholtz S, Goeschel CJ, Needham D, Pham JC, Lipitz-Snyderman A, Watson SR, Posa P, Pronovost PJ.  The business case for quality: economic analysis of the Michigan keystone patient safety program in ICUs.  American Journal of Medical Quality 2011;26:333-339.

Weber WP, Barry M, Stempel MM, Junqueira MJ, Eaton AA, Patil SM, Morrow M, Cody HS 3rd. A 10-year trend analysis of sentinel lymph node frozen section and completion axillary dissection for breast cancer: are these procedures becoming obsolete? Annals of Surgical Oncology  2012;19:225-232.

Weiser MR, Gönen M, Chou JF, Kattan MW, Schrag D. Predicting survival after curative colectomy for cancer: individualizing colon cancer staging. Journal of Clinical Oncology 2011;29:4796-4802.

Westhoff CL, Torgal AT, Mayeda ER, Shimoni N, Stanczyk FZ, Pike MC. Predictors of noncompliance in an oral contraceptive clinical trial. Contraception 2011;[epub ahead of print].

Winawer SJ, Zauber AG. Incidence reduction following colonoscopic polypectomy. American Journal of Gastroenterology 2011;106:370.(Letter to editor).

Wu AH, Yu MC, Stanczyk FZ, Tseng CC, Pike MC. Anthropometric, dietary, and hormonal correlates of serum adiponectin in Asian American women. Nutrition and Cancer 2011; 63:549-557.

Xu YF, Wang GC, Zheng JH, Peng B. Partial cystectomy: Is it a reliable option for the treatment of bladder leiomyosarcoma? Canadian Urological Association Journal 2011;5:E11-13.

Yaligar J, Thakur SB, Bokacheva L, Carlin S, Thaler HT, Rizwan A, Lupu ME, Wang Y, Matei CC, Zakian KL, Koutcher JA. Lactate MRSI and DCE MRI as surrogate markers of prostate tumor aggressiveness. NMR Biomedicine 2012;25:113-122.

Yee DS, Ishill NM, Lowrance WT, Herr HW, Elkin EB. Ethnic differences in bladder cancer survival. Urology 2011;78:544-549.

Yee DS, Shariat SF, Lowrance WT, Maschino AC, Savage CJ, Cronin AM, Scardino PT, Eastham JA. Prognostic significance of lymphovascular invasion in radical prostatectomy specimens. BJU International 2011;108:502-507.

Yopp AC, Schwartz LH, Kemeny N, Gultekin DH, Gönen M, Bamboat Z, Shia J, Haviland D, D’Angelica MI, Fong Y, Dematteo RP, Allen PJ, Jarnagin WR. Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response. Annals of Surgical Oncology 2011;18:2192-2199.

Yoshizawa A, Motoi N, Riely GJ, Sima CS, Gerald WL, Kris MG, Park BJ, Rusch VW, Travis WD. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Modern Pathology 2011;24:653-664.

Young RJ, Gupta A, Shah AD, Graber JJ, Zhang Z, Shi W, Holodny AI, Omuro AM. Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma. Neurology 2011;76:1918-1924.

Young RJ, Lee V, Peck KK, Sierra T, Zhang Z, Jacks LM, Holodny AI. Diffusion tensor imaging and tractography of the corticospinal tract in the presence of enlarged virchow-robin spaces. Journal of Neuro-imaging 2011;[epub ahead of print].

Yuan J, Adamow M, Ginsberg BA, Rasalan TS, Ritter E, Gallardo HF, Xu Y, Pogoriler E, Terzulli S, Kuk D, Panageas KS, Ritter G, Sznol M, Halaban R, Jungbluth AA, Allison JP, Old LJ, Wolchok JD, Gnjatic S. Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab. Proceedings of the National Academy of Sciences 2011;108:16723-16728.

Zauber AG, Winawer SJ, O’Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, Shi W, Bond JH, Schapiro M, Panish JF, Stewart ET, Waye JD. Colonoscopic polypectomy and long term prevention of colorectal cancer deaths. New England Journal of Medicine 2011 (in press).

Zelefsky MJ, Chou JF, Pei X, Yamada Y, Kollmeier M, Cox B, Zhang Z, Schechter M, Cohen GN, Zaider M. Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: The Memorial Sloan Kettering Cancer Center experience. Brachytherapy 2011;[epub ahead of print].

Zelefsky MJ, Housman DM, Pei X, Alicikus Z, Magsanoc JM, Dauer LT, St Germain J, Yamada Y, Kollmeier M, Cox B, Zhang Z. Incidence of secondary cancer development after high-dose IMRT and image-guided brachytherapy for the treatment of localized prostate cancer. International Journal of Radiation Oncology, Biology, Physics 2011;[epub ahead of print].

Zelefsky MJ, Pei X, Chou JF, Schechter M, Kollmeier M, Cox B, Yamada Y, Fidaleo A, Sperling D, Happersett L, Zhang Z. Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes. European Urology 2011;60:1133-1139.

Zelefsky MJ, Yamada Y, Pei X, Hunt M, Cohen G, Zhang Z, Zaider M. Comparison of tumor control and toxicity outcomes of high-dose intensity-modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancer. Urology 2011;77:986-990.

Zhu X, Albertsen PC, Andriole GL, Roobol MJ, Schröder FH, Vickers AJ. Risk-based prostate cancer screening. European Urology 2011;[epub ahead of print].

Zivanovic O, Jacks LM, Iasonos A, Leitao MM Jr, Soslow RA, Veras E, Chi DS, Abu-Rustum NR, Barakat RR, Brennan MF, Hensley ML. A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma. Cancer 2012;118:660-669.

Abou-Alfa GK, Chapman PB, Feilchenfeldt J, Brennan MF, Capanu M, Gansukh B, Jacobs G, Levin A, Neville D, Kelsen DP, O’Reilly EM. Targeting mutated k-ras in pancreatic adenocarcinoma using an adjuvant vaccine. American Journal of Clinical Oncology 2010;[epub ahead of print].

Abou-Alfa GK, Johnson P, Knox JJ, Capanu M, Davidenko I, Lacava J, Leung T, Gansukh B, Saltz LB. Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial. Journal of the American Medical Association 2010;304:2154-2160.

Abu-Rustum NR, Zhou Q, Gomez JD, Alektiar KM, Hensley ML, Soslow RA, Levine DA, Chi DS, Barakat RR, Iasonos A. A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care. Gynecologic Oncology 2010;116:399-403.

Adamy A, Favaretto RL, Nogueira L, Savage CJ, Russo P, Coleman J, Guillonneau B, Touijer K. Recovery of renal function after open and laparoscopic partial nephrectomy. European Journal of Urology 2010;58 596-601.

Ahles TA, Saykin AJ, McDonald BC, Li Y, Furstenberg CT, Hanscom BS, Mulrooney TJ, Schwartz GN, Kaufman PA. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. Journal of Clinical Oncology 2010;28:4434-4440.

Akin O, Riedl CC, Ishill NM, Moskowitz CS, Zhang J, Hricak H. Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer. European Radiology 2010;20:995-1002.

Alicikus ZA, Yamada Y, Zhang Z, Pei X, Hunt M, Kollmeier M, Cox B, Zelefsky MJ. Ten-year outcomes of high-dose intensity-modulated radiotherapy for localized prostate cancer. Cancer 2010;[epub ahead of print].

Allegra CJ, Aberle DR, Ganschow P, Hahn SM, Lee CN, Millon-Underwood S, Pike MC, Reed SD, Saftlas AF, Scarvalone SA, Schwartz AM, Slomski C, Yothers G, Zon R. National Institutes of Health state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ September 22-24, 2009. Journal of the National Cancer Institute 2010;102:161-169.

Amar D, Munoz D, Shi W, Zhang H, Thaler HT. A clinical prediction rule for pulmonary complications after thoracic surgery for primary lung cancer. Anesthesia and Analgesia 2010;110:1343-1348.

Arora N, King TA, Jacks LM, Stempel MM, Patil S, Morris E, Morrow M. Impact of breast density on the presenting features of malignancy. Annals of Surgical Oncology 2010;17(suppl 3):211-218.

Atkinson TM, Mendoza TR, Sit L, Passik S, Scher HI, Cleeland C, Basch E. The brief pain inventory and its “pain at its worst in the last 24 hours” item: clinical trial endpoint considerations. Pain Medicine 2010;11:337-346.

Atkinson TM, Rosenfeld BD, Sit L, Mendoza TR, Fruscione M, Lavene D, Shaw M, Li Y, Hay J, Cleeland C, Scher HI, Breitbart WS, Basch E. Using confirmatory factor analysis to evaluate construct validity of the brief pain inventory. Journal of Pain and Symptom Management 2010;(in press).

Avery S, Shi W, Lubin M, Gonzales AM, Heller G, Castro-Malaspina H, Giralt S, Kernan NA, Scaradavou A, Barker JN. Influence of infused cell dose and HLA-match on engraftment after double-unit cord blood allografts.  Blood 2010;[epub ahead of print].

Babur O, Demir E, Gönen M, Sander C, Dogrusoz U. Discovering modulators of gene expression. Nucleic Acids Research 2010;[epub ahead of print].

Bach PB. Gardasil: from bench, to bedside, to blunder. Lancet 2010;375:963-964.

Bandera EV, Williams-King MG, Sima C, Bayuga-Miller S, Pulick K, Wilcox H, Zauber AG, Olson SH. Coffee and tea consumption and endometrial cancer risk in a population-based study in New Jersey. Cancer Causes and Control 2010;21:1467-1473.

Barker CA, Mutter RW, Shapiro LQ, Zhang Z, Wolden SL, Yahalom J. Contrast media use in radiation oncology: a prospective, controlled educational intervention study with retrospective analysis of patient outcomes. Journal of the American College of Radiology 2010;7:967-974.

Barker JN, Byam CE, Kernan NA, Lee SS, Hawke RM, Doshi KA, Wells DS, Heller G, Papadopoulos EB, Scaradavou A, Young JW, van den Brink MR. Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities. Biology of Blood and Marrow Transplantation 2010;16:1541-1548.

Bastide C, Savage C, Cronin A, Zelefsky MJ, Eastham JA, Touijer K, Scardino PT, Guillonneau BD. Location and number of positive surgical margins as prognostic factors of biochemical recurrence after salvage radiation therapy after radical prostatectomy. BJU International 2010;106:1454-1457.

Baxi SS, Snow JG, Liberman L, Elkin EB. The future of mammography: radiology residents’ experiences, attitudes, and opinions. AJR American Journal of Roentgenology 2010;194:1680-1686.

Bernstein JL, Haile RW, Stovall M, Boice JD Jr, Shore RE, Langholz B, Thomas DC, Bernstein L, Lynch CF, Olsen JH, Malone KE, Mellemkjaer L, Borresen-Dale AL, Rosenstein BS, Teraoka SN, Diep AT, Smith SA, Capanu M, Reiner AS, Liang X, Gatti RA, Concannon P; WECARE Study Collaborative Group. Radiation exposure, the ATM Gene, and contralateral breast cancer in the women’s environmental cancer and radiation epidemiology study. Journal of the National Cancer Institute 2010;102:475-483.

Bennett AV, Patrick DL, Lump JF, Edwards TC, Goss Ch. Comparison of 7-day and repeated 24-hour recall of symptoms of cystic fibrosis. Journal of Cystic Fibrosis 2010;9:419-424.

Bernstein JL, Thomas DC, Shore RE, Robson M, Boice JD, Stovall M, Andersson M, Bernstein L, Malone KE, Reiner AS, Lynch CF, Capanu M, Smith SA, Tellhed L, Xue S, Teraoka SN, Begg CB, Olsen JH, Mellemkjaer L, Liang X, Olson E, Diep AT, the WECARE Study Collaborative Group, Borg A, Concannon P, Haile RW. Radiation-induced second primary breast cancer and BRCA1 and BRCA2 mutation carrier status: A report from the WECARE Study. Journal of the National Cancer Institute 2010;[epub ahead of print].

Berrington de Gonzalez A, Kim KP, Knudsen AB, Lansdorp-Vogelaar I, Rutter CM, Smith-Bindman R, Yee J, Kuntz KM, van Ballegooijen M, Zauber AG, Berg CD. Radiation-related cancer risks from CT colonography screening: a risk-benefit analysis. AJR American Journal of Radiology 2010;(in press).

Bertagnolli MM, Hsu M, Hawk ET, Eagle CJ, Zauber AG. Adenoma prevention with celeboxib (APC study investigators. Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial. Cancer Prevention and Research 2010;3:588-596.

Bhandari S, Cheung NK, Kushner BH, Kramer K, Modak S, Larson SM, Yeh S, Heller G, Sklar CA. Hypothyroidism after (131)I-monoclonal antibody treatment of neuroblastoma. Pediatric Blood Cancer 2010;55:76-80.

Borg A, Haile RW, Malone KE, Capanu M, Diep A, Törngren T, Teraoka S, Begg CB, Thomas DC, Concannon P, Mellemkjaer L, Bernstein L, Tellhed L, Xue S, Olson ER, Liang X, Dolle J, Børresen-Dale AL, Bernstein JL. Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study. Human Mutations 2010; 31:E1200-1240.

Breitbart W, Rosenfeld B, Gibson C, Kramer M, Li Y, Tomarken A, Nelson C, Pessin H, Esch J, Galietta M, Garcia N, Brechtl J, Schuster M. Impact of treatment for depression on desire for hastened death in patients with advanced AIDS. Psychosomatics 2010;51:98-105.

Brooks JD, Cairns P, Shore RE, Klein CB, Wirgin I, Afanasyeva Y, Zeleniuch-Jacquotte A. DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study. Cancer Epidemiology 2010;34:717-723.

Burkhalter  JE, Hay JL, Coups E, Warren B, Ostroff JS, Li Y. Perceived risk for cancer in an urban sexual minority. Journal of Behavioral Medicine 2010;[epub ahead of print].

Butte JM, Brennan MF, Gönen M, Tang LH, D’Angelica MI, Fong Y, Dematteo RP, Jarnagin WR, Allen PJ. Solid pseudopapillary tumors of the pancreas. Clinical features, surgical outcomes, and long-term survival in 45 consecutive patients from a single center. Journal of Gastrointestinal Surgery 2010;[epub ahead of print].


 

Butte JM, Matsuo K, Gönen M, D’Angelica MI, Waugh E, Allen PJ, Fong Y, Dematteo RP, Blumgart L, Endo I, De La Fuente H, Jarnagin WR. Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. Journal of the American College of Surgeons 2010 [epub ahead of print].

Bylund CL, Gueguen JA, D’Agostino TA, Li Y, Sonet E. Doctor-patient communication about cancer-related internet information. Journal of Psychosocial Oncology 2010;28:127-142.

Capanu M, Begg CB. Hierarchical modeling for estimating relative risks of rare genetic variants: properties of the pseudo-likelihood method. Biometrics 2010;[epub ahead of print].

Carter J, Applegarth L, Josephs L, Grill E, Baser RE, Rosenwaks Z. A cross-sectional cohort study of infertile women awaiting oocyte donation: the emotional, sexual, and quality-of-life impact. Fertility and Sterility 2010;(in press).

Carter J, Chi DS, Brown CL, Abu-Rustum NR, Sonoda Y, Aghajanian C, Levine DA, Baser RE, Raviv L, Barakat RR. Cancer-related infertility in survivorship. International Journal of Gynecological Cancer 2010:20:2-8.

Carter J, Raviv L, Applegarth L, Ford JS, Josephs L, Grill E, Sklar C, Sonoda Y, Baser RE, Barakat RR. A cross-sectional study of the psychosexual impact of cancer-related infertility in women: third-party reproductive assistance. Journal of Cancer Survivorship 2010;4:236-246.

Carter J, Raviv L, Appollo K, Baser RE, Iasonos A, Barakat RR. A pilot study using the gynecologic cancer lymphedema questionnaire (GCLQ) as a clinical care tool to identify lower extremity lymphedema in gynecologic cancer survivors. Gynecologic Oncology 2010;117:317-323.

Carter J, Sonoda Y, Baser RE, Raviv L, Chi DS, Barakat RR, Iasonos A, Brown CL, Abu-Rustum NR. A 2-year prospective study assessing the emotional, sexual, and quality of life concerns of women undergoing radical trachelectomy versus radical hysterectomy for treatment of early-stage cervical cancer. Gynecologic Oncology 2010;119:358-365.

Carver BS, Cronin AM, Eggener S, Savage CJ, Motzer RJ, Bajorin D, Bosl GJ, Sheinfeld J. The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer. Urology 2010;75:1431-1435.

Chade DC, Shariat SF, Godoy G, Savage CJ, Cronin AM, Bochner BH, Donat SM, Herr HW, Dalbagni G. Clinical outcomes of primary bladder carcinoma in situ in a contemporary series. Journal of Urology 2010;184:74-80.

Chandran U, Bandera EV, Williams-King MG, Sima C, Bayuga S, Pulick K, Wilcox H, Zauber AG, Olson SH. Adherence to the dietary guidelines for Americans and endometrial cancer risk. Cancer Causes and Control 2010; 21:1895-1904.

Chou JF, Row D, Gönen M, Liu YH, Schrag D, Weiser MR. Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer: a population-based study. Cancer 2010;116:2560-2570.  

Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM. Leptomeningeal metastases in the MRI era. Neurology 2010;74:1449-1454.

Comen E, Balistreri L, Gönen M, Dutra-Clarke A, Fazio M, Vijai J, Stadler Z, Kauff N, Kirchhoff T, Hudis C, Offit K, Robson M. Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women. Breast Cancer Research and Treatment 2010;[epub ahead of print].

Correa DD, Zhou Q, Thaler HT, Maziarz M, Hurley K, Hensley ML. Cognitive functions in long-term survivors of ovarian cancer. Gynecologic Oncology 2010;119:366-369.

Cortessis VK, Yuan JM, Van Den Berg D, Jiang X, Gago-Dominguez M, Stern MC, Castelao JE, Xiang YB, Gao YT, Pike MC, Conti DV. Risk of urinary bladder cancer is associated with 8q24 variant rs9642880[T]: results from the Los Angeles-Shanghai case-control study. Cancer Epidemiology, Biomarkers, Prevention 2010;[epub ahead of print].

Dalbagni G, Kaag M, Cronin A, Vora K, Bochner B, Donat SM, Herr HW. Variability of treatment selection among surgeons for patients with cT1 urothelial carcinoma. BJU International 2010;106:1502-1507.

Damast S, Ho AY, Montgomery L, Fornier MN, Ishill N, Elkin E, Beal K, McCormick B. Locoregional outcomes of inflammatory breast cancer patients treated with standard fractionation radiation and daily skin bolus in the taxane era. International Journal of Radiation Oncology, Biology, Physics 2010;77:1105-1112.

Damast S, Wright J, Bilsky M, Hsu M, Zhang Z, Lovelock M, Cox B, Zatcky J, Yamada Y. Impact of dose on local failure rates after image-guided re-irradiation of recurrent paraspinal metastases. International Journal of Radiation Oncology, Biology, Physics 2010;[epub ahead of print].

Dang C, Lin N, Moy B, Come S, Sugarman S, Morris P, Abbruzzi A, Chen C, Steingart R, Patil S, Norton L, Winer E, Hudis C. Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea. Journal of Clinical Oncology 2010;28:2982-2988. Erratum in: Journal of Clinical Oncology 2010;28:3670.

D’Angelica M, Kornprat P, Gönen M, Dematteo RP, Fong Y, Blumgart LH, Jarnagin WR. Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases. Annals of Surgerical Oncology 2010; [epub ahead of print].

Deutsch I, Zelefsky MJ, Zhang Z, Mo Q, Zaider M, Cohen G, Cahlon O, Yamada Y. Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT. Brachytherapy 2010;9:313-318.

Deutsch I, Zelefsky MJ, Zhang Z, Mo Q, Zaider M, Cohen G, Cahlon O, Yamada Y. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. International Journal of Radiation Oncology, Biology, Physics 2010;78:486-493.

Dharma Rao T, Park KJ, Smith-Jones P, Iasonos A, Linkov I, Soslow RA, Spriggs DR. Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16. Applied Immunohistochemistry & Molecular Morphology 2010;18:462-472.

Dickson MA, Rathkopf DE, Carvajal RD, Grant S, Roberts JD, Reid JM, Ames MM, McGovern RM, Lefkowitz RA, Gönen M, Cane LM, Dials HJ, Schwartz GK. A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumors. Investigative New Drugs 2010; [epub ahead of print].

Dickson MA, Shah MA, Rathkopf D, Tse A, Carvajal RD, Wu N, Lefkowitz RA, Gönen M, Cane LM, Dials HJ, Schwartz GK. A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol. Cancer Chemotherapy and Pharmacology 2010;66:1113-1121.

Doherty JA, Rossing MA, Cushing-Haugen KL, Chen C, Van Den Berg DJ, Wu AH, Pike MC, Ness RB, Moysich K, Chenevix-Trench G, Beesley J, Webb PM, Chang-Claude J, Wang-Gohrke S, Goodman MT, Lurie G, Thompson PJ, Carney ME, Hogdall E, Kjaer SK, Hogdall C, Goode EL, Cunningham JM, Fridley BL, Vierkant RA, Berchuck A, Moorman PG, Schildkraut JM, Palmieri RT, Cramer DW, Terry KL, Yang HP, Garcia-Closas M, Chanock S, Lissowska J, Song H, Pharoah PD, Shah M, Perkins B, McGuire V, Whittemore AS, Di Cioccio RA, Gentry-Maharaj A, Menon U, Gayther SA, Ramus SJ, Ziogas A, Brewster W, Anton-Culver H; Australian Ovarian Cancer Study Management Group; Australian Cancer Study (Ovarian Cancer), Pearce CL; Ovarian Cancer Association Consortium (OCAC). Ovarian Cancer Association Consortium (OCAC).  ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.  Cancer Epidemiology, Biomarkers, Prevention 2010;19:245-250.

Donat SM, Siegrist T, Cronin A, Savage C, Milowsky MI, Herr HW. Radical cystectomy in octogenarians—does morbidity outweigh the potential survival benefits? Journal of Urology 2010;183:2171-2177.

Drullinsky P, Sugarman SM, Fornier MN, D’Andrea G, Gilewski T, Lake D, Traina T, Wasserheit-Lieblich C, Sklarin N, Atieh-Graham D, Mills N, Troso-Sandoval T, Seidman AD, Yuan J, Patel H, Patil S, Norton L, Hudis C. Dose dense cyclophosphamide, methotrexate, fluorouracil is feasible at 14-day intervals: a pilot study of every-14-day dosing as adjuvant therapy for breast cancer. Clinical Breast Cancer 2010;10:440-444.

Dunkel IJ, Gardner SL, Garvin JH Jr, Goldman S, Shi W, Finlay JL. High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma. Neuro-Oncology 2010;12:297-303.

Edwards-Bennett SM, Jacks LM, McCormick B, Zhang Z, Azu M, Ho A, Powell S, Brown C. Patterns of utilization of adjuvant radiation therapy and outcomes in black women after breast conservation at a large multidisciplinary cancer center. International Journal of Radiation Oncology, Biology, Physics 2010;(in press).

Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I, Seeff LC, van Ballegooijen M, Goede Sl, Ries LA. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116:544-573.

Edwards QT, Li A, Pike MC, Kolonel L, Henderson BE, McKean-Cowdin R.  Patterns of regular use of mammography – body weight and ethnicity: the Multiethnic Cohort.  Journal of the American Academy of Nurse Practitioners 2010;22:162-169.

Edwards-Bennett SM, Jacks LM, Moskowitz CH, Wu EJ, Zhang Z, Noy A, Portlock CS, Straus DJ, Zelenetz AD, Yahalom. Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience. Annals of Oncology 2010; 21:574-581.

Eldjerou LK, Chaudhury S, Baisre-de Leon A, He M, Arcila ME, Heller G, O’Reilly RJ, Barker JN, Moore MA. An in vivo model of double unit cord blood transplantation that correlates with clinical engraftment. Blood 2010;116:3999-4006.

Elkin EB, Bach PB. Cancer’s next frontier: addressing high and increasing costs. Journal of the American Medical Association 2010;303:1086-1087.

Elkin EB, Blinder VS. Advances in breast cancer: Reducing risk and improving health outcomes. In Finkel ML (editor), Perspectives in Public Health: Challenges for the 21st Century. Santa Barbara, CA: Praeger, 2010.

Elkin EB, Ishill NM, Snow JG, Panageas KS, Bach PB, Liberman L, Wang F, Schrag D. Geographic access and the use of screening mammography. Medical Care 2010;48:349-356.

Esemuede I, Forslund A, Khan SA, Qin LX, Gimbel MI, Nash GM, Zeng Z, Rosenberg S, Shia J, Barany F, Paty PB. Improved testing for microsatellite instability in colorectal cancer using a simplified 3-marker assay. Annals of Surgical Oncology 2010;17:3370-3378.

Favaretto RL, Shariat SF, Chade DC, Godoy G, Kaag M, Cronin AM, Bochner BH, Coleman J, Dalbagni G. Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique? Eur Urol. 2010;58:645-651.

Feeney J, Horwitz S, Gönen M, Schöder H. Characterization of T-cell lymphomas by FDG PET/CT. AJR American Journal of Roentgenology 2010;195:333-340.

Feifer A, Savage C, Rayala H, Lowrance W, Gotto G, Sprenkle P, Gupta A, Taylor J, Bernstein M, Adeniran A, Tickoo SK, Reuter VE, Russo P. Prognostic impact of muscular venous branch invasion in localized renal cell carcinoma cases. Journal of Urology 2010;[epub ahead of print].

Feldman DR, Sheinfeld J, Bajorin DF, Fischer P, Turkula S, Ishill N, Patil S, Bains M, Reich LM, Bosl GJ, Motzer RJ. TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis. Journal of Clinical Oncology 2010;28:1706-1713. Erratum in: Journal of Clinical Oncology 2010;28:5126.

Feldman DR, Turkula S, Ginsberg MS, Ishill N, Patil S, Carousso M, Bosl GJ, Motzer RJ. Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors. Investigational New Drugs 2010;28:523-528.

Fields RC, Hameed M, Qin LX, Moraco N, Jia X, Maki RG, Singer S, Brennan MF.
Dermatofibrosarcoma protuberans (DFSP): predictors of recurrence and the use of
systemic therapy. Annals of Surgical Oncology 2010;[epub ahead of print].

Figueiredo JC, Brooks JD, Conti DV, Poynter JN, Teraoka SN, Malone KE, Bernstein L, Lee WD,  Duggan DJ, Siniard A, Concannon P, Capanu  M, Lynch CF, Olsen JH, Haile RW, Bernstein JL. Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: Potential modifying effect of BRCA1/BRCA2 mutation carrier status. Breast Cancer Research and Treatment 2010; [epub ahead of print].

Figueiredo JC, Haile RW, Bernstein L, Malone KE, Largent J, Langholz B, Lynch CF, Bertelsen L, Capanu M, Concannon P, Borg A, Børresen-Dale AL, Diep A, Teraoka S, Torngren T, Xue S, Bernstein JL. Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study. Breast Cancer Research and Treatment 2010;120:175-183.

Fine SW, Gopalan A, Leversha MA, Al-Ahmadie HA, Tickoo SK, Zhou Q, Satagopan JM, Scardino PT, Gerald WL, Reuter VE. TMPRSS2-ERG gene fusion is associated with low gleason scores and not with high-grade morphological features. Modern Pathology 2010;23:1325-1333.

Fischer M, Matsuo K, Gönen M, Grant F, Dematteo RP, D’Angelica MI, Mascarenhas J, Brennan MF, Allen PJ, Blumgart LH, Jarnagin WR. Relationship between intraoperative fluid administration and perioperative outcome after pancreaticoduodenectomy: results of a prospective randomized trial of acute normovolemic hemodilution compared with standard intraoperative management. Annals of Surgery 2010;252:952-958.

Fu M, Maresh EL, Soslow RA, Alavi M, Mah V, Zhou Q, Iasonos A, Goodglick L, Gordon LK, Braun J, Wadehra M. Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer. Clinical Cancer Research 2010;16:3954-2963.

Fuchsjäger MH, Pucar D, Zelefsky MJ, Mehdizade A, Zhang Z, Mo Q, BenPorat LS, Shukla-Dave A, Wang L, Reuter VE, Hricak H.  Predicting post-external-beam radiation therapy PSA relapse of prostate cancer using pre-treatment MRI. International Journal of Radiation Oncology, Biology, Physics 2010;78:743-750.

Furberg H, Ostroff J, Lerman C, Sullivan PF. The public health utility of genome-wide association study results for smoking behavior. Genome Medicine 2010;2:26.

Fury MG, Drobnjak M, Sima CS, Asher M, Shah J, Lee N, Carlson D, Wende HG, Pfister DG. Tissue microarray evidence of association between p16 and phosphorylated eIF4E in tonsillar squamous cell carcinoma. Head & Neck 2010; [epub ahead of print].

Fury MG, Haque S, Stambuk H, Shen R, Carlson D, Pfister D. A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer. Cancer 2010;[epub ahead of print].

Gago-Dominguez M, Jiang X, Conti DV, Castelao JE, Stern MC, Cortessis VK, Pike MC, Xiang YB, Gao YT, Yuan JM, Van Den Berg D. Genetic variations on chromosomes 5p15 and 15q25 and bladder cancer risk: findings from the Los Angeles-Shanghai case-control study. Carcinogenesis 2010;[epub ahead of print].

Gaudet MM, Press MF, Haile RW, Lynch CF, Glaser SL, Schildkraut J, Gammon MD, Thompson WD, Bernstein JL. Risk factors by molecular subtypes of breast cancer among a population-based study of women 56 years or younger. Cancer Epidemiology, Biomarkers Prevention 2010; (in press). 

Ginsberg BA, Gallardo HF, Rasalan TS, Adamow M, Mu Z, Tandon S, Bewkes BB,Roman RA, Chapman PB, Schwartz GK, Carvajal RD, Panageas KS, Terzulli SL, Houghton AN, Yuan JD, Wolchok JD. Immunologic response to xenogeneic gp100 DNA in melanoma patients: comparison of particle-mediated epidermal delivery with intramuscular injection. Clinical Cancer Research 2010;16:4057-4065.

Girard N, Lou E, Azzoli CG, Reddy R, Robson M, Harlan M, Orlow I, Yatabe Y, Ladanyi M, Viale A, Kris MG, Riely G, Miller V, Klein RJ, Matsuo K, Pao W. Analysis of genetic variants in never-smokers with lung cancer facilitated by an internet-based blood collection protocol: a preliminary report. Clinical Cancer Research 2010;16:755-763.

Gladdy RA, Qin LX, Moraco N, Edgar MA, Antonescu CR, Alektiar KM, Brennan MF,
Singer S. Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas? Journal of Clinical Oncology 2010;28:2064-2069.

Goldfarb S, Dickler M, Traina T. Bevacizumab in the treatment of metastatic breast cancer. Current Medical Literature-Breast Cancer 2010; 22:1–7.

Goldfarb S, Hudis C, Dickler M. Bevacizumab in metastatic breast cancer: when may it be used? Therapeutic Advances in Medical Oncology 2010;[epub ahead of press].

Goldfarb SB, Traina TA, Dickler MN. Bevacizumab for advanced breast cancer. Womens Health (London, England) 2010;6:17-25. Review.

Gönen M. The Bayesian t-test and beyond. Methods in Molecular Biology 2010;620:179-199.

Gönen M, Heller G. Lehmann family of ROC curves. Medical Decision Making 2010;30:509-517.

Gönen M, Weiser MR. Whither TNM? Seminars in Oncology 2010;37:27-30.

González SJ, González L, Wong J, Brader P, Zakowski M, Gönen M, Daghighian F, Fong Y, Strong VE. An analysis of the utility of handheld PET probes for the intraoperative localization of malignant tissue. Journal of Gastrointestinal Surgery 2010;[epub ahead of print].

Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK, Birrer MJ, Berchuck A, Schildkraut J, Tomlinson I, Kiemeney LA, Cook LS, Gronwald J, Garcia-Closas M, Gore ME, Campbell I, Whittemore AS, Sutphen R, Phelan C, Anton-Culver H, Pearce CL, Lambrechts D, Rossing MA, Chang-Claude J, Moysich KB, Goodman MT, Dörk T, Nevanlinna H, Ness RB, Rafnar T, Hogdall C, Hogdall E, Fridley BL, Cunningham JM, Sieh W, McGuire V, Godwin AK, Cramer DW, Hernandez D, Levine D, Lu K, Iversen ES, Palmieri RT, Houlston R, van Altena AM, Aben KK, Massuger LF, Brooks-Wilson A, Kelemen LE, Le ND, Jakubowska A, Lubinski J, Medrek K, Stafford A, Easton DF, Tyrer J, Bolton KL, Harrington P, Eccles D, Chen A, Molina AN, Davila BN, Arango H, Tsai YY, Chen Z, Risch HA, McLaughlin J, Narod SA, Ziogas A, Brewster W, Gentry-Maharaj A, Menon U, Wu AH, Stram DO, Pike MC, Wellcome Trust Case-Control Consortium, Beesley J, Webb PM; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group; Ovarian Cancer Association Consortium (OCAC), Chen X, Ekici AB, Thiel FC, Beckmann MW, Yang H, Wentzensen N, Lissowska J, Fasching PA, Despierre E, Amant F, Vergote I, Doherty J, Hein R, Wang-Gohrke S, Lurie G, Carney ME, Thompson PJ, Runnebaum I, Hillemanns P, Dürst M, Antonenkova N, Bogdanova N, Leminen A, Butzow R, Heikkinen T, Stefansson K, Sulem P, Besenbacher S, Sellers TA, Gayther SA, Pharoah PD; Ovarian Cancer Association Consortium (OCAC).  A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nature Genetics 2010;42:874-879.

Goodman KA, Wiegner EA, Maturen KE, Zhang Z, Mo Q, Yang G, Gibbs IC, Fisher GA, Koong AC. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. International Journal of Radiation Oncology, Biology, Physics 2010;78:486-493.

Gotto GT, Cronin AM, Laudone VP. Important considerations in the clinical use of preoperative prostate cancer predictive nomograms. European Journal of Urology 2010;58:637-638.

Grewal RK, Tuttle RM, Fox J, Borkar S, Chou JF, Gonen M, Strauss HW, Larson SM, Schöder H. The effect of post therapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer. Journal of Nuclear Medicine 2010;51:1361-1367.

Guest R, Baser R, Li Y, Brown AE, Scardino P, Kissane DW. Cancer surgeons’ distress and well-being I: the tension between a culture of productivity and the need for self-care. Annals of Surgical Oncology 2010;(in press).

Guest R, Baser R, Li Y, Brown AE, Scardino P, Kissane DW. Cancer surgeons’ distress and well-being II: modifiable factors and the potential for organizational interventions.  Annals of Surgical Oncology 2010;(in press).

Gupta A, Young RJ, Sood S, Karimi S, Zhang Z, Mo Q, Gutin PH, Holodny AI, Lassman AB. Isolated diffusion restriction precedes the development of enhancing tumor in a subset of patients with glioblastoma. American Journal of Neuroradiology 2010; (in press).

Halpern HA, Pastores SM, Chou JF, Chawla S, Thaler HT Advance directives in an oncologic intensive care unit: a contemporary analysis of their frequency, type, and impact. Journal of Palliative Medicine 2010;(in press).

Haupage S, Peck KK, Branski RC, Hsu M, Holodny A, Kraus D. Functional MRI of tongue motor tasks in patients with tongue cancer: observations before and after partial glossectomy. Neuroradiology 2010;52:1185-1191.

Hay J, DiBonaventura M, Baser R, Press N, Shoveller J, Bowen D. Personal attributions for melanoma risk in melanoma-affected patients and family members. Journal of Behavioral Medicine 2010;1-11.

Heller G. Proportional hazards regression with interval censored data using an inverse probability weight.  Lifetime Data Analysis 2010;[epub ahead of print].

Hong H, Yen HY, Brockmeyer A, Liu Y, Chodankar R, Pike MC, Stanczyk FZ, Maxson R, Dubeau L. Changes in the mouse estrus cycle in response to BRCA1 inactivation suggest a potential link between risk factors for familial and sporadic ovarian cancer. Cancer Research 2010;70:221-228.

Hottinger AF, Iwamoto FM, Karimi S, Riedel E, Dantis J, Park J, Panageas KS,  Lassman, Abrey LE, Fleisher M, Holland EC, DeAngelis LM, Hormigo A. YKL-40 and MMP-9 as serum markers for patients with primary CNS lymphoma.  Annals of Neurology 2010;(in press).

House MG, Ito H, Gönen M, Fong Y, Allen PJ, DeMatteo RP, Brennan MF, Blumgart LH, Jarnagin WR, D’Angelica MI. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. Journal of the American College Surgeons 2010;210:744-752.

Huitzil-Melendez FD, Capanu M, O’Reilly EM, Duffy A, Gansukh B, Saltz LL, Abou-Alfa GK. Advanced hepatocellular carcinoma: which staging systems best predict prognosis? Journal of Clinical Oncology 2010;28:2889-2895.

Iasonos A, Ostrovnaya I. Estimating the dose-toxicity curve in completed phase I studies. Statistics in Medicine 2010;(in press).

Ilson DH, Kelsen DP, Shah M, Schwartz G, Levine DA, Boyd J, Capanu M, Miron B, Klimstra D. A phase II trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagus. Cancer 2010;[epub ahead of print].

Ito K, Elkin EB, Girotra M, Morris JM. Cost-effectiveness of fracture prevention in men receiving androgen deprivation therapy for localized prostate cancer. Annals of Internal Medicine 2010;152:621-629.

Ito K, Ito H, Allen PJ, Gönen M, Klimstra D, D’Angelica MI, Fong Y, Dematteo RP, Brennan MF, Blumgart LH, Jarnagin WR. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. Annals of Surgery 2010;251:675-681.

Jang TL, Bekelman JE, Liu Y, Bach PB, Basch EM, Elkin EB, Zelefsky MJ, Scardino PT, Begg CB, Schrag D. Physician visits prior to treatment for clinically localized prostate cancer. Archives of Internal Medicine 2010;170:440-450.

Janjigian YY, McDonnell K, Kris MG, Shen R, Sima CS, Bach PB, Rizvi NA, Riely GJ. Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/ IV nonsmall cell lung cancer. Cancer 2010;116: 670-675.

Janjigian YY, Park BJ, Zakowski MF, Ladanyi M, Pao W, D’Angelo SP, Kris MG, Shen R, Zheng J, Azzoli CG. Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations. Journal of Thoracic Oncology 2010;[epub ahead of print].

Jardines L, Goyal S, Fisher P, Weitzel J, Royce M, Goldfarb S. Breast cancer overview. Cancer Management: A Multidisciplinary Approach 13th Edition. UBM Medica 2010.

Jardines L, Goyal S, Royce M, Goldfarb S. Stages 0 and 1 breast cancer. Cancer Management: A Multidisciplinary Approach 13th Edition. UBM Medica 2010.

Jardines L, Goyal S, Royce M, Goldfarb S. Stage II breast cancer. Cancer Management: A Multidisciplinary Approach 13th Edition. UBM Medica 2010.

Jardines L, Goyal S, Royce M, Jaiyesimi I, Goldfarb S. Stages III and IV breast cancer. Cancer Management: A Multidisciplinary Approach 13th Edition. UBM Medica 2010.

Jayaraman S, Gönen M, Brennan MF, D’Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR, Allen PJ. Laparoscopic distal pancreatectomy: evolution of a technique at a single institution. Journal of the American College of Surgeons 2010;211:503-509.

Jiang X, Castelao JE, Yuan JM, Groshen S, Stern MC, Conti DV, Cortessis VK, Coetzee GA, Pike MC, Gago-Dominguez M. Hypertension, diuretics and antihypertensives in relation to bladder cancer. Carcinogenesis 2010;31:1964-1971.

Johnatty SE, Beesley J, Chen X, Macgregor S, Duffy DL, Spurdle AB, deFazio A,

Gava N, Webb PM, Rossing MA, Doherty JA, Goodman MT, Lurie G, Thompson PJ,

Wilkens LR, Ness RB, Moysich KB, Chang-Claude J, Wang-Gohrke S, Cramer DW, Terry

KL, Hankinson SE, Tworoger SS, Garcia-Closas M, Yang H, Lissowska J, Chanock SJ,

Pharoah PD, Song H, Whitemore AS, Pearce CL, Stram DO, Wu AH, Pike MC, Gayther

SA, Ramus SJ, Menon U, Gentry-Maharaj A, Anton-Culver H, Ziogas A, Hogdall E,

Kjaer SK, Hogdall C, Berchuck A, Schildkraut JM, Iversen ES, Moorman PG, Phelan

CM, Sellers TA, Cunningham JM, Vierkant RA, Rider DN, Goode EL, Haviv I, Chenevix-Trench G; Ovarian Cancer Association Consortium; Australian Ovarian Cancer Study Group; Australian Cancer Study (Ovarian Cancer). Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility “hot-spot”. PLoS Genetics 2010;6:e1001016.

Kaag MG, Toyen C, Russo P, Cronin A, Thompson RH, Schiff J, Bernstein M, Bains M. Radical nephrectomy with vena caval thrombectomy: a contemporary experience. BJU International 2010;[epub ahead of print] .

Karam AK, Hsu M, Patil S, Stempel M, Traina TA, Ho AY, Cody HS, Morrow M, Gemignani ML. Determinants of outcome in elderly patients with positive sentinel  lymph nodes. American Journal of Surgery 2010;[epub ahead of print].

Katz SC, Donkor C, Glasgow K, Pillarisetty VG, Gönen M, Espat NJ, Klimstra DS, D’Angelica MI, Allen PJ, Jarnagin W, Dematteo RP, Brennan MF, Tang LH. T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases. HPB (Oxford) 2010;12:674-683.

Kemeny NE, Jarnagin WR, Capanu M, Fong Y, Gewirtz AN, Dematteo RP, D’Angelica MI.  Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer. Journal of Clinical Oncology 2010;[epub ahead of print].

Kingham TP, Panageas KS, Ariyan CE, Busam KJ, Brady MS, Coit DG. Outcome of patients with a positive sentinel lymph node who do not undergo completion lymphadenectomy. Annals of Surgical Oncology 2010;17:514-520.

Klimstra DS, Modlin IR, Adsay NV, Chetty R, Deshpande V, Gönen M, Jensen RT, Kidd M, Kulke MH, Lloyd RV, Moran C, Moss SF, Oberg K, O’Toole D, Rindi G, Robert ME, Suster S, Tang LH, Tzen CY, Washington MK, Wiedenmann B, Yao J. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. The American Journal of Surgical Pathology 2010;34:300-313.

Knudsen AB, Lansdorp-Vogelaar I, Rutter CM, Savarino JE, van Ballegooijen M, Kuntz KM, Zauber AG. Cost-effectiveness of compluted tomographic colonography screening for colorectal cancer in the medicare population. Journal of the National Cancer Institute 2010;102:1238-1252.

Kolev V, Mironov S, Mironov O, Ishill N, Moskowitz CS, Gardner GJ, Levine DA, Hricak H, Barakat RR, Chi DS. Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer. International Journal of Gynecological Cancer 2010;20:979-984.

Kollmeier MA, Katz MS, Mak K, Yamada Y, Feder DJ, Zhang Z, Jia X, Shi W, Zelefsky MJ. Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiation therapy. International Journal of Radiation Oncology, Biology, Physics 2010;(in press).

Koutcher L, Sherman E, Fury M, Wolden S, Zhang Z, Mo Q, Stewart L, Schupak K, Gelblum D, Wong R, Kraus D, Shah J, Zelefsky M, Pfister D, Lee N. Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics 2010;(in press). 

Ku GY, Yuan J, Page DB, Schroeder SE, Panageas KS, Carvajal RD, Chapman PB, Schwartz GK, Allison JP, Wolchok JD. Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival. Cancer 2010;116:1767-1775.

Kumar S, Bramlage M, Jacks LM, Goldberg JI, Patil SM, Giri DD, Van Zee KJ. Minimal disease in the sentinel lymph node: how to best measure sentinel node micrometastases to predict risk of additional non-sentinel lymph node disease.  Annals of Surgical Oncology 2010;17:2909-2919.

Kuligina E, Reiner AS, Imyanitov EN, Begg CB. Evaluating cancer epidemiologic risk factors using multiple primary malignancies. Epidemiology 2010;21:366-372.

Kushner BH, Kramer K, Modak S, Qin LX, Cheung NK. Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastoma. Cancer 2010;116:3054-3060.

Lacouture ME, Maitland ML, Segaert S, Setser A, Baran R, Fox LP, Epstein JB, Barasch A, Einhorn L, Wagner L, West DP, Rapoport BL, Kris MG, Basch E, Eaby B, Kurtin S, Olsen EA, Chen A, Dancey JE, Trotti A. A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group. Support Care Cancer 2010;18:509-522.

Lansdorp-Vogelaar I, Kuntz KM, Knudsen Ab, Wilschut JA, Zauber AG, van Ballegooijen M. Stool DNA testing to screen for colorectal cancer in the medicare population: a cost-effectiveness analysis. Annals of Internal Medicine 2010; 153:368-377.

Lassman AB, Iwamoto FM, Cloughesy TF, Aldape KD, Rivera AL, Eichler A, Louis DN, Paleologos NA, Fisher B, Ashby L, Carirncross JG, Roldan GB, Wen PY, Ligon, KL, Schiff D, Robins I, Rocque BG, Chamberlain MC, Mason WP, Weaver S, Green RM, Kamar FG, Abrey LE, DeAngelis LM, Jhanwar S, Rosenblum MK, Panageas KS. International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. Neurology-Oncology 2010;(in press).

Levin TT, Riskind J, Li Y. Looming cognitive style and quality of life in a cancer cohort. Palliative Supportive Care 2010;8:449-454.

Lindau S, Sandbo S, Goldfarb S, Dickler M. Sexuality, breast cancer and aging: a multidisciplinary and life course perspective. Cancer and Sexuality; editors: Mulhall JP, Goldstein I, Incrocci L, Rosen R. Springer 2010;(in press).

Liu F, Zhao B, Krug LM, Ishill NM, Lim RC, Guo P, Gorski M, Flores R, Moskowitz CS, Rusch VW, Schwartz LH. Assessment of therapy responses and prediction of survival in malignant pleural mesothelioma through computer-aided volumetric measurement on computed tomography scans. Journal of Thoracic Oncology 2010;5:879-884.

Lovelock DM, Zhang Z, Jackson A, Keam J, Bekelman J, Bilsky M, Lis E, Yamada Y. Correlation of local failure with measures of dose insufficiency in the high-dose single-fraction treatment of bony metastases. International Journal of Radiation Oncology, Biology, Physics 2010;77:1282-1287.

Lowrance WT, Elkin EB, Eastham JA. Minimally invasive vs open radical prostatectomy (letter to the editor). Journal of the American Medical Association 2010;303:619-620.

Lowrance WT, Elkin EB, Jacks LM, Yee DS, Jang TL, Laudone VP, Guillonneau BD, Scardino PT, Eastham JA. Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes. Journal of Urology 2010;183:1366-1372. Erratum in: Journal of Urology 2010;184:808.

Lowrance WT, Yee DS, Savage C, Cronin AM, O’Brien MF, Donat SM, Vickers A, Russo P. Complications after radical and partial nephrectomy as a function of age. The Journal of Urology 2010;183:1725-1730.

Lowrance WT, Elkin EB, Scardino PT, Eastham JA. Words of wisdom. Re: Comparative effectiveness of minimally invasive vs open radical prostatectomy. European Urology 2010;57:538.

Ludwig E, Olson SH, Bayuga S, Simon JA, Schattner MA, Gerdes H, Allen PJ, Jarnagin WR, Kurtz RC.  Feasibility and yield of screening in relatives from familial pancreatic cancer families. American Journal of Gastroenterology 2010;(in press).

Ma J, Liu W, Zhang L, Pan K, Zhao H, Zhou T, Winawer S, Zauber A, Classen M, You W. A placebo controlled trial of 10-day bismuth-based quadruple therapy to eradicate helicobacter pylori infection; a pilot study for the large Linqu Country trial. European Journal of Gastroenterology & Hepatology 2010;22:597-601.

Maker AV, Katabi N, Gönen M, Dematteo RP, D’Angelica MI, Fong Y, Jarnagin WR, Brennan MF, Allen PJ. Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas. Annals of Surgical Oncology 2010;[epub ahead of print].

Malone KE, Begg CB, Haile RW, Borg A, Concannon P, Tellhed L, Xue S, Teraoka S, Bernstein L, Capanu M, Reiner AS, Riedel ER, Thomas DC, Mellemkjaer L, Lynch CF, Boice JD Jr, Anton-Culver H, Bernstein JL. Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. Journal of Clinical Oncology 2010; 28:2404-2410.

Marti JL, Dauer LT, Stempel M, Patil S, Kaplan JB, Montgomery LL. Cumulative imaging radiation exposure following breast-conservation therapy. Annals of Surgical Oncology 2010;[epub ahead of print].

Marubayashi S, Koppikar P, Taldone T, Abdel-Wahab O, West N, Bhagwat N, Caldas-Lopes E, Ross KN, Gönen M, Gozman A, Ahn JH, Rodina A, Ouerfelli O, Yang G, Hedvat C, Bradner JE, Chiosis G, Levine RL. HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans. Journal of Clinical Investigation 2010;120:3578-3593.

Mathew S, Adel N, Rice RD, Panageas K, Duck ET, Comenzo RL, Kewalramani T, Nimer SD. Retrospective comparison of the effects of filgrastim and pegfilgrastim on the pace of engraftment in auto-SCT patients. Bone Marrow Transplantation 2010;45:1522-1527.

Medina OP, Pillarsetty N, Glekas A, Punzalan B, Longo V, Gönen M, Zanzonico P, Smith-Jones P, Larson SM. Optimizing tumor targeting of the lipophilic EGFR-binding radiotracer SKI243 using a liposomal nanoparticle delivery system. Journal of Controlled Release 2010;[epub ahead of print].

Meirelles GS, Gönen M, Strauss HW. 18F-FDG uptake and calcifications in the thoracic aorta on positron emission tomography/computed tomography examinations: frequency and stability on serial scans. Journal of Thoracic Imaging 2010;[epub ahead of print].

Meirelles GS, Schoder H, Ravizzini GC, Gönen M, Fox JJ, Humm J, Morris M, Scher HI, Larson SM. Prognostic value of baseline [18f] fluorodeoxyglucose positron emission tomography and 99mtc-mdp bone scan in progressing metastatic prostate cancer. Clinical Cancer Research 2010;[epub ahead of print].

Mezhir JJ, Gönen M, Ammori JB, Strong VE, Brennan MF, Coit DG. Treatment and outcome of patients with gastric remnant cancer after resection for peptic ulcer disease. Annals of Surgical Oncology 2010;[epub ahead of print].

Mironov O, Ishill NM, Mironov S, Vargas HA, Zheng J, Moskowitz CS, Sonoda Y, Papas RS, Chi DS, Hricak H.Pleural Effusion detected at CT prior to primary cytoreduction for stage III or IV ovarian carcinoma: effect on survival. Radiology 2010;[epub ahead of print].

Mo Q, Liang F. A hidden Ising model for ChIP-chip data analysis. Bioinformatics 2010;26:777-783.

Mo Q, Liang F. Bayesian modeling of ChIP-chip data through a high-order Ising model. Biometrics 2010;66:1284-1294.

Molina AM, Feldman DR, Ginsberg MS, Kroog G, Tickoo SK, Jia X, Georges M, Patil S, Baum MS, Reuter VE, Motzer RJ. Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma. Investigational New Drugs 2010;[epub ahead of print].

Molina AM, Tickoo SK, Ishill N, Trinos MJ, Schwartz LH, Patil S, Feldman DR, Reuter VE, Russo P, Motzer RJ. Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease. American Journal of Clinical Oncology 2010;[epub ahead of print].

Moreira AL, Gonen M, Rekhtman N, Downey RJ. Progenitor stem cell marker expression by pulmonary carcinomas. Modern Pathology 2010;23:889-895.

Morris PG, Lynch C, Feeney JN, Patil S, Howard J, Larson SM, Dickler M, Hudis CA, Jochelson M, McArthur HL. Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancer. Journal of Clinical Oncology 2010;28:3154-3159.

Morris PG, Poznak CV, Modi S, Mak AF, Patil S, Larson S, Hudis CA, Divgi C, Grewal RK. Intravenous bisphosphonate therapy does not acutely alter nuclear bone scan results. Clinical Breast Cancer 2010;10:33-39.

Morris K, Tuorto S, Gönen M, Schwartz L, Dematteo R, D’Angelica M, Jarnagin WR, Fong Y. Simple measurement of intra-abdominal fat for abdominal surgery outcome prediction. Archives of Surgery 2010;145:1069-1073.

Morrogh M, Miner TJ, Park A, Jenckes A, Gönen M, Seidman A, Morrow M, Jaques DP, King TA.A prospective evaluation of the durability of palliative interventions for patients with metastatic breast cancer. Cancer 2010;116:3338-3347.

Morrogh M, Park A, Elkin EB, King TA. Lessons learned from 416 cases of nipple discharge of the breast. American Journal of Surgery 2010;[epub ahead of print].

Mosher CE, DuHamel KN, Rini CM, Li Y, Isola L, Labay L, Rowley S, Papadopoulos E, Moskowitz C, Scigliano E, Grosskreutz C, Redd WH. Barriers to mental health service use among hematopoietic SCT survivors. Bone Marrow Transplantation 2010;45:570-579.

Moskowitz CH, Schöder H, Teruya-Feldstein J, Sima C, Iasonos A, Portlock CS, Straus D, Noy A, Palomba ML, O’Connor OA, Horwitz S, Weaver SA, Meikle JL, Filippa DA, Caravelli JF, Hamlin PA, Zelenetz AD. Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in advanced-stage diffuse large B-cell lymphoma. Journal of Clinical Oncology 2010;28:1896-1903.

Moskowitz CH, Yahalom J, Zelenetz AD, Zhang Z, Filippa D, Teruya-Feldstein J, Kewalramani T, Moskowitz AJ, Rice RD, Maragulia J, Vanak J, Trippett T, Hamlin P, Horowitz S, Noy A, O’Connor OA, Portlock C, Straus D, Nimer SD. High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging. British Journal of Haematology 2010;148:890-897.

Moulding HD, Lis E, Lovelock DM, Zhang Z, Yamada Y, Bilsky MH. Local disease control after decompressive surgery and adjuvant high dose single fraction radiosurgery for spine metastases. Journal of Neurology - Spine 2010;13:87-93.

Nagula S, Ishill N, Nash C, Markowitz AJ, Schattner MA, Temple L, Weiser MR, Thaler HT, Zauber A, Gerdes H. Quality of life and symptom control after stent placement or surgical palliation of malignant colorectal obstruction. American College of Surgeons 2010;210:45-53.

Nakahara T, Uchi H, Lesokhin AM, Avogadri F, Rizzuto GA, Hirschhorn-Cymerman D, Panageas KS, Merghoub T, Wolchok JD, Houghton AN. Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs. Blood 2010;115:4384-4392. 

Nash GM, Row D, Weiss A, Shia J, Guillem JG, Paty PB, Gönen M, Weiser MR, Temple LK, Fitzmaurice G, Wong WD. A predictive model for lymph node yield in colon cancer resection specimens. Annals of Surgery 2010;[epub ahead of print].

Nash GM, Weiss A, Dasgupta R, Gonen M, Guillem JG, Wong WD. Close distal margin and rectal cancer recurrence after sphincter-preserving rectal resection. Diseases of the Colon and Rectum 2010;53:1365-1373 

Navi BB, Reichman JS, Berlin D, Reiner AS, Panageas KS, Segal AZ, DeAngelis LM. Intracerebral and subarachnoid hemorrhage in patients with cancer. Neurology 2010;74:494-501.

Near AM, Wu AH, Templeman C, Van Den Berg DJ, Doherty JA, Rossing MA, Goode EL, Cunningham JM, Vierkant RA, Fridley BL, Chenevix-Trench G, Webb PM, Kjær SK, Hogdall E, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Schildkraut JM, Moorman PG, Palmieri RT, Ness RB, Moysich K, Cramer DW, Terry KL, Vitonis AF, Pike MC, Berchuck A, Pearce CL; Ovarian Cancer Association Consortium; Australian Cancer Study (Ovarian Cancer) (ACS); Australian Ovarian Cancer Study Group (AOCS). Ovarian Cancer Association Consortium. Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort. Fertility and Sterility 2010;[epub ahead of print].

Neuman HB, Morrogh M, Gönen M, Van Zee KJ, Morrow M, King TA. Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter? Cancer 2010;[epub ahead of print].

Neuman HB, Patil S, Fuzesi S, Wong WD, Weiser MR, Guillem JG, Paty PB, Nash GM, Temple LK. Impact of a temporary stoma on the quality of life of rectal cancer patients undergoing treatment. Annals of Surgical Oncology 2010;[epub ahead of print].

Ney DE, Reiner AS, Panageas KS, Brown HS, Deangelis LM, Abrey LE. Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience. Cancer 2010;116:4605-4612.

Notaridou M, Quaye L, Dafou D, Jones C, Song H, Høgdall E, Kjaer SK, Christensen L, Høgdall C, Blaakaer J, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Gentry-Maharaj A, Wozniak E, Sher T, Jacobs IJ, Tyrer J, Schildkraut JM, Moorman PG, Iversen ES, Jakubowska A, Medrek K, Lubiński J, Ness RB, Moysich KB, Lurie G, Wilkens LR, Carney ME, Wang-Gohrke S, Doherty JA, Rossing MA, Beckmann MW, Thiel FC, Ekici AB, Chen X, Beesley J, Gronwald J, Fasching PA, Chang-Claude J, Goodman MT, Chenevix-Trench G, Berchuck A, Pearce CL, Whittemore AS, Menon U, Pharoah PD, Gayther SA, Ramus SJ; The Australian Ovarian Cancer Study Group/Australian Cancer Study (Ovarian Cancer); on behalf of the Ovarian Cancer Association Consortium. Ovarian Cancer Association Consortium. Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. International Journal of Cancer 2010;[epub ahead of print].

O’Cearbhaill R, Zhou Q, Iasonos A, Hensley ML, Tew WP, Aghajanian C, Spriggs DR, Lichtman SM, Sabbatini PJ. The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment. Gynecologic Oncology 2010;116:326-331.

O’Cearbhaill R, Zhou Q, Iasonos A, Soslow RA, Leitao MM, Aghajanian C, Hensley ML. Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors. Gynecologic Oncology 2010;116:424-429.

O’Connor OA, Portlock C, Moskowitz C, Hamlin P, Straus D, Gerecitano J, Gönen M, Dumitrescu O, Sarasohn D, Butos J, Neylon E, Mac-Gregor Cortelli B, Blumel S, Evens AM, Zelenetz AD, Wright J, Cooper B, Winter J, Vose J. Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypes. Clinical Cancer Research 2010;16:719-726.

Oliveria SA, Heneghan MK, Cushman LF, Ughetta EA, Halpern AC. Skin cancer screening by dermatologists, family practitioners, and internists: barriers and facilitators. Journal of the American Academy of Dermatology 2010;[epub ahead of print].

Olson SH, Chou JF, Ludwig E, O’Reilly E, Allen PJ, Jarnagin WR, Bayuga S, Simon J, Gonen M, Reisacher WR, Kurtz RC. Allergies, obesity, other risk factors and survival from pancreatic cancer. International Journal of Cancer 2010;127:2412-2419.

Olson SH, Layne T, Simon JA, O’Reilly E, Allen PJ, Kurtz RC.  Studying cancer in minorities: look at the numbers. Cancer 2010;(in press).

Osborne JR, Port E, Gönen M, Doane A, Yeung H, Gerald W, Cook JB, Larson S. 18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis. Journal of Nuclear Medicine 2010;51:543-550.

Ostrovnaya I, Begg CB. “Testing clonal relatedness of tumors using array CGH: A statistical challenge”,  Clinical Cancer Research 2010;16:1358.

Ostrovnaya I, Nanjangud G, Olshen AB. A classification model for distinguishing copy number variants from cancer-related alterations. BMC Bioinformatics 2010;11:297.

Ostrovnaya I, Olshen A, Seshan VE, Orlow I, Albertson DG, Begg CB, “A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data.” Statistics in Medicine 2010;29:1608-1621.

Oxnard GR, Arcila ME, Sima CS, Riely GJ, Chmielecki J, Kris MG, Pao W, Ladanyi M, Miller VA. Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR mutant lung cancer: Distinct natural history of patients with tumors harboring the T790M mutation. Clinical Cancer Research 2010;[epub ahead of print].

Park SY, Gönen M, Kim HJ, Michor F, Polyak K. Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. Journal of Clinical Investigation 2010;120:636-644.

Patel KJ, Rice RD, Hawke R, Abboud M, Heller G, Scaradavou A, Young JW, Barker JN. Pre-engraftment syndrome after double unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease.  Biology of Blood and Marrow Transplantation 2010;16:35-40.

Patil S, Figlin RA, Hutson TE, Michaelson MD, Négrier S, Kim ST, Huang X, Motzer RJ. Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma. Annals of Oncology 2010;[epub ahead of print].

Patil S, Ishill N, Deluca J, Motzer RJ. Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients: implications for clinical trial design and interpretation. Cancer 2010;116:347-354.

Penack O, Henke E, Suh D, King CG, Smith OM, Na IK, Holland AM, Ghosh A, Lu SX, Jenq RR, Liu C, Murphy GF, Lu TT, May C, Scheinberg DA, Gao DC, Mittal V, Heller G, Benezra R, van den Brink MR. Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth. Journal of the National Cancer Institute 2010;102: 894-908.

Perales MA, Jenq R, Goldberg JD, Wilton AS, Lee SS, Castro-Malaspina HR, Hsu K, Papadopoulos EB, van den Brink MR, Boulad F, Kernan NA, Small TN, Wolden S, Collins NH, Chiu M, Heller G, O’Reilly RJ, Kewalramani T, Young JW, Jakubowski AA. Second-line age-adjusted international prognostic index in patients with advanced non-hodgkin lymphoma after t-cell depleted allogeneic hematopoietic SCT. Bone Marrow Transplantation 2010;45:1408-1416.

Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, Arslan AA, Bueno-de-Mesquita HB, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, Klein AP, LaCroix A, Li D, Mandelson M, Olson SH, Risch HA, Zheng W, Albanes D, Bamlet W, Berg CD, Boutron-Rualt M-C, Buring JE, Bracci PM, Canzian F, Clipp S, Cotterchio M, de Andrade M, Duell EJ, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hankinson SE, Hassan M, Howard B, Hunter DJ, Hutchinson A, Jenab M, Kaaks R, Kooperberg C, Krogh V, Kurtz RC, Lynch SM, McWilliams RR, Mendelsohn JB, Michaud DS, Overvad K, Parikh H, Patel AV, Peeters PHM, Rajkovic A, Riboli E, Rodriguez L, Seminara D, Shu X-O, Thomas G, Tobias GS, Trichopoulos D, Van Den Eeden SK, Virtamo J, Wactawski-Wende J, Wang Z, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Fraumeni JF, Jr., Hoover RN, Hartge P, Chanock SJ. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nature Genetics 2010;42:224-228.

Pfister DG, Cassileth BR, Deng GE, Yeung KS, Lee JS, Garrity D, Cronin A, Lee N, Kraus D, Shaha AR, Shah J, Vickers AJ. Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial. Journal of Clinical Oncology 2010;28:2565-2570.

Phelan CM, Tsai YY, Goode EL, Vierkant RA, Fridley BL, Beesley J, Chen XQ, Webb PM, Chanock S, Cramer DW, Moysich K, Edwards RP, Chang-Claude J, Garcia-Closas M, Yang H, Wang-Gohrke S, Hein R, Green AC, Lissowska J, Carney ME, Lurie G, Wilkens LR, Ness RB, Pearce CL, Wu AH, Van Den Berg DJ, Stram DO, Terry KL, Whiteman DC, Whittemore AS, DiCioccio RA, McGuire V, Doherty JA, Rossing MA, Anton-Culver H, Ziogas A, Hogdall C, Hogdall E, Krüger Kjaer S, Blaakaer J, Quaye L, Ramus SJ, Jacobs I, Song H, Pharoah PD, Iversen ES, Marks JR, Pike MC, Gayther SA, Cunningham JM, Goodman MT, Schildkraut JM, Chenevix-Trench G, Berchuck A, Sellers TA; Ovarian Cancer Association Consortium, Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group. Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium.  Cancer Epidemiology, Biomarkers, Prevention 2010;19:600-604.

Pinochet R, Nogueira L, Cronin AM, Katz D, Rabbani F, Guillonneau B, Touijer K. Role of short-term antibiotic therapy at the moment of catheter removal after laparoscopic radical prostatectomy. Urology International 2010;85:415-420.

Politi K, Fan PD, Shen R, Zakowski M, Varmus H. Erlotinib resistance in mouse models of epidermal growth factor receptor-induced lung adenocarcinoma. Disease Models Mechanisms 2010;3:111-119.

Port ER, Patil S, Stempel M, Morrow M, Cody HS 3rd. Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment? Cancer 2010;116:1987-1991.

Poynter JN, Langholz B, Largent J, Mellemkjaer L, Bernstein L, Malone KE, Lynch CF, Borg A, Concannon P, Teraoka SN, Xue S, Diep AT, Törngren T, Begg CB, Capanu M, Haile RW; WECARE Study Collaborative Group, Bernstein JL. Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study. Cancer Causes Control 2010;21:839-846.

Pugliese MS, Karam AK, Hsu M, Stempel MM, Patil SM, Ho AY, Traina TA, Van Zee KJ, Cody HS 3rd, Morrow M, Gemignani ML. Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer. Annals of Surgical Oncology 2010;17:1063-1068.

Pugliese M, Stempel M, Patil S, Hsu M, Ho A, Traina T, Morrow M, Cody H 3rd, Gemignani ML. The clinical impact and outcomes of immunohistochemistry-only metastasis in breast cancer. American Journal of Surgery 2010;200:368-373.

Razavi P, Pike MC, Horn-Ross PL, Templeman C, Bernstein L, Ursin G. Long-term postmenopausal hormone therapy and endometrial cancer. Cancer Epidemiology, Biomarkers, Prevention 2010;19:475-483.

Reding KW, Bernstein JL, Langholz BM, Bernstein L, Haile RW, Begg CB, Lynch CF, Concannon P, Borg A, Teraoka SN, Törngren T, Diep A, Xue S, Bertelsen L, Liang X, Reiner AS, Capanu M, Malone KE; WECARE Collaborative Study Group. Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Research and Treatment 2010;123:491-498.

Reinersman JM, Johnson ML, Riely GJ, Chitale DA, Nicastri AD, Soff GA, Schwartz AG, Sima CS, Ayalew G, Lau C, Zakowski MF, Rusch VW, Ladanyi M, Kris MG. Frequency of EGFR and KRAS mutations in lung adenocarcinomas in African Americans. Journal of Thoracic Oncology 2010;(in press).

Robertson LB, Armstrong GN, Olver BD, Lloyd AL, Shete S, Lau C, Claus EB, Barnholtz-Sloan J, Lai R, Il’yasova D, Schildkraut J, Bernstein JL, Olson SH, Jenkins RB, Yang P, Rynearson AL, Wrensch M, McCoy L, Wienkce JK, McCarthy B, Davis F, Vick NA, Johansen C, Bødtcher H, Sadetzki S, Bruchim RB, Yechezkel GH, Andersson U, Melin BS, Bondy ML, Houlston RS. Survey of familial glioma and role of germline p16INK4A/p14ARF and p53 mutation. Familial Cancer 2010;9:413-421.

Robson PC, Heffernan N, Gönen M, Thornton R, Brody LA, Holmes R, Brown KT, Covey AM, Fleischer D, Getrajdman GI, Jarnagin W, Sofocleous C, Blumgart L, D’Angelica M. Prospective study of outcomes after percutaneous biliary drainage for malignant biliary obstruction. Annals of Surgical Oncology 2010;[epub ahead of print].

Rodriguez-Urrego PA, Cronin AM, Al-Ahmadie HA, Gopalan A, Tickoo SK, Reuter VE, Fine SW. Interobserver and intraobserver reproducibility in digital and routine microscopic assessment of prostate needle biopsies. Human Pathology 2010;[epub ahead of print].

Rose AE, Satagopan JM, Oddoux C, Zhou Q, Xu R, Olshen AB, Yu JZ, Dash A, Jean-Giles J, Reuter V, Gerald WL, Lee P, Osman I. Copy number and gene expression differences between African American and Caucasian American prostate cancer. Journal of Translational Medicine 2010;[epub ahead of print].

Rosenblat TL, McDevitt MR, Mulford DA, Pandit-Taskar N, Divgi CR, Panageas KS, Heaney ML, Chanel S, Morgenstern A, Sgouros G, Larson SM, Scheinberg DA, Jurcic JG.  Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia.  Clinical Cancer Research 2010;16:5303-5311.

Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, Real FX, Van Den Berg D, Matullo G, Baris D, Thun M, Kiemeney LA, Vineis P, De Vivo I, Albanes D, Purdue MP, Rafnar T, Hildebrandt MA, Kiltie AE, Cussenot O, Golka K, Kumar R, Taylor JA, Mayordomo JI, Jacobs KB, Kogevinas M, Hutchinson A, Wang Z, Fu YP, Prokunina-Olsson L, Burdett L, Yeager M, Wheeler W, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole G Jr, Grubb R 3rd, Black A, Jacobs EJ, Diver WR, Gapstur SM, Weinstein SJ, Virtamo J, Cortessis VK, Gago-Dominguez M, Pike MC, Stern MC, Yuan JM, Hunter DJ, McGrath M, Dinney CP, Czerniak B, Chen M, Yang H, Vermeulen SH, Aben KK, Witjes JA, Makkinje RR, Sulem P, Besenbacher S, Stefansson K, Riboli E, Brennan P, Panico S, Navarro C, Allen NE, Bueno-de-Mesquita HB, Trichopoulos D, Caporaso N, Landi MT, Canzian F, Ljungberg B, Tjonneland A, Clavel-Chapelon F, Bishop DT, Teo MT, Knowles MA, Guarrera S, Polidoro S, Ricceri F, Sacerdote C, Allione A, Cancel-Tassin G, Selinski S, Hengstler JG, Dietrich H, Fletcher T, Rudnai P, Gurzau E, Koppova K, Bolick SC, Godfrey A, Xu Z, Sanz-Velez JI, D García-Prats M, Sanchez M, Valdivia G, Porru S, Benhamou S, Hoover RN, Fraumeni JF Jr, Silverman DT, Chanock SJ. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nature Genetics 2010;42:978-984.

Rudloff  U, Brogi E, Reiner AS, Goldberg JI, Brockway JP, Wynveen CA, McCormick B, Patil S, Van Zee KJ. The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy. Annals of Surgery 2010;251:583-591.

Rudloff  U, Jacks LM, Goldberg JI, Wynveen CA, Brogi E, Patil S, Van Zee KJ. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. Journal of Clinical Oncology 2010;28:3762-3769.

Sabbatini P, Spriggs D, Aghajanian C, Hensley M, Tew W, Konner J, Bell-McGuinn K, Juretzka M, Iasonos A. Consolidation strategies in ovarian cancer: observations for future clinical trials. Gynecologic Oncology 2010;116:66-71.

Sala E, Kataoka M, Pandit-Taskar N, Ishill N, Mironov S, Moskowitz CS, Mironov O, Collins MA, Chi DS, Larson S, Hricak H. Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients’ survival. Radiology 2010;257:125-134.

Salz T, DeFrank JT, Brewer NT.  False positive mammograms in Europe: Do they affect reattendance?  [Invited commentary]  Breast Cancer Research and Treatment 2010;(in press).

Salz T, Gottlieb SL, Smith JS, Brewer NT. The association between cervical abnormalities and attitudes toward cervical cancer prevention. Journal of Women’s Health 2010;19:2011-2016.

Salz T, Richman AR, Brewer NT. Meta-analyses of the effect of false-positive mammograms on generic and specific psychosocial outcomes. Psycho-oncology 2010;19:1026-1034.

Salz T, Weinberger M, Ayanian JZ, Brewer NT, Earle CC, Elston Lafata J, Fisher DA, Weiner BJ, Sandler RS. Variation in use of surveillance colonoscopy among colorectal cancer survivors in the United States. BMC Health Services Research 2010;10:256.

Satagopan JM, Zhou Q, Oliveria SA, Dusza SW, Weinstock Ma, Berwick M, Halpern AC. Properties of preliminary test estimators and shrinkage estimators for evaluating multiple exposures – application to questionnaire data from the SONIC study. Journal of the Royal Statistical Society – Series C 2010;(in press).

Savage CJ, Lilja H, Cronin AM, Ulmert D, Vickers AJ. Empirical estimates of the lead time distribution for prostate cancer based on two independent representative cohorts of men not subject to prostate-specific antigen screening. Cancer Epidemiology Biomarkers Prevention 2010;19:1201-1207.

Scheurer ME, Etzel CJ, Liu M, Barnholtz-Sloan J, Wiklund F, Tavelin B, Wrensch MR, Melin BS, Bondy ML, Olson SH:GLIOGENE Consortium. Familial aggregation of glioma: a pooled analysis. American Journal of Epidemiology 2010;172:1099-1107.

Schmidtlein CR, Beattie BJ, Bailey DL, Akhurst TJ, Wang W, Gönen M, Kirov AS, Humm JL. Using an external gating signal to estimate noise in PET with an emphasis on tracer avid tumors. Physics in Medicine and Biology 2010;55:6299-6326.

Scope A, Dusza SW, Marghoob AA, Satagopan JM, Braga CTJ, Psati EL, Weinstock MA, Oliveria SA, Bishop M, Geller AC, Halpern AC. Clinical and dermascopic stability and volatility of melanocytic nevi in a population-based cohort of children in the Framingham school system. Journal of Investigative Dermatology 2010;[epub ahead of print].

Setton J, Caria N, Romanyshyn J, Koutcher L, Wolden SL, Zelefsky MJ, Rowan N, Sherman EJ, Fury MG, Pfister DG, Wong RJ, Shah JP, Kraus DH, Shi W, Zhang Z, Schupak KD, Gelblum DY, Rao SD, Lee NY. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center Experience. International Journal of Radiation Oncology, Biology, Physics 2010;(in press).

Shah MA, Capanu M, Soff G, Asmis T, Kelsen DP. Risk factors for developing a new venous thromboembolism in ambulatory patients with non-hematologic malignancies and impact on survival for gastroesophageal malignancies. Journal of Thrombosis and Haemostasis 2010;8:1702-1709.

Shah MA, Jhawer M, Ilson DH, Lefkowitz RA, Robinson E, Capanu M, Kelsen DP. Phase II study of modified docetaxel, cisplatin, and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma. Journal of Clinical Oncology 2010;[epub ahead of print].

Shah MA, Power DG, Kindler HL, Holen KD, Kemeny MM, Ilson DH, Tang L, Capanu M, Wright JJ, Kelsen DP. A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma. Investigational New Drugs 2010;[epub ahead of print].  

Shah GD, Socci ND, Gold JS, Wolchok JD, Carvajal RD, Panageas KS, Viale A,Brady MS, Coit DG, Chapman PB. Phase II trial of neoadjuvant temozolomide in resectable melanoma patients. Annals of Oncology 2010;21:1718-1722.
 

Shih KK, Zhou Q, Huh J, Morgan JC, Iasonos A, Aghajanian C, Chi DS, Barakat RR, Abu-Rustum NR. Risk factors for recurrence of ovarian borderline tumors. Gynecologic Oncology 2010;[epub ahead of print].

Shih KK, Zhou QC, Aghajanian C, Huh J, Soslow RA, Morgan JC, Iasonos A, Chi DS, Barakat RR, Abu-Rustum NR. Patterns of recurrence and role of adjuvant chemotherapy in stage II-IV serous ovarian borderline tumors. Gynecologic Oncology 2010;119:270-273.

Sica G, Yoshizawa A, Sima CS, Azzoli CG, Downey RJ, Rusch VW, Travis WD, Moreira AL. A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. American Journal of Surgical Pathology 2010;34:1155-1162.

Siegrist T, Savage C, Shabsigh A, Cronin A, Donat SM. Analysis of gender differences in early perioperative complications following radical cystectomy at a tertiary cancer center using a standardized reporting methodology. Urologic Oncology 2010;28:112-117.

Silberhumer GR, Brader P, Wong J, Serganova IS, Gönen M, Gonzalez SJ, Blasberg R, Zamarin D, Fong Y. Genetically engineered oncolytic newcastle disease virus effectively induces sustained remission of malignant pleural mesothelioma. Molecular Cancer Therapies 2010;[Epub ahead of print].

Sima CS, Panageas KS, Heller G, Schrag D. Analytical strategies for characterizing chemotherapy diffusion with patient-level population-based data. Applied Health Economics and Health Policy 2010;8:37-51.

Sima CS, Panageas KS, Schrag D. Cancer screening among patients with advanced cancer. Journal of the American Medical Association 2010;304:1584-1591.

Singnurkar A, Solomon SB, Gönen M, Larson SM, Schöder H. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions. Journal of Nuclear Medicine 2010;[epub ahead of print].

Smith SM, Ford JS, Rakowski W, Moskowitz CS, Diller L, Hudson MM, Mertens AC, Stanton AL, Henderson TO, Leisenring WM, Robison LL, Oeffinger KC. Inconsistent mammography perceptions and practices among women at risk of breast cancer following a pediatric malignancy: a report from the Childhood Cancer Survivor Study. Cancer Causes Control 2010;21:1585-1595.

Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gönen M, Obuchowski N, Pencina MJ, Kattan MW. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010;21:128-138.

Strong VE, Song KY, Park CH, Jacks LM, Gönen M, Shah M, Coit DG, Brennan MF. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Annals of Surgery 2010;[epub ahead of print].

Stubblefield MD, Manfield L, Riedel ER. A preliminary report on the efficacy of a dynamic jaw opening device (dynasplint trismus system) as part of the multimodal treatment of trismus in patients with head and neck cancer. Archives of Physical Medicine and Rehabilitation 2010;91:1278-1282.

Terezakis SA, Hunt MA, Kowalski A, McCann P, Schmidtlein CR, Reiner A, Gönen M, Kirov AS, Gonzales AM, Schöder H, Yahalom J. 18FFDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of  lymphoma and hematologic malignancies. International Journal of Radiation Oncology, Biology, Physics 2010;[epub ahead of print].

Terushkin V, Oliveria SA, Marghoob AA, Halpern AC. Use of and beliefs about total body photography and dermatoscopy among US dermatology training programs: an update. Journal of the American Academy of Dermatology 2010;62:794-803.

Thomas NE. Kricker A, From L, Busam K, Millikan RC, Ritchey ME, Armstrong BK, Lee-Taylor J, Marrett LD, Anton-Culver H, Zanetti R, Rosso S, Gallagher RP, Dwyer T, Goumas C, Kanetsky PA, Begg CB, Orlow I, Wilcox H, Paine S, Berwick M, The GEM Study Group. Associations of cumulative sun exposure and phenotypic characteristics with histologic solar elastosis. Cancer Epidemiology Biomarkers and Prevention 2010;19:2932-2941.

Touijer K, Fuenzalida RP, Rabbani F, Paparel P, Nogueira L, Cronin AM, Fine SW, Guillonneau B. Extending the indications and anatomical limits of pelvic lymph node dissection for prostate cancer: improved staging or increased morbidity? BJU International 2010;[epub ahead of print].

Traina TA, Rugo HS, Caravelli JF, Patil S, Yeh B, Melisko ME, Park JW, Geneus S, Paulson M, Grothusen J, Seidman AD, Fornier M, Lake D, Dang C, Robson M, Theodoulou M, Flombaum CD, Norton L, Hudis CA, Dickler MN. Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer. Journal of Clinical Oncology 2010;28:628-633.

Turbendian HK, Strong VE, Hsu M, Ghossein RA, Fahey TJ 3rd. Adrenocortical carcinoma: the influence of large vessel extension. Surgery 2010;148:1057-1064; discussion 1064.

Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R, Gonen M, Brokhin M, Omry G, Fagin JA, Shaha A. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid 2010;20:1341-1349.

van Ballegooijen M, Boer R, Zauber AG. Simulation of colorectal cancer screening: what we do and do not know and does it matter. Best Practice and Research. Clinical Gastroenterology 2010;24:427-437.

Vickers A. Dutasteride reduces incident prostate cancer in men after negative prostate biopsy. Evidence-based Medicine 2010;15:119-120.

Vickers A, Bianco F, Cronin A, Eastham J, Klein E, Kattan M, Scardino P. The learning curve for surgical margins after open radical prostatectomy: implications for margin status as an oncological end point. The Journal of Urology 2010;183:1360-1365.

Vickers A, Cronin A, Roobol M, Savage C, Peltola M, Pettersson K, Scardino PT, Schröder F, Lilja H. Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication. Journal of Clinical Oncology 2010;28:2493-2498.

Vickers AJ, Cronin AM, Aus G, Pihl CG, Becker C, Pettersson K, Scardino PT, Hugosson J, Lilja H. Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European randomized study of prostate cancer screening in Gothenburg, Sweden. Cancer 2010;116:2612-2620.

Vickers AJ, Cronin AM, Maschino AC, Lewith G, Macpherson H, Victor N, Sherman KJ, Witt C, Linde K; Acupuncture Trialists’ Collaboration. Individual patient data meta-analysis of acupuncture for chronic pain: protocol of the Acupuncture Trialists’ Collaboration. Trials 2010;11:90.

Vickers AJ, Cronin AM, Masterson TA, Eastham JA. How do you tell whether a change in surgical technique leads to a change in outcome? The Journal of Urology 2010;183:1510-1514.

Vickers AJ, Cronin AM, Roobol MJ, Hugosson J, Jones JS, Kattan MW, Klein E, Hamdy F, Neal D, Donovan J, Parekh DJ, Ankerst D, Bartsch G, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Freedland SJ, Moreira DM, Schröder FH, Lilja H. The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group. Clinical Cancer Research 2010;16:4374-4381.

Vickers AJ, Cronin AM, Roobol MJ, Savage CJ, Peltola M, Pettersson K, Scardino PT, Schröder FH, Lilja H. A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European randomized study of screening for prostate cancer, Rotterdam. Clinical Cancer Research 2010;16:3232-3239.

Vickers AJ, Cronin AM. Data and programming code from the studies on the learning curve for radical prostatectomy. BMC Research Notes 2010;3:234.

Vickers AJ, Cronin AM. Everything you always wanted to know about evaluating prediction models (but were too afraid to ask). Urology 2010;76:1298-1301.

Vickers AJ, Cronin AM. Traditional statistical methods for evaluating prediction models are uninformative as to clinical value: towards a decision analytic framework. Seminars in Oncology 2010;37:31-38. Review.

Vickers AJ, Fearn P, Scardino PT, Kattan MW. Why can’t nomograms be more like Netflix? Urology 2010;75:511-513.

Vickers AJ, Salz T, Basch E, Cooperberg MR, Carroll PR, Tighe F, Eastham J, Rosen RC. Electronic patient self-assessment and management (SAM): a novel framework for cancer survivorship. BMC Medical Informatics Decision Making 2010;10:34.

Vickers AJ, Savage CJ, Lilja H. Finasteride to prevent prostate cancer: should all men or only a high-risk subgroup be treated? Journal of Clinical Oncology 2010;28:1112-1116.

Vickers AJ, Savage CJ, Shouery M, Eastham JA, Scardino PT, Basch EM. Validation study of a web-based assessment of functional recovery after radical prostatectomy. Health and Quality of Life Outcomes 2010;8:82.

Vickers AJ, Wolters T, Savage CJ, Cronin AM, O’Brien MF, Roobol MJ, Aus G, Scardino PT, Hugosson J, Schröder FH, Lilja H. Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy. The Journal of Urology 2010;184:907-912.

von Bodman C, Godoy G, Chade DC, Cronin A, Tafe LJ, Fine SW, Laudone V, Scardino PT, Eastham JA. Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy. The Journal of Urology 2010;184:143-148.

Westhoff CL, Torgal AH, Mayeda ER, Pike MC, Stanczyk FZ.  Pharmacokinetics of a combined oral contraceptive in obese and normal weight women.  Contraception 2010;81:474-480.

Wright JL, Patil SM, Temple LK, Minsky BD, Saltz LB, Goodman KA. Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning. International Journal of Radiation Oncology, Biology, Physics 2010;78:1064-1072.

Yee DS, Lowrance WT, Eastham JA, Maschino AC, Cronin AM, Rabbani F. Long-term  follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in  a randomized trial. BJU International 2010;105:185-190.

Yee DS, Shariate SF, Lowrance WT, Maschino AC, Savage CJ, Cronin AM, Scardino PT, Eastham JA. Prognostic significance of lymphovascular invasion in radical prostatectomy specimens. British Journal of Urology International 2010;[epub ahead of print].

Young RJ, Gupta A, Shah AD, Graber JJ, Zhang Z, Shi W, Holodny AI, Omuro AMP. Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma. Neurology 2010;(in press).

Zakian KL, Hricak H, Ishill N, Reuter VE, Eberhardt S, Moskowitz CS, Shukla-Dave A, Wang L, Scardino PT, Eastham JA, Koutcher JA. An exploratory study of endorectal magnetic resonance imaging and spectroscopy of the prostate as preoperative predictive biomarkers of biochemical relapse after radical prostatectomy. Journal of Urology 2010;184:2320-2327.

Zauber AG. Cost-effectiveness of colonoscopy. Gastrointestinal Endoscopy Clinics of North America 2010;20:751-770.

Zelefsky MJ, Eastham JA, Cronin AM, Fuks Z, Zhang Z, Yamada Y, Vickers A, Scardino PT. Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. Journal of Clinical Oncology 2010;28:1508-1513.

Zelefsky MJ, Worman M, Cohen GN, Pei X, Kollmeier M, Yamada J, Cox B, Zhang Z, Bieniek E, Dauer L, Zaider M. Real-time intraoperative computed tomography assessment of quality of permanent interstitial seed implantation for prostate cancer. Urology 2010;76:1138-1142.

Zelefsky MJ, Yamada Y, Pei X, Hunt M, Cohen GN, Zhang Z, Zaider M. Comparison of tumor control and toxicity outcomes of high dose intensity modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancer. Urology 2010;(in press).

Zhang Z, Mo Q. Biased Estimator. Encyclopedia of Research Design 2010. Editor: Neil J. Salkind. Sage Publications 2010;(in press).

Zhang Z, Sun J. Interval censoring. Statistical Methods in Medical Research 2010;19:53-70.

Zhang Z, Zhao X, Sun L. Goodness-of-fit tests for additive mean residual life model under right censoring. Lifetime Data Analysis 2010;16:385-408.

Zhao B, Oxnard GR, Moskowitz CS, Kris MG, Pao W, Guo P, Rusch VM, Ladanyi M, Rizvi NA, Schwartz LH. A pilot study of volume measurement as a method of tumor response evaluation to aid biomarker development. Clinical Cancer Research 2010;16:4647-4653.

Zivanovic O, Sima CS, Iasonos A, Hoskins WJ, Pingle PR, Leitao MM Jr, Sonoda Y, Abu-Rustum NR, Barakat RR, Chi DS. The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum. Gynecologic Oncology 2010;116:351-357.

Aberle DR, Allegra CJ, Ganschow P, Hahn SM, Lee CN, Millon-Underwood S, Pike MC, Reed SD, Saftlas AF, Scarvalone SA, Schwartz AM, Slomski C, Yothers G, Zon R.  NIH state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ (DCIS).  NIH Consensus State Sci Statements 2010 [epub ahead of print].

Abu-Rustum NR, Zhou Q, Gomez JD, Alektiar KM, Hensley ML, Soslow RA, Levine DA, Chi DS, Barakat RR, Iasonos A. A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care. Gynecologic Oncology 2010 (in press).

Akin O, Riedl CC, Ishill NM, Moskowitz CS, Zhang J, Hricak H. Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer. European Radiology 2010 [epub ahead of print].

Allen PJ, Qin LX, Tang L, Klimstra D, Brennan MF, Lokshin A. Pancreatic cyst fluid protein expression profiling for discriminating between serous cystadenoma and intraductal papillary mucinous neoplasm. Annals of Surgery 2009;250:754-760.

Amar D, Munoz D, Shi W, Zhang H, Thaler HT. A clinical prediction rule for pulmonary complications after thoracic surgery for primary lung cancer. Anesthesia and Analgesia 2010 [epub ahead of print].

Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GS, Arslan AA, Bueno- de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Zheng W, Albanes D, Bamlet W, Berg CD, Berrino F, Bingham S, Buring JE, Bracci PM, Canzian F, Clavel-Chapelon F, Clipp S, Cotterchio M, de Andrade M, Duell EJ, Fox JW Jr., Gallinger S, Gaziano JM, Giovannucci EL, Goggins M, González CA, Hallmans G, Hankinson SE, Hassan M, Holly EA, Hunter DJ, Hutchinson A, Jackson R, Jacobs K, Jenab M, Kaaks R, Klein AP, Kooperberg C, Kurtz RC, Li D, Lynch SM, Mandelson M, McWilliams RR, Mendelsohn JB, Michaud DS, Olson SH, Overvad K, Patel AV, Peeters PHM, Rajkovic A, Riboli E, Risch HA, Shu X-O, Thomas G, Tobias GS, Trichopoulos D, Van Den Eeden SK, Virtamo J, Wactawski-Wende J, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Chanock SJ, Hartge P, Hoover RN. Genome- wide association study identifies ABO blood group susceptibility variants for pancreatic cancer. Nature Genetics 2010 [epub ahead of print].

Antonescu CR, Yoshida A, Guo T, Chang NE, Zhang L, Agaram NP, Qin LX, Brennan MF, Singer S, Maki RG. KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors. Cancer Research 2009;69:7175-7179.

Ariyan C, Brady MS, Gönen M, Busam K, Coit D. Positive nonsentinel node status predicts mortality in patients with cutaneous melanoma. Annals of Surgical Oncology 2009;16:186-190.

Atkinson TM, Mendoza TR, Sit L, Passik S, Scher HI, Cleeland C, Basch E. The brief pain inventory and its “pain at its worst in the last 24 hours” item: clinical trial endpoint considerations. Pain Medicine 2010 [epub ahead of print].

Atkinson TM, Ryan JP, Lent A, Wallis A, Schachter H, Coder R. Three trail making tests for use in neuropsychological assessments with brief intertest intervals. Journal of Clinical and Experimental Neuropsychology 2010 [epub ahead of print].

Auer RC, Schulman AR, Tuorto S, Gönen M, Gonsalves J, Schwartz L, Ginsberg MS, Fong Y. Use of helical CT is associated with an increased incidence of postoperative pulmonary emboli in cancer patients with no change in the number of fatal pulmonary emboli. Journal of the American College Surgeons 2009;208:871-878; discussion 878-880.

Bach PB.  Quality wrapped in volume inside a hospital.  Annals of Internal Medicine 2009;150:729-730.

Bach PB. Commentary on health information exchange. NPR’s Marketplace, April 2, 2009.

Bach PB. Limits on Medicare’s ability to control rising spending on cancer drugs. New England Journal of Medicine 2009;360: 626-633.

Bach PB. Smoking as a factor in causing lung cancer. Journal of the American Medical Association 2009;301:539-541.

Baker SG, Cook NR, Vickers A, Kramer BS. Using relative utility curves to evaluate risk prediction. Journal Of The Royal Statistical Society Series A 2009;172:729-748.

Bamboat ZM, Stableford JA, Plitas G, Burt BM, Nguyen HM, Welles AP, Gönen M, Young JW, DeMatteo RP. Human liver dendritic cells promote T cell hyporesponsiveness. Journal of Immunology 2009;182:1901-1911.

Bandera EV, Williams MG, Sima C, Bayuga S, Pulick K, Wilcox H, Soslow R, Zauber AG, Olson SH. Phytoestrogen consumption and endometrial cancer risk: a population-based case-control study in New Jersey. Cancer Causes and Control 2009;20:1117-1127.

Barker JN, Abboud M, Rice RD, Hawke R, Schaible A, Heller G, La Russa V, Scaradavou A. A “no-wash” albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions. Biology of Blood and Marrow Transplantation 2009;15:1596-1602.

Basch E. Patient-reported outcomes in drug safety evaluation. Annals of Oncology 2009;20:1905-1906.

Basch E, Goldfarb S. Electronic patient-reported outcomes for collecting sensitive information from patients. The Journal of Supportive Oncology 2009;7:98-99.

Basch E, Jia X, Heller G, Barz A, Sit L, Fruscione M, Appawu M, Iasonos A, Atkinson T, Goldfarb S; Culkin A, Kris MG, Schrag D. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. Journal of the National Cancer Institute 2009;101:1624-1632.

Baxi SS, Liberman L, Lee C, Elkin EB. Breast imaging fellowships in the United States: Who, what and where? American Journal of Roentgenology 2009;192:403-407.

Baxi SS, Snow JG, Liberman L, Elkin EB. The future of mammography: Radiology residents’ experiences, attitudes and opinions. American Journal of Roentgenology 2010 (in press).

Begg CB. Mammography screening guidelines (Letter). Annals of Internal Medicine 2010 (in press).

Berglund RK, Stephenson AJ, Cronin AM, Vickers AJ, Eastham JA, Klein EA, Guillonneau BD. Comparison of observed biochemical recurrence-free survival in patients with low PSA values undergoing radical prostatectomy and predictions of preoperative nomogram. Urology 2009;73:1098-1103.

Bernstein JL, Haile RW, Stovall M, Boice J, Shore R, Langholz B, Thomas D, Bernstein L, Lynch C, Olsen J, Malone K, Mellemkjaer L, Borrensen-Dale A, Rosenstein B, Teraoka S, Diep A, Smith S, Capanu M, Reiner A, Liang X, Gatti RA, The WECARE Study Collaborative Group, Concannon P. Radiation exposure, the ATM gene, and contralateral breast cancer in the WECARE study. Journal of the National Cancer Institute 2010 (in press).

Bernstein JL, Thomas DC, Shore RE, Robson M, Boice JD, Stovall M, Andersson M, Bernstein L, Malone KE, Reiner AS, Lynch CF, Capanu M, Smith SA, Tellhed L, Xue S, Teraoka SN, Begg CB, Olsen JH, Mellemkjaer L, Liang X, Olson E, Diep AT, The WECARE Study Collaborative Group, Borg A, Concannon P, Haile RW. Radiation-induced second primary breast cancer and BRCA1 and BRCA2 mutation carrier status: a report from the WECARE study. Journal of the National Cancer Institute 2010. (in press).

Bertagnolli MM, Eagle CJM, Zauber AG, Redston M, Breazna A, Kim KM, Tang J, Rosenstein RB, Umar A, Bagheri, D, Collins NT, Burn J, Chung DC, Dewar T, Foley TR,  Hoffman N, Macrae F, Pruitt RE, Saltzman JR, Salzberg B, Sylwestrowicz T, Hawk ET, Adenoma Prevention with Celecoxib (APC) Study Investigators.  Five year efficacy and safety analysis of the adenoma prevention with celecoxib (APC) trial. Cancer Research Prevention 2009;2:310-312.

Bertagnolli MM, Hsu M, Hawk ET, Eagle CJ, Zauber AG. Statin use and colorectal adenoma risk:  results from the adenoma prevention with celecoxib (APC) trial. Cancer Prevention Research 2010 (in press).

Boorjian SA, Berglund RK, Maschino AC, Savage CJ, Herr HW. Fibrin clot inhibitor medication and efficacy of bacillus Calmette-Guerin for bladder urothelial cancer. Journal of Urology 2009;182:1306-1312.

Borg A, Haile RW, Capanu M, Malone KE, Diep A, Törngren T, Teraoka S, Begg CB, Thomas DC, Concannon P, Mellemkjaer L, Bernstein L, Tellhed L, Xue S, Olson ER, Liang X, Dolle J, Børresen-Dale A, The WECARE Study Collaborative Group, Bernstein JL. Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: The WECARE Study. Human Mutation 2010 (in press).

Breitbart W, Rosenfeld B, Gibson C, Kramer M, Li Y, Tomarken A, Nelson C, Pessin H, Esch J, Galietta M, Garcia N, Brechtl J, and Schuster M.  Impact of treatment for depression on desire for hastened death in patients with advanced AIDS. Psychosomatics 2010 (in press).

Brintzenhofe-Szoc KM, Levin TT, Li Y, Kissane DW, Zabora JR. Mixed anxiety/ depression symptoms in a large cancer cohort: prevalence by cancer type. Psychosomatics 2009;50:383-391.

Brooks J, Cairns P, Zeleniuch-Jacquotte A. Promoter methylation and the detection of breast cancer. Cancer Causes & Control 2009;20:1539-1550.

Brown LM, Gridley G, Wu AH, Falk RT, Hauptmann M, Kolonel LN, West DW, Nomura AM, Pike MC, Hoover RN, Ziegler RG.  Low level alcohol intake, cigarette smoking and risk of breast cancer in Asian-American women.  Breast Cancer Research and Treatment 2010 [epub ahead of print].

Bruun L, Savage C, Cronin AM, Hugosson J, Lilja H, Christensson A. Increase in percent free prostate-specific antigen in men with chronic kidney disease. Nephrology, Dialysis, Transplantation 2009;24:1238-1241.

Bylund CL, Gueguen JA, D’Agostino TA, Li Y, Sonet E.  Doctor-patient communication about cancer-related internet information. Journal of Psychosocial Oncology 2010 (in press).

Cahlon O, Brennan MF, Jia X, Qin LX, Singer S, Alektiar KM. A postoperative nomogram for local recurrence risk in extremity soft tissue sarcomas after limb-sparing surgery without adjuvant radiation. Journal of Clinical Oncology 2010 (in press).

Carpizo DR, Are C, Jarnagin W, Dematteo R, Fong Y, Gönen M, Blumgart L, D’Angelica M. Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center. Annals of Surgical Oncology 2010 [epub ahead of print].

Carvajal RD, Tse A, Shah MA, Lefkowitz RA, Gonen M, Gilman-Rosen L, Kortmansky J, Kelsen DP, Schwartz GK, O’Reilly EM. A phase II study of flavopiridol (alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer.  Pancreatology 2009;9:404-409.

Cassileth BR, Rizvi N, Deng G, Yeung KS, Vickers A, Guillen S, Woo D, Coleton M, Kris MG. Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients. Cancer Chemotherapy and Pharmacology 2009;65:67-71.

Challacombe BJ, Murphy D, Lilja H, Vickers AJ, Costello AJ. The continuing role of prostate-specific antigen asa merker for localized prostate cancer: ‘do not throw the baby out with the bathwater’. British Journal of Urology International 2009;104:1553-1554.

Chan AT, Zauber AG, Hsu M, Breazna A, Hunter DJ, Rosenstein RB, Eagle CJ, Hawk ET, Bertagnolli MM. Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma. Gastroenterology 2009;136:2127-2136.

Clarke JL, Iwamoto FM, Sul J, Panageas K, Lassman AB, DeAngelis LM, Hormigo A, Nolan CP, Gavrilovic I, Karimi S, Abrey LE. Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma. Journal of Clinical Oncology 2009;27:3861-3867.

Cohen N, Mihu CN, Seo SK, Chung D, Chou J, Heller G, Papanicolaou GA. Hematologic safety profile of linezolid in the early periengraftment period after allogeneic stem cell transplantation. Biology Blood Marrow Transplant 2009;15:1337-1341.

Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA, Lenderking WR, Cella D, Basch E. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures. Value Health 2009;12:419-429.

Dalbagni G, Vora K, Kaag M, Cronin A, Bochner B, Donat SM, Herr HW. Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer. European Urology 2010 [epub ahead of print].

Deng G, Lin H, Seidman A, Fornier M, D’Andrea G, Wesa K, Yeung S, Cunningham-Rundles S, Vickers AJ, Cassileth B. A phase I/II trial of a polysaccharide extract from grifola frondosa (maitake mushroom) in breast cancer patients: immunological effects. Journal of Cancer Research and Clinical Oncology 2009;135:1215-1221.

Donat SM, Shabsigh A, Savage C, Cronin AM, Bochner BH, Dalbagni G, Herr HW, Milowsky MI. Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience. European Urology 2009;55:177-185.

Duffy A, Capanu M, Allen P, Kurtz R, Olson SH, Ludwig E, Klimstra DS, O’Reilly EM. Pancreatic adenocarcinoma in a young patient population —12-year experience at Memorial Sloan Kettering Cancer Center. Journal of Surgical Oncology 2009;100:8-12.

Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I, Seeff LC, van Ballegooijen M, Goede SL, Ries LA. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010; 116:544-73

Edwards QT, Li AX, Pike MC, Kolonel LN, Ursin G, Henderson BE, McKean-Cowdin R.  Ethnic differences in the use of regular mammography: the Multiethnic Cohort.  Breast Cancer Research and Treatment 2009;115:163-170.

Edwards-Bennett SM, Jacks LM, Moskowitz CH, Wu EJ, Zhang Z, Noy A, Portlock CS, Straus DJ, Zelenetz AD, Yahalom. Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience. Annals of Oncology 2010 [epub ahead of print].

Eggener SE, Vickers AJ, Serio AM, Donovan MJ, Khan FM, Bayer-Zubek V, Verbel D, Cordon-Cardo C, Reuter VE, Bianco FJ Jr, Scardino PT. Comparison of models to predict clinical failure after radical prostatectomy. Cancer 2009;115:303-310.

Elkin EB, Blinder VS. Advances in breast cancer: Reducing risk and improving health outcomes. In Finkel ML (editor), Perspectives in Public Health: Challenges for the 21st Century. Santa Barbara, CA: Praeger 2010 (in press).

Elkin EB, Ishill NM, Snow JG, Panageas KS, Bach PB, Liberman L, Wang F, Schrag D. Geographic access and the use of screening mammography. Medical Care 2010 (in press). 

Fahy BN, D’Angelica M, DeMatteo RP, Blumgart LH, Weiser MR, Ostrovnaya I, Gonen M, Jarnagin WR. Synchronous hepatic metastases from colon cancer: changing treatment strategies and results of surgical intervention. Annals of Surgical Oncology 2009;16:361-370.

Feldman DR, Baum MS, Ginsberg MS, Hassoun H, Flombaum CD, Velasco S, Fischer P, Ronnen E, Ishill N, Patil S, Motzer RJ. Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma. Journal of Clinical Oncology 2009;27:1432-1439.

Feldman DR, Sheinfeld J, Bajorin DF, Fischer P, Turkula S, Ishill N, Patil S, Bains M, Reich LM, Bosl GJ, Motzer RJ.  TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis. Journal of Clinical Oncology 2010 (in press).

Feldman DR, Turkula S, Ginsberg MS, Ishill N, Patil S, Carousso M, Bosl GJ, Motzer RJ. Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors. Investigational New Drugs 2010 [epub ahead of print].

Figueiredo JC, Haile RW, Bernstein JL. Oral contraceptives and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Current Breast Cancer Reports 2010 (in press).

Figueiredo JC, Haile RW, Bernstein L, Malone KE, Largent J, Langholz B, Lynch CF, Bertelsen L, Capanu M, Concannon P, Borg A, Børresen-Dale AL, Diep A, Teraoka S, Torngren T, Xue S, Bernstein JL. Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE study. Breast Cancer Research and Treatment 2010 [epub ahead of print].

Filion C, Motoi T, Olshen AB, Laé M, Emnett RJ, Gutmann DH, Perry A, Ladanyi M, Labelle Y.  The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene. Journal of Pathology 2009;217:83-93.

Fontes ML, Amar D, Kulak A, Koval K, Zhang H, Shi W, Thaler H. Increased preoperative white blood cell count predicts postoperative atrial fibrillation after coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia 2009;23:484-487.

Fortuny J, Sima C, Bayuga S, Wilcox H, Pulick K, Faulkner S, Zauber AG, Olson SH. Risk of endometrial cancer in relation to medical conditions and medication use. Cancer Epidemiology Biomarkers and Prevention 2009;18:1448-1456.

Fuchsjäger MH, Pucar D, Zelefsky MJ, Mehdizade A, Zhang Z, Mo Q, BenPorat LS, Shukla-Dave A, Wang L, Reuter VE, Hricak H.  Predicting post-external-beam radiation therapy psa relapse of prostate cancer using pre-treatment mri. International Journal of Radiation Oncology, Biology & Physics 2010 (in press).

Gallagher DJ, Milowsky MI, Iasonos A, Maluf FC, Russo P, Dalbagni G, Donat MS, Boyle MG, Zheng J, Riches J, Bajorin DF. Sequential adjuvant chemotherapy after surgical resection of high-risk urothelial carcinoma. Cancer 2009;115:5193-5201.

Gallagher DJ, Zheng J, Capanu M, Haviland D, Paty P, Dematteo RP, D’Angelica M, Fong Y, Jarnagin WR, Allen PJ, Kemeny N. Response to neoadjuvant chemotherapy  does not predict overall survival for patients with synchronous colorectal hepatic metastases. Annals of Surgical Oncology 2009;16:1844-18451.

Gareau DS, Patel YG, Li Y, Aranda I, Halpern AC, Nehal KS, Rajadhyaksha M. Confocal mosaicing microscopy in skin excisions: a demonstration of rapid surgical pathology. Journal of Microscopy 2009;233:149-159.

Garg K, Shih K, Barakat R, Zhou Q, Iasonos A, Soslow RA. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset. American Journal of Surgical Pathology 2009;33:1869-1877.

Gaudet MM, Hunter K, Pharoah P, Dunning AM, Driver K, Lissowska J, Sherman M, Peplonska B, Brinton LA, Chanock S, Garcia-Closas M. Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis. International Journal of Cancer 2009;124:1716-1720.

Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, Humphreys MK, Dunning AM, Morrison J, Giles GG, Severi G, Baglietto L, English DR, Couch FJ, Olson JE, Wang X,  Chang-Claude J, Flesch-Janys D, Abbas S, Salazar R, Mannermaa A, Kataja V, Kosma VM, Lindblom A, Margolin S, Heikkinen T, Kämpjärvi K, Aaltonen K, Nevanlinna H, Bogdanova N, Coinac I,  Schürmann P, Dörk T, Bartram CR, Schmutzler RK, Tchatchou S, Burwinkel B, Brauch, Torres D, Hamann U, Justenhoven C, Ribas G, Arias JI, Benitez J, Bojesen, Nordestgaard BG,  Flyger HL, Peto J, Fletcher O, Johnson N, dos Santos Silva I, Fasching PA, Beckmann MW, Strick R, Ekici AB, Broeks A, Schmidt MK, van Leeuwen FE, Van ’t Veer FJ, Southey MC, Hopper JL, Apicella C, McCredie MRE, Haiman CA, Henderson BE, Le March L, Kolonel LN, Kristensen V, Alnæs GG, Hunter  DJ, Kraft P, Cox DG, Hankinson SE, Seynaeve C, Vreeswijk MPG, Tollenaar RAEM, Devilee P, Chanock S, Lissowska J, Brinton L, Peplonska B, Czene K, Hall P, Li Y, Liu J, Balasubramanian S, Rafii S, Reed MWR, Pooley KA, Conroy D, Baynes C, Kang D, Yoo KY, Noh DY, Ahn SH, Shen CY, Wang HC, Yu JC, Wu PE, Anton-Culver H, Ziogoas A, Egan K, Newcomb P, Titus-Ernstoff L, Trentham Dietz A,  Sigurdson AJ, Alexander BH, Bhatti P, Allen-Brady K, Cannon-Albright LA, Wong J, AOCS Study Group, Chenevix-Trench G, Spurdle AB, Beesley J, Pharoah PDP, Easton DF, Garcia-Closas M on behalf of the Breast Cancer Association Consortium.  Five Polymorphisms and breast cancer risk: results from the breast cancer association consortium. Cancer Epidemiology Biomarkers and Prevention 2010 (in press).

Gerecitano J, Portlock C, Moskowitz C, Hamlin P, Straus D, Zelenetz AD, Zhang Z, Dumitrescu O, Sarasohn D, Lin D, Pappanicholaou J, Cortelli BM, Neylon E, Hamelers R, Wright J, O’Connor OA. Phase 2 study of weekly bortezomib in mantle cell and follicular lymphoma. British Journal of Haematology 2009;146:652-655.

Gershon TR, Shirazi A, Qin LX, Gerald WL, Kenney AM, Cheung NK. Enteric neural crest differentiation in ganglioneuromas implicates Hedgehog signaling in peripheral neuroblastic tumor pathogenesis. PLoS One 2009;4:e7491.

Girard N, Lou E, Azzoli CG, Reddy R, Robson M, Harlan M, Orlow I, Yatabe Y, Ladanyi M, Viale A, Kris MG, Riely G, Miller V, Klein RJ, Matsuo K, Pao W. Analysis of genetic variants in never-smokers with lung cancer facilitated by an Internet-based blood collection protocol: a preliminary report. Clinical Cancer Research 2010 (in press).

Girard N, Ostrovnaya I, Lau C, Park B, Ladanyi M, Finley D, Deshpande C, Rusch V, Orlow I, Travis WD, Pao W, Begg CB. Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers. Clinical Cancer Research 2009;15:5184-5190.

Girard N, Shen R, Guo T, Zakowski MF, Heguy A, Riely GJ, Huang J, Lau C, Lash AE, Ladanyi M, Viale A, Antonescu CR, Travis WD, Rusch VW, Kris MG, Pao W. Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas. Clinical Cancer Research 2009;15:6790-6799.

Gladdy RA, Qin LX, Moraco N, Edgar MA, Antonescu CR, Alektiar K, Brennan MF, Singer S. Do radiation associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas? Journal of Clinical Oncology 2010 (in press).

Gold HT, Hall MJ, Blinder V, Schackman BR. Cost effectiveness of pharmacogenetic testing for UGT1A1 before irinotecan administration for metastatic colorectal cancer. Cancer 2009;115:3858-3867.

Gold JS, Gönen M, Gutiérrez A, Broto JM, García-del-Muro X, Smyrk TC, Maki RG, Singer S, Brennan MF, Antonescu CR, Donohue JH, DeMatteo RP. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncology 2009;10:1045-1052.

Goldfarb SB, Traina T, Dickler MN. Bevacizumab for advanced breast cancer. Women’s Health (London, England) 2010;6:17-25.

Goldfarb S, Dickler M. Commentary on Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity. Breast Diseases: A Year Book Quarterly 2009;20:333-335.

Goldsmith YB, Liu J, Chou J, Hoffman J, Comenzo RL, Steingart RM. Frequencies and types of arrhythmias in patients with systemic light-chain amyloidosis with cardiac involvement undergoing stem cell transplantation on telemetry monitoring. American Journal of Cardiology 2009;104:990-994.

Gönen M, Heller G. Lehmann Family of ROC Curves. Medical Decision Making 2010 (in press).

Gönen M, Schrag D, Weiser MR. Nodal staging score: a tool to assess adequate staging of node-negative colon cancer. Journal of Clinical Oncology 2009;27:6166-6171.

Gönen M. Bayesian clinical trials: no more excuses. Clinical Trials 2009;6:203-204.

Gönen M. Statistical aspects of gene signatures and molecular targets. Gastrointestinal Cancer Research 2009;3(2 Suppl):S19-21.

Gong Y, Yao E, Shen R, Goel A, Arcila M, Teruya-Feldstein J, Zakowski MF, Frankel S, Peifer M, Thomas RK, Ladanyi M, Pao W. Expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507). PLoS One 2009; 4:e7273.

Goodman KA, Wiegner EA, Maturen KE, Zhang Z, Mo Q, Yang G, Gibbs IC, Fisher GA, Koong AC.  Dose escalation study of single fraction stereotactic body radiotherapy for liver malignancies. International Journal of Radiation Oncology, Biology & Physics 2010 (in press).

Gopalan A, Leversha MA, Satagopan JM, Zhou Q, Al-Ahmadie HA, Fine SW, Eastham JA, Scardino PT, Scher HI, Tickoo SK, Reuter VE, Gerald WL. TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy. Cancer Research 2009;69:1400-1406.

Goteti K, Edwin Garner C, Utley L, Dai J, Ashwell S, Moustakas DT, Gönen M, Schwartz GK, Kern SE, Zabludoff S, Brassil PJ. Preclinical pharmacokinetic/ pharmacodynamic models to predict synergistic effects of co-administered anti-cancer agents. Cancer Chemotherapy and Pharmacology 2010 [epub ahead of print].

Greenlee H, Gammon MD, Abrahamson PE, Gaudet MM, Terry MB, Hershman DL, Desai M, Teitelbaum SL, Neugut AI, Jacobson JS. Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the Long Island Breast Cancer Study Project. Cancer 2010 (in press).

Grewal RK, Larson SM, Pentlow CE, Pentlow KS, Gonen M, Qualey R, Natbony L, Tuttle RM. Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation. Journal of Nuclear Medicine 2009;50:1605-1610.

Helo P, Cronin AM, Danila DC, Wenske S, Gonzalez-Espinoza R, Anand A, Koscuiszka M, Väänänen RM, Pettersson K, Chun FK, Steuber T, Huland H, Guillonneau BD, Eastham JA, Scardino PT, Fleisher M, Scher HI, Lilja H. Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with cell search assay and association with bone metastases and with survival. Clinical Chemistry 2009;55:765-773.

Hensley ML, Ishill N, Soslow R, Larkin J, Abu-Rustum N, Sabbatini P, Konner J, Tew W, Spriggs D, Aghajanian CA. Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: results of a prospective study. Gynecologic Oncology 2009;112:563-567.

Himle JA, Baser RE, Taylor RJ, Campbell RD, Jackson JS. Anxiety disorders among African Americans, Blacks of Caribbean descent, and non-Hispanic whites in the United States. Journal of Anxiety Disorders 2009;23:578-590.

Hoppe BS, Moskowitz CH, Zhang Z, Maragulia JC, Rice RD, Reiner AS, Hamlin PA, Zelenetz AD, Yahalom J. The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma. Bone Marrow Transplantation 2009;43:941-948.

Huang WC, Elkin EB, Levey AS, Jang TL, Russo P. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors—is there a difference in mortality and cardiovascular outcomes? Journal of Urology 2009;181:55-61.

Hurria A, Li D, Hansen K, Patil S, Gupta R, Nelson C, Lichtman SM, Tew WP, Hamlin P, Zuckerman E, Gardes J, Limaye S, Lachs M, Kelly E. Distress in older patients with cancer. Journal of Clinical Oncology 2009;27:4346-4351.

Ito K, Elkin EB, Girotra M, Morris JM. Cost-effectiveness of fracture prevention in men receiving androgen deprivation therapy for localized prostate cancer. Annals of Internal Medicine 2010 (in press).

Iwamoto FM, Cooper AR, Reiner AS, Nayak L, Abrey LE. Glioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center Experience (1997-2007). Cancer 2009;115:3758-3766. 

Iwamoto FM, Reiner AS, Nayak L, Panageas KS, Elkin EB, Abrey LE. Prognosis and patterns of care in elderly patients with glioma. Cancer 2009;115:5534-5540.

 Jang TL, Bekelman JE, Liu Y, Bach PB, Basch EM, Elkin EB, Zelefsky MJ, Scardino PT, Begg CB, Schrag D. Physician visits prior to treatment for clinically localized prostate cancer. Archives of Internal Medicine 2010 (in press).

 Janjigian YY, McDonnell K, Kris MG, Shen R, Sima CS, Bach PB, Rizvi NA, Riely GJ. Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer. Cancer 2010 [epub ahead of print].

Jarnagin WR, Schwartz LH, Gultekin DH, Gönen M, Haviland D, Shia J, D’Angelica M, Fong Y, Dematteo R, Tse A, Blumgart LH, Kemeny N. Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. Annals of Oncology 2009;20:1589-1595.

Jhawer M, Coit D, Brennan M, Qin LX, Gönen M, Klimstra D, Tang L, Kelsen DP, Shah MA. Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation. American Journal of Clinical Oncology 2009,32:356-362.

Jiang X, Castelao JE, Groshen S, Cortessis VK, Shibata D, Conti DV, Yuan JM, Pike MC, Gago-Dominguez M.  Urinary tract infections and reduced risk of bladder cancer in Los Angeles.  British Journal of Cancer 2009;100:834-839.

Johnatty SE, Beesley J, Chen X, Spurdle AB, Defazio A, Webb PM; Australian Ovarian Cancer Study Group; Australian Cancer Study (Ovarian Cancer), Goode EL, Rider DN, Vierkant RA, Anderson S, Wu AH, Pike M, Van Den Berg D, Moysich K, Ness R, Doherty J, Rossing MA, Pearce CL, Chenevix-Trench G.  Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium.  Twin Research and Humun Genetics 2009;12:269-275.

Kalinsky K, Jacks LM, Heguy A, Patil S, Drobnjak M, Bhanot UK, Hedvat CV, Traina TA, Solit D, Gerald W, Moynahan ME. PIK3CA mutation associates with improved outcome in breast cancer. Clinical Cancer Research 2009;15:5049-5059.

Kane Pryor K, Reinsel R, Mehta M, Li Y, Wixted J, Veselis R A. The dissociable effects of anesthetic drugs on the establishment and decay of human memory are linked to arousal and theta coherence. Proceedings of the National Academy of Sciences 2010 (in press).

Kappel LW, Goldberg GL, King CG, Suh DY, Smith OM, Ligh C, Holland AM, Grubin J, Mark NM, Liu C, Iwakura Y, Heller G, van den Brink MR. IL-17 contributes to CD4-mediated graft-versus-host disease. Blood 2009;113:945-952.

Karam AK, Hsu M, Patil S, Stempel M, Traina TA, Ho AY, Cody HS, Port ER, Morrow M, Gemignani ML. Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodes. Annals of Surgical Oncology 2009;16:1952-1958.

Kattan MW, Vickers AJ, Yu C, Bianco FJ, Cronin AM, Eastham JA, Klein EA, Reuther AM Edson Pontes J, Scardino PT. Preoperative and postoperative nomograms incorporating surgeon experience for clinical localized prostate cancer. Cancer 2009;115:1005-1010.

Katz SC, Shia J, Liau KH, Gönen M, Ruo L, Jarnagin WR, Fong Y, D’Angelica MI, Blumgart LH, Dematteo RP. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Annals of Surgery 2009;249:617-623.

Katz SC, Pillarisetty V, Bamboat ZM, Shia J, Hedvat C, Gönen M, Jarnagin W, Fong Y, Blumgart L, D’Angelica M, Dematteo RP. T-cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases. Annals of Surgery Oncology 2010 [epub ahead of print].

Kelly KJ, Wong J, Gladdy R, Moore-Dalal K, Woo Y, Gönen M, Brennan M, Allen P, Fong Y, Coit D. Prognostic impact of RT-PCR-based detection of peritoneal micrometastases in patients with pancreatic cancer undergoing curative resection. Annals of Surgical Oncology 2010 [epub ahead of print].

Kemeny N, Capanu M, D’Angelica M, Jarnagin W, Haviland D, Dematteo R, Fong Y.  Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer. Annals of Oncology 2009;20:1236-1241.

Kemeny N, Huitzil Melendez FD, Capanu M, Paty P, Fong Y, Schwartz L, Jarnagin W, Patel D, D’Angelica M. Conversion to Resectability utilizing Hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. Journal of Clinical Oncology 2009; 27:3465-3471.

Kemeny NE, Melendez FD, Capanu M, Paty PB, Fong Y, Schwartz LH, Jarnagin WR, Patel D, D’Angelica M. Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. Journal of Clinical Oncology 2009;27:3465-3471.

Khoury MJ, Bertram L, Boffetta P, Butterworth AS, Chanock SJ, Dolan SM, Fortier I, Garcia-Closas M, Gwinn M, Higgins JP, Janssens AC, Ostell J, Owen RP, Pagon RA, Rebbeck TR, Rothman N, Bernstein JL, Burton PR, Campbell H, Chockalingam A, Furberg H, Little J, O’Brien TR, Seminara D, Vineis P, Winn DM, Yu W, Ioannidis JP. Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. American Journal of Epidemiology 2009;170:269-279.

Kingham TP, Panageas KS, Ariyan CE, Busam KJ, Brady MS, Coit DG. Outcome of patients with a positive sentinel lymph node who do not undergo completion lymphadenectomy. Annals of Surgical Oncology 2010 [epub ahead of print].

Kirchhoff T, Chen ZQ, Gold B, Pal P, Gaudet MM, Kosarin K, Levine DA, Gregersen P, Spencer S, Harlan M, Robson M, Klein RJ, Hudis CA, Norton L, Dean M, Offit K. The 6q22.33 locus and breast cancer susceptibility. Cancer Epidemiology, Biomarkers and Prevention 2009;18:2468-2475.

Knight JA, Bernstein L, Largent J, Capanu M, Begg CB, Mellemkjaer L, Lynch CF, Malone KE, Reiner AS, Liang X, Haile RW, Boice Jr. JD, WECARE Study Collaborative Group, Bernstein JL. Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: the women’s environmental cancer and radiation epidemiology study. American Journal of Epidemiology 2009;169:962-968.

Knudsen AB,  Lansdorp-Vogelaar I,  Rutter CM,  Savarino JE, van Ballegooijen M, Kuntz KM,  Zauber AG.  Cost-effectiveness of CT colonography screening for colorectal cancer among the Medicare population. Journal of the National Cancer Institute 2010 (in press).

Kollmeier MA, Katz MS, Mak K, Yamada Y, Feder DJ, Zhang Z, Jia X, Shi W, Zelefsky MJ. Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiation therapy. International Journal of Radiation Oncology Biology Physics 2010 (in press).

Korde LA, Wu AH, Fears T, Nomura AM, West DW, Kolonel LN, Pike MC, Hoover RN, Ziegler RG.  Childhood soy intake and breast cancer risk in Asian American women.  Cancer Epidemiology, Biomarkers & Prevention 2009;18:1050-1059.

Korkola JE, Houldsworth J, Feldman DR, Olshen AB, Qin L, Patil S, Reuter VE, Bosl GJ, Chaganti RSK. Identification and validation of a gene expression signature that predicts outcome in adult male germ cell tumor patients. Journal of Clinical Oncology 2009;27:5240-5247.

Ku GY, Yuan J, Page DB, Schroeder SEA, Subudhi SK, Won E, Panageas KS,  Carvajal RD, Chapman PB, Schwartz GK, Allison JP, Wolchok JD. Phase II trial of compassionate-use ipilimumab in patients with advanced melanoma: the Memorial Sloan-Kettering experience. Cancer 2010 (in press).

Kuligina E, Reiner A, Imyanitov EN, Begg CB. Evaluating cancer epidemiologic risk factors using multiple primary malignancies. Epidemiology 2010 (in press).

Kushner BH, Kramer K, Modak S, Qin LX, Yataghena K, Jhanwar SC, Cheung NK. Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma. Pediatric Blood Cancer 2009;53:17-22.

Lamanna N, Jurcic JG, Noy A, Maslak P, Gencarelli AN, Panageas KS, Heaney ML, Brentjens  RJ, Golde DW, Scheinberg DA, Zelenetz AD, Weiss MA. Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses. Journal of Clinical Oncology 2009;27:491-497. 

Lambert R, Kudo SE, Vieth M, Allen JI, Fujii H, Fujii T, Kashida H, Matsuda T, Mori M, Saito H, Shimoda T, Tanaka S, Watanabe H, Sung JJ, Feld AD, Inadomi JM, O’Brien MJ, Lieberman DA, Ransohoff DF, Soetikno RM, Zauber A, Teixeira CR, Rey JF, Jaramillo E, Rubio CA, Van Gossum A, Jung M, Jass JR, Triadafilopoulos G. Pragmatic classification of superficial neoplastic colorectal lesions. Gastrointestinal Endoscopy 2009;70:1182-1199.

Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Boer R, Wilschut J, Habbema JD. At what costs will screening with CT colonography be competitive? A cost-effectiveness approach. International Journal of Cancer 2009;124:1161-1168.

Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Boer R, Wilschut J, Winawer SJ, Habbema JD. Individualizing colonoscopy screening by sex and race. Gastrointestinal Endoscopy 2009;70:96-108.

Lansdorp-Vogelaar I, van Ballegooijen M, Boer R, Zauber A, Habbema JD. A novel hypothesis on the sensitivity of the fecal occult blood test: Results of a joint analysis of 3 randomized controlled trials. Cancer 2009;115:2410-2419.

Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Habbema JD, Kuipers EJ. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. Journal of the National Cancer Institute 2009;101:1412-22.

Langholz B, Thomas DC, Stovall M, Smith SA, Boice JD Jr, Shore RE, Bernstein L, Lynch CF, Zhang X, Bernstein JL. Statistical methods for analysis of radiation effects with tumor and dose location-specific information with application to the WECARE study of asynchronous contralateral breast cancer. Biometrics 2009;65:599-608.

Leversha MA, Han J, Asgari Z, Danila DC, Lin O, Gonzalez-Espinoza R, Anand A, Lilja H, Heller G, Fleisher M, Scher HI. Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer. Clinical Cancer Research 2009;15:2091-2097.

Li L, Lu Y, Qin LX, Bar-Joseph Z, Werner-Washburne M, Breeden LL. Budding yeast SSD1-V regulates transcript levels of many longevity genes and extends chronological life span in purified quiescent cells. Molecular Biology of the Cell 2009;20:3851-3864.

Li Y, Rapkin B. Classification and regression tree uncovered hierarchy of psychosocial determinants underlying quality-of-life response shift in HIV/AIDS. Journal of Clinical Epidemiology 2009;62:1138-1147.

Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for tension-type headache. Cochrane Database of Systematic Reviews 2009;(1):CD007587.

Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for migraine prophylaxis. Cochrane Database of Systematic Reviews 2009;(1):CD001218.

Lowrance WT, Elkin EB, Eastham JA. Letter to the editor. Journal of the American Medical Association 2010 (in press).

Lowrance WT, Elkin EB, Jacks LM, Yee DS, Jang TL, Laudone VP, MD, Guillonneau BD, Scardino PT, Eastham JA. Comparative effectiveness of surgical treatments for prostate cancer: A population-based analysis of postoperative outcomes. Journal of Urology 2010 (in press).

Lowrance WT, Yee DS, Maschino AC, Cronin AM, Bernstein M, Thompson RH, Russo P. Developments in the surgical management of sporadic synchronous bilateral renal tumours. BJU International 2010 [epub ahead of print].

Lovelock DM, Zhang Z, Jackson A, Keam J, Bekelman J, Bilsky M, Lis E, Yamada Y. Correlation of local failure with measures of dose insufficiency in the high-dose single-fraction treatment of bonymetastases.  International Journal of Radiation Oncology, Biology & Physics 2010 (in press).

Lyman S, Dunn WR, Spock C, Bach PB, Mandl LA, Marx RG. Validity of same-side reoperation after total hip and knee arthroplasty using administrative databases. The Journal of Knee Surgery 2009;22:17-20.

Lyman S, Marx RG, Bach PB.  Cost-effectiveness analysis of an established, effective procedure. Archives of Internal Medicine 2009;169:1102-1103.

Ma J, Liu W, Zhang L, Pan K, Zhao H, Zhou T, Winawer S, Zauber A, Classen M, You W. A placebo-controlled trial of 10-day bismuth-based quadruple therapy to eradicate Helicobacter pylori infection; a pilot study for the large Linqu County trial. European Journal of Gastroenterology & Hepatology 2010 [epub ahead of print].

Maki RG, D’Adamo DR, Keohan ML, Saulle M, Schuetze SM, Undevia SD, Livingston MB, Cooney MM, Hensley ML, Mita MM, Takimoto CH, Kraft AS, Elias AD, Brockstein B, Blachère NE, Edgar MA, Schwartz LH, Qin LX, Antonescu CR, Schwartz GK. Phase II study of sorafenib in patients with metastatic or recurrent sarcomas. Journal of Clinical Oncology 2009;27:3133-3140.

Malone KE, Begg CB, Haile RW, Borg A, Concannon P, Tellhed L, Xue S, Teraoka S, Bernstein L, Capanu M, Reiner A, Riedel ER, Thomas DC, Mellemkjaer L, Lynch CF, Boice JD, Anton-Culver H, Bernstein JL. A population-based study of the relative and absolute risks of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. Journal of Clinical Oncology 2010 (in press).

Martinez ME, Baron JA, Lieberman DA, Schatzkin A, Lanza E, Winawer SJ, Zauber AG, Jian R, Ahnen DN, Bond JH, Church TR, Robertson DF, Smith-Warner SA, Jacobs ET, Alberts DS, Greenberg ER. A pooled analysis of advanced colorectal neoplasia diagnosis after colonoscopic polypectomy. Gastroenterology 2009;136:832-841.

Matthew S, Adel N, Rice RD, Panageas K, Duck ET, Comenzo RL, Kewalrmani T, Nimer SD. Retrospective comparison of he effects of filgrastim and pegfilgrastim on the pace of engraftment in auto-SCT patients.  Bone Marrow Transplantation 2010 (in press).

Mazaheri Y, Hricak H, Fine SW, Akin O, Shukla-Dave A, Ishill NM, Moskowitz CS, Grater JE, Reuter VE, Zakian KL, Touijer KA, Koutcher JA. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. Radiology 2009;252:449-457.

Meltzer LJ, Steinmiller E, Simms S, Grossman M; Complex Care Consultation Team, Li Y. Staff engagement during complex pediatric medical care: the role of patient, family, and treatment variables. Patient Education and Counseling 2009;74:77-83.

Meng RD, Shelton CC, Li YM, Qin LX, Notterman D, Paty PB, Schwartz GK. Gamma-secretase inhibitors abrogate oxaliplatin-induced activation of the notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. Cancer Research 2009;69:573-582.

Mezhir JJ, Brennan MF, Baser RE, D’Angelica MI, Fong Y, Dematteo RP, Jarnagin WR, Allen PJ. A matched case-control study of preoperative biliary drainage in patients with pancreatic adenocarcinoma: routine drainage is not justified. Journal of Gastrointestinal Surgery 2010 [epub ahead of print].

Miksad RA, Gönen M, Lynch TJ, Roberts TG Jr. Interpreting trial results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancer. Journal of Clinical Oncology 2009;27:2245-2252.

Milowsky MI, Nanus DM, Maluf FC, Mironov S, Shi W, Iasonos A, Riches J, Regazzi A, Bajorin DF. Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium. Journal of Clinical Oncology 2009;27:4062-4067.

Mo Q, Liang F.  Bayesian modeling of ChIP-chip data through a high-order ising model.  Biometrics 2010 (in press).

Mo Q, Lu SH, Garippa C, Brownstein MJ, Simon NG. Genome-wide analysis of DHEA and DHT induced gene expression in mouse hypothalamus and hippocampus. Journal of Steroid Biochemistry Molecular Biology 2009;114:135-143.

Moroz E, Carlin S, Dyomina K, Burke S, Thaler HT, Blasberg R, Serganova I. Real-time imaging of HIF-1alpha stabilization and degradation. PLoS One 2009;4:e5077.

Morrogh M, Park A, Elkin EB, King TA. Lessons learned from 416 cases of nipple discharge of the breast. American Journal of Surgery 2010 (in press).

Morris PG, Bach PB. Adjuvant anthracyclines and taxanes: quantifying the costs of therapeutic advances in breast cancer. Onkologie 2009;32:464-466.

Morris MJ, Basch EM, Wilding G, Hussain M, Carducci MA, Higano C, Kantoff P, Oh WK, Small EJ, George D, Mathew P, Beer TM, Slovin SF, Ryan C, Logothetis C, Scher HI. Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical research. Clinical Genitourinary Cancer 2009;7:51-57.

Morris MJ, Pandit-Taskar N, Carrasquillo J, Divgi CR, Slovin S, Kelly WK, Rathkopf D, Gignac GA, Solit D, Schwartz L, Stephenson RD, Hong C, Delacruz A, Curley T, Heller G, Jia X, O’Donoghue J, Larson S, Scher HI. Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer. Journal of Clinical Oncology 2009;27:2436-2442.

Mosher CE, DuHamel KN, Rini CM, Li Y, Isola L, Labay L, Rowley S, Papadopoulos E, Moskowitz C, Scigliano E, Grosskreutz C, Redd, WH. Barriers to mental health service use among hematopoietic SCT survivors.  Bone Marrow Transplantation 2009;1–10.

Moskowitz AJ, Perales MA, Kewalramani T, Yahalom J, Castro-Malaspina H, Zhang Z, Vanak J, Zelenetz AD, Moskowitz CH. Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory hodgkin lymphoma. British Journal of Haematology 2009;146:158-163.

Moskowitz CS. “Variance and Covariance.” The Encyclopedia of Medical Decision Making. Sage Publications Incorporated 2010 (in press).

Moskowitz CS, Jia X, Schwartz LH, Gönen M. A simulation study to evaluate the impact of the number of lesions measured on response assessment. European Journal of Cancer 2009;45:300-310.

Moulding HD, Lis E, Lovelock DM, Zhang Z, Yamada Y, Bilsky MH. Local disease control after decompressive surgery and adjuvant high dose single fraction radiosurgery for spine metastases. Journal of Neurology 2010 (in press).

Mujumdar UJ, Hay JL, Monroe-Hinds YC, Hummer AJ, Begg CB, Wilcox HB, Oliveria SA, Berwick M. Sun protection and skin self-examination in melanoma survivors. Psycho-Oncology 2009;18:1106-1115.

Nagula S, Ishill N, Nash C, Markowitz AJ, Schattner MA, Weiser MR, Temple L, Zauber A, Thaler HT, Gerdes H. Quality of life and symptom control after stent placement or surgical palliation of malignant colorectal obstruction. Journal of the American College of Surgeons 2010 (in press).

Nakahara T, Uchi H, Lesokhin A, Avogadri F, Rizzuto G, Hirschhorn Cymerman D, Panageas KS, Merghoub T, Wolchok JD, Houghton AN. Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs.  Blood 2010 (in press).

Nash GM, Weiser MR, Guillem JG, Temple LK, Shia J, Gönen M, Wong WD, Paty PB. Long-term survival after transanal excision of T1 rectal cancer. Diseases of the Colon and Rectum 2009;52:577-582.

Navi BB, Reichman J, Berlin D, Reiner AS, Panageas K, Segal AZ, DeAngelis LM. Intracerebral and subarachnoid hemorrhage in cancer patients. Neurology 2010 (in press).

Neuman HB, Elkin EB, Guillem JG, Paty PB, Weiser MR, Wong D, Temple LK. Treatment for patients with rectal cancer and a clinical complete response to neoadjuvant therapy: A decision analysis. Diseases of the Colon and Rectum 2009;52:863-871.

Nogueira L, Katz D, Pinochet R, Godoy G, Kurta J, Savage CJ, Cronin AM, Guillonneau B, Touijer KA, Coleman JA. Critical evaluation of perioperative complications in laparoscopic partial nephrectomy. Urology 2010 [epub ahead of print].

Nogueira L, Wang L, Fine SW, Pinochet R, Kurta JM, Katz D, Savage CJ, Cronin AM, Hricak H, Scardino PT, Akin O, Coleman JA. Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI. Urology 2010 [epub ahead of print].

Noy A, Schöder H, Gönen M, Weissler M, Ertelt K, Cohler C, Portlock C, Hamlin P, Yeung HW. The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL). Annals of Oncology 2009;20:508-512.

O’Brien MF, Cronin AM, Fearn PA, Smith B, Stasi J, Guillonneau B, Scardino PT, Eastham JA, Vickers AJ, Lilja H. Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy. Journal of Clinical Oncology 2009;27:3591-3597.

O’Cearbhaill R, Zhou Q, Iasonos A, Hensley ML, Tew WP, Aghajanian C, Spriggs DR, Lichtman SM, Sabbatini PJ. The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment. Gynecologic Oncology 2010 [epub ahead of print].

O’Cearbhaill R, Zhou Q, Iasonos A, Soslow RA, Leitao MM, Aghajanian C, Hensley ML. Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors. Gynecologic Oncology 2010 [epub ahead of print].

O’Connor OA, Moskowitz C, Portlock C, Hamlin P, Straus D, Dumitrescu O, Sarasohn D, Gönen M, Butos J, Neylon E, Hamelers R, Mac-Gregor Cortelli B, Blumel S, Zelenetz AD, Gordon L, Wright JJ, Vose J, Cooper B, Winter J. Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentre Phase 2 clinical trial. British Journal of Haematology 2009;145:34-39.

Oeffinger KC, Ford JS, Moskowitz CS, Diller LR, Hudson MM, Chou JF, Smith SM, Mertens AC, Henderson TO, Friedman DL, Leisenring WM, Robison LL. Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. Journal of the American Medical Association 2009;301:404-414.

Oeffinger KC, Ford JS, Moskowitz CS, Henderson TO. Missed opportunities: breast cancer surveillance and pediatric cancer survivors. Breast Diseases: A Year Book Quarterly 2009;20: 245-248.

Oliveria SA, Satagopan JM, Geller AC, Dusza SW, Weinstock MA, Berwick M, Bishop M, Heneghan MK, Halpern AC. Study of nevi in children (SONIC): baseline findings and predictors of nevus count. American Journal of Epidemiology 2009;169:41-53.

Olson SH, Chen C, De Vivo I, Doherty JA, Hartmuller V, Horn-Ross PL, Lacey JV Jr, Lynch SM, Sansbury L, Setiawan VW, Schouten LJ, Shu XO. Maximizing resources to study an uncommon cancer: E2C2—Epidemiology of Endometrial Cancer Consortium. Cancer Causes and Control 2009;20:491-496.

Orlow I, Tommasi D, Bloom B, Ostrovnaya I, Cotignola J, Mujumdar U, Busam KJ, Jungbluth AA, Scolyer RA, Thompson JF, Armstrong BK, Berwick M, Thomas NE, Begg CB. Evaluation of the clonal origin of multiple primary melanomas using molecular profiling. Journal of Investigative Dermatology 2009;129:1972-1982.

Ostrovnaya I, Begg CB. Testing clonal relatedness of tumors using array CGH: A statistical challenge. Clinical Cancer Research 2010 (in press).

Ostrovnaya I, Olshen AB, Seshan VE, Orlow I, Albertson DG, Begg CB. A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data. Statistics in Medicine 2010 (in press).

Panageas KS.  Random versus fixed effects.  Encyclopedia of Medical Decision Making. SAGE Publications 2009; 508-11.

Papapetrou EP, Tomishima MJ, Chambers SM, Gruber Y, Reed E, Menon J, Tabar V, Mo Q, Studer L, Sadelain M. Stoichiometric and temporal requirements of oct4, sox2, kIf4, and cMyc expression for efficient human iPSC induction and differentiation.  Proceedings of the National Academy of Sciences 2009;106:12759-12764.

Paparel P, Cronin AM, Savage C, Scardino PT, Eastham JA. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy. European Urology 2009;55:404-410.

Park JO, Qin LX, Prete FP, Antonescu C, Brennan MF, Singer S. Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule. Annals of Surgery 2009;250:977-982.

Patel KJ, Rice RD, Hawke R, Abboud M, Heller G, Scaradavou A, Young JW, Barker JN. Pre-engraftment syndrome after double unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease. Biology of Blood and Marrow Transplantation 2010 (in press).

Patil S, Ishill N, Deluca J, Motzer RJ. Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients: implications for clinical trial design and interpretation. Cancer 2010 [epub ahead of print].

Pearce CL, Chung K, Pike MC, Wu AH.  Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin. Cancer 2009; 115:531-539.

Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, Arslan AA, Bueno-de-Mesquita HB, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, Klein AP, LaCroix A, Li D, Mandelson M, Olson SH, Risch HA, Zheng W, Albanes D, Bamlet W, Berg CD, Boutron-Rualt M-C, Buring JE, Bracci PM, Canzian F, Clipp S, Cotterchio M, de Andrade M, Duell EJ, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hankinson SE, Hassan M, Howard B, Hunter DJ, Hutchinson A, Jenab M, Kaaks R, Kooperberg C, Krogh V, Kurtz RC, Lynch SM, McWilliams RR, Mendelsohn JB, Michaud DS, Overvad K, Parikh H,Patel AV, Peeters PHM, Rajkovic A, Riboli E, Rodriguez L, Seminara D, Shu X-O, Thomas G, Tobias GS, Trichopoulos D, Van Den Eeden SK, Virtamo J, Wactawski-Wende J, Wang Z, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Fraumeni JF, Jr., Hoover RN, Hartge P, Chanock SJ. A genome-wide association study identifies pancreatic cancer susceptibility loci on     chromosomes 13q22.1, 1q32.1 and 5p15.33. Nature Genetics 2010 (in press).

Pettus JA, Masterson T, Sokol A, Cronin AM, Savage C, Sandhu JS, Mulhall JP, Scardino PT, Rabbani F. Prostate size is associated with surgical difficulty but not functional outcome at 1 year after radical prostatectomy. Journal of Urology 2009;182:949-955.

Pham HH, O’Malley AS, Bach PB, Saiontz-Martinez C, Schrag D. Primary care physicians’ links to other physicians through Medicare patients: the scope of care coordination. Annals of Internal Medicine 2009;150:236-242.

Phillips KA, Marshall DA, Haas JS, Elkin EB, Liang SY, Hassett MJ, Ferrusi I, Brock JE, Van Bebber SL. Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients. Cancer 2009;115:5166-5174.

Politi K, Fan PD, Shen R, Zakowski M, Varmus H. Erlotinib resistance in mouse models of epidermal growth factor receptor-induced lung adenocarcinoma. Disease Models and Mechanisms 2010 [epub ahead of print].

Popovic N, Bridenbaugh EA, Neiger JD, Hu JJ, Vannucci M, Mo Q, Trzeciakowski J, Miller MW, Fossum TW, Humphrey JD, Wilson E. Transforming growth factor beta signaling in hypertensive remodeling of porcine aorta.  American Journal of Physiology: Heart and Circulatory Physiology 2009;297:2044-2053.

Port ER, Patil S, Stempel M, Morrow M, Cody HS.  The number of nodes removed in sentinel node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment? Cancer 2010 (in press).

Poultsides GA, Servais EL, Saltz LB, Patil S, Kemeny NE, Guillem JG, Weiser M, Temple LK, Wong WD, Paty PB. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. Journal of Clinical Oncology 2009;27:3379-3384.

Poynter JN, Langholz B, Largent J, Mellemkjaer L, Capanu M, Bernstein L, Begg CB, Malone KE, Lynch CF, Borg A, Concannon P, Haile RW, The WECARE Study Collaborative Group, Bernstein JL. Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study. Cancer Causes and Control 2010 (in press).

Power DG, Schattner MA, Gerdes H, Brenner B, Markowitz AJ, Capanu M, Coit DG,  Brennan M, Kelsen DP, Shah MA. Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer. Journal of the American College of Surgery 2009;208:173-178.

Pugliese MS, Karam AK, Hsu M, Stempel MM, Patil SM, Ho AY, Traina TA, Van Zee KJ, Cody HS 3rd, Morrow M, Gemignani ML. Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer. Annals of Surgical Oncology 2010 [epub ahead of print].

Purdue MP, Engel LS, Langseth H, Needham LL, Andersen A, Barr DB, Blair A, Rothman N, McGlynn KA. Prediagnostic serum concentrations of organochlorine compounds and risk of testicular germ cell tumors. Environmental Health Perspectives 2009;117:1514-1519.

Qin LX, Satagopan JM. Normalization method for transcriptional studies of heterogeneous samples—simultaneous array normalization and identification of equivalent expression. Statistical Applications in Genetics and Molecular Biology 2009;8:Article10.

Quaye L, Song H, Ramus SJ, Gentry-Maharaj A, Hogdall E, DiCioccio RA, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Wozniak E, Doherty JA, Rossing MA, Ness RB, Moysich KB, Hogdall C, Blaakaer J, Easton DF, Ponder BA, Jacobs IJ, Menon U, Whittemore AS, Kruger-Kjaer S, Pearce CL, Pharoah PD, Gayther SA.  Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. British Journal of Cancer 2009;100: 993-1001.

Rathkopf D, Dickson MA, Feldman DR, Carvajal RD, Shah MA, Wu N, Lefkowitz R, Gönen M, Cane LM, Dials HJ, Winkelmann JL, Bosl GJ, Schwartz GK. Phase I study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumors. Clin Cancer Research 2009;15:7405-7411.

Reding KW, Malone KE, Langholz BM, Bernstein L, Haile RW, Begg CB, Lynch CF, Concannon P, Borg A, Teraoka SN, Törngren T, Diep A, Xue S, Bertelsen L, Liang X, Reiner ASCapanu M, The WECARE Collaborative Study Group, Bernstein JL. Adjuvant systemic therapy for breast cancer and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment 2010 (in press).

Regales L, Gong Y, Shen R, Stanchina E, Vivanco I, Goel A, Koutcher JA, Spassova M, Ouerfelli O, Mellinghoff IK, Zakowski MF, Politi KA, Pao W. Novel dual targeting of EGFR can overcome a major drug resistance mutation in EGFR-mutant lung cancer. Journal of Clinical Investigation 2009;119:3000-3010.

Rimmer A, Brennan MF, Zhang Z, Singer S, Alektiar KM. Influence of compartmental involvement on the patterns of morbidity in soft tissue sarcoma of the thigh. Cancer 2009;115:149-157  

Rizzuto GA, Merghoub T, Hirschhorn-Cymerman D, Liu C, Lesokhin AM, Sahawneh D,Zhong  H, Panageas KS, Perales MA, Altan-Bonnet G, Wolchok JD, Houghton AN. Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response. Journal of Experimental Medicine 2009;206:849-866.

Rudloff U, Brogi E, Brockway JP, Goldberg JI, Cranor M, Wynveen CA, Nehhozinam T, Reiner AS, Patil S, Van Zee KJ. Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy. Cancer 2009;115:1203-1214.

Rutter CM, Kuntz KM, Zauber AG; Colorectal Cancer Modeling Group in the Cancer Intervention and Surveillance Modeling Network. Extracolonic findings from CTC: balancing risks and benefits. AJR American Journal of  Roentgenology 2009;193:W470.

Salz T, Brewer NT, Sandler RS, Weiner BJ, Martin CF, Weinberger M. Association of health beliefs and colonoscopy use among survivors of colorectal cancer. Journal of Cancer Survivorship 2010 [epub ahead of print].

Salz T, Brewer NT. Offering chemotherapy and hospice jointly: One solution to hospice underuse. Medical Decision Making 2009;29:521-531.

Salz T, Richman AR, Brewer NT.  Meta-analyses of the effect of false-positive mammograms on generic and specific psychosocial outcomes.  Psycho-Oncology 2010 (in press).

Savage CJ, Vickers AJ. Empirical study of data sharing by authors publishing in PLoS journals. Public Library of Science One 2009;4:e7078.

Savage CJ, Vickers AJ. Low annual caseloads of United States surgeons conducting radical prostatectomy. Journal of Urology 2009;182:2677-2679.

Schaubel DE, Wolfe RA, Sima CS, Merion RM. Estimating the effect of a time-dependent treatment by levels of an internal time-dependent covariate: application to the contrast between liver wait-list and post-transplant mortality. Journal of the American Statistical Association 2009;104:49–59.

Scher HI, Jia X, de Bono JS, Fleisher M, Pienta KJ, Raghavan D, Heller G. Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. Lancet Oncology 2009;10:233-239.

Schmidt C, Gerdes H, Hawkins W, Zucker E, Zhou Q, Riedel E, Jaques D, Markowitz A, Coit D, Schattner M. A prospective observational study examining quality of life in patients with malignant gastric outlet obstruction. American Journal of Surgery 2009;198:92-99.

Schmidt CR, Panageas KS, Coit DG, Patel A, Brady MS. An increased number of sentinel lymph nodes is associated with advanced Breslow depth and lymphovascular invasion in patients with primary melanoma. Annals of Surgical Oncology 2009;16:948-952.

Scope A, Marghoob AA, Chen CS, Lieb JA, Weinstock MA, Halpern AC; SONIC Study Group. Dermoscopic patterns and subclinical melanocytic nests in normal-appearing skin. The British Journal of Dermatology 2009;160:1318-1321.

Secin FP, Bianco FJ, Cronin A, Eastham JA, Scardino PT, Guillonneau B, Vickers AJ. Is it necessary to remove the seminal vesicles completely at radical prostatectomy? Decision curve analysis of European Society of Urologic Oncology criteria. Journal of Urology 2009;181:609-613.

Selçuk Can A, Akal Yıldız E, Samur G, Rakıcıoğlu N, Pekcan G, Ozbayrakçı S, Palaoğlu KE, Gönen M, Bersot TP. Optimal waist:height ratio cut-off point for cardiometabolic risk factors in Turkish adults. Public Health Nutrition 2010 [epub ahead of print].

Setiawan VW, Doherty JA, Shu XO, Akbari MR, Chen C, De Vivo I, DeMichele A, Goodman MT, Haiman CA, Henderson BE, Horn-Ross P, Le Marchand L, Levine DA, Liang X, Lurie G, McGrath M, Narod SA, Rebbeck TR, Ursin G, Weiss NS, Xiang Y-B, Zheng W, Olson SH. Estrogen-related variants in CYP19A1 and endometrial cancer risk: pooled analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2). Cancer Epidemiology, Biomarkers & Prevention 2009;18:242-247.

Shabsigh A, Korets R, Vora KC, Brooks CM, Cronin AM, Savage C, Raj G, Bochner BH, Dalbagni G, Herr HW, Donat SM. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. European Urology 2009;55:164-174.

Shah GD, Socci ND, Gold JS, Wolchok JD, Carvajal, RD, Panageas KS, Viale A, Brady MS, Coit DG, Chapman PB.  Phase II trial of neoadjuvant temozolomide in resectable melanoma patients. Annals of Oncology 2010 (in press).

Shariat SF, Kattan MW, Vickers AJ, Karakiewicz PI, Scardino PT. Critical review of prostate cancer predictive tools. Future Oncology 2009;5:1555-1584.

Shelton CC, Tian Y, Frattini MG, Li YM. An exo-cell assay for examining real-time gamma-secretase activity and inhibition. Molecular Neurodegeneration 2009;4:22.

Scher HI, Jia X, de Bono JS, Fleisher M, Pienta KJ, Raghavan D, Heller G. Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. Lancet Oncology 2009;10:233-239.

Serganova I, Moroz E, Vider J, Gogiberidze G, Moroz M, Pillarsetty N, Doubrovin M, Minn A, Thaler HT, Massague J, Gelovani J, Blasberg R. Multimodality imaging of TGFbeta signaling in breast cancer metastases. FASEB Journal 2009;23:2662-2672. 

Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC, Henderson BE.  Breast cancer risk factors defined by estrogen and progesterone receptor status: the Multiethnic Cohort Study.  American Journal of Epidemiology 2009; 169:1251-1259.

Shen R, Olshen AB, Ladanyi M. Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis. Bioinformatics 2009;25:2906-2912.

Shukla-Dave A, Hricak H, Ishill N, Moskowitz CS, Drobnjak M, Reuter VE, Zakian KL, Scardino PT, Cordon-Cardo C. Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles. Clinical Cancer Research 2009;15:3842-3849.

Shukla-Dave A, Hricak H, Ishill NM, Moskowitz CS, Drobnjak M, Reuter VE, Zakian KL, Scardino PT, Cordon-Cardo C. Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-akt, and androgen receptor expression in prostate cancer. Radiology 2009;250:803-812.

Shukla-Dave A, Lee N, Stambuk H, Wang Y, Huang W, Thaler HT, Patel SG, Shah JP, Koutcher JA. Average arterial input function for quantitative dynamic contrast enhanced magnetic resonance imaging of neck nodal metastases. BMC Medical Physics 2009;9:4.

Silberhumer GR, Zakian K, Malhotra S, Brader P, Gönen M, Koutcher J, Fong Y. Relationship between 31P metabolites and oncolytic viral therapy sensitivity in human colorectal cancer xenografts. British Journal of Surgery 2009;96:809-816.

Sima CS, Jarnagin WR, Fong Y, Elkin E, Fischer M, Wuest D, D’Angelica M, DeMatteo RP, Blumgart LH, Gönen M. Predicting the risk of perioperative transfusion for patients undergoing elective hepatectomy. Annals of Surgery 2009;250:914-921.

Sima CS, Panageas KS, Heller G, Schrag D. Analytical strategies for characterizing chemotherapy diffusion with patient-level population-based data. Applied Health Economics and Health Policy 2010 (in press).

Small CM, Carney GE, Mo Q, Vannucci M, Jones AG. A microarray analysis of sex- and gonad-biased gene expression in the zebrafish: evidence for masculinization of the transcriptome. BMC Genomics 2009;10:579.

Sofocleous CT, Petre N, Manova-Todorova K, Petrovic L, Gönen M. Assessment of viable tumour tissue attached to needle applicators after local ablation of liver tumours. Digestive Surgery 2009;26:434-435.

Steinberg AG, Bain L, Ewing R, Li Y. Meeting the public’s health information needs: A plain language website outreach project: To reaching underserved parents of deaf children. Health Communication 2010 (in press).

Steinberg ML, Hubbard K, Utti C, Clas B, Hwang BJ, Hill HZ, Orlow I. Patterns of persistent DNA damage associated with sun exposure and the glutathione s-transferase M1 genotype in melanoma patients. Photochemistry and Photobiology 2009;85:379-386.

Stephenson AJ, Kattan MW, Eastham JA, Bianco FJ, Jr., Yossepowitch O, Vickers AJ, Klein EA, Wood DP, Scardino PT. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. Journal of  Clinical Oncology 2009;27:4300-4305.

Stern MC, Van Den Berg D, Yuan JM, Conti DV, Gago-Dominguez M, Pike MC, Xiang YB, Gao YT, Cortessis VK.  Sequence variant on 3q28 and urinary bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study.  Cancer Epidemiology, Biomarkers & Prevention 2009;18:3057-3061.

Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010;21:128-138.

Stone J, Folkerd E, Doody D, Schroen C, Treloar SA, Giles GG, Pike MC, English DR, Southey MC, Hopper JL, Dowsett M.  Familial correlations in postmenopausal serum concentrations of sex steroid hormones and other mitogens: a twins and sisters study.  The Journal of Clinical Endocrinology and Metabolism 2009; 94:4793-4800.

Strong VE, Devaud N, Allen PJ, Gonen M, Brennan MF, Coit D. Laparoscopic versus open subtotal gastrectomy for adenocarcinoma: a case-control study. Annals of Surgical Oncology 2009;16:1507-1513.

Sugarman S, Wasserheit C, Hodgman E, Coglianese M, D’Alassandro A, Fournier M, Troso-Sandoval T, D’Andrea G, Drullinsky P, Lake D, George R, Mills N, Moynahan M, Smith J, Panageas K, Norton L, Hudis C. A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma. Breast Cancer Research and Treatment 2009;115:609-612.

Sun L and  Zhang Z. A class of transformed mean residual life models with censored survival data. Journal of the American Statistical Association, 2009; 104:803-815.

Taylor D, Pearce CL, Hovanessian-Larsen L, Downey S, Spicer DV, Bartow S, Pike MC, Wu AH, Hawes D.  Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast.  Breast Cancer Research and Treatment 2009; 118:161-168.

Teloken PE, Thompson RH, Tickoo SK, Cronin A, Savage C, Reuter VE, Russo P. Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma. Journal of Urology 2009;182:2132-2136.

Temple L, Fuzesi S, Patil S. The importance of determining quality of life in clinical trials. Surgery 2009;145:622-626.

Thomas NE, Kanetsky PA, Edmiston SN, Alexander A, Begg CB, Groben PA, Hao H, Busam K, Ollila DW, Berwick M, Conway K. Relationship between germline MC1R variants and BRAF-mutant melanoma in a North Carolina population-based study (letter). Journal of Investigative Dermatology 2010 [epub ahead of print].

Thompson RH, Hill JR, Babayev Y, Cronin A, Kaag M, Kundu S, Bernstein M, Coleman J, Dalbagni G, Touijer K, Russo P. Metastatic renal cell carcinoma risk according to tumor size. Journal of Urology 2009;182:41-45.

Thompson RH, Kaag M, Vickers A, Kundu S, Bernstein M, Lowrance W, Galvin D, Dalbagni G, Touijer K, Russo P. Contemporary use of partial nephrectomy at a tertiary care center in the United States. Journal of Urology 2009;181:993-997.

Thornton RH, Covey A, Petre EN, Riedel ER, Maluccio MA, Sofocleous CT, Brody LA, Getrajdman GI, D’Angelica M, Fong Y, Brown KT. A comparison of outcomes from treating hepatocellular carcinoma by hepatic artery embolization in patients younger or older than 70 years. Cancer 2009;115:5000-5006.

Touijer K, Secin FP, Cronin AM, Katz D, Bianco F, Vora K, Reuter V, Vickers AJ, Guillonneau B. Oncologic outcome after laparoscopic radical prostatectomy: 10 years of experience. European Urology 2009;55:1014-1019.

Traina TA, Rugo HS, Caravelli JF, Patil S, Yeh B, Melisko ME, Park JW, Geneus  S, Paulson M, Grothusen J, Seidman AD, Fornier M, Lake D, Dang C, Robson M, Theodoulou M, Flombaum CD, Norton L, Hudis CA, Dickler MN. Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer. Journal of Clinical Oncology 2010 [epub ahead of print].

Veselis RA, Pryor KO, Reinsel RA, Li Y, Mehta M, Johnson R Jr. Propofol and midazolam inhibit conscious memory processes very soon after encoding: an event-related potential study of familiarity and recollection in volunteers. Anesthesiology 2009;110:295-312.

Vickers AJ. Decision curve analysis. In: Kattan MW, ed. Encyclopedia of Medical Decision Making. New York, NY:Sage Publications 2009.

Vickers AJ. Phase II designs for anticancer botanicals and supplements. Journal of the Society for Integrative Oncology 2009;7:35-40.

Vickers AJ. What is a p value anyway? 34 stories to help you actually understand statistics. Boston, MA: Addison-Wesley 2009.

Vickers AJ, Cronin AM, Kattan MW, Gonen M, Scardino PT, Milowsky MI, Dalbagni G, Bochner BH; International Bladder Cancer Nomogram Consortium. Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach. Cancer 2009;115:5460-5469.

Vickers AJ, Elkin EB, Peele PB, Dickler M, Siminoff LA. Long-term health outcomes of a decision aid: data from a randomized trial of adjuvant! In women with localized breast cancer. Medical Decision Making 2009;29:461-467.

Vickers AJ, Elkin EB, Steyerberg E. Net reclassification improvement and decision theory. Statistics in Medicine 2009;28:525-526.

Vickers AJ, Fearn P, Scardino PT, Kattan MW. Why can’t nomograms be more like Netflix? Urology 2010 [epub ahead of print].

Vickers AJ, Lilja H. Cutpoints in clinical chemistry: time for fundamental reassessment. Clinical Chemistry 2009;55:15-17.

Vickers AJ, Lilja H. Prostate cancer: Estimating the benefits of PSA screening. Nature Reviews Urology 2009;6:301-303.

Vickers AJ, Maschino AC. The Acupuncture Trialists’ Collaboration: individual patient data meta-analysis of chronic pain trials. Acupuncture in Medicine 2009;27:126-127.

Vickers AJ, Savage CJ. New prognostic markers: the pathway from research to clinical practice. Grand Rounds in Urology 2009;8:7-13.

Vickers AJ, Savage C, O’Brien MF, Lilja H. Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer. Journal of Clinical Oncology 2009;27:398-403.

Vickers AJ, Savage CJ, Hruza M, Tuerk I, Koenig P, Martínez-Piñeiro L, Janetschek G, Guillonneau B. The surgical learning curve for laparoscopic radical prostatectomy: a retrospective cohort study. Lancet Oncology 2009;10:475-480.

Vickers AJ, Scardino PT. The clinically-integrated randomized trial: proposed novel method for conducting large trials at low cost. Trials 2009;10:14.

Vickers AJ, Wolters T, Savage CJ, Cronin AM, O’Brien MF, Pettersson K, Roobol MJ, Aus G, Scardino PT, Hugosson J, Schröder FH, Lilja H. Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort. European Urology 2010 [epub ahead of print].

Voigt LP, Pastores SM, Raoof ND, Thaler HT, Halpern NA. Review of a large clinical series: intrahospital transport of critically ill patients: outcomes, timing, and patterns. Journal of Intensive Care Medicine 2009;24:108-115.

Wang L, Zou X, Berger AD, Twiss C, Peng Y, Li Y, Chiu J, Guo H, Satagopan J, Wilton A, Gerald W, Basch R, Wang Z, Osman I, Lee P. Increased expression of histone deacetylaces (HDACs) and inhibition of prostate cancer growth and invasion by HDAC inhibitor SAHA. American Journal of Translational Research 2009;1:62-71.

Wenske S, Korets R, Cronin AM, Vickers AJ, Fleisher M, Scher HI, Pettersson K, Guillonneau B, Scardino PT, Eastham JA, Lilja H. Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy. International Journal of Cancer 2009;124:659-663.

Westhoff CL, Torgal AH, Mayeda ER, Pike MC, Stanczyk FZ. Pharmacokinetics of a combined oral contraceptive in obese and normal weight women. Contraception 2010 (in press).

Wiechmann L, Sampson M, Stempel M, Jacks LM, Patil SM, King T, Morrow M. Presenting features of breast cancer differ by molecular subtype. Annals of Surgical Oncology 2009;16:2705-2710.

Woodward AT, Bullard KM, Taylor RJ, Chatters LM, Baser RE, Perron BE, Jackson JS. Complementary and alternative medicin for mental disorders among African Americans, Black Caribbeans, and Whites. Psychiatric Services 2009;60:1342-1349.

Woolcott CG, Maskarinec G, Pike MC, Henderson BE, Wilkens LR, Kolonel LN.  Breast cancer risk and hysterectomy status: the Multiethnic Cohort study.  Cancer Causes & Control 2009;20:539-547.

Wu AH, Pearce CL, Tseng CC, Templeman C, Pike MC.  Markers of inflammation and risk of ovarian cancer in Los Angeles County.  International Journal of Cancer 2009; 124:1409-1415.

Wu AH, Yu MC, Tseng CC, Stanczyk FZ, Pike MC.  Dietary patterns and breast cancer risk in Asian American women. The American Journal of Clinical Nutrition 2009;89:1145-1154.

Yang HP, Garcia-Closas M, Lacey JV Jr, Brinton LA, Lissowska J, Peplonska B, Chanock S, Gaudet MM. Genetic variation in the androgen receptor gene and endometrial cancer risk. Cancer Epidemiology Biomarkers and Prevention 2010 (in press).

Yeates K, Wiebe N, Gill J, Sima C, Schaubel D, Holland D, Hemmelgarn B, Tonelli M. Similar outcomes among black and white renal allograft recipients. Journal of the American Society of Nephrology 2009;20:172-179.

Yee DS, Lowrance WT, Eastham JA, Maschino AC, Cronin AM, Rabbani F. Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial. BJU International 2010 [epub ahead of print].

Yuan J, Ku GY, Gallardo HF, Orlandi F, Manukian G, Rasalan TS, Xu Y, Li H, Vyas S, Mu Z, Chapman PB, Krown SE, Panageas K, Terzulli SL, Old LJ, Houghton AN, Wolchok JD. Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma. Cancer Immunology 2009;9:5.

Zauber AG, Knudsen AB, Rutter CM, Lansdorp-Vogelaar I, Savarino JE, van Ballegooijen M, Kuntz KM. Cost-effectiveness of CT colonography to screen for colorectal cancer. Technology Assessment Report. Project ID CTCC0608 for Agency for Health Care Quality from the Cancer Intervention and Surveillance Modeling Network (CISNET) for MISCAN, SimCRC, and CRC-SPIN models. January 22, 2009.

Zauderer M, Patil S, Hurria A. Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer. Breast Cancer Research and Treatment 2009;117:205-210.

Zelefsky MJ, Eastham JA, Cronin AM, Fuks Z, Zhang Z, Yamada Y, Vickers A, Scardino PT. Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. Journal of Clinical Oncology 2010 (in press).

Zelefsky MJ, Shi W, Yamada Y, Kollmeier MA, Cox B, Park J, Seshan VE. Postradiotherapy 2-year prostate-specific antigen nadir as a predictor of long-term prostate cancer mortality. International Journal of Radiation Oncology, Biology, Physics 2009;75:1350-1356.

Zhang J, Hricak H, Shukla-Dave A, Akin O, Ishill NM, Carlino LJ, Reuter VE, Eastham JA. Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging. Radiology 2009;253:425-434.

Zhang Z. Linear transformation models for interval-censored data: prediction of survival probability and model checking. Statistical Modeling 2009;9:321-343.

Zhang Z, Mo Q. Biased Estimator. Encyclopedia of Research Design 2010. Editor: Neil J. Salkind. Sage Publications 2010 (in press).

Zhang Z, Sun J. Interval censoring. Statistical Methods in Medical Research 2010 [epub ahead of print].

Zhang Z, Zhao X. Goodness-of-fit tests for additive mean residual life model under right censoring. Lifetime Data Analysis 2010 (in press).

Zhao B, James LP, Moskowitz CS, Guo P, Ginsberg MS, Lefkowitz RA, Qin Y, Riely GJ, Kris MG, Schwartz LH. Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small cell lung cancer. Radiology 2009;252:263-272.

Zivanovic O, Leitao MM, Iasonos A, Jacks LM, Zhou Q, Abu-Rustum NR, Soslow RA, Juretzka MM, Chi DS, Barakat RR, Brennan MF, Hensley ML. Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and American joint committee on cancer staging systems. Journal of Clinical Oncology 2009;27:2066-2072.

Zivanovic O, Sima CS, Iasonos A, Bell-McGuinn KM, Sabbatini PJ, Leitao MM, Levine DA, Gardner GJ, Barakat RR, Chi DS. Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer. Gynecologic Oncology 2009;115:209-214.

Zivanovic O, Sima CS, Iasonos A, Hoskins WJ, Pingle PR, Leitao MM Jr, Sonoda Y, Abu-Rustum NR, Barakat RR, Chi DS. The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum. Gynecologic Oncology 2010 [epub ahead of print].

Abbasi NR, Yancovitz M, Gutkowicz-Krusin D, Panageas KS, Mihm MC, Googe P, King R, Prieto V, Osman I, Friedman RJ, Rigel DS, Kopf AW, Polsky D. Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma. Archives of Dermatology 2008;144:469-474.

Abu-Rustum NR, Iasonos A, Zhou Q, Oke E, Soslow RA, Alektiar KM, Chi DS, Barakat RR. Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma? American Journal of Obstetrics and Gynecology 2008;198:457. Discussion 1-5.

Akin O, Sala E, Moskowitz CS, Ishill N, Soslow RA, Chi DS, Hricak H. Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion. Radiology 2008;248:511-517.

Al-Ahmadie HA, Alden D, Qin LX, Olgac S, Fine SW, Gopalan A, Russo P, Motzer RJ, Reuter VE, Tickoo SK. Carbonic anhydrase IX expression in clear cell renal cell carcinoma: an immunohistochemical study comparing 2 antibodies. The American Journal of Surgical Pathology 2008;32:377-382.

Allen PJ, Reiner AS, Gonen M, Klimstra DK, Blumgart LH, Brennan MF, D’Angelica M, DeMatteo R, Fong Y, Jarnagin WR. Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions. Official Journal of the International Hepato Pancreato Biliary Association 2008;10:341-346.

Amar D, Desiderio DP, Heerdt PM, Kolker AC, Zhang H, Thaler HT. Practice patterns in choice of left double-lumen tube size for thoracic surgery. Anesthesia and Analgesia 2008; 106:379-383.

Ambrosini G, Seelman SL, Qin LX, Schwartz GK. The cyclin dependent kinase flavopiridol potentiates the effects of topoisomerase 1 poisons by suppressing Rad51 expression in p53-dependent manner. Cancer Research 2008;68:2312-2320.

Amin B, Nehal KS, Jungbluth AA, Zaidi B, Brady MS, Coit DC, Zhou Q, Busam KJ. Histologic distinction between benign subungual melanotic macule and malignant melanoma. The American Journal of Surgical Pathology 2008;32:835-843.

Ariyan C, Brady MS, Gonen M, Busam K, Coit D. Positive nonsentinel node status predicts mortality in patients with cutaneous melanoma. Annals of Surgical Oncology 2008; [epub ahead of print].

Assimes TL, Olshen AB, Narasimhan B, Olshen RA. Associations among multiple markers and complex disease: models, algorithms, and applications. Advances In Genetics 2008;60:437-64. Review.

Bach PB. Cost sharing for health care-whose skin? Which game? New England Journal of Medicine 2008;358:411-413.

Bach PB. Do surgical quality gaps cause healthcare disparities? Medical Care 2008;46:889-892.

Bach PB. Is our natural-history model of lung cancer wrong? Lancet Oncology 2008;9:693-697.

Bach PB. Lung cancer screening. Journal of the National Comprehensive Cancer Network 2008; 6:271-275.

Bach PB. Over diagnosis in lung cancer: different perspectives, definitions, implications. Thorax 2008;63:298-300.

Bach PB. Response to “CT screening for lung cancer: update 2007”. The Oncologist 2008;13:608-609; author reply 610-612.

Bach PB. Untreated patients in “CT screening for lung cancer: update 2007”. The Oncologist 2008; 13: 1030-1032; author reply 1033.

Bach PB.  “Paying doctors to ignore patients.” The New York Times, July 24, 2008 opinion section.

Barbour AP, Jones M, Gönen M, Gotley DC, Thomas J, Thomson DB, Burmeister B, Smithers BM. Refining Esophageal Cancer Staging After Neoadjuvant Therapy: Importance of Treatment Response. Annals of Surgical Oncology 2008 Jul 29. [Epub ahead of print]

Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, Schulze TG, Cichon S, Rietschel M, Nothen MM, Gerogi A, Schumacher J, Schwarz M, Abou Jamra R, Hofels S, Propping P, Satagopan J, Detra-Wadleigh SD, Hardy J, McMahon FJ. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Molecular Psychiatry 2008; 13:197-207.

Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, Langholz B, Bernstein L, Olsen JH, Lynch CF, Anton-Culver H, Capanu M, Liang X, Hummer AJ, Sima C, Bernstein JL. Variation of breast cancer risk among BRCA1/2 carriers. Journal of the American Medical Association 2008;299:194-201.

Begg CB. Commentary: Meta-analysis methods for diagnostic accuracy. Journal of Clinical Epidemiology 2008; 61: 1081-1082.

Bennett JJ, Schmidt CR, Klimstra DS, Grobmyer SR, Ishill NM, D’Angelica M, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Perihepatic lymph node micrometastases impact outcome after partial hepatectomy for colorectal metastases. Annals of Surgical Oncology 2008;15:1130-1136.

Bernstein L, Largent J, Capanu M, Begg CB, Mellemkjaer L, Lynch C, Malone K, Reiner AS, Liang X, Haile R, Boice J, Bernstein JL.  Alcohol intake and cigarette smoking and risk of a contralateral breast cancer in the Women’s Environmental Cancer and Radiation Epidemiology Study.  American Journal of Epidemiology 2008; (in press).

Bertelsen L, Bernstein L, Olsen JH, Mellemkjaer L, Haile RW, Lynch CF, Malone KE, Anton-Culver H, Christensen J, Langholz B, Thomas DC, Begg CB, Capanu M, Ejlertsen B, Stovall M, Boice JD Jr, Shore RE; Women’s Environment, Cancer and Radiation Epidemiology Study Collaborative Group, Bernstein JL. Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women’s Environment, Cancer and Radiation Epidemiology Study. Journal of the National Cancer Institute 2008;100:32-40.

Black D, Levine DA, Nicoll L, Chou JF, Iasonos A, Brown CL, Sonoda Y, Chi DS,  Leitao MM, Abu-Rustum NR, Ferguson SE, Barakat RR. Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer. Gynecologic Oncology 2008;109:39-42.

Blinder V, Mazumdar M. Public policy issues in cancer rehabilitation. Principles and Practice of Cancer Rehabilitation, Editors: Michael Stubblefield, Michael O’Dell, Christian Custodio, and Teresa Fitzpatrick. Demos Medical Publishing, Woodbridge, CT, in press.

Breitbart W, Rosenfeld B, Gibson C, Kramer M, Li Y, Tomarken A, Nelson C, Pessin H, Esch J, Galietta M, Garcia N, Brechtl J, and Schuster M.  Impact of treatment for depression on desire for hastened death in patients with advanced AIDS. Psychosomatics 2008; (in press).

BrintzenhofeSzoc KM, Levin TT, Li Y, Zabora J. The Prevalence of Mixed Anxiety-depression by Cancer Type. Psychosomatics 2008; (in press).

Brooks DD, Winawer SJ, Rex DK, Zauber AG, Kahi CJ, Smith RA, Levin B, Wender R: U.S. Multi-Society Task Force on Colorectal Cancer; American Cancer Society. Colonoscopy surveillance after polypectomy and colorectal cancer resection. American Family Physician 2008;77:995-1002.

Caceres A, Zhou Q, Iasonos A, Gerdes H, Chi DS, Barakat RR. Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: an updated series. Gynecologic Oncology 2008;108:482-485.

Can AS, Bersot TP, Gönen M. Anthropometric indices and their relationship with cardiometabolic risk factors in a sample of Turkish adults. Public Health Nutrition 2008; [epub ahead of print].

Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455:1061-1068.

Canter RJ, Qin LX, Ferrone CR, Maki RG, Singer S, Brennan MF. Why do patients with low-grade soft tissue sarcoma die? Annals of Surgical Oncology 2008;15:3550-3560.

Canter RJ, Qin LX, Maki RG, Brennan MF, Ladanyi M, Singer S. A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients. Clinical Cancer Research 2008;14:8191-8197.

Capanu M, Orlow I, Berwick M, Hummer A, Thomas D, Begg CB. The use of hierarchical models for estimating relative risks of individual genetic variants: an application to a study of melanoma. Statistics in Medicine 2008;27:1973-1992.

Capanu M, Presnell B. Misspecification tests for binomial and beta-binomial models. Statistics in Medicine 2008;27:2536-2554.

Castro-Malaspina H, Jabubowski AA, Papadopoulos EB, Boulad F, Young JW, Kernan NA, Perales MA, Small TN, Hsu K, Chiu M, Heller G, Collins NH, Jhanwar SC, van den Brink M, Nimer SD, O’Reilly RJ. Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings. Biology of Blood and Marrow Transplanation 2008;14:458-468.

Chaudhury S, Auerbach AD, Kernan NA, Small TN, Prockop SE, Scaradavou A, Heller G, Wolden S, O’Reilly RJ, Boulad F. Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi Anaemia. British Journal of Haematology 2008;140:644-655.

Cho CS, Gonen M, Shia J, Kattan MW, Klimstra DS, Jarnagin WR, D’Angelica MI, Blumgart LH, DeMatteo RP. A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma. Journal of the American College of Surgeons 2008;206:281-291.

Cho NL, Redston M, Zauber AG, Carothers AM, Hornick J, Wilton A, Sontag S, Nishioka N, Giardiello FM, Saltzman JR, Gostout C, Eagle CJ, Hawk ET, Bertagnolli MM.  Aberrant crypt foci in the adenoma prevention with celecoxib trial. Cancer Prevention Research 2008;1:21-31.

Chung A, Yu J, Stempel M, Patil SM, Cody H, Montgomery LM.  Is the “10% rule” equally valid for all subsets of sentinel-node positive breast cancer patients? Annals of Surgical Oncology 2008;15:2728-2733.

Clarke JL, Iwamoto FM, Sul J, Panageas KS, Lassman AB, DeAngelis LM, Hormigo A, Nolan  C,   Gavrilovic I, Karimi S, Abrey LE.  Randomized phase II trial of chemoradiotherapy followed by dose-dense versus metronomic temozolomide for newly diagnosed glioblastoma.  Journal of Clinical Oncology 2008; (in press).

Concannon P, Haile RW, Børresen-Dale AL, Rosenstein BS, Gatti, RA, Teraoka SN,  Diep AT, Jansen L, Atencio DP, Langholz B, Capanu M, Liang X, Begg CB, Thomas DC, Bernstein L, Olsen JH, Malone KE, Lynch CF, Anton-Culver H, The WECARE Study Collaborative Group and Bernstein JL. Variants in the ATM gene associated with a reduced risk of second primary breast cancer. Cancer Research 2008; 68:6486-6491.

Conin AM, Vickers AJ. Statistical methods to correct for verification bias in diagnostic studies are inadequate when there are few false negatives: a simulation study. BMC Medical Research Methodology 2008;8:75.

Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA, Lenderking WR, Cella D, Basch E. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO good research practices task force report. Value in Health 2008; [epub ahead of print].

Correa DD, Shi W,Thaler HT, Cheung AM, DeAngelis LM, Abrey LE.  Longitudinal cognitive follow up in low grade gliomas. Journal of Neuro-oncology 2008;86:321-327.

D’Angelica M, Gönen M. Impact of margin width on outcome after resection of colorectal liver metastases. Annals of Surgery 2008;247:905-906.

Dahl D, Bohannan Z, Mo Q, Vannucci M, Tsai J.  Knowledge based classification of amino acids based on torsion angle distributions. Journal of Molecular Biology 2008;378:749-758.

Dalal KM, Woo Y, Kelly K, Galanis C, Gonen M, Fong Y, Coit DG. Detection of micrometastases in peritoneal washings of gastric cancer patients by the reverse transcriptase polymerase chain reaction. Gastric Cancer 2008;11:206-213.

Dang C, D’Andrea G, Lake D, Sugarman S, Fornier M, Moynahan ME, Gilewski T, Hurria A, Mills N, Troso-Sandoval T, George R, Robson M, Dickler M, Smith K, Panageas KS, Norton L, Hudis CA. Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible. Clinical Breast Cancer 2008;8:418-424.

Dang C, Fornier M, Sugarman S, Troso-Sandoval T, Lake D, D’Andrea G, Seidman A, Sklarin N, Dickler M, Currie V, Gilewski T, Moynahan ME, Drullinsky P, Robson M, Wasserheit-Leiblich C, Mills N, Steingart R, Panageas K, Norton L, Hudis C. The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer. Journal of Clinical Oncology 2008;26:1216-1222.

Dash A, Lee P, Zhou Q, Jean-Gilles J, Taneja S, Satagopan J, Reuter V, Gerald W, Eastham J, Osman I. Impact of socioeconomic factors on prostate cancer outcomes in black patients treated with surgery. Urology 2008;72:641-646.

Dematteo RP, Gold JS, Saran L, Gonen M, Liau KH, Maki RG, Singer S, Besmer P, Brennan MF, Antonescu CR. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor. Cancer 2008;112:608-615.

Deng G, Rusch V, Vickers A, Malhotra V, Ginex P, Downey R, Bains M, Park B, Rizk N, Flores R, Yeung S, Cassileth B. Randomized controlled trial of a special acupuncture technique for pain after thoracotomy. Journal of Thoracic and Cardiovascular Surgery. 2008;136:1464-1469.

Dickler MN, Rugo HS, Eberle CA, Brogi E, Caravelli JF, Panageas KS, Boyd J, Yeh B, Lake DE, Dang CT, Gilewski TA, Bromberg JF, Seidman AD, D’Andrea GM, Moasser MM, Melisko M, Park JW, Dancey J, Norton L, Hudis CA. A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer. Clinical Cancer Research 2008;14:7878-7883.

Diefenbach CS, Gnjatic S, Sabbatini P, Aghajanian C, Hensley ML, Spriggs DR, Iasonos A, Lee H, Dupont B, Pezzulli S, Jungbluth AA, Old LJ, Dupont J. Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission. Clinical Cancer Research 2008;14:2740-2748.

Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, D’Angelica M, DeMatteo RP, Blumgart LH, O’Reilly EM. Gallbladder cancer (GBC): 10 year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). Journal of Surgical Oncology 2008;98:485-489.

Duffy A, Kortmansky J, Schwartz GK, Capanu M, Puleio S, Minsky B, Saltz L, Kelsen DP, O’Reilly EM. A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma. Annals of Oncology 2008;19:86-91.

Ekenel M, Iwamoto FM, Ben-Porat LS, Panageas KS, Yahalom J, DeAngelis LM, Abrey LE. Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy. Cancer 2008;113:1025-1031.

Elkin EB, Ishill N, Riley GF, Bach PB, Gonen M, Begg CB, Schrag D. Disenrollment from medicare managed care among beneficiaries with and without a cancer diagnosis. Journal of the National Cancer Institute 2008;100:1013-1021.

Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, D’Angelica M, DeMatteo RP, Fong Y, Schwartz L, Kemeny N, O’Reilly E, Abou-Alfa GK, Shimada H, Blumgart LH, Jarnagin WR. Intrahepatic cholangiocarcinoma: rising frequency improved survival and determinants of outcome after resection. Annuals of Surgery 2008;248:84-96.

Endo I, House MG, Klimstra DS, Gonen M, D’Angelica M, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma. Annals of Surgical Oncology 2008;15:2104-2112.

Estilo CL, Van Poznak CH, Wiliams T, Bohle GC, Lwin PT, Zhou Q, Riedel ER, Carlson DL, Schoder H, Farooki A, Fornier M, Halpern JL, Tunick SJ, Huryn JM. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy. The Oncologist 2008;13:911-920.

Fahy BN, D’Angelica M, DeMatteo RP, Blumgart LH, Weiser MR, Ostrovnaya I, Gonen M, Jarnagin WR. Synchronous hepatic metastases from colon cancer: changing treatment strategies and results of surgical intervention. Annals of Surgical Oncology 2008;[epub ahead of print].

Feldman DR, Kondagunta GV, Schwartz L, Patil S, Ishill N, DeLuca J, Russo P, Motzer RJ. Phase II trial of pegylated interferon-alpha 2b in patients with advanced renal cell carcinoma. Clinical Genitourinary Cancer 2008;6:25-30.

Ferrone CR, Brennan MF, Gonen M, Coit DG, Fong Y, Chung S, Tang L, Klimstra D, Allen PJ. Pancreatic adenocarcinoma: the actual 5-year survivors. Journal of Gastrointestinal Surgery 2008;12:701-706.

Figueiredo JC, Bernstein L, Capanu M, Malone KE, Lynch CF, Haile RW, the WECARE Study Collaborative Group and Bernstein JL.  Oral contraceptives, post-menopausal hormones and risk of asynchronous bilateral breast cancer: the WECARE Study Group. Journal of Clinical Oncology 2008; 26:1411-1418.

Flynn LW, Park J, Patil SM, Cody HS 3rd, Port ER. Sentinel lymph node biopsy is successful and accurate in male breast carcinoma. Journal of the American College of Surgeons 2008;206:616-621.

Forslund A, Zeng A, Qin LX, Rosenberg S, Ndubuisi M, Pincas H, Gerald W, Notterman D, Barany F, Paty PB. MDM2 gene amplification is correlated to tumor progression but not to presence of SNP309 or TP53 mutational status in primary colorectal cancers. Molecular Cancer Research 2008;6:205-211.

Fortuny J, Sima C, Bayuga S, Wilcox H, Pulick KE, Faulkner S, Zauber AG, Olson SH. Risk of endometrial cancer in relation to medical conditions and medication use. Cancer Epidemiology, Biomarkers & Prevention 2008; (in press).

Gallagher DJ, Milowsky MI, Ishill N, Trout A, Boyle MG, Riches J, Fleisher M, Bajorin DF. Detection of circulating tumor cells in patients with urothelial cancer. Annals of Oncology 2008;[epub ahead of print].

Gaudet MM, Chanock S, Dunning A, Driver K, Brinton LA, Lissowska J, Peplonska B, Pharoah P, Garcia-Closas M. HSD17B1 genetic variants and hormone receptor-defined breast cancer.  Cancer Epidemiology, Biomarkers and Prevention 2008;17:2766-2772.

Gaudet MM, Hunter K, Pharoah P, Dunning AM, Driver K, Lissowska J, Sherman M, Peplonska B, Brinton LA, Chanock S, Garcia-Closas M.  Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis.  International Journal of Cancer 2008;(in press).

Gaudet MM, Lacey JV Jr, Lissowska J, Peplonska B, Brinton LA, Chanock S, Garcia-Closas M. Genetic variation in CYP17 and endometrial cancer risk. Human Genetics 2008;123:155-162.

Ghosh P, Gönen M. Bayesian modeling of multivariate average bioequivalence. Statistics in Medicine 2008;27:2402-2419.

Gignac GA, Morris MJ, Heller G, Schwartz LH, Scher HI. Assessing outcomes in prostate cancer clinical trials: a twenty-first century tower of Babel. Cancer 2008;113:966-974.

Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, Garber J, Friedman E, Narod S, Olshen AB, Gregersen P, Kosarin K, Olsh A, Bergeron J, Ellis NA, Klein RJ, Clark AG, Norton L, Dean M, Boyd J, Offit K. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proceedings of the National Academy of Sciences of the United States of America USA 2008;105:4340-4345. Epub 2008 Mar 7.

Gold JS, Are C, Kornprat P, Jarnagin WR, Gönen M, Fong Y, DeMatteo RP, Blumgart LH, D’Angelica M. Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients. Annals of Surgery 2008;247:109-117.

Gonen M. Area between curves: what you see is not what you get. Journal of Clinical Oncology 2008;26:2236; author reply 2236-2237.

Gopalan A, Leversha MA, Satagopan JM, Zhou Q, Al-Ahmadie HA, Fine SW, Eastham JA, Scardino PT, Scher HI, Tickoo SK, Reuter VE, Gerald WL. TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy. Cancer Research 2008; (in press).

Greco C, Nehmeh SA, Schoder H, Gonen M, Raphael B, Stambuk HE, Humm JL, Larson SM, Lee NY. Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancer. American Journal of Clinical Oncology 2008;31:439-445.

Riely GJ, Kris MG, Rosenbaum D, Marks J, Li A, Chitale DA, Nafa K, Riedel ER, Hsu M, Pao W, Miller VA, Ladanyi M. Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma. Clinical Cancer Research 2008;14:5731-5734.

Hoppe BS, Moskowitz CH, Filippa DA, Moskowitz CS, Kewalramani T, Zelenetz AD, Yahalom J.  Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: long-term disease control and toxicity. Journal of Clinical Oncology 2008;26:1858-1864. Erratum in: Journal of Clinical Oncology 2008;26:4053.

Hoppe BS, Moskowitz CH, Zhang Z, Maragulia JC, Rice RD, Reiner AS, Hamlin PA, Zelenetz AD, Yahalom J. The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma. Bone Marrow Transplantation 2008;(in press).

Houldsworth J, Petlakh M, Olshen AB, Chaganti RS. Pathway activation in large B-cell non-Hodgkin lymphoma cell lines by doxorubicin reveals prognostic markers of in vivo response. Leukemia Lymphoma 2008;49:2170-2180.

House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M, Gonen M, Olson SH, Kurtz RC, Brennan MF, Allen PJ. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. Journal of Gastrointestinal Surgery 2008;12:270-278.

Hubbard K, Steinberg ML, Hill H, Orlow I. Mitochondrial DNA deletions in skin from melanoma patients. Ethnicity & Disease 2008; 18:S2-38-43.

Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. Journal of Clinical Oncology 2008;26:1364-1370. Review.

Iasonos A, Wilton AS, Riedel ER, Seshan VE, Spriggs DR. A comprehensive comparison of the continual reassessment method to the standard 3 + 3 dose escalation scheme in Phase I dose-finding studies. Clinical Trials 2008;5:465-477.

Ito H, Are C, Gonen M, D’Angelica M, Dematteo RP, Kemeny NE, Fong Y, Blumgart LH, Jarnagin WR. Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Annals of Surgery 2008;247:994-1002.

Iwamoto FM, Reiner AS, Nayak L, Panageas KS, Elkin EB, Abrey LE.  Importance of histology and grading in older glioma patients. Annals of Neurology 2008, (in press).

Iwamoto FM, Reiner AS, Panageas KS, Elkin EB, Abrey LE. Patterns of care in elderly glioblastoma patients. Annals of Neurology 2008;64:628-634.

Janetzki S, Panageas KS, Ben-Porat L, Boyer J, Britten CM, Clay TM, Kalos M, Maecker HT, Romero P, Yuan J, Kast WM, Hoos A, Elispot Proficiency Panel of the CVC Immune Assay Working Group. Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI). Cancer Immunology Immunotherapy 2008;57:303-315.

Jarnagin WR, Gonen M, Kaithel SK, Fong Y, D’Angelica MI, DeMatteo RP, Grant F, Wuest D, Kundu K, Blumgart LH, Fischer M. A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection. Annals of Surgery 2008;248:360-369.

Jathavedam A, Feldman DR, Ishill N, Turkula S, Patil S, Bosl GJ, Motzer RJ, Weinstock DM. Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors. Biology of Blood and Marrow Transplantation 2008;14:595-600.

Jhawer M, Coit D, Brennan M, Qin LX, Gonen M, Klimstra D, Tang L, Kelsen DP, Shah MA. Perineural invasion following preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation. American Journal of Clinical Oncology 2008 (in press).

Juretska M, Hensley ML, Tew W, Konner J, Aghajanian C, Leitao M, Iasonos A, Soslow R, Park K, Sabbatini P. A phase 2 trial of oral imatinib in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma in second or greater remission. European Journal of Gynaecolgoical Oncology 2008;29:568-572.

Kappel LW, Goldberg GL, King CG, Suh DY, Smith OM, Ligh C, Holland AM, Grubin J, Mark NM, Liu C, Iwakura Y, Heller G, van den Brink MR. IL-17 contributes to CD4-mediated graft-versus-host disease. Blood 2008;[epub ahead of print].

Kattan MW, Gönen M. The prediction philosophy in statistics. Urologic Oncology 2008;26:316-319.

Kattan MW, Gönen M, Jarnagin WR, Dematteo R, D’Angelica M, Weiser M, Blumgart LH, Fong Y. A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer. Annals of Surgery 2008;247:282-287.

Kemeny N, Capanu M, D’Angelica M, Jarnagin W, Haviland D, Dematteo R, Fong Y. Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer. Annals of Oncology 2008, (in press).

Kim TD, Terwey TH, Zakrzewski JL, Suh D, Kochman AA, Chen ME, King CG, Borsotti C, Grubin J, Smith OM, Heller G, Liu C, Murphy GF, Alpdogan O, van den Brink MR. Organ-derived dendritic cells have differential effects on alloreactive T cells. Blood 2008;111:2929-2940.

King V, Vaze AA, Moskowitz CS, Smith LJ, Ginsberg MS. D-dimer assay to exclude pulmonary embolism in high-risk oncologic population: correlation with CT pulmonary angiography in an urgent care setting. Radiology 2008;247:854-861.

Kissane D, Li Y. Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: A randomized prospective trial. Cancer 2008; 112:443-444.

Klein EA, Bianco FJ, Serio AM, Eastham JA, Kattan MW, Pontes JE, Vickers AJ,  Scardino PT.  Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories. Journal of Urology 2008;179:2212-2216.

Klein EA, Kattan M, Stephenson A, Vickers A. How many lymphadenectomies does it take to cure one patient? European Urology 2008;53:13-15.

Klimek VM, Fircanis S, Maslak P, Guernah I, Baum M, Wu N, Panageas K, Wright JJ, Pandolfi PP, Nimer SD. Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide(romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes.  Clinical Cancer Research 2008;14:826-832.

Koppie TM, Serio AM, Vickers AJ, Vora K, Dalbagni G, Donat SM, Herr HW, Bochner BH.  Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer 2008;112:2384-2392.

Korkola JE, Heck S, Olshen AB, Reuter VE, Bosl GJ, Houldsworth J, Chaganti RS. In vivo differentiation and genomic evolution in adult male germ cell tumors.  Genes Chromosomes Cancer 2008;47:43-55.

Kreisl TN, Panageas KS, Elkin EB, Deangelis LM, Abrey LE. Treatment patterns and prognosis in patients with human immunodeficiency virus and primary central system lymphoma. Leukemia Lymphoma 2008;49:1710-1716.

Ku GY, Ilson DH, Schwartz LH, Capanu M, O’Reilley E, Shah MA, Kelsen DP, Schwartz GK. Phase II trial of sequential paclitaxel and one hour infusion bryostatin-1 in patients with advanced esophageal cancer. Cancer Chemotherapy and Pharmacology 2008;62:875-880.

Kudo S, Lambert R, Allen JI, Fujii H, Fujii T, Kashida H, Matsuda T, Mori M, Saito H, Shimoda T, Tanaka S, Watanabe H, Sung JJ, Feld AD, Inadomi JM, O’Brien MJ, Lieberman DA, Ransohoff DF, Soetikno RM, Triadafilopoulos G, Zauber A, Teixeira CR, Rey JF, Jaramillo E, Rubio CA, Van Gossum A, Jung M, Vieth M, Jass JR, Hurlstone PD. Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointestinal Endoscopy 2008;68(4 Suppl):S3-47. Review.

Kurihara N, Fan K, Thaler HT, Yang K, Lipkin M. Effect of a Western-style diet fortified with increased calcium and vitamin D on mammary gland of C57BL/6 mice. Journal of Medicinal Food 2008; 11:201-206.

Lamanna N, Jurcic JG, Noy A, Maslak P, Gencarelli AN, Panageas KS, Heaney ML,  Brentjens RJ, Golde DW, Scheinberg DA, Zelenetz AD, Weiss MA. Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses. Journal of Clinical Oncology 2008;[epub ahead of print].

Langholz B, Thomas DC, Stovall M, Smith SA, Boice JD Jr, Shore RE, Bernstein L, Lynch CF, Zhang X, Bernstein JL, The WECARE Study Group.  Statistical methods for analysis of radiation effects with tumor and dose location-specific information with application to the WECARE study of asynchronous contralateral breast cancer.  Biometrics 2008; [epub ahead of print]

Lansdorp-Vogelaar I, van Ballegooijen M, Boer R, Zauber A, Habbema JDF. A novel hypothesis on the sensitivity of FOBT. Results of a joint analysis of three randomized controlled trials.  Cancer 2008; (in press).

Landsdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Boer R, Wilschut J, Winawer SJ, Habbema JDF. Individualizing colonoscopy screening by gender and race. Gastrointestinal Endoscopy 2008; (in press).

Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? Journal of the National Cancer Institute 2008;100:773-783.

Levin TT, Li Y, Weiner JM, Lewis F, Bartell A, Piercy J, Kissane DW: How do-not-resuscitate orders are utilized in cancer patients: timing relative to death and communication-training implications. Palliative and Supportive Care 2008; 6341-348.

Levy O, Deangelis LM, Filippa DA, Panageas KS, Abrey LE. Bcl-6 predicts improved prognosis in primary central nervous system lymphoma. Cancer 2008;112:151-156. 

Lilja H, Ulmert D, Vickers AJ.  Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nature Reviews Cancer 2008;8:268-278. Review. Erratum in Nature Reviews Cancer 2008;8:403.

Lipoff JB, Scope A, Dusza SW, Marghoob AA, Oliveria SA, Halpern AC. Complex dermoscopic pattern: a potential risk marker for melanoma. British Journal of Dermatology 2008;158:821-824.

Lissowska J, Gaudet MM, Brinton LA, Peplonska B, Sherman M, Szeszenia-Dabrowska N, Zatonski W, Garcia-Closas M.  Intake of fruits, and vegetables in relation to breast cancer risk by hormone receptor status.  Breast Cancer Research Treatment 2008;107:113-117.

Maithel Sk, Maloney S, Winston C, Gonen M, D’Angelica MI, DeMatteo RP, Jarnagin WR, Brennan MF, Allen PJ. Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma. Annals of Surgical Oncology 2008;15:3512-3520.

Makker V, Abu-Rustum NR, Alektiar KM, Aghajanian CA, Zhou Q, Iasonos A, Hensley ML. A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma. Gynecologic Oncology 2008;111:249-254.

Marks JL, Broderick S, Zhou Q, Chitale D. Li AR, Zakowski MF, Kris MG, Rusch VW, Azzoli CG, Seshan VE, Ladanyi M, Pao W. Prognostic and therapeutic implications of EGFR and KRAS mutation in resected lung adenocarcinoma. Journal of Thoracic Oncology 2008;3:111-116.

Masterson TA, Serio AM, Mulhall JP, Vickers AJ, Eastham JA.  Modified technique for neurovascular bundle preservation during radical prostatectomy: association between technique and recovery of erectile function. BJU International 2008;101:1217-1222.

Mazaheri Y, Shukla-Dave A, Hricak H, Fine SW, Zhang J, Inurrigarro G, Moskowitz CS, Ishill NM, Reuter VE, Touijer K, Zakian KL, Koutcher JA. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging—correlation with pathologic findings. Radiology 2008;246:480-488.

McLaughlin SA, Ochoa-Frongia LM, Patil SM, Cody HS, Sclafani LM.  Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy.  Journal of American College of Surgeons 2008; 206: 76-82.

Mellemkjær L, Dahl C, Olsen JH, Bertelsen L, Guldberg P, Christensen J, Børresen-Dale A, Stovall M, Langholz B, Bernstein L, Lynch, CF, Malone KE, Haile R, Andersson M, Thomas DC, Concannon P, Capanu M, Boice Jr. JD,  The WECARE Study Collaborative Group, Bernstein JL. Risk for contralateral breast cancer among carriers of CHEK2*1100delC: a population-based multi-center case-control study. British Journal of Cancer 2008;98:728-733.

Meltzer LJ, Steinmiller E, Simms S, Grossman M, The CCCT, Li Y.  Staff engagement during complex pediatric medical care: The role of patient, family, and treatment variables.  Patient Education and Counseling 2008; [epub ahead of print].

Miglioretti DL, Rutter CM, Bradford SC, Zauber AG, Kessler LG, Feuer EJ, Grossman DC.  Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization.  Medical Care 2008;46(9 Suppl 1):S91-6.

Miller VA, Riely GJ, Zakowski MF, Li AR, Patel JD, Heelan RT, Kris MG, Sandler AB, Carbone DP, Tsao A, Herbst RS, Heller G, Ladanyi M, Pao W, Johnson DH. Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib. Journal of Clinical Oncology 2008;26:1472-1478.

Miyagawa T, Gogiberidze G, Serganova I, Cai S, Balatoni JA, Thaler HT, Ageyeva L, Pillarsetty  N, Finn RD, Blasberg RG. Imaging of HSV-tk reporter gene expression: comparison between [18F]FEAU, [18F]FFEAU, and other imaging probes. Journal of Nuclear Medicine 2008;49:637-648.

Moore Dalal K, Zhou Q, Panageas KS, Brady MS, Jaques DP, Coit DG. Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy. Annals of Surgical Oncology 2008;15:2206-2214.

Moskowitz CS, Jia X, Schwartz LH, Gönen M. A simulation study to evaluate the impact of the number of lesions measured on response assessment. European Journal of Cancer 2008; [epub ahead of print].

Moskowitz CS, Seshan VE, Riedel ER, Begg CB. Estimating the empirical Lorenz curve and Gini coefficient in the presence of error with nested data. Statistics in Medicine 2008;27:3191-3208.

Neuman HB, Elkin EB, Guillem JG, Paty PB, Weiser MR, Wong D, Temple LK. Treatment for patients with rectal cancer and a clinical complete response to neoadjuvant therapy: A decision analysis. Disease of the Colon and Rectum 2008; (in press).

Neuman HB, Patel A, Ishill N, Hanlon C, Brady MS, Halpern AC, Houghton A, Coit DG. A single-institution validation of the AJCC staging system for stage IV melanoma. Annals of Surgical Oncology 2008;15:2034-2041.

Oeffinger KC, Ford JS, Moskowitz CS, Diller LR, Hudson MM, Chou JF, Smith SM, Mertens AC, Henderson TO, Friedman DL, Leisenring WM, Robison LL. Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. JAMA 2008 (in press).

Oliveria SA, Satagopan JM, Geller AC, Dusza SW, Weinstock MA, Berwick M,

Bishop M, Heneghan MK, Halpern AC. Study of Nevi in Children (SONIC): baseline findings and predictors of nevus count. American Journal of Epidemiology 2008[epub ahead of print].

Olshen AB, Gold B, Lohmueller KE, Struewing JP, Satagopan J, Stefanov SA, Eskin E, Kirchhoff T, Lautenberger JA, Klein RJ, Friedman E, Norton L, Ellis NA, Viale A, Lee CS, Borgen PI, Clark AG, Offit K, Boyd J. Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping. BMC Genetics 2008;9:14.

Olson S, Orlow I, Bayuga S, Sima C, Bandera EV, Pulick K, Faulkner S, Tommasi D, Egan D, Roy P, Wilcox H, Asya A, Modica I, Asad H, Soslow R, Zauber AG. Variants in hormone biosynthesis genes and risk of endometrial cancer. Cancer Causes Control 2008;19:955-963.

Orlow I, Park BJ, Mujumdar U, Patel H, Siu-Lau P, Clas BA, Downey R, Flores R, Bains M, Rizk N, Dominguez G, Jani J, Berwick M, Begg CB, Kris MG, Rusch VW. DNA damage and repair capacity in patients with lung cancer: prediction of multiple primary tumors. Journal of Clinical Oncology 2008;26:3560-3566.

Ostrovnaya I, Seshan VE, Begg CB. Comparison of properties of tests for assessing tumor clonality. Biometrics 2008;64:1018-1022.

Ouyang X, Jessen WJ, Al-Ahmadie H, Serio AM, Lin Y, Shih WJ, Reuter VE, Scardino PT, Shen MM, Aronow BJ, Vickers AJ, Gerald WL, Abate-Shen C. Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer. Cancer Research 2008;68:2132-2144.

Panageas KS:  Random versus fixed effects.  Encyclopedia of Medical Decision Making 2008, (in press).

Pandit-Taskar N, O’Donoghue JA, Morris MJ, Wills EA, Schwartz LH, Gonen M, Scher HI, Larson SM, Divgi CR. Antibody mass escalation study in patients with castration-resistant prostate cancer using 111InJ591: lesion detectability and dosimetric projections for 90Y radioimmunotherapy. Journal of Nuclear Medicine 2008;49:1066-1074.

Paoluzzi L, Gönen M, Bhagat G, Furman RR, Gardner JR, Scotto L, Gueorguiev VD, Heaney ML, Manova K, O’Connor OA. The BH3-only mimetic ABT-737 synergizes the anti-neoplastic activity of proteasome inhibitors in lymphoid malignancies. Blood 2008; [epub ahead of print].

Paoluzzi L, Gönen M, Gardner JR, Mastrella J, Yang D, Holmlund J, Sorensen M, Leopold L, Manova K, Marcucci G, Heaney ML, O’ Connor OA.Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma. Blood 2008; [epub ahead of print].

Park J, Linde K, Manheimer E, Molsberger A, Sherman K, Smith C, Sung J, Vickers A, Schnyer R. The status and future of acupuncture clinical research. Journal of Alternative and Complementary Medicine 2008;14:871-881.

Patel PH, Kondagunta GV, Schwartz L, Ishill N, Bacik J, DeLuca J, Russo P, Motzer RJ. Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma. Investigational New Drugs 2008;26:273-276.

Perales MA, Yuan J, Powel S, Gallardo HF, Rasalan TS, Gonzalez C, Manukian G, Wang J, Zhang Y, Chapman PB, Krown SE, Livingston PO, Ejadi S, Panageas KS, Engelhorn ME, Terzulli SL, Houghton AN, Wolchok JD. Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma. Molecular Therapy 2008;16:2022-2029.

Qin LX. An integrative analysis of microRNA and mRNA expression – a case study. Cancer Informatics 2008;6:369-379.

Qin LX, Satagopan JM. Normalization method for transcription studies of heterogeneous samples: Simultaneous array normalization and identification of equivalent expression. Statistical Application is Genetics and Molecular Biology 2008; (in press).

Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Landmann RG, Guillem JG, Paty PB, Temple LK, Wong WD, Weiser MR. Identification of patients with high-risk stage II colon cancer for adjuvant therapy. Diseases of the Colon and Rectum 2008;51:503-507.

Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Saltz LB, Goodman KA, Minsky BD, Wong WD, Weiser MR. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer 2008;113:57-64.

Ragupathi G, Yeung KS, Leung PC, Lee M, Lau CB, Vickers A, Hood C, Deng G, Cheung NK, Cassileth B, Livingston P. Evaluation of widely consumed botanicals and immunological adjuvants. Vaccine 2008;26:4860-4865.

Raizer JJ, Hwu WJ, Panageas KS, Wilton A, Baldwin DE, Bailey E, von Althann C, Lamb LA, Alvarado G, Bilsky MH, Gutin PH. Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features. Neuro-Oncology 2008;10:199-207.

Rathkopf D, Carducci MA, Morris MJ, Slovin SF, Eisenberger MA, Pili R, Denmeade SR, Kelsen M, Curley T, Halter M, Collins C, Fleisher M, Heller G, Baker SD, Scher HI. Phase II trial of docetaxel with rapid androgen cycling for progressive non-castrate prostate cancer. Journal of Clinical Oncology 2008;26:2959-2965.

Rietschel P, Wolchok JD, Krown S, Gerst S, Jungbluth A, Busam K, Smith K, Orlow I, Panageas K, Chapman PB. Phase II study of extended dose temozolomide in patients with melanoma. Journal of Clinical Oncology 2008;26:2299-2304.

Rimner A, Brennan MF, Zhang Z, Singer S, Alektiar KM. Influence of compartmental involvement on the patterns of morbidity in soft tissue sarcoma of the thigh. Cancer 2008;(in press).

Roohipour R, Patil S, Goodman KA, Minsky BD, Wong WD, Guillem JG, Paty PB, Weiser MR, Neuman HB, Shia J, Schrag D, Temple LK. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Diseases of the Colon and Rectum 2008;51:147-153.

Rossner Jr P, Gammon MD, Zhang Y, Terry MB, Hibshoosh H, Memeo L, Mansukhani M, Long C, Garbowski G, Agrawal M, Kalra TS, Gaudet MM, Teitelbaum ST, Neugut A, Santella RM.  Mutations in p53, p53 protein overexpression and breast cancer survival. Journal of Cell and Molecular Medicine 2008;(in press).

Sagiv SK, Gaudet MM, Eng SM, Abrahamson PE, Shantakumar S, Teitelbaum SL, Bell P, Tomas JA, Neugut AI, Santella RM, Gammon MD.  Polycyclic aromatic hydrocarbon-DNA adducts and survival among women with breast cancer.  Environmental Research 2008;(in press).

Salz T, Sandler RS.  The effect of hospital and surgeon volume on outcomes for rectal cancer surgery.  Clinical Gastroenterology and Hepatology 2008; 6:1185-1193.

Sawai A, Chandarlapaty S, Greulich H, Gonen M, Ye Q, Arteaga CL, Sellers W, Rosen N, Solit DB. Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel. Cancer Research 2008;68:589-596.

Scher HI, Halabi S, Tannock I, Morris M, Carducci M, Eisenberger MA, Higano C, Bubley GJ, Dreicer R, Petrylak D, Kantoff P, Heller G, Basch E, Kelly WK, Figg W, Small EJ, Beer TM, Sternberg C, Wilding G, Martin A, Hussain M. Design and endpoints of phase 2 trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the prostate cancer clinical trials working group (PCWG2). Journal of Clinical Oncology 2008;26:1148-1159.

Schmidt CR, Gerdes H, William GH, Zucker E, Zhou Q, Riedel E, Jaques DP, Markowitz AJ, Coit DG, Schattner MA. Palliation for malignant gastric outlet obstruction: a prospective quality of life study. Gastrointestinal Endoscopy 2008;67:AB251.

Scope A, Marghoob AA, Dusza SW, Satagopan JM, Agero AL, Benvenuto-Andrade C, Lieb JA, Weinstock MA, Oliveria SA, Geller AC, Halpern AC. Dermoscopic patterns of naevi in fifth grade children of the Framingham school system. British Journal of Dermatology 2008;158:1041-1049.

Secin FP, Jiborn T, Bjartell AS, Fournier G, Salomon L, Abbou CC, Haber GP, Gill IS, Crocitto LE, Nelson RA, Cansino Alcaide JR, Martínez-Piñeiro L, Cohen MS, Tuerk I, Schulman C, Gianduzzo T, Eden C, Baumgartner R, Smith JA, Entezari K, van Velthoven R, Janestschek G, Serio AM, Vickers AJ, Touijer K, Guillonneau B. Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy.  European Urology 2008;53:134-145.

Shen R, Chinnaiyan AM, Ghosh D. Pathway analysis reveals functional convergence of gene expression profiles in breast cancer. BMC Medical Genomics 2008;27:1:28.

Shen R, Ghosh D, Taylor JM. Modeling intra-tumor protein expression heterogeneity in tissue microarray experiments. Statistics in Medicine 2008;27:1944-1959.

Shen R, Taylor JM, Ghosh D. Reconstructing tumor-wise protein expression in tissue microarray studies using a Bayesian cell mixture model. Bioinformatics 2008;24:2880-2886.

Shia J, Klimstra DS, Nitzkorski JR, Low PS, Gonen M, Landmann R, Weiser MR, Franklin WA, Prendergast FG, Murphy L, Tang LH, Temple L, Guillem JG, Wong WD, Paty PB. Immunohistochemical expression of folate receptor alpha in colorectal carcinoma: patterns and biological significance. Human Pathology 2008;39:498-505.

Sofocleous CT, Nascimento RG, Petrovic LM, Klimstra DS, Gonen M, Brown KT, Brody LA, Covey Am, Thornton RH, Fong Y, Solomon SB, Schwartz LH, DeMatteo RP, Getrajdman GI. Histopathologic and immunohistochemical features of tissue adherent to multitined electrodes after RF ablation of liver malignancies can help predict local tumor progression: initial results. Radiology 2008;249:364-374.

Solit DB, Osman I, Polsky D, Panageas KS, Daud A, Goydos JS, Teitcher J, Wolchok JD, Germino FJ, Krown SE, Coit D, Rosen N, Chapman PB. Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma. Clinical Cancer Research 2008;14:8302-8307.

Steinberg AG, Bain L, Ewing R, Li Y.  Meeting the public’s health information needs: a plain language website outreach project: to reaching underserved parents of deaf children.  Health Communication 2008; (in press).

Steinberg ML, Hubbard K, Utti C, Clas B, Hwang BJ, Hill HZ, Orlow I. Patterns of persistent DNA damage associated with sun exposure and the glutathione S-transferase M1 genotype in melanoma patients.  Photochemistry and Photobiology 2008; (in press).

Steyerberg EW, Vickers AJ. Decision curve analysis: a discussion. Medical Decision Making 2008;28:146-9.

Stovall M, Smith SA, Langholz BM, Boice JD, Shore RE,  Andersson M., Buchholz TA, Capanu M, Bernstein L, Lynch CF,  Malone KE,  Anton-Culver H, Haile RW, Reiner A,  Thomas D. C., WECARE Study Collaborative Group,  Bernstein JL. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study.   Journal of Radiation Oncology, Biology and Physics 2008; 72:1021-1030.

Sugarman S, Wasserheit C, Hodgman E, Coglianese M, D’Alassandro A, Fournier M, Troso-Sandoval T, D’Andrea G, Drullinsky P, Lake D, George R, Mills N, Moynahan M, Smith J, Panageas K, Norton L, Hudis C. A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma. Breast Cancer Research and Treatment 2008; [epub ahead of print].

Sun L, Zhang Z. A class of transformed mean residual life models under right censoring. Journal of the American Statistical Association 2008;(in press).

Swartz MD, Mo Q, Murphy ME, Lupton JR, Turner ND, Hong MY, Vannucci M. Bayesian variable selection in clustering high dimensional data with substructure. Journal of Agricultural, Biological and Environmental Statistics 2008;13:407-423.

Tan LK, Giri D, Hummer AJ, Panageas KS, Brogi E, Norton L, Hudis C, Borgen PI,Cody HS 3rd. Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. Journal of Clinical Oncology 2008;26:1803-1809.

Thompson RH, Ordonez MA, Iasonos A, Secin FP, Guillonneau B, Russo P, Touijer K. Renal cell carcinoma in young and old patients—is there a difference? Journal of Urology 2008;180:1262-1266; discussion 1266.

Touijer K, Eastham JA, Secin FP, Romero Otero J, Serio A, Stasi J, Sanchez-Salas R, Vickers A, Reuter VE, Scardino PT, Guillonneau B.  Comprehensive prospective comparative analysis of outcomes between open and laparoscopic radical prostatectomy conducted in 2003 to 2005. Journal of Urology 2008;179:1811-7.

Touijer K, Secin FP, Cronin Am, Katz D, Bianco F, Vora K, Reuter V, Vickers AJ, Guillonneau B. Oncologic outcome after laparoscopic radical prostatectomy: 10 years of experience. European Urology 2008; [epub ahead of print].

Traina TA, Poggesi I, Robson M, Asnis A, Duncan BA, Heerdt A, Dang C, Lake D, Moasser M, Panageas K, Borgen P, Norton L, Hudis C, Dickler MN.  Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer. Breast Cancer Research and Treatment 2008;111:377-388.

Traina TA, Theodoulou M, Feigin F, Patil SM, Tan KL, Edwards C, Dugan U, Norton L, Hudis C.  Phase I study of a novel capecitabine schedule based upon the Norton-Simon mathematical model in patients with metastatic breast cancer. Journal of Clinical Oncology 2008; 26: 1797-1802.

Tran W, Serio AM, Raj GV, Dalbagni G, Vickers AJ, Bochner BH, Herr H, Donat SM. Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance. Journal of Urology 2008;179:96-100.

Tse AN, Klimstra DS, Gonen M, Shah M, Sheikh T, Sikowski R, Carvajal R, Mui J, Tipian C, O’Reilly E, Chung K, Maki R, Lefkowitz R, Brown K, Manova-Todorava K, Wu N, Egorin MJ, Kelsen D, Schwartz GK. A phase I dose-escalation study of irinotecan in combination with 17-allylamino 17-demethoxygeldanamycin in patients with solid tumors. Clinical Cancer Research 2008;14:6704-6711.

Ulmert D, Cronin AM, Björk T, O’Brien MF, Scardino PT, Eastham JA, Becker C, Berglund G, Vickers AJ, Lilja H.  Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study. BMC Medicine 2008;6:6.

Ulmert D, Serio AM, O’Brien MF, Becker C, Eastham JA, Scardino PT, Björk T, Berglund G, Vickers AJ, Lilja H.  Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative,  unscreened population. Journal of Clinical Oncology 2008;26:835-841.

Veselis RA, Pryor KO, Reinsel RA,  Li Y, Mehta M, Johnson Jr. R. Effects of propofol and midazolam on long term memory start soon after encoding – ERP evidence.  Anesthesiology 2008; (in press).

Vickers AJ. Editorial comment on: Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer. European Urology 2008;54:802-803.

Vickers AJ, Basch E, Kattan MW. Against diagnosis. Annals of Internal Medicine 2008;149:200-203.

Vickers AJ, Bianco FJ, Gonen M, Cronin AM, Eastham JA, Schrag D, Klein EA, Reuther AM, Kattan MW, Pontes JE, Scardino PT.  Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique. European Urology 2008;53:960-966.

Vickers AJ, Cassileth BR. Living proof and the pseudoscience of alternative cancer treatments. Journal of the Society of Integrative Oncology 2008;6:37-40.

Vickers AJ, Cronin AM, Aus G, Pihl CG, Becker C, Pettersson K, Scardino PT, Hugosson J, Lilja H. A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer; data from the European randomized study of prostate cancer screening in Goteborg, Sweden. BMC Medicine 2008;6:19.

Vickers AJ, Cronin AM, Elkin EB, Gonen M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Medical Informatics and Decision Making 2008;8:53.

Vickers AJ, Jang K, Sargent D, Lilja H, Kattan MW. Systematic review of statistical methods used in molecular marker studies in cancer. Cancer 2008;112:1862-1868.

Vickers AJ. Basic introduction to research: how not to do research. Journal of the Society of Integrative Oncology 2008;6:82-85.

Vickers AJ. Decision analysis for the evaluation of diagnostic tests, prediction models and molecular markers. American Statistician 2008;62:314-320.

Vickers AJ. Do we want more cancer patients on clinical trials If so, what are the barriers to greater accrual? Trials 2008;9:31.

Vickers AV, Elkin EB, Peele PB, Dickler M, Siminoff LA. Long-term health outcomes of a decision aid: Data from a randomized trial of Adjuvant! in women with localized breast cancer. Medical Decision Making 2008; (in press).

Vin Y, Sima CS, Getrajdman GI, Brown KT, Covey A, Brennan MF, Allen PJ. Management and outcomes of post-pancreatectomy fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005. Journal of the American College of Surgeons 2008;207:490-498.

Voigt LP, Pastores SM, Raoof ND, Thaler HT, Halpern NA. Intrahospital transport of critically ill patients: outcomes, timing, and patterns. Journal of Intensive Care Medicine 2008; (in press).

Weingart SN, Brown E, Bach PB, Eng K, Johnson SA, Kuzel TM, Langbaum TS, Leedy RD, Muller RJ, Newcomer LN, O’Brien S, Reinke D, Rubino M, Saltz L, Walters RS. NCCN task force report: oral chemotherapy. Journal of the National Comprehensive Cancer Network 2008; Suppl 3:S1-14. review.

Weiser MR, Landmann RG, Kattan MW, Gonen M, Shia J, Chou J, Paty PB, Guillem JG, Temple LK, Schrag D, Saltz LB, Wong WD. Individualized prediction of colon cancer recurrence using a nomogram. Journal of Clinical Oncology 2008;26:380-385.

White R, Winston C, Gonen M, D’Angelica M, Jarnagin W, Fong Y, Conlon K, Brennan M, Allen P. Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms. Journal of the American College of Surgeons 2008;206:445-450.

Zakrzewski JL, Suh D, Markley JC, Smith OM, King C, Goldberg GL, Jenq R, Holland AM, Grubin J, Cabrera-Perez J, Brentjens RJ, Lu SX, Rizzuto G, Sant’Angelo DB, Riviere I, Sadelain M, Heller G, Zúñiga-Pflücker JC, Lu C, van den Brink MR.  Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors. Nature Biotechnology 2008;26:453-461.

Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM.  Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.  Annals of Internal Medicine 2008;149:659-669.

Zauber AG, Levin TR, Jaffe CC, Galen BA, Ransohoff DF, Brown ML.  Implications of new colorectal cancer screening technologies for primary care practice.  Medical Care 2008;49:(9 Suppl):S139-146.

Zauderer M, Patil SM, Hurria A.  Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer.  Breast Cancer Research and Treatment 2008; [epub ahead of print].

Zelefsky MJ,  Shi W, Yamada Y, Kollmeier M, Cox B, Park J, Seshan V. Post-radiotherapy two-year PSA nadir as a predictor of long-term prostate cancer mortality. International Journal of Radiation Oncology, Biology, Physics 2008;(in press).

Zelefsky MJ, Yamada Y, Fuks Z, Zhang Z, Hunt M, Cahlon O, Park J, Shippy A. Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. International Journal of Radiation Oncology Biology Physics 2008;71:1028-1033.

Zhang J, Mironov S, Hricak H, Ishill NM, Moskowitz CS, Soslow RA, Chi DS. Characterization of adnexal masses using feature analysis at contrast-enhanced helical computed tomography. Journal of Computer Assisted Tomography 2008;32:533-540.

Zhang J, Tehrani YM, Wang L, Ishill NM, Schwartz LH, Hricak H. Renal masses: characterization with diffusion-weighted MR imaging—a preliminary experience. Radiology 2008;247:458-64.

Zhang J, Yang X, Yin X, Zhang Z, Fuks Z, Kolesnick R. Downregulation of KSR1 in pancreatic cancer xenografts by antisense oligonucleotides correlates with tumor drug uptake. Cancer Biology and Therapy 2008;7:1490–1495.

Zhang Z, Mo Q. Biased estimator. Encyclopedia of Research Design 2008;(in press).

Zhang Z, Sun J. Interval censoring. Statistical Methodology for Medical Research 2008;(in press).

Zhang Z. Linear transformation models for interval-censored data: prediction and model checking. Statistical Modeling 2008;(in press).

Zhou P, Comenzo RL, Olshen AB, Bonvini E, Koenig S, Maslak PG, Fleisher M, Hoffman J, Jhanwar S, Young JW, Nimer SD, Boruchov AM. CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy. Blood 2008;111:3403-3406.

Zhou P, Teruya-Feldstein J, Lu P, Fleisher M, Olshen A, Comenzo RL.  Calreticulin expression in the clonal plasma cells of patients with systemic light-chain (AL-) amyloidosis is associated with response to high-dose melphalan. Blood 2008;111:549-557.

Zivanovic O, Alektiar KM, Sonoda Y, Zhou Q, Iasonos A, Tew WP, Diaz JP, Chi DS, Barakat RR, Abu-Rustum NR. Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy. Gynecologic Oncology 2008;111:265-270.

Zivanovic O, Eisenhauer EL, Zhou Q, Iasonos A, Sabbatini P, Sonoda Y, Abu-Rustum NR, Barakat RR, Chi DS.The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer. Gynecologic Oncology 2008;108:287-292.

Zivanovic O, Eisenhauer EL, Zhou Q, Iasonos A, Sabbatini P, Sonoda Y, Abu-Rustum NR, Barakat RR, Chi DS. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube and primary peritoneal cancer. Gynecologic Oncology 2008;108:287-292.

Zivanovic O, Leitao MM, Iasonos A, Jacks LM, Zhou Q, Abu-Rustum NR, Soslow R, Juretzka MM, Chi DS, Barakat RR, Brennan MF, Hensley ML. Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the FIGO and AJCC staging systems. Journal of Clinical Oncology 2008; (in press).

Abbasi NR, Yancovitz M, Gutkowicz-Krusin D, Panageas KS, Mihm MC, Googe P, King R, Prieto V, Osman I, Friedman RJ, Rigel DS, Kopf AW, Polsky D. Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma. Archives of Dermatology (in press).

Abu-Rustum NR, Iasonos A, Zhou Q, Oke E,  Soslow RA, Alektiar KM, Chi DS, Barakat RR.. Is there a therapeutic benefit to regional lymphadenectomy in the surgical treatment of endometrial cancer? American Journal of Obstetrics and Gynecology (in press).

Al-Ahmadie HA, Alden D, Qin LX, Olgac S, Fine SW, Gopalan A, Russo P, Motzer RJ, Reuter VE, Tickoo SK. Carbonic anhydrase IX expression in clear cell renal cell carcinoma: an immunohistochemical study comparing two antibodies. American Journal of Surgical Pathology (in press).

Amar D, Zhang H, Park B, Heerdt PM, Fleisher M, Thaler HT. Inflammation and outcome after general thoracic surgery. European Journal of Cardio-thoracic Surgery 2007;32:431-434.

Are C, Gönen M, Zazzali K, Dematteo RP, Jarnagin WR, Fong Y, Blumgart LH, D’Angelica M. The impact of margins on outcome after hepatic resection for colorectal metastasis. Annals of Surgery 2007; 246:295-300.

Asmis TR, Capanu M, Kelsen DP, Shah MA. Systemic chemotherapy does not increase the risk of gastrointestinal perforation.  Annals of Oncology 2007;18:2006-2008.

Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. Computed tomography screening and lung cancer outcomes. Journal of the American Medical Association 2007; 297:953-961. Erratum in: Journal of the American Medical Association 2007; 298:518.

Bach PB, Silvestri GA, Hanger M, Jett JR. American College of Chest Physicians Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132 (3 Suppl):69S-77S.

Bach PB. CT screening for lung cancer. Cleveland Clinic Journal of Medicine 2007; 74:769-770; author reply 770.

Bach PB. CT screening for lung cancer. New England Journal of Medicine 2007; 356:744; author reply 746-747.

Bagatell R, Gore L, Egorin MJ, Ho R, Heller G, Boucher N, Zuhowski EG, Whitlock JA, Hunger SP, Narendran A, Katzenstein HM, Arceci RJ, Boklan J, Herzog CE, Whitesell L, Ivy SP, Trippett TM. Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study. Clinical Cancer Research 2007:13;1783-1788.

Barbour AP, Rizk NP, Gönen M, Tang L, Bains MS, Rusch VW, Coit DG, Brennan MF. Adenocarcinoma of the gastroesophageal junction: Influence of esophageal resection margin and operative approach on outcome. Annals of Surgery 2007;246:1-8.

Barrio AV, Clark BD, Goldberg JI, Hoque LW, Bernik SF, Flynn LW, Susnik B, Giri D, Polo K, Patil SM, Van Zee KJ. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Annals of Surgical Oncology 2007;14:2961-2970.

Basch E, Artz D, Iasonos A, Speakman J, Shannon K, Lin K, Pun C, Yong H, Fearn P, Barz A, Scher HI, McCabe M, Schrag D. Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities. Journal of the American Medical Information Association 2007;14:264-268.

Basch E, Bent S, Collins J, Dacey C, Hammerness P, Harrison M, Smith M, Szapary P, Ulbricht C, Vora M, Weissner W. Natural standard resource collaboration, flax and flaxseed oil (linum usitatissimum): a review by the Natural Standard Research Collaboration.  Journal of the Society for Integrative Oncology 2007;5:92-105.

Basch E, Iasonos A, Barz A, Culkin A, Kris MG, Artz D, Fearn P, Speakman J, Farquhar R, Scher HI, McCabe M, Schrag D. Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy.  Journal of Clinical Oncology 2007;25:5374-5380.

Basch E. Expectations for specialized knowledge in oncology: time to reassess. Nature Clinical Practice Oncology 2007;4:263.

Begg CB, Eng KH, Hummer AJ. Statistical tests for clonality. Biometrics 2007;63:522-530.

Begg CB. Letter to the editor of Biometrics. Biometrics 2007;63:964-965; author reply 965-966.

Begg CB. Targeted therapy in oncology. Clinical Trials 2007;4:162.

Bertelsen L, Bernstein L, Olsen JH, Mellemkjaer L, Haile RW, Lynch CF, Malone KE, Anton-Culver H, Christensen J, Langholz B, Thomas DC, Begg CB, Capanu M, Ejlertsen B, Stovall M, Boice JD Jr, Shore RE, Women’s Environment, Cancer and Radiation Epidemiology Study Collaborative Group, Bernstein JL. Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the women’s environment, cancer and radiation epidemiology study. Journal of the National Cancer Institute 2007;100:32-40.

Berwick M, Satagopan JM, Ben-Porat L, Carlson A, Mah K, Henry R, Diotti R, Milton K, Pujara K, Landers T, Dev Batish S, Morales J, Schindler D, Hanenberg H, Hromas R, Levran O, Auerbach AD. Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer.  Cancer Research 2007;67:9591-9596.

Bjartell AS, Al-Ahmadie H, Serio AM, Eastham JA, Eggener SE, Fine SW, Udby L, Gerald WL, Vickers AJ, Lilja H, Reuter VE, Scardino PT. Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy. Clinical Cancer Research 2007;13:4130-4138.

Black D, Iasonos A, Ahmed H, Chi DS, Barakat RR, Abu-Rustum NR. Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer.  Gynecologic Oncology 2007;107:66-70.

BrintzenhofeSzoc KM, Levin TT, Li Y, Zabora J. The prevalence of mixed anxiety-depression by cancer type. Psychosomatics 2007; (in press).

Bylund C, Gueguen J, Sabee C, Imes R, Li Y, Sanford A. Provider-patient dialogue about internet health information: an exploration of strategies to improve the provider-patient relationship. Patient Education and Counseling 2007;66:346-352.

Canter RJ, Qin LX, Downey RJ, Brennan MF, Singer S, Maki RG. Perioperative chemotherapy in patients undergoing pulmonary resection for metastatic soft-tissue sarcoma of the extremity: a retrospective analysis. Cancer 2007;110:2050-2060.

Capanu M, Presnell B. Misspecification tests for binomial and beta-binomial models. Statistics in Medicine 2007; [Epub ahead of print].

Carver BS, Serio AM, Bajorin D, Motzer RJ, Stasi J, Bosl GJ, Vickers AJ, Sheinfeld J. Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors. Journal of Clinical Oncology 2007;25:5603-5608.

Cassileth BR, Deng GE, Gomez JE, Johnstone PA, Kumar N, Vickers AJ. Complementary therapies and integrative oncology in lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(3 Suppl):340S-354S.

Chadalavada RS, Korkola JE, Houldsworth J, Olshen AB, Bosl GJ, Studer L, Chaganti RS. Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells. Stem Cells 2007;25:771-778.

Chelliah A, Heydon KH, Zaotis TE, Rettig SL, Dominguez TE, Lin R, Patil S, Feudtner C, St John KH, Bell LM, Coffin SE. Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients. Journal of Pediatric Infectious Diseases 2007; 26:816-820.

Chemaitilly W, Boulad F, Heller G, Kernan N, Small TN, O’Reilly RJ, Sklar CA. Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation. Bone Marrow Transplant 2007;40:29-35.

Cheung IY, Feng Y, Vickers A, Gerald W, Cheung NK. Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastoma. Journal of Molecular Diagnostics 2007;9:237-241.

Chewning JH, Castro-Malaspina H, Jakubowski A, Kernan NA, Papadopoulos EB, Small TN, Heller G, Hsu KC, Perales MA, van den Brink MR, Young JW, Prockop SE, Collins NH, O’Reilly RJ, Boulad F. Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure. Biology Blood Marrow Transplant 2007;13:1313-1323.

Cho NL, Redson M, Zauber AG, Carothers AM, Hornick J, Wilton A, Sontag S, Nishioka N, Giardiello F, Saltzman JR, Gostout C, Eagle CJ, Hawk ET, Bertagnolli MM. Aberrant crypt foci I(AXF) are not surrogate biomarkers of sporadic adenoma prevention with celecoxib: results from the adenoma prevention with celecoxib (APC) trial. Cancer Research Prevention (in press).

Choi H, Shen R, Chinnaiyan AM, Ghosh D. A latent variable approach for meta-analysis of gene expression data from multiple microarray experiments. BMC Bioinformatics 2007;8:364.

Cohen AD, Zhou P, Chou J, Teruya-Feldstein J, Reich L, Hassoun H, Levine B, Filippa DA, Riedel E, Kewalramani T, Stubblefield MD, Fleisher M, Nimer S, Comenzo RL. Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial. British Journal of Haematology 2007;139:224-233.

Correa DD, DeAngelis LM, Shi W, Thaler HT, Lin M, Abrey LE. Cognitive functions in low-grade gliomas: disease and treatment effects. Journal of Neurooncology 2007;81:175-184.

Correa DD, Shi W, Thaler HT, Cheung AM, Deangelis LM, Abrey LE. Longitudinal cognitive follow-up in low grade gliomas.  Journal of Neuro-oncology [Epub ahead of print].

Cotignola J, Reva B, Mitra N, Ishill N, Chuai S, Patel A, Shah S, Vanderbeek G, Coit D, Busam K, Halpern A, Houghton A, Sander C, Berwick M, Orlow I. Matrix metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma. BMC Medical Genetics 2007;8:10.

Cotignola J, Roy P, Patel A, Ishill N, Shah S, Houghton A, Coit D, Halpern A, Busam K, Berwick M, Orlow I.  Functional polymorphisms in the promoter regions of MMP2 and MMP3 are not associated with melanoma progression.  Journal of Negative Results in Biomedicine 2007;6:9.

Dalal KM, Woo Y, Galanis C, Gönen M, Tang L, Allen P, Dematteo R, Fong Y, Coit DG. Detection of micrometastases in peritoneal washings of pancreatic cancer patients by the reverse transcriptase polymerase chain reaction. Journal of Gastrointestinal Surgery [Epub ahead of print].

Dang C, Fornier M, Sugarman S, Troso-Sandoval T, Lake D, D’Andrea G, Seidman A, Sklarin N, Dickler M, Currie V, Gilewski T, Moynahan ME, Drullinsky P, Robson M, Wasserheit-Leiblich C, Mills N, Steingart R, Panageas K, Norton L, Hudis C. Dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER2/neu verexpressed/amplified breast cancer is feasible. Journal of Clinical Oncology (in press).

Danila DC, Heller G, Gignac GA, Gonzalez-Espinoza R, Anand A, Tanaka E,  Lilja H, Schwartz L, Larson S, Fleisher M, Scher HI. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clinical Cancer Research 2007;13:7053-7058.

DeMatteo RP, Gold JS, Saran L, Gönen M, Liau KH, Maki RG, Singer S, Besmer P, Brennan MF, Antonescu CR. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer [Epub ahead of print]

DeMatteo RP, Maki RG, Singer S, Gönen M, Brennan MF, Antonescu CR. Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor. Annals of Surgery 2007;245:347-352.

Deng G, Vickers A, Yeung S, Cassileth B. Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients. Journal of Clinical Oncology 2007;25:5584-5590.

Diefenbach CS, Shah Z, Iasonos A, Barakat RR, Levine DA, Aghajanian C, Sabbatini P, Hensley ML, Konner J, Tew W, Spriggs D, Fleisher M, Thaler H, Dupont J. Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer.  Gynecologic Oncology 2007;104:435-442.

Divgi CR, Pandit-Taskar N, Jungbluth AA, Reuter VE, Gönen M, Ruan S, Pierre C, Nagel A, Pryma DA, Humm J, Larson SM, Old LJ, Russo P. Preoperative characterization of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 ((124)I-cG250) and PET in patients with renal masses: a phase I trial. Lancet Oncology 2007;8:304-310.

Dos Santos L, Mok E, Iasonos A, Park K, Soslow RA, Aghajanian C, Alektiar K, Barakat RR, Abu-Rustum NR. Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature. Gynecologic Oncology 2007;105:321-324.

Downey RJ, Akhurst T, Gönen M, Park B, Rusch V. Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer. Journal of Thoracic Cardiovascular Surgery 2007;133:1419-1427.

Duffy A, Kortmansky J, Schwartz GK, Capanu M, Puleio S, Minsky B, Saltz L, Kelsen DP, O’Reilly EM.  A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma. Annals of Oncology 2007;19:86-91.

Dunkel IJ, Thomas CL, Shi W, Beaverson KL, Novetsky D, Lyden D, Finlay JL, McCormick B, Abramson DH. A phase II trial of carboplatin for intraocular retinoblastoma. Pediatrics Blood & Cancer 2007;49:643-648.

Eastham JA, Kuroiwa K, Ohori M, Serio AM, Gorbonos A, Maru N, Vickers AJ, Slawin KM, Wheeler TM, Reuter VE, Scardino PT. Prognostic significance of location of positive margins in radical prostatectomy specimens.  Urology 2007;70:965-969.

Eggener SE, Yossepowitch O, Serio AM, Vickers AJ, Scardino PT, Eastham JA. Radical prostatectomy shortly after prostate biopsy does not affect operative difficulty or efficacy.  Urology 2007;69:1128-1133.

Eilber FC, Brennan MF, Eilber FR, Eckardt JJ, Grobmyer SR, Riedel E, Forscher C, Maki RG, Singer S. Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Annals of Surgery 2007;246:105-113.

Elkin EB, Kim SH, Casper ES, Kissane DW, Schrag D. Desire for information and involvement in treatment decisions: elderly cancer patients’ preferences and their physicians’ perceptions. Journal of Clinical Oncology 2007;25:5275-5280.

Endres HG, Böwing G, Diener HC, Lange S, Maier C, Molsberger A, Zenz M, Vickers AJ, Tegenthoff M.  Acupuncture for tension-type headache: a multicentre, sham-controlled, patient-and observer-blinded, randomized trial. Journal of Headache and Pain 2007;8:306-314.

Engel LS, Laden F, Andersen A, Strickland PT, Blair A, Needham LL, Barr DB, Wolff MS, Helzlsouer K, Hunter DJ, Lan Q, Cantor KP, Comstock GW, Brock JW, Bush D, Hoover RN, Rothman N. Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin’s lymphoma: a report from three cohorts. Cancer Research 2007;67:5545-5552.

Engel LS, Lan Q, Rothman N.  Polychlorinated biphenyls and non-Hodgkin lymphoma. Cancer Epidemiology Biomarkers and Prevention 2007;16:373-376.

Feldman DR, Kondagunta GV, Ginsberg MS, Ishill N, Patil SM, Cestaro J, Obens E, Sheinfeld J, Bosl GJ, Motzer RJ.  Phase II Trial of ixabepilone in patients with cisplatin-refractory germ cell tumors. Investigational New Drugs 2007;25:487-490.

Ferrone CR, Brennan MF, Gönen M, Coit DG, Fong Y, Chung S, Tang L, Klimstra D, Allen PJ. Pancreatic adenocarcinoma: the actual 5-year survivors. Journal of Gastrointestinal Surgery [Epub ahead of print].

Ferrone CR, Tang LH, Tomlinson J, Gönen M, Hochwald SN, Brennan MF, Klimstra DS, Allen PJ. Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? Journal of Clinical Oncology 2007;25:5609-5615.

Figueiredo JC, Bernstein L, Capanu M, Malone KE, Lynch CF, Haile RW, the WECARE Study Collaborative Group, Bernstein JL. Oral contraceptives, post-menopausal hormones and risk of asynchronous bilateral breast cancer: the WECARE study group. Journal of Clinical Oncology (in press).

Fornier M, Rathkopf D, Shah M, Patil SM, O’Reilly E, Tse A, Hudis C, Kelsen DP, Schwartz L.  Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors, CCR-07-1218 Version 2. Clinical Cancer Research (in press).

Fornier MN, Seidman AD, Lake D, D’Andrea G, Bromberg J, Robson M, VanPoznak C, Panageas KS, Atienza M, Norton L, Hudis C. Increased dose-density is feasible: a pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10 or 11 day intervals with filgrastim support in women with breast cancer. Clinical Cancer Research 2007;13:223-227.

Forslund A, Zeng A, Qin LX, Rosenberg S, Ndubuisi M, Pincas H, Gerald W, Notterman D, Barany F, Paty PB. MDM2 gene amplification is correlated to tumor progression but not to presence of SNP309 or TP53 mutational status in primary colorectal cancers. Molecular Cancer Research (in press).

Fortuny J, Johnson CC, Bohlke K, Chow WH, Hart G, Kucera G, Mujumdar U, Ownby D, Wells K, Yood MU, Engel LS. Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers.  Clinical Gastronenterology and Hepatology 2007;5:1154-1159.

Gallagher DJ, Capanu M, Raggio G, Kemeny N. Hepatic arterial infusion (HAI) plus systemic irinotecan (CPT-11) in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis. Annals of Oncology 2007; 18:1995-1999.

Galsky MD, Iasonos A, Mironov S, Scattergood J, Boyle MG, Bajorin DF. Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function.  Cancer 2007;109:549-555.

Galsky MD, Iasonos A, Mironov S, Scattergood J, Donat SM, Bochner BH, Herr HW, Russo P, Boyle MG, Bajorin DF. Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract. Urology 2007;69:255-259.

Galsky MD, Mironov S, Iasonos A, Scattergood J, Boyle MG, Bajorin DF. Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma. Investigational New Drugs 2007;25:265-270.

Ghosh P, Gönen M. Bayesian modeling of multivariate average bioequivalence. Statistics in Medicine [Epub ahead of print].

Gilewski TA, Ragupathi G, Dickler M, Powell S, Bhuta S, Panageas K, Koganty RR, Chin-Eng, J, Hudis C, Norton L, Houghton AN, Livingston PO.  Immunization of high-risk breast cancer patients with clustered sTn-KLH conjugate plus the immunologic adjuvant QS-21. Clin Cancer Res. 2007; 13(10):2977-85

Gilheeney SW, Lyden DC, Sgouros S, Antunes N, Gerald W, Kramer K, Lis E, Meyers P, Rosen N, Thaler HT, Trippett T, Wexler L, Dunkel IJ. A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies.  Pediatric Blood & Cancer 2007;49:261-265.

Gold JS, Are C, Kornprat P, Jarnagin WR, Gönen M, Fong Y, DeMatteo RP, Blumgart LH, D’Angelica M. Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients. Annals of Surgery [Epub ahead of print].

Gold JS, Tang LH, Gönen M, Coit DG, Brennan MF, Allen PJ. Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma. Annals of Surgical Oncology [Epub ahead of print].

Gross ND, Boyle JO, Du B, Kekatpure VD, Lantowski A, Thaler HT, Weksler BB, Subbaramaiah K, Dannenberg AJ. Inhibition of Jun NH2-terminal kinases suppresses the growth of experimental head and neck squamous cell carcinoma. Clinical Cancer Research 2007;13: 5910-5917.

Guillem JG, Chessin DB, Shia J, Suriawinata A, Riedel E, Moore HG, Minsky BD, Wong WD. A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation. Annals of Surgery 2007;245:88-93.

Haas GP, Delongchamps NB, Jones RF, Chandan V, Serio AM, Vickers AJ, Jumbelic M, Threatte G, Korets R, Lilja H, de la Roza G. Needle biopsies on autopsy prostates: sensitivity of cancer detection based on  true prevalence.  Journal of the National Cancer Institute 2007;99: 1484-1489.

Halpern NA, Pastores SM, Thaler HT, Greenstein RJ. Critical care medicine use and cost among Medicare beneficiaries 1995-2000: major discrepancies between two United States federal Medicare databases. Critical Care Medicine 2007;35:692-699.

Hanley JA, Dendukuri N, Begg CB. Multiple imputation for correcting verification bias by Ofer Harel and Xiao-Hua Zhou. Statistics in Medicine 2006;25:3769-3786. Statistics in Medicine 2007;26:3046-3047; author reply 3047-3045.

Harrison ML, Gore ME, Spriggs D, Kaye S, Iasonos A, Hensley M, Aghajanian C, Venkatraman E, Sabbatini P. Duration of second or greater complete clinical remission in ovarian cancer: exploring potential endpoints for clinical trials. Gynecologic Oncology 2007; 106:469-475.

Hay J, Burkhalter J, Ostroff J, Li Y, Quiles Z, Moadel A. Changes in cancer-related risk perception and smoking across time in newly-diagnosed cancer patients. Journal of Behavioral Medicine 2007;30:131-142.

Heller G, Kattan M, Scher H. Improving the decision to pursue a phase 3 clinical trial by adjusting for patient-specific factors in evaluating phase 2 treatment efficacy. Medical Decision Making 2007;27:380-386.

Heller G, Qin J. Inference on the limiting false discovery rate and the p-value threshold parameter assuming weak dependence between gene expression levels within subject. Statistical Applications in Genetics and Molecular Biology 2007:6:Article 14.

Heller G. Smoothed rank regression with censored data. Journal of American Statistical Association 2007;102:552-559.

Ho AY, Fan G, Atencio DP, Green S, Formenti SC, Haffty BG, Iyengar P, Bernstein JL, Stock RG, Cesaretti JA, Rosenstein BS. Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy.  International Journal of Radiation Oncology, Biology, Physics 2007;69:677-684.

House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M, Gönen M, Olson SH, Kurtz RC, Brennan MF, Allen PJ. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. Journal of Gastrointestinal Surgery [Epub ahead of print].

House MG, Gönen M, Jarnagin WR, D’Angelica M, Dematteo RP, Fong Y, Brennan MF, Allen PJ. Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. Journal of Gastrointestinal Surgery [Epub ahead of print].

Hurria A, Lichtman SM, Gardes J, Li D, Limaye S, Patil SM, Zuckerman E, Tew W, Hamlin P, Abou-Alfa GK, Lachs M, Kelly E. Identifying vulnerable older adults with cancer: integrating geriatric assessment into oncology practice. Journal of the American Geriatrics Society [Epub ahead of print].

Hurria A, Naeim A, Elkin EB, Limaye S, Grover A, Hudis C, Pearce C, Robson M. Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists. Critical Reviews in Oncology/Hematology 2007;61:255-260.

Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. Journal of Clinical Oncology (in press).

Janetzki S, Panageas KS, Ben-Porat L, Boyer J, Britten CM, Clay TM, Kalos M, Maecker HT, Romero P, Yuan J, Martin Kast W, Hoos A, for the elispot proficiency panel of the CVC immune Assay Working Group. Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the cancer vaccine consortium (CVC/SVI).  Cancer Immunology, Immunotherapy [Epub ahead of print].

Juretzka MM, Barakat RR, Chi DS, Iasonos A, Dupont J, Abu-Rustum NR, Poynor EA, Aghajanian C, Spriggs D, Hensley ML, Sabbatini P. CA125 level as a predictor of progression free survival and overall survival in ovarian cancer patients with surgically defined disease status at the end of primary therapy. Gynecologic Oncology 2007;104:176-180.

Kaimal G, Steinberg AG, Ennis S, Harasink SM, Ewing R, Li Y. Parental narratives about genetic testing for hearing loss: a one year follow up study. Journal of Genetic Counseling. 2007;6:775-787.

Kamel F, Engel LS, Gladen BC, Hoppin JA, Alavanja MC, Sandler DP. Neurologic symptoms in licensed pesticide applicators in the Agricultural Health Study. Human & Experimental Toxicology 2007;26:243-250.

King V, Ginsberg MS, Vaze AA, Moskowitz CS, Smith LJ. Utility of the d-dimer assay for the exclusion of pulmonary embolism in a high risk oncologic population: a correlation with CT pulmonary angiogram in the urgent care setting. Radiology (in press).

Kissane D, Grabsch B, Clarke D, Smith G, Love A, Bloch S, Snyder R, Li Y. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psycho-Oncology 2007;16:277-286.

Klimek VM, Fircanis S, Maslak P, Guernah I, Baum M, Wu N, Panageas K, Wright JJ, Pandolfi PP, Nimer SD. Tolerability, pharmacodynamics and pharmacokinetics studies of depsipeptide (romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes. Clinical Cancer Research (in press).

Kondagunta GV, Bacik J, Sheinfeld J, Bajorin D, Bains M, Reich L, Deluca J, Budnick A, Ishill N, Mazumdar M, Bosl GJ, Motzer RJ. Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors. Journal of Clinical Oncology 2007;25:85-90. Erratum in: Journal of Clinical Oncology 2007;25:2149.

Kricker A, Armstrong BK, Goumas C, Litchfield M, Begg CB, Hummer AJ, Marrett LD, Theis B, Millikan RC, Thomas N, Culver HA, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Busam K, From L, Mujumdar U, Zanetti R, Berwick M, for the GEM Study Group. Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes Control 2007;18:295-304.

Laé M, Ahn EH, Mercado GE, Chuai S, Edgar M, Pawel BR, Olshen A, Barr FG, Ladanyi M.  Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas.  Journal of Pathology 2007;212:143-151.

Largent JA, Capanu M, Bernstein L, Langholz B, Mellemkaer L, Malone KE, Begg CB, Haile RW, Lynch CF, Anton-Culver H, Wolitzer A, Bernstein JL. Reproductive history and risk of second primary breast cancer: the WECARE study. Cancer Epidemiology, Biomarkers & Prevention 2007;16:906-911.

Lassmann S, Tang L, Capanu M, Brabletz T, Schöpflin A, Zur Hausen A, Gonen M, Kemeny N, Shia J, Klimstra D, Werner M.  Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy. Gastroenterology 2007;133:1831-1839.

Leiser AL, Chi DS, Ishill NM, Tew WP. Carcinosarcoma of the ovary treated with platinum and taxane: the Memorial Sloan-Kettering Cancer Center experience.

Gynecologic Oncology 2007;105:657-661.

Levin TT, Riskind J, Li Y. Depression, anxiety and quality of life in a chronic lymphocytic leukemia cohort. General Hospital Psychiatry 2007;29:251-256.

Levin TT, Riskind JH, Li Y. Looming cognitive style in a cancer cohort. General Hospital Psychiatry 2007;29:32-38.

Levine D, Park K, Juretzka M, Esch J, Hensley M, Aghajanian C, Lewin S, Konner J, Derosa F, Spriggs D, Iasonos A, Sabbatini P. A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission. Cancer 2007;110:2448-2456.

Li Y, Steinberg A, Bain L, Yaeger D, Bieler A, Ewing R, Kaimal G, Krantz I. Assessing parental attitudes toward genetic testing for childhood hearing loss: before and after genetic consultation. American Journal of Medical Genetics 2007;143:1546-1553.

Lilja H, Ulmert D, Björk T, Becker C, Serio AM, Nilsson JA, Abrahamsson PA, Vickers AJ, Berglund G. Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years. Journal of Clinical Oncology 2007;25:431-436.

Lilja H, Vickers AJ, Scardino P. Measurements of proteases or protease system components in blood to enhance prediction of disease risk or outcome in possible cancer. Journal of Clinical Oncology 2007;25:347-348.

Malmer B, Adatto P, Armstrong G, Barnholtz-Sloan J, Bernstein JL, Claus E, Davis F, Houlston R, Il’yasova D, Jenkins R, Johansen C, Lai R, Lau C, McCarthy B, Nielsen H, Olson SH, Sadetzki S, Shete S, Wiklund F, Wrensch M, Yang P, Bondy  M. GLIOGENE an international consortium to understand familial glioma.  Cancer Epidemiology, Biomarkers & Prevention 2007;16:1730-1734.

Mansour JC, Tang L, Shah M, Bentrem D, Klimstra DS, Gönen M, Kelsen DP, Brennan MF, Coit DG. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer? Annals of Surgical Oncology [Epub ahead of print].

McIntyre AR, Drummond RA, Riedel ER, Lipman NS. Automated mouse euthanasia in an individually ventilated caging system: system development and assessment. Journal of the American Association of Laboratory and Animal Science 2007;46:65-73.

McLaughlin SA, Ochoa-Frongia LM, Patil SM, Cody HS 3rd, Sclafani LM.  Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy. Journal of American College of Surgeons [Epub ahead of print].

Mehra R, Han B, Tomlins SA, Wang L, Menon A, Wasco MJ, Shen R, Montie JE, Chinnaiyan AM, Shah RB. Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases. Cancer Research 2007;67:7991-7995.

Mehra R, Tomlins SA, Shen R, Nadeem O, Wang L, Wei JT, Pienta KJ, Ghosh D, Rubin MA, Chinnaiyan AM, Shah RB. Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer. Modern Pathology 2007;20:538-544.

Mellemkjær L, Dahl C, Olsen JH, Bertelsen L, Guldberg P, Christensen J, Børresen-Dale A-L, Stovall M, Langholz B, Bernstein L, Lynch CF, Malone KE, Haile RW, Andersson M, Thomas DC, Concannon P, Capanu M, Boice JD,  the WECARE Study Collaborative Group, Bernstein JL. Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study. British Journal of Cancer (in press).

Miller G, Biernacki P, Kemeny NE, Gönen M, Downey R, Jarnagin WR, D’Angelica M, Fong Y, Blumgart LH, DeMatteo RP. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. Journal of the American College of Surgeons 2007;205:231-238.

Morris MJ, Kelly WK, Slovin S, Ryan C, Eicher C, Heller G, Scher HI. A phase II trial of bortezomib and prednisone for castration resistant metastatic prostate cancer. Journal of Urolgoy 2007;178:2378-2383.

Moskowitz CS, Seshan VE, Riedel ER, Begg CB. Estimating the empirical Lorenz curve and Gini coefficient in the presence of error with nested data. Statistics in Medicine (in press)

Motzer RJ, Basch E. Targeted drugs for metastatic renal cell carcinoma. Lancet 2007;370:2071-2073.

Olson S, Bandera E, Orlow I. Genetic variants, sex steroid hormone levels, and endometrial cancer: a HuGE review. American Journal of Epidemiology 2007;165:235-245.

Olson S, Orlow I, Simon J, Tommasi D, Roy P, Bayuga S, Ludwig E, Zauber AG, Kurtz RC. Allergies, variants in IL4 and IL4Ra genes, and risk of pancreatic cancer. Cancer Detection and Prevention 2007;31:345-351.

O’Malley AS, Pham HH, Schrag D, Wu B, Bach PB. Potentially avoidable hospitalizations for COPD and pneumonia: the role of physician and practice characteristics. Medical Care 2007;45: 562-570.

Ong SC, Schoder H,  Patel SG, Tabangay-Lim IM, Doddamane I, Gönen M, Shaha AR, Tuttle RM, Shah JP, Larson SM. Accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels. Journal of Nuclear Medicine 2007;48:501-507.

Orlow I, Begg CB, Cotignola J, Roy P, Hummer AJ, Clas BA, Mujumdar U, Canchola R, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Wilcox H, Busam K, From L, Berwick M; GEM Study Group.  CDKN2A germline mutations in individuals with cutaneous malignant melanoma. Journal of Investigational Dermatology 2007;127:1234-1243.

Orlow I, Park BJ, Mujumdar U, Patel H, Siu-Lau P, Clas BA, Downey R, Flores R, Bains M, Rizk N, Dominguez G, Jani J, Berwick M, Begg CB, Kris MG, Rusch VW. DNA damage and repair capacity in lung cancer patients: prediction of multiple primary tumors. Journal of Clinical Oncology (in press)

Panageas KS, Ben-Porat L, Dickler MN, Chapman PB, Schrag D. When your look matters: the effect of assessment schedule on progression-free survival. Journal of the National Cancer Institute 2007;99:428-432.

Panageas KS, Elkin EB, Ben-Porat L, Deangelis LM, Abrey LE. Patterns of treatment in older adults with primary central nervous system lymphoma. Cancer 2007;110:1338-1344.

Panageas KS, Schrag D, Russell Localio A, Venkatraman ES, Begg CB. Properties of analysis methods that account for clustering in volume-outcome studies when the primary predictor is cluster size. Statistics in Medicine 2007;26:2017-2035.

Park JO, Gönen M, D’Angelica MI, Dematteo RP, Fong Y, Wuest D, Blumgart LH, Jarnagin WR. Autologous versus allogeneic transfusions: no difference in perioperative outcome after partial hepatectomy: autologous transfusion on hepatectomy outcome. Journal of Gastrointestinal Surgery [Epub ahead of print]

Parks R, Gönen M, Kemeny N, Jarnagin W, D’Angelica M, Dematteo R, Garden OJ, Blumgart LH, Fong Y. Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. Journal of American College of Surgeons 2007; 204:753-761.

Patel PH, Kondagunta GV, Schwartz L, Ishill N, Bacik J, Deluca J, Russo P, Motzer RJ.

Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma.

Investigational New Drugs [Epub ahead of print].

Perales MA, Ishill N, Lomazow WA, Weinstock DM, Papadopoulos EB, Dastigir H, Chiu M, Boulad F, Castro-Malaspina HR, Heller G, Jakubowski AA, O’reilly RJ, Small TN, Young JW, Kernan NA. Long-term follow-up of patients treated with daclizumab for steroid -refractory acute graft-versus-host disease. Bone Marrow Transplant 2007;40:481-486.

Pham HH, Schrag D, O’Malley AS, Wu B, Bach PB. Care patterns in medicare and their implications for pay for performance. New England Journal of Medicine 2007;356:1130-1139.

Raizer JJ, Hwu W-J, Panageas KS, Wilton A, Baldwin DE, Bailey E, Von Althann C, Lamb LA, Alvarado G, Bilsky MH, Gutin PH. Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features from neuro-oncology. Neuro-oncology (in press).

Raj GV, Bach AM, Iasonos A, Korets R, Blitstein J, Hann L, Russo P. Predicting the histology of renal masses using pre-operative doppler ultrasonography. Journal of Urology 2007;177:53-58.

Raj GV, Herr H, Serio AM, Donat SM, Bochner BH, Vickers AJ, Dalbagni G. Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer. Journal of Urology 2007;177:1283-1286; discussion 1286.

Ramirez-Montagut T, Chow A, Kochman AA, Smith OM, Suh D, Sindhi H, Lu S, Borsotti C, Grubin J, Patel N, Terwey TH, Kim TD, Heller G, Murphy GF, Liu C, Alpodogan O, van den Brink MR. IFN-gamma and Fas ligand are required for graft versus tumor activity against renal cell carcinoma in the absence of lethal graft versus host disease. Journal of Immunology 2007; 179:1669-1680.

Reid-Nicholson M, Gatscha RM, Riedel ER, Lin O. Atypical squamous cells, cannot exclude high grade intraepithelial lesion (ASC-H): does HPV matter? Diagnostic Cytopathology 2007;35:1-5.

Rietschel P, Wolchok JD, Krown S, Gerst S, Jungbluth A, Busam K, Smith K, Orlow I, Panageas K, Chapman PB. Phase II study of extended dose temozolomide in patients with melanoma. Journal of Clinical Oncology (in press).

Roohipour R, Patil SM, Goodman KA, Minsky B, Wong WD, Guillem JG, Paty PB, Weiser MR, Neuman HB, Shia J, Schrag D, Temple LKF. Squamous cell carcinoma of the anal canal: predictors of treatment outcome. Diseases of the Colon and Rectum (in press).

Russo P, Snyder M, Vickers A, Kondagunta V, Motzer R. Cytoreductive nephrectomy and nephrectomy/complete metastasectomy for metastatic renal cancer. TSW Urology 2007;2:42–52

Sabbatini P, Mooney D, Iasonos A, Thaler H, Aghajanian C, Hensley M, Tew W, Konner J, Spriggs D, Abu-Rustum N, Dupont J. CA-125 patterns in recurrent ovarian cancer treated with carboplatin, liposomal doxorubicin, or topotecan. International Journal of Gynecologic Cancer 2007;17:589-594

Sabbatini PJ, Ragupathi G, Hood C, Aghajanian CA, Juretzka M, Iasonos A, Hensley ML, Spassova MK, Ouerfelli O, Spriggs DR, Tew WP, Konner J, Clausen H, Abu Rustum N, Dansihefsky SJ, Livingston PO. Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer. Clinical Cancer Research 2007;13:4170-41777.

Saltz LB, Lenz HJ, Kindler HL, Hochster HS, Wadler S, Hoff PM, Kemeny NE, Hollywood EM, Gönen M, Quinones M, Morse M, Chen HX. Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: The BOND-2 Study. Journal of Clinical Oncology [Epub ahead of print].

Satagopan JM, Sen S, Churchill GA. Sequential quantitative trait locus mapping in experimental crosses. Statistical Applications Genetic Molecular Biology 2007;6:Article 12. [Epub ahead of print].

Scher H, Warren M, Heller G. The association between measures of progression and survival in castrate-metastatic prostate cancer. Clinical Cancer Research 2007:13;1488-1492.

Schoder H, Gönen M. Screening for Cancer with PET and PET/CT: Potential and limitations. Journal of Nuclear Medicine 2007;48 Suppl:4S-18S.

Secin FP, Jiborn T, Bjartell AS, Fournier G, Salomon L, Abbou CC, Haber GP, Gill IS, Crocitto LE, Nelson RA, Cansino-Alcaide JR, Martínez-Piñeiro L, Cohen MS, Tuerk I, Schulman C, Gianduzzo T, Eden C, Baumgartner R, Smith JA, Entezari K, van Velthoven R, Janetschek G, Serio AM, Vickers AJ, Touijer K, Guillonneau B. Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy. European Urology [Epub ahead of print].

Secin FP, Koppie TM, Salamanca JI, Bokhari S, Raj GV, Olgac S, Serio A, Vickers AJ, Bochner BH. An evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer. International Journal of Urology 2007;14:26-32.

Secin FP, Serio A, Bianco FJ Jr, Karanikolas NT, Kuroiwa K, Vickers A, Touijer K, Guillonneau B. Preoperative and intraoperative risk factors for side-specific positive surgical margins in laparoscopic radical prostatectomy for prostate cancer. European Urology 2007;51:764-771.

Seminara D, Khoury MJ, O’Brien TR, Manolio T, Gwinn ML, Little J, Higgins JP, Bernstein JL, Boffetta P, Bondy M, Bray MS, Brenchley PE, Buffler PA, Casas JP, Chokkalingam AP, Danesh J, Davey Smith G, Dolan S, Duncan R, Gruis NA, Hashibe M, Hunter D, Jarvelin MR, Malmer B, Maraganore DM, Newton-Bishop JA, Riboli E, Salanti G, Taioli E, Timpson N, Uitterlinden AG, Vineis P, Wareham N, Winn DM, Zimmern R, Ioannidis JP. Human Genome Epidemiology Network; the Network of Investigator Networks: The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology 2007;18:1-8.

Sen S, Satagopan JM, Broman KW, Churchill GA. R/qtlDesign: inbred line cross experimental design. Mammalian Genome 2007;18:87-93.

Shaffer DR, Leversha MA, Danilla DC, Lin O, Gonzalez-Espinoza R, Gu B, Anand A, Smith K, Maslak P, Doyle GV, Terstappen LW, Lilja H, Heller G, Fleisher M, Scher HI. Circulating tumor cell analysis in patients with progressive castration resistant prostate cancer. Clinical Cancer Research 2007:13;2023-2029.

Shen R, Ghosh D, Taylor JMG. Modeling intra-tumor protein expression heterogeneity in tissue microarray experiments. Statistics in Medicine (in press).

Shukla-Dave A, Hricak H, Moskowitz CS, Ishill N, Akin O, Kuroiwa K, Spector J, Kumar M, Reuter VE, Koutcher JA, Zakian KL. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines. Radiology 2007;245:499-506.

Small TN, Young JW, Castro-Malaspina H, Prockop S, Wilton A, Heller G, Boulad F, Chiu M, Hsu K, Jakubowski A, Kernan NA, Perales MA, O’Reilly RJ, Papadopoulos EB. Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies. Biology Blood Marrow Transplant 2007:3;235-244.

Sofocleous CT, Nascimento RG, Gönen M, Theodoulou M, Covey AM, Brody LA, Solomon SM, Thornton R, Fong Y, Getrajdman GI, Brown KT. Radiofrequency ablation in the management of liver metastases from breast cancer. American Journal of Roentgenology 2007; 189:883-889.

Solit DB, Ivy SP, Kopil C, Sikorski R, Morris MJ, Slovin SF, Kelly WK, DeLaCruz A, Curley T, Heller G, Larson S, Schwartz L, Egorin MJ, Rosen N, Scher HI. Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer. Clinical Cancer Research 2007:13;1775-1782.

Sovak MA, Dupont J, Hensley ML, Ishill N, Gerst S, Abu-Rustum N, Anderson S, Barakat R, Konner J, Poyner E, Sabbatini P, Spriggs DR, Aghajanian C. Paclitaxel and carboplatin in the treatment of advanced or recurrent endometrial cancer: a large retrospective study. International Journal of Gynecological Cancer 2007;17:197-203.

Steinberg A, Kaimal G, Bain L, Krantz I, Li Y. Parental narratives of genetic testing for children with hearing loss: a qualitative inquiry. American Journal of Medical Genetics 2007;143:1533-1545.

Steinberg A, Kaimal K, Li Y, Ewing R, Soslow L, Lewis K, Krantz I. Parental narratives of genetic testing for hearing loss: audiologic implications for clinical work with children and families. American Journal of Audiology 2007;16:57-67.

Steinberg AG, Bain L, Ewing R, Li Y. Meeting the public’s health information needs: a plain language website outreach project: to reaching underserved parents of deaf children. Health Communication (in press).

Stephan MT, Ponomarev V, Brentjens RJ, Chang AH, Dobrenkov KV, Heller G, Sadelain M.T cell-encoded CD80 and 4-1BBL induce auto-and transcostimulation, resulting in potent tumor rejection. Nature Medicine 2007;13:1440-1449.

Steuber T, Vickers AJ, Haese A, Danø K, Høyer-Hansen G, Kattan MW, Eastham JA, Scardino PT, Huland H, Lilja H. Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy. International Journal of Cancer 2007;120:1499-1504.

Steuber T, Vickers AJ, Serio AM, Vaisanen V, Haese A, Danø K, Pettersson K, Eastham JA, Scardino PT, Huland H, Lilja H. Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer. Clinical Chemistry 2007;53:233-240.

Strong VE, D’Angelica M, Tang L, Prete F, Gönen M, Coit D, Touijer KA, Fong Y, Brennan MF. Laparoscopic adrenalectomy for isolated adrenal metastasis. Annals of Surgical Oncology [Epub ahead of print].

Tan LK, Giri DD, Hummer AJ, Panageas KS, Brogi E, Norton L, Hudis C, Borgen PI, Cody HS. Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. Journal of Clinical Oncology (in press).

Taylor RA, Patel A, Panageas KS, Busam KJ, Brady MS. Tumor infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. Journal of Clinical Oncology 2007;25:869-875.

Thomas NE, Edmiston SN, Alexander A, Millikan RC, Groben PA, Hao H, Tolbert D, Berwick M, Busam K, Begg CB, Mattingly D, Ollila DW, Tse CK, Hummer A, Lee-Taylor J, Conway K.  Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. Cancer Epidemiology, Biomarkers and Prevention 2007;16:991-997.

Thompson EE, Pan L, Ostrovnaya I, Weiss LA, Gern JE, Lemanske RF Jr, Nicolae DL, Ober C.  Integrin beta 3 genotype influences asthma and allergy phenotypes in the first 6 years of life. Journal of Allergy and Clinical Immunology 2007;119:1423-1429.

Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gönen M, Kemeny N, Brennan MF, Blumgart LH, D’Angelica M. Actual 10-year survival after resection of colorectal liver metastases defines cure. Journal of Clinical Oncology 2007;25:4575-4580.

Touijer K, Kuroiwa K, Eastham JA, Vickers A, Reuter VE, Scardino PT, Guillonneau B. Risk-adjusted analysis of positive surgical margins following laparoscopic and retropubic radical prostatectomy. European Urology 2007;52:1090-1096.

Traina TA, Theodoulou M, Feigin F, Patil SM, Tan KL, Edwards C, Dugan U, Norton L, Hudis C.  Phase I study of a novel capecitabine schedule based upon the Norton-Simon mathematical model in patients with metastatic breast cancer. Journal of Clinical Oncology (in press).

Tran W, Serio AM, Raj GV, Dalbagni G, Vickers AJ, Bochner BH, Herr H, Donat SM.  Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance.  Journal of Urology [Epub ahead of print].

Trotti A, Colevas AD, Setser A, Basch E. Patient-reported outcomes and the evolution of adverse event reporting in oncology. Journal of Clinical Oncology 2007;25:5121-5127.

Tunis SR, Carino TV, Williams RD 2nd , Bach PB. Federal initiatives to support rapid learning about new technologies. Health Affairs (Millwood) 2007;26:140-149.

Venkatraman ES, Olshen AB. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 2007;23:657-663.

Vickers A. How should we define patients who are at high risk of death from prostate cancer? Nature Clinical Practice Urology 2007;4:646-647.

Vickers AJ, Ballen V, Scher HI. Setting the bar in phase II trials: the use of historical data for determining “go/no go” decision for definitive phase III testing. Clinical Cancer Research 2007; 13:972-976.

Vickers AJ, Bianco FJ, Serio AM, Eastham JA, Schrag D, Klein EA, Reuther AM, Kattan MW, Pontes JE, Scardino PT. The surgical learning curve for prostate cancer control after radical prostatectomy.  Journal of the National Cancer Institute 2007;99:1171-1177.

Vickers AJ, Elkin EB, Steyerberg E. Net reclassification improvement and decision theory. Statistics in Medicine [Epub ahead of print].

Vickers AJ, Kattan MW, Daniel S. Method for evaluating prediction models that apply the results of randomized trials to individual patients. Trials 2007;8:14.

Vickers AJ, Ulmert D, Serio AM, Björk T, Scardino PT, Eastham JA, Berglund G, Lilja H. The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: towards a biologically-based screening strategy. International Journal of Cancer 2007;121:2212-2217.

Vickers AJ. How to improve accrual to clinical trials of symptom control 2: design issues. Journal of the Society for Integrative Oncology 2007;5:61-64.

Vickers AJ. Which botanicals or other unconventional anticancer agents should we take to clinical trial?  Journal of the Society for Integrative Oncology 2007;5:125-129.

Vickers AJ. How to improve accrual to clinical trials of symptom control 1: recruitment strategies. Journal of the Society for Integrative Oncology 2007;5:38-42.

Wang L, Mazaheri Y, Zhang J, Ishill NM, Kuroiwa K, Hricak H. Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. Radiology [Epub ahead of print].

Wang L, Zhang J, Schwartz LH, Eisenberg H, Ishill NM, Moskowitz CS, Scardino P, Hricak H. Incremental value of multiplanar cross-referencing for prostate cancer staging with endorectal MRI. American Journal of Roentgenology 2007;188:99-104.

Weinstein H, Bates AT, Spaltro BE, Thaler HT, Steingart RM. Influence of preoperative exercise capacity on length of stay after thoracic cancer surgery. Annals of Thoracic Surgery 2007;84:197-202.

Weinstock DM, Conlon M, Iovino C, Aubrey T, Gudiol C, Riedel E, Young JW, Kiehn TE, Zuccotti G. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biology of Blood and Marrow Transplant 2007;13:615-621.

Wolchok JD, Yuan J, Houghton AN, Gallardo HF, Rasalan TS, Wang J, Zhang Y, Ranganathan R, Chapman PB, Krown SE, Livingston PO, Heywood M, Riviere I, Panageas KS, Terzulli SL, Perales MA. Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma.  Molecular Therapy 2007;15:2044-2050.

Yeh JJ, Gönen M, Tomlinson JS, Idrees K, Brennan MF, Fong Y. Effect of blood transfusion on outcome after pancreaticoduodenectomy for exocrine tumour of the pancreas. British Journal of Surgery [Epub ahead of print].

Yu J, Cao Q, Mehra R, Laxman B, Yu J, Tomlins SA, Creighton CJ, Dhanasekaran SM, Shen R, Chen G, Morris DS, Marquez VE, Shah RB, Ghosh D, Varambally S, Chinnaiyan AM. Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancer. Cancer Cell 2007;12:419-431.

Yu J, Heller G, Chewning J, Kim S, Yokoyama WM, Hsu KC. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. Journal of Immunology 2007;179:5977-5989.

Yuan J, Kendle R, Ireland J, Heller G, Sadelain M, Young JW, Rivere I. Scalable expansion of potent genetically modified human Langerhans cells in a closed system for clinical applications. Journal of Immunotherapy 2007;30:634-643.

Zauber AG, Levin TR, Jaffe CC, Galen BA, Ransohoff DR, Brown ML. Implications of new colorectal cancer screening technologies for primary care practice. Medical Care (in press).

Zauber AG, Lansdorp-Vogelaar I, Wilschut J, Knudsen AB, van Ballegooijen M, Kuntz KM. Cost-effectiveness of DNA stool testing to screen for colorectal cancer: Report to AHRQ and CMS from the Cancer Intervention and Surveillance Modeling Network (CISNET) for MISCAN and SimCRC Models. Agency for Healthcare Research and Quality-Technology Assessment 2007; Dec 20:1-84.

Zhang J, Lefkowitz RA, Ishill NM, Wang L, Moskowitz CS, Russo P, Eisenberg H, Hricak H.  Solid renal cortical tumors: differentiation with CT. Radiology 2007;244:494-504.

Zhang J, Lefkowitz RA, Wang L, Ishill NM, Moskowitz CS, Russo P, Hricak H. Significance of peritumoral vascularity on CT in evaluation of renal cortical tumor. Journal of Computer Assisted Tomography 2007;31:717-723.

Zhang Z, Sun L, Sun J, Finkelstein DM. Regression analysis of failure time data with informative interval censoring. Statistics in Medicine 2007;26:2533-2546.

Zhou P, Teruya-Feldstein J, Lu P, Fleisher M, Olshen A, Comenzo RL. Calreticulin expression in the clonal plasma cells of patients with systemic light-chain (AL) amyloidosis is associated with response to high-dose melphalan. Blood [Epub ahead of print].

Zivanovic O, Eisenhauer EL, Zhou Q, Iasonos A, Sabbatini P, Sonoda Y, Abu-Rustum NR, Barakat RR, Chi DS. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.  Gynecologic Oncology [Epub ahead of print].

Abrey LE, Ben-Porat L, Panageas KS, Yahalom J, Berkey B, Curran W, Schultz C, Leibel S, Nelson D, Mehta M, DeAngelis LM. Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. Journal of Clinical Oncology 2006; 24: 5711-5715.

Abrey LE, Panageas KS. Identifying and addressing barriers to the delivery of optimal therapy for primary central nervous system lymphoma in the broader community. Leukemia Lymphoma 2006; 47: 2449-2452.

Abu-Rustum NR, Alektiar K, Iasonos A, Lev G, Sonoda Y, Aghajanian C, Chi DS, Barakat RR. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecologic Oncology 2006; 103: 714-718.

Akin O, Sala E, Moskowitz CS, Kuroiwa K, Ishill NM, Pucar D, Scardino PT, Hricak H. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 2006; 239: 784-792.

Allen PJ, D’Angelica M, Gonen M, Jaques DP, Coit DG, Jarnagin WR, DeMatteo R, Fong Y, Blumgart LH, Brennan MF. A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Annals of Surgery 2006; 244: 572-582.

Amar D, Goenka A, Zhang H, Park B, Thaler HT. Leukocytosis and increased risk of atrial fibrillation after general thoracic surgery. Annals of Thoracic Surgery 2006; 82: 1057-1061.

Anderson SE, Nonaka D, Chuai S, Olshen AB, Chi D, Sabbatini P, Soslow RA. p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas. International Journal of Gynecological Cancer 2006; 16: 849-853.

Arber N, Eagle C, Spicak J, Racz I, Dite P, Hajer J, Zavoral M, Lechuga MJ, Gerletti P, Tang J, Rosenstein RB, Macdonald K, Bhadra P, Fowler R, Wittes J, Zauber AG, Solomon SD, Levin B.  Celecoxib for the prevention of colorectal adenomatous polyps.  N Engl J Med 2006;355:885-95.

Arber N, Solomon S, Wittes J, Lechuga M, Gerletti P, MacDonald K, Eale C, Pfeffer M, McMurray J, Fowler R, Finn P, Zauber A, Ruschitzka F, Levin B.  Cardiovascular outcomes from a long-term randomized colorectal adenoma chemoprevention trial of a once-daily dose of celecoxib. Gastroenterology 2006: 130 S A: 57 381

Are C, Gonen M, D’Angelica M, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Differential diagnosis of proximal biliary obstruction. Surgery 2006; 140: 756-763.

Bach PB, McClellan MB. The first months of the prescription-drug benefit-a CMS update. New England Journal of Medicine 2006; 354: 2312-2314.

Ballas LK, Elkin EB, Schrag D, Minsky BD, Bach PB. Radiation therapy facilities in the United States. International Journal of Radiation Oncology, Biology, Physics 2006; 66: 1204-1211.

Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW, Coit DG, Brennan MF. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): Impact of adequate staging on outcome. Annals of Surgical Oncology 2006; [Epub ahead of print]

Basch E, Iasonos A, McDonough T, Barz A, Culkin A, Kris MG, Scher HI, Schrag D. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncology 2006; 7: 903-909.

Basch EM, Artz D, Speakman J, Iasonos A, Shannon K, Lin K, Pun C, Yong H, Barz A, McCabe M, Schrag D. Design, implementation, and evaluation of a web portal for patient symptom monitoring. Journal of the American Medical Information Association 2006; 14: (in press).

Begg CB, Brawley O, Califf RM, Demets DL, Ellenberg SS, Kaplan RS. Marketing drugs too early in testing. Science 2006; 312: 195.

Begg CB, Eng KH, Hummer AJ. Statistical tests for clonality. Biometrics 2006 (in press).

Begg CB, Hummer AJ, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Busam K, From L, Berwick M; GEM Study Group. A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. International Journal of Epidemiology 2006; 35: 756-764.

Begg CB. Response to “Case-control and case-only designs with genotype and family history data: estimating relative risk, residual familial aggregation, and cumulative risk” by Chatterjee et al. Biometrics 2006; (in press).

Bekelman JE, Rosenzweig KE, Bach PB, Schrag D. Trends in the use of postoperative radiotherapy for resected non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 2006; 66: 492-499.

Ben-Porat L, Panageas KS, Hanlon C, Patel A, Halpern A, Houghton AN, Coit D. Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on cancer staging system for melanoma. Cancer 2006; 106: 163-171.

Berger AD, Satagopan J, Lee P, Taneja SS, Osman I. Differences in clinicopathologic features of prostate cancer between black and white patients treated in the 1990s and 2000s. Urology 2006; 67: 120-124.

Berman E, Nicolaides M, Maki RG, Fleisher M, Chanel S, Scheu K, Wilson BA, Heller G, Sauter NP.  Altered bone and mineral metabolism in patients receiving imatinib mesylate. New England Journal of Medicine 2006; 354: 2006-2013.

Bernstein JL, Teraoka S, Southey MC, Jenkins MA, Andrulis IL, Knight JA, John EM, Lapinski R, Wolitzer AL, Whittemore AS, West D, Seminara D, Olson ER, Spurdle AB, Chenevix-Trench G, Giles GG, Hopper JL, Concannon P. Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry. Human Mutations 2006; 27: 1122-1128.

Bernstein JL, Teraoka SN, John EM, Andrulis IL, Knight JA, Lapinski R, Olson ER, Wolitzer AL, Seminara D, Whittemore AS, Concannon P. The CHEK2*1100delC allelic variant and risk of breast cancer: screening results from the Breast Cancer Family Registry. Cancer Epidemiology, Biomarkers and Prevention 2006; 15: 348-352.  

Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, Kim K, Tang J, Rosenstein RB, Wittes J, Corle D, Hess TM, Woloj GM, Boisserie F, Anderson WF, Viner JL, Bagheri D, Burn J, Chung DC, Dewar T, Foley TR, Hoffman N, Macrae F, Pruitt RE, Saltzman JR, Salzberg B, Sylwestrowicz T, Gordon GB, Hawk ET; APC Study Investigators. Celecoxib for the prevention of sporadic colorectal adenomas. New England Journal of Medicine 2006; 355: 873-884. 

Berwick M, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Busam K, From L, Mujumdar U, Wilcox H, Begg CB; GEM Study Group.  The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer Epidemiology, Biomarkers and Prevention 2006; 15: 1520-1525.

Bickell NA, Wang JJ, Oluwole S, Schrag D, Godfrey H, Hiotis K, Mendez J, Guth AA. Missed opportunities: racial disparities in adjuvant breast cancer treatment. Journal of Clinical Oncology 2006; 24: 1357-1362.

Boyle JO, Lillico AJ, Kuriakose MA. Feasibility of international chemoprevention trials. New York Presbyterian Hospital Cancer Prevention Newsletter, Issue 8, Fall 2006.

Brady MS, Akhurst T, Spanknebel K, Hilton S, Gonen M, Patel A, Larson S.  Utility of preoperative [(18)]f fluorodeoxyglucose-positron emission tomography scanning in high-risk melanoma patients. Annals of Surgical Oncology 2006; 13: 525-532.

Brendler T, Gruenwald J, Ulbricht C, Basch E. Natural Standard Research Collaboration. Devil’s Claw (Harpagophytum procumbens DC): an evidence-based systematic review by the Natural Standard Research Collaboration. Journal of Herbal Pharmacotherapy 2006; 6: 89-126.

Brenner B, Shah MA, Karpeh MS, Gonen M, Brennan MF, Coit DG, Klimstra DS, Tang LH, Kelsen DP. A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Annals of  Oncology 2006; 17: 1404-1411.

Budak-Alpdogan T, Przybylowski M, Gonen M, Sadelain M, Bertino J, Riviere I. Functional assessment of the engraftment potential of gammaretrovirus-modified CD34+ cells, using a short serum-free transduction protocol. Human Gene Therapy 2006; 17: 780-794.

Capanu M, Jones GA, Randles RH. Testing for preference using a sum of Wilcoxon signed rank statistics. Computational Statistics and Data Analysis 2006; 51: 793-796

Carver BS, Bianco FJ, Shavegan B, Vickers AJ, Motzer RJ, Bosl GJ, Sheinfeld J. Predicting teratoma in the retroperitoneum for men undergoing post-chemotherapy retroperitoneal lymph node dissection. Journal of Urology 2006; 176: 100-104.

Chadalavada RS, Korkola JE, Houldsworth J, Olshen AB, Bosl GJ, Studer L, Chaganti RS. Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells. Stem Cells 2006; [Epub ahead of print]

Chen W, Houldsworth J, Olshen AB, Nanjangud G, Chaganti S, Venkatraman ES, Halaas J, Teruya-Feldstein J, Zelenetz AD, Chaganti RS. Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas. Blood 2006; 107: 2477-2485.

Cheung IY, Vickers AJ, Cheung NK. Sialyltransferase STX (ST8SiaII): a novel molecular marker of neuroblastoma. International Journal of Cancer 2006; 119: 152-156.

Cheung NKV, Vickers AJ, Gorlick R. FcγRIIa polymorphism correlates with treatment outcome of metatastic neuroblastoma following immunotherapy using murine IgG3 anti-GD2 antibody and GM-CSF. Journal of Clinical Oncology 2006; 24: 2885-2890.

Chi DS, McCaughty K, Diaz JP, Huh J, Schwabenbauer S, Hummer AJ, Venkatraman ES, Aghajanian C, Sonoda Y, Abu-Rustum NR, Barakat RR. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma. Cancer 2006; 106: 1933-1939.

Cronin KA, Gail MH, Zou Z, Bach PB, Virtamo J, Albanes D. Validation of a model of lung cancer risk prediction among smokers. Journal of the National Cancer Institute 2006; 98: 637-640.

Cucchiaro G, Farrar, JT, Guite JW, Li Y.  What postoperative outcomes matter to pediatric ptients?  Anesthesia and Analgesia 2006; (in press).

D’Angelica M, Kornprat P, Gonen M, Chung KY, Jarnagin WR, Dematteo RP, Fong Y, Kemeny N, Blumgart LH, Saltz LB. Lack of evidence for increased operative morbidity after  hepatectomy with perioperative use of bevacizumab: A matched case-control study. Annals of Surgical Oncology 2006; [Epub ahead of print].

D’Angelica M, Maddineni S, Fong Y, Martin RC, Cohen MS, Ben-Porat L, Gonen M, DeMatteo RP, Blumgart LH, Jarnagin WR. Optimal abdominal incision for partial hepatectomy: increased late complications with Mercedes-type incisions compared to extended right subcostal incisions. World Journal of Surgery 2006; 30: 410-418.

Dash A, Galsky MD, Vickers AJ, Serio AM, Koppie TM, Dalbagni G, Bochner BH. Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder. Cancer. 2006; 107: 506-513.

Dash A, Vickers AJ, Schacter L, Bach A, Snyder M, Russo P. Elective partial versus elective radical nephrectomy for clear cell renal cell carcinoma 4-7 cm in size. BJU International 2006; 97: 939-945.

Davis JA, McBride MG, Chrisant MRK, Patil SM, Hanna BD, Paridon SM. Longitudinal assessment of cardiovascular exercise performance after pediatric heart transplantation. The Journal of Heart and Lung Transplantation 2006; 25: 626-633.

DiBlasio CJ, Masterson TA, Fearn PA, Seo HS, Rabbani F, Vickers AJ, Eastham JA, Scardino PT. The association between total and positive lymph node counts, disease progression in clinically localized prostate cancer. Journal of Urology 2006; 175: 1320-1324.

Diefenbach CS, Shah Z, Iasonos A, Barakat RR, Levine DA, Aghajanian C, Sabbatini P, Hensley ML, Konner J, Tew W, Spriggs D, Fleisher M, Thaler H, Dupont J. Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer. Gynecologic Oncology 2007;104:435-42.

Diefenbach CS, Soslow RA, Iasonos A, Linkov I, Hedvat C, Bonham L, Singer J, Barakat RR, Aghajanian C, Dupont J. Lysophosphatidic acid acyltransferase-beta (LPAAT-beta) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival. Cancer 2006; 107: 1511-1519.

Donohue JF, Bianco FJ, Kuroiwa K, Vickers AJ, Wheeler TM, Scardino PT, Reuter V, Eastham JA. Poorly differentiated prostate cancer treated by radical prostatectomy: Long-term outcome and incidence of downgrading. Journal of Urology 2006; 176: 991-995.

Douglas DA, Zhong H, Ro JY, Oddoux C, Berger AD, Pincus MR, Satagopan JM, Gerald WL, Scher HI, Lee P, Osman I. Novel mutations of epidermal growth factor receptor in localized prostate cancer. Frontiers in Bioscience 2006; 11: 2518-2525.

Dupont J, Aghajanian C, Andrea G, Lovegren M, Chuai S, Venkatraman E, Hensley M, Anderson S, Spriggs D, Sabbatini P.  Topotecan and liposomal doxorubicin in recurrent ovarian cancer: is sequence important? International Journal of Gynecology Cancer 2006; 16 Suppl 1:68-73.

Elkin EB, Hurria A, Mitra N, Schrag D, Panageas KS. Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort. Journal of Clinical Oncology 2006; 24: 2757-2764.

Elkin EB, Vickers AJ, Kattan MW. Primer: using decision analysis to improve clinical decision making in urology. National Clinical Practice in Urology 2006; 3: 439-448.

Engel LS, Laden F, Andersen A, Strickland PT, Blair A, Needham LL, Barr DB, Wolff MS, Helzlsouer K, Hunter DJ, Lan Q, Cantor KP, Comstock G, Brock JW, Bush D, Hoover RN, Rothman N. Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin lymphoma: a report from three cohorts. Cancer Research 2006; (in press).

Engel LS, Lan Q, Rothman N. Polychlorinated biphenyls and non-Hodgkin lymphoma. Cancer Epidemiology, Biomarkers, and Prevention 2006; (in press).

Ergun-Longmire B, Mertens AC, Mitby P, Qin J, Heller G, Shi W, Yasui Y, Robison LL, Sklar CA. Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. Journal of Clinical Endocrinology and Metabolism 2006; 91: 3494-3498.

Ezzo JM, Richardson MA, Vickers AJ, Allen C, Dibble SL, Issell BF, Lao L, Pearl M, Ramirez G, Roscoe JA, Shen J, Shivnan JC, Streitberger K, Treish I, Zhang G. Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. Cochrand Database of Systematic Reviews 2006; Apr 19: (2): CD002285.

Feltquate D, Nordquist L, Eicher C, Morris M, Smaletz O, Slovin S, Curley T, Wilton A, Fleisher M, Heller G, Scher HI. Rapid androgen cycling as treatment for patients with prostate cancer. Clinical Cancer Research 2006; 12: 7414-7421.

Ferguson SE, Olshen AB, Levine DA, Viale A, Barakat RR, Boyd J. Molecular profiling of endometrial cancers from African-American and Caucasian women. Gynecologic Oncology 2006; 101: 209-213.

Fleming MT, Morris MJ, Heller G, Scher HI. Post-therapy changes in PSA as an outcome measure in prostate cancer clinical trials. National Clinical Practice in Oncology 2006; 3: 658-667. Review.

Flores RM, Akhurst T, Gonen M, Zakowski M, Dycoco J, Larson SM, Rusch VW. Positron emission tomography predicts survival in malignant pleural mesothelioma. Journal of Thoracic Cardiovascular Surgery 2006; 132: 763-768.

Fong Y, Wagman L, Gonen M, Crawford J, Reed W, Swanson R, Pan C, Ritchey J, Stewart A, Choti M.  Evidence-based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database. Annals of Surgery 2006; 243: 767-771; discussion 771-774.

Fornier MN, Seidman AD, Lake D, D’Andrea G, Bromberg J, Robson M, VanPoznak C, Panageas KS, Atienza M, Norton L, Hudis C.  Increased dose-density is feasible: A pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10 or 11 day intervals with filgrastim support in women with breast cancer, Clinical Cancer Research 2006; (in press).

Fridlyand J, Snijders AM, Ylstra B, Li H, Olshen A, Segraves R, Dairkee S, Tokuyasu T, Ljung BM, Jain AN, McLennan J, Ziegler J, Chin K, Devries S, Feiler H, Gray JW, Waldman F, Pinkel D, Albertson DG.  Breast tumor copy number aberration phenotypes and genomic instability.  BMC Cancer 2006; 6: 96.

Fury MG, Zahalsky A, Wong R, Venkatraman E, Lis E, Hann L, Aliff T, Gerald W, Fleisher M, Pfister DG. A Phase II study of SU5416 in patients with advanced or recurrent head and neck cancers. Investigational New Drugs 2006 (in press).

Galsky MD, Mironov S, Iasonos A, Scattergood J, Boyle MG, Bajorin DF. Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma. Investigational New Drugs 2006; [Epub ahead of print]

Gerecitano J, Goy A, Wright J, MacGregor-Cortelli B, Neylon E, Gonen M, Esseltine D, Boral A, Schenkein D, Busam K, Teruya-Feldstein J, Sachs D, O’Connor OA. Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: a possible surrogate marker of response? British Journal of Haematology 2006; 134: 391-398.

Gilheeney SW, Lyden DC, Sgouros S, Antunes N, Gerald W, Kramer K, Lis E, Meyers P, Rosen N, Thaler HT, Trippett T, Wexler L, Dunkel IJ. A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies. Pediatric Blood Cancer 2006; [Epub ahead of print]

Gold JS, van der Zwan SM, Gönen M, Maki RG, Singer S, Brennan MF, Antonescu CR, Dematteo RP. Outcome of metastatic GIST in the era before tyrosine kinase inhibitors. Annals of  Surgical Oncology 2006; [Epub ahead of print]

Goldfrank D, Chuai S, Bernstein JL, Ramon Y Cajal T, Lee JB, Alonso MC, Diez O, Baiget M, Kauff ND, Offit K, Robson M. Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2. Cancer Epidemiology, Biomarkers and  Prevention 2006; 15: 2311-2313.

Gollub MJ, Yoon S, Smith LM, Moskowitz CS. Does the CT whirl sign really predict small bowel volvulus? Experience in an oncologic population. Journal of Computed Assisted Tomography 2006; 30: 25-32.

Grobmyer SR, Wang L, Gonen M, Fong Y, Klimstra D, D’Angelica M, DeMatteo RP, Schwartz L, Blumgart LH, Jarnagin WR.  Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Annals of Surgery 2006; 244: 260-264.

Halpern NA, Pastores SM, Thaler HT, Greenstein RJ. Changes in critical care beds and occupancy in the United States 1985-2000: Differences attributable to hospital size. Critical Care Medicine 2006; 34: 2105-2112.

Hanley JA, Dendukuri N, Begg CB.  Response to “Multiple imputation for correcting verification bias” (letter).  Statistics in Medicine 2006; (in press).

Hay J, Burkhalter J, Ostroff J, Li Y, Quiles Z, Moadel A.  Changes in cancer-related risk perception and  smoking across time in newly-diagnosed cancer patients.  Journal of Behavioral Medicine 2006; (in press).

Heller G. Power calculations for preclinical studies using a K-sample rank test and the Lehmann alternative hypothesis. Statistics in Medicine 2006; 25: 2543-2553.

Hensley ML, Correa DD, Thaler H, Wilton A, Venkatraman E, Sabbatini P, Chi DS, Dupont J, Spriggs D, Aghajanian C. Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: pathologic complete response and longitudinal assessment of impact on cognitive functioning. Gynecologic Oncology 2006; 102: 270-277.

Hormigo A, Gu B, Karimi S, Riedel E, Panageas KS, Edgar MA, Tanwar MK, Rao JS, Fleisher M, DeAngelis LM, Holland EC. YKL-40 and matrix etalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas. Clinical Cancer Research 2006; 12: 5698-5704.

Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj G, Scardino PT, Russo P. Chronic kidney disease following nephrectomy in patients with renal cortical tumors. Lancet Oncology 2006; 7: 735-740.

Hurria A, Fleming MT, Baker SD, Kelly WK, Cutchall K, Panageas K, Caravelli J, Yeung H, Kris MG, Gomez J, Miller VA, D’Andrea G, Scher HI, Norton L, Hudis C. Pharmacokinetics and toxicity of weekly docetaxel in older patients. Clinical Cancer Research 2006; 12 (20 Pt 1): 6100-6105.

Hurria A, Hurria A, Zuckerman E, Panageas KS, Fornier M, D’Andrea G, Dang C, Moasser M, Robson M, Seidman A, Currie V, VanPoznak C, Theodoulou M, Lachs MS, Hudis C. A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy. Journal of the American Geriatrics Society 2006: 54: 1119-1124.

Hurria A, Rosen C, Hudis C, Zuckerman E, Panageas KS, Lachs MS, Witmer M, van Gorp WG, Fornier M, D’Andrea G, Moasser M, Dang C, Van Poznak C, Hurria A, Holland J. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. Journal of the American Geriatric Society 2006; 54: 925-931.

Hwu WJ, Panageas KS, Menell JH, Lamb LA, Aird S, Krown SE, Williams LJ, Chapman PB, Livingston PO, Wolchok JD, Houghton AN. Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanoma. Cancer 2006; 106: 2445-2451.

Indurkhya A, Mitra N, Schrag D. Using propensity scores to estimate the cost-effectiveness of medical therapies. Statistics in Medicine 2006; 25: 1561-1576.

Ioannidis JP, Gwinn M, Little J, Higgins JP, Bernstein JL, Boffetta P, Bondy M, Bray MS, Brenchley PE, Buffler PA, Casas JP, Chokkalingam A, Danesh J, Smith GD, Dolan S, Duncan R, Gruis NA, Hartge P, Hashibe M, Hunter DJ, Jarvelin MR, Malmer B, Maraganore DM, Newton-Bishop JA, O’Brien TR, Petersen G, Riboli E, Salanti G, Seminara D, Smeeth L, Taioli E, Timpson N, Uitterlinden AG, Vineis P, Wareham N, Winn DM, Zimmern R, Khoury MJ; Human Genome Epidemiology Network and the Network of Investigator Networks. A road map for efficient and reliable human genome epidemiology. Nature Genetics 2006; 38: 3-5.

Jarnagin WR, Klimstra DS, Hezel M, Gonen M, Fong Y, Roggin K, Cymes K, DeMatteo RP, D’Angelica M, Blumgart LH, Singh B. Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. Journal of Clinical Oncology 2006; 24: 1152-1160.

Jarnagin WR, Zager JS, Hezel M, Stanziale SF, Adusumilli PS, Gonen M, Ebright MI, Culliford A, Gusani NJ, Fong Y.  Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy. Cancer Gene Therapy 2006; 13: 326-334.

Kamel F, Engel LS, Gladen BC, Hoppin JA, Alavanja MC, Sandler DP. Pesticide use and neurologic symptoms in the Agricultural Health Study. Human Experimental Toxicology 2006; (in press).

Kanetsky PA, Rebbeck TR, Hummer AJ, Panossian S, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Busam K, From L, Mujumdar U, Wilcox H, Begg CB, Berwick M.  Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Research 2006; 66: 9330-9337.

Khokhar A, Vickers AJ,  Moore MS, Mironov S, Stover DE, Feinstein MB. Significance of non-calcified pulmonary nodules among patients with extra-pulmonary cancers.  Thorax 2006; 61: 331-336.

Kissane DW, McKenzie M, Bloch S, Moskowitz C, McKenzie DP, and O’Neill I.  Family focused grief therapy: a randomized controlled trial in palliative care and bereavement. American Journal of Psychiatry 2006; 163: 1208-1218.

Kligler B, Ulbricht C, Basch E, Kirkwood CD, Abrams TR, Miranda M, Singh Khalsa KP, Giles M, Boon H, Woods J. Andrographis paniculata for the treatment of upper respiratory infection: a systematic review by the natural standard research collaboration. Explore (NY) 2006; 2: 25-29. Review.

Koppie TM, Vickers AJ, Vora K, Dalbagni G, Bochner BH. Standardization of pelvic lymphadenectomy performed at radical cystectomy: Can we establish a minimum number of lymph nodes that should be removed? Cancer 2006; 107: 2368-2374.

Korkola JE, Houldsworth J, Chadalavada RS, Olshen AB, Dobrzynski D, Reuter VE, Bosl GJ, Chaganti RS. Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Research 2006; 66: 820-827.

Kornprat P, Jarnagin WR, Gonen M, Dematteo RP, Fong Y, Blumgart LH, D’Angelica M.  Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Annals of Surgical Oncology 2006; [Epub ahead of print].

Kricker A, Armstrong BK, Goumas C, Litchfield M, Begg CB, Hummer AJ, Marrett LD, Theis B, Millikan RC, Thomas N, Anton-Culver H, Gallagher RP, Dwyer T, Rebbeck TR, Busam K, From L, Mujumdar U, Zanetti R, Berwick M.  Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes and Control 2006; (in press)

Lamanna N, Kalaycio M, Maslak P, Jurcic JG, Heaney M, Brentjens R, Zelenetz AD, Horgan D, Gencarelli A, Panageas KS, Scheinberg DA, Weiss MA.  Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia. Journal of Clinical Oncology 2006; 24: 1575-1581.

Langholz B, Bernstein JL, Bernstein L, Olsen JH, Borresen-Dale AL, Rosenstein BS, Gatti RA; The WECARE Study Collaborative Group; Concannon P. On the proposed association of the ATM variants 5557G>A and IVS38-8T>C and bilateral breast cancer. International Journal of Cancer 2006; 119: 724-725.

Largent JA, Capanu M, Bernstein L, Langholz, B, Mellemkjaer L, Malone KE, Begg CB, Haile RW, Lynch CF, Anton-Culver H, Wolitzer A, Bernstein JL.  Reproductive history and risk of second primary breast cancer:  the WECARE Study. Cancer Epidemiology Biomarkers and Prevention 2006; (in press).

Lassman AB, Abrey LE, Shah GD, Panageas KS, Begemann M, Malkin MG, Raizer JJ. Systemic high-dose intravenous methotrexate for central nervous system metastases. Journal of Neurooncology  2006; 78: 255-260. Erratum in: Journal of Neurooncology 2006; 78: 261. Shah, Gaurav G [corrected to Shah, Gaurav D].

Lee NY, de Arruda FF, Puri DR, Wolden SL, Narayana A, Mechalakos J, Venkatraman ES, Kraus D, Shaha A, Shah JP, Pfister DG, Zelefsky MJ. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. International Journal of Radiation Oncology, Biology, Physics 2006; 66: 966-974.

Leiser AL, Anderson SE, Nonaka D, Chuai S, Olshen AB, Chi DS, Soslow RA. Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma. Gynecologic Oncology 2006; 101: 86-91.

Levin TT, Riskind JH, Li Y. Looming Cognitive Style in a Cancer Cohort. General Hospital Psychiatry 2006; (in press).

Li Y.  Using the open-source statistical language R to analyze the Rasch model.   Behavioral Research Methods, Instruments, & Computers 2006; 38: 532-541.

Liau KH, Ruo L, Shia J, Padela A, Gönen M, Jarnagin WR, Fong Y, D’Angelica MI, Blumgart LH, DeMatteo RP. Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma. Cancer 2006; 104: 1945-1955.

Loganathan RS, Stover DE, Shi W, Venkatraman E. Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest 2006; 129: 1305-1312.

Lopez-Rios F, Chuai S, Flores R, Shimizu S, Ohno T, Wakahara K, Illei PB, Hussain S, Krug L, Zakowski MF, Rusch V, Olshen AB, Ladanyi M. Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. Cancer Research 2006; 66: 2970-2979.

Lyman S, Sherman S, Carter TI, Bach PB, Mandl LA, Marx RG. Prevalence and risk factors for symptomatic thromboembolic events after shoulder arthroplasty. Clinical Orthopaedics and Related Research 2006; 448:152-156.

Maluf  FC, Cordon-Cardo C, Verbel DA, Satagopan JM, Boyle MG, Herr H, Bajorin DF. Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment. Annals of Oncology 2006; 17: 1677-1686.

McCreath WA, Eisenhauer EL, Abu-Rustum NR, Venkatraman ES, Caceres A, Bier R, Huh J, Cho J, Barakat RR, Chi DS. Identification of prognostic factors after positive second-look surgery in epithelial ovarian carcinoma. Gynecologic Oncology 2006; 102: 8-14.

McQuellon RP, Thaler HT, Cella D, Moore DH. Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study. Gynecologic Oncology 2006; 101: 296-304.

Millikan RC, Hummer A, Begg C, Player J, René de Cotret A, Winkel S, Mohrenweiser H, Thomas N, Armstrong B, Kricker A, Marrett LD, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Rebbeck T, Busam K, From L, Mujumdar U, Berwick M. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the genes environment and melanoma study.  Carcinogenesis 2006; 27: 3610-3618.

Milton DT, Azzoli CG, Heelan RT, Venkatraman E, Gomez JE, Kris MG, Krug LM,Pao W, Rizvi NA, Dunne M, Miller VA.  A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer. Cancer 2006; 107: 1034-1041.

Moskowitz CS, Pepe MS. Comparing the predictive values of diagnostic tests: sample size and analysis for paired study designs. Clinical Trials 2006; 3: 272-279.

Mourton SM, Chi DS, Sonoda Y, Alektiar KM, Venkatraman ES, Barakat RR, Abu-Rustum NR. Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies. Gynecologic Oncology 2006; 100: 533-536.

Mullerad M, Eisenberg DP, Akhurst TJ, Adusumilli PS, Riedl CC, Bhargava A, Gönen M, Finn R, Scardino PT, Fong Y. Use of positron emission tomography to target prostate cancer gene therapy by oncolytic herpes simplex virus. Molecular Imaging and Biology 2006; 8: 30-35.

Olson SH, Bandera EV, Orlow I. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: A HuGE Review. American Journal of Epidemiology 2006; [Epub ahead of print]

Orlow I, Begg CB, Cotignola J, Pampa R, Hummer AJ, Clas BA, Mujumdar U, Canchola R, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Wilcox H, Busam K, From L, Berwick M for GEM Study Group. CDKN24 Germline Mutations in Individuals with Cutaneous Malignant Melanoma. Journal of Investigative Dermatology 2007; (in press).

Panageas KS, Ben-Porat L, Dickler MN, Chapman PB, Schrag D.  When you look matters: The  effect of assessment schedule on progression free survival, J Natl Can Inst, in press.

Panageas KS, Schrag D, Localio AR, Venkatraman ES, Begg CB. Properties of analysis methods that account for clustering in volume-outcome studies when the primary predictor is cluster size.  Statistics in Medicine 2006; (in press).

Patil SM, Shope JT, Raghunathan TE, Bingham CR. The role of personality characteristics in young adult driving. Traffic Injury Prevention 2006; 7: 328-334.

Perales MA, Diab A, Cohen AD, Huggins DW, Guevara-Patino JA, Hubbard VM, Engelhorn ME, Kochman AA, Eng JM, Mortazavi F, Alpdogan O, Terwey TH, Heller G, Wolchok JD, Houghton AN, van den Brink MR. DNA immunization against tissue-restricted antigens enhances tumor immunity after allogeneic hemopoietic stem cell transplantation. Journal of Immunology 2006; 177: 4159-4167.

Pettus JA, Eggener SE, Shabsigh A, Yanke B, Snyder ME, Serio A, Vickers A, Russo P, Donat SM. Perioperative clinical thromboembolic events after radical or partial nephrectomy. Urology 2006; 68: 988-992.

Pham D, Kris MG, Riely GJ, Sarkaria IS, McDonough T, Chuai S, Venkatraman ES, Miller VA, Ladanyi M, Pao W, Wilson RK, Singh B, Rusch VW. Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung denocarcinomas. Journal of Clinical Oncology 2006; 24: 1700-1704.

Port ER, Yeung H, Gonen M, Liberman L, Caravelli J, Borgen P, Larson S.  18F-2-fluoro-2-deoxy-D-glucose positron emission tomography scanning affects surgical management in selected patients with high-risk, operable breast carcinoma. Annals of Surgical Oncology 2006; 13: 677-684.

Pryma DA, Schoder H, Gonen M, Robbins RJ, Larson SM, Yeung HW. Diagnostic accuracy and prognostic value of 18F-FDG PET in hurthle cell thyroid cancer patients. Journal of Nuclear Medicine 2006; 47: 1260-1266.

Qin LX, Beyer R, Hudson N, Linford N, Morris D, Kerr KF. Validation of data transformation methods for oligonucleotide arrays with qRT-PCR measurements. BMC Bioinformatics 2006; 7: 23.

Qin LX, Self SG. The clustering of regression models method with applications to gene expression data. Biometrics 2006; 62: 526-533.

Raj GV, Bochner BH, Vickers AJ, Teper E, Lin O, Donat SM, Herr H, Dalbagni G. Association between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract. Journal of Urology 2006; 175: 2038-2041.

Raj GV, Iasonos A, Herr H, Donat SM. Formulas calculating creatinine clearance are inadequate for determining eligibility for cisplatin-based chemotherapy in bladder cancer. Journal of Clinical Oncology 2006; 24: 3095-3100.

Raj GV, Tal R, Vickers AJ, Bochner BH, Serio A, Donat SM, Herr H, Olgac S, Dalbagni G. Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer. Cancer. 2006; 107: 2167-2172.

Raj GV, Bochner BH, Serio AM, Vickers AJ, Donat SM, Herr H, Lin O, Dalbagni G. Natural history of patients with positive urinary cytologies after radical cystectomy. Journal of Urology 2006; 176: 2000-2005.

Reid ME, Duffield-Lillico AJ, Sunga A, Alberts DS, Marshall JR. Selenium supplementation and colorectal adenomas: an analysis of the Nutritional Prevention of Cancer Trial.  International Journal of Cancer 2006; 118: 1777-1781.

Riely GJ, Pao W, Pham D, Li AR, Rizvi N, Venkatraman ES, Zakowski MF, Kris MG, Ladanyi M, Miller VA. Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib. Clin Cancer Research 2006; 12(3 Pt 1):839-844.

Rizk N, Downey RJ, Akhurst T, Gonen M, Bains MS, Larson S, Rusch V. Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection. Annals of Thoracic Surgery 2006; 81: 1076-1081.

Robbins RJ, Wan Q, Grewal RK, Reibke R, Gönen M, Strauss HW, Tuttle RM, Drucker W, Larson SM. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. Journal of Clinical Endocrinology and Metabolism 2006; 91: 498-505.

Sabbatini P, Dupont J, Aghajanian C, Derosa F, Poynor E, Anderson S, Hensley M, Livingston P, Iasonos A, Spriggs D, McGuire W, Reinartz S, Schneider S, Grande C, Lele S, Rodabaugh K, Kepner J, Ferrone S, Odunsi K. Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer. Clinical Cancer Research 2006; 12: 5503-5510.

Sala E, Akin O, Moskowitz CS, Eisenberg HF, Kuroiwa K, Ishill NM, Rajashanker B, Scardino PT, Hricak H. Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis. Radiology 2006; 238: 929-937.

Sala E, Eberhardt SC, Akin O, Moskowitz CS, Onyebuchi CN, Kuroiwa K, Ishill N, Zelefsky MJ, Eastham JA, Hricak H. Endorectal MR imaging before salvage prostatectomy: tumor localization and staging. Radiology 2006; 238: 176-183.

Sandhu JS, Vickers AJ, Bochner B, Donat SM, Herr HW, Dalbagni G. Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer. BJU International 2006; 98: 59-62.

Santiago JF, Gonen M, Yeung H, Macapinlac H, Larson S. A retrospective analysis of the impact of 18F-FDG PET scans on clinical management of 133 breast cancer patients. Quarterly Journal of Nuclear Medicine and Molecular Imaging. 2006; 50: 61-67.

Schoder H, Carlson DL, Kraus DH, Stambuk HE, Gonen M, Erdi YE, Yeung HW, Huvos AG, Shah JP, Larson SM, Wong RJ. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. Journal of Nuclear Medicine 2006; 47: 755-762.

Schrag D, Earle C, Xu F, Panageas KS, Yabroff KR, Bristow RE, Trimble EL, Warren JL. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. Journal of the National Cancer Institute 2006; 98: 163-171.

Schrag D, Xu F, Hanger M, Elkin E, Bickell NA, Bach PB. Fragmentation of care for frequently hospitalized urban residents. Medical Care 2006; 44: 560-567.

Secin FP, Bianco FJ, Vickers AJ, Fearn P, Scardino PT, Eastham JA. Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy. Cancer 2006; 106: 2369-2375.

Sen S, Satagopan JM, Broman K, Churchill GA. R/qtlDesign: Inbred line cross experimental design. Mammalian Genome 2006 (in press).

Shah MA, Ramanathan RK, Ilson DH, Levnor A, D’Adamo D, O’Reilly E, Tse A, Trocola R, Schwartz L, Capanu M, Schwartz GK, Kelsen DP. A multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma. Journal of Clinical Oncology 2006; 24: 5201-5206.

Shike M, Genao A, Zauber A, Burke M, Schattner M, Grant W, Cuyjet V, Samuel S, Marsh F, Russo L, Rodriguez R, Freeman H.  A prospective study of community screening colonoscopy in African American Women (AAW) and Latino women (LW): Barriers, compliance, results and satisfaction. Gastroenterology 2006: 130; S A:187 S1255.

Solomon SD, Pfeffer MA, McMurray JJV, Fowler R, Finn P, Levin B, Eagle C, Hawk E, Lechuga M, Zauber AG, Bertagnolli M, Arber N, Wittes J.  Effect of celecoxib on cardiovascular events and blood pressure in two trials for prevention of colorectal adenoma. Circulation 2006,114:1028-1035.

Steenhoff AP, Shah SS, Ratner AJ, Patil SM, McGowan KL. Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia. Clinical Infectious Diseases 2006; 42: 907-914.

Steenhoff AP, Shah SS, Ratner AJ, Patil SM, McGowan KL. Reply to Robertson et al. Clinical Infectious Diseases. Clinical Infectious Diseases 2006; 43: 544-545.

Steinberg AG, Bain L, Ewing R, Li Y.  Meeting the Public’s Health Information Needs: A plain language website outreach project: to reaching underserved parents of deaf children. Health Communication 2006; (in press).

Steuber T, Vickers AJ, Haese A, Becker C, Pettersson K, Chun FK-H, Kattan MW, Eastham JA, Scardino PT, Huland H, Lilja H. Risk assessment for biochemical recurrence prior to radical prostatectomy: Significant enhancement contributed by human glandular kallikrein 2 and free prostate-specific antigen (PSA) in men with moderate PSA-elevation in serum. International Journal of Cancer 2006; 118: 1234-1240.

Stiles BM, Adusumilli PS, Stanziale SF, Eisenberg DP, Bhargava A, Kim TH, Chan MK, Huq R, Gonen M, Fong Y. Estrogen enhances the efficacy of an oncolytic HSV-1 mutant in the treatment of estrogen receptor-positive breast cancer. International Journal of Oncology 2006; 28: 1429-1439.

Su YB, Vickers AJ, Zelefsky MJ, Kraus DH, Shaha AR, Shah JP, Serio AM, Barrison LB, Bosl GJ, Pfister DG. Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor (G-CSF) during post-operative radiotherapy for squamous head and neck cancer. Cancer Journal 2006; 12: 182-188.

Taylor RA, Patel A, Panageas KS, Busam KJ, Brady MS.  Tumor infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma, J Clin Onc, in press.

Toner LE, Vrhovac R, Smith EA, Gardner J, Heaney M, Gönen M, Teruya-Feldstein J, Sirotnak F, O’Connor OA. The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin’s lymphoma. Clinical Cancer Research 2006; 12: (3 Pt 1):924-932.

Touijer K, Kuroiwa K, Vickers AJ, Reuter VE, Guillonneau B. Impact of a multidisciplinary continuous quality improvement program on the positive surgical margin rate after laparoscopic radical prostatectomy. European Urology 2006; 49: 853-858.

Travis LB, Rabkin CS, Brown LM, Allan JM, Alter BP, Ambrosone CB, Begg CB, Caporaso N, Chanock S, DeMichele A, Figg WD, Gospodarowicz MK, Hall EJ, Hisada M, Inskip P, Kleinerman R, Little JB, Malkin D, Ng AK, Offit K, Pui CH, Robison LL, Rothman N, Shields PG, Strong L, Taniguchi T, Tucker MA, Greene MH. Cancer survivorship—genetic susceptibility and second primary cancers: research strategies and recommendations. Journal of the National Cancer Institute 2006; 98: 15-25.

Tuma R, Almyroudis N, Sohn S, Panageas K, Rice R, Galinkin D, Blain M, Montefusco M, Pamer E, Nimer S, Kewalramani T. The serum IL-12:IL-6 ratio reliably distinguishes infectious from non-infectious causes of fever during autologous stem cell transplantation. Cytotherapy 2006; 8: 327-334.

Ulbricht C, Basch E, Bent S, Boon H, Corrado M, Foppa I, Hashmi S, Hammerness P, Kingsbury E, Smith M, Szapary P, Vora M, Weissner W. Evidence-based systematic review of saw palmetto by the Natural  Standard Research Collaboration. Journal of Society of Intergrative Oncology 2006; 4: 170-186.

Ulbricht C, Basch E, Weissner W, Hackman D. An evidence-based systematic review of herb and supplement interactions by the Natural Standard Research Collaboration. Expert Opinion on Drug Safety 2006; 5: 719-728. Review.

Van Poznak C, Cross SS, Saggese M, Hudis C, Panageas KS, Norton L, Coleman RE, Holen I. Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours. Journal of Clinical Pathology 2006; 59: 56-63.

Venkatraman ES, Olshen AB. A faster CBS algorithm for the analysis of array CGH data.  Biostatistics 2006; (in press).

Vickers AJ, Bianco FJ, Boorjian S, Scardino P, Eastham JA. Does delay between diagnosis and radical prostatectomy increase the risk of cancer recurrence? Cancer 2006; 106: 576-580.

Vickers AJ, Kramer BS, Baker SG. Selecting patients for randomized trials: a systematic approach based on risk group. Trials 2006; 7: 30.

Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Medical Decision Making 2006; 26: 565-574.

Vickers AJ, Kuo J, Cassileth BR. Unconventional anticancer agents: a systematic review of clinical trials. Journal of Clinical Oncology 2006; 24: 136-140.

Vickers AJ, Rusch VW, Malhotra VT, Downey RJ, Cassileth BR. Acupuncture is a feasible treatment for post-thoracotomy pain: Results of a prospective clinical trial. BMC Anaesthesia 2006; 6: 5.

Vickers AJ. How to design a Phase I trial of an anticancer botanical. Journal of the Society for Integrative Oncology 2006; 4: 46-51.

Vickers AJ. How to measure quality of life in integrative oncology research. Journal of the Society for Integrative Oncology 2006; 4: 100-103.

Vickers AJ. How to randomize. Journal of the Society for Integrative Oncology 2006; 4: 194-198.

Vickers AJ. Multiple assessment in quality of life trials: how many questionnaires? How often should they be given? Journal of the Society for Integrative Oncology 2006; 4: 135-139.

Vickers AJ. Whose data set is it anyway? Sharing raw data from randomized trials. Trials 2006: 7: 15.

Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, Fleisher M, Lilja H, Brogi E, Boyd J, Sanchez-Carbayo M, Holland EC, Cordon-Cardo C, Scher HI, Tempst P. Differential exoprotease activities confer tumor-specific serum peptidome patterns. Journal of Clinical Investigation 2006; 116: 271-284.

Vogelaar I, van Ballegooijen M, Schrag D, Boer R, Winawer SJ, Habbema JD, Zauber AG. How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer 2006; 107: 1624-1633.

Weyant MJ, Bains MS, Venkatraman E, Downey RJ, Park BJ, Flores RM, Rizk N, Rusch VW.  Results of chest wall resection and reconstruction with and without rigid prosthesis. Annals of Thorcic Surgery 2006; 81: 279-285.

Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O’Brien MJ, Levin B, Smith RA, Lieberman DA, Burt RW, Levin TR, Bond JH, Brooks D, Byers T, Hyman N, Kirk L, Thorson A, Simmang C, Johnson D, Rex DK. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer Journal for Clincians 2006; 56: 143-159; quiz 184-185.

Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O’Brien MJ, Levin B, Smith RA, Lieberman DA, Burt RW, Levin TR, Bond JH, Brooks D, Byers T, Hyman N, Kirk L, Thorson A, Simmang C, Johnson D, Rex DK; US Multi-society task force on colorectal cancer; American Cancer Society. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US multi-society task force on colorectal cancer and the American Cancer Society. Gastroenterology 2006; 130: 1872-1885. 

Yoon SS, Kim SH, Gonen M, Heffernan NM, Detwiller KY, Jarnagin WR, D’Angelica M, Blumgart LH, Tanabe KK, Dematteo RP. Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases. Annals of Surgical Oncology 2006; 13: 353-362.

Yossepowitch O, Eggener SE, Serio A, Huang WC, Snyder ME, Vickers AJ, Russo P. Temporary renal ischemia during nephron-sparing surgery is associated with short-term but not long-term impairment of renal function. Journal of Urology 2006; 176: 1339-1343.

Yuan J, Gallardo HF, Rasalan T, Ranganathan R, Wang J, Zhang Y, Panageas K, Stan R, Young JW, Houghton AN, Wolchok JD. In-vitro expansion of ag-specific t-cells by HLA-A*0201-transfected K562 cells for immune monitoring. Cytotherapy 2006; 8: 498-508.

Yuan J, Latouche JB, Hodges J, Houghton AN, Heller G, Sadelain M, Riviere I, Young JW. Langerhans-type dendritic cells genetically modified to express full-length antigen optimally stimulate CTLs in a CD4-dependent manner. Journal of Immunology 2006; 176: 2357-2365.  

Zakrzewski JL, Kochman AA, Lu SX, Terwey TH, Kim TD, Hubbard VM, Muriglan SJ, Suh D, Smith OM, Grubin J, Patel N, Chow A, Cabrera-Perez J, Radhakrishnan R, Diab A, Perales MA, Rizzuto G, Menet E, Pamer EG, Heller G, Zuniga-Pflucker JC, Alpdogan O, van den Brink MR.  Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Nature Medicine 2006; 12: 1039-1047.

Zauber AG, Vogelaar I, van Ballegooijen M, Boer R, Schrag D, Habbema D, Winawer SJ.  Impact of initial polypectomy versus follow-up surveillance colonoscopy on colorectal cancer in post-polypectomy patients.  Gastroenterology 2006; 130: SA: 186: S1249

Zauber AG, Winawer SJ. High-quality colonoscopies must be an integral part of screening and surveillance programs. Gastroenterology 2006; 130: 620-621; author reply 621-622. 

Zelefsky MJ, Ben-Porat L, Chan HM, Fearn PA, Venkatraman ES. Evaluation of postradiotherapy PSA patterns and correlation with 10-year disease free survival outcomes for prostate cancer. International Journal of Radiation Oncology, Biology, Physics 2006; 66: 382-388.

Zhao B, Schwartz LH, Moskowitz CS, Ginsberg MS, Rizvi NA, Kris MG. Lung cancer: computerized quantification of tumor response—initial results. Radiology 2006; 241: 892-898.

AD Berger, J Satagopan, P Lee, SS Taneja, I Osman. Differences in clinicopathologic features of prostate cancer between black and white patients treated in the 1990s and 2000s. Urology (in press).

Alektiar KM, Venkatraman E, Chi DS, Barakat RR.  Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.  International Journal of Radiation Oncology Biology Physics 2005;62:111-117.

Altorki NK, Port JL, Zhang F, Golijanin D, Thaler HT, Duffield-Lillico AJ, Subbaramaiah K, Dannenberg AJ.  Chemotherapy induces the expression of cyclooxygenase-2 in non-small cell lung cancer. Clinical Cancer Research. 2005;11:4191-7.

Amar D, Zhang H, Heerdt PM, Park B, Fleisher M, Thaler HT.  Statin use is associated with a reduction in a trial fibrillation after thoracic surgery independent of C-reactive protein.  Chest 2005; 128:3421-7.

Araten DJ, Golde DW, Zhang RH, Thaler HT, Gargiulo L, Notaro R, Luzzatto L.  A quantitative measurement of the human somatic mutation rate.  Cancer Research 2005; 65:8111-7.

Araten DJ, Thaler HT, Luzzatto L.  High incidence of thrombosis in African-American and Latin-American patients with paroxysmal nocturnal hemoglobinuria.  Thrombosis and Hemostasis 2005;93:88-91.

Bach PB.  Racial disparities and site of care.  Ethnicity and Disease 2005;15:S31-33.

Barrera R, Shi W, Amar D, Thaler HT, Gabovich N, Bains MS, White DA.  Smoking and timing of cessation: impact on pulmonary complications after thoracotomy.  Chest 2005; 127:1977-83.

Basch E, Artz D, Dulko D, Scher K, Sabbatini P, Hensley M, Mitra N, Speakman J,                                    McCabe   M, Schrag D.  Patient online self-reporting of toxicity symptoms during chemotherapy. Journal Clinical Oncology 2005;23:3552-3561.

Beekman K, Morris M, Slovin S, Heller G, Wilton A, Bianco F Jr. Scardino PT, Scher HI.  Androgen deprivation for minimal metastatic disease: threshold for achieving undetectable prostate-specific antigen.  Urology 2005;65:947-952.

Begg CB. Systematic reviews of diagnostic accuracy studies require study by study examination: first for heterogeneity, and then for sources of heterogeneity. J Clin Epidemiol 2005;58:882-93.

Begg CB, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Mitra N, Busam K, From L, Berwick M.  Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample (with editorial).  Journal of National Cancer Institute 2005;97:1507-15.

Bennett J, Gönen M, D’Angelica M, Jaques DP, Brennan MF, Coit DG.  Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer? Journal of American College of Surgeons. 2005 Oct;201(4):503-10.

Bernstein JL, Concannon P, Langholz B, Thompson WD, Bernstein L, Stovall M, Thomas DC;  WECARE Study Collaborative Group. Multi-center screening of mutations in the ATM gene among women with breast cancer - the WECARE Study. Radiation Research. 2005 Jun; 163(6):698-9.

Bernstein JL, Godbold J, Raptis G, Watson M, Levinson B, Aaronson SA, Flemin   TP.  Identification of mammaglobin as a novel serum marker for breast cancer. Clinical Cancer Research. 2005 Sep 15;11(18):6528-35.

Bhargava R, Shia J, Hummer AJ, Thaler HT, Tornos C, Soslow RA.  Distinction of endometrial stromal sarcomas from ‘hemangiopericytomatous’ tumors using a panel of immunohistochemical stains.  Modern Pathology 2005; 1: 40-47.

Bianco FJ Jr, Riedel ER, Begg CB, Kattan MW, Scardino PT.  Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters.  Journal of Urolology 2005; 173:2099-2103.

 

Booth J, Capanu M, Heigenhauser L, Exact conditional p-value calculation for the quasi-symmetry model, Journal of Computational and Graphical Statistics, Sept 2005,  14:3716-725.

Boruchov, AM, Heller G, Veri MC, Bovini E, Ravetch JV, Young JW. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions.  Journal Clinical Investigations. 2005 Oct; 115(10):2914-23.

Brooks DR, Austin JHM, Heelan R, Ginsberg M, Shin V, Olson SH, Muscat JE, Stellman SD. Influence of type of cigarette on peripheral versus central lung cancer.  Cancer Epidemiology, Biomarkers and Prevention 2005;14:576-581.

Cassileth BR, Vickers AJ. High prevalence of complementary and alternative medicine use among cancer patients: implications for research and clinical care (editorial). Journal of Clinical Oncology 2005;23:2590-2592.

Cesaretti JA, Stock RG, Lehrer S, Atencio DA, Bernstein JL, Stone NN, Wallenstein S, Green S, Loeb K, Kollmeier M, Smith M, Rosenstein BS.  ATM Sequence Variants are Predictive of Adverse Radiotherapy Response Among Patients Treated for Prostate Cancer. International Journal Radiation Oncology Biology Physics 2005;61:196-202.

Chadalavada RS, Houldsworth J, Olshen AB, Bosl GJ, Studer L, Chaganti RS.  Transcriptional program of bone morphogenetic protein-2-induced epithelial and smooth muscle differentiation of pluripotent human embryonal carcinoma cells.  Functional and Integrative Genomics 2005;5:59-69.

Charles CA, Yee VS, Dusza SW, Marghoob AA, Oliveria SA, Kopf A, Rigel D, Halpern AC.  Variation in the diagnosis, treatment, and management of melanoma in situ: a survey of US dermatologists.  Archives of Dermatology 2005;141:723-729.

Chen W, Houldsworth J, Olshen AB, Nabjangud G, Chaganti S, Venkatraman ES, Halaas J, Teruya-Feldstein J, Zelenetz AD, Chaganti RS.  Array comparative genomic hybrization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas. Blood 2005 Nov 29 PMID: [Epub ahead of print].

Chung KY, Shia J, Kemeny NE, Shah M, Schwartz GK, Tse A, Hamilton A, Pan D,    Schrag D, Schwartz L, Klimstra DS, Fridman D, Kelsen DP, Saltz LB.  Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.  Journal of Clinical Oncology 2005; 20:1803-1810.

Douglas DA, Zhong H, Ro JY, Oddoux C, Berger A, Pincus MR, Satagopan JM, Gerald WL, Scher HI, Lee P, Osman I. Novel mutations of the epiderman growth factor receptor in localized prostate cancer. Frontiers in Bioscience (in press).

Dusza SW, Oliveria SA, Geller AC, Marghoob AA, Halpern AC. Student/parent agreement in self-reported sun behaviors. Journal of American Academy Dermatology 2005;52:896-900.

Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW.  Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. Journal of National Cancer Institute 2005 Oct 5;97(19):1407-27.

Eitan R, Saenz CC, Venkatraman ES, Hann L, Bach A, Gretz E, Barakat RR, Chi DS.  Pilot study prospectively evaluating the use of the measurement of preoperative sonographic endometrial thickness in postmenopausal patients with endometrial cancer.  Menopause 2005;12:27-30.

Elkin EB, Hudis C, Begg CB, Schrag D.  The effect of changes in tumor size on breast cancer survival in the U.S., 1975-1999. Cancer 2005 Sep 15;104(6):1149-57.

Elkin EB, Weinstein MC, Kuntz KM, Bunnell CA, Weeks JC. Adjuvant ovarian suppression versus chemotherapy for premenopausal, hormone-responsive breast cancer: quality of life and efficacy tradeoffs. Breast Cancer Research and Treatment, 2005; 93: 25-35.

Engel LS, Hill DA, Hoppin JA, Lubin JH, Lynch CF, Pierce J, Samanic C, Sandler DP, Blair A, Alavanja MC. Pesticide use and breast cancer risk among farmers’ wives in the Agricultural Health Study. American Journal Epidemiology 2005;161:121-135.

Engel LS, Strickland PT, Cantor KP, Needham LL, Helzlsouer K, Comstock G, Bush D, Brock JW, Rothman N. A nested case-control study of prediagnostic serum PCB congener concentrations and risk of non-Hodgkin’s lymphoma. (Submitted).

Ezzo JM, Vickers AJ, Richardson MA, Allen C, Dibble SL, Issell BF, Lao L, Pearl M, Ramirez G, Roscoe JA, Shen J, Shivnan JC, Streitberger K, Treish I, Zhang G. Acupuncture-Point Stimulation for Chemotherapy-Induced Nausea and Vomiting: a systematic review. Journal of Clinical Oncology 2005; 23(28):7188-98.

Ferguson SE, Olshen AB, Viale A, Barakat RR, Boyd J.  Stratification of intermediate-risk endometrial cancer patients into groups at high risk or low risk for recurrence based on tumor gene expression profiles.  Clinical Cancer Research 2005;11:2252-2257.

Ferrone CR, Ben Porat L, Panageas KS, Berwick M, Halpern AC, Patel A,  Coit DG. Multiple Primary Melanomas: Clinicopathologic Features and Risk Factors in 385 patients.  Journal of American Medical Association, 2005; 294(13):1647-54.

Fong Y, Gönen M, Rubin M, Radzyner M, Brennan MF. Long-term survival is superior after resection for cancer in high-volume centers. Annals of Surgery, 2005, 242:540-7.

Fornier MN, Modi S, Panageas KS, NortonL, Hudis C. incidence of Chemotherapy-induced long-term amenorrhea in breast cancer patients age 40 years and younger after adjuvant anthracycline and taxane.  Cancer, 2005; 104(8):  1575-9.

Geller AC, O’Riordan DL, Oliveria SA, Valvo S, Teich M, Halpern AC. Overcoming obstacles to skin cancer examinations and prevention counseling for high-risk patients: Results of a national survey of primary care physicians. Journal of the American Board of Family Practice 2004;17:416-423.

Gollub MJ, Jhaveri S, Schwartz E, Felderman H, Cooper C, Markowitz AJ, Kurtz RC, Thaler H.  CT colonography features of sigmoid diverticular disease. Clinical   Imaging 2005;3:200-6.

Gollub MJ, Lefkowitz R, Moskowitz CS, Ilson D, Kelsen D, Felderman H.  Pelvic CT          in patient with esophageal cancer.  American Journal of Roentgenology 2005;184:487-490.

Gönen M, Heller G. Concordance probability and discriminatory power in proportional hazards regression. Biometrika, 2005; 92: 965-970.

Gönen M, Johnson WO, Lu T, Westfall PH. The Bayesian two-sample t-test. The American Statistician, 2005; 59: 252-257.

Gönen M. A Bayesian evaluation of enrolling additional patients at the maximum tolerated dose in Phase I trials. Contemporary Clinical Trials, 2005; 26:131-140.

Gönen M. Planning a dose-response study when doses are subject-specific. Statistics in Medicine 2005; 24:2613-2623.

Gross ND, Boyle JO, Morrow JD, Williams MK, Moskowitz CS, Subbaramaiah K, Dannenberg AJ, Duffield-Lillico AJ. Levels of PGE-M, the major urinary metabolite of PGE2, are increased in smokers.  Clinical Cancer Research. 2005;11(16):6087-6093.

Gupta GP, Minn AJ, Kang Y, Siegel PM, Serganova I, Cordon-Cardo C, Olshen AB, Gerald WL, Massague J. Identifying Site–specific Metastasis Genes and Functions. Cold Spring Harbor Symposia Quantitative Biology. 2005; 70:1-10.

Gure AO, Chua R, Williamson B, Gönen M, Ferrera CA, Gnjatic S, Ritter G, Simpson AJG, Chen YT, Old LJ, Altorki NK. Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non-Small Cell Lung Cancer. Clinical Cancer Research 2005;11 8055-8062.

Hale E, Stein J, Ben-Porat L, Panageas KS, Eichenbaum MS, Marghoob AA, Osman I, Kopf AW, Polsky D. Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic nevi–results from the NYU-LCMN registry.  Br J Dermatol 2005; 152: 512-517.

Halpern NA, Pastores SM, Thaler HT, Greenstein RJ, Changes in critical care beds and occupancy in the United States 1985-2000. Differences attributable to hospital size.  Critical Care Medicine (in press).

Hawkins WG, Busam KJ, Ben Porat L, Panageas KS, Coit DG, Gyorki DE, Linehan DC, Brady  MS. Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma. Annals of Surgical Oncology 2005; 12: 207-213.

Hawkins WG, Dematteo RP, Cohen MS, Jarnagin WR, Fong Y, D’Angelica M, Gönen M, Blumgart LH. Caudate hepatectomy for cancer: A single institution experience with 150 patients. Journal of American College of Surgeons. 2005; 200:345-52.

Heller G. Power calculations for preclinical studies using a K-sample rank test and the Lehmann alternative hypothesis.  Statistics in Medicine (in press).

Hensley ML, Correa DD, Thaler H, Wilton A, Venkatraman E, Sabbatini P, Chi D; Dupont J, Spriggs D, Aghajanian C, Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of      advanced –stage ovarian cancer:  pathologic complete response and longitudinal assessment of impact on cognitive functioning. Gynecologic Oncology (in press).

Hillner BE, Schrag D, Sargent DJ, Fuchs CS, Goldberg RM. Cost-effectiveness projections of oxaliplatin and infusional fluorouracil versus irinotecan and bolus fluorouracil in first-line therapy for metastatic colorectal carcinoma.  Cancer. 2005 Sep 21;104(9):1871-84.

Howard MA, Cordeiro P, Disa J, Samson W, Gönen M, Schoelle H, Mehrara B. Free tissue transfer in the elderly: incidence of perioperative complications following microsurgical reconstruction of 197 septuagenarians and octogenarians. Plastic Reconstructive Surgery. 2005 Nov;116(6):1659-68.

Howe LR, Chang S, Tolle KC, Dillon R, Young LJT, Newman RA, Yang P, Thaler HT, Muller WJ, Brown AMC, Hla T, Subbaramaiah K, Dannenberg AJ.  HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in Cox-2-deficient mice.  Cancer Research 2005; 65: 10113-9.

Hsu KC, Keever-Taylor CA, Wilton A, Pinto C, Heller G, Arkun K, O’Reilly RJ, Horowitz MM, Dupont B.  Improved outcome in HLA-identical sibling hematopoietic stem cell transplantation for acute myelogenous leukemia (AML) predicted by KIR and HLA genotypes.  Blood 2005;105:4878-4884.

Huang S, Li Y, Podsypanina K, Chamorro M, Olshen AB, Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice.  Genome Biology. 2005;6(10): R84, Epub 2005 Sep 30.

Hubbard VM, Eng JM, Ramirez-Montagut T, Tjoe KH, Muriglan SJ, Kochman AA, Terwey TH, Willis LM, Schiro R, Heller G, Murphy GF, Liu C, Alpdogan O, VandenBrink MR.  Absence of inducible costimulator on alloreactive T cells reduces graft-versus-host disease and induces Th2 deviation.  Blood 2005 (in press).

Hurria A, Brogan K, Panageas KS, Jakubowski A, Zauderer M, Norton L, Howard J, Hudis C. Change in Cycle 1 to Cycle 2 Hematologic Counts Predicts Toxicity in Older Patients with Breast Cancer Receiving Adjuvant Chemotherapy. Drugs and Aging, 2005; 22(8):709-15.

Hurria A, Gupta S, Zauderer M, Zuckerman E, Cohen HJ, Muss H, Panageas KS, Holland J, Saltz L, Kris MG, Noy A, Gomez J, Rodin M, Jakubowski A, Hudis C, Pearce C, Kornblith A. Developing a Cancer-Specific Geriatric Assessment  (CSGA): A Feasibility Study. Cancer 104(9): 1998-2005.

Hurria A, Hurria A, Brogan K, Panageas KS, Pearce C. Norton L, Jakubowski A, Howard J, Hudis  C, Effect  of creatinine clearance on patterns of toxicity in older patients receiving  adjuvant chemotherapy for breast cancer. Drugs and Aging, 2005; 22(9): 785-91.

Hurria, A, Brogan K, Panageas KS, Pearce C, Norton L,  Jakubowski A, Zauderer M, Howard J,  Hudis C.  Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy.  Breast Cancer Research and Treatment 2005; 92:151-156.

Hwu, WJ, Lis E, Menell JH, Panageas KS, Lamb LA, Merrell J, Williams LJ, Krown SE, Chapman PB, Livingston PO, Wolchok JD, Houghton AN.  Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study.  Cancer 2005; 103:2590-2597.

Indurkhya A, Mitra N, Schrag D.  Impact of propensity scores on estimating the cost-effectiveness of medical therapies.  Statistics in Medicine 2005.

Ioannidis JPA, Bernstein J, Boffetta P, Danesh J, Dolan S, Hartge P, Hunter D, et al. A network of investigator networks in human genome epidemiology. American Journal Epidemiology. 2005 Aug 15;162(4):302-4.

Jarnagin WR, Zager JS, Hezel M, Stanziale SF, Adusumilli PS, Gönen M, Ebright MI, Culliford A, Gusani NJ, Fong Y.Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy. Cancer Gene Therapy. 2005 Sep 2; [Epub ahead of print]

Jimenez RE, Panageas KS, Busam KJ, Brady MS. Prognostic implications of multiple lymphatic basin drainage in patients with truncal melanoma. Journal of Clinical Oncology 2005;23:518-524.

Kamel F, Engel LS, Gladen BC, Hoppin JA, Alavanja MC, Sandler DP.  Neurologic symptoms in licensed private pesticide applicators in the agricultural health study.  Environmental Health Perspectives 2005;113:877-882.

Kang D, Gridley G, Huang WY, Engel LS, Winn DM, Brown LM, Bravo-Otero E, Wu T, Diehl SR, Hayes RB.  Microsatellite polymorphisms in the epidermal growth factor receptor (EGFR) gene and the transforming growth factor-alpha (TGFA) gene and risk of oral cancer in Puerto Rico.  Pharmacogenetics and Genomics 2005;15:343-347.

Kemeny N, Eid A, Stockman J, Gönen M, Schwartz L, Tetzlaff E, Paty P. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma. Journal of Surgical Oncolology. 2005 Jul 18;91(2):97-101.

Kemeny N, Gönen M. Hepatic arterial infusion after liver resection. (Letter)
New England Journal of Medicine. 2005;352:734-5.

Kemeny N, Jarnagin W, Paty P, Gönen M, Schwartz L, Morse M, Leonard G, D’Angelica M, Dematteo R, Blumgart L, Fong Y.  Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. Journal of Clinical Oncology 2005; 23:4888-96.

Kesh S, Mensah NY, Peterlongo P, Jaffe D, Hsu K, van den Brink M, O’Reilly R, Pamer E, Satagopan J, Papanicolaou GA. TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation. Annals of the New York Academy of Sciences 2005; 1062: 95-103.

Kim MJ, Holodny AI, Hou BL, Peck KK, Moskowitz CS, Bogomolny DL, and Gutin PH.  The effect of prior surgery on BOLD fMRI in the pre-operative assessments of brain tumors. American Journal Neuroradiology. 2005 Sep;26(8):1980-5.

Korkola JE, Houldsworth J, Dobrzynski D, Olshen AB, Reuter VE, Bosl GJ, Chaganti RS.  Gene expression-based classification of nonseminomatous male germ cell tumors.  Oncogene 2005 (in press).

Kortmansky J, Shah MA, Kaubisch A, Weyerbacher A, Yi S, Tong W, Sowers R, Gönen M, O’Reilly E, Kemeny N, Ilson DI, Saltz LB, Maki RG, Kelsen DP, Schwartz GK. Phase I Trial of the Cyclin-Dependent Kinase Inhibitor and Protein Kinase C Inhibitor 7-Hydroxystaurosporine in Combination With Fluorouracil in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 2005; 23:1875-1884.

Kraus DH, Gönen M, Mener D, Brown AE, Bilsky MH, Shah JP. A Standardized Regimen of Antibiotics Prevents Infectious Complications in Skull Base Surgery. Laryngoscope. 2005 Aug;115(8):1347-1357.

Krug LM, Miller VA, Patel J, Crapanzano J, Azzoli CG, Gomez J, Kris MG, Heelan RT, Pizzo B, Tyson L, Sheehan C, Ross JS, Venkatraman E.  Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced non-small cell lung carcinoma. Cancer. 2005 Nov 15; 104(10):2149-55.

LaVigne EA, Oliveria SA, Dusza SW, Geller AC, Halpern  AC, Marghoob AA. Clinical and dermoscopic changes in common melanocytic nevi in school children: the Framingham Nevus Study. Dermatology. 2005;211(3):234-9.

Leliser AL, Anderson SE, Nonaka D, Chuai S, Olshen AB, Chi DS, Apoptotic and cell cycle regulatory markers in uterine leiomyosarcomas. Gynecologic Oncology. 2005 Nov 8 [Epub ahead of print].

Liau KH, Ruo L, Shia J, Padela A, Gönen M, Jarnagin WR, Fong Y, D’Angelica MI, Blumgart LH, DeMatteo RP. Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma. Cancer, 2005, [Epub ahead of print].

Lyman S, Jones EC, Bach PB, Peterson MG, Marx RG.  The association between hospital volume and total shoulder arthroplasty outcomes. Clinical Orthopedics and Related Research.

 2005 Mar;(432):132-7.

Maluccio M, Covey AM, Gandhi R, Gönen M, Getrajdman GI, Brody LA, Fong Y, Jarnagin W, D’Angelica M, Blumgart L, Dematteo R, Brown KT. Comparison of Survival Rates after Bland Arterial Embolization and Ablation Versus Surgical Resection for Treating Solitary Hepatocellular Carcinoma up to 7 cm. Journal of Vascular and Interventional Radiology. 2005 Jul;16(7):955-61.

McQuellon, RP, Thaler, HT, Cella, D, Moore, DH. Quality of Life (QOL) Outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer. Gynecology Oncology. (In press).

Members of the Toxicogenomics Research Consortium. Standardizing global gene expression analysis between laboratories and across platforms. Nature Methods 2005, 2:351-356.

Mikhail M, Velasquez  E, Shapiro R,  Berman R, Pavlick A,  Sorhaindo L, Spira J, Mir C, Panageas KS, Polsky D, Osman I.   PTEN Expression in Melanoma: Relationships with Patients’ Survival, Bcl-2 Expression, and Proliferation. Clinical Cancer Research, 2005; 11(14): 5153-5157.

Millikan RC, Hummer A, Begg C, Player J, de Cotret AR, Winkel S, Mohreweiser H, Thomas N, Armstrong B, Kricker A, Marrett LD, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Rebbeck T, Busam K, From L, Mujumdar U, Berwick M.  Polymorphisms in nucleotide excision repair genes and risk of malignant melanoma: the genes environment and melanoma study.  Carcinogenesis, 2005 Oct 29; [Epub ahead of print].

Millikan RC, Hummer AJ, Wolff MS, Hishida A, Begg CB.  HER2 codon 655 polymorphism and breast cancer: results from kin-cohort and case-control analyses.  Breast Cancer Research and Treatment 2005;89:309-312.

Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J.  Genes that mediate breast cancer metastasis to lung. Nature. 2005 Jul 28; 436(7050):518-24.

Modak S, Koehne G, Vickers A, O’Reilly RJ, Cheung NK. Rituximab therapy of lymphoma is enhanced by orally administered (1→3), (1→4)-D-β-glucan. Leukemia Research 2005;29:679–83

Modi S, Currie VE, Seidman AD, Bach AM, Panageas KS, Theodoulou M, Moasser MM, D’Andrea GM, Lake DE, Choi J, Norton L, Hudis CA.  A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane.  Clinical Breast Cancer 2005; 6:55-60.

Modi S, DiGiovanna MP, Lu Z, Moskowitz C, Panageas KS, VanPoznak C, Hudis CA, Norton L, Tan  L, Stern DF, Carter D, Seidman AD. Phosphorylated/activated HER2 as a marker of clinical resistance to single agent taxane chemotherapy for metastatic breast cancer. Cancer Investigations, 2005; 2396):483-487.

Modi S, Seidman AD, Dickler M, Moasser M, D’Andrea G, Moynahan ME, Menell J, Panageas KS, Tan L, Hudis CA.  A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer. Breast Cancer Research and Treatment 2005; 90:157-163.

Morris MJ, Akhurst T, Larson SM, Ditullio M, Chu E, Siedlecki K, Verbel D, Heller G, Kelly WK, Slovin S, Schwartz L, Scher HI.  Flurodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy.  Clinical Cancer Research 2005;11:3210-3216.

Moskowitz CH, Zelenetz AD, Kewalramani T, Hamlin P, Lessac-Chenen S, Houldworth J, Olshen A, Chaganti R, Nimer S. Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed an refractor DLBCL. Blood. 2005 Nov 15;106(10);3383-5. Epub 2005 Aug 2005.

Mourton SM, Chi DS, Sonoda Y, Alektiar KM, Venkatraman ES, Barakat RR, Abu-Rustum NR. Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies. Gynecologic Oncology. 2005 Oct 13; [Epub ahead of print]

Mullerad M, Eisenberg DP, Akhurst TJ, Adusumilli PS, Riedl CC, Bhargava A, Gönen M, Finn R, Scardino PT, Fong Y. Use of Positron Emission Tomography to Target Prostate Cancer Gene Therapy by Oncolytic Herpes Simplex Virus. Molecular Imaging and Biology. 2005 Dec 16;:1-6 [Epub ahead of print]

Olshen AB, Cosman PC, Rodrigo AG, Bickel PJ, Olshen RA.  Vector quantization of amino acids: analysis of the HIV V3 loop region. Journal of Statistical Planning and Inference 2005 March 1;(1-2):277-298.

Olson SH, Iyer S, Scott J, Erez O, Samuel S, Markovits T, Schwartz M, Toro C, Lau N, Gambarin-Gelwan M, Kurtz RC. Cancer history and other personal factors affect quality of life in patients with hepatitis C.   Health Quality of Life Outcomes 2005;3:39.

Omuro AMP, Ben-Porat LS, Panageas KS, Kim AK, Correa DD, Yahalom J, DeAngelis LM, Abrey LE. Delayed neurotoxicity in primary central nervous system lymphoma Archives of Neurology, 2005;62:1595-1600.

Orlow I, Berwick M, Hummer A, Begg CB. Absence of Association of CDKN2A Ala148Thr with Breast Cancer. Journal  Medical  Genetics (e-letter) July 4th 2005

Panageas KS, Elkin EB, DeAngelis LM, Ben Porat L, Abrey LE.  Trends in survival from Primary Central Nervous System Lymphoma 1975-1999: a population-based analysis.  Cancer, 2005; 104:2466-2472.

Patel MI, Subbaramaiah K, Du B, Chang M, Yang P, Newman RA, Cordon-Cardo C, Thaler HT, Dannenberg AJ.  Celecoxib inhibits prostate cancer growth.  Evidence of a COX-2 independent mechanism. Clinical Cancer Research 2005; 11:1999-2007.

Pham HH, Schrag D, Hargraves JL, Bach PB. Delivery of preventive services to older adults

by primary care physicians. Journal of the American Medical Association 2005 Jul 27;294

(4):473-81.

Phelan DL, Oliveria SA, Halpern AC.  Patient experiences with photo books in monthly skin self-examinations.  Dermatology Nursing 2005;17:109-114.

Pinto JT, Van Raamsdonk J, Leavitt BR, Hayden MR, Thaler HT, Krasnikov BF, Cooper AJL.  Treatment of YAC128 mice and their wild-type litter mates with cystamine does not lead to its accumulation in plasma or brain: implications for the treatment of Huntington disease.  Journal of Neurochemistry.  2005; 94:1087-101.

Pucar D, Shukla-Dave A, Hricak H, Moskowitz CS, Kuroiwa K, Olgac S, Ebora L, Scardino PT, Koutcher JA, Zakien KL.  Correlation of MR imaging and spectroscopy with step section histopathology in prostate cancer after external beam radiation therapy –initial exploratory analysis. Radiology. 2005 Aug; 236(2):545-53.

Raizer JJ, Koutcher JA, Abrey LA, Panageas KS, DeAngelis LM, Lis E, Xu S, Zakian K.  Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma. Journal of Neurooncology 2005; 71:173-180.

Reid ME, Duffield-Lillico AJ, Sunga A, Alberts DS, Marshall JR. Selenium supplementation and colorectal adenomas: an analysis of the Nutritional Prevention of Cancer Trial.  International Journal of Cancer, 2006;118(7):1777-81.

Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH, Chapman PB.  Variates of survival in metastatic uveal melanoma.  Journal of Clinical Oncology, 2005; 23(31):8076- 8080.

Robbins RJ, Wan Q, Grewal RK, Reibke R, Gönen M, Strauss HW, Tuttle RM, Drucker W, Larson SM. Real-time Prognosis for Metastatic Thyroid Carcinoma Based on FDG-PET Scanning. Journal of Clinical Endocrinology and Metabolism. 2005 Nov 22; [Epub ahead of print]

Saranchuk JW, Kattan MW, Elkin E, Touijer AK, Scardino PT, Eastham JA.  Achieving optimal outcomes after radical prostatectomy.  Journal of Clinical Oncology 2005;23:4146-4151.

Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C, Kepner J, Odunsi T, Ritter G, Lele S, Chen Y-T, Ohtani H, Old LJ, Odunsi K. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proceedings of National Academy of Sciences 2005;102:18538-43.

Schoder H, Hermann K, Gönen M, Hricak H, Eberhard S, Scardino P, Scher H, Larson SM. 2-[18F] fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy. Clinical Cancer Research. 2005 Jul 1;11:4761-9.

Schoder H, Noy A, Gönen M, Weng L, Green D, Erdi YE, Larson SM, Yeung HW. Intensity of 18Fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive Non-Hodgkin’s Lymphoma. Journal of Clinical Oncology. 2005 Apr 18; [Epub ahead of print]

Schrag D, Chung KY, Flombaum C, Saltz L.  Cetuximab therapy and symptomatic hypomagnesemia.  Journal of National Cancer Institute 2005;97:1221-4.

Dohan D, Schrag D.  Using navigators to improve care of underserved patients.  Cancer 2005;10:848-55.

Schrag D, Mitra N, Xu F, Rabbani F, Bach PB, Herr H, Begg CB.  Cystectomy for muscle-invasive bladder cancer: Patterns and outcomes of care in the medicare population.  Urology 2005;65:1118-1125.

Schrag D, Weiser M, Schattner M, Shia J, Akhurst T.  An increasingly common challenge: management of the complete responder with multi-focal metastatic colorectal cancer.  Journal of Clinical Oncology 2005;23:1799-1802.

 Schrag D.  Discussing drug costs with patients.  Clinical Advances in Hematology Oncology 2005;3:525-6.

Secin FP, Karanikolas N, Kuroiwa K, Vickers A, Touijer K, Guillonneau B. positive surgical margins and accessory pudendal artery preservation during laparoscopic radical prostatectomy. European Urology. 2005; 48(5):786-92

Secin FP, Karanikolas N, Touijer AK, Salamanca JI, Heller G. Power Calculations for Preclinical Studies using a K-sample rank test and the Lehmann Alternative Hypothesis.  Statistics in Medicine (in press).

Sen S, Satagopan JM, Churchill GA. Quantitative trait locus study design from an information perspective.  Genetics 2005;170:447-464.

Shaffer DR, Viale A, Ishiwata R, Leversha M, Olgac S, Manova K, Satagopan J, Scher H, Koff A. Evidence for a p27 tumor suppressive function independent of its role regulating cell proliferation in the prostate. Proceedings of the National Academy of Sciences 2005;102:210-215.

Shah MA, Kemeny N, Hummer A, Drobnjak M, Motwani M, Cordon-Cardo C,  Gönen M, Schwartz GK. Drg1 Expression in 131 Colorectal Liver Metastases: Correlation with Clinical Variables and Patient Outcomes. Clinical Cancer Research 2005 11: 3296-3302.

Shah MA, Kortmansky J, Motwani M, Drobnjak M, Gönen M, Yi S, Weyerbacher A, Cordon-Cardo C, Lefkowitz R, Brenner B, O’Reilly E, Saltz L, Tong W, Kelsen DP, Schwartz GK. A Phase I Clinical Trial of the Sequential Combination of Irinotecan Followed by Flavopiridol. Clinical Cancer Research 2005; 11:3836-3845.

Solomon SD, McMurray JJV, Pfeffer MA, Wittes J, FowlerR, FinnP, Anderson WF, Zauber A, Hawk E,  Bertagnolli M.  Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.  New Engand Journal of Medicine 2005;352:1071-1080.

Spanknebel K, Coit DG, Bieligk SC, Gönen M, Rosai J, Klimstra DS. Characterization of Micrometastatic Disease in Melanoma Sentinel Lymph Nodes by Enhanced Pathology: Recommendations for Standardizing Pathologic Analysis. American Journal of Surgical Pathology. 2005;29:305-317.

Specht, Kattan MW, Gönen M, Fey J, VanZee KJ. Predicting Nonsentinel Node Status After Positive Sentinel Lymph Biopsy for Breast Cancer: Clinicians Versus Nomogram. Annuls of Surgical Oncology. 2005; 12:654-659.

Stephenson AJ, Smith A, Kattan MW, Satagopan J, Reuter VE, Scardino PT, Gerald WL. Integration of gene expression profiling and clinical variables to predict prostate cancer recurrence after radical prostatectomy. Cancer 2005;104:290-298.

Stier E, Freeman-Wang T, Hochberg L, Hummer A, Venkatraman E, Walker P.  Using the cone biopsy to compare colposcopy clinics in New York and London.  Journal of Lower Genital Tract Disease 2005;2:106-111.

Tao Y, Klause A, Vickers A, Bae K, Ellis M. Clinical and Biomarker Endpoint Analysis in Neoadjuvant Endocrine Therapy Trials. Journal of Steroid Biochemistry and Molecular Biology 2005; 95:91-5.

Temple LK, Bacik J, Savatta SG, Gottesman L, Paty PB, Weiser MR, Guillem JG, Minsky BD, Kalman M, Thaler HT, Schrag D, Wong WD.  The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer.  Diseases of the Colon and Rectum 2005;48:1353-1365.

Ulbricht C, Basch E, Boon H, Ernst E, Hammerness P, Sollars D, Tsourounis C, Woods J, Bent S.  Safety review of kava (Piper methysticum) by the Natural Standard Research Collaboration. Expert Opinion on Drug Safety. 2005 Jul;4(4):779-94.

Vecchio FM, Valentini V, Minsky BD, Padula GD, Venkatraman ES, Balducci M, Micciche F, Ricci R, Morganti AG, Gambacorta MA, Maurizi F, Coco C.  The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.  International Journal of Radiation Oncology, Biology, Physics 2005:62:752-760.

Vickers AJ, Bianco FJ, Boorjian S, Scardino P, Eastham JA. Does delay between diagnosis and radical prostatectomy increase the risk of cancer recurrence? Cancer 2005 [Epub ahead of print]

Vickers AJ, Feinstein MB, Deng GE, Cassileth BR Acupuncture for dyspnea in advanced cancer: a randomized, placebo-controlled pilot trial (ISRCTN89462491). BiomedCentral Palliative Medicine 2005;4(1):5

Vickers AJ. Analysis of variance is easily misapplied in the analysis of randomized trials: a critique and discussion of alternative statistical approaches. Psychosomatic Medicine 2005;67:652-5

Vickers AJ. How to interpret data from randomized trials. The Scandinavian prostatectomy study illustrates two common errors. Nature Clinical Practice Urology 2005;9:2-3

Vickers AJ. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data. BiomedCentral Medical Research Methodology 2005;5:35

Vural B, Chen LC, Saip P, Chen YT, Ustuner Z, Gönen M, Simpson AJ, Old LJ, Ozbek U, Gure AO. Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters. Cancer. 2005 May 4; [Epub ahead of print]

Yanke BV, Gönen M, Scardino PT, Kattan MW. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer. Journal of Urology. 2005, 173:421-424.

Yeung HW, Schoder H, Smith A, Gönen M, Larson SM. Clinical Value of Combined PET/CT Imaging in the Interpretation of FDG PET Studies in Cancer Patients. Molecular Imaging and Biology. 2005 7(3):229-35

Yuan J, Latouche JB, Reagan JL, Heller G, Riviere I, Sadelain M, Young JW.  Langerhans cells derived from genetically modified human CD34+ hemopoietic progenitors are more potent than peptide-pulsed Langerhans cells for inducing antigen-specific CD8+ cytolytic T lymphocyte responses.  Journal of Immunology. 2005;174:758-66.

Zakian K, Thaler HT, Fong Y, Koutcher J.  Liver regeneration in man is characterized by significant changes in cellular phosphorous metabolism: assessment using proton-decoupled 31P – magnetic resonance spectroscopic imaging.  Magnetic Resonance in Medicine. 2005; 54:264-71.

Zauber NP, Sabbath-Solitare M, Marotta S, Zauber AG, Foulkes W, Chan M, Turner F, Bishop DT. Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms. Cancer 2005, 2005 Aug 15;104(4):719-29.

Zelefsky MJ, Ben-Porat L, Scher HI, Chan HM, Fearn PA, Fuks ZY, Leibel SA, Venkatraman ES.  Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer.  Journal of Clinical Oncology 2005;23:826-831.

Zhao B, Schwartz LH, Moskowitz CS, Wang L, Ginsberg MS, Cooper CA, and Kalagian JP.  Pulmonary metastases: effect of CT section thickness on measurement-initial experience. Radiology 2005;234:934-939.

Adusumilli PS, Ben-Porat L, Pereira M, Roesler D, Leitman IM: The prevalence and predictors of herbal medicine use in surgical patients. Journal of American College of Surgeons 2004;198:583-590.

Alonzo TA, Braun TM, Moskowitz CS.  Small sample estimation of relative accuracy for binary tests.  Statistics in Medicine 2004;23:21-34.

Amar D, Shi W, Hogue CW Jr, Zhang H, Passman RS, Thomas B, Bach, PB, Damiano R, Thaler HT.  Clinical prediction rule for atrial fibrillation after coronary artery bypass grafting. Journal of American College of Cardiology 2004;44:1248-1253.

Antonescu CR, Viale A, Sarran L, Tschernyausky SJ, Gonen M, Segal NH, Maki RG, Socci ND, DeMatteo RP, Besmer P: Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site. Clinical Cancer Research 2004;10:3282-3290.

Araten DJ, Thaler HT, Luzzatto L.  High incidence of thrombosis in African-American and Latin-American patients with paroxysmal nocturnal hemoglobinuria.  Thrombosis and Haemostasis (in press).

Bach PB, Elkin EB, Pastorino U, Kattan MW, Mushlin AI, Begg CB, Parkin DM: Benchmarking lung cancer mortality rates in current and former smokers. Chest 2004;126:1742-1749.

Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL: Primary care physicians who treat blacks and whites. New England Journal of Medicine 2004;351:575-584.

Bach PB, Schrag D, Begg CB. Resurrecting treatment histories of dead patients: a study design that should be laid to rest. Journal of the American Medical Association 2004;292:2765-2770.

Bacik J, Mazumdar M, Murphy BA, Fairclough DL, Eremenco S, Mariani T, Motzer RJ, Cella D: The functional assessment of cancer therapy-BRM (FACT-BRM): a new tool for the assessment of quality of life in patients treated with biologic response modifiers.  Quality of Life Research 2004;13:137-154.

Basch EM, Thaler HT, Shi W, Yakren S, Schrag D: Use of information resources by patients with cancer and their companions. Cancer 2004;100:2476-2483.

Begg CB, Hummer A, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Klotz JB, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Berwick MR: Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control 2004;15:957-965.

Benson AB, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van Cutsem E, Brouwers M, Charette M and Haller DG.  American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.  Journal of Clinical Oncology 2004;22:3408-19.

Bernick PE, Klimstra DS, Shia J, Minsky B, Saltz L, Shi W, Thaler H, Guillem J, Paty P, Cohen AM, Wong WD.  Neuroendocrine Carcinomas of the Colon and Rectum.  Neuroendocrine carcinomas of the colon and rectum.  Diseases of the Colon and Rectum 2004;47:163-9.

Bernstein JL, Langholz B, Haile RW, Bernstein L, Thomas DC, Stovall M, Malone KE, Lynch CF, Olsen JH, Anton-Culver H, Shore RE, Boice JD Jr., Berkowitz GS, Gatti RA, Teitelbaum SL, Smith SA, Rosenstein BS, Borresen-Dale AL, Concannon P. Thompson WD, Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Breast Cancer Research and Treatment 2004;6:R199-214.

Berwick M, Matullo G, Song YS, Guarrera S, Dominguez G, Orlow I, Walker M, Vineis P: Association between aryl hydrocarbon receptor genotype and survival in soft tissue sarcoma. Journal of Clinical Oncology 2004;22:3997-4001.

Berwick M, Orlow I, Mahabir S, Myskowski P, Coit D, Brady MS, Roy P, Song Y, Canchola R, Barz A, Halpern A, Bolognia J, Eng S, Elahi A, Begg CB: Estimating the relative risk of developing melanoma in INK4A carriers. European Journal of Cancer Prevention 2004;13:65-70.

Bhargava R, Shia J, Hummer AJ, Thaler HT, Tornos C, Soslow RA.  Distinction of endometrial stromal sarcomas from ‘hemangiopericytomatous’ tumors using a panel of immunohistochemical stains.  Modern Pathology (in press).

Brooks DR, Austin JHM, Heelan R, Ginsberg M, Shin V, Olson SH, Muscat JE, Stellman SD. Peripheral versus central lung cancer: influence of type of cigarette. Cancer Epidemiology, Biomarkers and Prevention (in press).

Brenner B, Ilson DH, Minsky BD, Bains MS, Tong W, Gonen M, Kelsen DP: Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy. Journal of Clinical Oncology 2004;22:45-52.

Brenner B, Shah MA, Gonen M, Klimstra DS, Shia J, Kelsen DP: Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases. British Journal of Cancer 2004;90:1720-1726.

Brownstein CM, Mertens AC, Mitby PA, Stovall M, Qin J, Heller G, Robison LL, Sklar CA: Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study. Journal of Clinical Endocrinology and Metabolism 2004;89:4422-4427.

Busam KJ, Mujumdar U, Hummer AJ, Nobrega J, Hawkins WG, Coit DG, Brady MS: Cutaneous desmoplastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors. American Journal of Surgical Pathology 2004;28:1518-1525.

Cai T Moskowitz CS: Semi-parametric estimation of the binormal ROC curve for a continuous diagnostic test. Biostatistics 2004;5:573-586.

Carlo WF, Hummer AJ, Schwartz L, Sullivan D, Gonen M, Jarnagin W, Fong Y, Kemeny N:  Extent of hepatic resection does not correlate with toxicity following adjuvant chemotherapy. Journal of Surgical Oncology 2004;87:85-90.

Cassileth BR, Vickers AJ. Massage therapy for symptom control: Outcome study at a major cancer center. Journal of Pain and Symptom Management 2004;28:244-9.

Cassileth BR, Vickers AJ. Complementary therapy. In: Prostate Cancer. Ed by P Carroll and A D’Amico. New York: Lippincott, Williams and Wilkins 2004

Cassileth BR, Vickers AJ. High prevalence of complementary and alternative medicine use among cancer patients: implications for research and clinical care (editorial). Journal of Clinical Oncology (in press).

Cesaretti JA, Stock RG, Lehrer S, Atencio DA, Bernstein JL, Stone NN, Wallenstein S, Green S, Loeb K, Kollmeier M, Smith M, Rosenstein BS.  ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer.  International Journal of Radiation Oncology Biology Physics (in press).

Cestari DM, Weine DM, Panageas KS, Segal AZ, DeAngelis LM: Stroke in patients with cancer: incidence and etiology. Neurology 2004;62:2025-2030.

Chadalavada RSV, Houldsworth J, Olshen AB, Bosl G, Studer L, Chaganti RSK. Transcriptional program of bone morphogenetic protein-2-induced epithelial and smooth muscle differentiation of pluripotent human embryonal carcinoma cells.  Functional and Integrative Genomics (in press).

Chang DZ, Panageas KS, Osman I, Polsky D, Busam K, Chapman PB: Clinical significance of BRAF mutations in metastatic melanoma. Journal of Translational Medicine 2004;2:46.

Chang VT, Hwang SS, Kasimis B, Thaler HT.  Shorter symptom assessment instruments: the condensed Memorial symptom assessment scale (CMSAS).  Cancer Investigation 2004;22:526-53.

Chang VT, Hwang SS, Thaler HT, Kasimis B, Portenoy RK.  The Memorial symptom assessment scale.  Expert Review of Pharmacoeconomics and Outcomes Research 2004;4:171-178.

Chi DS, Abu-Rustum NR, Sonoda Y, Awtrey C, Hummer A, Venkatraman ES, Franklin CC, Hamilton F, Gemignani ML, Barakat RR: Ten-year experience with laparoscopy on a gynecologic oncology service: analysis of risk factors for complications and conversion to laparotomy. American Journal of Obstetrics and Gynecology  2004;191:1138-1145.

Chi SN, Conklin LS, Qin J, Meyers PA, Huvos AG, Healey JH, Gorlick R: The patterns of relapse in osteosarcoma: the Memorial Sloan-Kettering experience. Pediatric Blood Cancer 2004;42:46-51.

Christos PJ, Oliveria SA, Masse LC, McCormick LK, Halpern AC: Skin cancer prevention and detection by nurses: attitudes, perceptions, and barriers. Journal of Cancer Education 2004;19:50-57.

Correa DD, DeAngelis LM, Shi W, Thaler H, Glass A, Abrey LE: Cognitive functions in survivors of primary central nervous system lymphoma. Neurology 2004;62:548-555.

Couedel C, Mills KD, Barchi M, Shen L, Olshen A, Johnson RD, Nussenzweig A, Essers J, Kanaar R, Li GC, Alt FW, Jasin M: Collaboration of homologous recombination and nonhomologous end-joining factors for the survival and integrity of mice and cells.  Genes and Development 2004;18:1293-1304.

Covey AM, Gandhi R, Brody LA, Getrajdman G, Thaler HT, Brown KT:  Factors associated with pneumothorax and pneumothorax requiring treatment after percutaneous lung biopsy in 443 consecutive patients. Journal of Vascular and Interventional Radiology 2004;15:479-483.

D’Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS: Patterns of initial recurrence in completely resected gastric adenocarcinoma. Annals of Surgery 2004;240:808-816.

Dang CT, D’Andrea GM, Moynahan ME, Dickler MN, Seidman AD, Fornier M, Robson ME, Theodoulou M, Lake D, Currie VE, Hurria A, Panageas KS, Norton L, Hudis CA: Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer. Clinical Cancer Research 2004;10:5754-5761.

Dang CT, Dannenberg AJ, Subbaramaiah K, Dickler MN, Moasser MM, Seidman AD, D’Andrea GM, Theodoulou M, Panageas KS, Norton L, Hudis CA: Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatments. Clinical Cancer Research 2004;10:4062-4067.

Darvishian F, Hummer AJ, Thaler HT, Bhargava R, Linkov I, Asher M, Soslow RA: Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases.  American Journal of Surgical Pathology 2004;28:1568-1578.

Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S, Rusch V:  Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. Journal of Clinical Oncology 2004;22:3255-3260.

Duffield-Lillico AJ, Begg CB: Reflections on the landmark studies of beta-carotene supplementation. Journal of the National Cancer Institute 2004;96:1729-1731.

Duffield-Lillico AJ, Shureiqi I, Lippman SM. Can selenium prevent colorectal cancer? A signpost from epidemiology. Journal of the National Cancer Institute 2004;96:1645-1647.

Dupont J, Wang X, Marchall DS, Leitao M, Hedvat CV, Hummer A, Thaler H, O’Reilly RJ, Soslow R.  Wilms tumor gene (WT1) and p53 expression in ovarian and endometrial carcinomas: a study of 217 cases using tissue microarrays.  Gynecologic Oncology 2004;94:449-455.

Dupont J, Tanwar MK, Thaler HT, Fleisher M, Kauff N, Hensley ML, Sabbatini P, Anderson S, Aghajanian C, Holland EC, Spriggs DR: Early detection and prognosis of ovarian cancer using serum YKL-40. Journal of Clinical Oncology 2004;22:3330-3339.

Dusza SW, Oliveria SA, Geller AC, Marghoob AA, Halpern AC.  Student/parent agreement in self-reported sun behaviors.  Journal of the American Acadey of Dermatology (in press).

Eilber FC, Eilber FR, Eckardt J, Rosen G, Riedel E, Maki RG, Brennan MF, Singer S: The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma. Annals of Surgery 2004;240:686-695; discussion 695-697.

Elkin EB, Cowen ME, Cahill D, Steffel M, Kattan MW: Preference assessment method affects decision-analytic recommendations: a prostate cancer treatment example.  Medical Decision Making 2004;24:504-510.

Elkin EB, Weinstein MC, Winer EP, Kuntz KM, Schnitt SJ, Weeks JC: HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis.  Journal of Clinical Oncology 2004;22:854-863.

Engel LS, Hill DA, Hoppin JA, Lubin JH, Lynch CF, Pierce J, Samanic C, Sandler DP, Blair A, Alavanja MC. Pesticide use and breast cancer risk among farmers’ wives in the Agricultural Health Study. American Journal of Epidemiology (in press)

Ferguson SE, Olshen AB, Viale A, Awtrey CS, Barakat RR, Boyd J: Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma. Gynecologic Oncology 2004;92:719-725.

Ferguson SE, Olshen AB, Viale A, Barakat RR, Boyd J.  Stratification of intermediate-risk endometrial cancer patients into groups at high or low risk for recurrence based on tumor gene expression profiling.  Clinical Cancer Research (in press).

Fretts RC, Elkin EB, Myers ER, Heffner LJ: Should older women have antepartum testing to prevent unexplained stillbirth? Obstetrics and Gynecology 2004;104:56-64.

Funt SA, Hricak H, Abu-Rustum N, Mazumdar M, Felderman H, Chi DS: Role of CT in the management of recurrent ovarian cancer. American Journal of Roentgenology 2004;182:393-398.

Geller AC, O’Riordan DL, Oliveria SA, Valvo S, Teich M, Halpern AC: Overcoming obstacles to skin cancer examinations and prevention counseling for high-risk patients: results of a national survey of primary care physicians. Journal of the American Board of Family Practice 2004;17:416-423.

Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H, Chen M, Lippert R, Halldorsson BV, Woodworth B, White T, Clark AG, Parl FF, Broder S, Dean M, Offit K: Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Research 2004;64:8891-8900.

Gollub MJ, Lefkowitz R, Moskowitz CS, Ilson D, Kelsen D, Felderman H.  Pelvic CT in patient with esophageal cancer – is it worthwhile?  American Journal of Roentgenology (in press).

Gonen M: Sample size and power for McNemar’s test with clustered data.  Statistical Methods in Medical Research 2004;23:2283-2294.

Gönen M. A Bayesian evaluation of enrolling additional patients at the maximum tolerated dose in Phase I trials. Controlled Clinical Trials (in press).

Gonen M.  Planning a dose-response study with subject-specific doses.  Statistics in Medicine (in press).

Grobmyer SR, Maki RG, Demetri GD, Mazumdar M, Riedel E, Brennan MF, Singer S: Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Annals of Oncology 2004;15:1667-1672.

Guillem JG, Moore HG, Akhurst T, Klimstra DS, Ruo L, Mazumdar M, Minsky BD, Saltz L, Wong WD, Larson S: Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. Journal of American College of Surgeons 2004;199:1-7.

Hafron J, Mitra N, Dalbagni G, Bochner B, Herr H, Donat SM.  Does body mass index (BMI) affect survival in patients undergoing radical or partial cystectomy for bladder cancer?  Journal of Urology (in press).

Hale E, Stein J, Ben-Porat L, Panageas KS, Eichenbaum MS, Marghoob AA, Osman I, Kopf AW, Polsky D. Association of Melanoma and Neurocutaneous Melanocytosis with Large Congenital Melanocytic Nevi – Results from the NYU-LCMN Registry.  Archives of Dermatology (in press).

Hawkins WG, DeMatteo RP, Jarnagin WR, Ben-Porat L, Blumgart LH, Fong Y: Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Annals of Surgical Oncology 2004;11:310-315.

Hawkins WG, Busam KJ, Ben-Porat L, Panageas KS, Eichenbaum MS, Marghoob AA, Osman I, Kopf AW, Polsky D.  Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic nevi – results from the NYU-LCMN Registry.  Archives of Dermatology (in press).

Heller G: Incorporating follow-up time in M-estimation for survival data.  Lifetime Data Analysis 2004;10:51-64.

Heller G, Venkatraman ES. A nonparametric test to compare survival distributions with covariate adjustment. Journal of the Royal Statistical Society, Series B 2004; 66 719-733.

Hershman D, Jacobson S, McBride R, Mitra N, Sundararajan V, Grann VR, Neugut AI. Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer. Gynecologic Oncology 2004;94: 540-549.

Holzbeierlein J, Lal P, LaTulippe E, Smith A, Satagopan J, Zhang L, Ryan C, Smith S, Scher H, Scardino P, Reuter V, Gerald WL: Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. American Journal of Pathology 2004;164:217-227.

Hong L, Alektiar KM, Hunt M, Venkatraman E, Leibel SA.  Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.  International Journal of Radiation Oncology Biology Physics 2004;59:752-759.

Houldsworth J, Olshen AB, Cattoretti G, Donnelly GB, Teruya-Feldstein J, Qin J, Palanisamy N, Shen Y, Dyomina K, Petlakh M, Pan Q, Zelenetz AD, Dalla-Favera R, Chaganti RS: Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas. Blood. 2004;103:1862-1868.

Hricak H, Wang L, Wei DC, Coakley FV, Akin O, Reuter VE, Gonen M, Kattan MW, Onyebuchi CN, Scardino PT:  The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy. Cancer 2004;100: 2655-2663.

Huang HY, Lal P, Qin J, Brennan MF, Antonescu CR: Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems. Human Pathology 2004;35:612-621.

Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ, Deykin A, Fagan JK, Fahy JV, Fish J, Kraft M, Kunselman SJ, Lazarus SC, Lemanske RF Jr., Liggett SB, Martin RJ, Mitra N, Peters SP, Silverman E, Sorkness CA, Szefler SJ, Wechsler ME, Weiss ST, Drazen JM, National Heart, Lung and Blood Institute’s Asthma Clinical Research Network: Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomized, placebo-controlled cross-over trial Lancet 2004;364:1505-1512.

Janetzki S, Schaed S, Blachere NE, Ben-Porat L, Houghton AN, Panageas KS: Evaluation of elispot assays: influence of method and operator on variability of results.  Journal of Immunological Methods 2004;291:175-183.

Jimenez RE, Panageas KS, Busam KJ, Brady MS.  Prognostic implications of multiple lymphatic basin drainage in patients with truncal melanoma.  Journal of Clinical Oncology (in press).

Kalish RB, McCullough L, Gupta M, Thaler HT, Chervenak FA.  Intrapartum elective cesarean delivery: A previously unrecognized clinical entity. Obstetrics and Gynecology 2004;103:1137-1141

Kalish RB, Thaler HT, Chasen ST, Gupta M, Berman SJ, Rosenwaks Z, Chevenak FA: First- and second-trimester ultrasound assessment of gestational age. American Journal of Obstetrics and Gynecology 2004;191:975-978.

Kattan MW, Giri D, Panageas KS, Hummer A, Cranor M, Van Zee KJ, Hudis CA, Norton L, Borgen PI, Tan LK: A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy. Cancer 2004;101:2509-2515.

Kattan MW, Vickers AJ. Incorporating predictions of individual patient risk in clinical trials. Urologic Oncology 2004;22(4):348-52.

Kewalramani T, Zelenetz AD, Nimer SD, Portlock C, Straus D, Noy A, O’Connor O, Filippa DA, Teruya-Feldstein J, Gencarelli A, Qin J, Waxman A, Yahalom J, Moskowitz CH: Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma. Blood 2004;103:3684-3688.

Kim MJ, Holodny AI, Hou BL, Peck KK, Moskowitz CS, Bogomolny DL, and Gutin  PH.  The effect of prior surgery on BOLD fMRI in the pre-operative assessments of brain tumors. American Journal of Neuroradiology (in press).

King TA, Gemignani ML, Li W, Giri DD, Panageas KS, Bogomolniy F, Arroyo C, Olvera N, Robson ME, Offit K, Borgen PI, Boyd J: Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancers. Cancer Research 2004;64:5051-5053.

Kirchhoff T, Satagopan JM, Kauff ND, Huang H, Kolachana P, Palmer C, Rapaport H, Nafa K, Ellis NA, Offit K: Frequency of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish patients with colorectal cancer. Journal of the National Cancer Institute 2004;96:68-70.

Kirchhoff T, Kauff ND, Mitra N, Nafa K, Huang H, Palmer C, Gulati T, Wadsworth E, Donat S, Robson ME, Ellis N, Offit K. “BRCA Mutations and Risk of Prostate Cancer in Ashkenazi Jews”. Clinical Cancer Research 2004;10:2918-2921.

Kondagunta GV, Bacik J, Schwartz L, Sheinfeld J, Bajorin D, Vuky J, Marion S, Mazumdar M, Bosl GJ, Motzer RJ: Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors. Investigational New Drugs. 2004;22:177-179.

Kondagunta GV, Drucker B, Schwartz L, Bacik J, Marion S, Russo P, Mazumdar M, Motzer RJ: Phase II trial of bortezomib for patients with advanced renal cell carcinoma. Journal of Clinical Oncology 2004;22:3720-3725.

Kondagunta GV, Sheinfeld J, Mazumdar M, Marianai TV, Bajorin D, Bacik J, Bosl GJ, Motzer RJ: Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy. Journal of Clinical Oncology 2004;22:464-467.

Koul S, McKiernan JM, Narayan G, Houldsworth J, Bacik J, Dobrzynski DL, Assaad AM, Mansukhani M, Reuter VE, Bosl GJ, Chaganti RS, Murty VV: Role of promoter hypermethylation in cisplatin treatment response of male germ cell tumors. Molecular Cancer 2004;3:16.

La Quaglia MP, Kushner BH, Su W, Heller G, Kramer K, Abramson S, Rosen N, Wolden S, Cheung NK.  The impact of gross total resection on local control and survival in high-risk neuroblastoma.  Journal of Pediatric Surgery 2004;39:412-417.

Lassman AB, Dai C, Fuller GN, Vickers A, Holland EC. Overexpression of c-Myc promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice. Neuron Glia Biology (in press).

LaVigne EA, Oliveria SA, Dusza SW, Geller AC, Halpern AC, Marghoob AA.  Clinical and dermoscopic changes in common melanocytic nevi in school children: the Framingham Nevus Study.  Dermatology (in press).

Leitao MM Jr, Boyd J, Hummer A, Olvera N, Arroyo CD, Venkatraman E, Baergen RN, Dizon DS, Barakat RR, Soslow RA. Clinicopathologic analysis of early-stage sporadic ovarian carcinoma. American Journal of Surgical Pathology 2004;28:147-59.

Leitao MM, Soslow RA, Nonaka D, Olshen AB, Aghajanian C, Sabbatini P, Dupont J, Hensley M, Sonoda Y, Barakat RR, Anderson S:Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer 2004;101:1455-1462.

Loeve F, Boer R, Zauber AG, Van Ballegooijen M, Van Oortmarssen GJ, Winawer SJ, Habbema JD: National Polyp Study data: evidence for regression of adenomas. International Journal of Cancer 2004;111:633-639.

Marghoob AA, Dusza S, Oliveria S, Halpern AC: Number of satellite nevi as a correlate for neurocutaneous melanocytosis in patients with large congenital melanocytic nevi.  Archives of Dermatology 2004;140:171-175.

Marshall JR, Reid ME, Duffield-Lillico AJ. RESPONSE: Re: Selenium supplementation and the secondary prevention of non-melanoma skin cancer in a randomized trial.   Journal of the National Cancer Institute 2004;96:333-334.

Mazumdar M, Smith A, Schwartz LH: A statistical simulation study finds discordance between WHO criteria and RECIST guideline. Journal of Clinical Epidemiology 2004;57:358-365.

Mazumdar M: Group sequential design for comparative diagnostic accuracy studies: implications and guidelines for practitioners. Medical Decision Making 2004;24:525-533.

Meyerhardt JA, Tepper JE, NiedzwieckiD , Hollis DR, Schrag D, Ayanian JZ, O’Connell MJ,  Weeks JC, Mayer RK, Willett CG, MacDonald JS, Benson AB, and Fuchs CS.  Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.  Journal of Clinical Oncology 2004;22:166-74.

Miller VA, Kris MG, Shah N, Patel J, Azzoli C, Gomez J, Krug LM, Pao W, Rizvi N, Pizzo B, Tyson L, Venkatraman E, Ben-Porat L, Memoli N, Zakowski M, Rusch V, Heelan RT: Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. Journal of Clinical Oncology 2004;22:1103-1109.

Millikan RC, Hummer AJ, Wolff MS, Hishida A, Begg CB.  HER2 codon 655 polymorphism and breast cancer: results from kin-cohort and case-control analyses.  Breast Cancer Research and Treatment (in press).

Mitra N, Indhurkya A.  A propensity-score approach to estimating the cost-effectiveness of medical therapies from observational data  Health Economics (in press).

Mitra N, Ye TZ, Smith A, Chuai S, Kirchhoff T, Peterlongo P, Nafa K, Phillips MS, Offit K, Ellis NA: Localization of cancer susceptibility genes by genome-wide single-nucleotide polymorphism linkage-disequilibrium mapping. Cancer Research 2004;64:8116-8125.

Modak S, Koehne G, Vickers A, O’Reilly RJ, Cheung NK. Rituximab therapy of lymphoma is enhanced by orally administered (1→3), (1→4)-D-β-glucan. Leukemia Research (in press).

Modi S, DiGiovanna MP, Lu Z, Moskowitz C, Panageas KS, VanPoznak C, Hudis CA, Norton L,  Tan  L, Stern DF, Carter D, Seidman AD. Phosphorylated/activated HER2 as a marker of clinical resistance to single agent taxane chemotherapy for metastatic breast cancer. Cancer Investigation (in press).

Monge P, Wesseling C, Engel LS, Keifer M, Zuurbier M, Rojas M, Partanen T: An icon-based interview for the assessment of occupational pesticide exposure in a case-control study of childhood leukemia. International Journal of Occupational Environmental Health 2004;10:72-78.

Moore DH, Blessing JA, McQuellon RP, Thaler HT, Cella D, Benda J, Miller DS, Olt G, King S, Boggess JF, Rocereto TF.  Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. Journal of Clinical Oncology 2004;22:3113-3119.193.

Moore HG, Shia J, Klimstra DS, Ruo L, Mazumdar M, Schwartz GK, Minsky BD, Saltz L, Guillem JG: Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome. Annals of Surgical Oncology 2004;11:955-961.

Moore HG, Shoup M, Riedel E, Minsky BD, Alektiar KM, Ercolani M, Paty PB, Wong WD, Guillem JG: Colorectal cancer pelvic recurrences: determinants of resectability.  Diseases of the Colon and Rectum 2004;47:1599-1606.

Moore KH, Thaler HT, Tan LK, Borgen PI, Cody HJ 3rd: Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biologic metastasis or procedural artifact? Cancer 2004;100:929-934.

Mora J, Alaminos M, de Torres C, Illei P, Qin J, Cheung NK, Gerald WL: Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21-23 in the biology of favourable stage 4 tumours. British Journal of Cancer 2004;91:1112-1118.

Moskowitz CS, Pepe MS: Quantifying and comparing the accuracy of binary biomarkers when predicting a failure time outcome. Statistics in Medicine 2004;23:1555-1570.

Moskowitz CS, Pepe MS.  Quantifying and comparing the predictive accuracy of continuous prognostic factors for binary outcomes.  Biostatistics 2004;5:113-127.

Motzer RJ, Bacik J, Mazumdar M: Prognostic factors for survival of patients with stageIV renal cell carcinoma memorial sloan-kettering cancer center experience. Clinical Cancer Research 2004;10:6302S-6303S.

Motzer RJ, Bacik J, Schwartz LH, Reuter V, Russo P, Marion S, Mazumdar M: Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. Journal of Clinical Oncology 2004; 22: 454-463.

Motzer RJ, Mazumdar M: Predicting survival of patients with metastatic renal cell carcinoma.  Urologe Ausgabe 2004;43 Suppl 3:135-136.

O’Brien MJ, Winawer SJ, Zauber AG, Bushey MT, Sternberg SS, Gottlieb LS, Bond JH, Waye JD, Schapiro M, National Polyp Study Workgroup: Flat adenomas in the National Polyp Study: is there increased risk for high-grade dysplasia initially or during surveillance? Clinical Gastroenterology Hepatology 2004;2:905-911.

Olgac S, Mazumdar M, Dalbagni G, Reuter VE: Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases. American Journal of Surgical Pathology 2004;28:1545-1552.

Oliveria SA, Chau D, Christos PJ, Charles CA, Mushlin AI, Halpern AC: Diagnostic accuracy of patients in performing skin self-examination and the impact of photography.  Archives of Dermatology 2004;140:57-62.

Oliveria SA, Dusza SW, Phelan DL, Ostroff JS, Berwick M, Halpern AC: Patient adherence to skin self-examination. effect of nurse intervention with photographs.  American Journal of Preventative Medicine 2004; 26:152-155.

Oliveria SA, Geller AC, Dusza SW, Marghoob AA, Sachs D, Weinstock MA, Buckminster M, Halpern AC: The Framingham school nevus study: a pilot study.  Archives of Dermatology 2004;140:545-551.

Olshen AB, Venkatraman ES, Lucito R, Wigler M: Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004;5:557-572.

Olshen AB, Cosman PC, Rodrigo AG, Bickel PJ, Olshen RA.  Vector quantization of amino acids: analysis of the HIV V3 loop region.  Journal of Statistical Planning and Inference (in press).

Olson SH, Carlson MD, Ostrer H, Harlap S, Stone A, Winters M, Ambrosone CB: Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer. Gynecologic Oncology 2004;93:615-620.

Osman I, Kang M, Lee A, Polsky D, Chang C, David D, Mitra N, Wu X, Sun T, Bajorin D:  Clinical implications of detection of circulating bladder cancer cells expressing uroplakins and epidermal growth factor receptor. International Journal of Cancer 2004;111:934-939.

Pandit-Taskar N, Schoder H, Gonen M, Larson SM, Yeung HW: Clinical significance of unexplained abnormal focal FDG uptake in the abdomen during whole-body PET.  American Journal of Roentgenology 2004;183:1143-1147.

Pao W, Miller VA, Venkatraman E, Kris MG.  Predicting sensitivity of non-small-cell lung cancer to gefitinib: is there a role for P-Akt? Journal of the National Cancer Institute 2004; 96:1117-1119.

Patel JD, Bach PB, Kris MG: Lung cancer in US women: A contemporary epidemic. Journal of the American Medical Association 2004;291:1763-1768.

Patel MI, Subbaramaiah K, Du B, Chang M, Yang P, Newman RA, Cordon-Cardo C, Thaler HT, Dannenberg AJ.  Celecoxib inhibits prostate cancer growth.  Evidence of a COX-2 independent mechanism.  Clinical Cancer Research (in press).

Peterlongo P, Mitra N, Chuai S, Kirchoff T, Palmer C, Huang H, Nafa K, Offit K, Ellis NA. “Increasing risk of colorectal cancer due to MYH mutations”.  International Journal of Cancer (in press).

Petrovic A, Alpdogan O, Willis LM, Eng JM, Greenberg AS, Kappel BJ, Liu C, Murphy GJ, Heller G, van den Brink MRM. LPAM(alpha(4)beta(7) integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease. Blood 2004;103:1542-1547.

Portlock CS, Donnelly GB, Qin J, Straus D, Yahalom J, Zelenetz A, Noy A, O’Connor O, Horwitz S, Moskowitz C, Filippa DA: Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin’s disease. British Journal of Haematology 2004;125:701-708.

Portlock CS, Qin J, Schaindlin P, Roistacher N, Myers J, Filippa D, Louie D, Zelenetz AD, O’Brien JP, Moskowitz C, Norton L, Yahalom J, Straus DJ, Bertino JR: The NHL-15 protocol for aggressive non-Hodgkin’s lymphomas: a sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide.  Annals of Oncology 2004;15:1495-1503.

Prasad M, Ben-Porat L, Hoppe B, Aghajanian C, Sabbatini P, Chi DS, Hensley ML: Costs of treatment and outcomes associated with second-line therapy and greater for relapsed ovarian cancer. Gynecologic Oncology 2004;93:223-228.

Pucar D, Koutcher JA, Sha A, Dyke JP, Schwartz L, Thaler H, Kurhanewica J, Scardino PT, Kelly WK, Hricak H, Zakian KL.  MRSI in predicting pathologic stage and PSA relapse in high-risk prosate cancer patients treated with aggressive neoadjuvant therapy prior to radical prostatectomy or radiation therapy.  Clinical Prostate Cancer 2004;3:174-181.

Raizer JJ, Koutcher JA, Abrey LA, Panageas KS, DeAngelis LM, Lis E, Xu S, Zakian K.  Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma. Journal of Neuro-Oncology (in press).

Reid ME, Stratton MS, Lillico AJ, Fakih M, Natarajan R, Clark LC, Marshall JR.  Report of high-dose selenium supplementation: repsonse and toxicities.  Journal of Trace Elements in Medicine and Biology 2004;18:69-74.

Rengan R, Rosenzweig KE, Venkatraman E, Koutcher LA, Fox JL, Nayak R, Amols H, Yorke E, Jackson A, Ling CC, Leibel SA.  Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer.  International Journal of Radiation Oncology Biology Physics 2004; 60:741-747.

Rizk NP, Bach PB, Schrag D, Bains MS, Turnbull AD, Karpeh M, Brennan MF, Rusch VW: The impact of complications on outcomes after resections for esophageal and gastroesophageal junction carcinoma. Journal of American College of Surgeons 2004;198:42-50.

Robson ME, Chappuis PO, Satagopan J, Wong N, Boyd J, Goffin JR, Hudis C, Roberge D, Norton L, Begin LR, Offit K, Foulkes WD: A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Research and Treatment 2004;6:R8-R17.

Ryan CJ, Zelefsky MJ, Heller G, Regan K, Leibel SA, Scher HI, Kelly WK. Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer. Urology 2004;64:90-94.

Sabbatini P, Aghajanian C, Leitao M, Venkatraman E, Anderson S, Dupont J, Dizon D, O’Flaherty C, Bloss J, Chi D, Spriggs D.  Intraperitoneal cisplatin with intraperitoneal gemcitabine in patients with epithelial ovarian cancer: results of a phase I/II Trial.  Clinical Cancer Research 2004;10:2962-2967.

Sarkaria IS, Pham D, Ghossein RA, Talbot SG, Hezel M, Dudas ME, Ebright MI, Chuai S, Memoli N, Venkatraman ES, Miller VA, Kris MG, Zakowski MF, Rusch VW, Singh B.  SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma. Annals of Thoracic Surgery 2004;78:1734-1741

Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD: A note on competing risks in survival data analysis. British Journal of Cancer 2004;91:1229-1235.

Satagopan JM, Venkatraman ES, Begg CB: Two-stage designs for gene-disease association studies with sample size constraints. Biometrics 2004;60:589-597.

Satish Kumar M, Mrudula T, Mitra N, Bhanuprakash Reddy G: Enhanced degradation and decreased stability of eye lens alpha-crystallin upon methylglyoxal modification.  Experimental Eye Research 2004;79:577-583.

Scher HI, Eisenberger M, D’Amico AV, Halabi S, Small EJ, Morris M, Kattan MW, Roach M, Kantoff P, Pienta KJ, Carducci MA, Agus D, Slovin SF, Heller G, Kelly WK Lange PH, Petrylak D, Berg W, Higano C, Wilding G, Moul JW, Partin AN, Logothetis C, Soule HR: Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group. Journal of Clinical Oncology 2004;22:537-556. Erratum in: Journal of Clinical Oncology 2004;22:3205.

Schoder H, Yeung HW, Gonen M, Kraus D, Larson SM: Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 2004;231:65-72.

Schoder H. Erdi YE, Chao K, Gonen M, Larson SM, Yeung HW: Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients. Journal of Nuclear Medicine 2004;45:559-566.

Schrag D, Garewal HS, Burstein HJ, Samson DJ, Von Hoff DD and Somerfield MR.  American Society of Clinical Oncology Technology Assessment: Chemotherapy Sensitivity and Resistance Assays.  Journal of Clinical Oncology 2004;22:3631-3638.

Schrag D: The price tag on progress—chemotherapy for colorectal cancer.  New England Journal of Medicine 2004;351:317-319.

Schrag D, Xu F, Mitra N, Rabbani F, Bach PB, Herr H, Begg CB.  Cystectomy for muscle invasive bladder cancer: patterns and outcomes of care in the medicare population.  Urology (in press).

Schrag D, Hsia J, Golub M, Weiser M.  An increasingly common challenge: management of complete responders with metastatic colorectal cancer.  Journal of Clinical Oncology (in press).

Shaffer DR, Viale A, Ishiwata R, Leversha M, Olgac S, Manova K, Satagopan J, Scher H, Koff A. p27 deficiency accelerates prostate tumor progression initiated by SV40 large T antigen by allowing early loss of heterozygosity. Proceedings of the National Academy of Sciences (in press).

Sherman EJ, Rubin DM, Venkatraman E, Schwartz GK, Miller VA, Radzyner MH, Ruchlin HS, Spriggs D, Pfister DG. Using patients as their own controls for cost evaluation of phase I clinical trials.  Journal of Clinical Oncology 2004;22:1308-1314.

Shia J, Guillem JG, Moore HG, Tickoo SK, Qin J, Ruo L, Suriawinata A, Paty PB, Minsky BD, Weiser MR, Temple LK, Wong WD, Klimstra DS: Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. American Journal of Surgical Pathology 2004;28:215-223.

Shuch B, Mikhail M, Satagopan J, Lee P, Yee H, Chang C, Cordon-Cardo C, Taneja SS Osman I: Racial disparity of epidermal growth factor receptor expression in prostate cancer. Journal of Clinical Oncology 2004;22:4673-4677.

Sinha S, Mitra N, Kumar G, Bajaj K, Surolia A:  Unfolding studies on Soybean agglutinin and Concanavalin A tetramers:A Comparative Account. Biophysical Journal 2004 [Epub ahead of print]

Stanziale SF, Petrowsky H, Adusumilli PS, Ben-Porat L, Gonen M, Fong Y: Infection with oncolytic herpes simplex virus-1 induces apoptosis in neighboring human cancer cells: a potential target to increase anticancer activity. Clinical Cancer Research 2004;10:3225-3232.

Straus DJ, Portlock CS, Qin J, Myers J, Zelenetz AD, Moskowitz C, Nov A, Goy A, Yahalom J: Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease. Blood. 2004;104:3483-3489.

Su YB, Vickers A, Zelefsky MJ, Kraus DH, Shaha AR, Shah JP, Lake S, Harrison LB, Bosl GJ, Pfister DG. Double-blind, randomized trial of granulocyte-colony stimulating factor (GCSF) versus (v.) placebo during postoperative radiation (RT) for advanced resectable squamous cell head and neck cancer (SCCHN) Proceedings of the American Society of Clinical Oncology (in press).

Takaro TK, Engel LS, Keifer M, Bigbee WL, Kavanagh TJ, Checkoway H:  Glycophorin A is a potential biomarker for the mutagenic effects of pesticides. International Journal of Occupational Environmental Health 2004;10:256-261.

Tao Y, Klause A, Vickers A, Bae K, Ellis M. Clinical and Biomarker Endpoint Analysis in Neoadjuvant Endocrine Therapy Trials. Journal of Steroid Biochemistry and Molecular Biology (in press).

Temple LK, Hsieh L, Wong WD, Saltz L, Schrag D: Use of surgery among elderly patients with stage IV colorectal cancer. Journal of Clinical Oncology 2004;22:3475-3484.

Temple LKF, Bacik J, Savatta S, Gottesman L, Paty P, Weiser M, Guillem J, Minsky BD, Kalman M, Thaler HT, Schrag D, Wong WD.  The development of a validated instrument to evaluate bowel function after sphincter preserving surgery for rectal cancer. Diseases of the Colon and Rectum (in press).

Venkatraman ES, Mitra N, Begg CB.  A method for evaluating the impact of individual haplotypes on disease incidence in molecular epidemiology studies.  Statistical Applications in Genetics and Molecular Biology 2004;3:1-20.  http://www.bepress.com/sagmb/vol3/iss1/art27

Vickers AJ. Statistical reanalysis of four recent randomized trials of acupuncture for pain using analysis of covariance. Clinical Journal of Pain 2004;20(5):319-23

Vickers AJ, Cassileth BR, Strauss D. Acupuncture for post-chemotherapy fatigue: a Phase II study. Journal of Clinical Oncology 2004;22(9):1731-5

Vickers AJ. Statistical considerations for use of composite health-related quality-of-life scores in randomized trials. Quality of Life Research 2004;13 :717 –723

Vickers AJ, Rees RW, Zollman CE, McCarney R, Smith C, Ellis N, Fisher P, Van Haselen R. Acupuncture for chronic headache in primary care: a large, pragmatic, randomised trial. British Medical Journal 2004;328:744-747.

Vickers A. Alternative cancer cures: “unproven” or “disproven”? CA Cancer J Clin.  2004;54(2):110-8.

Wagner JE, Tolar J, Levran O, Scholl T, Deffenbaugh A, Satagopan J, Ben-Porat L, Mah K, Batish SD, Kutler DI, MacMillan ML, Hanenberg H, Auerbach AD: Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. Blood. 2004;103:3226-3229.

Wang JC, Boland P, Mitra N, Yamada Y, Lis E, Stubblefield M, Bilsky MH. “Single-stage posterolateral transpedicular approach (PTA) for resection of epidural metastatic spine tumors involving the vertebral body with circumferential reconstruction: Results in 140 patients”. Journal of  Neurosurgery Spine 2004;1:287-98.

Weitz J, D’Angelica M, Jarnagin W, Gonen M, Fong Y, Blumgart L, Dematteo R: Selective use of diagnostic laparoscopy prior to planned hepatectomy for patients with hepatocellular carcinoma. Surgery 2004;135:273-281.

Wonderling D, Vickers AJ, Grieve R, McCarney R. Cost-effectiveness analysis of a randomised trial of acupuncture for migraine and chronic tension headache in primary care. British Medical Journal  2004;328:747-9.

Wreesmann VB, Shi W, Thaler HT, Poluri A, Kraus DH, Pfister D, Shaha AR, Shah JP, Rao PH, Singh B: Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. Journal of Clinical Oncology 2004;22:3965-3972.

Yoon SS, Segal NH, Olshen AB, Brennan MF, Singer S: Circulating angiogenic factor levels correlate with extent of disease and risk of recurrence in patients with soft tissue sarcoma. Annals of Oncology 2004;15:1261-1266.

Zauber AG: Quality control for flexible sigmoidoscopy: which polyps count?   Gastroenterology 2004;126:1474-1477.

Zauber P, Sabbath-Solitare M, Marotta S, Zauber A, Bishop T.  Comparative molecular pathology of sporadic hyperplastic polyps and neoplastic lesions from the same individual.  Journal of Clinical Pthology 2004;57:1084-1088.

Zhao B, Schwartz LH, Moskowitz CS, Wang L, Ginsberg MS, Cooper CA, and Kalagian JP.  Impact of CT slice thickness on tumor measurement techniques and results. Radiology (in press).